Citrus Sinensis ID: 015298

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccHHHcccccccccccccEEEccccccEEEEEEEEEccccccccEEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEcccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccHcccHHHccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccc
Coil and Loop (DISEMBL)
masvgvaptscvressghtvgvdklpeemndmkirddkemeatvvdgngteTGHIIVTTiggrngqpkqTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffsttdkDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSigvchrdikpqnllvnphthqvklcdfgsakvlvkgepnisyicsryyrapelifgateyttaIDIWSAGCVVAELmlgkplfpgdsgvDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifpkrmppeAVDLVSRLLqyspnlrctALDALIhpffdelrdpnarlpsgrflpplfnfkshelksvPVEILVKLIpeharkqcpflgl
Flexible Loop (DISEMBL)
masvgvaptscvressghtvgvdklpeemNDMKIRDDKEMeatvvdgngteTGHIIvttiggrngqpKQTISYMAERIVGQGSFGVVFQAKCLETGETvaikkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHfnklnqrmpMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIpeharkqcpflgl
Low Complexity Region (SEG)
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL
Disordered region (IsUnstruct)
***********************************************NGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR********
Disordered Region (DISOPRED)
********************************************************VTTIG****QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFL**
Disordered Region (DISEMBL)
*****************HTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL
Disordered Region (DISPRO)
******************************************TVVD**GTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPF***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	409	2.2.26 [Sep-21-2011]
P43288	405	Shaggy-related protein ki	yes	no	0.990	1.0	0.904	0.0
P43289	409	Shaggy-related protein ki	no	no	1.0	1.0	0.887	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	1.0	0.995	0.907	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	1.0	1.0	0.892	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.997	0.992	0.870	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	1.0	0.997	0.846	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.997	0.992	0.831	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.977	0.847	0.752	0.0
O04160	468	Shaggy-related protein ki	N/A	no	0.926	0.809	0.760	0.0
Q39012	407	Shaggy-related protein ki	no	no	0.904	0.909	0.778	1e-180

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  781 bits (2016), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/409 (90%), Positives = 391/409 (95%), Gaps = 4/409 (0%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+AP    R+S+G    VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPNPGARDSTG----VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 56

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 57  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 116

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 117 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 176

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 177 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 236

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 237 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 296

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  ALD L+HPFFDEL
Sbjct: 297 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDEL 356

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPNARLP+GRFLPPLFNFK HELK VP+E++ KL+PEHARKQCP+LGL
Sbjct: 357 RDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  780 bits (2015), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/409 (88%), Positives = 392/409 (95%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+ P++ VRES+G+    D+LPEEM DMKI+DDKEMEAT+V+GN TETGHIIVTTI
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP++YVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFR+LSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC ALD+L+HPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPNARLP+GRFLPPLFNFK HELK VPVE++ KL+PEHARKQCP+L L
Sbjct: 361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  776 bits (2004), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/411 (90%), Positives = 389/411 (94%), Gaps = 2/411 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDK-LPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVT 58
           MASVGVAPTS  RE  G   +GVD  LPEEM+DMKIRDD+EMEATVVDGNGTETGHIIVT
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVDDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVT 60

Query: 59  TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
           TIGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM
Sbjct: 61  TIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 120

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           RLLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH++KLNQRMPMIYVKLY 
Sbjct: 121 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYT 180

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           YQIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY
Sbjct: 181 YQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 240

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           YRAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+ GVDQLVEIIKVLGTPTREEI
Sbjct: 241 YRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEI 300

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           KCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRLLQYSPNLRC ALD L HPFFD
Sbjct: 301 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFFD 360

Query: 359 ELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           ELRDPNARLP+GRFLPPLFNFK HELK VPVE L+KL+PEHARKQCPFLGL
Sbjct: 361 ELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  775 bits (2002), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/409 (89%), Positives = 389/409 (95%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           M SVG+AP S +RESS H+VGVD+LPEEMNDM+IRDDKE+EA +VDGNGTETGHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGR+GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVV LKHCFFSTT+KDE+YLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIH +IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTAL+A+ H FFDEL
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPN RLP+GR LPPLFNFK+HELK V  E L+KL+PEHARKQCP LGL
Sbjct: 361 RDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  755 bits (1950), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/409 (87%), Positives = 385/409 (94%), Gaps = 1/409 (0%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEA-TVVDGNGTETGHIIVTT 59
           MAS GVAP S   + +  +VGV+KLPEEMNDMKIRDDKEMEA T+VDGNGTETGHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV RV++H+NK+NQRMPMIYVKLY+Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI RAL+YIH SIGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAIDIWSAGCV+ EL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TAL+AL+HPF+D+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDD 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLG 408
           +RDPN RLP+GRFLPPLFNFK +ELK VP E+LVKL+P HARKQC   G
Sbjct: 361 VRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  735 bits (1898), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/410 (84%), Positives = 377/410 (91%), Gaps = 1/410 (0%)

Query: 1   MASVGVAP-TSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           MASVG  P +S   + S  ++  +KLPE +N+MKI+DDKEMEA VVDGNGTETGHIIVTT
Sbjct: 1   MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAERIVGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV+RV KH+++ NQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI RAL+YIH  +GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTT IDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLR TA++A++HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           LRDPN RLP+GR LPPLFNFK  ELK   +E+L KLIP+HARKQC FL L
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  729 bits (1882), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/409 (83%), Positives = 377/409 (92%), Gaps = 1/409 (0%)

Query: 1   MASVGVAPTSCVRE-SSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           MA+ GVAP S + + ++   + VDKLP+E+  M+I+DDKEMEA VVDGN TE GH+IVTT
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKDDKEMEAHVVDGNSTEAGHVIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAER VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV+LKHCFFSTT+KDELYLNLVLE+VPETVHRV++H++K+NQRMP+IYVKLY+Y
Sbjct: 121 LLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLYSY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI R+L+YIH  +GV HRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYT+AIDIWSAGCV+ EL+LG+PLFPG SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TAL+AL+HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFFDE 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLG 408
           LRDPN RLP+GR LPPLFNFK++ELK VP E+LVKL+P HARKQC    
Sbjct: 361 LRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  650 bits (1678), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/408 (75%), Positives = 349/408 (85%), Gaps = 8/408 (1%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETG 53
           ++   VA TS V   S   V  D+LP+ M +MKIRD       DK+ME TVV+G+GTETG
Sbjct: 60  LSQESVAGTSNVPAVSEKPVD-DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
            +I TT+GGR+G+PKQTISYMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
           ELQ MRL DHPNVV L+H FFSTTDKDELYLNLVLEYVPETV+R  KH+ K+NQ MP+I+
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           V+LY YQI RAL+Y+HR +GVCHRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           ICSRYYRAPELIFGATEYT AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
           TREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTAL+A  
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418

Query: 354 HPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
           HPFFD+LRDPN  LP+GR LPPLFNF + EL     E+  +LIP H +
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  639 bits (1647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 296/389 (76%), Positives = 338/389 (86%), Gaps = 10/389 (2%)

Query: 23  DKLPEEMNDMKIRDD----------KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS 72
           D+LPE MNDM++R+D          K+ME  +V+G GTETG +I TT+GGR+G+PKQTIS
Sbjct: 74  DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQTIS 133

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           YMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H 
Sbjct: 134 YMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHS 193

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           FFSTTDKDELYLNLVLE+VPETV+R +KH+ K+NQ MP+I V+LY YQI RAL+Y+HR +
Sbjct: 194 FFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLHRVV 253

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           GVCHRDIKPQNLLVN HTHQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 254 GVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 313

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
            AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQ
Sbjct: 314 NAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQ 373

Query: 313 IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRF 372
           IKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTAL+A  HPFFD+LR PN  LP+GR 
Sbjct: 374 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRAPNVSLPNGRA 433

Query: 373 LPPLFNFKSHELKSVPVEILVKLIPEHAR 401
           LPPLFNF + EL     E+  +LIP H +
Sbjct: 434 LPPLFNFTAQELAGASTELRQRLIPAHCQ 462

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  630 bits (1624), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 289/371 (77%), Positives = 334/371 (90%), Gaps = 1/371 (0%)

Query: 33  KIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKC 92
           ++  DKEM A V++GN   TGHII TTIGG+NG+PKQTISYMAER+VG GSFG+VFQAKC
Sbjct: 30  ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query: 93  LETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP 152
           LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct: 90  LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query: 153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ 212
           ET++RV++H+   NQRMP+ YVKLY YQIFR L+YIH   GVCHRD+KPQNLLV+P THQ
Sbjct: 150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query: 213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWSAGCV+AEL+LG+P
Sbjct: 210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query: 273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD 332
           LFPG++ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct: 270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query: 333 LVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEIL 392
           L SRLLQYSP+LRCTAL+A  HPFF+ELR+PNARLP+GR LPPLFNFK  EL    +E++
Sbjct: 330 LASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELI 388

Query: 393 VKLIPEHARKQ 403
            +LIPEH R+Q
Sbjct: 389 NRLIPEHVRRQ 399

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	409
225450484	409	PREDICTED: shaggy-related protein kinase	1.0	1.0	0.931	0.0
82623409	409	NtK-1-like [Solanum tuberosum]	1.0	1.0	0.919	0.0
224124570	409	predicted protein [Populus trichocarpa]	1.0	1.0	0.921	0.0
233142272	410	glycogen synthase kinase [Glycine max]	1.0	0.997	0.921	0.0
363807566	410	glycogen synthase kinase-3 [Glycine max]	1.0	0.997	0.919	0.0
383280813	410	glycogen synthase kinase-3 [Glycine soja	1.0	0.997	0.919	0.0
356575303	426	PREDICTED: glycogen synthase kinase-3 ho	0.997	0.957	0.914	0.0
81075765	409	Ser/Thr protein kinase-like [Solanum tub	1.0	1.0	0.911	0.0
297812879	409	hypothetical protein ARALYDRAFT_489503 [	1.0	1.0	0.909	0.0
449435574	409	PREDICTED: shaggy-related protein kinase	1.0	1.0	0.916	0.0

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  803 bits (2074), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/409 (93%), Positives = 396/409 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RE SGH  GVD+LPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPTSGLREPSGHNAGVDRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AELMLG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+DAL H FFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAMDALTHSFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RD + RLP+GRFLPPLFNFK HELK VPVEILVKLIPEHARKQCPFLGL
Sbjct: 361 RDSSTRLPNGRFLPPLFNFKPHELKGVPVEILVKLIPEHARKQCPFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|82623409|gb|ABB87119.1| NtK-1-like [Solanum tuberosum]

 Score =  800 bits (2066), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/409 (91%), Positives = 397/409 (97%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RESSGH  GVD+LPEEMNDM+IRDDKEMEAT+VDGNGTETGHIIVTTI
Sbjct: 1   MASVGLAPTSGLRESSGHNAGVDRLPEEMNDMRIRDDKEMEATIVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC ALDAL+HPFFDEL
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCGALDALVHPFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPN RLP+GRFLPPLFNFK+HELK+V  EIL+KL+PEHARKQCP LGL
Sbjct: 361 RDPNTRLPNGRFLPPLFNFKAHELKNVHAEILLKLVPEHARKQCPSLGL 409

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124570|ref|XP_002330056.1| predicted protein [Populus trichocarpa] gi|222871481|gb|EEF08612.1| predicted protein [Populus trichocarpa]

 Score =  798 bits (2062), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/409 (92%), Positives = 394/409 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           M SVGVAP+S +RE+S H  GVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MGSVGVAPSSGLREASAHNAGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH++KLNQ+MP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQKMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTALDAL HPFFDEL
Sbjct: 301 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALDALTHPFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RD N RLP+GRFLPPLFNFKSHELK V VE LVKLIPEHARKQCPFLGL
Sbjct: 361 RDQNTRLPNGRFLPPLFNFKSHELKGVSVETLVKLIPEHARKQCPFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|233142272|gb|ACQ91102.1| glycogen synthase kinase [Glycine max]

 Score =  797 bits (2059), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/410 (92%), Positives = 396/410 (96%), Gaps = 1/410 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           M SVGVAPTS +RE+SGH   GVD+LPEEMNDMKIRDD+EMEATVVDGNGTETGHIIVTT
Sbjct: 1   MTSVGVAPTSGLREASGHGAAGVDRLPEEMNDMKIRDDREMEATVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV LKHCFFSTT+KDELYLNLVLEYVPETV+RV+KH+NKLNQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVCLKHCFFSTTEKDELYLNLVLEYVPETVNRVIKHYNKLNQRMPLIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTALDAL HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALDALTHPFFDE 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           LRDPN+RLP+GRFLPPLFNFKSHELK VP EILVKL+PEHARKQCPFLGL
Sbjct: 361 LRDPNSRLPNGRFLPPLFNFKSHELKGVPAEILVKLVPEHARKQCPFLGL 410

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807566|ref|NP_001242661.1| glycogen synthase kinase-3 [Glycine max] gi|255635748|gb|ACU18223.1| unknown [Glycine max]

 Score =  796 bits (2057), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/410 (91%), Positives = 396/410 (96%), Gaps = 1/410 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           M SVGVAPTS +RE+SGH   GVD+LPEEMNDMKIRDD+EMEATVVDGNGTETGHIIVTT
Sbjct: 1   MTSVGVAPTSGLREASGHGAAGVDRLPEEMNDMKIRDDREMEATVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGGRNGQPKQTISYMAER+VG GSFGVVFQAKC ETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCSETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV+LKHCFFSTT+KDELYLNLVLEYVPETV+RV+KH+NKLNQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVNRVIKHYNKLNQRMPLIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTALDAL HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALDALTHPFFDE 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           LRDPN+RLP+GRFLPPLFNFKSHELK VP EILVKL+PEHARKQCPFLGL
Sbjct: 361 LRDPNSRLPNGRFLPPLFNFKSHELKGVPAEILVKLVPEHARKQCPFLGL 410

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|383280813|gb|AFH00876.1| glycogen synthase kinase-3 [Glycine soja]

 Score =  795 bits (2052), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/410 (91%), Positives = 396/410 (96%), Gaps = 1/410 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           M SVGVAPTS +RE+SGH   GVD+LPEEMNDMKIRDD+EMEATVVDGNGTETGHIIVTT
Sbjct: 1   MTSVGVAPTSGLREASGHGAAGVDRLPEEMNDMKIRDDREMEATVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV+LKHCFFSTT+KDELYLNLVLEYVPETV+RV+KH+NKLNQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVNRVIKHYNKLNQRMPLIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QIFRALSYIHR IGV HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QIFRALSYIHRCIGVYHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTALDAL HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALDALTHPFFDE 360

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           LRDPN+RLP+GRFLPPLFNFKSHELK VP EILVKL+PEHARKQCPFLGL
Sbjct: 361 LRDPNSRLPNGRFLPPLFNFKSHELKGVPAEILVKLVPEHARKQCPFLGL 410

Source: Glycine soja

Species: Glycine soja

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575303|ref|XP_003555781.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-1-like [Glycine max]

 Score =  792 bits (2046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/409 (91%), Positives = 392/409 (95%), Gaps = 1/409 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           M SVGVAPTS +RE+SGH     D+LPEEMNDMKIRDD+EMEATVVDGNGTETGHIIVTT
Sbjct: 17  MTSVGVAPTSGLREASGHGAAAADRLPEEMNDMKIRDDREMEATVVDGNGTETGHIIVTT 76

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 77  IGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 136

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV+LKHCFFSTT+KDELYLNLVLEYVPETV+RV+KH+NKLNQRMP+IYVKLY Y
Sbjct: 137 LLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVNRVIKHYNKLNQRMPLIYVKLYTY 196

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 197 QIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 256

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYT+AIDIWS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 257 RAPELIFGATEYTSAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 316

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA DAL HPFFDE
Sbjct: 317 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAFDALTHPFFDE 376

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLG 408
           LRDPN RLP+GRFLPPLFNFKSHELK VP EILVKL+PEHARKQCPFLG
Sbjct: 377 LRDPNTRLPNGRFLPPLFNFKSHELKGVPSEILVKLVPEHARKQCPFLG 425

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|81075765|gb|ABB55385.1| Ser/Thr protein kinase-like [Solanum tuberosum]

 Score =  792 bits (2045), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/409 (91%), Positives = 394/409 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RESSGH  GVD+LPEEMNDM+IRDDKEMEA +V G GTETGHIIVTTI
Sbjct: 1   MASVGLAPTSGLRESSGHNAGVDRLPEEMNDMRIRDDKEMEAAMVAGIGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC ALDAL+HPFFDEL
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCGALDALVHPFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPN RLP+GRFLPPLFNFK+HELK+V  EIL+KL+PEHARKQCP LGL
Sbjct: 361 RDPNTRLPNGRFLPPLFNFKAHELKNVHAEILLKLVPEHARKQCPSLGL 409

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297812879|ref|XP_002874323.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata] gi|297320160|gb|EFH50582.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/409 (90%), Positives = 393/409 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+AP    R+S+ H +GVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPNPGARDSTTHAIGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  ALD L+HPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPNARLP+GRFLPPLFNFK HELK VPVE++ KL+PEHARKQCP+LGL
Sbjct: 361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLGL 409

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449435574|ref|XP_004135570.1| PREDICTED: shaggy-related protein kinase alpha-like [Cucumis sativus]

 Score =  791 bits (2042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/409 (91%), Positives = 393/409 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MAS+GV  TS +RE +GH VGVD+LPEEMNDMKIRDDKE+EATVVDGNGTETGHIIVTTI
Sbjct: 1   MASMGVVSTSNLREPAGHNVGVDRLPEEMNDMKIRDDKEVEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNG  KQTISYMAER VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGYSKQTISYMAERAVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVV+LKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYMYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC+ALDAL H FFDEL
Sbjct: 301 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCSALDALTHQFFDEL 360

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
           RDPN RLP+GRFLPPLFNFK+HELK VPVEILVKLIPEHARKQCPFLGL
Sbjct: 361 RDPNTRLPNGRFLPPLFNFKAHELKGVPVEILVKLIPEHARKQCPFLGL 409

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	409
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.990	1.0	0.904	2e-205
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	1.0	1.0	0.887	6.9e-205
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	1.0	0.997	0.846	5.9e-192
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.977	0.847	0.752	4.1e-168
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.975	0.968	0.735	1.6e-164
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.904	0.909	0.778	5.5e-164
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.990	0.961	0.708	3.9e-163
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.904	0.973	0.778	1.3e-162
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.963	0.899	0.692	2.5e-152
UNIPROTKB|Q91757	420	gsk3b "Glycogen synthase kinas	0.892	0.869	0.638	2.2e-128

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1987 (704.5 bits), Expect = 2.0e-205, P = 2.0e-205
 Identities = 370/409 (90%), Positives = 391/409 (95%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
             MASVG+AP    R+S+G    VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct:     1 MASVGIAPNPGARDSTG----VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 56

Query:    61 GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
             GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct:    57 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 116

Query:   121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
             LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct:   117 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 176

Query:   181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
             IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   177 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 236

Query:   241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct:   237 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 296

Query:   301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  ALD L+HPFFDEL
Sbjct:   297 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDEL 356

Query:   361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
             RDPNARLP+GRFLPPLFNFK HELK VP+E++ KL+PEHARKQCP+LGL
Sbjct:   357 RDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1982 (702.8 bits), Expect = 6.9e-205, P = 6.9e-205
 Identities = 363/409 (88%), Positives = 392/409 (95%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
             MASVG+ P++ VRES+G+    D+LPEEM DMKI+DDKEMEAT+V+GN TETGHIIVTTI
Sbjct:     1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query:    61 GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
             GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct:    61 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query:   121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
             LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP++YVKLY YQ
Sbjct:   121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query:   181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
             IFR+LSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query:   241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct:   241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query:   301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC ALD+L+HPFFDEL
Sbjct:   301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDEL 360

Query:   361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
             RDPNARLP+GRFLPPLFNFK HELK VPVE++ KL+PEHARKQCP+L L
Sbjct:   361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1860 (659.8 bits), Expect = 5.9e-192, P = 5.9e-192
 Identities = 347/410 (84%), Positives = 377/410 (91%)

Query:     1 MASVGVAPTSCVR-ESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
             MASVG  P S +  + S  ++  +KLPE +N+MKI+DDKEMEA VVDGNGTETGHIIVTT
Sbjct:     1 MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query:    60 IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
             IGG+NGQPKQTISYMAERIVGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct:    61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query:   120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV+RV KH+++ NQRMP+IYVKLY Y
Sbjct:   121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query:   180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
             QI RAL+YIH  +GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct:   181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query:   240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
             RAPELIFGATEYTT IDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct:   241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query:   300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
             CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLR TA++A++HPFFDE
Sbjct:   301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query:   360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
             LRDPN RLP+GR LPPLFNFK  ELK   +E+L KLIP+HARKQC FL L
Sbjct:   361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1635 (580.6 bits), Expect = 4.1e-168, P = 4.1e-168
 Identities = 307/408 (75%), Positives = 349/408 (85%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETG 53
             ++   VA TS V   S   V  D+LP+ M +MKIRD       DK+ME TVV+G+GTETG
Sbjct:    60 LSQESVAGTSNVPAVSEKPVD-DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query:    54 HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
              +I TT+GGR+G+PKQTISYMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNR
Sbjct:   119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query:   114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             ELQ MRL DHPNVV L+H FFSTTDKDELYLNLVLEYVPETV+R  KH+ K+NQ MP+I+
Sbjct:   179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query:   174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             V+LY YQI RAL+Y+HR +GVCHRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISY
Sbjct:   239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298

Query:   234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
             ICSRYYRAPELIFGATEYT AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTP
Sbjct:   299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358

Query:   294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
             TREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTAL+A  
Sbjct:   359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418

Query:   354 HPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
             HPFFD+LRDPN  LP+GR LPPLFNF + EL     E+  +LIP H +
Sbjct:   419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1601 (568.6 bits), Expect = 1.6e-164, P = 1.6e-164
 Identities = 298/405 (73%), Positives = 345/405 (85%)

Query:     1 MASVGVAPTS--CVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVT 58
             M S+ + P     +     H  G D L    +   I +DKEM A V++GN   TGHII T
Sbjct:     1 MTSIPLGPPQPPSLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIIST 57

Query:    59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
             TIGG+NG+PKQTISYMAER+VG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ M
Sbjct:    58 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLM 117

Query:   119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             RL+DHPNVVSLKHCFFSTT +DEL+LNLV+EYVPET++RV+KH+   NQRMP+ YVKLY 
Sbjct:   118 RLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYT 177

Query:   179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             YQIFR L+YIH + GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRY
Sbjct:   178 YQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRY 237

Query:   239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             YRAPELIFGATEYT++IDIWSAGCV+AEL+LG+PLFPG++ VDQLVEIIKVLGTPTREEI
Sbjct:   238 YRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEI 297

Query:   299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
             +CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LRCTAL+A  HPFF+
Sbjct:   298 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFN 357

Query:   359 ELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ 403
             ELR+PNARLP+GR LPPLFNFK  EL     E++ +LIPEH R+Q
Sbjct:   358 ELREPNARLPNGRPLPPLFNFKQ-ELSGASPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1596 (566.9 bits), Expect = 5.5e-164, P = 5.5e-164
 Identities = 289/371 (77%), Positives = 334/371 (90%)

Query:    33 KIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKC 92
             ++  DKEM A V++GN   TGHII TTIGG+NG+PKQTISYMAER+VG GSFG+VFQAKC
Sbjct:    30 ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query:    93 LETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP 152
             LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct:    90 LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query:   153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ 212
             ET++RV++H+   NQRMP+ YVKLY YQIFR L+YIH   GVCHRD+KPQNLLV+P THQ
Sbjct:   150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query:   213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
             VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWSAGCV+AEL+LG+P
Sbjct:   210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query:   273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD 332
             LFPG++ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct:   270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query:   333 LVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEIL 392
             L SRLLQYSP+LRCTAL+A  HPFF+ELR+PNARLP+GR LPPLFNFK  EL    +E++
Sbjct:   330 LASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGASMELI 388

Query:   393 VKLIPEHARKQ 403
              +LIPEH R+Q
Sbjct:   389 NRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1588 (564.1 bits), Expect = 3.9e-163, P = 3.9e-163
 Identities = 291/411 (70%), Positives = 343/411 (83%)

Query:     5 GVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVT 58
             GV  +   +     +  VD L  ++ + +IRD      +++ E  ++DG G E GH+I T
Sbjct:     9 GVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRT 68

Query:    59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
             T+ GRNGQ +QT+SY++E +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M
Sbjct:    69 TLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIM 128

Query:   119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++LDHPN V+LKH FFS TD +E+YLNLVLE+VPETV+RV + +++ NQ MP+IYVKLY 
Sbjct:   129 QMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYT 188

Query:   179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             YQI RAL+YIH S G+CHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPN+SYICSRY
Sbjct:   189 YQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRY 248

Query:   239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             YRAPELIFGA+EYTTAIDIWS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEI
Sbjct:   249 YRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 308

Query:   299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
             KCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDL+ R  QYSPNLRCTAL+A IHP FD
Sbjct:   309 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFD 368

Query:   359 ELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFLGL 409
             ELRDPN RLP+GR LPPLFNFK  EL  +P EI+ +L+PEHARKQ  F+ L
Sbjct:   369 ELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1583 (562.3 bits), Expect = 1.3e-162, P = 1.3e-162
 Identities = 291/374 (77%), Positives = 334/374 (89%)

Query:    36 DDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLET 95
             DDKEM A VVDG+   TGHII TTIGG+NG+PKQTISYMAER+VG GSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:    96 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETV 155
             GETVAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
             +RV+KH++  NQRMP++YVKLY YQIFR L+YIH   GVCHRD+KPQNLLV+P THQVK+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
             CDFGSAK LVKGE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCV+AEL+LG+PLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS 335
             G++ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  S
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   336 RLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKL 395
             RLLQYSP+LRCTAL+A  HPFFDELR+PNARLP+GR  PPLFNFK     S P E++ KL
Sbjct:   303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSP-ELVNKL 361

Query:   396 IPEHARKQCPFLGL 409
             IP+H ++Q   LGL
Sbjct:   362 IPDHIKRQ---LGL 372

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1486 (528.2 bits), Expect = 2.5e-152, P = 2.5e-152
 Identities = 273/394 (69%), Positives = 326/394 (82%)

Query:     9 TSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPK 68
             TS  ++S   +   D LP+E+ ++ + DDK+M+  ++ GNGTE+G II T   G N Q  
Sbjct:    45 TSYEKDSVSSSENSDHLPKEIREVGLGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKD 104

Query:    69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 128
             +TISY AE ++G GSFGVVFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV 
Sbjct:   105 KTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVE 164

Query:   129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             LKH FFSTT+KDELYLNLVLEYVPET++R  + + K+NQ MP+IY++LY YQI RA++Y+
Sbjct:   165 LKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYL 224

Query:   189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
             H+ +GVCHRDIKPQNLLVN  TH+VK+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGA
Sbjct:   225 HQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGA 284

Query:   249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             TEYT+AID+WS GCV+AEL LG PLFPG++ VDQLVEIIK+LGTP REEIK MNP Y +F
Sbjct:   285 TEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDF 344

Query:   309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
             KFPQIKA PWHKIF +++ PEA+DL SRLLQYSPNLRCTAL+A  HPFFD+LRDP A LP
Sbjct:   345 KFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLP 404

Query:   369 SGRFLPPLFNFKSHELKSVPVEILVKLIPEHARK 402
             +GR LPPLF+F + EL    VE+  +LIPEHARK
Sbjct:   405 NGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)]

 Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
 Identities = 242/379 (63%), Positives = 297/379 (78%)

Query:    26 PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
             P     MK+  DK       DG+   T   +V T  G+    +Q ++Y   +++G GSFG
Sbjct:    20 PSSFGSMKVSRDK-------DGSKVTT---VVAT-PGQGPDRQQEVTYTDTKVIGNGSFG 68

Query:    86 VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
             VV+QAK  +TGE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct:    69 VVYQAKLCDTGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128

Query:   145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
             NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct:   129 NLVLDYVPETVYRVARHYSRAKQALPIIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187

Query:   205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
             L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct:   188 LLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247

Query:   265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
             AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct:   248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRA 307

Query:   325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
             R PPEA+ L SRLL+Y+P  R T LDA  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct:   308 RTPPEAIALCSRLLEYTPTSRLTPLDACAHSFFDELRDPNLKLPNGREFPALFNFTTQEL 367

Query:   385 KSVPVEILVKLIPEHARKQ 403
              S P  +   LIP HAR Q
Sbjct:   368 SSNP-SLSSILIPAHARNQ 385

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IDA

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8875	1.0	1.0	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9046	0.9902	1.0	yes	no
Q96287	KSG8_ARATH	2, ., 7, ., 1, 1, ., 1	0.7524	0.9779	0.8474	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5926	0.8435	0.8914	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7789	0.9046	0.9090	no	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7864	0.9022	0.8956	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7739	0.9095	0.9789	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7080	0.9902	0.9619	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5652	0.7188	0.7945	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6625	0.7848	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7104	0.9902	0.9642	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8924	1.0	1.0	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6368	0.8948	0.8714	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6137	0.8092	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9075	1.0	0.9951	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8312	0.9975	0.9927	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8704	0.9975	0.9927	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7609	0.9266	0.8098	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6368	0.8948	0.8714	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8463	1.0	0.9975	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6315	0.8948	0.8714	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6342	0.8948	0.8714	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6368	0.8948	0.8714	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.993
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	409
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-137
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-94
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-91
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-85
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-85
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-81
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-80
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-80
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-78
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-77
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-77
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-73
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-71
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-70
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-70
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-68
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-68
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-67
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-63
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-62
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-62
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-62
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-62
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-62
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-61
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-60
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-60
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-60
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-59
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-58
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-57
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-57
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-56
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-56
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-55
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-54
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-54
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-52
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-51
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-50
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-50
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-49
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-49
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-47
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-47
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-47
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-46
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-43
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-41
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-40
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-40
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-39
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-39
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-38
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-37
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-33
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-31
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-31
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-30
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-29
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-28
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-28
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-25
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-23
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-21
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-19
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-16
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.001
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  398 bits (1023), Expect = e-137
 Identities = 172/331 (51%), Positives = 242/331 (73%), Gaps = 5/331 (1%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           SY    I+G GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 132 CFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            +++     ++  ++LN+V+E++P+TVH+ +KH+ + N  +P+  VKLY+YQ+ RAL+YI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    +CHRD+KPQNLL++P+TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T YTT ID+WS GC++AE++LG P+F G S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
           KFP +K     K+FPK  P +A++ +S+ L+Y P  R   ++AL  PFFD+LRDP  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 369 SG-RFLPPLFNFKSHELKSVPVEILVKLIPE 398
                LP LFNF   E+K +      K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  286 bits (734), Expect = 1e-94
 Identities = 125/339 (36%), Positives = 187/339 (55%), Gaps = 28/339 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 127 VSLKHCF--FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L       S  D +++Y+  V E +   +H+V+K      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYR 240
           L Y+H S  V HRD+KP N+LVN     +K+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+  ++ YT AIDIWS GC+ AEL+  KPLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 301 M-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + +     +    P+    P  K+FP    PEA+DL+ ++L + P  R TA +AL HP+ 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 358 DELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            +L DP    P      P F+F   +   +  E L +LI
Sbjct: 293 AQLHDPE-DEPVA---KPPFDFDFFDDDELTEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  276 bits (708), Expect = 3e-91
 Identities = 115/296 (38%), Positives = 174/296 (58%), Gaps = 35/296 (11%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSL 129
            +G+G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                +   + +LYL  V EY    +    K+ +K    +    +K   YQ+ R L+Y H
Sbjct: 64  LDVIHT---ERKLYL--VFEYCDMDLK---KYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
            S  + HRD+KPQN+L+N     +KL DFG A+    G P  +Y   + + +YRAPE++ 
Sbjct: 116 -SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G+  Y+TA+DIWS GC+ AE++ GKPLFPGDS +DQL +I ++LGTPT E      P  T
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVT 227

Query: 307 EFK-----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +       FP+       K+ P R+ PE +DL+S++LQY+P  R +A +AL HP+F
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  261 bits (669), Expect = 2e-85
 Identities = 112/294 (38%), Positives = 170/294 (57%), Gaps = 20/294 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 126
           Y     +G+G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L   F     K +LYL  V E++   +++++K   +    +P   +K Y YQ+ + L+
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H   G+ HRD+KP+NLL+N     +KL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN- 304
            G   Y+T +DIWS GC+ AEL+  +PLFPG S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 305 -YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              +F FP+    P  K+FP    P+A+DL+S++L Y P+ R TA  AL HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  260 bits (666), Expect = 6e-85
 Identities = 108/290 (37%), Positives = 172/290 (59%), Gaps = 23/290 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G+ G+VF+AK  ETGETVA+KKV   +          RE++ ++   HP VV L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F   +        LV+EY+P  +  V++      + +P   VK Y   + + ++Y+H + 
Sbjct: 68  FPHGSG-----FVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMH-AN 118

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGATE 250
           G+ HRD+KP NLL++     +K+ DFG A++  + EP +    + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 307
           Y   +D+W+ GC+ AEL+ G PLFPG++ ++QL  + + LGTP  E    +  + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             FP+ K  P  +IFP    PEA+DL+  LL Y P+ R +A +AL HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  250 bits (640), Expect = 2e-81
 Identities = 107/291 (36%), Positives = 154/291 (52%), Gaps = 43/291 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 127
           Y     +G+GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L   F    D+D+LYL  V+EY     +  ++K       R+     + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           Y+H S G+ HRD+KP+N+L++   H VKL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLH-SKGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y  A+DIWS G ++ EL+ GKP FPGD   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------ 213

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                     P        + PEA DL+ +LL   P  R TA +AL HPFF
Sbjct: 214 ----------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  248 bits (636), Expect = 3e-80
 Identities = 113/299 (37%), Positives = 165/299 (55%), Gaps = 29/299 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 123
           Y   + +G+G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN++ L   F          +NLV E++   + +V+K  +K +  +    +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIK--DK-SIVLTPADIKSYMLMTLR 113

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SRYYR 240
            L Y+H +  + HRD+KP NLL+      +KL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+FGA  Y   +D+WS GC+ AEL+L  P  PGDS +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 301 MN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +   P+Y EFK       P  +IFP     +A+DL+ RLL  +PN R TA  AL HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIFPAA-SDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  249 bits (638), Expect = 5e-80
 Identities = 115/309 (37%), Positives = 180/309 (58%), Gaps = 31/309 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRE---LQTMRLLDH 123
           Y   + +G+G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L +   +  DKD +YL  V EY+   +H V++    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------YICSR 237
           AL YIH S  V HRD+KP N+L+N     VKL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE++ G+T YT  +D+WS GC++ E++LGKPLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 298 IKCMNPNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
           I+ +   +        P     P  ++ PK    +A+DL+ +LL ++PN R TA +AL H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 355 PFFDELRDP 363
           P+  +  +P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  242 bits (620), Expect = 3e-78
 Identities = 96/289 (33%), Positives = 143/289 (49%), Gaps = 39/289 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F    DKD LYL  V+EY           +      +     K  A QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 248
            S G+ HRD+KP+N+L++     VK+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 -SNGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y   +D+WS G ++ EL+ GKP F G++ +DQL  I ++LG P               
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                    + +        EA DL+ + L   P+ R TA + L HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  241 bits (617), Expect = 1e-77
 Identities = 112/291 (38%), Positives = 175/291 (60%), Gaps = 26/291 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLK 130
           +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    + DELY   V EY+   +++++K      +      ++   YQI + L++IH+
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHK 117

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
             G  HRD+KP+NLLV+     VK+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 -HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMNPNYT 306
           Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            F+FPQ      H++ P    PEA+DL+  +L++ P  R TA  AL HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  241 bits (616), Expect = 2e-77
 Identities = 110/290 (37%), Positives = 165/290 (56%), Gaps = 21/290 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A++Y H   
Sbjct: 69  FRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGATE 250
            + HRDIKP+N+LV+     +KLCDFG A+ L      P   Y+ +R+YRAPEL+ G T 
Sbjct: 120 NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG--TPTREEIKCMNPNYTEF 308
           Y   +D+W+ GC++AEL+ G+PLFPGDS +DQL  I K LG   P+ +E+   NP +   
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238

Query: 309 KFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP+        + +P ++   A+D +   L+  P  R T  + L HP+F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  229 bits (586), Expect = 6e-73
 Identities = 98/296 (33%), Positives = 159/296 (53%), Gaps = 24/296 (8%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 126
           E+I  +G+G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V LK    S   K  +Y+  V EY+   +  ++        +     +K Y  Q+   L 
Sbjct: 61  VRLKEIVTSK-GKGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQ 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPEL 244
           Y+H + G+ HRDIK  N+L+N     +KL DFG A+   K       + + + +YR PEL
Sbjct: 115 YLHSN-GILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCM 301
           + GAT Y   +D+WS GC++AEL LGKP+F G + ++QL +I ++ G+PT E    +  +
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            P +   K  +       + F   + P A+DL+ +LL   P  R +A  AL H +F
Sbjct: 233 -PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  225 bits (576), Expect = 7e-71
 Identities = 109/307 (35%), Positives = 166/307 (54%), Gaps = 24/307 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPN 125
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +++++         D   + +V++ +   +H ++      +Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYR 240
            YIH S  V HRD+KP NLLVN     +++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIH-SANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+    EYTTAID+WS GC+ AE++  + LFPG + V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 301 MNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           +       Y +   P+ +  PW KIFPK   PEA+DL+S++LQ+ P  R T   AL HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 357 FDELRDP 363
             +  DP
Sbjct: 297 LAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 2e-70
 Identities = 104/307 (33%), Positives = 178/307 (57%), Gaps = 26/307 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 127
           Y     +G+G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 128 SLKHCFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +       +    +++Y+  V E +   +++++K      Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRA 241
            YIH S  V HRD+KP NLL+N     +K+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIH-SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++  +  YT AIDIWS GC++AE++  +PLFPG   + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 302 -NP---NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            +    NY +   P     PW+K+FP    P+A+DL+ ++L ++P+ R T  +AL HP+ 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 358 DELRDPN 364
           ++  DP+
Sbjct: 296 EQYHDPS 302

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  224 bits (572), Expect = 3e-70
 Identities = 115/326 (35%), Positives = 184/326 (56%), Gaps = 25/326 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y+  + +G+G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 127 VSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +++K        ++   ++Y+  V E +   +H++++     +Q +   + + + YQ+ R
Sbjct: 67  IAIKDIM-PPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLR 119

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 242
            L YIH S  V HRD+KP NLL+N +   +K+CDFG A+    KG+    Y+ +R+YRAP
Sbjct: 120 GLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           EL+   +EYTTAID+WS GC+ AEL+  KPLFPG   V QL  I ++LG+P+ E++  + 
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           N     +    P      + ++FP    P A+DL+ ++L + P+ R T  +AL HP+   
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPH-ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELK 385
           L DP+         P  F+F+   L 
Sbjct: 297 LHDPSDEPVCQT--PFSFDFEEDALT 320

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  216 bits (551), Expect = 9e-68
 Identities = 104/292 (35%), Positives = 167/292 (57%), Gaps = 28/292 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRS 191
             S     +LYL  V E++      + K+ +      +    +K Y YQ+ + ++Y H S
Sbjct: 67  VHSEN---KLYL--VFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH-S 117

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             V HRD+KPQNLL++     +KL DFG A+    G P  +Y   + + +YRAPE++ G+
Sbjct: 118 HRVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNY 305
            +Y+T +DIWS GC+ AE++  +PLFPGDS +DQL  I + LGTP  +    +  + P+Y
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDY 233

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
               FP+       K+ P  +  + +DL+S++L Y P  R +A  AL HP+F
Sbjct: 234 KP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  217 bits (556), Expect = 9e-68
 Identities = 106/305 (34%), Positives = 166/305 (54%), Gaps = 26/305 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 125 NVVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+ L   F   +  ++   + LV   +   ++ +VK      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L YIH S G+ HRD+KP N+ VN    ++K+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y   +DIWS GC++AEL+ GK LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 304 ----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA +AL HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 360 LRDPN 364
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  214 bits (546), Expect = 5e-67
 Identities = 120/291 (41%), Positives = 173/291 (59%), Gaps = 23/291 (7%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 131
           +VG+GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F     K  LYL  V E+V  TV   ++ + N L++      V+ Y +QI R + + H 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGAT 249
              + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 307
           +Y  A+DIW+ GC+V E++ G+PLFPGDS +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 308 FKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            + P++K   P  K FPK +    +DL  + L+  P+ R ++   L H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  204 bits (521), Expect = 3e-63
 Identities = 104/289 (35%), Positives = 159/289 (55%), Gaps = 25/289 (8%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 131
           G+G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM--IYVKLYAYQIFRALSYIH 189
             F   D+    L LV E +   ++ ++K      ++ P+    VK Y YQ+ ++L ++H
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           R+ G+ HRDIKP+N+L+      +KL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 RN-GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-NYTEF 308
            Y   +DIW+ GCV  E++   PLFPG + +DQ+ +I  VLGTP  E +K      +  +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP  K     K+ P     E +DL+ +LL Y P+ R TA  AL HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  204 bits (521), Expect = 1e-62
 Identities = 108/304 (35%), Positives = 175/304 (57%), Gaps = 25/304 (8%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH 123
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N++SL   F S    +++Y   V E +   +HR++      ++ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISP--LEDIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 242
            L Y+H S GV HRD+KP N+L+N +   +K+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVH-SAGVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           E++    +Y   +DIWSAGC+ AE++ GKPLFPG   V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           + N   F    P+ +  P+ + F     P A+DL+ ++L + P  R +A +AL HP+   
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293

Query: 360 LRDP 363
             DP
Sbjct: 294 YHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  203 bits (518), Expect = 1e-62
 Identities = 108/297 (36%), Positives = 170/297 (57%), Gaps = 38/297 (12%)

Query: 81  QGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFF 134
           +G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K    
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
            +   D++Y+  V+EYV   +  +++      Q      VK    Q+   ++++H +  +
Sbjct: 75  GSNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WI 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 251
            HRD+K  NLL+N +   +K+CDFG A+    G P   Y   + + +YRAPEL+ GA EY
Sbjct: 128 LHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-KF 310
           +TAID+WS GC+ AEL+  KPLFPG S +DQL +I K+LGTPT +        +  F + 
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK-------IWPGFSEL 237

Query: 311 PQIKA-----HPWHKIFPKRMPP-----EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           P  K      +P++++  K+ P         DL++RLL Y P  R +A DAL HP+F
Sbjct: 238 PGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  203 bits (517), Expect = 6e-62
 Identities = 122/328 (37%), Positives = 183/328 (55%), Gaps = 25/328 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y  + ++G+GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V +KH     + ++   + +V E +   +H+V+K  + L       + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 242
           YIH +  V HRD+KP+N+L N    ++K+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 243 ELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-K 299
           EL  G+  ++YT AIDIWS GC+ AE++ GKPLFPG + V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 300 CMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             N     +     + +  P+ + FP    P A+ L+ RLL + P  R TA +AL  P+F
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPN-ADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 358 DELRDPNARLPSGRFLPPL-FNFKSHEL 384
             L     R PS + +  L F F+   L
Sbjct: 294 KGLAKVE-REPSAQPITKLEFEFERRRL 320

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  202 bits (516), Expect = 7e-62
 Identities = 111/304 (36%), Positives = 161/304 (52%), Gaps = 27/304 (8%)

Query: 79  VGQGSFGVVFQAKCLET--GETVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 129
           +GQG++G+V  A+  ET   ETVAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 130 KHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
                      +ELYL    E +   +H++++      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 243
           H S  V HRD+KP NLLVN    ++K+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 H-SANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKC 300
           ++     YT AID+WS GC++AEL+  KP+F G   VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                     P I   P+  IFP    P A+DL+ +LL + P  R +  +AL HP+    
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Query: 361 RDPN 364
            DP+
Sbjct: 299 HDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  200 bits (511), Expect = 7e-62
 Identities = 106/293 (36%), Positives = 167/293 (56%), Gaps = 30/293 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++ + + + +         +P+  +K Y +Q+ + L++ H S 
Sbjct: 68  IHT---ENKLYL--VFEFLHQDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCH-SH 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 120 RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       + P  T   
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLP 232

Query: 310 -----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                FP+     + K+ P  +  +  DL+S++L Y PN R +A  AL HPFF
Sbjct: 233 DYKPSFPKWARQDFSKVVPP-LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  199 bits (507), Expect = 3e-61
 Identities = 103/295 (34%), Positives = 167/295 (56%), Gaps = 25/295 (8%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVV 127
           E++  +G+GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V
Sbjct: 4   EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETV-HRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   F     + +  L+LV EY   TV + + K+   + + +    +K   +Q  +A++
Sbjct: 64  NLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL----IKKIIWQTLQAVN 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELI 245
           + H+     HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+
Sbjct: 115 FCHKH-NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG--TPTREEIKCMNP 303
            G T+Y   +D+W+ GCV AEL+ G+PL+PG S VDQL  I K LG   P  ++I   N 
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 304 NYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            +     P+ +   P    FP  +   A+  +   LQ  P  R +  + L HP+F
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  197 bits (502), Expect = 2e-60
 Identities = 108/292 (36%), Positives = 165/292 (56%), Gaps = 28/292 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     +  L LV EY  + +    K+F+  N  +    VK + +Q+ + L++ H S 
Sbjct: 68  LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCH-SH 118

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N +  ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYT 306
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 307 EF-KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            +  +P   +     + PK +     DL+  LL  +P  R +A +AL HP+F
Sbjct: 236 PYPMYPATTS--LVNVVPK-LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  195 bits (499), Expect = 3e-60
 Identities = 97/291 (33%), Positives = 140/291 (48%), Gaps = 46/291 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 130
            ++G+GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             + S  D+++  LN+ LEYV   ++  ++K F KL + +    ++ Y  QI   L+Y+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIF 246
            + G+ HRDIK  N+LV+     VKL DFG AK L   E        R   Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  EY  A DIWS GC V E+  GKP +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
               P+I         P+ +  EA D + + L+  P  R TA + L HPF 
Sbjct: 223 ----PEI---------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  196 bits (500), Expect = 5e-60
 Identities = 112/301 (37%), Positives = 175/301 (58%), Gaps = 30/301 (9%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           E+I G+G++GVV++A+   T ET+A+KK+  ++  +       RE+  ++ + H N+V L
Sbjct: 8   EKI-GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK---HFNKLNQRMPMIYVKLYAYQIFRALS 186
           +    S     E  L LV EY+   + + +     F K N R+    +K Y YQI R ++
Sbjct: 67  QDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y H S  V HRD+KPQNLL++  T+ +KL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN- 302
           ++ G+  Y+T +DIWS GC+ AE++  KPLFPGDS +D+L +I ++LGTP  E    +  
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
            P+Y    FP+        + P  + P  VDL+S++L+  P+ R TA  AL H +F +L 
Sbjct: 234 LPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Query: 362 D 362
           D
Sbjct: 292 D 292

Length = 294

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  193 bits (493), Expect = 3e-59
 Identities = 103/289 (35%), Positives = 170/289 (58%), Gaps = 22/289 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             T +K    L LV EY+ + + + +   + +   +    VK + YQ+ + +++ H +  
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 250
           V HRD+KPQNLL+N    ++KL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 308
           Y+T+IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP+       ++FP    P  +DL+ RLLQ +P LR +A DAL HP+F
Sbjct: 237 TFPRYPPQDLQQLFP-HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  190 bits (485), Expect = 7e-58
 Identities = 99/296 (33%), Positives = 161/296 (54%), Gaps = 23/296 (7%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNVVSLK 130
            +G+G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +V L 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                     +  L LV EY+   + + +  +     + +P   +K + YQ+ + +++ H
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
              GV HRD+KPQNLLV+     +K+ D G  +      P  SY   I + +YRAPE++ 
Sbjct: 128 -KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLL 184

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G+T Y+T +DIWS GC+ AE+   +PLFPGDS + QL+ I K+LGTPT +      P  +
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVS 240

Query: 307 EFK----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           + +    FPQ K     +  P  + PE +DL+ ++L+Y P  R +A  AL HP+FD
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  189 bits (482), Expect = 2e-57
 Identities = 98/293 (33%), Positives = 155/293 (52%), Gaps = 24/293 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HP 124
            +G+G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HP
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           N+V L           EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + ++H S  + HRD+KPQN+LV     QVK+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N +
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVS 235

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                FP      +    P+ +  E +DL+ ++L ++P+ R +A +AL HP+F
Sbjct: 236 LPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  189 bits (481), Expect = 3e-57
 Identities = 102/299 (34%), Positives = 164/299 (54%), Gaps = 26/299 (8%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 126
           +Y     +G+GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRAL 185
           V+L H    T       L LV EY+       +K + +     + M  V+L+ +Q+ R L
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 242
           +Y H+   V HRD+KPQNLL++    ++KL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 AYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIK-- 299
           +++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E     
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             NP +  + FP     P     P+    P   +L  + LQY P  R +A +A+ HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  187 bits (478), Expect = 2e-56
 Identities = 102/297 (34%), Positives = 155/297 (52%), Gaps = 30/297 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
                  K    + LV+EY  + +  ++   + +        VK    Q+ R L Y+H +
Sbjct: 74  V---VVGKHLDSIFLVMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  NLL+      +K+ DFG A+    G P       + + +YRAPEL+ G 
Sbjct: 128 F-IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYT 306
           T YTTAID+W+ GC++AEL+  KPL PG S ++QL  II++LGTP        +  P   
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243

Query: 307 EFKFPQIKAHPW----HKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           +F  P+    P+    HK FP  +    + L++ LL Y P  R TA +AL   +F E
Sbjct: 244 KFTLPK---QPYNNLKHK-FPW-LSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  186 bits (475), Expect = 5e-56
 Identities = 99/304 (32%), Positives = 151/304 (49%), Gaps = 35/304 (11%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 132
           G+G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                DK +     V    P   H +       + ++    +K Y  Q+   ++Y+H + 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN- 134

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------------ICSRYYR 240
            + HRDIK  N+L++ +   +K+ DFG A+      PN               + +R+YR
Sbjct: 135 HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PEL+ G   YTTA+DIW  GCV AE+   +P+  G S +DQL  I K+ GTPT E    
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW-- 251

Query: 301 MNPNYTEFKFPQIKAHPWHKIFP-------KRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
             P +     P  +       +P        ++ PE +DL+S+LL   P  R TA DAL 
Sbjct: 252 --PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 354 HPFF 357
           HP+F
Sbjct: 308 HPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  184 bits (470), Expect = 1e-55
 Identities = 102/294 (34%), Positives = 160/294 (54%), Gaps = 31/294 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 128
           +G+G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L+          E  L L+ E++   + + +    K  Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H    V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--P 303
            G+  Y+T +DIWS G + AE+   KPLF GDS +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +Y    FP+ K         K +  + +DL+ ++L Y P  R +A  AL HP+F
Sbjct: 234 DYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  182 bits (464), Expect = 4e-54
 Identities = 106/304 (34%), Positives = 166/304 (54%), Gaps = 25/304 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 126
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L   F S    DE     LV+ Y+   + +++ H   L++      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDK----VQYLVYQMLCGL 130

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 244
            YIH + G+ HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-- 302
           I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 303 --PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              +Y +   P+     +  +FP +  P+AVDL+ ++L+   + R TA +AL HP+FD  
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Query: 361 RDPN 364
           RD +
Sbjct: 304 RDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  182 bits (464), Expect = 4e-54
 Identities = 104/297 (35%), Positives = 164/297 (55%), Gaps = 22/297 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 132
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D  +   LV+ ++   + +++KH     +++    ++   YQ+ + L YIH +
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH-A 136

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP NL VN    ++K+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 137 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 307
           T  +DIWS GC++AE++ GKPLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
            K P+ +   +  + P    P AV+++ ++L      R TA +AL HP+F+E  DP 
Sbjct: 254 -KLPRFRKKDFRSLLPN-ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  180 bits (458), Expect = 2e-53
 Identities = 95/308 (30%), Positives = 164/308 (53%), Gaps = 34/308 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 128
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 129 LKHCFFSTTDKDELYLN---------LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           +      +       +          +V EY+   +  V++        +   + +L+ Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ 233
           Q+ R L YIH S  V HRD+KP N+ +N     +K+ DFG A+++   +P+ S+      
Sbjct: 122 QLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSE 177

Query: 234 -ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL---VEIIKV 289
            + +++YR+P L+     YT AID+W+AGC+ AE++ GKPLF G   ++Q+   +E + V
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL 349
           +    R E+  + P++      + +  P   + P  + PEA+D + ++L ++P  R TA 
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAE 295

Query: 350 DALIHPFF 357
           +AL+HP+ 
Sbjct: 296 EALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (444), Expect = 1e-52
 Identities = 70/247 (28%), Positives = 122/247 (49%), Gaps = 40/247 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                +DE +L LV+EY    ++  ++K   +   ++    +     QI   L Y+H S 
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH-SN 111

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 251
           G+ HRD+KP+N+L++    +VKL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 310
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 311 PQIKAHP 317
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  178 bits (454), Expect = 2e-52
 Identities = 114/321 (35%), Positives = 167/321 (52%), Gaps = 65/321 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 128
           +R +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 129 --------LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
                       F      +E+Y+  V E +   +H+++       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-----IC 235
           I R L Y+H S G+ HRDIKP NLLVN +   +K+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           ++YYRAPE++ G+  YT+A+DIWS GC+ AEL+  + LF   S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 296 EEIK--CMNPNYTEFKFPQIKAHPWHKIFPKRMPP-------------EAVDLVSRLLQY 340
           E ++  C             +AH      P + P              EAV L+ R+L +
Sbjct: 227 EAMRSACEGA----------RAHILRG--PHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274

Query: 341 SPNLRCTALDALIHPFFDELR 361
            P+ R +A DAL HP+ DE R
Sbjct: 275 DPDKRISAADALAHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  179 bits (453), Expect = 3e-52
 Identities = 93/336 (27%), Positives = 141/336 (41%), Gaps = 48/336 (14%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHP 124
           SY   R +G+GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 125 -NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-------SYICS 236
           AL Y+H   G+ HRDIKP+N+L++     VKL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 237 RYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLG 291
             Y APE++ G +    +++ DIWS G  + EL+ G P F G+       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
           TP                     A P     P+ +   A DL+ +LL   P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 352 LIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSV 387
           L H     L+   + L            +     S+
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSL 308

Length = 384

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 1e-51
 Identities = 112/317 (35%), Positives = 153/317 (48%), Gaps = 46/317 (14%)

Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +G+G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK-HFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F    DK  +YL  + +Y    + +++K H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 189 HRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA-------KVLVKGEPNISYICSRY 238
           H S  V HRD+KP N+LV    P    VK+ D G A       K L   +P +  I   +
Sbjct: 125 H-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKV 289
           YRAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 290 LGTPTREE---IKCMNPNYTEFKFPQIKAHPWHKIFPKRM------PPEAVDLVSRLLQY 340
           LGTPT ++   IK M P Y                  K M        +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 341 SPNLRCTALDALIHPFF 357
            P  R TA +AL HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  172 bits (438), Expect = 7e-51
 Identities = 101/307 (32%), Positives = 171/307 (55%), Gaps = 23/307 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L H    T    E  L LV EY+ + +    ++ +     + M  VKL+ +Q+ R L+
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLK---QYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           N  +  + +P+ +A   H   P R+  +  +L+S+LLQ+    R +A +A+ HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHNHAP-RLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 362 DPNARLP 368
           +   +LP
Sbjct: 294 ERIHKLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  170 bits (433), Expect = 2e-50
 Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 42/283 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHCFF 134
           +G+G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     + 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
               KDEL+  +V+E+    ++  ++K     NQ +    +     ++ + L Y+H S G
Sbjct: 68  ---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH-SNG 118

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRDIK  N+L+     +VKL DFG +  L   +   + + + Y+ APE+I G   Y  
Sbjct: 119 IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDY 176

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
             DIWS G    EL  GKP +  +    + +  I   G P                    
Sbjct: 177 KADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPGLRN---------------- 219

Query: 314 KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                    P++   E  D + + LQ +P  R TA   L HPF
Sbjct: 220 ---------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  170 bits (432), Expect = 4e-50
 Identities = 110/292 (37%), Positives = 168/292 (57%), Gaps = 24/292 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 131
           +VG+G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F     + +LYL  V EYV + +  +++   ++   +P   V+ Y YQ+ +A+ + H++
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 249
             + HRDIKP+NLL++ H   +KLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 307
            Y  A+D+WS GC++ EL  G+PLFPG+S +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 308 FKFPQIKAHP--WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            +FP +  HP    + +   +    +DL+  LL+ +P  R      L HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  171 bits (435), Expect = 6e-50
 Identities = 100/316 (31%), Positives = 154/316 (48%), Gaps = 53/316 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------------------RELQTMR 119
           +G+G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            + H N++ L   +         ++NLV++ +   + +VV        R+    VK    
Sbjct: 76  EIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILL 126

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----VLVKGEPNISYI 234
           QI   L+ +H+   + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 235 CSR----------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AEL+ GKPLFPG++ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 285 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            I ++LGTP  +   + K + P YTEF   + K      IFP     +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLKLN 300

Query: 342 PNLRCTALDALIHPFF 357
           P  R +A +AL H +F
Sbjct: 301 PLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  168 bits (427), Expect = 4e-49
 Identities = 94/308 (30%), Positives = 158/308 (51%), Gaps = 49/308 (15%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 132 CFFSTTD-----KDELYLNLVLEYVPETVHRVVK----HFNKLNQRMPMIYVKLYAYQIF 182
                 D     KD+    LV EY+   +  +++    HF++ +       +K +  Q+ 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYR 240
             L+Y H+     HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR
Sbjct: 127 EGLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PEL+ G   Y  AID+WS GC++ EL   KP+F  +  + QL  I ++ G+P       
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PA 240

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRM------------PPEAVDLVSRLLQYSPNLRCTA 348
           + P+  +  +       ++ + PK+             P  A+DL+  +L   P+ RCTA
Sbjct: 241 VWPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 349 LDALIHPF 356
            +AL  P+
Sbjct: 294 EEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  167 bits (425), Expect = 4e-49
 Identities = 100/289 (34%), Positives = 160/289 (55%), Gaps = 23/289 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+V+L H  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL-HDI 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             T    E  L LV EY+   + + + +   L   M M  VK++ +Q+ R LSY H+   
Sbjct: 72  IHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLSYCHKR-K 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 250
           + HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G+TE
Sbjct: 124 ILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK--CMNPNYTEF 308
           Y+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       N  +  +
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FPQ +A P     P R+  + +DL+S LL Y    R +A  AL H +F
Sbjct: 241 LFPQYRAQPLINHAP-RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  169 bits (429), Expect = 4e-49
 Identities = 102/304 (33%), Positives = 163/304 (53%), Gaps = 24/304 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 127 VSLKHCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           + L   F   T   + +E+YL  V   +   ++ +VK      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L YIH S G+ HRD+KP N+ VN    ++++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y   +DIWS GC++AEL+ GK LFPG+  +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 304 NYTEFKF---PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
            +        P +      KIF +   P A+DL+ ++L    + R +A +AL HP+F + 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 361 RDPN 364
            DP 
Sbjct: 305 HDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  167 bits (425), Expect = 7e-49
 Identities = 102/299 (34%), Positives = 166/299 (55%), Gaps = 23/299 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L       TDK    L LV EY+ + +    ++ +     M M  VK++ YQI R L+
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLK---QYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 304 N--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           N  +  + FP+ K  P     P R+  E ++L+++ LQY    R +A +A+ H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAP-RLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  163 bits (415), Expect = 1e-47
 Identities = 106/301 (35%), Positives = 169/301 (56%), Gaps = 30/301 (9%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN 125
           SY+    +G+GS+  V++      G+ VA+K V+  K  +       RE   ++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +V L H    T +     L  V EY+  +    +++H   L+       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRA 241
           L+YIH    + HRD+KPQNLL++ +  ++KL DFG A+   K  P+ +Y   + + +YR 
Sbjct: 116 LAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKC 300
           P+++ GAT+Y++A+DIW AGC+  E++ G+P FPG S V +QL +I  VLG PT +    
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 301 MN--PNYTEFKFPQIKAHPWHKIFPKRM--PPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++  PNY    F   K      ++ KR+  PP+A DL S++L   P  R +A DAL+HP+
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Query: 357 F 357
           F
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  165 bits (420), Expect = 1e-47
 Identities = 106/319 (33%), Positives = 166/319 (52%), Gaps = 44/319 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKK-------VLQDKR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 125 NVVSLKHCFFSTTDKD-----ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           N++ L + F  T  K      ++YL  V+E +   + +V+   +  ++RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYLL-----Y 125

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           Q+   + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 300 CMNP---NYTEFKFPQIKAHPWHKIFP------------KRMPPEAVDLVSRLLQYSPNL 344
            + P   NY E + P+   + + ++FP            K    +A DL+S++L   P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 345 RCTALDALIHPFFDELRDP 363
           R +  DAL HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  164 bits (417), Expect = 2e-47
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 137

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 138 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 7e-46
 Identities = 91/292 (31%), Positives = 140/292 (47%), Gaps = 55/292 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 131
           +G+GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F     + E  L LVLEY P  E    + K       R      + YA +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLH 110

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S+G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 -SLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  A+D WS G ++ E++ GKP F  +    ++ E I       ++ ++         
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL------KDPLR--------- 211

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA-LI--HPFF 357
                        FP+ + PEA DL+S LLQ  P  R  +  A  I  HPFF
Sbjct: 212 -------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  152 bits (385), Expect = 6e-43
 Identities = 94/299 (31%), Positives = 147/299 (49%), Gaps = 26/299 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +GQG+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L  
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 132 -CFFSTT----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            C    T     K   YL  V E+     H +    +  N +  +  +K     +   L 
Sbjct: 79  ICRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRA 241
           YIHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR 
Sbjct: 134 YIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-KC 300
           PEL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E     
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 301 MN-PNYTEFKFPQ-IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                + + + PQ  K     ++ P    P A+DL+ +LL   P  R  A  AL H FF
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  147 bits (371), Expect = 3e-41
 Identities = 93/289 (32%), Positives = 146/289 (50%), Gaps = 18/289 (6%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 129
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 130 KH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              C  S TD+ E  + LV E+V + +   +         +P   +K    Q  R L ++
Sbjct: 68  MDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGLDFL 124

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H +  + HRD+KP+N+LV     QVKL DFG A++          + + +YRAPE++  +
Sbjct: 125 HANC-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    +      
Sbjct: 183 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPRG 240

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            F      P   + P+ +      L+  +L ++P+ R +A  AL HPFF
Sbjct: 241 AFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  144 bits (367), Expect = 8e-41
 Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 60/301 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + +G+GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +     F     +++  L +V+EY     + + +K   K  +  P   +  +  Q+  AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 236
            Y+H S  + HRDIKPQN+ +      VKL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            YY +PEL      Y    DIWS GCV+ EL   K  F G++ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           +   +   Y                       E  +LVS LLQ  P  R +    L  PF
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPF 257

Query: 357 F 357
            
Sbjct: 258 I 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 2e-40
 Identities = 89/288 (30%), Positives = 138/288 (47%), Gaps = 48/288 (16%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 131
           ++G+G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  +    L ++LEY    ++ +++K F    + +    V +Y YQ+ + L+Y+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 249
             GV HRDIK  N+L       VKL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
             +TA DIWS GC V EL+ G P +                          +NP    F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             Q    P     P+ + PE  D + +  Q  PNLR TA   L HP+ 
Sbjct: 211 IVQDDHPP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  143 bits (363), Expect = 2e-40
 Identities = 91/290 (31%), Positives = 135/290 (46%), Gaps = 48/290 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 127
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                 +  T+++E  L + LE VP  ++ +++K +       P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSF----PEPVIRLYTRQILLGLE 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           Y+H      HRDIK  N+LV+     VKL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLH-DRNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y  A DIWS GC V E+  GKP +    GV  +                       
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----------------------- 211

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FK  + K  P     P  +  EA D + + LQ  P+LR TA + L HPF
Sbjct: 212 -FKIGRSKELP---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  143 bits (363), Expect = 4e-40
 Identities = 92/290 (31%), Positives = 137/290 (47%), Gaps = 54/290 (18%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHCFF 134
           GQGS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     F+
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                 E  +++VLEY+   ++  ++K   K+ + +    +   A QI + L Y+H    
Sbjct: 70  K-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTKRH 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGA 248
           + HRDIKP NLL+N    +VK+ DFG +KVL     N    C+ +     Y +PE I G 
Sbjct: 121 IIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGK-P-LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           + Y+ A DIWS G  + E  LGK P L PG     +L++ I            C  P   
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPPP- 221

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                            +   PE  D +S  LQ  P  R +A + L HPF
Sbjct: 222 ---SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  144 bits (363), Expect = 6e-40
 Identities = 105/305 (34%), Positives = 161/305 (52%), Gaps = 32/305 (10%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 126
           SY     +G+GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V L H    T +     L LV EYV  +    + KH   L+       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 242
           SYIH+   + HRD+KPQNLL++  T ++KL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCM 301
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 302 N--PNYTEFKFPQIKA----HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
           +  P++   +F           W+K+        A DL S+LLQ  P  R +A  AL H 
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKL---SYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289

Query: 356 FFDEL 360
           +F +L
Sbjct: 290 YFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  142 bits (361), Expect = 7e-40
 Identities = 89/292 (30%), Positives = 141/292 (48%), Gaps = 50/292 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 132
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           +     ++++Y+   +EY    T+  +++H     + +    +++Y  Q+   L+Y+H S
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLH-S 117

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 246
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 247 GAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           G     +  A DIWS GCVV E+  GK  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                 P I           ++ PE  D + R L+  P  R TA + L HPF
Sbjct: 225 ------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  141 bits (358), Expect = 3e-39
 Identities = 87/320 (27%), Positives = 142/320 (44%), Gaps = 77/320 (24%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 124
           +   +I+G+GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            ++ L + F    D++ LY   VLEY P   + + ++ +  L+++      + YA +I  
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRY- 238
           AL Y+H S G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 239 ----------------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
                           Y +PEL+        + D+W+ GC++ +++ GKP F G      
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGS----- 225

Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
                                   E+  F +I    +   FP   PP+A DL+ +LL   
Sbjct: 226 -----------------------NEYLTFQKILKLEYS--FPPNFPPDAKDLIEKLLVLD 260

Query: 342 PNLRCTALDALI----HPFF 357
           P  R    +       HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  140 bits (355), Expect = 6e-39
 Identities = 102/296 (34%), Positives = 157/296 (53%), Gaps = 31/296 (10%)

Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+    +P   +K   +Q+ R L 
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 125 FLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+     P   
Sbjct: 183 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR-- 235

Query: 307 EFKFPQIK-----AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +   P+       A P  K     +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 236 DVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  142 bits (358), Expect = 1e-38
 Identities = 105/348 (30%), Positives = 174/348 (50%), Gaps = 37/348 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + PQ     + ++FP  + P           +A DL+S++L   P+ R +  +A
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 352 LIHPFFDELRDP-NARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPE 398
           L HP+     DP  A  P     PP       E +   +E   +LI +
Sbjct: 313 LRHPYITVWYDPAEAEAP-----PPQIYDAQLEEREHAIEEWKELIYK 355

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  139 bits (351), Expect = 1e-37
 Identities = 99/312 (31%), Positives = 162/312 (51%), Gaps = 31/312 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 132

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  +A
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 309 LQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  135 bits (341), Expect = 3e-36
 Identities = 95/312 (30%), Positives = 161/312 (51%), Gaps = 31/312 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  129 bits (327), Expect = 5e-35
 Identities = 91/301 (30%), Positives = 147/301 (48%), Gaps = 63/301 (20%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKH 131
           + +G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            ++S   K  LYL  V+EY+P   +  ++++   L++ +     ++Y  +I  AL Y+H 
Sbjct: 59  -YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLH- 110

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISY--------ICSRYYRA 241
           S G+ HRD+KP N+L++ + H +KL DFG +KV LV+ + N++         + +  Y A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   ++  +D WS GC++ E ++G P F G+                T EEI   
Sbjct: 170 PEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI--- 209

Query: 302 NPNYTEFKFPQIKAH--PWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDALI-HPF 356
                   F  I      W +     +  EA+DL+S+LL   P  R    +++ +  HPF
Sbjct: 210 --------FQNILNGKIEWPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Query: 357 F 357
           F
Sbjct: 260 F 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (318), Expect = 2e-33
 Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 56/291 (19%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     +  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL- 85

Query: 136 TTDKDELYLNLVLEY--------VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
               DEL+  +V+EY        +      + ++F ++N+   + YV     ++ + L Y
Sbjct: 86  --VGDELW--VVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYV---CREVLQGLEY 131

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIF 246
           +H S  V HRDIK  N+L++     VKL DFG A  L K +    S + + Y+ APE+I 
Sbjct: 132 LH-SQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              +Y   +DIWS G +  E+  G+P +  +  +  L  I    G P  +          
Sbjct: 190 R-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN--------- 238

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                           P++  PE  D +++ L   P  R +A + L HPF 
Sbjct: 239 ----------------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  125 bits (317), Expect = 3e-33
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 62/297 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F     +D+  L LV+EYVP  E       H  K + R P    + YA Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGELFS----HLRK-SGRFPEPVARFYAAQVVLALEY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LH-SLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y  A+D W+ G ++ E++ G P F  D    Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKI----------LEG------ 213

Query: 307 EFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSP-----NLRCTALDALIHPFF 357
                        K+ FP    P+A DL+  LLQ        NL+    D   HP+F
Sbjct: 214 -------------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  123 bits (310), Expect = 4e-32
 Identities = 102/319 (31%), Positives = 154/319 (48%), Gaps = 50/319 (15%)

Query: 79  VGQGSFGVVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S  D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 190 RSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYY 239
            +  V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF---------PGDSGVDQLVEIIKVL 290
           RAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 291 GTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
           G P     E+IK M  + T  K            IK    HK+ P     +A  L+ +LL
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS---KAFHLLQKLL 298

Query: 339 QYSPNLRCTALDALIHPFF 357
              P  R T+  A+  P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  120 bits (304), Expect = 1e-31
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 43/285 (15%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
            +G+GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 136 TTDKDELYLNLVLEY-VPETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            TD     L +V+EY    +V  ++K  NK L +      +    YQ  + L Y+H +  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE----IAAILYQTLKGLEYLHSN-K 119

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYT 252
             HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y 
Sbjct: 120 KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYN 177

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
              DIWS G    E+  GKP                    P  +    ++P    F  P 
Sbjct: 178 NKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMIPN 213

Query: 313 IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            K  P     P++  PE  D V + L   P  R +A+  L HPF 
Sbjct: 214 -KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 88/308 (28%), Positives = 139/308 (45%), Gaps = 67/308 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-------QDKRYKN------RELQTMR 119
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYA 178
            L H N+V            D  +LN+ LEYVP  +V  ++ ++    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------- 231
            QI + L+Y+H + G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLH-NRGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 232 ---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
              S   S ++ APE++   T YT   DIWS GC+V E++ GK  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +                         A P     P  +  EA+D + +  +   N R TA
Sbjct: 224 IGE----------------------NASP---EIPSNISSEAIDFLEKTFEIDHNKRPTA 258

Query: 349 LDALIHPF 356
            + L HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  120 bits (302), Expect = 4e-31
 Identities = 101/320 (31%), Positives = 154/320 (48%), Gaps = 52/320 (16%)

Query: 79  VGQGSFGVVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S +D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 190 RSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYY 239
            +  V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF---------PGDSGVDQLVEIIKVL 290
           RAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 291 GTPTR---EEIKCMNPNY----------TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
           G P     E+I+ M P Y          T      IK    HK+ P     +   L+ +L
Sbjct: 242 GFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS---KVFLLLQKL 297

Query: 338 LQYSPNLRCTALDALIHPFF 357
           L   P  R T+  AL  P+F
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  118 bits (297), Expect = 9e-31
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 56/296 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G FG V   K      T A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 132 CFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F    KD+ Y+ +++EY       T+ R    F++   R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +H + G+ +RD+KP+NLL++     VKL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LH-NRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  ++D WS G ++ EL+ G+P F  D   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPFGEDDE-DPME---------IYNDILKGNGKLE- 214

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI-----HPFFD 358
                         FP  +   A DL+ +LL+ +P  R   L   I     H +F+
Sbjct: 215 --------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (297), Expect = 1e-30
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 71/295 (24%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRA 184
           V L       T+++ L +  V+EY+P      +  + + N+   + +  +  +A QI R 
Sbjct: 64  VKLLGV---CTEEEPLMI--VMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N LV      VK+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S      E+++ L  
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS----NAEVLEYLKK 219

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             R                           P   PPE   L+ +     P  R T
Sbjct: 220 GYRLPK------------------------PPNCPPELYKLMLQCWAEDPEDRPT 250

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  117 bits (296), Expect = 2e-30
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 70/294 (23%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L       T+++ LY+  V+EY+       +  + + N+ ++ +  +  +A QI R +
Sbjct: 64  VKLLGV---CTEEEPLYI--VMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  S    HRD+  +N LV      VK+ DFG ++ L   +         YYR     
Sbjct: 116 EYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGK 164

Query: 241 ------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTP 293
                 APE +    ++T+  D+WS G ++ E+  LG+  +PG S      E+++ L   
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----EVLEYLKNG 219

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            R                           P   PPE  DL+ +     P  R T
Sbjct: 220 YRLPQ------------------------PPNCPPELYDLMLQCWAEDPEDRPT 249

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  115 bits (290), Expect = 9e-30
 Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 37/283 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKHCFF 134
           G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V     F+
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           +  D     +++ +EY+      + K   ++  R+P   +   A  + + L+Y+H    +
Sbjct: 70  NNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
            HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+  
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYSVK 179

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            DIWS G  + EL  G+  FP     D    I ++L     + I    P       P++ 
Sbjct: 180 SDIWSLGLSLIELATGR--FPYPPENDPPDGIFELL-----QYIVNEPP-------PRLP 225

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +  +         P+  D V+  L   P  R +  + L HPF 
Sbjct: 226 SGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (286), Expect = 4e-29
 Identities = 78/290 (26%), Positives = 131/290 (45%), Gaps = 46/290 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           R++G+G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F     +DE  + LV++ +     R   H ++   +     VK +  +I  AL Y+H
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLRY--HLSQ-KVKFSEEQVKFWICEIVLALEYLH 117

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S G+ HRDIKP N+L++   H V + DF  A  +       S   +  Y APE++    
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+ A+D WS G    E + GK  + G S                R++I+          
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDALIHPFF 357
             Q  A     ++P     EA+D +++LL+  P  R      D   HP+F
Sbjct: 214 --QETADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  112 bits (283), Expect = 9e-29
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 64/301 (21%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   +  
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YTS 67

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F     DEL+  LV+ Y+   ++  ++K  + +      +I   L   ++ + L Y+H +
Sbjct: 68  F--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHSN 121

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELIF 246
            G  HRDIK  N+L+      VK+ DFG +  L  G          ++ +  + APE++ 
Sbjct: 122 -GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKP----LFPGDSGVDQLVEIIKVL------GTPTRE 296
               Y    DIWS G    EL  G        P           +KVL        P+ E
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPP-----------MKVLMLTLQNDPPSLE 228

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                      F+                       ++S  LQ  P+ R TA + L H F
Sbjct: 229 TGADYKKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKF 266

Query: 357 F 357
           F
Sbjct: 267 F 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (282), Expect = 1e-28
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 125
           +  E+ +G+G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+     F      +   LN+VLE      + R++KHF K  + +P   +  Y  Q+  A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 243
           L ++H S  + HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMH-SKRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
            I     Y    DIWS GC++ E+   +  F GD
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 52/291 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLK 130
           + +G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL- 62

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             ++S   KD  YL LV+EY+       ++K    L    P  + K Y  ++   +  +H
Sbjct: 63  --YYSFQSKD--YLYLVMEYLNGGDCASLIKTLGGL----PEDWAKQYIAEVVLGVEDLH 114

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  G+ HRDIKP+NLL++   H +KL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +     D WS GCV+ E + G P F  ++  D + + I          I     N+ E  
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEV 216

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-LDALI--HPFF 357
                             PEAVDL++RLL   P  R  A     I  HPFF
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  111 bits (280), Expect = 3e-28
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           + +G+G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF---NKLNQRMPMIYVKLYAYQIFRA 184
            L       T  + LY  +V EY+P      +  F   +     +  +     A QI + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLL--QMALQIAKG 114

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N LV      VK+ DFG ++ + + +         YYR    
Sbjct: 115 MEYLE-SKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGG 163

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG
Sbjct: 164 GKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 8e-28
 Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 127
           +++GQG+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C      +D+  L++ +EY+P  +V   +K +  L + +     + Y  QI   + 
Sbjct: 68  QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+I G   Y    D+WS GC V E++  KP +   +  + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                   PQ+         P  + P+A + + R    +   R +A + L H F 
Sbjct: 226 --------PQL---------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 8e-28
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 129
           ++G+G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +          L +++EY      R +     + ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 248
           +  GV HRDIK  N+LV  +T  VKLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 1e-27
 Identities = 89/306 (29%), Positives = 137/306 (44%), Gaps = 43/306 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAI----KKVLQDKRYKNRELQTMRLL---DHPNVVSLKH 131
           VGQG +G VF AK  +TGE VA+    K +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F    D + LY  L +EYVP    R ++ +   L++     + + Y  ++F A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y   +D WS GC++ E + G P F G +  +    +     T  R       P Y + +F
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSG 370
                          +  EA DL+++L+        +  D   HPFF E+     R    
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273

Query: 371 RFLPPL 376
            F+P L
Sbjct: 274 PFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  109 bits (275), Expect = 1e-27
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 49/293 (16%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
            +G+GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                 D+    L +V+EY     + ++++   K  + +   ++     Q+  AL   H 
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 191 SIG----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 243
                  V HRD+KP N+ ++   + VKL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            +   + Y    DIWS GC++ EL    P F       QL   IK               
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK--------------- 223

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              E KF +I         P R   E  +++  +L   P+ R +  + L  P 
Sbjct: 224 ---EGKFRRI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  108 bits (272), Expect = 4e-27
 Identities = 85/304 (27%), Positives = 146/304 (48%), Gaps = 55/304 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYK------NRELQTM 118
           ++   ++G+G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLY 177
           + LDH N+V          +  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---LVKGEPNISYI 234
             Q+   L+Y+H S G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLH-SKGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 235 CSRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
            S ++ APE+I   ++ Y+  +DIWS GCVV E+  G+  +  +                
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215

Query: 294 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
             E I  M      FK   +  A P        + P A+D ++     +P+ R TA + L
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267

Query: 353 IHPF 356
            HPF
Sbjct: 268 QHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 3e-26
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 46/228 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 128
           + +G+G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETV-------HRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L       T+++ LY  LVLEY+            R V    + +  + +  +  +A QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKS-TLSLKDLLSFAIQI 114

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 240
            + + Y+  S    HRD+  +N LV      VK+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLA-SKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 241 -----------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  105 bits (265), Expect = 4e-26
 Identities = 85/298 (28%), Positives = 138/298 (46%), Gaps = 49/298 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           + S    DEL++  V+E++    +  +V H      RM    +      + +ALS++H +
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH-A 133

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATE 250
            GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y T +DIWS G +V E++ G+P +  +  + Q ++ I+    P  +              
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNLPPKLKN------------- 237

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
                         ++ P     + R+L   P  R TA + L HPF  +   P++ +P
Sbjct: 238 ------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (266), Expect = 5e-26
 Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 53/299 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA--YQIFRALSY 187
           K C+       E    LV+EY   +   +++   K     P+  V++ A  +   + L+Y
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAY 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +H S    HRDIK  N+L+      VKL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LH-SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 248 ATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
             E  Y   +D+WS G    EL   KP     + +  L  I                   
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------------- 226

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
            +   P + ++ W   F         + V   LQ  P  R ++ + L H F    R P 
Sbjct: 227 AQNDSPTLSSNDWSDYF--------RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  104 bits (261), Expect = 1e-25
 Identities = 73/297 (24%), Positives = 137/297 (46%), Gaps = 51/297 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 126
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +       +T +    + NL +E++   +V  ++  +    +    + +  Y  Q+ R L
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYR 240
           SY+H +  + HRD+K  NLL++    ++++ DFG+A  L       GE     + +  + 
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE++ G  +Y  + D+WS GCV+ E+   KP +  +   + L  I K         I  
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                     P I         P+ + P   D+  R L+  P  R  + + L HP F
Sbjct: 226 ATTA------PSI---------PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 81/321 (25%), Positives = 131/321 (40%), Gaps = 81/321 (25%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 130
           ++G+G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           +  F    +DE +L LV+EY+P  + ++ +++         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSV 117

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----------------------VLV 225
           H+ +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 226 KGEPNISYICSRY-------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           +   +               Y APE++ G T Y    D WS G ++ E++ G P F  D 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD- 233

Query: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFP--KRMPPEAVDLVSR 336
                                      T  K   I        FP    + PEA+DL+ R
Sbjct: 234 -----------------------TLQETYNK---IINWKESLRFPPDPPVSPEAIDLICR 267

Query: 337 LLQYSPNLRCTALDALIHPFF 357
           LL    +   +  +   HPFF
Sbjct: 268 LLCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-24
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 131
           ++G+G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 132 CFF---STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            F       + D+L+  LV+E     +V  +VK   K  +R+   ++     +  R L+Y
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 246
           +H +  V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 247 GATE------YTTAIDIWSAGCVVAELMLGKP 272
            A +      Y    D+WS G    EL  GKP
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (251), Expect = 2e-24
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 46/284 (16%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 133
           G+GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 134 FSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               D ++L +  V+EY P   + + +    K  + +P   +     Q+ R L  +H   
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQ 122

Query: 193 GVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            + HRD+K  N LLV      VK+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           +   DIWS GC++ E+    P F   S  D      KV                   K+P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KYP 219

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
            I         P     +  + +  +LQ  P LR      L  P
Sbjct: 220 PI---------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  100 bits (251), Expect = 3e-24
 Identities = 86/290 (29%), Positives = 131/290 (45%), Gaps = 43/290 (14%)

Query: 76  ERIV-GQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 130
           ER+V G+G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              +  +D +  +  + +E VP       +   +  L      I    Y  QI   L Y+
Sbjct: 70  ---YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 246
           H +  + HRDIK  N+LVN ++  VK+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    DIWS GC + E+  GKP F                       I+   P   
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAA 220

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FK    K HP     P+ +  EA + + R  +  P+ R +A D L  PF
Sbjct: 221 MFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 59/297 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 127
           +     +G+GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                F   +      L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLE 112

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 239
           Y+H   G  HRDIK  N+L++     VKL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I   + Y    DIWS G    EL  G+P     S +  +    +VL        K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPL---SDLHPM----RVL----FLIPK 212

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             NP       P ++ + + K F         D VS  L   P  R +A + L H F
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 41/299 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           G+G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           F   D     + + +E +  ++ +  K        +P   +   A  I +AL Y+H  + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
           V HRD+KP N+L+N    QVKLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y    D+WS G  + EL  G+  FP DS             TP  +++K           
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK----------- 218

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPS 369
            Q+   P  ++  ++  PE  D V++ L+ +   R    + L HPFF+     N  + S
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 54/298 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L H  F T  KD L+   V+EYV      ++ H  +   R      + YA +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYV--NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 H-ERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  A+D W+ G ++ E++ G+  F GD   D+L                        
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL------------------------ 204

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-----DALIHPFFDEL 360
             F  I        +P+ +  EA  ++   L  +P  R   L     D   HPFF E+
Sbjct: 205 --FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 52/312 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIH 189
           + F +  D     L LV+  +     +   H   + +   P      YA QI   L ++H
Sbjct: 60  YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           +   + +RD+KP+N+L++ H + V++ D G A  L  G+       +  Y APE++ G  
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K          
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN 364
                       +P +  PEA DL   LLQ  P  R      +A +   HP F +L    
Sbjct: 210 ---TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263

Query: 365 ARLPSGRFLPPL 376
            RL +G   PP 
Sbjct: 264 -RLEAGMLEPPF 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 86/305 (28%), Positives = 126/305 (41%), Gaps = 72/305 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 126
           Y+  R++G+G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV------PETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           ++  + F      D+  L + +EY        + V +  + F           V  Y +Q
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKGQLF-------EEEMVLWYLFQ 109

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNI 231
           I  A+SYIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P  
Sbjct: 110 IVSAVSYIH-KAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP-- 165

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
                 YY +PEL  G  +Y    DIW+ GCV+ EL+  K  F   + ++ +V+I     
Sbjct: 166 ------YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI----- 213

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
                    +  NYT                      E + LV  LLQ  P  R TA + 
Sbjct: 214 ---------VQGNYT--------------PVVSVYSSELISLVHSLLQQDPEKRPTADEV 250

Query: 352 LIHPF 356
           L  P 
Sbjct: 251 LDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 78/328 (23%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            F++  D+  LY+  ++EYVP     +  R    F+             YA +I  AL Y
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYLRNSGRFSNSTGL-------FYASEIVCALEY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 241
           +H S  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y A
Sbjct: 117 LH-SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLA 166

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I  +  +  A+D W+ G ++ E+++G P F      D    I               
Sbjct: 167 PEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGI--------------- 206

Query: 302 NPNYTEFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSP-----NLRCTALDALIHP 355
                   + +I A    K+ FP+ +   A DL+ +LL         N++  A D   H 
Sbjct: 207 --------YEKILA---GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255

Query: 356 FFDELRDPNARLPSGRFLPPLFNFKSHE 383
           +F  + D +  +P  +  PP+    SH+
Sbjct: 256 WFKSV-DWDD-VPQRKLKPPIVPKVSHD 281

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.9 bits (236), Expect = 2e-22
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 126
           Y   R+VG+G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +     F    DK    L +V+EY P  T+   ++   + N  +    +  +  QI  AL
Sbjct: 62  IEYYENFLE--DKA---LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H  + + HRD+K QN+L++ H   VK+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
            G   Y    DIW+ GCV+ EL   K  F  
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + R++KHF K  + +P   V  Y  Q+  
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           AL ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 127
           +++G+GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F T DK    L  VL+YV      +  H  +  +  P    + YA +I  AL Y
Sbjct: 60  GL-HYSFQTADK----LYFVLDYV--NGGELFFHLQR-ERSFPEPRARFYAAEIASALGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + +++K+F K  + +P   V  Y  Q+  
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           A+ ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 81/294 (27%), Positives = 122/294 (41%), Gaps = 49/294 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 131
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           C+       E    LV+EY   +   +++   K  Q + +  +   A Q    L+Y+H S
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLH-S 139

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
             + HRDIK  N+L+     QVKL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 140 HNMIHRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 251 -YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y   +D+WS G    EL   KP     + +  L  I                    +  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            P ++++ W   F           V   LQ  P  R  + + L H F    R  
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 59/298 (19%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 127
           ++G+G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                 +  T  D+  +++ +E+VP  ++  ++  F  L    P      Y  QI   ++
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI-------CSRYY 239
           Y+H +  V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I   + Y    DIWS GC V E+  GKP     + +D+L  +             
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF------------ 218

Query: 300 CMNPNYTEFKFPQIKAHP-WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                        I AH       P      A+D V+  L    + R +AL  L H F
Sbjct: 219 ------------YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 88/297 (29%), Positives = 136/297 (45%), Gaps = 47/297 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           + S    +EL++  ++E++       +    +LN+      +      + +AL Y+H S 
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLH-SQ 136

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 251
           GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
            T +DIWS G +V E++ G+P +  DS V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
             K    HKI      P   D + R+L   P  R TA + L HPF  +   P   +P
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 66/298 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 135 STTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAY---QIFRALS 186
               +D+L++  V+EY     + +         ++L            AY   +  + L+
Sbjct: 71  R---RDKLWI--VMEYCGGGSLQDIYQVTRGPLSEL----------QIAYVCRETLKGLA 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 244
           Y+H   G  HRDIK  N+L+      VKL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLH-ETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 245 IFGATE----YTTAIDIWSAGCVVAELMLGKP-LFPGDSGVDQLVEIIKVLGTPTREEIK 299
              A E    Y    DIW+ G    EL   +P +F         +  ++ L   ++    
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKSN-- 220

Query: 300 CMNPNYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                   F  P++K    W  +F         D + + L   P  R TA   L HPF
Sbjct: 221 --------FPPPKLKDKEKWSPVF--------HDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 88/330 (26%), Positives = 149/330 (45%), Gaps = 71/330 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 127
           +++  G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           S+  C F T    + +L +V+EYV       ++K+   L    P+   ++Y  +   AL 
Sbjct: 65  SM-FCSFET----KRHLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALE 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNI-------------- 231
           Y+H + G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLH-NYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 232 SYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
             +C +  Y APE+I     Y   +D W+ G ++ E ++G   F GD+  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---T 347
                ++I    P   E                  +P +A DL+SRLL+ +P  R     
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGG 266

Query: 348 ALDALIHPFFDELRDPNARL-PSGRFLPPL 376
           A +   H FF  L D N  L     F+P L
Sbjct: 267 AFEVKQHRFFLGL-DWNGLLRQKAEFIPQL 295

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 90/309 (29%), Positives = 139/309 (44%), Gaps = 67/309 (21%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRLLDH---------- 123
           R++G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 124 ----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLY 177
               P +V+L H  F T  K    L+L+L+YV        + F  L QR       V++Y
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVY 110

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC 235
             +I  AL ++H+ +G+ +RDIK +N+L++   H V L DFG +K  +  E     S+  
Sbjct: 111 IAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 236 SRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           +  Y APE+I G +  +  A+D WS G +  EL+ G   F  D   +   EI       +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------S 221

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA--- 351
           R  +K   P                  FPK M  EA D + +LL+  P  R  A  A   
Sbjct: 222 RRILKSKPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263

Query: 352 LIHPFFDEL 360
             HPFF  +
Sbjct: 264 KNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 88/336 (26%), Positives = 141/336 (41%), Gaps = 63/336 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 131
           +G+GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             FS    ++LYL L      E  H    H  +   R  +   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFH----HLQR-EGRFDLSRARFYTAELLCALENLH-K 111

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 250
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           YT A+D W+ G ++ E++ G P F  D  V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYR--KILQEPLR--------------- 211

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHPFFDELRDPNARL 367
                      FP     +A DL+  LL   P  R     A +   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 368 PSGRFLPPL----------FNFKSHELKSVPVEILV 393
                 PP            NF     +  P++ +V
Sbjct: 259 LMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVV 294

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 132
           +G+GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D+  LN+V+EY     +H+++K      + +P   V  +  QI   L+++H S
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH-S 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 247
             + HRDIK  NL ++ +   VK+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 120 KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
              Y    D+W+ G V+ E   GK  F  ++    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.7 bits (227), Expect = 8e-21
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 132

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 91.7 bits (227), Expect = 9e-21
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K C+       E    LV+EY   +   +++   K  Q + +  +   A Q    L+Y+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLH 142

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRDIK  N+L+     QVKL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 -SHNMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 52/300 (17%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLL 121
           I++   +++GQG+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            H  +V    C     D+ E  L + +EY+P  +V   +K +  L + +     + Y  Q
Sbjct: 62  QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICS 236
           I   +SY+H ++ + HRDIK  N+L +     VKL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ +PE+I G   Y    D+WS GC V E++  KP +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN- 227

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                         PQ+ +H         +   A D +  +   + + R +A + L HPF
Sbjct: 228 --------------PQLPSH---------ISEHARDFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 86/314 (27%), Positives = 149/314 (47%), Gaps = 53/314 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T +    +L  V+E++      ++ H      R  +     YA +I   L ++
Sbjct: 61  L-YCTFQTKE----HLFFVMEFL--NGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H S G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 H-SKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
             +YT ++D WS G ++ E+++G+  F GD   D+L E I+V  TP              
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTPH------------- 214

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL-IHPFFDELRDPNAR 366
                         +P+ +  E+ D++ +L +  P  R   +  +  HPFF  +   N  
Sbjct: 215 --------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NWT 257

Query: 367 LPSGRFLPPLFNFK 380
               R L P F  K
Sbjct: 258 ALEKRELDPPFKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 76/282 (26%), Positives = 119/282 (42%), Gaps = 42/282 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKH 131
             +G+G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V    
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 132 CFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F    D+    + + +EY    ++  + K   K   R+    +   A  + + LSY+H 
Sbjct: 67  AF---LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH- 122

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 246
           S  + HRDIKP N+L+     QVKLCDFG     V GE   S    +  + +Y APE I 
Sbjct: 123 SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDS----GVDQLVEIIKVLGTPT-------- 294
           G   Y+   D+WS G  + E+   +  FP +     G  +L+  I  +  P         
Sbjct: 177 GKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235

Query: 295 ---REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFPKRMP 327
               EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 87/315 (27%), Positives = 147/315 (46%), Gaps = 61/315 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRV--VKHFNKLNQRMPMIYVKLYAYQIFRA 184
           L  C F T +    +L  V+EY+   + +  +     F++   R        YA +I   
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-------FYAAEIICG 108

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE
Sbjct: 109 LQFLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G  +Y  ++D WS G ++ E+++G+  F G+   D+L + I         +      
Sbjct: 167 ILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR----- 212

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TALDALIHPFFDELRD 362
                        P    FP+ +  EA D +S+L +  P  R     D   HPFF   R 
Sbjct: 213 -------------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RG 253

Query: 363 PNARLPSGRFLPPLF 377
            +      R +PP F
Sbjct: 254 IDWERLEKREIPPPF 268

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.6 bits (219), Expect = 6e-20
 Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 27/236 (11%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 127
           +++GQG+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C     D  E  L++ +E++P  ++   +K +  L + +     + Y  QI   +S
Sbjct: 68  QYYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           E+I G   Y    DIWS GC V E++  KP +   +  + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 94/316 (29%), Positives = 146/316 (46%), Gaps = 53/316 (16%)

Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   +Y+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKL 176
           MR   H NVV + + +      DEL++  V+E++    +  +V H      RM    +  
Sbjct: 71  MRDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIAA 120

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYIC 235
               + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P   S + 
Sbjct: 121 VCLAVLKALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVG 178

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           + Y+ APELI     Y   +DIWS G +V E++ G+P +                  P  
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPL 222

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
           + +K +  N      P++K    HK+      P     + RLL   P  R TA + L HP
Sbjct: 223 KAMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHP 271

Query: 356 FFDELRDPNARLPSGR 371
           F  +   P+  +P  R
Sbjct: 272 FLAKAGPPSCIVPLMR 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 48/299 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           +G+G++G V++     TG T+A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           F      E  + + +EY+       +       + +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 248
           + HRD+KP N+LVN +  QVKLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVLGTPTREEIKCMNPNY 305
             YT   D+WS G  + E+ LG+  +P ++  +   QL  I+   G P            
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT---------- 229

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
                            P     +A D V++ L   PN R T    L HP+  + ++ +
Sbjct: 230 ----------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 65/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 127
           +++G+G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C     D +E  L++ +EY+P  ++   +K +  L + +     + Y  QI + +S
Sbjct: 68  QYYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           E+I G   Y    D+WS  C V E++  KP +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 89/291 (30%), Positives = 130/291 (44%), Gaps = 54/291 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 131
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F    D++ +Y   +LE+V      +  H  K   R P    K Y  ++  A  Y+H S
Sbjct: 86  SF---QDENRVYF--LLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH-S 136

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
             + +RD+KP+NLL++   H VK+ DFG AK +   +   +   +  Y APE+I  +  +
Sbjct: 137 KDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGH 192

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
             A+D W+ G ++ E + G P F  D              TP R   K +       KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-----DALIHPFF 357
                 W   F  R    A DLV  LLQ     R   L     D   HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 52/313 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L L    +    +   +N  N          YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           HR   + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             YT + D W  GC++ E++ GK  F       Q  E +K      REE++       E 
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF------RQRKEKVK------REEVERRVKEDQE- 222

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--C---TALDALIHPFFDELRDP 363
                        + ++    A  +  +LL   P  R  C    A +   HPFF   R  
Sbjct: 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---RTA 267

Query: 364 N-ARLPSGRFLPP 375
           N  RL +G   PP
Sbjct: 268 NFKRLEAGMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 80/300 (26%), Positives = 132/300 (44%), Gaps = 65/300 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D     L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR--- 213

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 214 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 79/291 (27%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +  +     + + +E++   ++ R+ K    +    P+  +   A  +   L+Y++   
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 253 TAIDIWSAGCVVAELMLGKPLFP------GDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              D+WS G  + EL LGK  FP       D G D  + I+ +L                
Sbjct: 181 VKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLL---------------- 222

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                QI   P  ++     P +  D V   L   P  R T       P F
Sbjct: 223 ----QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 86.5 bits (214), Expect = 8e-19
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 60/306 (19%)

Query: 77  RIVGQGSFGVVF---QAKCLETGETVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 123
           +++G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQI 181
           P +V+L H  F T  K    L+L+L+YV        + F  L QR       V+ Y+ +I
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGG-----EMFTHLYQRDNFSEDEVRFYSGEI 114

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-Y 239
             AL ++H+ +G+ +RDIK +N+L++   H V L DFG +K  +  E   +Y  C    Y
Sbjct: 115 ILALEHLHK-LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I G   +  A+D WS G ++ EL+ G   F  +   +   E+       +R  +K
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILK 225

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIH 354
           C  P                  FP  + PEA DL+ +LL+  P  R       A +   H
Sbjct: 226 CDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267

Query: 355 PFFDEL 360
           PFF  L
Sbjct: 268 PFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 82/306 (26%), Positives = 144/306 (47%), Gaps = 59/306 (19%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 124
           +++G G++G VF  + +   ++G+  A+K      ++Q  +         ++L+H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIF 182
            +V+L + F + T      L+L+L+Y+        + F  L+QR       V++Y+ +I 
Sbjct: 66  FLVTLHYAFQTDTK-----LHLILDYINGG-----ELFTHLSQRERFKEQEVQIYSGEIV 115

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 240
            AL ++H+ +G+ +RDIK +N+L++ + H V L DFG +K   + E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 241 APELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           AP+++ G    +  A+D WS G ++ EL+ G   F  D   +   EI       +R  +K
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 226

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDA---LIH 354
              P                  +P+ M   A D++ RLL   P  R  C   DA     H
Sbjct: 227 SEPP------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268

Query: 355 PFFDEL 360
           PFF ++
Sbjct: 269 PFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 127
           +++G+GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F TT+K    L  VL++V      +  H  +  +  P    + YA +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFV--NGGELFFHLQR-ERSFPEPRARFYAAEIASALGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H SI + +RD+KP+N+L++   H V L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 80/304 (26%), Positives = 126/304 (41%), Gaps = 48/304 (15%)

Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 126
           + +G+G FG V      +     TGE VA+K        Q +    RE++ +R LDH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V  K             L L++EY+P    R     ++    +  +   L++ QI + + 
Sbjct: 69  VKYKGV---CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL--LFSSQICKGMD 123

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYY 239
           Y+  S    HRD+  +N+LV      VK+ DFG AKVL +        EP  S I   +Y
Sbjct: 124 YLG-SQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE +  +  +++A D+WS G  + EL        GD       E ++++G    + I 
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYEL-----FTYGDPSQSPPAEFLRMIGIAQGQMIV 232

Query: 300 CMNPNYTE--FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                  +   + P+          P   P E  DL+    +  P  R  +   LI    
Sbjct: 233 TRLLELLKEGERLPR----------PPSCPDEVYDLMKLCWEAEPQDR-PSFADLI-LIV 280

Query: 358 DELR 361
           D LR
Sbjct: 281 DRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 47/299 (15%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+  +   E+I GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKKKYTRF-EKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             HPN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQN- 237

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                                   P+++     D ++R L+     R +A + L HPF 
Sbjct: 238 ------------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 52/296 (17%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           +F         L +++E+     +  ++    +L + +    ++    Q+  AL+++H  
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----F 246
             V HRD+K  N+L+      VKL DFG SAK     +   ++I + Y+ APE++    F
Sbjct: 123 K-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y    DIWS G  + EL   +P                    P  E    +NP   
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPMRV 216

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
             K    K+ P     P +      D +   L   P+ R TA + L HPF  +  D
Sbjct: 217 LLKIL--KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 80/300 (26%), Positives = 137/300 (45%), Gaps = 41/300 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHCFF 134
           G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     F+
Sbjct: 10  GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           S  +     +++ +E++   ++ +V+K       R+P   +   +  + R L+Y+     
Sbjct: 70  SDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T YT 
Sbjct: 121 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYTV 177

Query: 254 AIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
             DIWS G  + E+ +G+ P+ P D+      E+  + G P  E     +        P 
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 313 IKAHPWHKIF----------PKRMP-----PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             +     IF          P ++P      E  D V + L+ +P  R    +   HPF 
Sbjct: 233 --SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 22/229 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 132
           +G+G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 133 FFSTTDK---DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F   D     EL +++ L+   + V+        L   +P   +   A    +AL+Y+ 
Sbjct: 72  LFREGDCWICMEL-MDISLDKFYKYVY------EVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI--FG 247
             + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I    
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTR 295
              Y    D+WS G  + E+  GK  +P  +S  DQL +++K  G P  
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 53/293 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           + +G+GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI---YVKLYAYQIFRALSY 187
             F S  +   L++  V+EY       ++K  N+  QR  +     +  +  QI   L +
Sbjct: 65  --FASFQENGRLFI--VMEYCDGG--DLMKRINR--QRGVLFSEDQILSWFVQISLGLKH 116

Query: 188 IH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPEL 244
           IH R I   HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE 
Sbjct: 117 IHDRKI--LHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE- 172

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I     Y    DIWS GCV+ EL   K  F G++ + QLV  I       +     ++PN
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI------CQGYFAPISPN 225

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           ++                      +   L+S+L + SP  R +    L  PF 
Sbjct: 226 FSR---------------------DLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 84/321 (26%), Positives = 147/321 (45%), Gaps = 53/321 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K   ++ +++    +   +  + + L+Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           Y+   DIWS G  + E+ +G+ P+ P D+   +L+    V G P   E    +P      
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE---TSPR----- 230

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPS 369
            P+    P     P   PP A   +  LL Y  N                  +P  +LPS
Sbjct: 231 -PRPPGRPLSSYGPDSRPPMA---IFELLDYIVN------------------EPPPKLPS 268

Query: 370 GRFLPPLFNFKSHELKSVPVE 390
           G F     +F +  L   P E
Sbjct: 269 GVFGAEFQDFVNKCLIKNPAE 289

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 50/294 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T  K+ L+   V+EY+      ++ H    + +  +     YA +I   L ++
Sbjct: 61  L-YCTFQT--KENLF--FVMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 H-SKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
             +Y T++D WS G ++ E+++G+  F G    +              + I+  NP Y  
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY-- 215

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDEL 360
                          P+ +  EA D++ +L    P  R     D   HPFF E+
Sbjct: 216 ---------------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 66/305 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           L HC F T D+    L  V+EYV        + R  K F++   R        YA ++  
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRK-FDEPRSR-------FYAAEVTL 107

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 242
           AL ++HR  GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y AP
Sbjct: 108 ALMFLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E I    EY  ++D W+ G ++ E+M G+P F  D+  D L E I        +++    
Sbjct: 166 E-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI------LHDDV---- 213

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDA-----LIHP 355
                             ++P  +  EAV ++   +  +PN R  C A          HP
Sbjct: 214 ------------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255

Query: 356 FFDEL 360
           FF E+
Sbjct: 256 FFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 91/315 (28%), Positives = 146/315 (46%), Gaps = 51/315 (16%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTM 118
           G P++ +    +  +G+GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLY 177
           R   H NVV + + +      DEL++  V+E++    +  +V H      RM    +   
Sbjct: 74  RDYHHENVVDMYNSYLV---GDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATV 123

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICS 236
              + RALSY+H   GV HRDIK  ++L+     ++KL DFG    + K  P   S + +
Sbjct: 124 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ APE+I     Y T +DIWS G +V E++ G+P +                  P  +
Sbjct: 182 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQ 225

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            ++ +  N      P++K    HK+    +    +DL   +L   P+ R TA + L HPF
Sbjct: 226 AMRRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPF 274

Query: 357 FDELRDPNARLPSGR 371
                 P+  +P  R
Sbjct: 275 LKLAGPPSCIVPLMR 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 82.6 bits (204), Expect = 9e-18
 Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 41/297 (13%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 132
           I+G G+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           FF      E  +++  E++      V +       ++P   +   A  + + L+Y+  S+
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW-SL 114

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    QVKLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
              D+WS G    EL LG+  +P        +  +++L     E+             P 
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219

Query: 313 IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPS 369
           +    + + F        V  +++ ++  P  R    + + HPF  +  D NA + S
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVS 268

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 83/299 (27%), Positives = 140/299 (46%), Gaps = 55/299 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           R++G+GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T D+    L  V+E+V      ++ H  K ++R      + YA +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFV--NGGDLMFHIQK-SRRFDEARARFYAAEITSALMFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 H-DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  ++D W+ G ++ E++ G   F  ++  D L E I        +E+         
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV--------- 213

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD------ALIHPFFDEL 360
                        ++P  +  +AVD++   +  +P +R  +L        L HPFF EL
Sbjct: 214 -------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 81/316 (25%), Positives = 134/316 (42%), Gaps = 60/316 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 128
           +G+G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           LK  F + +D     L LV +Y+  +   +  H  K   R      K Y  ++  AL ++
Sbjct: 61  LKFSFQTDSD-----LYLVTDYM--SGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H+   + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              YT  +D WS G +V E+  G  P +  D    Q+                     Y 
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQM---------------------YR 207

Query: 307 EFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALI----HPFFDELR 361
              F +++       FPK  +  E    V  LL  +P  R  A    +    HPFF    
Sbjct: 208 NIAFGKVR-------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF---A 257

Query: 362 DPNARLPSGRFLPPLF 377
           D +  L S + + P F
Sbjct: 258 DIDWDLLSKKQITPPF 273

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 89/342 (26%), Positives = 136/342 (39%), Gaps = 110/342 (32%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 129
           +++G+G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +DE YL L++EY+P  + +  ++K  +   +     Y+   A  I  A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYI---AETIL-AIDS 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYIC 235
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 236 SR--------------------Y-------YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
                                 Y       Y APE +F  T Y    D WS G ++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 269 LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFPKRM 326
           +G P F  D               P     K +N               W +   FP  +
Sbjct: 234 VGYPPFCSD--------------NPQETYRKIIN---------------WKETLQFPDEV 264

Query: 327 P--PEAVDLVSRLLQYSPNLRCTALDAL---------IHPFF 357
           P  PEA DL+ RL        C A   L          HPFF
Sbjct: 265 PLSPEAKDLIKRLC-------CEAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 82/286 (28%), Positives = 136/286 (47%), Gaps = 49/286 (17%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 126
           +++GQGSFG VF  + +   + G+  A+K VL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRA 184
           V L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  A
Sbjct: 61  VKL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALA 110

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE
Sbjct: 111 LDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTPT-------- 294
           ++     +T + D WS G ++ E++ G   F G    + +  I+K  LG P         
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 295 --REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFPKRMPP 328
             R   K  NP       P     IK HP      W+K++ + + P
Sbjct: 228 LLRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRL 120
           G PK+   Y     +GQG+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L +PN+V+    F      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H +  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQN- 237

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                                   P+++ P   D ++R L+     R +A + L HPF 
Sbjct: 238 ------------------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y   R+VG+GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V+ +  +    +   LY+ +      +  H++ +   KL   +P   V  +  QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 244
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
            F    Y    D+W+ GC V E+   K  F        +  II                 
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----------------- 215

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             E K P +         PK   PE  +L++ +L   P  R +    L  P+
Sbjct: 216 --EGKLPPM---------PKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 60/298 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 109

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 167

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 214

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                            FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 215 -----------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 38/210 (18%)

Query: 79  VGQGSFGVVFQAKCL------ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 128
           +G+G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            K   +S   ++   L LV+EY+P    R  + KH  +L+ R  +    LYA QI + + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 187 YI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSR 237
           Y+   R +   HRD+  +N+LV      VK+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 19/224 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y   R+VG+GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + K  F     + + +L +V+EY    + + ++     KL    P   +  +  Q+   +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 244
            +IH    V HRDIK +N+ +     +VKL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           I+    Y    DIWS GC++ EL   K  F  +S  + ++++ +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 48/304 (15%)

Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 6   RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   +HP +V L   F+      +  L +++E+ P      +    +L++ +    +++ 
Sbjct: 63  LATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVI 115

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL Y+H S+ + HRD+K  N+L+      +KL DFG SAK +   +   S+I +
Sbjct: 116 CRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 237 RYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++   T     Y    DIWS G  + E+   +P                    
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 213

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P     P +   E  D +   L   P  R +A   L
Sbjct: 214 PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267

Query: 353 IHPF 356
            HPF
Sbjct: 268 EHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 85/324 (26%), Positives = 137/324 (42%), Gaps = 71/324 (21%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 130
           +VG+G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           + F    DKD LYL  V+EY P  + +  + ++ ++ ++ M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-------KVLVK---GEPNISYICSRY 238
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 239 YRAPELI-----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           Y APE++      G   Y    D WS G +  E++ G+  F   +       I+      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222

Query: 294 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                     N+  F KFP     P       ++  + +DL+  LL      R       
Sbjct: 223 ----------NFQRFLKFP---EDP-------KVSSDFLDLIQSLLC-GQKERLGYEGLC 261

Query: 353 IHPFFDELRDPNARLPSGRFLPPL 376
            HPFF ++   N R     F+P L
Sbjct: 262 CHPFFSKIDWNNIRNSLPPFVPTL 285

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 30/229 (13%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 126
           ERI  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 8   ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V     F+S  +     +++ +E++   ++ +V+K      +R+P   +   +  + R L
Sbjct: 66  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 117 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 174

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP 293
            G T Y+   DIWS G  + EL +G+ P+ P D+      E+  + G P
Sbjct: 175 QG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 101/408 (24%), Positives = 166/408 (40%), Gaps = 120/408 (29%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 129
           +++G+G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +D  YL L++E++P  + +  ++K+             + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEA 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYIC 235
           +H+ +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 236 SRY------------------------------------YRAPELIFGATEYTTAIDIWS 259
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 260 AGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPW 318
            G ++ E ++G P F  ++  +   +II                N+ E   FP    H  
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH-- 274

Query: 319 HKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFF-----DELRDPNARLPSGR 371
                  +  EA DL+ RL+  + N   R  A +   HPFF     D +R   A  P   
Sbjct: 275 -------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA--P--- 322

Query: 372 FLPPLFN------FKSHELKSVPVEILVKL-----IPEHARKQCPFLG 408
           F+P L +      F + EL+ VP    +K        E       F+G
Sbjct: 323 FIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIG 370

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 84/328 (25%), Positives = 134/328 (40%), Gaps = 87/328 (26%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 129
           +++G+G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY-----VKLYAYQIFRA 184
              F + T     YL LV++Y P           +L QR P         + YA ++  A
Sbjct: 67  YASFQTET-----YLCLVMDYCPG------GELFRLLQRQPGKCLSEEVARFYAAEVLLA 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF-------------------GSAKVLV 225
           L Y+H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V
Sbjct: 116 LEYLH-LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 226 KGEPNISYICS-----------RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
              P+ ++                Y APE+I G   + +A+D W+ G ++ E++ G   F
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232

Query: 275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLV 334
            G +  +    I+K                  E  FP     P        +   A DL+
Sbjct: 233 KGSNRDETFSNILK-----------------KEVTFPG---SP-------PVSSSARDLI 265

Query: 335 SRLLQYSPNLRC----TALDALIHPFFD 358
            +LL   P+ R      A +   HPFF 
Sbjct: 266 RKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 59/299 (19%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHP 124
           +++G+G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +V L    F T  K    L L+LEY+      +  H  +    M       Y  +I  A
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H   G+ +RD+KP+N+L++   H VKL DFG  K  +         C    Y APE
Sbjct: 113 LEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            I   + +  A+D WS G ++ +++ G P F  ++    + +I+K          K   P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
            Y                    + PEA DL+ +LL+ +P+ R       A +   HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 65/300 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 213

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 214 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 54/289 (18%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 126
           I+G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 127 VSLKHCFFSTTDKDELYLNLV----LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           V + + F  T DK    L+L+    L Y       + +H       M     + YA +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG----------------------KPLFPGDSGV 280
           E++     Y ++ D +S GC++ +L+ G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           +    +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 127
           +++G+GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F T +K    L  VL+YV      +  H  +  +       + YA ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYV--NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+N+L++   H V L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 77  RIVGQGSFGVVFQAKCL-ETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 128
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F     KDE YL LVLE+V   +      F + N+R P      YA QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
            +S+ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 -QSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
              +  A D W+ G  + E+++G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.5 bits (190), Expect = 7e-16
 Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALDFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQN- 237

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                                   P+R+     D ++R L+   + R +A + L HPF 
Sbjct: 238 ------------------------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 49/277 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P      YA +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGA 248
           R  G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I   
Sbjct: 119 RR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I             M  N +  
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI-------------MEHNVS-- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        +PK +  EAV +   L+   P+ R
Sbjct: 220 -------------YPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 57/296 (19%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 127
           ++G+G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L  CF     +D +    V+EY       ++ H +             YA  +   L Y
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGG--DLMMHIHT--DVFSEPRAVFYAACVVLGLQY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H +  + +RD+K  NLL++     VK+ DFG  K  +      S  C +  + APE++ 
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             T YT A+D W  G ++ E+++G+  FPGD                  EE+        
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
              F  I        +P+ +  EA+ ++ RLL+ +P  R       A D    PFF
Sbjct: 210 ---FDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 26/210 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 127
           +++G+GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L H  F T DK    L  VL+Y+   E  + + +    L  R      + YA +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 244
            Y+H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           +     Y   +D W  G V+ E++ G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 75/297 (25%), Positives = 137/297 (46%), Gaps = 48/297 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY-T 306
             +Y  ++D W+ G ++ E+M G+  F              ++G+         NP+  T
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPF-------------DIVGSSD-------NPDQNT 209

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL------DALIHPFF 357
           E    Q+      +I P+ +  +A  ++   L   P  R          D   HPFF
Sbjct: 210 EDYLFQVILEKQIRI-PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 91/334 (27%), Positives = 138/334 (41%), Gaps = 66/334 (19%)

Query: 62  GRNGQPKQTISYMA-ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNR 113
                P    S    ER+  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRM 169
           E++ +R ++HPNVV   H  F    +    + ++LE++     E  H   + F       
Sbjct: 122 EIEILRDVNHPNVVKC-HDMFDHNGE----IQVLLEFMDGGSLEGTHIADEQF------- 169

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-E 228
               +   A QI   ++Y+HR   + HRDIKP NLL+N     VK+ DFG +++L +  +
Sbjct: 170 ----LADVARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 229 PNISYICSRYYRAPELI-----FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQ 282
           P  S + +  Y +PE I      GA +   A DIWS G  + E  LG+ P   G  G D 
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFPFGVGRQG-DW 281

Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
              +  +          CM+        P+          P     E    +S  LQ  P
Sbjct: 282 ASLMCAI----------CMSQP------PEA---------PATASREFRHFISCCLQREP 316

Query: 343 NLRCTALDALIHPFFDELRDPNARLPSGRFLPPL 376
             R +A+  L HPF   LR    +   G  L  L
Sbjct: 317 AKRWSAMQLLQHPFI--LRAQPGQGQGGPNLHQL 348

Length = 353

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 77  RIVGQGSFGVVFQAK-CLETGE--TVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 128
           R +G+G FG V+Q        E   VA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L         ++ +++  V+E  P    R   +       + +  + LY+YQ+  AL+Y+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELR--SYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 189 HRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
             S    HRDI  +N+LV +P    VKL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 E-SKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LMLG   F G
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 33/221 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            H  F    +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++  AL  
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 242
           IH S+G  HRD+KP N+L++   H +KL DFG+    +K + N    C        Y +P
Sbjct: 158 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISP 212

Query: 243 ELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           E++    G   Y    D WS G  + E+++G   F  DS V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 80/310 (25%), Positives = 132/310 (42%), Gaps = 50/310 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIH 189
           + F S T     +L LV+  +      +  H   + +R + M  V  Y+ QI   + ++H
Sbjct: 60  YAFESKT-----HLCLVMSLM--NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I    
Sbjct: 113 -SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + N+TE  
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE-- 224

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL----DALIHPFFDELRDPNA 365
                              E+ D+    L   P  R  +     D   H FF  +  P  
Sbjct: 225 -------------------ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP-- 263

Query: 366 RLPSGRFLPP 375
           RL +G   PP
Sbjct: 264 RLEAGLIPPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           S   +D+L++   +E+      + + H         + YV   + +  + L Y+H S G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYV---SRETLQGLYYLH-SKGK 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
            HRDIK  N+L+  + H VKL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 251 -YTTAIDIWSAGCVVAELM-LGKPLF 274
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 26/228 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 126
           Y+  + +G+GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIF 182
           V  +  F    +   LY+  V++Y           + K+N +  +++    +  +  QI 
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 183 RALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYR 240
            AL ++H R I   HRDIK QN+ +      +KL DFG A+VL    E   + I + YY 
Sbjct: 112 LALKHVHDRKI--LHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYL 168

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           +PE I     Y    DIW+ GCV+ E+   K  F   +  + +++II+
Sbjct: 169 SPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 79/319 (24%), Positives = 149/319 (46%), Gaps = 51/319 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 127
           R++G+GS+  V   +  +T    A+K V++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMK-VIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L  CF + +      L  V+E+V      ++ H  +  +++P  + + Y+ +I  AL++
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNF 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 246
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF--------PGDSGVDQLVEII--KVLGTPTRE 296
           G  +Y  ++D W+ G ++ E+M G+  F        P  +  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 297 EIKC-------MNPNYTE-------FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
            +K        +N +  E         F  IK+HP    F + +  + ++    L  Y P
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP----FFRNIDWDLLEQKQVLPPYKP 284

Query: 343 NLRCT-ALDALIHPFFDEL 360
           N+     LD     F DE 
Sbjct: 285 NIESDRDLDNFDPQFTDEP 303

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 43/237 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 125
           Y   +++G+G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           VV L  C F    +D+ YL +V+EY+P  + V+ +       N  +P  + K Y  ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 233
           AL  IH S+G+ HRD+KP N+L++ H H +KL DFG+   + +          G P+   
Sbjct: 154 ALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 234 ICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 41/214 (19%)

Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           R++G+G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K C    +++    L L++EYVP    R  + KH   L Q +      L+A QI   +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 243
           +Y+H S    HRD+  +N+L++ +   VK+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLH-SQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 244 ---LIFGATE------YTTAIDIWSAGCVVAELM 268
              + + A E      ++ A D+WS G  + EL+
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 52/314 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 128
           R++G+G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L +    +    +   +N  N          YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           HR     +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             YT + D W  GC++ E++ G+  F G        E +K      REE+          
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV---------- 213

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CT---ALDALIHPFFDELRDP 363
                +     +++  +   EA  +   LL   P  R  C    A +   HPFF   R+ 
Sbjct: 214 ---DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF---RNM 267

Query: 364 N-ARLPSGRFLPPL 376
           N  RL +G   PP 
Sbjct: 268 NFKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 93/345 (26%), Positives = 143/345 (41%), Gaps = 101/345 (29%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRAL 185
           L   ++S  DKD LY   V++Y+P            L  RM   P +  + Y  ++  A+
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRMEVFPEVLARFYIAELTLAI 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG---------SAKVLVKG--------E 228
             +H+ +G  HRDIKP N+L++   H +KL DFG         ++K   KG        E
Sbjct: 115 ESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 229 PNI-------------------------------SYICSRYYRAPELIFGATEYTTAIDI 257
           P+                                S + +  Y APE++     YT   D 
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDW 231

Query: 258 WSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 317
           WS G ++ E+++G+P F              +  TPT  ++K +N   T    PQ+K   
Sbjct: 232 WSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK--- 274

Query: 318 WHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDEL 360
                   + PEAVDL+++L   +     R  A D   HPFF E+
Sbjct: 275 --------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 85/315 (26%), Positives = 137/315 (43%), Gaps = 65/315 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 129
           +++G+G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F     +DE  L LV++Y       ++   +K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYY 239
           + +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI     
Sbjct: 120 Q-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEIL 175

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           +A E   G   Y    D WS G  + E++ G+  F  +S V+   +I+            
Sbjct: 176 QAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------------ 221

Query: 300 CMNPNYTE-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHP 355
               N+ E F+FP              +  EA DL+ RL+  SP  R       D   HP
Sbjct: 222 ----NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHP 267

Query: 356 FF-----DELRDPNA 365
           FF     D +R+  A
Sbjct: 268 FFEGIDWDNIRNSTA 282

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 9e-15
 Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 47/242 (19%)

Query: 79  VGQGSFGVVFQAKCLETGE---TVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 130
           +G G+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    + L   LV+E  P   + +    + K  + +P+  +K  A+Q+   ++Y+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 190 RSIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------- 240
               V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 241 ----APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVEIIKVLGTP 293
               APE I     +++  D+WS G  + E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 294 TR 295
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 46/288 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 133
           +G G+FG V++A+  ETG  +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +   +     L +++E+        V    +L + +    +++   Q   AL+Y+H +  
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAV--MLELERPLTEPQIRVVCKQTLEALNYLHEN-K 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 250
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 251 --YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WS G  + E+   +P                    P  E    +NP     
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 218

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           K    K+ P     P R   E  D + + L+ + + R T    L HPF
Sbjct: 219 KIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 43/237 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 125
           Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++  
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 233
           AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+   
Sbjct: 154 ALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--- 208

Query: 234 ICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/207 (27%), Positives = 108/207 (52%), Gaps = 20/207 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 128
           R++G+GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF +T+      L LV+EYV      ++ H  +  +++P  + + YA +I  AL+++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYV--NGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  +      S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             EY  ++D W+ G ++ E+M G+  F
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 83/313 (26%), Positives = 139/313 (44%), Gaps = 50/313 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L L    +    +   ++             YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H+   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++   
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             YT + D W+ GC++ E++ G+  F       Q  + IK      REE++ +     E 
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE- 222

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP 363
                        + ++  P+A  L   LL   P  R       A +   HP F ++   
Sbjct: 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268

Query: 364 NARLPSGRFLPPL 376
             RL +G   PP 
Sbjct: 269 FKRLEAGMLEPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 27/210 (12%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 126
           I+G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYAYQIFRA 184
           V + + F +    D+L   L L    +  + + +H  F++   R        YA +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-------FYATEIILG 109

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           +   T Y ++ D +S GC++ +L+ G   F
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 55/295 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLD---HPNVVSL 129
           +++G+G+FG V   +   +G+  A+K    +V+  K      L   R+L    HP + SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K+ F  T D+    L  V+EYV      +  H ++  +       + Y  +I  AL Y+H
Sbjct: 61  KYSF-QTKDR----LCFVMEYV--NGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +   
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLED 169

Query: 249 TEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      E+IK        
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EDIK-------- 213

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                         FP+ +  +A  L+S LL   PN R       A + + H FF
Sbjct: 214 --------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 54/294 (18%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P  +   YA +I   L ++H
Sbjct: 67  HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFFLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I   
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AY 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I             M  N +  
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI-------------MEHNVS-- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTA---LDALIHPFF 357
                        +PK +  EAV +   LL   P  R  C      D   H FF
Sbjct: 220 -------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 65/270 (24%), Positives = 122/270 (45%), Gaps = 39/270 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 129
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F + +D     + + +E +   + +++K   ++   +P   +      I +AL Y+ 
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 248
              GV HRD+KP N+L++  +  VKLCDFG +  LV  +    S  C+ Y  APE I   
Sbjct: 132 EKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPP 189

Query: 249 T---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
               +Y    D+WS G  + EL  G+  +       +++  I     P+    +  +P++
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249

Query: 306 TEF-------------KFPQIKAHPWHKIF 322
             F             K+ ++  HP+ + +
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 6e-14
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239

Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 60/247 (24%), Positives = 111/247 (44%), Gaps = 30/247 (12%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVL-------QDKRYKNRELQTM----- 118
            Y     +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +     
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 119 ---RLLDHPNVVSLKHCFFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKL---NQRMPM 171
                L HPN+V     F    + D LY+ + L E  P     + +HFN L    QR   
Sbjct: 61  IIKEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAP-----LGEHFNSLKEKKQRFTE 112

Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +     Q+  AL Y+H+   + HRD+ P N+++     +V + DFG AK         
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLT 171

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           S + +  Y  PE++     Y    D+W+ GC++ ++   +P F   + +    +I++ + 
Sbjct: 172 SVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230

Query: 292 TPTREEI 298
            P  E +
Sbjct: 231 EPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           S   +++L+  + +EY      + + H       + + YV     +  + L+Y+H S G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV---CRETLQGLAYLH-SKGK 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
            HRDIK  N+L+  +   VKL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 251 -YTTAIDIWSAGCVVAELM-LGKPLF 274
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L +    +    +   +N  N          YA ++   L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            R   + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I   
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLF 274
            +YT + D W  GC++ E++ G+  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 81/317 (25%), Positives = 138/317 (43%), Gaps = 50/317 (15%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 131
           ++G+G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 132 C--FFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              +F     +  ++ +V+ +Y P  +  ++KH    + R    ++    +Q   AL Y 
Sbjct: 196 IQRYFQN---ETGHMCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247

Query: 189 HRSIGVCHRDIKPQNLL-------VNPHTHQ--------VKLCDFGSAKVLVKGEPNISY 233
           H  + + H D+KP+N+L       V+P T++        V++CD G      +     + 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305

Query: 234 ICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           + +R+YR+PE++ G    Y+T  D+WS GC++ EL  GK L+     ++ L  + K LG 
Sbjct: 306 VSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363

Query: 293 -PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFPKRMPPEAV------DLVSRLLQ 339
            P+    +C        Y      +    P H  +I   R   E +      DL+  LL 
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423

Query: 340 YSPNLRCTALDALIHPF 356
           Y    R  A     HP+
Sbjct: 424 YDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 64/271 (23%)

Query: 101 IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----- 152
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ 212
           + + +          ++    VK    Q+  AL+ +H    + H DIK +N+L +    +
Sbjct: 98  DLLKK--------EGKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDR 148

Query: 213 VKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP 327
           + GK   P     D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 328 PEAVDLVSRLLQYSPNLRCTALDALI-HPFF 357
             A D V  +L+Y+ N R T  + +I HPF 
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.2 bits (171), Expect = 8e-13
 Identities = 66/252 (26%), Positives = 114/252 (45%), Gaps = 45/252 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 127 VSLKHCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           V     F +  ++ +LY+  ++E+     +   + +  K F K+ +   +   +    Q+
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR----QL 127

Query: 182 FRALSYIHR------SIGVCHRDIKPQNLLVNPHTHQV----------------KLCDFG 219
             AL+Y H          V HRD+KPQN+ ++     +                K+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 220 SAKVLVKGEPNISYIC--SRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPG 276
            +K +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  GK  F  
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 277 DSGVDQLVEIIK 288
            +   QL+  +K
Sbjct: 246 ANNFSQLISELK 257

Length = 1021

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 73/325 (22%), Positives = 115/325 (35%), Gaps = 58/325 (17%)

Query: 85  GVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTD 138
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 139 KDELYL-----------NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICSRYY 239
           IH S G  HR +K  ++L++     V L     +  ++K         +   S + +  +
Sbjct: 117 IH-SKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 240 RAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR--- 295
            +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232

Query: 296 -----EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
                     M+ + +  + P  +       + +         V   LQ  P  R +A  
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Query: 351 ALIHPFFDELRDPNARLPSGRFLPP 375
            L H FF + +  N  L     L P
Sbjct: 292 LLNHSFFKQCKRRNTSLLD--LLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 83/311 (26%), Positives = 140/311 (45%), Gaps = 44/311 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           T     +DE YL LV++Y       ++   +K   R+P    + Y  ++  A+  IH+  
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 246
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+                N+ 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 224

Query: 307 E-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL-QYSPNLRCTALDAL-IHPFFDELRDP 363
           E F+FP   +H         +  EA DL+ RL+      L    ++    H FF+ +   
Sbjct: 225 ERFQFP---SH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275

Query: 364 NARLPSGRFLP 374
           N R     ++P
Sbjct: 276 NIRNLEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 40/289 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 133
           +G+G++G VF+    + G   A+K +L      + E++        L DHPNVV     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 134 FSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +    K+   L LVLE     +V  +VK F K  +RM    +    ++    L ++H + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA--- 248
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 249 -TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            + Y    D+WS G    EL  G P                    P  +    ++P    
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP--------------------PLAD----LHPMRAL 238

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           FK P+      H+  P+    E  D + + L      R T  D L H F
Sbjct: 239 FKIPRNPPPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 132
            +VG G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 133 FFSTT---DKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           F   +     D+L+  LV+E+    +V  +VK  N     +   ++     +I R L+++
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVK--NTKGNALKEDWIAYICREILRGLAHL 137

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF 246
           H    V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I 
Sbjct: 138 HAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIA 194

Query: 247 ----GATEYTTAIDIWSAGCVVAELMLGKP 272
                   Y    DIWS G    E+  G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 30/226 (13%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     S+       + L+ + +P    +  V  H + +  +    Y+  +  QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQ----YLLNWCVQIAKGM 122

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           SY+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
           E I     YT   D+WS G  V ELM  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 133
           +VG G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 134 FSTTD---KDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    D+L+  LV+E+    +V  ++K  N     +   ++     +I R LS++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 246
           +   V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 247 ---GATEYTTAIDIWSAGCVVAELMLGKP 272
                  Y    D+WS G    E+  G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 69/296 (23%), Positives = 126/296 (42%), Gaps = 32/296 (10%)

Query: 82  GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 141
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130

Query: 142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP 201
               +    +P     +  +  K ++ +P+    +   QI   L Y+H +  + HRD+K 
Sbjct: 131 ----ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKT 185

Query: 202 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAG 261
           +N+ +N    QV + D G+A+  V     +    +    APE +    +Y +  DIWSAG
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 262 CVVAELMLGKP--LF---------PGDSGVDQLVEIIKVLGT-----PTREEIKCMNPNY 305
            V+ E ML  P  +F            S    L++II  L       P     + +   +
Sbjct: 244 IVLFE-MLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGF 301

Query: 306 TEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
            E+   + + +  +  F +  +P +   LV ++L +   +R +A + L +P F +L
Sbjct: 302 IEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 47/276 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++    ++  R    +   YA +I   L ++H 
Sbjct: 67  HSCFQTMDR----LYFVMEYV--NGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH- 118

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  ++D W+ G ++ E++ G+  F G+   D+L                          
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DEL-------------------------- 209

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           F  I  H  +  +PK M  EAV +   L+   P  R
Sbjct: 210 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 63/252 (25%)

Query: 78  IVGQGSFGVVFQAKCLETGE-----TVAIKKVLQDKRYKN-----RELQTMRLL-DHPNV 126
            +G+G+FG V +A+ +         TVA+K +  D   K+      E++ M+++  H N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL---------- 176
           ++L       T +  LY+  V+EY     H  ++ F +   R P  Y             
Sbjct: 79  INLLGV---CTQEGPLYV--VVEYAA---HGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129

Query: 177 -------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                  +AYQ+ R + ++  S    HRD+  +N+LV    H +K+ DFG A+       
Sbjct: 130 TQKDLVSFAYQVARGMEFL-ASKKCIHRDLAARNVLVT-EDHVMKIADFGLAR------- 180

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           +I +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 181 DIHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 238 IP-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 79/329 (24%), Positives = 136/329 (41%), Gaps = 85/329 (25%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F+S  DK  LYL  ++E++P   +  ++   + L++     Y+     +   A+  IH+ 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEATQFYIA----ETVLAIDAIHQ- 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFG-------------------------------- 219
           +G  HRDIKP NLL++   H VKL DFG                                
Sbjct: 120 LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 220 --SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
              A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+++G P F 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFPKRMP--PEAV 331
            +              TP     K MN               W +  +FP  +P   +A 
Sbjct: 238 SE--------------TPQETYRKVMN---------------WKETLVFPPEVPISEKAK 268

Query: 332 DLVSRLLQYSPN-LRCTALDALI-HPFFD 358
           DL+ R    S N +    ++ +  HPFF+
Sbjct: 269 DLILRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 66/294 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 72  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 122

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +   + ++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 179

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
           +  DIWS G    EL  G+P                                      P 
Sbjct: 180 SKADIWSLGITAIELAKGEP--------------------------------------PH 201

Query: 313 IKAHPWHKIF--PKRMPPE--------AVDLVSRLLQYSPNLRCTALDALIHPF 356
            + HP   +F  PK  PP           + V   L   P+ R TA + L H F
Sbjct: 202 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 64/295 (21%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 73  YMAERIVGQGSFGVVF--QAKCLETGETVAIKKVL-------QDKRYKNRELQTMRLLDH 123
           Y+ ++ +G+GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           P +V   H  F   D       ++ EY     +   ++      + +    V  +  Q+ 
Sbjct: 62  PAIVKF-HASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 241
             + Y+H+   + HRD+K +N+ +    + +K+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y +  DIWS GC++ E+      F    G + L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAF---EGQNFLSVVLRIVEGPT------- 222

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                    P +         P+    +   ++  +L   P+LR +A + L +PF
Sbjct: 223 ---------PSL---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 72/294 (24%), Positives = 114/294 (38%), Gaps = 66/294 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +      ++      +K    +I + L Y+H    
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
           +  DIWS G    EL  G+P                                      P 
Sbjct: 180 SKADIWSLGITAIELAKGEP--------------------------------------PN 201

Query: 313 IKAHPWHKIF--PKRMPPEAVDLVSR--------LLQYSPNLRCTALDALIHPF 356
              HP   +F  PK  PP      S+         L   P+ R TA + L H F
Sbjct: 202 SDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 43/243 (17%)

Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             K      T+     + L++E++P     E + R     N L Q++       YA QI 
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN-LKQQLK------YAVQIC 119

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----- 237
           + + Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 238 --YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
             ++ APE +  +  Y  A D+WS G  + EL     L   DS    +   +K++G PT 
Sbjct: 175 PVFWYAPECLIQSKFY-IASDVWSFGVTLYEL-----LTYCDSESSPMTLFLKMIG-PTH 227

Query: 296 EEI 298
            ++
Sbjct: 228 GQM 230

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 79/302 (26%), Positives = 128/302 (42%), Gaps = 49/302 (16%)

Query: 88  FQAKCLE--TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 145
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F  T +K   +  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK---FTC 159

Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           L+L      ++  +       + + +  +      + RA+ Y+H +  + HRDIK +N+ 
Sbjct: 160 LILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIF 214

Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTTAIDI 257
           +N H   V L DFG+A   V    N      +YY         APEL+     Y  A+DI
Sbjct: 215 IN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVDI 266

Query: 258 WSAGCVVAELMLGK-PLFPGDSGVD-------QLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           WSAG V+ E+      LF  D G+D       Q+  II+  GT   E       N  E  
Sbjct: 267 WSAGIVLFEMATCHDSLFEKD-GLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY 325

Query: 310 FPQIK-------AHP-WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
               K       + P W  ++   +P +   L+ ++L +  + R +A   L    F ++ 
Sbjct: 326 IGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383

Query: 362 DP 363
           DP
Sbjct: 384 DP 385

Length = 391

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 133
           +G+G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +         L LVLE     +V  +VK      QR+    +    Y     L ++H + 
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 252 TTA----IDIWSAGCVVAELMLGKP 272
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 54/269 (20%)

Query: 95  TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET 154
           T +T  +K + +   Y +RE  T+     PN+V L     S   +D ++L  VL++    
Sbjct: 17  TQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVS---EDSVFL--VLQHAEGG 70

Query: 155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK 214
             ++  H +K    +P   VK +A ++  AL  +HR   VC RD+ P N+L++   H ++
Sbjct: 71  --KLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQ 125

Query: 215 LCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL 273
           L  F       + E +         Y APE + G +E T A D WS G ++ EL+ GK L
Sbjct: 126 LTYFSR---WSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Query: 274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDL 333
                                   ++C +P+        I  H    I P+ +  EA  L
Sbjct: 182 ------------------------VEC-HPS-------GINTHTTLNI-PEWVSEEARSL 208

Query: 334 VSRLLQYSPNLRCTALDALI-----HPFF 357
           + +LLQ++P  R  A  A +     HPFF
Sbjct: 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 22/224 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 129
           +++G+G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F    D++ LYL  V++Y       ++   +K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 246
           + +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 247 ---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
              G  +Y    D WS G  + E++ G+  F  +S V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 25/219 (11%)

Query: 73  YMAERIVGQGSFGVVFQA-KCLETGETVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 127
           Y+   +VG+      F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 128 SLKHCF-FSTTDKDELYLNLVLEY-VPETVHRVVKHFNKLNQRMPM--IYVKLYAYQIFR 183
             KH   F + DK    L L++EY     +++ +K   +L + +P     V L  YQI  
Sbjct: 129 --KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVL 180

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYR 240
           AL  +H S  + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY 
Sbjct: 181 ALDEVH-SRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDS 278
           APEL +    Y+   D+WS G ++ EL+ L +P F G S
Sbjct: 239 APEL-WERKRYSKKADMWSLGVILYELLTLHRP-FKGPS 275

Length = 478

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 61/251 (24%)

Query: 94  ETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 145
            TG  VAIK +  D         R++ RE      L HPN+V+L      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
            V EYVP  T+  V+     L         +L   Q+  AL+  H   G+ HRD+KPQN+
Sbjct: 56  AVFEYVPGRTLREVLAADGALP---AGETGRLML-QVLDALACAHNQ-GIVHRDLKPQNI 110

Query: 205 LVN-----PHTHQVKLCDFG------------SAKVLVKGEPNISYICSRYYRAPELIFG 247
           +V+     PH    K+ DFG             A +    E     + +  Y APE + G
Sbjct: 111 MVSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTE----VLGTPTYCAPEQLRG 163

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
               T   D+++ G +  E + G+ +  G S    + EI+           + ++P   +
Sbjct: 164 EPV-TPNSDLYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--D 206

Query: 308 FKFPQ-IKAHP 317
              P  I  HP
Sbjct: 207 VSLPPWIAGHP 217

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 19/164 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKH 131
           + +G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69

Query: 132 CFFSTTDKDELYLNLVLEY-VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            ++S    + +YL  V+EY +   V  ++  +   ++ M + Y+     ++  AL Y+HR
Sbjct: 70  -YYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR 122

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             G+ HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 123 H-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 81/346 (23%), Positives = 122/346 (35%), Gaps = 113/346 (32%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRAL 185
           L   ++S  DKD LY   V++Y+P            L  R+        + Y  ++  A+
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRLGIFEEDLARFYIAELTCAI 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPH----------------THQVKL-------------- 215
             +H+ +G  HRDIKP N+L++                  TH  K               
Sbjct: 115 ESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 216 ---------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTTA 254
                    C     +   K            G PN        Y APE++   T YT  
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQL 224

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            D WS G ++ E+++G+P F  D              TP   ++K +N   T     Q K
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWETTLHIPSQAK 270

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHPFF 357
                      +  EA DL+ RL       R     A +   HPFF
Sbjct: 271 -----------LSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 50/239 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F+S  DK  LYL  ++E++P   +  ++   + L +     Y+     +   A+  IH+ 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEETQFYIA----ETVLAIDSIHQ- 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--------------------- 230
           +G  HRDIKP NLL++   H VKL DFG    L K                         
Sbjct: 120 LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 231 ---------------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
                           S + +  Y APE +F  T Y    D WS G ++ E+++G P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 72/294 (24%), Positives = 112/294 (38%), Gaps = 66/294 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L +     Y+     +I + L Y+H    
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSERK 122

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 179

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
              DIWS G    EL  G+P                                      P 
Sbjct: 180 FKADIWSLGITAIELAKGEP--------------------------------------PN 201

Query: 313 IKAHPWHKIF--PKRMPPEA--------VDLVSRLLQYSPNLRCTALDALIHPF 356
              HP   +F  PK  PP           + V   L   P  R TA + L H F
Sbjct: 202 SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 80/249 (32%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIK--------KVLQDKRYKNR 113
           P   + ++ E  +G+G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMP-- 170
           E + M  L HPN+V    C      K++    L  EY+    +H        L +  P  
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEF------LVRNSPHS 106

Query: 171 -------------------MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH 211
                               +++   A QI   + Y+  S    HRD+  +N LV     
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHI---AIQIAAGMEYL-SSHHFVHRDLAARNCLVGEG-L 161

Query: 212 QVKLCDFGSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTTAIDIW 258
            VK+ DFG ++ +   +         YYR             PE I +G  ++TT  DIW
Sbjct: 162 TVKISDFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIW 210

Query: 259 SAGCVVAEL 267
           S G V+ E+
Sbjct: 211 SFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YTT  D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             ++  +   P     +  +I    W    PK  P     V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGD-PKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 32/223 (14%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 123
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYA 178
             +V L   +   ++++ +Y+  V EY+      + +        +L Q + M      A
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            QI   ++Y+       HRD+  +N+LV  +    K+ DFG A+++   E   +   +++
Sbjct: 110 AQIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKF 166

Query: 239 ---YRAPELI-FGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
              + APE   +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 167 PIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 16/97 (16%)

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    
Sbjct: 266 ARQLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPF 318

Query: 238 YY--------RAPELIFGATEYTTAIDIWSAGCVVAE 266
           +Y         APE++ G   YT ++DIWSAG V+ E
Sbjct: 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 40/210 (19%)

Query: 79  VGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 130
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
               +        L +V E  P     + + +             +  +  YA QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110

Query: 186 SYIH--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+   R I   HRD+  +N+L+     +VK+ DFG  + L + E +  Y+   + +   
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164

Query: 241 ---APELIFGATEYTTAIDIWSAGCVVAEL 267
              APE +   T ++ A D+W  G  + E+
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 83/318 (26%), Positives = 133/318 (41%), Gaps = 60/318 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRV-VKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + F + TD     L LV+  +     R  + + ++ N   P      Y  QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 248
           +   + +RD+KP+N+L++   + V++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 QR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK--CMNPNYT 306
            EY  ++D ++ G  + E++  +  F       + VE          +E+K   +N + T
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARG---EKVE---------NKELKQRILNDSVT 219

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-------CTALDALIHPFFDE 359
                          +P +  P +      LL   P  R       C  L    HP F  
Sbjct: 220 ---------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLF-- 260

Query: 360 LRDPNARLPSGRFLPPLF 377
            RD N R      LPP F
Sbjct: 261 -RDLNWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 16/219 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   R++G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 127 VSLKHCFFSTTDKDE---LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           V     F     ++    L + LVL+Y     + + +K   K N+        L   Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            A+ ++H S  + HRDIK  N+L+  +   VKL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            APE I+    Y+   D++S G ++ EL+  K  F G++
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 78  IVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
            +G+G FG VF AK      E GET+ + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYA--YQI 181
            L        + +  Y  ++LEY      +   R  K  ++  +  P+   +  A   QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 237
              + ++  +  V HRD+  +N LV+    +VK+    S   L K   N  Y   R    
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYNSEYYKLRNALI 180

Query: 238 --YYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
              + APE +    +++T  D+WS G ++ E+
Sbjct: 181 PLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 17/171 (9%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQYS 341
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ +
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 74/300 (24%), Positives = 121/300 (40%), Gaps = 67/300 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
             +G+G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
                  K  +Y  +V+E VP     ++    K   R+ +  +   +      + Y+  S
Sbjct: 58  -IGVCVQKQPIY--IVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ES 111

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------APE- 243
               HRD+  +N LV    + +K+ DFG    + + E    Y  S   +       APE 
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+   
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE--- 209

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
              + ++ P           P+  P E    + RL+      +C A D    P F E+ +
Sbjct: 210 ---SGYRMPA----------PQLCPEE----IYRLML-----QCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 50/301 (16%)

Query: 82  GSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD 198
               + + V   +P+    +  + ++    +P+        ++  AL+Y+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 253
           +K +N+ ++   + V L DFG+A  L       +  C  +       +PEL+     Y  
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 254 AIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---- 308
             DIWSAG V+ E+ +    LF            +K   +  R  I+CM  +  EF    
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQNG 317

Query: 309 ---------KFPQIKAHPWH--KIFPKRMPPEAVD-LVSRLLQYSPNLRCTALDALIHPF 356
                    ++  +   P+    +  K      V+ L++++L +    R +A D L  P 
Sbjct: 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377

Query: 357 F 357
           F
Sbjct: 378 F 378

Length = 392

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 63/237 (26%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 116
           P+  I Y   R +GQG+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 117 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNK 164
            M   DHPN+V L          C    + +  D +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 165 LNQRMPMIYVKLY--AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 222
               +P+   +    A Q+   ++Y+     V HRD+  +N LV  +   VK+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 223 VLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
                  NI    + YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 36/226 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           R +G G FG V++   L    T VA+K +            E Q M+ L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66

Query: 133 FFSTTDKDELYL-------NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +   T ++ +Y+         +LEY+     R +    KL Q + M      A Q+   +
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQLIDM------AAQVASGM 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+  +    HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + AP
Sbjct: 117 AYL-EAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAP 173

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG--VDQLVE 285
           E       ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 174 EAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 125
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           +V+L     + T    + +  + EY     +   + R  + F  L   +       ++YQ
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS------FSYQ 149

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-- 238
           + + ++++  S    HRD+  +N+L+  H   VK+CDFG A+ ++     +    +R   
Sbjct: 150 VAKGMAFL-ASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 239 -YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 208 KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  +   +V EY+      +     K + +  +I +      I   + Y
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 122 L-SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 35/215 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            L     S T      + LV + +P     + VH   +H + +  ++ +     +  QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLN----WCVQIA 119

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---Y 239
           + + Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML--GKP 272
            A E I    ++T   D+WS G  + ELM   GKP
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 29/211 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 129
           +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F+  T+    Y NL L+Y+ E         N+  Q +  + +   A QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC--------NR--QEVNAVVLLYMATQISSAMEYLE 121

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 246
           +     HRD+  +N LV  + H VK+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 122 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL- 177

Query: 247 GATEYTTAIDIWSAGCVVAEL-MLGKPLFPG 276
              +++   D+W+ G ++ E+   G   +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 32/229 (13%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 127
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L   +   T +  LY+  V E++     ++ + +   KL++ M +   +     +   +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YY 239
            Y+ R+    HRD+  +N LV+  T  VK+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             PE +F  ++Y++  D+WS G ++ E+   GK  F   S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 35/210 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 128 SLKH-CFFSTTDKDELYLNL-----VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            L   C  ST    +L   L     +L+YV E    +              Y+  +  QI
Sbjct: 73  RLLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQI 118

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 238
            + ++Y+     V HRD+  +N+LV    H VK+ DFG AK+L   E        +    
Sbjct: 119 AKGMNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           + A E I     YT   D+WS G  V ELM
Sbjct: 177 WMALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 73/222 (32%)

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 238
           QI  AL  +H S G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   + 
Sbjct: 263 QILFALDGLH-STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 239 ----YRAPELIFGATEYTTA---------------------IDIWSAGCVVAELMLGKPL 273
               Y APE    +T+  +A                      DI+SAG     L+  +  
Sbjct: 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQMA 373

Query: 274 FPG---DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP-- 328
           FP    DS + Q              ++K  + +             W K+   R  P  
Sbjct: 374 FPNLRSDSNLIQF-----------NRQLKRNDYDLVA----------WRKLVEPRASPDL 412

Query: 329 ----EAVD--------LVSRLLQYSPNLRCTALDALIHPFFD 358
               E +D        L+  ++++    R +A  AL HP+FD
Sbjct: 413 RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 128
           +++G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 129 --LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
             L  C  ST       + LV + +P     ++ +  +   R+    +  +  QI + +S
Sbjct: 73  RLLGICLTST-------VQLVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 124 YL-EEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            I     +T   D+WS G  V ELM
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 23/172 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   +  Y+  
Sbjct: 178 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232

Query: 237 RYYR------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
              R      APE IF    YTT  D+WS G ++ E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
                +E  +   P Y   +   I    WH   P+  P   E V+++  LLQ
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHN-NPEDRPTFSELVEILGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 60/238 (25%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC--LETGET---VAIKKVLQD------KRYKNREL 115
            + TI     R +G+G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMP 170
           + +    H N+V         T+ D     +V EY+      + +         L     
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 171 ---------MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 221
                    ++ +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG +
Sbjct: 115 PMGELTLSQLLQI---AVQIASGMVYL-ASQHFVHRDLATRNCLVG-YDLVVKIGDFGMS 169

Query: 222 KVLVKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL 267
           + +        Y    YYR             PE I     +TT  D+WS G V+ E+
Sbjct: 170 RDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 58/244 (23%)

Query: 77  RIVGQGSFGVVFQAKCLE-----TGET-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 125
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 126 VVS-LKHCFFSTTDKDELYLNLVLEYVP--ETVH-----RVVKHFNKLNQRMPMIYVKLY 177
           +V  L  C       +  Y+  ++E +   + +      RV +    L     ++ + L 
Sbjct: 61  IVKLLGVCL----LNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL- 113

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISY 233
              + +   Y+ +   + HRD+  +N LV+   +     VK+ DFG A+ + K       
Sbjct: 114 --DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK------- 163

Query: 234 ICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG 279
             S YYR            APE L+ G   +TT  D+WS G ++ E++ LG+  +P  + 
Sbjct: 164 --SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNN 219

Query: 280 VDQL 283
            + L
Sbjct: 220 QEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 81/305 (26%)

Query: 76  ERIVGQGSFGVVFQ--AKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPN 125
            R +GQGSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-------NKLNQRMP-------- 170
           VV L              L +V    P  V   V          + L  R P        
Sbjct: 71  VVRL--------------LGVVSTGQPTLV---VMELMAKGDLKSYLRSRRPEAENNPGL 113

Query: 171 ----MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 226
               +      A +I   ++Y+  +    HRD+  +N +V      VK+ DFG  +    
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVA-EDLTVKIGDFGMTR---- 167

Query: 227 GEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPL 273
              +I    + YYR            APE +     +TT  D+WS G V+ E+  L +  
Sbjct: 168 ---DIYE--TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221

Query: 274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDL 333
           + G S  +++++ +   G     E  C +      +        W   +  +M P  +++
Sbjct: 222 YQGLSN-EEVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEI 271

Query: 334 VSRLL 338
           VS L 
Sbjct: 272 VSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 43/282 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 128
           R++G+G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALSY 187
           L          +   L +VL Y+    H  +++F +     P +   + +  Q+ + + Y
Sbjct: 61  LLGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 245
           +     V HRD+  +N +++  +  VK+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 246 FGATE------YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + A E      +TT  D+WS G ++ ELM  G P +P     D  V +++  G    +  
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQ 339
            C +P Y      ++    WH   PK  M P   +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWH---PKPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRAL 185
            L+     +       + ++ EY+    +  +  F + N  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYY 239
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELM 268
            APE I    ++T+A D+WS G V+ E+M
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E ++G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     T  +  + +   +E      +  +  F + N  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 23/153 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 129
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRALS 186
              ++S  DKD LY   V++Y+P            L  RM   P    + Y  ++  A+ 
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRMGIFPEDLARFYIAELTCAVE 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
            +H+ +G  HRDIKP N+L++   H +KL DFG
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 15/108 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++ Q+ + + ++  S    HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +       + APE IF    YT   D+WS G ++ E+  LGK  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 131
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHR-VVKHF--NKLNQRMPMIYVKLYAYQIFRALSYI 188
            F   +  + +Y+      + E + +  +  F  +   Q +P+  +   A Q+   ++Y+
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSRYYRAPE 243
                  HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + APE
Sbjct: 121 E-EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTAPE 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
                  ++T  D+WS G ++ E+   G+  +PG
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 136 TTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            T +  ++  +V EY+         R  K        + M         +  A+ Y+  +
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDM------CSDVCEAMEYLESN 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 246
            G  HRD+  +N LV    + VK+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 247 GATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEII 287
             + +++  D+WS G ++ E+   GK  +   S   ++VE +
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---Y 233
           + YQ+ R + ++  S    HRD+  +N+L+      VK+CDFG A+ ++     +S    
Sbjct: 242 FTYQVARGMEFL-ASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 49/201 (24%), Positives = 79/201 (39%), Gaps = 34/201 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 136 TTDKDELYLNLVLEYVPETV------HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
               + LY  +V EY+ +         R         Q         +A  +   + Y+ 
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQ-------LGFALDVCEGMEYL- 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 246
                 HRD+  +N+LV+      K+ DFG AK     E +      +    + APE + 
Sbjct: 119 EEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL- 171

Query: 247 GATEYTTAIDIWSAGCVVAEL 267
              +++T  D+WS G ++ E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ++++G G FG VF+      G     VAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK----HFNKLNQRMPMIYVKLYAYQIF 182
            L+     T  K  +   ++ EY+    + + ++     F+   Q + M+       +  
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----- 237
             ++Y+HR       D+  +N+LVN    + K+ DFG ++VL + +P  +Y  S      
Sbjct: 124 SDMNYVHR-------DLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPI 174

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
            + APE I    ++T+A D+WS G V+ E+M
Sbjct: 175 RWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 49/238 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A            TVA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL---------- 176
           + L    +    +D   L L++EY     +  ++ F + ++++   Y+            
Sbjct: 66  IKL----YGACSQDGPLL-LIVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 177 --------------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 222
                         +A+QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 223 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            + + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 45/222 (20%)

Query: 78  IVGQGSFGVVFQAKCLETG----ETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 128
           ++ +G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 129 LKHCFFSTTDKDELYL------NLVL-----EYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           + H      +   +        NL L             +       L+ +     +   
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA------LSTQQ----LVHM 122

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-- 235
           A QI   +SY+H+  GV H+DI  +N +++    QVK+ D   ++ L   +    Y C  
Sbjct: 123 AIQIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 236 ---SRYYR--APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
              +R  +  A E +    EY++A D+WS G ++ ELM LG+
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 15/108 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + +S++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 31/208 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ++       L LV +  P    +  V +H + L+   P   +  +  QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLD---PQRLLN-WCVQIAKG 121

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYR 240
           + Y+     + HR++  +N+L+   +  V++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
              ++FG   YT   D+WS G  V E+M
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 123
           P++T+  + +++ G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLK-LVKKL-GAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQI 181
           P +V L    ++   ++ +Y+  + EY+    +  +  F K  + + +   KL   A QI
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 237
              +++I R     HRD++  N+LV+  T   K+ DFG A+++   E    Y        
Sbjct: 112 AEGMAFIERK-NYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKF 165

Query: 238 --YYRAPELI-FGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
              + APE I +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 166 PIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 77/347 (22%), Positives = 132/347 (38%), Gaps = 85/347 (24%)

Query: 78  IVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
           ++G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F +    +EL++             +  HF      + + Y+      + +AL YIH
Sbjct: 65  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 190 RSIGVCHRDIKPQNLLVN-----------------PHTHQVKLC-DFG--SAKVLVKGEP 229
             +G  HR +K  ++L++                  H  ++++  DF   S KVL    P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL----P 173

Query: 230 NISYICSRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
            +S         PE++    + Y    DI+S G    EL  G   F        L+E  K
Sbjct: 174 WLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K 222

Query: 289 VLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIF 322
           + GT                  P+R        E      P  +     +  +HP+++ F
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTF 279

Query: 323 PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL-RDPNARLP 368
                P     V + LQ +P+ R +A   L H FF ++ R  +  LP
Sbjct: 280 ----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 42/190 (22%)

Query: 100 AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTDKDELYLNLVL-EYV 151
           A     +D     +E++ +  L  PN+  L                 +   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 152 PETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT 210
            ET           N +       LY A QI   + Y+  S+   HRD+  +N LV    
Sbjct: 115 AETS------GLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCLVGK-N 166

Query: 211 HQVKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDIW 258
           + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+W
Sbjct: 167 YTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVW 216

Query: 259 SAGCVVAELM 268
           + G  + E++
Sbjct: 217 AFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 132
           ++G+G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               T +  +Y  +V+E VP      +    K    +    +  +A      ++Y+  S 
Sbjct: 58  IGVCTQRQPIY--IVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL-ESK 112

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPE-LI 245
              HRD+  +N LV    + +K+ DFG    + + E +  Y  S        + APE L 
Sbjct: 113 NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 246 FGATEYTTAIDIWSAGCVVAE-LMLGKPLFPG 276
           +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 168 YG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 74/242 (30%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL---LDHPNVV-- 127
           R++G+G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V  
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 128 --------------------SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ 167
                               +LK    S   K+ L   L  +    +V   +  F+K   
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK---TSVGAFLSIFHK--- 121

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---- 223
                        I   + Y+H S GV HRD+KP N+L+      V L D+G+A      
Sbjct: 122 -------------ICATIEYVH-SKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLE 166

Query: 224 ------LVKGEPNISY---------ICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAE 266
                 +   E NI Y         + +  Y APE + G  A+E T   DI++ G ++ +
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQ 223

Query: 267 LM 268
           ++
Sbjct: 224 ML 225

Length = 932

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
           I+G+G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL------ 64

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNK------LNQR----MPMIYVKLYAYQIFRAL 185
                   L ++L      ++ V++  +K      L  R    + +I +  ++  +   +
Sbjct: 65  --------LGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            Y+  S  + HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +
Sbjct: 114 EYL-ESKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL 169

Query: 246 FGATEYTTAIDIWSAGCVVAELM-LGKPLFP 275
               ++++  D+WS G ++ E+   G+  +P
Sbjct: 170 -KHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 15/167 (8%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 233
           ++YQ+   + ++  S    HRD+  +N+L+      VK+CDFG A+ +++    I   S 
Sbjct: 244 FSYQVANGMEFL-ASKNCVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
                + APE IF    YTT  D+WS G ++ E+  LG   +P     +Q    IK    
Sbjct: 302 FLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK---- 356

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP-PEAVDLVSRLL 338
                 +   P +   +  +I    W + F  R    + V LV  LL
Sbjct: 357 ---RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 50/288 (17%)

Query: 77  RIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           R++G+G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ------RMPMIYVKLYAYQI 181
            L      +  K  L + +V+  +P   H  +  F  +++       +P+  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 240
              + Y+  S    HRD+  +N ++N +   V + DFG +K +  G+         YYR 
Sbjct: 123 ASGMEYL-SSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGD---------YYRQ 171

Query: 241 --APELIFG--ATE------YTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
             A +L     A E      YTT  D+W+ G  + E+M  G+  + G    +    +IK 
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK- 230

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
            G   ++   C+   Y      ++    W    PK   P    L  +L
Sbjct: 231 -GNRLKQPPDCLEDVY------ELMCQCWSPE-PKCR-PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 40/117 (34%), Positives = 57/117 (48%), Gaps = 10/117 (8%)

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSR 237
           Q+  A+ YIH    + HRDIK +N+ +N     V L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-GDSGVD---QLVEIIKVL 290
              +PE++ G   Y    DIWS G ++ + ML     P GD G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLD-MLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G FG+V+    LE  + VAIK +    + ++ +   E Q M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALSYIHRSI 192
             +      + LV E++    H  +  + +  QR       L      +   ++Y+  S 
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESS- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGAT 249
            V HRD+  +N LV      VK+ DFG  + ++  +   S   +++   + +PE +F  +
Sbjct: 120 NVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176

Query: 250 EYTTAIDIWSAGCVVAEL 267
           +Y++  D+WS G ++ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVV 127
           S    + +G G FG V+       G T VA+K +            E Q M+ L H  +V
Sbjct: 7   SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L    ++   ++ +Y+  V EY+ + ++   +K       ++P + V + A Q+   ++
Sbjct: 65  QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           YI R +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE
Sbjct: 117 YIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173

Query: 244 L-IFGATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
             ++G   +T   D+WS G ++ EL+  G+  +PG
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 30/75 (40%), Positives = 40/75 (53%), Gaps = 5/75 (6%)

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPN 230
           +K    Q+   L  +HR IG+ HRDIKP+NLLV     QVK+ DFG+A  +  G    P 
Sbjct: 311 IKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPL 368

Query: 231 ISYICSRYYRAPELI 245
              +  RY    EL+
Sbjct: 369 YGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 37/218 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 19/200 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
            T +  +Y  +V EY+      ++ +  +  +R     +      +   ++Y+  S    
Sbjct: 68  CTKQRPIY--IVTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYL-ESKQFI 122

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 252
           HRD+  +N LV+     VK+ DFG ++ ++  E   S + S++   +  PE +   ++++
Sbjct: 123 HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKFS 179

Query: 253 TAIDIWSAGCVVAELM-LGK 271
           +  D+W+ G ++ E+  LGK
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 50/222 (22%)

Query: 79  VGQGSFGVVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL 129
           +G+G+FG VF A+C     E  + +   K L++     ++   RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK------HFNKLNQRMPMIYVKL-----Y 177
              F+    +    L +V EY+    ++R ++            + +    + L      
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A QI   + Y+  S+   HRD+  +N LV      VK+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 238 YYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
           YYR             PE I    ++TT  DIWS G V+ E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 48/226 (21%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 126
           +I+G+G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 127 VSLKHCFFSTTDKDELYLNLV-LEYVPETVHRVVKHFNKLN---QRMPMIYVKLYAYQIF 182
           + L    F  +   ++   +V L ++          +++L    +++P+  +  +   I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y+  +    HRD+  +N ++      V + DFG +K +  G+         YYR  
Sbjct: 124 LGMEYL-SNRNFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 243 ELI-----FGATE------YTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +      + A E      YT+  D+W+ G  + E+   G+  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 29/210 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +GQG FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
              ++ +Y+  V E++ + ++   +K  +    ++P + V + A QI   ++YI R +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDM-AAQIADGMAYIER-MNY 123

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL-IFG 247
            HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE  ++G
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYG 178

Query: 248 ATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
              +T   D+WS G ++ EL+  G+  +PG
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 57/229 (24%)

Query: 79  VGQGSFGVVFQ------AKCLETGET--------VAIKKVLQD--KRYKN---RELQTMR 119
           +G+G FG V        A+ L  G          VA+K +  D  K  +N   +E++ M 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMI 172
            L +PN++ L      + D     L ++ EY+         +   +   F   N    + 
Sbjct: 73  RLKNPNIIRLL-GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 173 YVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 230
              L   A QI   + Y+  S+   HRD+  +N LV  H + +K+ DFG ++ L  G+  
Sbjct: 128 IANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLVGNH-YTIKIADFGMSRNLYSGD-- 183

Query: 231 ISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL 267
                  YYR            A E I    ++TTA D+W+ G  + E+
Sbjct: 184 -------YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 77/330 (23%), Positives = 139/330 (42%), Gaps = 83/330 (25%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNR-----ELQ 116
            ++ I+ + E  +GQGSFG+V++  A+ +  GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMI 172
            M+     +VV L         K +  L +V+E +     ++  R ++   + N   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 173 YVK---LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            ++     A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL-MLGKPLFPG 276
                   YYR            APE +     +TT+ D+WS G V+ E+  L +  + G
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224

Query: 277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSR 336
            S  +Q+++ +             M+  Y +               P   P    DL+  
Sbjct: 225 LSN-EQVLKFV-------------MDGGYLD--------------QPDNCPERVTDLMRM 256

Query: 337 LLQYSPNLRCTALDAL------IHPFFDEL 360
             Q++P +R T L+ +      +HP F E+
Sbjct: 257 CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 29/221 (13%)

Query: 77  RIVGQGSFGVVFQAKCLETGET--VAIK--KVLQDKRYKN----RELQTMRLLDHPNVVS 128
           + +G+G FG V + +  +      VA+K  K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF---NKLN---QRMPMIYVKLYAYQIF 182
           L      T + +     +V+  +P   H  +  F   ++L    Q +P   +  +   I 
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y+  S    HRD+  +N ++N + + V + DFG +K +  G+    Y   R  + P
Sbjct: 123 SGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP 177

Query: 243 ELIFGATE------YTTAIDIWSAGCVVAELML-GKPLFPG 276
            + + A E      YTT  D+WS G  + E+   G+  +PG
Sbjct: 178 -VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 42/224 (18%), Positives = 94/224 (41%), Gaps = 39/224 (17%)

Query: 64  NGQPKQTIS---YMAERIVGQGSFGVVFQAKCLE---------------TGETVAIKKVL 105
            G P   I+   +  ++++G G FG V++ +C                   ET+ ++ ++
Sbjct: 2   EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61

Query: 106 QDKRY-KNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF 162
            +  Y  ++      +  +DH  +     C   +  +  +Y   +L      + ++V++ 
Sbjct: 62  YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFIL------LEKLVENT 113

Query: 163 NKLNQRM---PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
            ++ +R+       +K     +   L YIH   G+ H DIKP+N++V+ + ++  + D+G
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGN-NRGYIIDYG 171

Query: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCV 263
            A   +    +I      Y +  + +   T Y   +D  +  CV
Sbjct: 172 IASHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 64/255 (25%), Positives = 107/255 (41%), Gaps = 54/255 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIY 173
           V     +    D D L   +V EY+             P+ +  V     +    + +  
Sbjct: 70  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++ +         
Sbjct: 125 MLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYS------- 175

Query: 234 ICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAELM-LGK-PLFP-GDS 278
             + YYR             PE I    ++TT  D+WS G ++ E+   GK P F   ++
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 279 GVDQLVEIIKVLGTP 293
            V + +   +VL  P
Sbjct: 233 EVIECITQGRVLERP 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 40.3 bits (94), Expect = 9e-04
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 32/204 (15%)

Query: 79  VGQGSFGVVFQA--KCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  + + L   LV+E        + K  +     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 191 SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAP 242
              V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 243 ELIFGATEYTTAIDIWSAGCVVAE 266
           E I    ++++  D+WS G  + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 69/297 (23%), Positives = 112/297 (37%), Gaps = 65/297 (21%)

Query: 79  VGQGSFGVVFQAKCLETGETVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 129
           +G G FG V   +    G + A  + K L+     +      +E+Q  R L+HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 130 KHCFFSTTDKDELYLNLVLEYVP----------ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             C  S       YL LVLE+ P                      + QRM        A 
Sbjct: 62  GQCIESIP-----YL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--------AC 107

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 238
           ++   L ++H++  + H D+  +N  +      VK+ D+G A      +  I+  C    
Sbjct: 108 EVASGLLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 239 --YRAPEL--IFGA----TEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
             + APEL  I G      + T   +IWS G  + EL       +P  S    L ++++ 
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR- 224

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF------PKRMPPEAVDLVSRLLQY 340
                 ++IK   P           +  W+++       P+  P    + V  LL Y
Sbjct: 225 -----EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRP--TAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 45/222 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           E ++G+G+FG V +A   + G     AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVP--------------ETVHRVVKHFNKLNQRMPMI 172
           +L   C      ++  YL + +EY P              ET     K     +      
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
            ++ +A  +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE    
Sbjct: 121 LLQ-FASDVATGMQYLSEKQFI-HRDLAARNVLVGENL-ASKIADFG----LSRGEE--V 171

Query: 233 YICSRYYRAPELIFGATE------YTTAIDIWSAGCVVAELM 268
           Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 172 YVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 63/303 (20%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMR 119
           T+ +M E  +G+  FG V++         E  + VAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 120 L-LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VH------------------RVV 159
             L HPN+V    C      K++  L+++  Y   + +H                  + V
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           K     +   P  +V +   QI   + ++  S  V H+D+  +N+LV    + VK+ D G
Sbjct: 118 K-----STLEPADFVHIVT-QIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLG 169

Query: 220 SAKVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLF 274
             + +   +       S +  R+     +++G  +++   DIWS G V+ E+   G   +
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPY 227

Query: 275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLV 334
            G S  D ++E+I+      R+ + C  P+        +    W++ FP R  P   D+ 
Sbjct: 228 CGYSNQD-VIEMIR-----NRQVLPC--PDDCPAWVYTLMLECWNE-FPSRR-PRFKDIH 277

Query: 335 SRL 337
           SRL
Sbjct: 278 SRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 38/134 (28%), Positives = 56/134 (41%), Gaps = 38/134 (28%)

Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
           G PN        Y APE++   T YT   D WS G ++ E+++G+P F            
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPF------------ 248

Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
             +  TP   ++K +N   +    PQ K           + PEA DL+ +L +  P  R 
Sbjct: 249 --LAQTPLETQMKVINWQTSLHIPPQAK-----------LSPEASDLIIKLCR-GPEDRL 294

Query: 347 --TALDAL-IHPFF 357
                D +  HPFF
Sbjct: 295 GKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 24/104 (23%)

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A QI   + Y+  S+   HRD+  +N LV  +   +K+ DFG ++ L  G+         
Sbjct: 144 ALQIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD--------- 192

Query: 238 YYR------------APELIFGATEYTTAIDIWSAGCVVAELML 269
           YYR            A E I    ++TTA D+W+ G  + E+++
Sbjct: 193 YYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	409
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
smart00090	237	RIO RIO-like kinase.	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
PRK09902	216	hypothetical protein; Provisional	98.7
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.52
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.17
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.11
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.99
PLN02876	822	acyl-CoA dehydrogenase	97.92
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.87
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.84
KOG2270	520	consensus Serine/threonine protein kinase involved	97.72
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.71
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.59
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.56
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.49
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.48
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.44
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.4
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.34
PRK05231	319	homoserine kinase; Provisional	97.3
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.18
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.17
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.07
PRK10593	297	hypothetical protein; Provisional	97.05
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.87
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.73
PLN02236	344	choline kinase	96.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.57
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.53
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.43
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.38
PRK12396	409	5-methylribose kinase; Reviewed	96.31
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.17
PTZ00384	383	choline kinase; Provisional	95.86
PLN02756	418	S-methyl-5-thioribose kinase	95.4
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.07
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.63
PRK11768	325	serine/threonine protein kinase; Provisional	94.39
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.31
PRK10271	188	thiK thiamine kinase; Provisional	92.74
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.72
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.37
PTZ00296	442	choline kinase; Provisional	92.18

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-69  Score=488.58  Aligned_cols=352  Identities=72%  Similarity=1.180  Sum_probs=331.2

Q ss_pred             cceEEeecCCCCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccce
Q 015298           53 GHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC  132 (409)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  132 (409)
                      +....+...+.........+|...+++|+|+||.||.|....+++.||||+..++.+...+|+.+|++++|||||++..+
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            44555566666666677889999999999999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                      |+...+.+..|+.+|||||+.+|.+.++++...+..++...++-+..||++||.|||+. ||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCe
Confidence            88777666788999999999999999999888899999999999999999999999985 99999999999999999889


Q ss_pred             EEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      +||||||.|+....++++.++.+|++|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+..+++..|.+.+|.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRF  372 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~  372 (409)
                      |..+.+.++++++.+..++++....|...+....++++.+|+.++|+++|.+|.++.|++.||||..+++++.+++.+..
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~  324 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRP  324 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCCCHHHHhhcChHHHhhhCCC
Q 015298          373 LPPLFNFKSHELKSVPVEILVKLIPEHARKQCPF  406 (409)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (409)
                      +|++|+|+..+ .....+.+..++|++.+.+...
T Consensus       325 lp~lf~f~~~e-~~~~~~~~~~l~p~~~~~~~~~  357 (364)
T KOG0658|consen  325 LPPLFNFKRAE-LGISPELVNVLIPEHLREQEKD  357 (364)
T ss_pred             CCCccCchHHH-hccchHHHHhhccHhhhhhccc
Confidence            99999999996 4556699999999999887653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-58  Score=404.36  Aligned_cols=279  Identities=38%  Similarity=0.720  Sum_probs=246.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .|....++|+|+||.||+|+++.||+.||||++....      +...+|+++|++|+|+|+|.++++|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            5888899999999999999999999999999997543      3346899999999999999999999     5556689


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|+|||+.++++.+..+   ...++.+.++.+++|++.|+.|+|++ +||||||||+||||+.++ .+||||||+|+...
T Consensus        78 LVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            99999998877777654   57899999999999999999999997 999999999999999998 89999999999887


Q ss_pred             -cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH--HhhcC
Q 015298          226 -KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE--IKCMN  302 (409)
Q Consensus       226 -~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~  302 (409)
                       ++...+.++.|++|+|||.+.+...|+..+||||+||++.||++|++.|++.+..+++..|.+.+|...+..  +-..+
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             667778899999999999999988899999999999999999999999999999999999999999876654  44556


Q ss_pred             CCccccccCcccC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 PNYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      +-+....+|.... .++...++. ++.-+.||+++||..||.+|++.+++|.||||.++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            6676777777654 344444544 778999999999999999999999999999998653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-58  Score=411.16  Aligned_cols=322  Identities=38%  Similarity=0.659  Sum_probs=275.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .|...+.||.|+||.|+.|.++.+|+.||||++...      .+...+|+++|+.++|+||+.+.+++.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            566689999999999999999999999999998632      34567899999999999999999988763333444588


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|+|+|+.+|..+++.    ++.+++..++.+++||++||+|+|+. ||+||||||.|++++.+. .+||+|||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999998888875    45699999999999999999999986 999999999999999998 89999999999875


Q ss_pred             c---CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 K---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .   ....+.++.|.+|+|||++.....|+.+.||||+||||.||++|++.|.+.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   3444678889999999999888889999999999999999999999999999999999999999999998877655


Q ss_pred             CCc---cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNY---TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~---~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      ...   --..++..+..+|...++ +.++.+.+|+.+||..||.+|+|++|+|.||||..+.++.....+.+...   . 
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~---~-  331 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFD---S-  331 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCc---c-
Confidence            221   123577788888999888 68999999999999999999999999999999999998876543333211   1 


Q ss_pred             CcccccCCCHHHHhhcChHHHhhhCCCC
Q 015298          380 KSHELKSVPVEILVKLIPEHARKQCPFL  407 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (409)
                        .+.. .+++.|..+++......+|-.
T Consensus       332 --~~~~-~~~~~~r~~i~~e~~~~~~~~  356 (359)
T KOG0660|consen  332 --FEHE-LTEEELRELIYKEILDFHPDV  356 (359)
T ss_pred             --cccc-ccHHHHHHHHHHHHHhhCccc
Confidence              2333 678999999999988877653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-59  Score=429.51  Aligned_cols=282  Identities=37%  Similarity=0.679  Sum_probs=253.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHhcC-CCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|.++++||.|.||.||+|+...+|+.||||++++...     ...||+..|++|+ ||||+++.+++...+    ..
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            4589999999999999999999999999999999876532     2348999999998 999999999884322    26


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||||..+|..+++.+   +..|++..++.|+.||++||+|+|++ |+.||||||||||+.... .|||+|||+|+.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEecccccccc
Confidence            8999999999999998865   68899999999999999999999997 999999999999999766 899999999999


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      .......+.++.|++|+|||+|.....|+.+.||||+|||++|+++-++.|+|.++.+++.+|...+|.|....|...- 
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            9888888999999999999999888889999999999999999999999999999999999999999999988775421 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                       .....+.+++....++...++. .+.++.++|.+||.+||.+||||.++|+||||+.-.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence             2233467888888888888888 999999999999999999999999999999999654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-58  Score=417.32  Aligned_cols=257  Identities=33%  Similarity=0.488  Sum_probs=213.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----------hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ...|.+.+.||+|+||.|-+|..+.||+.||||++.+..           ....+|+++|++|+|||||+++++|     
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence            456899999999999999999999999999999996532           1235899999999999999999988     


Q ss_pred             CCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEE
Q 015298          139 KDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKL  215 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl  215 (409)
                      ..+.+.||||||++|+ |.+.+-.    ++.+.+...+.+++|++.|+.|||+. ||+||||||+|||++.+.  -.+||
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEe
Confidence            4444578999999964 4333332    67888988999999999999999996 999999999999997651  27999


Q ss_pred             eecCCccccccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGT  292 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~  292 (409)
                      +|||+|+...++....+.||||.|.|||++.+.  ..+..++|||||||+||-+++|.+||.+..... ...+|.++--.
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            999999999888888899999999999999543  234558999999999999999999998766554 55555543111


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                               +.......+++++++||++||..||++|||++++|+||||+...
T Consensus       401 -------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  401 -------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             -------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                                     11113345899999999999999999999999999999999654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-57  Score=428.17  Aligned_cols=249  Identities=32%  Similarity=0.522  Sum_probs=223.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .....+|++|.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999999999999999652       24456899999999999999999999     77788


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|||+|+|. ++|..+++.    .+.++|.+++.+++||+.||.|||++ +|+|||||..|++++.+. +|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 566666653    68899999999999999999999996 999999999999999988 89999999998


Q ss_pred             ccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ..... +...+.||||.|.|||++.. ...+..+||||+|||||.||+|++||...+-.+.+..|...-           
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-----------  234 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-----------  234 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-----------
Confidence            87644 67789999999999999974 558999999999999999999999999999999988887631           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        -.+|..+|.++++||.+||+.||.+|||++++|.|+||+..
T Consensus       235 ------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  235 ------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                              12566799999999999999999999999999999999543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.3e-57  Score=387.33  Aligned_cols=278  Identities=39%  Similarity=0.729  Sum_probs=243.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|...++||+|.||.||+|++..||+.||||+++..+      ....+|++.|+.++|+||+.++++|     .+...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            36889999999999999999999999999999996542      2346899999999999999999999     555558


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      .||+||++.+|...++..   .-.++...++.|+.++++||+|||.+ .|+||||||.|+||+++| .+||+|||+|+..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999998888753   46789999999999999999999997 999999999999999998 8999999999987


Q ss_pred             ccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          225 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       225 ~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ...... ...+.|++|+|||.++|...|+..+||||.|||+.||+.|.+.|.+.+..+++..|++.+|+|..+.|..+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            654433 334789999999999999999999999999999999999999999999999999999999999999998766 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                       ++|.++.  ..+..+....++. .+.++.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus       232 lpdY~~~~--~~P~~~~~~lf~a-as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLFPA-ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cccHHHHh--cCCCCcccccccc-ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence             5555544  3344444444544 678889999999999999999999999999999743

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-55  Score=435.58  Aligned_cols=329  Identities=52%  Similarity=0.984  Sum_probs=287.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecC---CCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~l  146 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++|+...   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            45799999999999999999999999999999999877777788999999999999999998775432   133456789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||||+++++...+..+......+++..++.++.||+.||.|||+. ||+||||||+|||++.+++.+||+|||+++....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999998888877666678899999999999999999999986 9999999999999997765799999999987766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+.++.+.++.|..+.+..+.+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55556778899999999987766789999999999999999999999999999999999999999999999888888888


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCC-CCCCCCCCCCCccccc
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPS-GRFLPPLFNFKSHELK  385 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  385 (409)
                      ...++......+...++...++++.+||.+||++||.+|+|+.|+|+||||..+.++....+. ....|.+++|...+..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            888888877888888888899999999999999999999999999999999998876544432 3457888999998887


Q ss_pred             CCCHHHHhhcChHH
Q 015298          386 SVPVEILVKLIPEH  399 (409)
Q Consensus       386 ~~~~~~~~~~~~~~  399 (409)
                      ....+.....++..
T Consensus       384 ~~~~~~~~~~~~~~  397 (440)
T PTZ00036        384 EMSDACRRKIIPKC  397 (440)
T ss_pred             hCCHHHHHHHhhHH
Confidence            77777666655543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=397.96  Aligned_cols=255  Identities=32%  Similarity=0.567  Sum_probs=216.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+.+..+.||+|..|+||+|+++.|++.+|+|.+...     .+.+.+|+++++..+|||||+++++|+....    -+.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3577788999999999999999999999999999432     3455689999999999999999999976442    388


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      |+||||+ |+|+.++..    .+++++....+++.++++||.|||+..+||||||||+|||++..| .|||||||.++..
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHh
Confidence            9999999 567666654    478999999999999999999999745999999999999999998 8999999999887


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHHhCCCCHHHHh
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-----SGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .+. ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||...     ...+.+..|..   .|++    
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP----  300 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP----  300 (364)
T ss_pred             hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC----
Confidence            666 66789999999999999765 5999999999999999999999999874     23333333332   1211    


Q ss_pred             hcCCCccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                                           .+|.. +|+++++||..||++||.+|+|+.|+++|||+++..+++
T Consensus       301 ---------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  301 ---------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ---------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                                 14454 899999999999999999999999999999999776543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-55  Score=391.55  Aligned_cols=285  Identities=34%  Similarity=0.569  Sum_probs=250.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh------hHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ....|..+..|++|.||.||+|+++.|++.||+|+++.+...      ..+|+.+|.+++|||||.+..+.....-   .
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---D  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---c
Confidence            345799999999999999999999999999999999765422      2589999999999999999887754332   2


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+|||||||+.+|..++...   .+++...+++.++.|+++|++|||.+ .|+|||||++|+|++..| .+||+|||+|+
T Consensus       151 ~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDFGLAR  225 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADFGLAR  225 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEecccchhh
Confidence            38899999999998888764   47899999999999999999999997 999999999999999888 89999999999


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .+.... ..+..+.|.+|+|||.+.+...|++++|+||+|||+.||+++++.|.+....+++.+|++.+|+|....|...
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            886553 3456778999999999999999999999999999999999999999999999999999999999999888765


Q ss_pred             C--CCccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          302 N--PNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       302 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .  +......++..+...++..|+.. +++...+|+.++|.+||.+|.||.|+|+|+||.+..
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            4  32334567777777777777765 789999999999999999999999999999999853

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-55  Score=406.74  Aligned_cols=282  Identities=37%  Similarity=0.615  Sum_probs=239.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .....|..+++||+|.||.||+|++..||+.||+|++..+.      ....+||.||++|+||||+++.+..+..   ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence            44567999999999999999999999999999999997553      3446999999999999999999988654   33


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+|||+|||+.+|..++..   ..-.|++.+++.+++||+.||+|||.+ ||+|||||.+|||||.+| .+||+|||+|
T Consensus       191 ~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFGLA  265 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFGLA  265 (560)
T ss_pred             ceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEeccccce
Confidence            45899999999988887763   245799999999999999999999986 999999999999999988 8999999999


Q ss_pred             cccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          222 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       222 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +++....  ..+..+.|.+|+|||+|.+...|+.++|+||+||||.||++|++.|.+.++.+++..|++..|.|....|.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            9775544  45678889999999999999999999999999999999999999999999999999999999999998887


Q ss_pred             hcC-CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          300 CMN-PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       300 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      ... +.+..+.....-...+.+. -..++..+.+|+..||..||.+|.||.++|.|+||.
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            322 1111111111111222222 235889999999999999999999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-54  Score=390.93  Aligned_cols=256  Identities=30%  Similarity=0.514  Sum_probs=221.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||.++.+.|++.||+|++++.       ......|..+|..++||.||+++-.|     ++..
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            45799999999999999999999999999999998654       23445799999999999999998777     5566


Q ss_pred             EEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+|+|+||+.|+ |...+.+    .+.+++..++.++.+|+.||.|||+. |||||||||+|||+|.+| .++|+|||++
T Consensus        99 kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~G-Hi~LtDFgL~  172 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQG-HIKLTDFGLC  172 (357)
T ss_pred             eEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCC-cEEEeccccc
Confidence            689999999974 4444433    78999999999999999999999986 999999999999999999 7999999999


Q ss_pred             cccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +... .+....+.|||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+....+.+|.+.-.         
T Consensus       173 k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~---------  242 (357)
T KOG0598|consen  173 KEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL---------  242 (357)
T ss_pred             hhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC---------
Confidence            8544 34556678999999999999776 599999999999999999999999999999999888876420         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC----CHHHHhCCCCccCCCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC----TALDALIHPFFDELRDPNA  365 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~----s~~ell~hp~f~~~~~~~~  365 (409)
                                         ...+..++.+++++|+++|+.||++|.    .+.++-+||||+.++|...
T Consensus       243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence                               113444899999999999999999996    6889999999999988743

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-53  Score=400.05  Aligned_cols=256  Identities=32%  Similarity=0.569  Sum_probs=225.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|..++.||+|+|++|++|+++.+++.||||++.+.       .+...+|-.+|.+| .||.|++|+..|     .+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            345899999999999999999999999999999998543       34556788999999 899999998777     66


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+|+|+||++ |.|.+++..    .+.|++..++.++.||+.||+|||+. |||||||||+|||+|.|+ .+||+|||
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDFG  219 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDFG  219 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeecc
Confidence            667899999999 677777776    47899999999999999999999986 999999999999999999 79999999


Q ss_pred             CccccccCCC--------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015298          220 SAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE  285 (409)
Q Consensus       220 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  285 (409)
                      .|+.+.+...              ..+++||..|.+||+|... ..++.+|||+||||||.|+.|.+||.+.++.-..++
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            9987743211              1458999999999999654 489999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      |+...-                             .++..+++.+.+||+++|..||.+|+|+.++.+||||.++.|.+.
T Consensus       299 I~~l~y-----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  299 IQALDY-----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             HHHhcc-----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            887521                             267789999999999999999999999999999999999988764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-52  Score=393.28  Aligned_cols=271  Identities=31%  Similarity=0.518  Sum_probs=228.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|.+++.||+|+||.||+|+-+.||+.||+|++++..       .....|-.+|...++|+||+++-.|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            4568999999999999999999999999999999997653       2334678889899999999998777     777


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++||||||++| ++..+|..    .+.|++.+++.++.+++.|++.||+. |+|||||||+|+|||..| .+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~G-HiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKG-HIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCC-CEeeccccc
Confidence            889999999996 45455443    68999999999999999999999985 999999999999999999 699999999


Q ss_pred             cccccc----------------------C-CC-------------------------CccccccccccccccccCCCCCC
Q 015298          221 AKVLVK----------------------G-EP-------------------------NISYICSRYYRAPELIFGATEYT  252 (409)
Q Consensus       221 a~~~~~----------------------~-~~-------------------------~~~~~gt~~y~aPE~l~~~~~~~  252 (409)
                      +.....                      . ..                         ..+.+|||.|+|||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            743211                      0 00                         02357899999999998765 99


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHH
Q 015298          253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD  332 (409)
Q Consensus       253 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  332 (409)
                      ..+|+|||||||||||.|.+||.+.+..+...+|+..-...               .+|          -...++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------~fP----------~~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------KFP----------EEVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------cCC----------CcCcccHHHHH
Confidence            99999999999999999999999999999999887732110               000          11246899999


Q ss_pred             HHHHhcccCCCCCC---CHHHHhCCCCccCCCCCCCCCCCCCCCCCCC
Q 015298          333 LVSRLLQYSPNLRC---TALDALIHPFFDELRDPNARLPSGRFLPPLF  377 (409)
Q Consensus       333 li~~~L~~dp~~R~---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  377 (409)
                      ||.+||+ ||.+|.   .++|+.+||||+.+.|...+....+++|.+.
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence            9999999 999998   4999999999999999998887788888773

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-52  Score=400.36  Aligned_cols=256  Identities=32%  Similarity=0.502  Sum_probs=229.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+-|.+++.||.|+.|.|.+|++..||+..|||++.+.       ...+++|+-+|+.+.|||+++++++|     +...
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence            34699999999999999999999999999999999766       45678999999999999999999999     5566


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ++|+|.||++| .|.+++..    .+++++.++.++++||+.|+.|+|.. +|+||||||+|+|+|.++ +|||+|||+|
T Consensus        86 ~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMA  159 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMA  159 (786)
T ss_pred             eEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeecccee
Confidence            69999999995 44444443    68999999999999999999999985 999999999999999988 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....++.-..+.||+|.|.|||++.+..+.+.++||||+|||||.||||++||++++....+.++.++.-          
T Consensus       160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f----------  229 (786)
T KOG0588|consen  160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF----------  229 (786)
T ss_pred             ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc----------
Confidence            9888888888999999999999999999899999999999999999999999998888777777665321          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                         .+|..+|.++++||++||..||.+|+|..|+++|||+.+......
T Consensus       230 -------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  230 -------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             -------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence                               156789999999999999999999999999999999998765543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=364.10  Aligned_cols=252  Identities=29%  Similarity=0.479  Sum_probs=221.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||.|+||.|.+++.+.+|..||+|++.+..       +...+|..+|+.+.||.++++++.+     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            457999999999999999999999999999999996543       3345799999999999999999888     6777


Q ss_pred             EEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      +++|||||++|+ |-.++    +..+++++..++.++.||+.||+|||+. +|++|||||+|||+|.+| .+||+|||+|
T Consensus       118 ~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFGFA  191 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFGFA  191 (355)
T ss_pred             eEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEeccce
Confidence            799999999975 33333    3378999999999999999999999985 999999999999999999 7999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      +.....  ..+.||||.|+|||++... .++.++|+|||||++|||+.|.+||...+..+++.+|...-           
T Consensus       192 K~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-----------  257 (355)
T KOG0616|consen  192 KRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-----------  257 (355)
T ss_pred             EEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-----------
Confidence            876443  6789999999999999664 49999999999999999999999999999999999888741           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN  364 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~  364 (409)
                                        -.+|..++.++++||+++|+.|-.+|.     ...++.+||||+.+.|..
T Consensus       258 ------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  258 ------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             ------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                              126777999999999999999999994     567899999999988764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.6e-52  Score=372.85  Aligned_cols=292  Identities=35%  Similarity=0.705  Sum_probs=245.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------hhHHHHHHHHhcCCCC-eecccceeeecCC-CCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  142 (409)
                      ..|...++||+|+||+||+|+++.+|+.||+|++.-+..      ...+|+.+++.|+|+| |+.+++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            357788889999999999999999999999999965433      2368999999999999 9999998865442 2334


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++|+||+.-+|..++.........++...++.+++||+.||+|||++ +|+||||||.||||+++| .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchHH
Confidence            6889999999999888887654436788899999999999999999997 999999999999999988 89999999998


Q ss_pred             ccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ... +.......++|.+|+|||++.+...|+...||||+|||++||+++++.|.+.+..+++..|+..+|+|..+.|...
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            765 3444667888999999999999988999999999999999999999999999999999999999999999888764


Q ss_pred             C--CCccccccCccc-CCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCC
Q 015298          302 N--PNYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR  366 (409)
Q Consensus       302 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~  366 (409)
                      .  +++.. .++... ...+....+ ..+++..+++.+||+++|.+|.|+..+|.||||.........
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            4  22222 333333 333333333 345799999999999999999999999999999988655433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-51  Score=390.44  Aligned_cols=251  Identities=31%  Similarity=0.488  Sum_probs=218.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---------chhhHHHHHHHHhcC-CCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  138 (409)
                      ..++|.+.+.||+|+||+|++|.+..+|+.||+|++.+.         .....+|+.+++.+. ||||+++++++..   
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t---   91 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT---   91 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence            456899999999999999999999999999999976543         223458999999999 9999999998843   


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-CCcEEEe
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLC  216 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-~~~ikl~  216 (409)
                        ...+++||||+.| .|.+.+..    .+++.+..++.+++||+.|++|||++ ||+||||||+|||++.+ + ++||+
T Consensus        92 --~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~-~~Kl~  163 (370)
T KOG0583|consen   92 --PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEG-NLKLS  163 (370)
T ss_pred             --CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCC-CEEEe
Confidence              3348999999996 56555554    68899999999999999999999986 99999999999999998 6 89999


Q ss_pred             ecCCcccc-ccCCCCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          217 DFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       217 Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |||++... ..+....+.+||+.|+|||++.+.. +-+.++||||+|++||.|++|..||...+.......|.+..    
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~----  239 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE----  239 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC----
Confidence            99999987 4667788999999999999998766 56789999999999999999999999977777766654421    


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCC-ChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM-PPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                               -.+|..+ |.++++|+++||..||.+|+|+.++++||||+.
T Consensus       240 -------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 -------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                     1145567 999999999999999999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=375.97  Aligned_cols=255  Identities=30%  Similarity=0.536  Sum_probs=220.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.++++.     +...
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            3467999999999999999999999999999999996542      3346799999999999999999998     5555


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-C----CcEEEe
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-T----HQVKLC  216 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-~----~~ikl~  216 (409)
                      ++|||||||+ |+|..++..    .+.+++..++.++.||+.||++||++ +||||||||+|||++.. .    ..+||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEec
Confidence            7999999999 677777765    56899999999999999999999997 99999999999999764 1    269999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||+|+...++....+.||+|.|||||++..+ .|+.++|+||+|+++|+|++|++||...+..+.+..+.+.-.     
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-----  231 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-----  231 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence            99999999988888899999999999999654 599999999999999999999999998888887775544211     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                           ....++..++..+.+++...|+.||..|.+..+-+.|+++..-
T Consensus       232 ---------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  232 ---------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             ---------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence                                 1112444577888899999999999999999999999998753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-51  Score=393.32  Aligned_cols=279  Identities=36%  Similarity=0.620  Sum_probs=231.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhH---HHHHHHHhcC-C-----CCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|.||+|.+|.+..|++.||||+++....+..   .|+.+|..|+ |     -|+|+++++|+     ...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----ccc
Confidence            78999999999999999999999999999999988876654   5888888886 3     48999999994     445


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC-CCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~-~~~~ikl~Dfg~a  221 (409)
                      ++|||+|.+..+|.++++...  ..+++...++.++.||+.||.+||+. ||||+||||||||+.. +...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            599999999999999998644  56799999999999999999999985 9999999999999853 3347999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....  ....+++.+++|+|||++.+.+ |+.+.||||||||++||++|.+.|.+.+..+++..|+..+|.|+..++...
T Consensus       339 c~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8653  3344888999999999998865 999999999999999999999999999999999999999999999877642


Q ss_pred             CCCcccccc----Cc-----------------------------c-cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC
Q 015298          302 NPNYTEFKF----PQ-----------------------------I-KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT  347 (409)
Q Consensus       302 ~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s  347 (409)
                      ......+.-    +.                             . ....+.......-...+.|||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            211111100    00                             0 1122222223334567899999999999999999


Q ss_pred             HHHHhCCCCccCCC
Q 015298          348 ALDALIHPFFDELR  361 (409)
Q Consensus       348 ~~ell~hp~f~~~~  361 (409)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-52  Score=363.93  Aligned_cols=255  Identities=30%  Similarity=0.493  Sum_probs=215.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec------cchhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|++.++||.|.||.||++.+..+|+.+|.|.+.-      ..+....|+.+|++|+|||||++++.-+.   ++...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence            3469999999999999999999999999999998852      23455689999999999999999873322   33334


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--cC-CcEeecCCCCceeecCCCCcEEEeecC
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR--SI-GVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~-~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ++||||||. |+|..+++++.+..+.+++..+|+++.|+|.||..+|.  .. -|+||||||.||+++.+| .+||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            779999999 79999999999999999999999999999999999997  31 299999999999999988 89999999


Q ss_pred             CccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +++....... ..+.+|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.+.+-.+...+|.++--.|.+   
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---  249 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---  249 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---
Confidence            9998765443 4578999999999999765 4999999999999999999999999999877777777665222211   


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                              ....|.++..+|..|+..||..||+.     +|++.++.
T Consensus       250 ------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  250 ------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             ------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                                    13468899999999999999999986     55555443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-51  Score=391.67  Aligned_cols=267  Identities=28%  Similarity=0.488  Sum_probs=227.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.++||+|.||+|+++..+.+++.||||.++++.       .....|.+|+... +||.++.++.+|     +.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            3568999999999999999999999999999999998764       2334577777776 599999999999     66


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..++|+||||+.|+.  +..  ....+.+++..++.|+..|+.||+|||++ ||||||||.+|||+|.+| .+||+|||+
T Consensus       441 ~~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eG-h~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEG-HVKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccC-cEEeccccc
Confidence            677999999999873  222  22258899999999999999999999997 999999999999999999 799999999


Q ss_pred             ccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++... .+....++||||.|||||++.+. .|+.++|+|||||+||||+.|+.||.+.++.+....|..-          
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            98654 55567789999999999999765 4999999999999999999999999999999998888762          


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCCC--CCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPNA--RLPSGRF  372 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~~--~~~~~~~  372 (409)
                                         ...+|..+|.++.++|+++|..||++|.-     +.++..||||+.+.|...  +.-.+++
T Consensus       584 -------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf  644 (694)
T KOG0694|consen  584 -------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPF  644 (694)
T ss_pred             -------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCC
Confidence                               22367789999999999999999999995     578999999999987643  3333444


Q ss_pred             CCCC
Q 015298          373 LPPL  376 (409)
Q Consensus       373 ~~~~  376 (409)
                      .|..
T Consensus       645 ~P~i  648 (694)
T KOG0694|consen  645 VPTI  648 (694)
T ss_pred             Cccc
Confidence            4433

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-49  Score=368.16  Aligned_cols=277  Identities=34%  Similarity=0.649  Sum_probs=227.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.++||||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            357999999999999999999999999999999986432     2345899999999999999999887     344468


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.++|...+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence            899999999877766532   34678999999999999999999986 999999999999999887 8999999998754


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+..+.+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3222 223456799999999987666689999999999999999999999999998999999999999988887765332


Q ss_pred             --CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 --NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                        .+....++.....++.. ....+++++++||++||++||.+|||+.|+|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              22222233322222222 223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=351.45  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=218.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec------cchhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+.|.+.+.||+|.|+.|++|.+..||+.+|+|++..      +.+...+|++|-+.|+||||+++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            45579999999999999999999999999999998742      345667999999999999999999887     6677


Q ss_pred             EEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC--CCcEEEeecC
Q 015298          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~--~~~ikl~Dfg  219 (409)
                      +.+||+|+|.|+ |...+-.    ....++..+..+++||+.||.|+|.+ ||||||+||+|+++-+.  +.-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccc
Confidence            789999999963 3333332    14678899999999999999999997 99999999999999433  3369999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +|.....+......+|||.|||||++... .|+..+|||+.|++||-|+.|.+||.+.+....+++|++.-..-+     
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~-----  232 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP-----  232 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC-----
Confidence            99988877777789999999999999664 599999999999999999999999999888888888887422111     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                          .....++++++++|+++||..||.+|+|+.|+|+|||+++
T Consensus       233 --------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  233 --------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             --------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                                1133468999999999999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-50  Score=367.75  Aligned_cols=258  Identities=32%  Similarity=0.540  Sum_probs=210.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|...+.||+|.||.||++.+..+|+..|+|.+...    .+...+|+.+|++++|||||++++.......   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            34688999999999999999999999999999998665    3446899999999999999999886432221   4578


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC-CCCcEEEeecCCccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~-~~~~ikl~Dfg~a~~  223 (409)
                      |.|||++ |+|.+++..+.   +.+++..++.+.+||+.||.|||++ ||+||||||+|||++. ++ .+||+|||+++.
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            9999999 57777776532   2799999999999999999999987 9999999999999998 56 899999999986


Q ss_pred             ccc----CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVK----GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ...    ........||+.|||||++........++|||||||++.||+||..||... ...+.+..+...-        
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------  239 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------  239 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--------
Confidence            653    223446889999999999975333446999999999999999999999874 3333333222210        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                         ....+|..+|+++++||.+||..||++||||.++|+|||.++...
T Consensus       240 -------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 -------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                               011367789999999999999999999999999999999987544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-49  Score=375.07  Aligned_cols=287  Identities=39%  Similarity=0.691  Sum_probs=226.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+++++.++||||+++++++..........++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999988632      12356799999999999999999987655444445678


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||++++|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999887776653    45799999999999999999999986 999999999999999888 89999999987543


Q ss_pred             cCCC----CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KGEP----NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~~~----~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ....    .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221    1345789999999998542 4588999999999999999999999999888888877777788777665543


Q ss_pred             cCCCcccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          301 MNPNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       301 ~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      ........   .+......++...++ .+++.+.++|.+||+.||++|||+.++++||||+.+.....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence            22111000   000001111111122 36788999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-50  Score=370.27  Aligned_cols=259  Identities=30%  Similarity=0.472  Sum_probs=214.5

Q ss_pred             CCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------------hhhHHHHHHHHhcCCCCee
Q 015298           66 QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVV  127 (409)
Q Consensus        66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~e~~~l~~l~h~niv  127 (409)
                      ...+.+.|.+++.||+|.||+|.+|++..+++.||||++.+..                  +...+|+.+|++|.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3456788999999999999999999999999999999995432                  2346899999999999999


Q ss_pred             cccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                      +++++.   ++.....+|||+|||..+-   +. +...... +++.+++.|+++++.||+|||.+ |||||||||+|+|+
T Consensus       172 ~LiEvL---DDP~s~~~YlVley~s~G~---v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl  243 (576)
T KOG0585|consen  172 KLIEVL---DDPESDKLYLVLEYCSKGE---VK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLL  243 (576)
T ss_pred             EEEEee---cCcccCceEEEEEeccCCc---cc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEE
Confidence            999877   4455667999999999531   11 1122344 89999999999999999999997 99999999999999


Q ss_pred             cCCCCcEEEeecCCccccccC------CCCccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015298          207 NPHTHQVKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGD  277 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~  277 (409)
                      +.+| .+||+|||.+.....+      ......+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||.+.
T Consensus       244 ~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  244 SSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             cCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            9997 8999999998765222      22345789999999999976   334678999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ...+...+|.+.-                 ..++.          ...+.++++|||.+||++||++|+++.++..|||.
T Consensus       323 ~~~~l~~KIvn~p-----------------L~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  323 FELELFDKIVNDP-----------------LEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             hHHHHHHHHhcCc-----------------ccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            9988888887621                 11111          11368999999999999999999999999999998


Q ss_pred             cCC
Q 015298          358 DEL  360 (409)
Q Consensus       358 ~~~  360 (409)
                      ..-
T Consensus       376 t~~  378 (576)
T KOG0585|consen  376 TRD  378 (576)
T ss_pred             ccC
Confidence            764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-50  Score=377.37  Aligned_cols=250  Identities=30%  Similarity=0.522  Sum_probs=216.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..|....+||+|+.|.||.|....+++.||||++...    ++...+|+.+|+..+|+|||.+++.|...++     +++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            4688889999999999999999999999999998543    3456789999999999999999999876644     899


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |||||+| +|.+.+..     ..+++.++..++++++.||+|||.+ ||+|||||.+|||++.+| .+||+|||++..+.
T Consensus       348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeeccc
Confidence            9999995 66666653     4599999999999999999999997 999999999999999998 79999999987665


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ...+.+|||+|||||++.. ..|++++||||||++++||+-|++||...+....+..|... |.|..         
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l---------  489 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL---------  489 (550)
T ss_pred             cccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc---------
Confidence            544 5678899999999999954 55999999999999999999999999987777777766653 22211         


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                      ..++.+|+.+++||.+||+.|+.+|++|.+||.||||+.
T Consensus       490 ----------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  490 ----------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ----------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                            145679999999999999999999999999999999953

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-48  Score=356.24  Aligned_cols=275  Identities=27%  Similarity=0.459  Sum_probs=230.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...|++.+.||.|.-|+||+|+.+.++..+|+|++.+..       ...+.|-+||+.++||.++.+|+.|     +.+.
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            457999999999999999999999999999999996542       3345689999999999999999999     6677


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      +.|++||||+| +|..+.+  .+.+..+++..++.++.+++.||+|||. +|||+|||||+||||.++| .|.|+||.++
T Consensus       151 ~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredG-HIMLsDFDLS  226 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDG-HIMLSDFDLS  226 (459)
T ss_pred             eeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCC-cEEeeecccc
Confidence            89999999996 4444433  3447889999999999999999999998 5999999999999999998 7999999986


Q ss_pred             ccccc---------------------------------C------------------------CCCcccccccccccccc
Q 015298          222 KVLVK---------------------------------G------------------------EPNISYICSRYYRAPEL  244 (409)
Q Consensus       222 ~~~~~---------------------------------~------------------------~~~~~~~gt~~y~aPE~  244 (409)
                      .....                                 .                        ....+++||-+|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            33200                                 0                        01124678999999999


Q ss_pred             ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCC
Q 015298          245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK  324 (409)
Q Consensus       245 l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (409)
                      +.+.. .+.++|+|+|||++|||+.|..||.+.+..+.+.+|...   +.              .++.          ..
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~---~l--------------~Fp~----------~~  358 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ---PL--------------KFPE----------EP  358 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC---CC--------------cCCC----------CC
Confidence            97755 899999999999999999999999999999998887652   11              1111          11


Q ss_pred             CCChhHHHHHHHhcccCCCCCCC----HHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCc
Q 015298          325 RMPPEAVDLVSRLLQYSPNLRCT----ALDALIHPFFDELRDPNARLPSGRFLPPLFNFKS  381 (409)
Q Consensus       325 ~~s~~l~~li~~~L~~dp~~R~s----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  381 (409)
                      .++..++|||+++|.+||++|+.    |+|+.+||||++++|.-.+...++.+|.......
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL  419 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence            46889999999999999999998    9999999999999999888888888888776643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.8e-50  Score=376.88  Aligned_cols=249  Identities=32%  Similarity=0.542  Sum_probs=217.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|.+.+.||+|.||.||+|+.+.|.+.||+|.+.+..      +...+|+++++.|+||||+.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            36888999999999999999999999999999986543      2356899999999999999999998     555559


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++|+||+.|.|..++..    ++.++++.++.++.|++.||.|||+. +|+|||+||.|||++..+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999998888876    78999999999999999999999986 999999999999999888 8999999999988


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..+.. ..+.-|||.|||||++.+ ..|+..+|+|||||++|||++|++||...+..+....|.+.   |.         
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v---------  217 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV---------  217 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence            66544 345679999999999975 45999999999999999999999999877666655555442   11         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                       ..|.+++..+..||..+|.+||.+|+|..+++.|||.++-
T Consensus       218 -----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                             1345789999999999999999999999999999999864

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-48  Score=364.85  Aligned_cols=282  Identities=32%  Similarity=0.545  Sum_probs=218.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++.     .....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999986432     23467999999999999999998873     34458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.+++...+..   ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            89999999887776653   245689999999999999999999986 999999999999999887 8999999998754


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 2234467899999999987666689999999999999999999999987543 45566666666766655443221


Q ss_pred             C--CccccccCcccCCCCcccC-CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 P--NYTEFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~--~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .  .+....+.......+...+ ....++.+.+||.+||+.||++|||+.++|+||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            1  1100011111111111111 112567899999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=356.86  Aligned_cols=273  Identities=27%  Similarity=0.471  Sum_probs=221.9

Q ss_pred             CCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           63 RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ....+.....|.+...||.|..++||+|++..+++.||||++.-++     ..+.+|+..++.++||||++++.+|....
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            3445566678999999999999999999999999999999996432     55678999999999999999999886544


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                      .     +++||+||. |++.++++.+.  ...+++..+..|.+++++||.|||.+ |.||||||+.||||+.+| .|||+
T Consensus        98 ~-----LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkLa  168 (516)
T KOG0582|consen   98 E-----LWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKLA  168 (516)
T ss_pred             e-----eEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEEc
Confidence            4     999999999 68888888766  45699999999999999999999997 999999999999999998 89999


Q ss_pred             ecCCccccccCCC-C----ccccccccccccccc-cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015298          217 DFGSAKVLVKGEP-N----ISYICSRYYRAPELI-FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (409)
Q Consensus       217 Dfg~a~~~~~~~~-~----~~~~gt~~y~aPE~l-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  290 (409)
                      |||.+..+..... .    ...+||++|||||++ .....|+.++||||||++..||.+|..||........+..-.+  
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--  246 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--  246 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            9997655543322 1    456899999999995 4445699999999999999999999999988777665543332  


Q ss_pred             CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      +.|+.......  +               ..-...++..++.+|..||+.||.+||||+++|+|+||++....
T Consensus       247 n~pp~~~t~~~--~---------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  247 NDPPTLLTSGL--D---------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             CCCCCcccccC--C---------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            33332111000  0               00122467799999999999999999999999999999986543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.3e-48  Score=359.44  Aligned_cols=279  Identities=35%  Similarity=0.587  Sum_probs=221.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcC-CCcEEEEEEeeccc------hhhHHHHHHHHhc---CCCCeecccceeeecCCCCc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~  141 (409)
                      +|++.+.||+|+||.||+|.+.. +|..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999864 46889999886432      2344677777665   69999999998754443445


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+++||||++++|...+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999998877775422  35689999999999999999999986 999999999999999887 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .............||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            866544444566789999999998654 4889999999999999999999999999999999999888877766544321


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      . ......+......+.... ...+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       237 ~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 V-ALPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             h-cccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            1 011111111122222222 23478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.3e-50  Score=345.72  Aligned_cols=285  Identities=28%  Similarity=0.449  Sum_probs=232.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ..|.-.+.||.|..++|.+|.++.+|..+|+|++....            ....+|+.||+++ .||||+++.+.|    
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----   92 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence            35778889999999999999999999999999984211            2234699999998 799999999998    


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                       +.+.++++|+|.|+ |.|.+++..    .-.+++...++|++|++.|+.|||.+ +||||||||+|||++.+. ++||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~is  165 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKIS  165 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEe
Confidence             67777999999999 666666654    57899999999999999999999986 999999999999999887 89999


Q ss_pred             ecCCccccccCCCCcccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      |||+|.....+......||||+|.|||.+.     +.+.|+..+|+|++|++||.|+.|.+||......-++..|+.+.-
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999984     344588999999999999999999999987766666666665421


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGR  371 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~  371 (409)
                      .-...                         -..++|...++||.+||+.||.+|.|+.|+|.||||.++...+.+    +
T Consensus       246 qF~sp-------------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r----~  296 (411)
T KOG0599|consen  246 QFRSP-------------------------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR----Q  296 (411)
T ss_pred             ccCCc-------------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc----c
Confidence            11111                         123478999999999999999999999999999999876443333    1


Q ss_pred             CCCCCCCCCcccccCCCHHHHhhcChHHHhhhCCC
Q 015298          372 FLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPF  406 (409)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (409)
                      ..|           -++++...+..-+.++|.-++
T Consensus       297 msP-----------~~~~~~~k~qt~~~aRkrFk~  320 (411)
T KOG0599|consen  297 MSP-----------VVEVELVKDQTSERARKRFKV  320 (411)
T ss_pred             cCC-----------CcchhhhhhhhhHHhhhheee
Confidence            111           334556666666666655443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-47  Score=355.14  Aligned_cols=275  Identities=37%  Similarity=0.709  Sum_probs=219.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|+++.+++.||+|++....      ....+|+.+++.++||||+++++++     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            6999999999999999999999999999999986432      3345799999999999999999888     3445688


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+++++...+..   ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999876655542   245789999999999999999999986 999999999999999887 89999999997654


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       226 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ...  ......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+....+..+...+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  223457899999999996644 8999999999999999999999999888877777777776666655443221 


Q ss_pred             -CCccccccCcc-cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 -PNYTEFKFPQI-KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 -~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                       +.+.....+.. ....+...+...+|.++.+||++||++||++|||+.++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             11111111111 01112222334578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.4e-47  Score=353.33  Aligned_cols=279  Identities=31%  Similarity=0.549  Sum_probs=221.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhc---CCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||+|.++.+|+.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999999999999999886421      2344677777665   799999999987655444556


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++++|||+.+++...+....  ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999988777765422  34589999999999999999999986 999999999999999887 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456789999999998654 48999999999999999999999999988888888888887777665543211


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                       ......+.......+.. ....+++.+.++|.+||++||++|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             00011111111111222 223478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.9e-47  Score=365.42  Aligned_cols=287  Identities=30%  Similarity=0.546  Sum_probs=224.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999999999999998643      2334579999999999999999998754322 1223


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||+++++...+.      ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence            478999999988766553      3588899999999999999999986 999999999999999888 89999999997


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+....+....
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            65444444556789999999999654 48999999999999999999999999988888888888888877665432211


Q ss_pred             ----------CCccccccCccc-CC--CCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          303 ----------PNYTEFKFPQIK-AH--PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       303 ----------~~~~~~~~~~~~-~~--~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                +.+....+.... ..  +.........++++++||.+||+.||++|||+.|+|+||||..+.++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  326 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE  326 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence                      111111100000 00  0000112235788999999999999999999999999999997766543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.4e-47  Score=364.16  Aligned_cols=289  Identities=30%  Similarity=0.541  Sum_probs=228.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            45899999999999999999999999999999998643      1334579999999999999999987743321 2234


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||+++++...+.      ..++...+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999988776653      3478888999999999999999986 999999999999999887 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+.+....
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            66544444556789999999999654 48999999999999999999999999999888888888888888766544332


Q ss_pred             CC----------ccccccCccc---CCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCC
Q 015298          303 PN----------YTEFKFPQIK---AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL  367 (409)
Q Consensus       303 ~~----------~~~~~~~~~~---~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~  367 (409)
                      +.          +..+.+....   ..++........+..+++||.+||+.||.+|||+.++|+||||..+.++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~  331 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE  331 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence            21          1111110000   01111111223467899999999999999999999999999999876665443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.5e-47  Score=356.71  Aligned_cols=280  Identities=34%  Similarity=0.657  Sum_probs=227.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            57999999999999999999999999999999986432     23457999999999999999999874     334578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+++++...+...   ...++...++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            99999998877665432   35688999999999999999999986 999999999999999887 89999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+.+.++.+....+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 2234567899999999876666899999999999999999999999999888888999999888887766543321


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                        +....++......+... ...+++++.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINH-APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhcCccCCCchhhh-ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence              11122222222222221 234789999999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-47  Score=363.07  Aligned_cols=251  Identities=30%  Similarity=0.434  Sum_probs=209.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            457999999999999999999999999999999986432       2356799999999999999999988     3444


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ++++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58899999985 66555543    56789999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...  .         
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~---------  231 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--R---------  231 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C---------
Confidence            765332  3356789999999999654 4789999999999999999999999877665555444321  0         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                        ..++..++..+++||.+||+.||.+|++     +.++++||||.+..+.
T Consensus       232 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        232 ------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                              0134457889999999999999999997     7999999999986544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-47  Score=355.49  Aligned_cols=259  Identities=23%  Similarity=0.373  Sum_probs=209.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|+..+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++.+++     ....++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            3889999999999999999999999999999885432       2345799999999999999998877     334458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|...+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            899999985 555444322  234689999999999999999999986 999999999999999887 899999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...+...          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------  220 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence            6544444556789999999999654 58999999999999999999999998765543333332221111          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPNA  365 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~~  365 (409)
                                     ...++..++.++.+||++||+.||.+|++     ++++++||||.++.+...
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL  272 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence                           01134568999999999999999999997     899999999998865543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-47  Score=355.75  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=209.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            699999999999999999999999999999998642       23356799999999999999998877     445568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+.+..    .+.+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999984 66666543    46789999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....             
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            5332  2345789999999998654 48999999999999999999999998877666555544310             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                      ..++..+++.+++||++||+.||.+|++     +.++++||||..+.+.
T Consensus       215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                            0134457899999999999999999995     9999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-46  Score=364.89  Aligned_cols=284  Identities=35%  Similarity=0.575  Sum_probs=224.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++...      .+...+|+++++.++|+||+++++++..........++
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999988542      13456799999999999999999987543322223578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+.++|...+..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999877766543    56799999999999999999999986 999999999999999887 89999999997653


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       226 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  223456789999999997766689999999999999999999999999999999999999888888765533211


Q ss_pred             CccccccCccc-CCCCc--ccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIK-AHPWH--KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~-~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ........... ...+.  ..+....++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            10000000000 00000  012344688999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=313.25  Aligned_cols=279  Identities=36%  Similarity=0.647  Sum_probs=235.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.-.++||+|.||+||+|+++.+++.||+|.+.-+.      ....+|+.+++.++|.|||++++...     .+..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence            4666789999999999999999999999999986543      34579999999999999999999873     334488


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|+|||...|..++..   .++.+..+.++.++.|+++||.++|++ ++.||||||.|.||+.+| .+|++|||+++...
T Consensus        78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            9999999887766554   478999999999999999999999997 999999999999999998 89999999998764


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      -.- -....+.|.+|++|.++++..-|++..|+||.||++.|+.. |++.|++.+..+++.+|++.+|.|..+.|..+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            332 22345669999999999999889999999999999999995 8999999999999999999999999999987653


Q ss_pred             CccccccCccc-CCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      -..-..++..+ ...|.++.| +++..-+|++.++|.-+|.+|++++++|+||||....
T Consensus       233 lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            22222233222 234444443 4677889999999999999999999999999998654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=359.76  Aligned_cols=256  Identities=31%  Similarity=0.499  Sum_probs=217.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcC-CCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  140 (409)
                      ....|.+.+.||.|.||.||+|.++.||+.+|+|.+.+..       ....+|+.+|+.+. |||||.+++.|     +.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence            3457999999999999999999999999999999996543       35678999999998 99999999999     44


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC---CcEEEe
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLC  216 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~---~~ikl~  216 (409)
                      ...+++|||++.| .|.+.+...     .+++..+..++.|++.++.|||+. ||+||||||+|+|+....   ..+|++
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEe
Confidence            4468999999995 454444432     399999999999999999999985 999999999999996542   279999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||++.....+......+||++|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......+...--     
T Consensus       182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-----  255 (382)
T KOG0032|consen  182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-----  255 (382)
T ss_pred             eCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----
Confidence            9999998877667778999999999999954 4599999999999999999999999999988887776655311     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                          .+.......++..+++||++||..||.+|+|+.++|+|||++...
T Consensus       256 --------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  256 --------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             --------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                                111123345799999999999999999999999999999998763

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-48  Score=328.56  Aligned_cols=251  Identities=29%  Similarity=0.447  Sum_probs=220.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|.+++.||.|-||.||+|+.+.++-.||+|++.+.       .....+|++|...|+||||++++++|     .+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccc
Confidence            46899999999999999999999999999999998654       24556899999999999999999999     5555


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+||++||.. |.+...+..  ....++++..++.+++|++.||.|+|.+ +++||||||+|+|++..+ .+||+|||-+
T Consensus        96 riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAdfGws  171 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  171 (281)
T ss_pred             eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccCCCce
Confidence            6999999998 566666653  2367899999999999999999999986 999999999999999998 8999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .... .....+.|||..|.+||...+. .++..+|+|++|++.||++.|.+||...+..+.+.+|.+.-           
T Consensus       172 V~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-----------  238 (281)
T KOG0580|consen  172 VHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-----------  238 (281)
T ss_pred             eecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-----------
Confidence            6544 5556788999999999999664 48999999999999999999999999998888888887741           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        -.+|..++.++.|+|.+||..+|.+|.+..|++.|||+...
T Consensus       239 ------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  239 ------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                              22567899999999999999999999999999999998753

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=390.86  Aligned_cols=304  Identities=28%  Similarity=0.455  Sum_probs=249.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec-------cchhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+++.||.|+||.|.+++++.|++.||+|++.+       +...+..|-.+|..-+.+=|+.++-.|     .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            45689999999999999999999999999999999865       234567888999888899999997777     788


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .|+|+|||||+| +|..++..    .+++++.++++|+..|+.||+-||+ +|+|||||||+|||+|..| .|||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~G-HikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSG-HIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccC-cEeeccchh
Confidence            889999999995 56666554    3489999999999999999999997 6999999999999999999 799999998


Q ss_pred             ccccccCCC--CccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          221 AKVLVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       221 a~~~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      +-.+..++.  ....+|||.|.+||+|..    ...|+..+|+||+||++|||+.|..||...+-.+++.+|+....   
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~---  298 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE---  298 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh---
Confidence            766653332  346789999999999942    24589999999999999999999999999999999999987411   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCccCCCCCCCCCCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---ALDALIHPFFDELRDPNARLPSGR  371 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s---~~ell~hp~f~~~~~~~~~~~~~~  371 (409)
                                  .+.||.          ...+|+++++||+++++ +|..|..   +.++-+||||.++.|.+.+-..++
T Consensus       299 ------------~l~FP~----------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  299 ------------SLSFPD----------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             ------------hcCCCc----------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence                        112221          02489999999999886 7889998   999999999999999999888888


Q ss_pred             CCCCC------CCCCcccccCCCHHHHhhcC-hHHHhhhCCCCCC
Q 015298          372 FLPPL------FNFKSHELKSVPVEILVKLI-PEHARKQCPFLGL  409 (409)
Q Consensus       372 ~~~~~------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  409 (409)
                      .+|.+      .||+..+-.--+++.+-..+ +.+.++++||+||
T Consensus       356 ~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGf  400 (1317)
T KOG0612|consen  356 VVPEVSSDDDTSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGF  400 (1317)
T ss_pred             CCCcCCCCCccccccccccccchhhccCCCCCCCCcCCcCCeeee
Confidence            88877      34533332222333343333 4566999999997

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=356.69  Aligned_cols=261  Identities=29%  Similarity=0.427  Sum_probs=230.0

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+-|.+.+.||+|.|+.|-+|++..||+.||||++.+.+      ....+|++.|+.++|||||++|++.     ..
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DT   88 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DT   88 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cc
Confidence            345567999999999999999999999999999999996653      3456899999999999999998876     33


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+|||+|.-.+ +|.+++-.   ....+.+..+++++.||+.|+.|+|+ +++|||||||+||.+-+..+-+||.|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeecc
Confidence            3348899999885 66666543   36789999999999999999999997 6999999999998775555589999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++..+.++....+.||+..|.|||++.+..+..+++||||||||||.|++|++||...+..+.+..|+.+..        
T Consensus       165 FSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--------  236 (864)
T KOG4717|consen  165 FSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--------  236 (864)
T ss_pred             ccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence            999999999999999999999999999999888999999999999999999999999999999988887532        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                           ..|..++.++++||..||+.||++|.|.+++..|+|++.+..+..
T Consensus       237 ---------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  237 ---------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             ---------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence                                 256678999999999999999999999999999999998865543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-48  Score=350.82  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=222.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|.||+|-+|.+...|+.||||.+.++.       ..+.+|++||..|+||||+.++++|     ++..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence            458999999999999999999999999999999987653       3456899999999999999999999     4555


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+.|||||.. |.|.+++..    .+.+++.+++.+++||+.|+.|+|++ +++|||||.+|||+|.++ ++||+|||++
T Consensus       127 KIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccchh
Confidence            5899999998 578888776    57899999999999999999999997 999999999999999998 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ..+.......++||+|-|.+||++.+.++-++.+|-||||++||.|+.|..||++.+....+.+|..+....        
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--------  272 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--------  272 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--------
Confidence            998888888999999999999999998888999999999999999999999999999888888877643221        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                            ...+.++.-||+.||..||++|.|+.++..|=|.+
T Consensus       273 ----------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  273 ----------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                  22467889999999999999999999999998875

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.3e-46  Score=360.32  Aligned_cols=285  Identities=32%  Similarity=0.558  Sum_probs=225.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            458999999999999999999999999999999986431      234579999999999999999998754322 2233


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++||||+++++...+.      ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999988766553      3588889999999999999999986 999999999999999887 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+.+....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            66554444567889999999998654 48999999999999999999999999988888888888888877765544332


Q ss_pred             CC----------ccccccCcccC---CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          303 PN----------YTEFKFPQIKA---HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       303 ~~----------~~~~~~~~~~~---~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      +.          +....++....   .+.........+.++++||.+||+.||.+|||+.|+|+||||..+.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            21          11111111000   011111223356789999999999999999999999999999877554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-47  Score=360.39  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=209.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-cEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||+++++++     ..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            3457999999999999999999976655 68999998543       12345799999999999999999988     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ..++++||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4568999999974 66666543    56799999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9976532  23456789999999999654 48899999999999999999999998877655555543311         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                          ..++..+++.+.++|++||+.||.+|+     |+.++++||||.++.+.
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                013456789999999999999999995     89999999999987654

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-47  Score=363.19  Aligned_cols=300  Identities=30%  Similarity=0.483  Sum_probs=227.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||+||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            699999999999999999999999999999998643       23456799999999999999999887     445568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999974 66666554    36799999999999999999999986 999999999999999888 899999999876


Q ss_pred             cccCC------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 015298          224 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL  273 (409)
Q Consensus       224 ~~~~~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~p  273 (409)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              22345789999999999665 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-HHHHh
Q 015298          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-ALDAL  352 (409)
Q Consensus       274 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-~~ell  352 (409)
                      |......+....+.......               .++          ....+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKESL---------------RFP----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCcc---------------cCC----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            98887666555544311100               000          111268999999999998 9999999 99999


Q ss_pred             CCCCccCCCCCCCCCCCCCCCCCC------CCCCcccc-cCCCHHHHhhcChHHHhhhCCCCCC
Q 015298          353 IHPFFDELRDPNARLPSGRFLPPL------FNFKSHEL-KSVPVEILVKLIPEHARKQCPFLGL  409 (409)
Q Consensus       353 ~hp~f~~~~~~~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  409 (409)
                      +||||+++.+..........+|.+      .+|+..+- +.++.............++.+|+|+
T Consensus       284 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (350)
T cd05573         284 SHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGF  347 (350)
T ss_pred             cCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhcCCCCcccccccccccccccccccccCccCCC
Confidence            999999876654332222222222      12222221 1111112333445556678888875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-47  Score=362.89  Aligned_cols=302  Identities=26%  Similarity=0.431  Sum_probs=227.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            6999999999999999999999999999999987532       3456789999999999999998877     344558


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++ ++|.+++...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            89999997 4666665532   36799999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCCC--CccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ......  .....||+.|+|||++..     ...++.++|||||||++|+|++|..||........+.++.......   
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---  228 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---  228 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc---
Confidence            543332  223468999999999853     3457889999999999999999999998877666655554321000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPL  376 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~  376 (409)
                                  .++          ....+++++.+||.+||. ||.+|||+.++++||||..+.+...........|.+
T Consensus       229 ------------~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~~~~~~~  285 (330)
T cd05601         229 ------------KFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTL  285 (330)
T ss_pred             ------------CCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCCCccCcC
Confidence                        000          112478999999999998 999999999999999999876554332222222222


Q ss_pred             ------CCCCcccccCCCHH---HHhhcChHHHhhhCCCCCC
Q 015298          377 ------FNFKSHELKSVPVE---ILVKLIPEHARKQCPFLGL  409 (409)
Q Consensus       377 ------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  409 (409)
                            .+|...+..+....   .-......+-.+.+|||||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (330)
T cd05601         286 KSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGF  327 (330)
T ss_pred             CCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCc
Confidence                  22332222221111   1223344556778999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.6e-46  Score=368.98  Aligned_cols=282  Identities=23%  Similarity=0.360  Sum_probs=212.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCC------CeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~  140 (409)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.++|.      ++++++++|..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            568999999999999999999999999999999986432   2345688888777554      57777776632    2


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---------
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---------  211 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---------  211 (409)
                      ..++|+||++++++|.+.+..    .+.+++..++.++.||+.||.|||.+.|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            345789999998887776654    4679999999999999999999997459999999999999986542         


Q ss_pred             ------cEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015298          212 ------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE  285 (409)
Q Consensus       212 ------~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  285 (409)
                            .+||+|||.+...  .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  4999999987543  2233457899999999999764 489999999999999999999999999888888888


Q ss_pred             HHHHhCCCCHHHHhhcCCC-cccc-----c-cCcccCCCCccc-----C-CCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          286 IIKVLGTPTREEIKCMNPN-YTEF-----K-FPQIKAHPWHKI-----F-PKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~-~~~~-----~-~~~~~~~~~~~~-----~-~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                      +.+.++.++.......... ..++     . .+......+...     . ....++.+.+||.+||++||.+|||+.|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888887665432210000 0000     0 000000000000     0 001246788999999999999999999999


Q ss_pred             CCCCccCCCC
Q 015298          353 IHPFFDELRD  362 (409)
Q Consensus       353 ~hp~f~~~~~  362 (409)
                      +||||.+...
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999997644

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.4e-47  Score=359.86  Aligned_cols=246  Identities=27%  Similarity=0.449  Sum_probs=202.6

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            36999999999999999999999999986532       2345689999999999999998887     34456899999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-C
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  227 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-~  227 (409)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 55444443    56789999999999999999999986 999999999999999887 899999999875322 2


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+...                  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------------------  210 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  210 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------------------
Confidence            333456799999999998654 4899999999999999999999999876655444433221                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                 ...++..+++++.+||++||+.||++||     ++.++++||||..+.+.
T Consensus       211 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         211 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                       0014456899999999999999999999     89999999999987544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-46  Score=358.73  Aligned_cols=285  Identities=34%  Similarity=0.626  Sum_probs=227.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+++++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            47999999999999999999999999999999986432      234579999999999999999987743221 22234


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++++++++++|...+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            68999999888776654     35799999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.....
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            533  234567899999999997756689999999999999999999999998888888888888877777655443322


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      .....   .++......+...+ ...++.+.+||.+||..||.+|||+.++|+||||.+..++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~  309 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED  309 (343)
T ss_pred             hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence            11110   11111111122212 236788999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-46  Score=365.67  Aligned_cols=278  Identities=24%  Similarity=0.338  Sum_probs=212.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|+++++.++||||++++++|..     ..+.++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence            4579999999999999999999999999999997643  345789999999999999999998843     345789999


Q ss_pred             ccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC--
Q 015298          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  227 (409)
Q Consensus       150 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~--  227 (409)
                      ++.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......  
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            999887766653    45789999999999999999999986 999999999999999887 8999999999754322  


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHHhCCCCHHHHhh
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-------SGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...       .....+..+....+.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            223356799999999998654 5899999999999999999999877543       23345666666666544321100


Q ss_pred             cCCCcccc--------ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEF--------KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ........        .........|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.+..+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            00000000        0000000111111  1357789999999999999999999999999999876544

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-45  Score=347.43  Aligned_cols=283  Identities=33%  Similarity=0.627  Sum_probs=226.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999986432     23457999999999999999999883     34458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.++|...+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            899999998877766532   45688999999999999999999986 999999999999999887 8999999998754


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||...+..+....+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3222 223446788999999987666688999999999999999999999999888888888888888777665543221


Q ss_pred             C--ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          304 N--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .  +....++....... ......+++.+++||.+||+.||.+|||+.++|+||||+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            1  11112222111111 11234578999999999999999999999999999999887644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-46  Score=358.56  Aligned_cols=278  Identities=23%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|+...  .....|+.+++.++||||+++++++..     ....++|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--cccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEE
Confidence            4579999999999999999999999999999997543  334579999999999999999998843     344789999


Q ss_pred             ccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC
Q 015298          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (409)
Q Consensus       150 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~  229 (409)
                      ++.+++...+..   ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.......
T Consensus       138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCcc
Confidence            999887776653   246789999999999999999999986 999999999999999887 899999999975544444


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHh
Q 015298          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSG---------VDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       230 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .....||+.|+|||++.+. .++.++|||||||++|+|+++. .+|.....         ...+..+...++..+.....
T Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4556789999999998654 4899999999999999999855 44443221         12333334433332211100


Q ss_pred             hcCCCccc--cccCcccCCCCc---ccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          300 CMNPNYTE--FKFPQIKAHPWH---KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       300 ~~~~~~~~--~~~~~~~~~~~~---~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      ........  ..+......++.   ..-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000000  000000001110   11122467889999999999999999999999999999864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=352.44  Aligned_cols=242  Identities=30%  Similarity=0.535  Sum_probs=199.8

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999986421       2345789999999999999998877     3445588999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC-CC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  229 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~-~~  229 (409)
                      ++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 55555543    56799999999999999999999986 999999999999999888 8999999998754322 22


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccc
Q 015298          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (409)
Q Consensus       230 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  309 (409)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...   +                
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~----------------  209 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P----------------  209 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C----------------
Confidence            3346789999999999654 4899999999999999999999999877665554443321   0                


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC---CHHHHhCCCCccCCC
Q 015298          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHPFFDELR  361 (409)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~---s~~ell~hp~f~~~~  361 (409)
                                ..++..+++++.+||.+||..||.+||   ++.++++||||.+..
T Consensus       210 ----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         210 ----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                      014456889999999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.6e-46  Score=360.36  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=209.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            345899999999999999999999999999999998642       12345799999999999999999877     445


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++++||||+++ +|..++.     ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            568999999985 6666554     34689999999999999999999986 999999999999999888 899999999


Q ss_pred             ccccccCC--CCccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGE--PNISYICSRYYRAPELIFGA---TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +.......  ......||+.|+|||++.+.   ..++.++|||||||++|+|++|..||.+.+....+..+.......  
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--  266 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL--  266 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--
Confidence            87654322  22356789999999998543   237889999999999999999999999877666655554321100  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRD  362 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~  362 (409)
                                   .++          -...+|.++.+||++||+.+|.+  |+|+.++++||||+...+
T Consensus       267 -------------~~~----------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         267 -------------TFP----------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             -------------CCC----------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                         000          01247899999999999999998  999999999999997543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.3e-46  Score=359.61  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=207.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ...
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            345799999999999999999999999999999998642       23356799999999999999999888     445


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++++||||+++ +|.+++.     ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            568999999984 6666654     24689999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCC--CccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +........  ....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||...+.......+.......  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  266 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--  266 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc--
Confidence            976543221  23567999999999986432   37889999999999999999999998887766666554321110  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELR  361 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~  361 (409)
                                   .++          ....++..++++|.+||..++.+  |+|+.++++||||+...
T Consensus       267 -------------~~p----------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         267 -------------NFP----------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             -------------CCC----------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence                         000          01236899999999999866554  89999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-46  Score=356.25  Aligned_cols=258  Identities=30%  Similarity=0.473  Sum_probs=211.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+++++.++||||+++++++     ....+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986432       2345799999999999999999887     444568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999984 67666643    46789999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+........         
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------  218 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------  218 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence            533  33456789999999999665 589999999999999999999999988777666555443211000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                            .+.     +.. ....+++++.+||.+||..+|.+|+++.++++||||.++.+..
T Consensus       219 ------~~~-----~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         219 ------RPV-----YDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             ------CCC-----CCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence                  000     000 0124689999999999999999999999999999999875543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-45  Score=350.14  Aligned_cols=277  Identities=31%  Similarity=0.543  Sum_probs=209.3

Q ss_pred             EEeeccCCceEEEEEEEc--CCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      .++||+|+||.||+|.++  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            458999999999999965  467899999986542  3456899999999999999999887542   234578999999


Q ss_pred             chhHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec----CCCCcEEEeecCCcc
Q 015298          152 PETVHRVVKHFNK-----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK  222 (409)
Q Consensus       152 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~----~~~~~ikl~Dfg~a~  222 (409)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+|||++    ..+ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            9988777654221     123589999999999999999999986 999999999999994    334 79999999997


Q ss_pred             ccccCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 015298          223 VLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKV  289 (409)
Q Consensus       223 ~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~  289 (409)
                      ......    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.....         .+.+..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    123467899999999997766689999999999999999999999975432         3566777888


Q ss_pred             hCCCCHHHHhhcCCCcc------ccc---cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          290 LGTPTREEIKCMNPNYT------EFK---FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ++.+....+.....-..      .+.   ........+........+.++.+||.+||++||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            88777665543221000      000   000000000001112346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-46  Score=360.24  Aligned_cols=255  Identities=31%  Similarity=0.492  Sum_probs=206.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999996431       2345799999999999999999888     445568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999985 56555543    46799999999999999999999986 999999999999999888 899999999865


Q ss_pred             cccCC---------------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHH
Q 015298          224 LVKGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV  264 (409)
Q Consensus       224 ~~~~~---------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il  264 (409)
                      .....                                       .....+||+.|+|||++.+. .++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence            42211                                       01134689999999998654 589999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC
Q 015298          265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL  344 (409)
Q Consensus       265 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~  344 (409)
                      |+|++|..||...+..+....+.......               .++          ....+++++.+||.+||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~----------~~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKETL---------------QFP----------DEVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCCcc---------------CCC----------CCCCCCHHHHHHHHHHcc-CHhh
Confidence            99999999998877666555543311000               000          011468999999999997 9999


Q ss_pred             CCC---HHHHhCCCCccCCCCCC
Q 015298          345 RCT---ALDALIHPFFDELRDPN  364 (409)
Q Consensus       345 R~s---~~ell~hp~f~~~~~~~  364 (409)
                      |++   +.++++||||+...+..
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCHHH
Confidence            998   99999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-46  Score=360.79  Aligned_cols=256  Identities=29%  Similarity=0.469  Sum_probs=204.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++.+..       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            6999999999999999999999999999999986432       2345799999999999999999888     445568


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            99999997 466666543    46789999999999999999999986 999999999999999887 899999999863


Q ss_pred             cccCC------------------------------------------------CCccccccccccccccccCCCCCCchh
Q 015298          224 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  255 (409)
Q Consensus       224 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~  255 (409)
                      .....                                                .....+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence            21100                                                00124689999999998654 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 015298          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (409)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (409)
                      |||||||++|+|++|.+||......+....+......               ..++          -...++.++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFP----------DDIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCC----------CCCCCCHHHHHHHH
Confidence            9999999999999999999887766655554431100               0000          01136899999999


Q ss_pred             HhcccCCCCC---CCHHHHhCCCCccCCCCCCC
Q 015298          336 RLLQYSPNLR---CTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       336 ~~L~~dp~~R---~s~~ell~hp~f~~~~~~~~  365 (409)
                      +||. +|.+|   +|+.+++.||||+...+...
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~  316 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI  316 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9998 77765   59999999999998765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-45  Score=356.64  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||+||+|.+..+++.||+|++.+..       ....+|+.+++.++|+||+++++.+     ....++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            6999999999999999999999999999999996532       2345789999999999999999887     444568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++| +|.+.+..    .+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999985 66665543    56799999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCC------------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 015298          224 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (409)
Q Consensus       224 ~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~l  267 (409)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01245799999999999654 489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCC---C
Q 015298          268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN---L  344 (409)
Q Consensus       268 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~---~  344 (409)
                      ++|..||.+.+..+...++.......               .++.          ...++++++++|.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            99999998877766666554321100               0000          11368899999999876 444   4


Q ss_pred             CCCHHHHhCCCCccCCCCCC
Q 015298          345 RCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       345 R~s~~ell~hp~f~~~~~~~  364 (409)
                      ||++.++++||||+++.+..
T Consensus       284 r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         284 APGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHhCCCCCCCCCHHH
Confidence            58999999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-45  Score=348.38  Aligned_cols=317  Identities=33%  Similarity=0.619  Sum_probs=241.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +.+|.+.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++++++..........+
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            458999999999999999999999999999999985321     234569999999999999999987654443444567


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++++||+.+++...+.     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeec
Confidence            8999999987766654     45799999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....    .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            33221    12356789999999876655689999999999999999999999998887777777877777777665543


Q ss_pred             cCCCccccc---cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCC
Q 015298          301 MNPNYTEFK---FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLF  377 (409)
Q Consensus       301 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  377 (409)
                      .........   .+.....++... ....++++.+||.+||+.||.+|||+.++++||||+.+.++.....    .+..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~----~~~~~  311 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV----AEEPF  311 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc----CCCCC
Confidence            221111000   111111111111 1236889999999999999999999999999999998876543221    11222


Q ss_pred             CCCcccccCCCHHHHhhcChH
Q 015298          378 NFKSHELKSVPVEILVKLIPE  398 (409)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~  398 (409)
                      -|+-......|.+.+.+++-.
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~  332 (336)
T cd07849         312 PFDFELFDDLPKEKLKELIFE  332 (336)
T ss_pred             ChhhccccccCHHHHHHHHHH
Confidence            344445567777777766544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.5e-47  Score=322.28  Aligned_cols=314  Identities=30%  Similarity=0.577  Sum_probs=263.2

Q ss_pred             CCCCChhhhhccccCCcccccceeeCCCCCcccceEEeecCCCCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEE
Q 015298           21 GVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVA  100 (409)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va  100 (409)
                      +.+++.+.+|..++++.+.+|....+...                    ..+|++.+++|.|-++.||.|.+..+++.++
T Consensus         8 s~ARvya~vn~~rp~eYWdYE~~~i~wg~--------------------~ddYeivrk~GRGKYSEVFeg~~~~~~eK~V   67 (338)
T KOG0668|consen    8 SVARVYADVNEERPREYWDYESLVIDWGN--------------------QDDYEIVRKVGRGKYSEVFEGINITNNEKCV   67 (338)
T ss_pred             hhhhhhhhccccCchhhcchhheeeeccc--------------------cchHHHHHHHcCccHhhHhcccccCCCceEE
Confidence            56788999999999999999886665442                    3479999999999999999999999999999


Q ss_pred             EEEeecc-chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHH
Q 015298          101 IKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA  178 (409)
Q Consensus       101 iK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~  178 (409)
                      ||+++.- .+.+.+|+.+|+.|. ||||++++++.-.   .......||+||++..-      +......++...++.++
T Consensus        68 iKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLiFE~v~n~D------fk~ly~tl~d~dIryY~  138 (338)
T KOG0668|consen   68 IKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLIFEYVNNTD------FKQLYPTLTDYDIRYYI  138 (338)
T ss_pred             EeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhHhhhhcccc------HHHHhhhhchhhHHHHH
Confidence            9999753 456789999999996 9999999987733   33344678999999641      22235678999999999


Q ss_pred             HHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHH
Q 015298          179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIW  258 (409)
Q Consensus       179 ~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw  258 (409)
                      .|++.||.|+|+. ||+|||+||.|++||.....++|+|||+|.++.++....-.+.+.+|--||.+...+.|...-|+|
T Consensus       139 ~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~W  217 (338)
T KOG0668|consen  139 YELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMW  217 (338)
T ss_pred             HHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHH
Confidence            9999999999985 999999999999999887789999999999998888877888899999999998888899999999


Q ss_pred             HHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHH-h----hcCCCccccccCcccCCCCcccCCCC----CCh
Q 015298          259 SAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEI-K----CMNPNYTEFKFPQIKAHPWHKIFPKR----MPP  328 (409)
Q Consensus       259 slG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~----~s~  328 (409)
                      ||||+|..|++.+-|| .+.++.+++.+|.+.+|+...... .    .+++.+.. -+.+....+|..+++..    .++
T Consensus       218 S~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~-i~~~~~rk~w~~Fi~~~n~hl~~p  296 (338)
T KOG0668|consen  218 SLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFED-ILGRHSRKPWSRFINSENQHLVSP  296 (338)
T ss_pred             HHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhh-HhhccccccHHHhCCccccccCCh
Confidence            9999999999987665 688999999999999997654322 1    13344433 24456678888887653    579


Q ss_pred             hHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          329 EAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       329 ~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      ++.|||.++|.+|.++|+||.|++.||||..+.....
T Consensus       297 eaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~  333 (338)
T KOG0668|consen  297 EAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAES  333 (338)
T ss_pred             HHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhh
Confidence            9999999999999999999999999999997765443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-45  Score=349.96  Aligned_cols=246  Identities=28%  Similarity=0.512  Sum_probs=201.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|+++.+++.||+|++.+..       .....|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            36899999999999999999999999986432       2234677777766 799999999888     3444588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 55544433    56799999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            223345678999999999865 458999999999999999999999998887766655543310                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------LDALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~------~ell~hp~f~~~~~~  363 (409)
                                   ..++..+++++.+||++||+.||.+|+++      .++++||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence                         01344578999999999999999999998      899999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.3e-45  Score=340.34  Aligned_cols=275  Identities=35%  Similarity=0.569  Sum_probs=216.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++     .+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            5899999999999999999999999999999986431      2345799999999999999999988     3444588


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +++||+++++.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999998877665432   45789999999999999999999986 999999999999999887 89999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            322 2233566889999999877666799999999999999999988774 55566677777777777776655433221


Q ss_pred             CccccccCcccC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ......++.... ..|.. ....+++++.+||.+||..||.+|||+.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVN-VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhh-hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111 11111 223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-45  Score=357.49  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=202.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|.+++.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999996432       23457999999999999999998883     44568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999985 66666543    46789999999999999999999986 999999999999999887 899999998753


Q ss_pred             cccCC------------------------------------------------CCccccccccccccccccCCCCCCchh
Q 015298          224 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  255 (409)
Q Consensus       224 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~  255 (409)
                      .....                                                .....+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01235789999999998654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 015298          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (409)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (409)
                      |||||||++|+|++|..||...+..+....+.......               ..          .....+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~----------~~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HI----------PPQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CC----------CCCCCCCHHHHHHHH
Confidence            99999999999999999998877655544443211000               00          011247899999999


Q ss_pred             Hhcc--cCCCCCCCHHHHhCCCCccCCCCC
Q 015298          336 RLLQ--YSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       336 ~~L~--~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      +|+.  .++..|+++.++++||||.++.+.
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            9665  455559999999999999987553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-45  Score=356.66  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=206.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     ..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            3346899999999999999999999999999999998542       12345789999999999999999887     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ..++++||||+++ +|..++.     ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeCC
Confidence            4568999999984 6666654     24689999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCC--CCccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ++.......  .....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||...+.......+....... 
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-  266 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-  266 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-
Confidence            997654322  223567999999999985432   37889999999999999999999998877666655554321100 


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELR  361 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~  361 (409)
                                    .++          ....++..++++|.+||..++.+  |+++.++++||||++..
T Consensus       267 --------------~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         267 --------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             --------------cCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                          000          12247899999999999844443  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=347.26  Aligned_cols=245  Identities=29%  Similarity=0.455  Sum_probs=201.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcE-EEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...+.+.||+|+||+||++.+  .|.. ||+|++....      ..+.+|+.+|.+++|||||++++++.....    .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            345556699999999999998  5556 9999996532      367789999999999999999998843321    47


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-cEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|||||++ |+|..++...  ....++...+..++.||++|+.|||++ + ||||||||+|||++.++.++||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            89999999 5666666543  467899999999999999999999986 9 99999999999999885479999999998


Q ss_pred             ccccC-CCCccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          223 VLVKG-EPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       223 ~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ..... .......||+.|||||++.+ ...|+.++||||||++||||+||+.||.+....+....+.....+|       
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-------  265 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-------  265 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence            76554 33444789999999999974 3569999999999999999999999999888755555444332222       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                                          .++...++.+..++.+||..||.+||+..+++
T Consensus       266 --------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  266 --------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             --------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence                                14555889999999999999999999999876

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-45  Score=350.54  Aligned_cols=245  Identities=27%  Similarity=0.445  Sum_probs=201.4

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||++.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46899999999999999999999999986531       2234689999999999999998887     33446889999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-C
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  227 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-~  227 (409)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 55444432    56789999999999999999999986 999999999999999887 899999999875322 2


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+....                 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----------------  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------------  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence            223346789999999998654 48999999999999999999999998776655544433210                 


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRD  362 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~  362 (409)
                                  ..++..+++++.+||.+||+.||.+|+     ++.++++||||.+..+
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                        013456899999999999999999998     8999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-46  Score=353.09  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=224.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|..++.+|.|+||.+++++++..+..|++|.+.-.      ++....|+.+++++.|||||.+.+.|+    .+..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            4799999999999999999999999999999998533      345578999999999999999999985    445569


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +|||+||+| ++.+.+....  +..++++.+..|+.|++.|+.|||++ +|+|||||+.||+++.++ .|+|+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999995 6777776544  67899999999999999999999986 999999999999999998 789999999999


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..+.. ...+..||++||+||++.+ ..|+.++|||||||++|||++-+++|...+-...+.+|.+....|         
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------  225 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------  225 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence            87776 6778999999999999965 459999999999999999999999999999999999998876444         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                         ++...+.+++.+|+.||..+|..||++.++|.+|.+..
T Consensus       226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                               45568999999999999999999999999999999874

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.5e-45  Score=339.68  Aligned_cols=277  Identities=35%  Similarity=0.622  Sum_probs=217.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4899999999999999999999999999999885321      34567999999999999999999884     344588


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+.+++.+.+.... ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988777665432 246789999999999999999999986 999999999999999887 89999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|+||++||.+....+....+....+.+....+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 1223456889999999876666789999999999999999999999988887777777777666655444321100


Q ss_pred             cc-ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YT-EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .. ...++........ .....+++++.++|.+||+.||.+|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00 0001111111111 1223478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-45  Score=350.95  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=200.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986532       2345789999999999999998877     34445889999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC-
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  227 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~-  227 (409)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 45444432    56799999999999999999999986 999999999999999887 8999999998753222 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...                  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------  210 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  210 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC------------------
Confidence            223346789999999998654 4899999999999999999999999876655444333210                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRD  362 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~  362 (409)
                                 ...++..+++++.+||++||+.||.+|+     ++.++++||||....+
T Consensus       211 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         211 -----------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             -----------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                       0014556899999999999999999997     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.9e-45  Score=347.09  Aligned_cols=306  Identities=35%  Similarity=0.643  Sum_probs=237.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||||.+...      .....+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            34799999999999999999999999999999988542      123457999999999999999999775443333345


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+||+.++|.+.+..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCccccc
Confidence            789999999887766653    46799999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .... .......++..|+|||.+.....++.++|+|||||++|+|++|+.||.+.+.......+....+.+..+.+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            5433 223345678899999998654558899999999999999999999999888777777788777777665543211


Q ss_pred             CCcccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      ......   ..+......+.. ....+++++.+||.+||+.||.+|||+.++++||||..+.+++....  ...|..++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~--~~~~~~~~~  314 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV--CQTPFSFDF  314 (337)
T ss_pred             chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc--CCCccchhh
Confidence            110000   001111111111 22357899999999999999999999999999999999877765322  234556667


Q ss_pred             Ccccc
Q 015298          380 KSHEL  384 (409)
Q Consensus       380 ~~~~~  384 (409)
                      ++.++
T Consensus       315 ~~~~~  319 (337)
T cd07858         315 EEDAL  319 (337)
T ss_pred             hhhhc
Confidence            66663

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-45  Score=354.52  Aligned_cols=281  Identities=22%  Similarity=0.327  Sum_probs=212.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc--CCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+... ....+|+++++.++||||+++++++     .....++++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            457999999999999999999764  45688999988654 3456899999999999999999887     334458899


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||++.+++...+..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            99999887776632    56799999999999999999999986 999999999999999887 8999999998765433


Q ss_pred             CC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhc
Q 015298          228 EP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---GVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       228 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2346789999999998654 48999999999999999999999997654   34556666665554332211000


Q ss_pred             CC----CccccccCcccCCCCcc-cCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          302 NP----NYTEFKFPQIKAHPWHK-IFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~----~~~~~~~~~~~~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ..    .+..+............ +....++.++++||.+||..||++|||+.++|.||||.+...+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence            00    00000000000000001 1122467889999999999999999999999999999875433

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=351.33  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=208.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..|.....||+|.||.||+|.+..+++.||+|++.-+     ...+++|+.+|..++++||.++++.|+....     ++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence            3688889999999999999999999999999999543     2455789999999999999999999955443     89


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||.| ++.++++.    +..+.+..+..++++++.||.|||.+ +.+|||||+.|||+..+| .+||+|||.+...
T Consensus        88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEecceeeee
Confidence            99999995 55566553    44558888889999999999999997 999999999999999987 8999999998766


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... ..+++|||+|||||++. ...|+.++||||||++.+||++|.+|+........+..|-+               
T Consensus       162 ~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------  225 (467)
T KOG0201|consen  162 TNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------  225 (467)
T ss_pred             echhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---------------
Confidence            54433 37899999999999997 45699999999999999999999999976654222222111               


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                               ..    -..+...+|+.+++|+..||.+||+.||||.++|+|+|++..
T Consensus       226 ---------~~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  226 ---------SA----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             ---------CC----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                     00    011233578999999999999999999999999999999973

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-45  Score=340.03  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=209.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|++.+.||+|+||+||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4889999999999999999999999999999986432       2345799999999999999998887     333458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|...+..  .....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            899999985 55554432  1235689999999999999999999986 999999999999999887 899999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.........+...+...          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------  220 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence            6544444456789999999998654 48899999999999999999999998766544433333321110          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN  364 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~  364 (409)
                                     ...++..+++.+.+||.+||..||.+||     ++.++++||||.+..+..
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence                           0113445789999999999999999999     999999999999865553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-46  Score=329.57  Aligned_cols=285  Identities=36%  Similarity=0.616  Sum_probs=227.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..|.+...||+|.||.||+|..+.++.    .+|||.++..+      ...-+|+.+++.++|||++.+..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            469999999999999999997665543    78999997653      3456899999999999999999998653    


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC----CCcEEE
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH----THQVKL  215 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~----~~~ikl  215 (409)
                      +..+++++||.+.+|+.+++.... ....++...++.|+.||+.|+.|||++ =|+||||||.|||+..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccC-eeEe
Confidence            445899999999999999986543 345789999999999999999999987 79999999999999877    5 8999


Q ss_pred             eecCCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CcHHH
Q 015298          216 CDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD---------SGVDQ  282 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---------~~~~~  282 (409)
                      +|||+++.+.+...    ....+.|.+|+|||.+.+...|+.+.|+||+|||+.||+|-++.|.+.         -..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998765432    234567999999999999999999999999999999999999999753         23478


Q ss_pred             HHHHHHHhCCCCHHHHhhcC--CCcccc--ccCcc--cCCCCcccC--CCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          283 LVEIIKVLGTPTREEIKCMN--PNYTEF--KFPQI--KAHPWHKIF--PKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~--~~~~~~--~~~~~--~~~~~~~~~--~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +.+|+..+|.|....|..+.  |++...  .++..  ....+...+  ...-++...+|+.+||.+||.+|+|+.++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            99999999999998876543  222100  11100  000000001  11235569999999999999999999999999


Q ss_pred             CCccCCC
Q 015298          355 PFFDELR  361 (409)
Q Consensus       355 p~f~~~~  361 (409)
                      +||.+-.
T Consensus       338 ~yF~~d~  344 (438)
T KOG0666|consen  338 PYFTEDP  344 (438)
T ss_pred             cccccCC
Confidence            9998653

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-45  Score=347.22  Aligned_cols=249  Identities=28%  Similarity=0.478  Sum_probs=202.6

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHH---HhcCCCCeecccceeeecCCCCcc
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      |++.+.||+|+||.||+|.+..+|+.||||++....       ....+|++++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            788999999999999999999999999999996432       2233455444   5668999999999883     344


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+.+ +|...+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58899999996 4433332     35799999999999999999999986 999999999999999888 8999999998


Q ss_pred             ccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ..... .......+|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            65322 2223456789999999998654 58999999999999999999999998877666655544310          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                         ..++..+++.+.++|.+||+.||.+||     ++.++++||||+++.+.
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                               013455789999999999999999999     79999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-45  Score=356.54  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=203.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+++++.++|+||+++++.+     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            699999999999999999999999999999998542       23355799999999999999999887     344568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+++..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            999999984 66666653    46789999999999999999999986 999999999999999887 899999999742


Q ss_pred             cccC--------------------------------------------CCCccccccccccccccccCCCCCCchhhHHH
Q 015298          224 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWS  259 (409)
Q Consensus       224 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diws  259 (409)
                      ....                                            ......+||+.|+|||++.+. .++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence            2100                                            001134789999999999654 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcc
Q 015298          260 AGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQ  339 (409)
Q Consensus       260 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~  339 (409)
                      |||++|+|++|+.||.+....+....+.......               .+          .....+++++.++|.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~----------~~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTL---------------HI----------PSQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCccc---------------cC----------CCCCCCCHHHHHHHHHHh-
Confidence            9999999999999998877655544433210000               00          011247899999999976 


Q ss_pred             cCCCCCC---CHHHHhCCCCccCCCCC
Q 015298          340 YSPNLRC---TALDALIHPFFDELRDP  363 (409)
Q Consensus       340 ~dp~~R~---s~~ell~hp~f~~~~~~  363 (409)
                      .+|.+|+   |+.++++||||+.+...
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~~  310 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDFA  310 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence            5999999   99999999999986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.8e-45  Score=356.10  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=204.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|.+++.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++.+.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5899999999999999999999999999999986532       24567999999999999999998883     34468


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+.+..    .+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 56665543    45789999999999999999999986 999999999999999888 899999999743


Q ss_pred             cccC------------------------------------------------CCCccccccccccccccccCCCCCCchh
Q 015298          224 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI  255 (409)
Q Consensus       224 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~  255 (409)
                      ....                                                ......+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001234689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 015298          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (409)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (409)
                      |||||||++|+|++|++||.+.+..+....+........               .          .....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------~----------p~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH---------------I----------PPQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC---------------C----------CCcccCCHHHHHHHH
Confidence            999999999999999999988776655554443111000               0          011347899999999


Q ss_pred             HhcccCCCCCCC---HHHHhCCCCccCCCCC
Q 015298          336 RLLQYSPNLRCT---ALDALIHPFFDELRDP  363 (409)
Q Consensus       336 ~~L~~dp~~R~s---~~ell~hp~f~~~~~~  363 (409)
                      +|+ .||.+|++   +.++++||||+.+.+.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            986 59999997   9999999999987544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-45  Score=339.31  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||+|+||+||+|.+..+|+.||+|.+....       .....|+++++.++|+||+++.+++     .....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999986432       2235689999999999999998877     3344588999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC-
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  229 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~-  229 (409)
                      ++ +|...+.........+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 56555544333456799999999999999999999986 999999999999999887 899999999876544322 


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccc
Q 015298          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (409)
Q Consensus       230 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  309 (409)
                      .....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2345789999999999654 48899999999999999999999997654332222222111000                


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCC
Q 015298          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN  364 (409)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~  364 (409)
                               ...++..+++++.+++.+||+.||.+|+     |+.++++||||+.+.+..
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence                     0013456899999999999999999999     889999999999876553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-45  Score=348.53  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=202.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--------hhhHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      +|.+.+.||+|+||.||++++.   .+|+.||+|++.+..        ....+|+.+++.+ .|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   578999999986421        2345789999999 599999998877     4


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999985 55555543    46799999999999999999999986 999999999999999888 8999999


Q ss_pred             CCccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          219 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       219 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+...+..    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9987643322  2234678999999999976556789999999999999999999999754322111111111100    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRD  362 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~  362 (409)
                                           ....++..+++.+.++|.+||+.||++|+     ++.++++||||+...+
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                 01114456789999999999999999999     8899999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.7e-45  Score=345.69  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=204.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCC-CeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  143 (409)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++....       .....|.+++..+.|+ +|+++++++.     ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999986432       2344688888888765 5777877763     3345


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999985 55555543    46789999999999999999999986 999999999999999887 89999999986


Q ss_pred             ccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            432 22233456789999999999654 48999999999999999999999998877666555543310           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCccCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----LDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~-----~ell~hp~f~~~~~~  363 (409)
                                        ..++..++.++.++|.+||..||.+|+++     .++++||||+.+.+.
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              11345678999999999999999999976     899999999987553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.1e-44  Score=346.36  Aligned_cols=255  Identities=28%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...+|...+.||+|+||.||+|.+..+|+.||||++....     ..+.+|+++++.++|+||+++++++     .....
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            3457899999999999999999999999999999986432     3456899999999999999999987     34445


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++||||+.++...   .    .....+..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       147 ~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence            88999999964221   1    23456778889999999999999986 999999999999999887 899999999976


Q ss_pred             cccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ..... ......||..|+|||.+..    ....+.++|||||||++|+|++|+.||......+....+.......     
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----  292 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence            54322 2345678999999998743    2234568999999999999999999997443322222211110000     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                          ....+..++.++.+||.+||..||++|||+.|+++||||.+-..
T Consensus       293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                                00123457899999999999999999999999999999997543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=327.42  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=210.6

Q ss_pred             ccceEEE-EeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      +.+|.+. ++||-|-.|+|..|.++.||+.+|+|++.. .....+|++.--+. .|||||.++++|.... .+..++.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence            4567775 579999999999999999999999998854 34456788765443 7999999999875433 346678899


Q ss_pred             EeccchhHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCcccc
Q 015298          148 LEYVPETVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  224 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a~~~  224 (409)
                      ||.|+|+  +++.... +..+.+++.++..|++||+.|+.|||+ ++|.||||||+|+|.+...  ..+||+|||+|+..
T Consensus       138 mE~meGG--eLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  138 MECMEGG--ELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             eecccch--HHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            9999975  3443332 235679999999999999999999998 5999999999999996433  37999999999987


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG----VDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .......+.+.||+|.|||++ +.++|+...|+||+||+||.|++|.+||.....    ..+..+|.......+.++|. 
T Consensus       215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs-  292 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS-  292 (400)
T ss_pred             CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh-
Confidence            766677788999999999998 667799999999999999999999999976543    33444444433333333332 


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                              .+|++++|+|+++|..+|.+|.|+.++++|||+.+..
T Consensus       293 ------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  293 ------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                                    3799999999999999999999999999999998753

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.9e-45  Score=343.89  Aligned_cols=245  Identities=29%  Similarity=0.505  Sum_probs=197.6

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHh-cCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+++.||+|++..+.       .....|..++.. ++||||+++++++     ....++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986532       122345566654 4899999999887     3344688999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 55555443    46799999999999999999999986 999999999999999887 8999999998754322


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       228 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                       ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             233456789999999998654 4899999999999999999999999887765555444321                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH-HHHhCCCCccCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-LDALIHPFFDELRD  362 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~-~ell~hp~f~~~~~  362 (409)
                                  ...++..++.++.+||.+||..||.+|+++ .++++||||..+.+
T Consensus       212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                        011345578999999999999999999986 58889999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-44  Score=341.12  Aligned_cols=277  Identities=31%  Similarity=0.540  Sum_probs=206.4

Q ss_pred             EEeeccCCceEEEEEEEcC--CCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ..+||+|+||.||+|.+..  ++..||+|.+....  ....+|+++++.++||||+++++++...   ....+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3689999999999999654  66899999886543  3456899999999999999999887542   334578999999


Q ss_pred             chhHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec----CCCCcEEEeecCCcc
Q 015298          152 PETVHRVVKHFNK-----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK  222 (409)
Q Consensus       152 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~----~~~~~ikl~Dfg~a~  222 (409)
                      ++++...+.....     ....+++..++.++.||+.||.|||+. ||+||||||+||++.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988777653221     123588999999999999999999986 999999999999993    334 79999999998


Q ss_pred             ccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 015298          223 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKV  289 (409)
Q Consensus       223 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~  289 (409)
                      .......    .....+|+.|+|||++.+...++.++|||||||++|+|+||++||.....         ...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543321    23456799999999997766689999999999999999999999975432         3455666666


Q ss_pred             hCCCCHHHHhhcCC--Ccccc----ccCcccCCCC---cccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          290 LGTPTREEIKCMNP--NYTEF----KFPQIKAHPW---HKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       290 ~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~---~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ++.+....+.....  .+...    ..........   ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77666554433211  10000    0000000000   011122346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.6e-45  Score=344.37  Aligned_cols=245  Identities=28%  Similarity=0.491  Sum_probs=200.4

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||+||+|.+..+++.||+|++.+..       ....+|.++++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999997532       2334678888877 7999999999873     344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 55444432    46799999999999999999999986 999999999999999888 899999999865322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223345789999999999654 4899999999999999999999999877765554443321                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCccCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----LDALIHPFFDELRD  362 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~-----~ell~hp~f~~~~~  362 (409)
                                  ...++..+++.+.+||.+||..||.+|||+     .++++||||+...+
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                        011345578999999999999999999999     99999999998754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-45  Score=349.26  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|+++++.++||||+++++++     ....++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986531       2335688899999999999998877     34456899999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-C
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  227 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-~  227 (409)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9985 45444432    567999999999999999999999723999999999999999887 899999999875322 2


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                  
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------------------  211 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  211 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------------------
Confidence            233356789999999998654 4899999999999999999999999877655444433221                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                 ...++..+++++.+||.+||+.||++|+     ++.++++||||.++.+.
T Consensus       212 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         212 -----------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                       0013456899999999999999999997     99999999999986544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-44  Score=345.16  Aligned_cols=286  Identities=32%  Similarity=0.583  Sum_probs=224.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            457999999999999999999999999999999985421      234479999999999999999988754322 2223


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++||||+.+++...+..      .++...+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            5789999999987776642      288999999999999999999986 999999999999999888 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+...++.|..+......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            66544444456688999999998654 48999999999999999999999999888888888888888888765443322


Q ss_pred             CCccccc--cCcccCCCCcccC------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          303 PNYTEFK--FPQIKAHPWHKIF------------PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       303 ~~~~~~~--~~~~~~~~~~~~~------------~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      .....+.  .+......+...+            +...++.+.+||.+||+.||++|||+.++|.||||+.+-++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence            1111000  0000001111111            123467799999999999999999999999999999776543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.3e-45  Score=343.43  Aligned_cols=246  Identities=26%  Similarity=0.476  Sum_probs=198.5

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHh-cCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+|+.||+|.+....       .....|..++.. ++||||+++++++     ....++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986532       223456677765 4899999999887     3445689999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 55555443    46789999999999999999999986 999999999999999887 899999999874322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2223456789999999999654 4899999999999999999999999877665544443221  0              


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH-HHHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-LDALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~-~ell~hp~f~~~~~~  363 (409)
                                   ..++..++.++.+||.+||..||.+|+++ +++++||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence                         01344578999999999999999999997 578899999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.6e-45  Score=345.77  Aligned_cols=246  Identities=30%  Similarity=0.505  Sum_probs=201.9

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+|+.||+|++..+.       .....|.++++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            36899999999999999999999999986532       2234677888765 799999999988     3444588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 55555443    56789999999999999999999986 999999999999999888 899999999875432 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2233456789999999998654 58999999999999999999999999887766665554310                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-------CHHHHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-------TALDALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-------s~~ell~hp~f~~~~~~  363 (409)
                                   ..++..++.++.++|.+||+.||++|+       ++.++++||||..+.+.
T Consensus       213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                         013445789999999999999999999       99999999999887554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.5e-44  Score=337.74  Aligned_cols=285  Identities=33%  Similarity=0.556  Sum_probs=224.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            457999999999999999999999999999999986432      1235799999999999999999887432   2234


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++||||+.++|.+++...   ...+++..+..++.||+.||.|||+. |++||||||+||+++.++ .+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            7899999998877776642   36789999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            54332 22233457889999998766668999999999999999999999999999888888888888877665443221


Q ss_pred             C--CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          303 P--NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       303 ~--~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .  ....+.........+... ....++.+.+||.+||++||++|||+.+++.||||++..-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            1  111111111111111111 12358899999999999999999999999999999865444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-44  Score=342.96  Aligned_cols=276  Identities=25%  Similarity=0.432  Sum_probs=207.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||.||++.+..+|..+|+|.+....     ..+.+|+++++.++||||+++++++..     ...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence            357999999999999999999999999999999986432     345689999999999999999998843     3357


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||++.+|+||||||+||+++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999985 67666653    457899999999999999999999753699999999999999887 899999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh---
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC---  300 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---  300 (409)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+... +   ++.+.......   
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~  227 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGEPH  227 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCCcc
Confidence            5332 23456789999999999654 48999999999999999999999997766544322 1   12111000000   


Q ss_pred             -cCCC-------ccccc------------cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 -MNPN-------YTEFK------------FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 -~~~~-------~~~~~------------~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                       ..+.       .....            +..+........-...+++++++||.+||++||++|||+.++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence             0000       00000            000000000000112468899999999999999999999999999999865


Q ss_pred             C
Q 015298          361 R  361 (409)
Q Consensus       361 ~  361 (409)
                      .
T Consensus       308 ~  308 (331)
T cd06649         308 E  308 (331)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.3e-44  Score=334.81  Aligned_cols=285  Identities=33%  Similarity=0.608  Sum_probs=221.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.+. ||||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875432      34567999999995 6999999988765544344567


Q ss_pred             EEEEeccchhHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++++.+.+...... ...+++..++.++.||+.||.|||+. ||+||||||+||+++.+.+.+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999888877654322 35689999999999999999999986 9999999999999998344899999999875


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+...++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            4322 122234568889999998665668999999999999999999999999888888888888777766654433211


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      .......++......... ....+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111000111111111111 1234789999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-44  Score=343.46  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=205.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+..       .....|..++..+ .|++|+++++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4889999999999999999999999999999987532       1233566777766 588999998887     33445


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999984 55555443    46789999999999999999999986 999999999999999888 89999999987


Q ss_pred             cccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2233456789999999999654 48999999999999999999999998877766655554311           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPN  364 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~  364 (409)
                                        ..++..++.++.+++.+||+.||.+|++     ..++++||||+.+.+..
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                              0134568999999999999999999998     48999999999876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-44  Score=344.63  Aligned_cols=247  Identities=26%  Similarity=0.478  Sum_probs=197.1

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46899999999999999999999999997531       2345788888888 799999999988     3445689999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc-cc
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VK  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~-~~  226 (409)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.. ..
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 55444432    56899999999999999999999986 999999999999999887 8999999998743 22


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  298 (409)
                      .......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+...+....  .      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~------  220 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--K------  220 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--C------
Confidence            3334456789999999999654 489999999999999999999999963211        1111111100  0      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT------ALDALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s------~~ell~hp~f~~~~~~  363 (409)
                                          ...++..++..+.++|++||+.||.+|+|      +.++++||||..+.+.
T Consensus       221 --------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         221 --------------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                                00145568899999999999999999997      7899999999987553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.6e-44  Score=332.96  Aligned_cols=276  Identities=39%  Similarity=0.746  Sum_probs=224.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            5899999999999999999999999999999986432      34568999999999999999999883     345588


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|+||+.++|.+.+...   ...+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977877776542   36799999999999999999999986 999999999999999887 89999999987664


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       226 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+......+..+...++.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            432  13345678899999998766667899999999999999999999998888888888888888887776554322 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                       .++....++.....++...+ ...+..+.++|.+||..||.+|||+.++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             12222223332222333322 34679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-44  Score=342.86  Aligned_cols=245  Identities=29%  Similarity=0.496  Sum_probs=200.0

Q ss_pred             EeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           77 RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +.||+|+||.||+|++.   .+++.||+|.+....        ....+|+.+++.++||||+++++++.     ....++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            57999999999999864   578999999986421        23357999999999999999998873     344588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+.+ +|...+..    ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999985 55554433    56788999999999999999999986 999999999999999887 8999999998744


Q ss_pred             cc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            32 2223346789999999998654 47899999999999999999999998877665555443310             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRD  362 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~  362 (409)
                                      ..++..+++++.+||.+||+.||++|+     ++.++++||||....+
T Consensus       217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                            013455789999999999999999999     8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-44  Score=349.08  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.++..++||||+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986421       2345689999999999999999887     444568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++| +|.+.+..    ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999985 56665543    46799999999999999999999986 999999999999999887 899999999864


Q ss_pred             cccCC------------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 015298          224 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (409)
Q Consensus       224 ~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~l  267 (409)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence            42110                                    01235789999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCC--CCCChhHHHHHHHhcccCCCCC
Q 015298          268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFP--KRMPPEAVDLVSRLLQYSPNLR  345 (409)
Q Consensus       268 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dp~~R  345 (409)
                      ++|..||...+..+....+.......                           .++  ..+++++++||.+|+. ||.+|
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~~li~~l~~-~p~~R  281 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKETL---------------------------VFPPEVPISEKAKDLILRFCT-DSENR  281 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCce---------------------------ecCCCCCCCHHHHHHHHHhcc-Chhhc
Confidence            99999998877766655554311000                           011  1368899999999874 99999


Q ss_pred             C---CHHHHhCCCCccCCCCCC
Q 015298          346 C---TALDALIHPFFDELRDPN  364 (409)
Q Consensus       346 ~---s~~ell~hp~f~~~~~~~  364 (409)
                      +   ++.++++||||+++.+..
T Consensus       282 ~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         282 IGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCCCHHHHhcCCCCCCCCHHH
Confidence            8   489999999999886543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.6e-45  Score=344.47  Aligned_cols=246  Identities=28%  Similarity=0.447  Sum_probs=197.9

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHH-HHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||+||+|.+..+|+.||+|++....       .....|. .+++.++||||+++++.+.     ....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986432       1122333 3567899999999988773     344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 55554443    56789999999999999999999986 999999999999999888 899999999875422 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence            2233456789999999998654 4899999999999999999999999887766555544331   0             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f~~~~~~  363 (409)
                                   ..++..+++.+.++|.+||+.||.+||++    .++++||||..+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                         01234578999999999999999999998    699999999886543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-44  Score=357.15  Aligned_cols=260  Identities=26%  Similarity=0.373  Sum_probs=213.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC---CC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  140 (409)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||||++....      ....+|+.++..++|+||+++++.+.....   ..
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            458999999999999999999999999999999986432      234578899999999999998876644322   12


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++ |+|.+.+.........+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFG  188 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFG  188 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEecc
Confidence            235789999998 578887776555567899999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccC---CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          220 SAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       220 ~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +++.....   ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....     
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-----  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-----  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence            98765332   123356789999999999654 489999999999999999999999988776555544432110     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                             ..++..+++++.+++.+||..||.+||++.++++|||++..
T Consensus       263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                   01345678999999999999999999999999999998864

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=342.62  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+.       ...+.+|+.+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999998642       12345788999999999999999887     344568


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. ++|.+++..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            99999997 466666543   246789999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCC--CccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ......  .....||+.|+|||++..    ...++.++|||||||++|+|++|+.||...+..+....+.......    
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----  227 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----  227 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc----
Confidence            543322  123468999999999853    2347889999999999999999999998877666655543311000    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~~~  364 (409)
                                 .++        . ....+++.+++||++||..++++  |+++.++++||||....+..
T Consensus       228 -----------~~~--------~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         228 -----------QFP--------P-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             -----------cCC--------C-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence                       000        0 11237899999999999765544  78999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-43  Score=332.72  Aligned_cols=282  Identities=37%  Similarity=0.640  Sum_probs=222.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch---------hhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+.....         ....|+++++.++|+||+++++++.     ...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            48899999999999999999999999999999865421         2346899999999999999999883     345


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +.++||||+.++|..++...   ...+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            68899999977777766531   13689999999999999999999986 999999999999999887 89999999997


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+....+.+.++...++.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            654432 2233456788999999866566889999999999999999999999888887878888777777666554322


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      ...............+... .....+..+.+||.+||.+||++|||+.+++.||||++...+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            1111111111111111111 2234688999999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-44  Score=339.10  Aligned_cols=313  Identities=37%  Similarity=0.652  Sum_probs=242.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+....      +...+|+.+++.++|+||+++.+++..........++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999999999999999886532      3456799999999999999999987654433334578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ++|+|+++++.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999877666643    45899999999999999999999986 999999999999999887 89999999998765


Q ss_pred             cCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          226 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       226 ~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+.+..+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2334567889999999977646899999999999999999999999999988888888888888877655422


Q ss_pred             CCCccc-c--ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCC
Q 015298          302 NPNYTE-F--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFN  378 (409)
Q Consensus       302 ~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  378 (409)
                      ...... +  ..+.....++... ...++..+.++|.+||++||.+|||+.+++.||||+++.++.......    ..++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~----~~~~  309 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAK----PPFD  309 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCC----Cccc
Confidence            111110 0  0111112222222 234789999999999999999999999999999999988765443222    2234


Q ss_pred             CCcccccCCCHHHHhhc
Q 015298          379 FKSHELKSVPVEILVKL  395 (409)
Q Consensus       379 ~~~~~~~~~~~~~~~~~  395 (409)
                      |......++-.+.+...
T Consensus       310 ~~~~~~~~~~~~~~~~~  326 (330)
T cd07834         310 FDFFDDDELTEEELKEL  326 (330)
T ss_pred             ccccchhhcCHHHHhHH
Confidence            44444444444544443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.8e-44  Score=331.84  Aligned_cols=275  Identities=37%  Similarity=0.679  Sum_probs=217.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|++.+.||.|++|.||+|.+..+|+.||||.+..+.      ....+|+++++.++||||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4899999999999999999999999999999886432      34567999999999999999999873     344578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+.+++...+...  ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            99999998777666532  245789999999999999999999986 999999999999999887 89999999987553


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--  302 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  302 (409)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|+||+.||...+..+...++....+.+....+....  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            322 22334568889999998766657889999999999999999999999888888888888877776654332111  


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      +.+. ..++.......... ...+++++.++|.+||+.||.+|||+.++++||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0000 01111111111111 23478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=338.58  Aligned_cols=265  Identities=27%  Similarity=0.398  Sum_probs=219.4

Q ss_pred             CCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           66 QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      .+...+.|+.-++||+||||.||-|+.+.||+.||+|++.+.       ......|-.+|.+++.+.||.+--.|.+.+ 
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-  258 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-  258 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-
Confidence            344456789999999999999999999999999999987432       123346889999999999999866663333 


Q ss_pred             CCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                          .+|+|+..|+|+ |.-.+.  +-.+..+++..++.++.+|+.||++||+. +||+|||||+|||+|..| +++|+|
T Consensus       259 ----~LClVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISD  330 (591)
T KOG0986|consen  259 ----ALCLVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISD  330 (591)
T ss_pred             ----ceEEEEEeecCCceeEEee--ccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeec
Confidence                389999999964 333333  33356899999999999999999999986 999999999999999888 799999


Q ss_pred             cCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       218 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      +|+|..+..+......+||.+|||||++.+.. |+...|+|||||++|+|+.|+.||..........++-+.....    
T Consensus       331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----  405 (591)
T KOG0986|consen  331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----  405 (591)
T ss_pred             cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc----
Confidence            99999998888888889999999999997655 9999999999999999999999997765544443333322111    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPNA  365 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~~  365 (409)
                                           ...+++.+|+++++|++.+|+.||.+|.     .++++-+||||+.+++...
T Consensus       406 ---------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  406 ---------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             ---------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence                                 1226778999999999999999999998     6779999999999988754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.4e-44  Score=334.06  Aligned_cols=279  Identities=37%  Similarity=0.634  Sum_probs=224.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|.+.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            46999999999999999999999999999999986432      12357999999999999999998875432   2458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||++++|.+++...   ...+++..++.++.||+.||+|||++ ||+|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            899999998877776542   24689999999999999999999986 999999999999999887 8999999998766


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+.+.++....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 2233456788999999987666578999999999999999999999999888888888888888877766543221


Q ss_pred             --CccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 --NYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                        ......+.......+...++.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              1111111122222333344444 68999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.3e-44  Score=338.80  Aligned_cols=246  Identities=28%  Similarity=0.498  Sum_probs=199.0

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHh-cCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+++.||+|.+....       .....|..+++. ++||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986532       223456777765 48999999998873     334588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99984 66655543    45789999999999999999999986 999999999999999887 899999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~--------------  212 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N--------------  212 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2233456789999999998654 4899999999999999999999999887765554443221  0              


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~-ell~hp~f~~~~~~  363 (409)
                                   ..++..++.++.+||.+||+.||++|+++. +++.||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                         013345788999999999999999999996 89999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.5e-44  Score=341.37  Aligned_cols=246  Identities=27%  Similarity=0.493  Sum_probs=194.9

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.++..+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999987531       2244677777766 8999999999883     344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc-c
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~-~  226 (409)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++... .
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99995 55444432    56799999999999999999999986 999999999999999888 89999999987532 2


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  298 (409)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.....        .+.+.+....  .      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~------  220 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--K------  220 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--C------
Confidence            2233456789999999999654 488999999999999999999999953111        1111111100  0      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCccCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT------ALDALIHPFFDELRD  362 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s------~~ell~hp~f~~~~~  362 (409)
                                          ...++..++..+.++|.+||+.||.+|++      +.++++||||+++.+
T Consensus       221 --------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         221 --------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                                01145568899999999999999999998      579999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7e-44  Score=332.58  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+|++.+++.+.     ....+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence            3788899999999999999999999999999885431       22456999999999999999988773     33458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|...+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            899999984 666665432  235689999999999999999999986 999999999999999887 799999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........|+..|+|||++.+. .++.++|+||+||++|+|++|+.||..................           
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----------  219 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------  219 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence            5444444456789999999999654 4899999999999999999999999865432211111111000           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                    ....++..+++++.+||.+||+.||.+|+|     +.++++||||+++...
T Consensus       220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                          001134457889999999999999999999     9999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=313.30  Aligned_cols=268  Identities=25%  Similarity=0.400  Sum_probs=218.9

Q ss_pred             ecCCCCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccce
Q 015298           59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHC  132 (409)
Q Consensus        59 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~  132 (409)
                      ++++........+....+..||+|..|+|++++.+.+|...|||.+....     +.+...+.++.+. +.|+||+.+++
T Consensus        80 ti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   80 TIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             EecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence            34444445555566778889999999999999999999999999996543     2223344444333 58999999999


Q ss_pred             eeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                      |....+     ++|.||.|..-+..++...   .+++++..+-++...+++||.||.++.||+|||+||+|||+|..| +
T Consensus       160 Fi~n~d-----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-n  230 (391)
T KOG0983|consen  160 FITNTD-----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-N  230 (391)
T ss_pred             EeeCch-----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-C
Confidence            976555     6789999987776776643   477999999999999999999999988999999999999999988 8


Q ss_pred             EEEeecCCccccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHH
Q 015298          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQLVEIIKV  289 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~  289 (409)
                      |||||||++....+........|-+.|||||.+..  ...|...+||||||++++||.||+.||.+. ...+.+.++.+.
T Consensus       231 iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~  310 (391)
T KOG0983|consen  231 IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE  310 (391)
T ss_pred             EEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence            99999999999988888888899999999999943  345889999999999999999999999875 455666666652


Q ss_pred             hCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .  |+.              +          .....+|+.+++|+..||.+|+.+||.-.++|+|||+....
T Consensus       311 e--PP~--------------L----------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  311 E--PPL--------------L----------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             C--CCC--------------C----------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            1  110              0          01234899999999999999999999999999999998654

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.9e-44  Score=331.72  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||+|+||.||++.+..+|+.||+|.+...       ......|+++++.++||||+++.+++     ....++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999998532       12334689999999999999998877     3445689999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      .| +|...+...  ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 565555332  234588888999999999999999986 999999999999999887 8999999998766554444


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      ....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+.......          .      
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------~------  214 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----------E------  214 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------c------
Confidence            4567899999999996655 8999999999999999999999997654322222221111000          0      


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCccCCCCCCCC
Q 015298          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFFDELRDPNAR  366 (409)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f~~~~~~~~~  366 (409)
                             . ......+++++.+||.+||+.||.+||++    .+++.||||+.+.++...
T Consensus       215 -------~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~  266 (277)
T cd05607         215 -------V-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE  266 (277)
T ss_pred             -------c-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHh
Confidence                   0 00112478999999999999999999999    678899999987665433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-43  Score=338.57  Aligned_cols=288  Identities=36%  Similarity=0.670  Sum_probs=229.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|.+.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            57999999999999999999999999999999986432      23457999999999999999998765433 344567


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999877666543    45699999999999999999999986 999999999999999888 8999999998765


Q ss_pred             ccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          225 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       225 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .....     .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.|+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1235678899999998665568999999999999999999999999988888888888888888766554


Q ss_pred             hcCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCC
Q 015298          300 CMNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR  366 (409)
Q Consensus       300 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~  366 (409)
                      ........   ..++.....+|... ....++++.++|.+||+.||.+|||+.+++.||||++...+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence            32211100   01122222222222 23468999999999999999999999999999999988776653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=350.13  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=213.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+-|.|+..||.|+||+||+|.++.++-..|.|++....    ....-|++||..++||+||++++.||..+.     ++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence            346889999999999999999999999988999885432    223458999999999999999999965544     89


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc-
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-  224 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~-  224 (409)
                      |..|||+|+--+.+-  ...+..+++..+..+++|+|.||.|||++ +|||||||..|||++.+| .|+|+|||.+... 
T Consensus       106 iliEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccch
Confidence            999999986544433  23478999999999999999999999997 999999999999999998 8999999986433 


Q ss_pred             ccCCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .......+++|||+|||||++.    ....|..++||||||++|.||..+.+|-...+....+.+|.+.-  |+      
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP------  253 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP------  253 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC------
Confidence            2333456799999999999983    44569999999999999999999999998888777777666531  11      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        .-..|...+..+.|||++||..||..||+++++|+||||.+.
T Consensus       254 ------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  254 ------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                              112456678899999999999999999999999999999964

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-43  Score=330.70  Aligned_cols=281  Identities=36%  Similarity=0.636  Sum_probs=220.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|.+.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++.     ...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            46999999999999999999999999999999885431      34567999999999999999999883     34458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+++++...+....  ...+++..++.++.||+.||+|||++ ||+||||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            8999999987776664321  23467888899999999999999987 99999999999999866557999999998754


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|+||.+||......+.+.++....+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3222 223346688999999987656688999999999999999999999998888888888887777776655442211


Q ss_pred             --CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 --NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                        ++. ..++....... ......+++++.+++.+||+.||++||++.++++||||.++.
T Consensus       234 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        234 LPDYK-SAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             chhhh-hhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence              100 00111000100 112345788999999999999999999999999999998764

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-43  Score=328.32  Aligned_cols=275  Identities=37%  Similarity=0.646  Sum_probs=216.0

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++++. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678999999999999999999999999999986532     12236888888885 99999999987542   1235789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||||+++++.+.+...   ...+++..+..++.|++.||.|||+. ||+||||+|+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999998877766532   35789999999999999999999986 9999999999999998 5 899999999986654


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc-
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY-  305 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-  305 (409)
                      ........++..|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+....+....+.+............ 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            4444456678999999987555567899999999999999999999999988888888888777776664432221110 


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ..+.++......... +...++.++.++|.+||.+||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            111111111111111 123568999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-44  Score=354.19  Aligned_cols=254  Identities=28%  Similarity=0.368  Sum_probs=210.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCC-CcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..|.+.+.||.|++|.||+|.+..+ ++.||+|.+....    ....+|+.+++.++||||+++++++.     ....++
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence            3599999999999999999998877 7889999774332    34457999999999999999999884     334588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      |||||+. |+|.+.+.........+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999998 577777765555566789999999999999999999986 999999999999999887 8999999999865


Q ss_pred             ccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            4332   1345678999999999865 45899999999999999999999999887766655554432110         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                         .++..++.++.+||.+||..||++||++.+++.|||++..
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               1234578999999999999999999999999999998753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-43  Score=337.79  Aligned_cols=320  Identities=33%  Similarity=0.597  Sum_probs=244.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      .++|.+.+.||+|++|.||+|++..+++.||+|++....      ....+|+.+++.++|||++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            457999999999999999999999999999999885421      234579999999999999999887744332 2233


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++|+||++++|.+++..     ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            4789999998888777653     5799999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+....+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65332  3445678899999998665568899999999999999999999999888888888888877777665544332


Q ss_pred             CCcccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      ......   ..+......+... ....++.+.+||.+||..||.+|||+.++++||||+++.++....     .+..++ 
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~-----~~~~~~-  317 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP-----VAPPYD-  317 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc-----cccccC-
Confidence            211100   0111111111111 123689999999999999999999999999999999887664322     233333 


Q ss_pred             CcccccCCCHHHHhhcChHHHhhhCC
Q 015298          380 KSHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      ....-.+..+..|..+|-....+.+|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         318 QSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             cchhhhhcCHHHHHHHhHHHHHhccC
Confidence            22233456677787777777666554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.7e-44  Score=340.78  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||++++..+++.||+|.+.+..       ....+|..++..++|+||+++++++     ....+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986421       2245688899999999999999887     445568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.| +|..++...   ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999984 666666532   35789999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCCC--ccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          224 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       224 ~~~~~~~--~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||...+..+....+.......    
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----  227 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----  227 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc----
Confidence            5433221  235689999999998542    347889999999999999999999998877666555544311000    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~~~~  365 (409)
                                 .++        . ....++++++++|.+||+.++++  |+++.++++||||+.+.+...
T Consensus       228 -----------~~p--------~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         228 -----------QFP--------S-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             -----------cCC--------C-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence                       000        0 11246899999999999976655  569999999999998765443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-44  Score=328.21  Aligned_cols=252  Identities=35%  Similarity=0.589  Sum_probs=205.7

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh------hHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |++++.||+|+||+||++.+..+++.||+|++......      ..+|+.+++.++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999999765322      2348999999999999999998844     445789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc-
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-  224 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~-  224 (409)
                      ||||+.+ +|.+.+.    ....+++..+..++.||+.||.+||++ ||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----ccccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999997 7777776    257889999999999999999999996 999999999999999777 8999999998753 


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223334456789999999998634568999999999999999999999998874444444444433222111110     


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                       .....+..+.++|.+||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-44  Score=342.38  Aligned_cols=245  Identities=28%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             EeeccCCceEEEEEEEc---CCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      +.||+|+||.||++++.   .+|+.||+|++....      ....+|+++++.++||||+++++++     .....+++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            57999999999999863   578999999986432      2345689999999999999999887     334458899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999984 56555432    56789999999999999999999986 999999999999999887 899999999876543


Q ss_pred             C-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 G-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      . .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+.+..               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 233456789999999998654 47899999999999999999999998877666555443210               


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRD  362 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~  362 (409)
                                    ..++..+++.+.+||.+||+.||.+||+     +.+++.||||..+.+
T Consensus       215 --------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         215 --------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence                          0134457899999999999999999999     788999999988654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=334.26  Aligned_cols=281  Identities=36%  Similarity=0.621  Sum_probs=214.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcC--CCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48999999999999999999988  89999999997632       3446799999999999999999988532   225


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC----CCCcEEEee
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP----HTHQVKLCD  217 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~----~~~~ikl~D  217 (409)
                      .+++||||+++++...+....... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            688999999988877776544333 3789999999999999999999986 9999999999999998    66 899999


Q ss_pred             cCCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 015298          218 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---------DQLV  284 (409)
Q Consensus       218 fg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~  284 (409)
                      ||++........    .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533222    223467889999999877666899999999999999999999999765433         3455


Q ss_pred             HHHHHhCCCCHHHHhhcC--CCcccc----ccCcccCCCCcccCC--CCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          285 EIIKVLGTPTREEIKCMN--PNYTEF----KFPQIKAHPWHKIFP--KRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                      .+...++.+....+....  +++...    .............+.  ...+.++.++|.+||.+||++|||+.+++.|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            566666666554442211  111110    000000000001111  156789999999999999999999999999999


Q ss_pred             c
Q 015298          357 F  357 (409)
Q Consensus       357 f  357 (409)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.4e-43  Score=326.31  Aligned_cols=276  Identities=36%  Similarity=0.662  Sum_probs=212.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|++....      +...+|+.+++.++|+|++++++++.     ...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence            36999999999999999999999999999999885432      23457999999999999999999883     34458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+++++...+.   .....+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceec
Confidence            8999999976544433   2245689999999999999999999986 999999999999999887 8999999999766


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+....+....+.+..+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            4433 223456788899999987656688999999999999999999999998887777776666555433321111110


Q ss_pred             C--ccccccCccc-CCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 N--YTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~--~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .  +.....+... ..+... ....++..+.+||.+||+.||++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0  0000111100 001111 112468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-43  Score=336.64  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=203.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (409)
                      +|...+.||+|+||.||+|.++.+|+.||+|++.++.       .....|..+++.+. |++|+++.+++     .....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3788999999999999999999999999999986532       22346778888776 46777887777     33345


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999985 55554432    46799999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            54322 223456789999999998654 48999999999999999999999998877666555554311           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                        ..++..++.++.+++.+||+.||.+|++     ..++++||||+.+.+.
T Consensus       218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence                              0134457899999999999999999997     5789999999987653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=328.31  Aligned_cols=277  Identities=34%  Similarity=0.649  Sum_probs=215.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||+|++|.||+|.++.+++.||+|.+....     ....+|+++++.++|+||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            357999999999999999999999999999999986432     2345799999999999999999987     344568


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.++|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||+++..
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECcccccccc
Confidence            899999998877766532   34789999999999999999999986 999999999999999888 8999999998654


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ... .......++..|+|||.+.+...++.++||||+|+++|+|++|..||.... ..+....+.+.++.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            221 112233567889999998765668899999999999999999999997665 556666677777777666554322


Q ss_pred             CC--ccccccCcccCCCCcccCCCCCC--hhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 PN--YTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 ~~--~~~~~~~~~~~~~~~~~~~~~~s--~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ..  +.....+.....+..... ..++  .++.++|.+||+.||.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            11  111111111111111111 1234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-43  Score=348.12  Aligned_cols=275  Identities=25%  Similarity=0.344  Sum_probs=204.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....  ....+|++++++++|+||+++++++..     ....++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            4579999999999999999999999999999996432  345689999999999999999987743     334789999


Q ss_pred             ccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC
Q 015298          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (409)
Q Consensus       150 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~  229 (409)
                      ++.++|...+...   ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9998877766532   34799999999999999999999986 999999999999999887 899999999976533221


Q ss_pred             ---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHH--
Q 015298          230 ---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-------GVDQLVEIIKVLGTPTREE--  297 (409)
Q Consensus       230 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~--  297 (409)
                         .....||+.|+|||++.+. .++.++|||||||+||||++|..|+....       ..+.+.++++..+......  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               2245689999999999664 48999999999999999999876543221       1234444444333211100  


Q ss_pred             ------HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          298 ------IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       298 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                            .............+......|....  .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  0000000000001111111222221  35778999999999999999999999999999974

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.1e-44  Score=339.38  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+..       ..+.+|+.++..++|+||+++++++     .....+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            6999999999999999999999999999999985421       2345788899999999999998887     344558


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            89999997 5666666532   45789999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCC--CccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ......  ....+||+.|+|||++.+    ...++.++|||||||++|+|++|+.||...+..+.+..+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-----  226 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-----
Confidence            433222  223578999999999852    345788999999999999999999999887766666555432100     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~~~~  365 (409)
                                ..++.         ....+++++++||++||+.++.+  |+++.++++||||.++.+...
T Consensus       227 ----------~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         227 ----------FQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence                      00000         12347899999999999765554  689999999999998765443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-43  Score=336.93  Aligned_cols=288  Identities=30%  Similarity=0.534  Sum_probs=218.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCC------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK------  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------  139 (409)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|.+....    ....+|+++++.++||||+++++++......      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            458999999999999999999999999999999985432    3356799999999999999998876432211      


Q ss_pred             ---CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          140 ---DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       140 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                         ...+.++||||++++|.+.+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++..++|+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEEC
Confidence               123578999999987766553     35689999999999999999999986 999999999999998666579999


Q ss_pred             ecCCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          217 DFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       217 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |||.+........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875432211    123457888999998866566889999999999999999999999988877777666665444


Q ss_pred             CCHHHHhhcCCCcccccc--CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          293 PTREEIKCMNPNYTEFKF--PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      +.................  ......+... +...++.++.+||.+||+.||.+|||+.+++.||||+.+..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  310 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF  310 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence            333222211100000000  0011111111 1235789999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=322.84  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=215.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|...++||+|.||+|-+|+.+.+|+.||+|+++++.-       ....|-++|+..+||.+..+.-.|     +..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            34579999999999999999999999999999999976532       233577899999999998887666     444


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+|+||||.+|+  ++.-+ ......+++..++.+...|+.||.|||++ +||+||||.+|.|+|.+| .|||.|||+.
T Consensus       241 drlCFVMeyanGG--eLf~H-Lsrer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDG-HIKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGG--ELFFH-LSRERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDG-HIKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCc--eEeee-hhhhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCC-ceEeeecccc
Confidence            5589999999975  22222 22267899999999999999999999986 999999999999999999 7999999998


Q ss_pred             cccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +... .+....++||||.|+|||++... .|+.++|+|.+|++||||++|+.||...+.......|...-          
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed----------  384 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED----------  384 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh----------
Confidence            7543 45566789999999999999554 59999999999999999999999999888776666655421          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                         -.+|.+++++++.|+..+|.+||++|.     .+.++.+|+||..+.|.
T Consensus       385 -------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  385 -------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             -------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence                               116778999999999999999999998     58899999999998775

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-43  Score=362.56  Aligned_cols=265  Identities=28%  Similarity=0.402  Sum_probs=213.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ....+|.+.+.||+|+||+||+|.+..++..||+|.+...      ...+..|+.+++.|+||||++++++|+..   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            3456899999999999999999999999999999998642      23356799999999999999999987543   23


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc------CCcEeecCCCCceeecCCC----
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS------IGVCHRDIKPQNLLVNPHT----  210 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~ivH~Dlkp~NIli~~~~----  210 (409)
                      ..++|||||+. ++|..++.........+++..++.|+.||+.||.|||+.      .+||||||||+||||+.+.    
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            45789999998 578888876555567899999999999999999999973      1499999999999996421    


Q ss_pred             ------------CcEEEeecCCccccccCCCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015298          211 ------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGD  277 (409)
Q Consensus       211 ------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~  277 (409)
                                  ..+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                        24899999999866444444556789999999998543 34789999999999999999999999876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .....+.......  +.                          ......+.++.+||..||..+|.+||++.++|.||||
T Consensus       247 ~~~~qli~~lk~~--p~--------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--PD--------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--CC--------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6555443332211  00                          0012358899999999999999999999999999999


Q ss_pred             cCCCCC
Q 015298          358 DELRDP  363 (409)
Q Consensus       358 ~~~~~~  363 (409)
                      +.+..+
T Consensus       299 k~i~~p  304 (1021)
T PTZ00266        299 KNVGPP  304 (1021)
T ss_pred             hhcCCC
Confidence            977554

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-43  Score=337.09  Aligned_cols=247  Identities=27%  Similarity=0.479  Sum_probs=197.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||+||+|.+..+++.||+|++....       ....+|+.++..+ .||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999997532       2345788888887 699999999987     3344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc-c
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~-~  226 (409)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 55544432    46799999999999999999999986 999999999999999888 89999999987532 2


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhh
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....      ..+.+.+....  .+       
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-------  219 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP-------  219 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC-------
Confidence            2333456789999999998654 58999999999999999999999996422      11222222111  00       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC------HHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT------ALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s------~~ell~hp~f~~~~~~  363 (409)
                                         ..++..++..+.++|.+||..||.+|++      ..++++||||+.+.+.
T Consensus       220 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         220 -------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                               0145567899999999999999999998      4699999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.3e-43  Score=328.09  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+++++.++|+||+.+.+++     ......
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            3788899999999999999999999999999985431       2345799999999999999998877     334458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||+.+ +|...+..  .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999995 45544432  1235799999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5444444456789999999998654 489999999999999999999999987665544444333221110         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                      ..++..++.++.+|+.+||+.||.+||+     +.+++.||||+.....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                            0134457889999999999999999999     8999999999987554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.9e-43  Score=326.36  Aligned_cols=276  Identities=35%  Similarity=0.660  Sum_probs=221.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+...     .....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999998643     2344579999999999999999998843     344789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||||+++++.+.+.... ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            99999998877765432 135689999999999999999999986 999999999999999887 899999999875433


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+...++......|....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 22334568899999998766667899999999999999999999999988888888888887777766554332 11


Q ss_pred             cc--cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          306 TE--FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       306 ~~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ..  ..++......... +....+..+.++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1111111111111 223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.4e-43  Score=332.43  Aligned_cols=311  Identities=36%  Similarity=0.616  Sum_probs=237.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCC--CcEEEEEEeecc------chhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLET--GETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+...      .....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999888  999999988642      12345799999998 5999999988654332 2233


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++++++|++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4678999999887776643    56789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .......     .....|++.|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+..+...++.+....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            5533221     22356889999999886656689999999999999999999999999888888899999888887765


Q ss_pred             HhhcCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCC
Q 015298          298 IKCMNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLP  374 (409)
Q Consensus       298 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~  374 (409)
                      +.........   ..........+.... ...+..+.+|+.+||+.||.+|||+.+++.||||++++++.....  ...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~--~~~~  310 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV--CQKP  310 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccc--cccc
Confidence            4433211100   011111111122212 235889999999999999999999999999999999987654433  3345


Q ss_pred             CCCCCCcccccCCCHHHHhhcC
Q 015298          375 PLFNFKSHELKSVPVEILVKLI  396 (409)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~  396 (409)
                      ..+.|.+.+    +++.+..+|
T Consensus       311 ~~~~~~~~~----~~~~~~~~~  328 (332)
T cd07857         311 FDFSFESED----SMEELRDMI  328 (332)
T ss_pred             ccCCccccc----cHHHHHHHH
Confidence            555665443    466665554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-43  Score=335.92  Aligned_cols=279  Identities=25%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||.||+|.+..+|..+|+|.+....     ..+.+|+++++.++||||+++++++..     ..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence            357999999999999999999999999999999886432     345689999999999999999998843     3458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+++..    ...+++..+..++.|++.||.|||++.+|+||||||+|||++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchh
Confidence            899999985 77666653    456899999999999999999999744799999999999999887 799999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHh---
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-GTPTREEIK---  299 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~---  299 (409)
                      .... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+....+.... +.+......   
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            5332 22345789999999998654 48999999999999999999999998665433322111000 000000000   


Q ss_pred             --------hcCCCcc----ccc-cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          300 --------CMNPNYT----EFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       300 --------~~~~~~~----~~~-~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                              ...+...    ... ...+........-...++.++++||.+||++||++|||+.+++.||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                    0000000    000 000000000000112367899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.3e-44  Score=339.16  Aligned_cols=245  Identities=28%  Similarity=0.460  Sum_probs=196.2

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHH-HHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||+||+|.+..+|+.||+|++....       .....|. .+++.++||||+++++.+     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46899999999999999999999999986431       1222343 356778999999998877     3344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+.+ +|...+.    ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 4544443    256799999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence            2233456789999999999654 4889999999999999999999999887766555444321   0             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCccCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFFDELRD  362 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f~~~~~  362 (409)
                                   ..++...+..+.++|.+||..||.+||++    .++++||||....+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                         01233478899999999999999999976    58999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-43  Score=337.68  Aligned_cols=245  Identities=25%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHH-HHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRE-LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|++..+++.||+|++....       .....| ..+++.++||||+++++++.     ....+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            36999999999999999999999999986432       111223 33567789999999988873     344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99996 55554443    56788999999999999999999986 999999999999999887 899999999875422 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+...   +.            
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~------------  213 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---PL------------  213 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---Cc------------
Confidence            2233456789999999998654 5899999999999999999999999887766665554331   00            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH----HHhCCCCccCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL----DALIHPFFDELRD  362 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~----ell~hp~f~~~~~  362 (409)
                                    .++..+++.+.++|.+||+.||.+|+++.    ++++|+||....+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         214 --------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                          02345789999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-44  Score=341.23  Aligned_cols=244  Identities=26%  Similarity=0.454  Sum_probs=195.5

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHHHHhc---CCCCeecccceeeecCCCCccEEEEEE
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ||+|+||+||+|++..+|+.||+|++.....       ....|..++..+   +||||+++++++     .....+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999864321       122355566554   699999998887     3344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 55555443    56799999999999999999999986 999999999999999887 899999999875432 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+.....               
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  214 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV---------------  214 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            22334567899999999997666689999999999999999999999988766555444432100               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC----CHHHHhCCCCccCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC----TALDALIHPFFDELR  361 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~----s~~ell~hp~f~~~~  361 (409)
                        .+           -...+++++.+||++||+.||.+||    ++.++++||||....
T Consensus       215 --~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         215 --RF-----------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             --CC-----------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence              00           0123688999999999999999998    799999999998764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=323.77  Aligned_cols=302  Identities=27%  Similarity=0.455  Sum_probs=228.1

Q ss_pred             ccceEEeecCCCCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhh---HHHHHHHHhcC------
Q 015298           52 TGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD------  122 (409)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~e~~~l~~l~------  122 (409)
                      .|-..+..+    |.....++|.+.++||.|.|++||+|.|..+.+.||+|+.+....+.   ..|+++|++++      
T Consensus        63 kGGYHpV~I----GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~  138 (590)
T KOG1290|consen   63 KGGYHPVRI----GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPND  138 (590)
T ss_pred             cCCCceeec----cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence            344444444    34455689999999999999999999999999999999998766544   46899998873      


Q ss_pred             --CCCeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCC
Q 015298          123 --HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (409)
Q Consensus       123 --h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlk  200 (409)
                        -.+||++++.|-.. +....++|||+|+++.+|+.++....  .+.++...++.|++||+.||.|||+.+||||.|||
T Consensus       139 ~~~~~VV~LlD~Fkhs-GpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK  215 (590)
T KOG1290|consen  139 PGKKCVVQLLDHFKHS-GPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK  215 (590)
T ss_pred             CCCceeeeeeccceec-CCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence              24799999987543 46677899999999999999998655  68899999999999999999999999999999999


Q ss_pred             CCceeecCCC----------------------------------------------------------------------
Q 015298          201 PQNLLVNPHT----------------------------------------------------------------------  210 (409)
Q Consensus       201 p~NIli~~~~----------------------------------------------------------------------  210 (409)
                      |+|||+....                                                                      
T Consensus       216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~  295 (590)
T KOG1290|consen  216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE  295 (590)
T ss_pred             cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence            9999984100                                                                      


Q ss_pred             --------------------------------------------------------------------------------
Q 015298          211 --------------------------------------------------------------------------------  210 (409)
Q Consensus       211 --------------------------------------------------------------------------------  210 (409)
                                                                                                      
T Consensus       296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~  375 (590)
T KOG1290|consen  296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA  375 (590)
T ss_pred             ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence                                                                                            


Q ss_pred             ---------------CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015298          211 ---------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP  275 (409)
Q Consensus       211 ---------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~  275 (409)
                                     .++||+|||.|.-..  ...+.-+.|+.|+|||++.+.. |++.+||||++|++|||+||...|.
T Consensus       376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFe  452 (590)
T KOG1290|consen  376 SNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFE  452 (590)
T ss_pred             cccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeec
Confidence                           013444444443221  1112234477899999998865 9999999999999999999999996


Q ss_pred             C------CCcHHHHHHHHHHhCCCCHHHHhhcCCCcccc-------ccCcccCCCCccc------CCCCCChhHHHHHHH
Q 015298          276 G------DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FPKRMPPEAVDLVSR  336 (409)
Q Consensus       276 ~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~------~~~~~s~~l~~li~~  336 (409)
                      .      ....+.+..|+..+|..++..+........-|       ....++..++...      ++.....++.+||.-
T Consensus       453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P  532 (590)
T KOG1290|consen  453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP  532 (590)
T ss_pred             CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence            3      35668899999999998887654322111111       1112222222221      223345678899999


Q ss_pred             hcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          337 LLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       337 ~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ||+++|++|+||.++|+|||++.+..+
T Consensus       533 mLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  533 MLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHhcCccccccHHHHhcCccccCCCCC
Confidence            999999999999999999999987655

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=323.68  Aligned_cols=281  Identities=27%  Similarity=0.483  Sum_probs=219.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCC--C----CeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDH--P----NVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.+|+|.||.|..|.+..++..||||+++.-.   ....-|+++|+++.+  |    -+|.+.++|     ..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            668999999999999999999999999999999986533   233458999999842  2    367777777     56


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-----------
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-----------  209 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-----------  209 (409)
                      ..++|||+|.++-++.+.+...  ...+++...++.++.|++.++++||+. +++|.||||+|||+.+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCc
Confidence            6679999999998877777642  256799999999999999999999985 99999999999997311           


Q ss_pred             --------CCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015298          210 --------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (409)
Q Consensus       210 --------~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (409)
                              ...|+|+|||.|+.....  ....+.|..|+|||++.+-. ++.++||||+||||+||+||...|+..++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    115999999999875433  36678899999999998754 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcC---------CCccccccCc------ccCCCCcccCCC--CCChhHHHHHHHhcccCCCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNL  344 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~~--~~s~~l~~li~~~L~~dp~~  344 (409)
                      .+..+...+|..+..++....         .++.+.....      ....++...+..  ....++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            998888899977776665541         1111110000      001111111111  12246889999999999999


Q ss_pred             CCCHHHHhCCCCccCCC
Q 015298          345 RCTALDALIHPFFDELR  361 (409)
Q Consensus       345 R~s~~ell~hp~f~~~~  361 (409)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-42  Score=331.28  Aligned_cols=315  Identities=32%  Similarity=0.577  Sum_probs=235.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCC-Ccc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~  142 (409)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            457999999999999999999999999999999985421      2345799999999999999999887543221 123


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||+|+++++..++.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            468999999877766654     35789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+.+..+.++........
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            6533  22345678899999998665558899999999999999999999999888777777777766655544332221


Q ss_pred             CCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      .....   ...+......+. .+...+++.+.++|.+||+.||.+|||+.+++.||||+...++.......+     +.-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~-----~~~  318 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP-----YDD  318 (343)
T ss_pred             chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC-----ccc
Confidence            11000   000111111111 123457889999999999999999999999999999998877644322222     111


Q ss_pred             CcccccCCCHHHHhhcChHHH
Q 015298          380 KSHELKSVPVEILVKLIPEHA  400 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~  400 (409)
                       ....-.++.++|.++.--.+
T Consensus       319 -~~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07880         319 -SFDEVDQSLEEWKRLTFTEI  338 (343)
T ss_pred             -cHHhhccchHHHHHHHHHHH
Confidence             12334556777777654443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-43  Score=336.05  Aligned_cols=246  Identities=28%  Similarity=0.437  Sum_probs=196.1

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHH-HHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|. .+++.++||||+++++.+     .....+++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986432       1122333 467889999999998877     3344588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc-
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~-  226 (409)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 55444432    56789999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence            2223456789999999998654 4889999999999999999999999887655544443321   1             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCccCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFFDELRDP  363 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f~~~~~~  363 (409)
                                   ..++...+..+.++|.+||+.||.+|+++    .++++||||..+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence                         01344578899999999999999999976    499999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=323.33  Aligned_cols=278  Identities=34%  Similarity=0.608  Sum_probs=211.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++.+++.     ...+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999985432     23467999999999999999999873     33457


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.+++...+...   ...+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEecccccccc
Confidence            899999998776655421   35678888999999999999999986 999999999999999887 8999999998754


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ... .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||..... .+.+.++...++.|....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            322 1223445688999999987655688899999999999999999999976543 45556666666666554332211


Q ss_pred             --CCccccccCcccCCCCcccCC-CCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 --PNYTEFKFPQIKAHPWHKIFP-KRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 --~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                        +.+....+............. ...+..+.+++.+||+.||.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              111111111111111111100 0136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=319.95  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=202.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|.+.+.||+|++|.||+|.+..+++.||+|.+....         ....+|+++++.++||||+++++++.     ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence            36999999999999999999999999999999885431         23467999999999999999999883     33


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++|+||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccc
Confidence            468999999985 56555543    45689999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +.........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+....+....      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------  223 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------  223 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence            8755332111    2356788999999997654 8999999999999999999999997765544433322210      


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                           ....++..++..+.++|.+||..||.+|||+.++++||||
T Consensus       224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                 0112445678999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.2e-43  Score=325.06  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=204.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHH-HHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||++.+..+|+.||+|.+....     .....|+.+ ++.++||||+++++++..     ....+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            6999999999999999999999999999999986532     122335543 667799999999998843     33478


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ++|||++++|.+.+.........+++..++.++.||+.||.|||++.+++||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            99999999888887765545578999999999999999999999855999999999999999887 89999999987654


Q ss_pred             cCCCCccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhc
Q 015298          226 KGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.... ..+.+..+....  ..       
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-------  226 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SP-------  226 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--CC-------
Confidence            43333345678899999988542   336889999999999999999999996532 223333222210  00       


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                        ......+|.++.++|.+||..+|.+||++.+++.||||.+..
T Consensus       227 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 ------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                              001124688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=322.37  Aligned_cols=274  Identities=36%  Similarity=0.661  Sum_probs=216.4

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |.+.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+++++.++|||++++++++.     ...+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            677899999999999999999999999999986432      33567999999999999999999873     3456889


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +|||++++|.+.+....  ...+++..+..++.|++.||+|||++ +++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888777665422  24689999999999999999999986 999999999999999877 899999999875432


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--C
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--P  303 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  303 (409)
                      .. ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||...+..+...++.+..+.+....+....  +
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 22234568889999988665557899999999999999999999999888877777887777777665543211  1


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ++. ..++......... ....++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            100 0111111111111 234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=328.09  Aligned_cols=266  Identities=28%  Similarity=0.500  Sum_probs=215.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            6999999999999999999999999999999986542       2345799999999999999999887     344568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+++..  .....+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999985 66666542  2246789999999999999999999986 999999999999999887 899999998765


Q ss_pred             cccCCC------------------------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 015298          224 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL  273 (409)
Q Consensus       224 ~~~~~~------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~p  273 (409)
                      ......                              .....|+..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              1134678899999999654 478999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC----HH
Q 015298          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT----AL  349 (409)
Q Consensus       274 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s----~~  349 (409)
                      |.+.+....+..+...   +.              .++          ....+++.+.++|.+||..||++|||    +.
T Consensus       232 f~~~~~~~~~~~~~~~---~~--------------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKK---EV--------------TFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcC---Cc--------------cCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            9877766555443321   00              000          01126899999999999999999999    99


Q ss_pred             HHhCCCCccCCCCCCCCCCCCCCCC
Q 015298          350 DALIHPFFDELRDPNARLPSGRFLP  374 (409)
Q Consensus       350 ell~hp~f~~~~~~~~~~~~~~~~~  374 (409)
                      ++++||||++..++..++...+.+|
T Consensus       285 ~ll~~~~~~~~~~~~~~~~~~~~~~  309 (316)
T cd05574         285 EIKQHPFFRGVNWALIRHTTPPIIP  309 (316)
T ss_pred             HHHcCchhhcCChhhcccCCCCCCC
Confidence            9999999999998888876655554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-42  Score=324.81  Aligned_cols=284  Identities=31%  Similarity=0.525  Sum_probs=215.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC---C
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  139 (409)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999885432      123569999999999999999987754322   2


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      .....++||||+.+++...+..   ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECcCC
Confidence            2345689999999877666543   234789999999999999999999987 999999999999999887 89999999


Q ss_pred             CccccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ++........     .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9876533221     12345678899999987665578899999999999999999999998887777766666666555


Q ss_pred             HHHHhhcCC--CccccccCcccCCCCcc-cCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          295 REEIKCMNP--NYTEFKFPQIKAHPWHK-IFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       295 ~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ...+.....  .+....++......... ..+...+..+.+||.+||..||.+|||++++|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            443322110  00011111110000000 0111246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=314.96  Aligned_cols=288  Identities=32%  Similarity=0.527  Sum_probs=231.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC---CCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~  141 (409)
                      ..|.-..+||+|.||.||+|+.+.+|+.||+|++.-+.      ....+|+.+|..|+|+|++.+++++-....   .+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            46888899999999999999999999999998764321      223589999999999999999987754433   344


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+++||.+|+.+|..++...   ..+++...+.+++.++..||.|+|++ .|+|||+|++|+||+.++ .+||+|||++
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence            558899999999888877643   46899999999999999999999986 999999999999999998 8999999999


Q ss_pred             cccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +.......     ....+.|.+|++||.+.+...|+++.|||+.||+|.+|+||.+.+.+.++.+++..|....|....+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76644322     2344569999999999999999999999999999999999999999999999999999999998888


Q ss_pred             HHhhcCC--CccccccCcccCCCCcc---cC-CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          297 EIKCMNP--NYTEFKFPQIKAHPWHK---IF-PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       297 ~~~~~~~--~~~~~~~~~~~~~~~~~---~~-~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .|..++.  -+..+..+.+.....+.   .. +-.-.+++.+|+.+||..||.+|++++++|+|.||..-..+
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            7765431  11112111111111111   00 11225789999999999999999999999999999854333

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-42  Score=329.76  Aligned_cols=278  Identities=35%  Similarity=0.579  Sum_probs=218.6

Q ss_pred             ccceEE-EEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------------------hhHHHHHHHHhcCCCCeeccc
Q 015298           70 TISYMA-ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLK  130 (409)
Q Consensus        70 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~~~  130 (409)
                      ..+|.. .+.||+|+||.||+|.+..+++.||+|.+.....                  ...+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            446765 5779999999999999999999999998854321                  245799999999999999999


Q ss_pred             ceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      +++.     ...+.++||||+.+++.+.+..    ...+++..+..++.|++.||.|||++ ||+||||+|+||+++.++
T Consensus        87 ~~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         87 DVYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKG  156 (335)
T ss_pred             EEEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCC
Confidence            9874     3345889999999988777654    45789999999999999999999986 999999999999999887


Q ss_pred             CcEEEeecCCccccccC---------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015298          211 HQVKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP  275 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~  275 (409)
                       .++|+|||.+......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        157 -ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             -CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             8999999998755411               111233467889999998766667999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcC--CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          276 GDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       276 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+..+.+..+...++.+....+....  +.+..+  .......... .....++++.++|.+||+.||.+|||+.++|.
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            998888888888888777665433211  001000  0000011111 12346889999999999999999999999999


Q ss_pred             CCCccCCC
Q 015298          354 HPFFDELR  361 (409)
Q Consensus       354 hp~f~~~~  361 (409)
                      ||||+...
T Consensus       313 ~~~~~~~~  320 (335)
T PTZ00024        313 HEYFKSDP  320 (335)
T ss_pred             CcccCCCC
Confidence            99998653

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=322.06  Aligned_cols=276  Identities=38%  Similarity=0.705  Sum_probs=219.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999999999999987542      2345689999999999999999998844     34588


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ++|||+++++...+..   ....+++..+..++.||+.||.|||++ |++||||+|+||+++.++ .++|+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            9999999876554432   245689999999999999999999997 999999999999999887 89999999987665


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       226 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ...  ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+....+.+..+...++........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  33346678899999999776468999999999999999999999999888777777777766655544332221 


Q ss_pred             -CCccccccCcc-cCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          303 -PNYTEFKFPQI-KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       303 -~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                       ..+....++.. ....+...++..++.++.+||++||..||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             11111111111 11112223445568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=337.45  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=221.0

Q ss_pred             CCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           66 QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      .....+.|.+.+.||+|.|++|.+|++..||..||||.+.+..      +...+|+++|+.|+|||||+++.+....   
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~---  127 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE---  127 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec---
Confidence            3455678999999999999999999999999999999996643      3356899999999999999999988443   


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                        ..+|+||||+.+ .+.+++..    .+++.+..++.++.|+++|++|||++ +|+|||||++|||++.+. ++||+||
T Consensus       128 --~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaDf  199 (596)
T KOG0586|consen  128 --ATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIADF  199 (596)
T ss_pred             --ceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeecc
Confidence              348999999985 44444443    67788899999999999999999997 999999999999999987 8999999


Q ss_pred             CCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       219 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      |++..+..+....+++|++.|.|||++.+..+.++++|+||+|++||.|+.|.+||++.+-.+.....+...        
T Consensus       200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--------  271 (596)
T KOG0586|consen  200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--------  271 (596)
T ss_pred             ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--------
Confidence            999999888888999999999999999998888999999999999999999999999877544333222110        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                           -.++.-++.++.++|+++|..+|.+|++++++++|.|.......
T Consensus       272 ---------------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  272 ---------------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ---------------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                                 01344578999999999999999999999999999999866544

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-42  Score=332.25  Aligned_cols=293  Identities=36%  Similarity=0.687  Sum_probs=228.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhc-CCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.+|+|++...      .....+|+.+++.+ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            345799999999999999999999999999999988532      12345799999999 99999999987743   233


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ...++||||++++|...+..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence            45789999999877666542     3778888899999999999999986 999999999999999888 8999999998


Q ss_pred             cccccCC------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          222 KVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       222 ~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      .......      ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7654332      1223567889999998866666889999999999999999999999988888888888888777766


Q ss_pred             HHHhhcCCCcccccc---CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCC
Q 015298          296 EEIKCMNPNYTEFKF---PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRF  372 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~  372 (409)
                      ..+..+........+   ............+. ++.++.++|.+||+.||.+|||+.++++||||+++..+.........
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~  313 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYP  313 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccC-CCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCC
Confidence            554433221111111   11111112222233 78999999999999999999999999999999998665544433333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.3e-42  Score=322.18  Aligned_cols=261  Identities=26%  Similarity=0.377  Sum_probs=208.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++++ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            568999999999999999999999999999999986432   3445788999988 899999999988655433345678


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+++.........+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999985 77777665444456789999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||......+.+..+.+.   +..    
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~----  251 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPP----  251 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCC----
Confidence            4322 123456788999999985432    2678999999999999999999999876654444433221   000    


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                         ....+...+..+.++|.+||..||.+||++.+++.||||+
T Consensus       252 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 -------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                               0011234677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-42  Score=321.28  Aligned_cols=276  Identities=37%  Similarity=0.666  Sum_probs=212.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     ....+.+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            6999999999999999999999999999999875432      2345799999999999999999988     4445688


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|+||+.+++...+..   ....+++..+..++.||+.||.|||+. ||+||||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            9999999754443322   245689999999999999999999986 999999999999999887 89999999987653


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......++..|+|||.+.+...++.++||||||+++|+|++|++||......+....+....+.............
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            332 2234567889999999876566788999999999999999999999888777777777766555433221111100


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                        ......+......-.......++..+.+|+.+||..||.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              00011111111000111123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-42  Score=323.51  Aligned_cols=282  Identities=34%  Similarity=0.600  Sum_probs=218.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC---CC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  140 (409)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|++....      ....+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            568999999999999999999999999999999885321      234679999999999999999987754332   23


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..++++|+||+.+++...+..   ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            446789999999876665543   245799999999999999999999986 999999999999999888 899999999


Q ss_pred             ccccccCCC------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015298          221 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       221 a~~~~~~~~------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  288 (409)
                      +........            .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875533221            12235678899999986655688999999999999999999999999888888888888


Q ss_pred             HhCCCCHHHHhhcC--CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          289 VLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       289 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ..+.+....+....  +..............+...+ ..+++.+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766655443211  11110000000001111111 2356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.9e-42  Score=322.42  Aligned_cols=249  Identities=30%  Similarity=0.491  Sum_probs=207.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+...       .....+|+++++.++||||+++++++.     ....+
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            699999999999999999999999999999998642       233457999999999999999999883     34458


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||+. ||+||||+|+||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 677666554    46799999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||......+....+...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            6443  3445688999999998654 4789999999999999999999999876644444433211  0           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                      ..++..++..++++|.+||..||.+|+     ++.++++||||+.+.+.
T Consensus       215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                            013445789999999999999999999     99999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.1e-42  Score=321.35  Aligned_cols=262  Identities=27%  Similarity=0.369  Sum_probs=208.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ....+|.+.+.||+|+||.||+|.+..+++.+|+|++....   ....+|+.+++.+ +||||++++++++........+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            34668999999999999999999999999999999875432   3456789999999 7999999999886554445567


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||+++ +|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~  172 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVSA  172 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCcee
Confidence            8899999984 67776665444456789999999999999999999986 999999999999999887 79999999987


Q ss_pred             ccccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ...... ......|++.|+|||.+..    ...++.++|||||||++|+|++|+.||........+..+....  +    
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~----  246 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--P----  246 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--C----
Confidence            654322 2234568899999999843    2347889999999999999999999997665433322211100  0    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                          .....+...+..+.++|.+||+.||++|||+.++++|+||
T Consensus       247 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 --------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                0001233457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=333.56  Aligned_cols=242  Identities=26%  Similarity=0.366  Sum_probs=203.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .+..++.||+|.||.||.|.+..+ ..||+|.++..   ...+.+|+++|+.|+|+|||++++++....     -++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            455678999999999999998433 37999988653   355678999999999999999999985433     378999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      |||. |+|.+.+..  .....+.......++.|||+|++||.++ ++|||||...||||+.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9999 788888876  3367899999999999999999999986 999999999999999887 8999999999954333


Q ss_pred             CCCcccc--ccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          228 EPNISYI--CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       228 ~~~~~~~--gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .......  -...|.|||.+... .++.+||||||||+||||+| |+.||.+.++.+.+..+.++.+.|           
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-----------  424 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-----------  424 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-----------
Confidence            2222211  13469999999654 59999999999999999998 999999999999999988865544           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                                       -|..+|+++.+++..||..+|++|||...+.
T Consensus       425 -----------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  425 -----------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                             3556899999999999999999999998664

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-42  Score=327.95  Aligned_cols=283  Identities=35%  Similarity=0.632  Sum_probs=221.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            47999999999999999999999999999999986421      234579999999999999999998754322 12234


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+||+...+....      ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||+++.
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987554332      34689999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            422  233456788999999987655688999999999999999999999998887777777777777666654443221


Q ss_pred             Cccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       304 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      ....   ...+......+...+ ...++++.+||.+||+.||.+||++.+++.||||+.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            1100   001111112222222 23688899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-41  Score=323.34  Aligned_cols=284  Identities=37%  Similarity=0.725  Sum_probs=223.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+++|.+.+.||.|+||.||+|.+..+|+.||+|++...      .....+|+++++.++||||+++.+++...    ..
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence            356899999999999999999999999999999987532      23456799999999999999999887432    22


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++++||++++|...+.     ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||.+.
T Consensus        84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCcccccc
Confidence            467999999887766654     35688888999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||...........+.+.++.++.+......
T Consensus       157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            5432  22345678899999998665568999999999999999999999999888777777777777777665443221


Q ss_pred             CCc-ccc--ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCC
Q 015298          303 PNY-TEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR  366 (409)
Q Consensus       303 ~~~-~~~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~  366 (409)
                      ... .++  ..+.....++.... ..+++.+.++|.+||+.+|++|||+.+++.||||...+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            110 000  01111111111111 3478899999999999999999999999999999988776544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=300.42  Aligned_cols=258  Identities=27%  Similarity=0.368  Sum_probs=203.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|++.+.||+|||+.||+++...++..||+|++....    ....+|++..++++|||+++++++............|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            358999999999999999999999999999999986443    4456899999999999999999887665554566688


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      |+++|.. |+|.+.+......+..+++.++..|+.+|++||++||+. .  ++||||||.|||++..+ .++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCcc
Confidence            9999987 789999998877778999999999999999999999986 7  99999999999999877 89999999876


Q ss_pred             ccccCCC----------CccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015298          223 VLVKGEP----------NISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (409)
Q Consensus       223 ~~~~~~~----------~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  290 (409)
                      ...-.-.          -....+|..|+|||.+.-  ....+.++|||||||+||.|+.|..||+..-         ...
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcC
Confidence            5421111          123456888999999832  2336889999999999999999999995311         000


Q ss_pred             CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +.-...      -....+.+++          ...+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       249 gSlaLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000000      0000011111          12479999999999999999999999999864

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=321.00  Aligned_cols=277  Identities=34%  Similarity=0.613  Sum_probs=217.8

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |.+.+.||+|++|.||+|.+..+|+.+|+|.+....      ....+|+++++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678999999999999999999999999999997542      23457999999999999999998874321   245889


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |+||+++++...+...   ...+++..++.++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998777666532   25789999999999999999999986 999999999999999887 899999999876644


Q ss_pred             CC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          227 GE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       227 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ..  ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+....+.+....+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            32  1233456788999998866556899999999999999999999999988888888888887777766554322110


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                        .................+....++.+.++|.+||..||.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000111122223348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=330.89  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=196.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhc-CCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+..|.+.++||+||.+.||++... ....||+|++...      ...+..|+..|.+| .|.+|++++++-     -.+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTD  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccC
Confidence            3457999999999999999999954 4456777766432      23456899999999 599999999976     346


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++||||||-+.+|..++...   ...++...++.+..||+.|+.++|.+ ||||.||||.|+|+-. | .+||+|||+|
T Consensus       433 ~~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G-~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-G-RLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-e-eEEeeeechh
Confidence            679999999998888888753   23455568899999999999999997 9999999999999874 4 7999999999


Q ss_pred             cccccCCCC---ccccccccccccccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015298          222 KVLVKGEPN---ISYICSRYYRAPELIFGAT----------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       222 ~~~~~~~~~---~~~~gt~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  288 (409)
                      ..+..+...   .+.+||+.||+||.+....          +.++++||||||||||+|+.|++||..-.+  .+.++. 
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~-  583 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLH-  583 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHH-
Confidence            988766554   3689999999999994321          256799999999999999999999964321  112211 


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      .+..|.           .++.|+.+.           -..++.++++.||.+||++|||+.++|+|||++-.
T Consensus       584 aI~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  584 AITDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hhcCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            112221           112222211           12349999999999999999999999999999753

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-42  Score=327.59  Aligned_cols=286  Identities=34%  Similarity=0.578  Sum_probs=224.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++.+++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            357999999999999999999999999999999986432      234579999999999999999987753322 2223


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++++++++++|.+.+.     ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEecccccc
Confidence            467899999887766654     34689999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+....+.+.........
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            5432  23345778999999998665568899999999999999999999998888777777777777776665544333


Q ss_pred             CCcccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          303 PNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       303 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      ......   ..+......+... ....++++.+||.+||+.||.+|+|+.+++.||||+++..+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            211110   0111111111111 1236889999999999999999999999999999998766553

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-42  Score=330.48  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=193.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            45899999999999999999975     2456789999986432     3356799999999 899999999876432  


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh----------------------------------------------------
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL----------------------------------------------------  165 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~----------------------------------------------------  165 (409)
                        ...+++||||++ |+|.+.+......                                                    
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              234789999998 5777766542110                                                    


Q ss_pred             ------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC---Ccccccc
Q 015298          166 ------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICS  236 (409)
Q Consensus       166 ------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt  236 (409)
                            ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.......   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                  23477888999999999999999986 999999999999999887 899999999976533221   1223456


Q ss_pred             ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccC
Q 015298          237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  315 (409)
Q Consensus       237 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (409)
                      +.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........                       
T Consensus       240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  295 (338)
T cd05102         240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-----------------------  295 (338)
T ss_pred             ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-----------------------
Confidence            789999998654 48999999999999999997 99999876544433332221000                       


Q ss_pred             CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          316 HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       316 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                          ...+...++.+.+++.+||..||.+|||+.++++
T Consensus       296 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 ----MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                0123457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-42  Score=322.00  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=204.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+....     ....+|+.+++.++|+||+++++++.     ...++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            5889999999999999999999999999999886431     24557999999999999999999874     3455889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|..++.. ......+++..+..++.||+.||.|||++.||+||||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999996 55554442 112347899999999999999999999645999999999999999877 89999999987553


Q ss_pred             cCCCCccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .. ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+......+.      
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------  227 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence            32 223446788999999985432     257899999999999999999999976544333333222211110      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                         ..++..+++++.+||.+||..+|.+||++.++++||||......
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                               01334578999999999999999999999999999999877544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=320.24  Aligned_cols=274  Identities=39%  Similarity=0.730  Sum_probs=219.3

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |.+.+.||+|++|.||+|.+..+|+.+++|.+....      ....+|+.+++.++|+||+++++++.     .....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            667889999999999999999999999999986432      23557999999999999999999874     3345889


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |+||+++++...+...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999998876666542   35789999999999999999999996 999999999999999887 899999999876644


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP--  303 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  303 (409)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 223356788899999987664689999999999999999999999999888888888888777776655444332  


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ......++......... ....++.++.+||.+||.+||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11111111111111111 223478999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=318.77  Aligned_cols=275  Identities=40%  Similarity=0.714  Sum_probs=220.0

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |.+.+.||+|++|.||+|.+..+++.||||.+....     ....+|+..+++++ |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999999999999999986532     23346889999998 9999999998843     445789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||||+++++.+.+....  ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888777765422  35789999999999999999999986 999999999999999887 899999999987655


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN--  304 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  304 (409)
                      ........++..|+|||.+.+...++.++|+||||+++|+|++|++||......+....+...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444455678889999999866666889999999999999999999999999888888888888887776544321100  


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .....++..........++ ..+..+.++|.+||+.||.+|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0111111111111122222 237899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.3e-42  Score=318.75  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=203.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhc-CCCCeecccceeeecCCC-CccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~  144 (409)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|.+...   ......|+.+++++ +|+||+++++++...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            45799999999999999999999999999999998644   23456788999988 699999999988654322 23467


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||+.+ +|.+++...  ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            899999985 666665532  245689999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      .... .......|++.|+|||++.+    ...++.++|+|||||++|+|++|..||...........+...   +     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence            5332 22334678899999999853    234788999999999999999999999765433322221110   0     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                         ........++..+.+||.+||..||.+|||+.++++||||
T Consensus       233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                               0011223468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=317.36  Aligned_cols=262  Identities=28%  Similarity=0.421  Sum_probs=209.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhc-CCCCeecccceeeecCC-CCcc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ...++|.+.+.||+|++|.||+|.+..+++.+++|++....   ..+.+|+.+++++ +|+||+++++++..... ....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34678999999999999999999999999999999986543   3456899999998 79999999998865443 3345


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ++++||||+.+ +|.+++.........+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCccc
Confidence            67899999995 66666665444457899999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ....... ......++..|+|||.+..    ...++.++|||||||++|+|++|..||..........++....   .. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP-  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC-
Confidence            7553322 2234567889999998743    2346788999999999999999999997655444444332210   00 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                            ....+...+..+.+||.+||..||++|||+.++++|||+
T Consensus       237 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 ----------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                  000122367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-42  Score=321.16  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=204.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +.|++.+.||.|+||.||+|.+..+++.+++|.+....    ....+|+.+++.++||||+++++++..     ...+++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            47999999999999999999999999999999986543    234568999999999999999998743     335889


Q ss_pred             EEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||++++ +...+..   ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999965 4333322   245689999999999999999999986 999999999999999877 89999999886543


Q ss_pred             cC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .. .......+++.|+|||.+.+    ...++.++|+|||||++|+|++|..||...+......++....  ++      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc------
Confidence            22 12234567889999999852    2346789999999999999999999997766544333332110  00      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                        ....+..++.++.++|.+||..||++||++.++++||||..+...
T Consensus       234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 ------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                              001233568899999999999999999999999999999877654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-42  Score=328.20  Aligned_cols=278  Identities=22%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             EEEeeccC--CceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           75 AERIVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        75 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ++++||+|  +|++||++.++.+|+.||+|++..+.      ....+|+++++.++||||+++++++..     ....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            45789999  78999999999999999999986432      345679999999999999999998843     345789


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||++ +++.+++....  ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            999998 46666664322  34689999999999999999999986 999999999999999887 89999998654332


Q ss_pred             cCCC--------CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 015298          226 KGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT----  292 (409)
Q Consensus       226 ~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----  292 (409)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|..||......+...........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 35889999999999999999999999876554433332221000    


Q ss_pred             ---CCHHHHhh-c-----CCCcccccc----CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          293 ---PTREEIKC-M-----NPNYTEFKF----PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       293 ---~~~~~~~~-~-----~~~~~~~~~----~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                         .+.+.+.. .     +....+...    ...........+...+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence               00000000 0     000000000    0000000001123346789999999999999999999999999999987


Q ss_pred             CC
Q 015298          360 LR  361 (409)
Q Consensus       360 ~~  361 (409)
                      +.
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            53

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-42  Score=317.13  Aligned_cols=274  Identities=39%  Similarity=0.708  Sum_probs=223.6

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |+..+.||+|++|.||+|.+..+++.||+|.+....      .....|+.+++.++|+|++++++++..     ..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            667889999999999999999999999999986532      234579999999999999999998843     345889


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |+||++++|.+.+....   ..+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999988887776522   5799999999999999999999996 999999999999999887 899999999876543


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN-  304 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  304 (409)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+.++....+.+....+...... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 2233455778999999876656899999999999999999999999999988888999988888887766543322 


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .....++..........++. ++..+.++|.+||..||++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            12223333333333333333 48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=310.31  Aligned_cols=320  Identities=30%  Similarity=0.504  Sum_probs=247.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCC-CccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  143 (409)
                      .+|.-.+.+|.|.- .|..|.|..+++.||+|+....      .+...+|+..+..++|+||++++.+|...... ....
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47999999999998 8999999999999999988543      34567899999999999999999988544321 1223


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .|+|||+|..++...+.      -.+..+.+..|+.|+++|++|||+. ||+||||||+||++..++ .+||.|||+|+.
T Consensus        96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhhcc
Confidence            67999999999888776      2467788899999999999999986 999999999999999998 899999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....-..+.++.|++|.|||++.+.. +...+||||+||++.||++|...|.+.+..++..++...+|.|.+..+..+.+
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            76665667888999999999998876 99999999999999999999999999999999999999999999887665432


Q ss_pred             ----------CccccccCcc-cCCCCcccCC--CCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCC
Q 015298          304 ----------NYTEFKFPQI-KAHPWHKIFP--KRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSG  370 (409)
Q Consensus       304 ----------~~~~~~~~~~-~~~~~~~~~~--~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~  370 (409)
                                .+..+.+... ++..|.....  ..-+..+++++.+||..||++|.+++++|+||||+-|.++..-  ..
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev--~a  324 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV--EA  324 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc--cC
Confidence                      2222222111 1112211111  1234668999999999999999999999999999955433221  11


Q ss_pred             CCCC-CCCCCCcccccCCCHHHHhhcChHHHhhhCC
Q 015298          371 RFLP-PLFNFKSHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       371 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      +..+ -...++..+ ++  .++|.++|-+.+...-+
T Consensus       325 p~pe~~d~~~d~~~-~t--~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  325 PPPEIYDKQLDERE-HT--IEEWKELIFKEVQRFEE  357 (369)
T ss_pred             CCCchhhhhccccc-CC--HHHHHHHHHHHHHhhcc
Confidence            1111 112333333 22  57788777776665544

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.4e-41  Score=310.29  Aligned_cols=249  Identities=28%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+..+.      ....+|+++++.++|+|++++.+.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4899999999999999999999999999999985432      23467899999999999999887652    2334578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++|||+++ ++.+.+...  ....+++..++.++.|++.||.+||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999984 666665532  245689999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+.....            
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            4322 22345678899999998654 488999999999999999999999987665444443332110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                      ...+..+++.+.+++.+||+.||.+|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 ----------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ----------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            01234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=345.02  Aligned_cols=248  Identities=25%  Similarity=0.435  Sum_probs=197.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcC-CCCeecccc-eeeecCCCC-ccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKH-CFFSTTDKD-ELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~  143 (409)
                      .++++.+.|.+|||+.||+|.+...|..||+|++....    +...+|+++|+.|+ |+|||.+++ ......... ..-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            47899999999999999999999888999999985432    34568999999996 999999999 433332222 344


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecCC
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      +.|.||||. |+|.+++..+.  ..+|++.++++|+.|+|+|+.+||. +.  |||||||-|||||+.++ ..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            779999999 68989888765  4559999999999999999999997 47  99999999999999988 899999998


Q ss_pred             ccccccCCC----------Cccccccccccccccc--cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015298          221 AKVLVKGEP----------NISYICSRYYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       221 a~~~~~~~~----------~~~~~gt~~y~aPE~l--~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  288 (409)
                      |........          .....-|+.|+|||.+  ..+...+.|+|||+|||+||.|+....||.......++.    
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln----  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN----  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe----
Confidence            864432221          1223448999999998  344558999999999999999999999997653322111    


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                    .+   +.+|.          ....+..+.+||+.||+.||.+||++.+++.
T Consensus       269 --------------g~---Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  269 --------------GN---YSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             --------------cc---ccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                          01   11111          1357899999999999999999999999873

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.5e-42  Score=319.34  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=199.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..+.     ..+.+|++++++++||||+++++++..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5888999999999999999999999999999986432     334579999999999999999998843     334789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||||++++.....       ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997543321       3578888999999999999999986 999999999999999988 899999999876533


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ---LVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      . ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......+.   ..........+.         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            2 23346789999999998654 489999999999999999999999965322110   011111111000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                    .........++++.++|.+||+.||.+||++.++++||||......
T Consensus       217 --------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         217 --------------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             --------------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence                          0000122367899999999999999999999999999999876544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=332.68  Aligned_cols=235  Identities=26%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccc-hh
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ET  154 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  154 (409)
                      ++-||+|+.|.||+|+.  .++.||||+++.   ..+.+++=|++|+||||+.+.+++     ....++|||||||. |.
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            35589999999999987  678999998743   345688899999999999999998     67778999999999 78


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCcccc
Q 015298          155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  234 (409)
Q Consensus       155 l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~  234 (409)
                      |..+++.    ...++......|..+|+.|+.|||.+ .|||||||.-||||+.+. .|||+|||.++...+.....+++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            8888776    67899999999999999999999997 999999999999999888 89999999998877776777899


Q ss_pred             ccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCccc
Q 015298          235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  314 (409)
Q Consensus       235 gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (409)
                      ||..|||||+++.. ..+.++|||||||||||||||+.||.+-+...++.    .+|                       
T Consensus       273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVG-----------------------  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVG-----------------------  324 (904)
T ss_pred             hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----ecc-----------------------
Confidence            99999999999764 58999999999999999999999997655433221    111                       


Q ss_pred             CCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       315 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+.-..|..+++-++=||+.||+-.|..||+..++|.|
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            1223334678899999999999999999999999999998

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=334.52  Aligned_cols=249  Identities=29%  Similarity=0.463  Sum_probs=214.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|.-.+.||.|+||.||.|++..+.+.||||++.-..       ..+.+|+..|+.++|||++.+.+||....+     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4777889999999999999999999999999985432       345689999999999999999999954433     7


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||||-|+-.+++.-.   ..++.+.++..|+.+.+.||.|||+. +.||||||..|||++..| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            899999999888887754   46899999999999999999999986 999999999999999888 8999999999875


Q ss_pred             ccCCCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                         .+..+++|||+|||||++.  ....|+-++||||||++..||.-.++|+...+....+..|...-. |..       
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-PtL-------  245 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PTL-------  245 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CCC-------
Confidence               3456899999999999984  233589999999999999999999999999998888888876421 110       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                         .....|+.++.|+..||++-|.+|||++++|+|+|...-
T Consensus       246 -------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  246 -------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             -------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence                               122358899999999999999999999999999998753

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-41  Score=310.28  Aligned_cols=249  Identities=28%  Similarity=0.461  Sum_probs=206.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      ...+.+|+++++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            589999999999999999999999999999998543      234567999999999999999998773     344588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ ||+|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 6777665422  45689999999999999999999986 99999999999999876657899999999876


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            555444556788899999998654 478999999999999999999999987766555444332110             


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                     ..++..++..+.+++.+||..||.+|||+.+++.||||
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                           01334578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.3e-41  Score=318.03  Aligned_cols=282  Identities=32%  Similarity=0.525  Sum_probs=218.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-----
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-----  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  138 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+++++.++||||+++++++....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            457999999999999999999999999999999986432      234579999999999999999988754331     


Q ss_pred             CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....++++|+||+++++...+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCcc
Confidence            122368899999998776665432   35789999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       219 g~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |++........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876543321  2223457789999988665557899999999999999999999999888888888888877776654


Q ss_pred             HHhhcCC--CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          297 EIKCMNP--NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       297 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      .+.....  .+............+.. ....++..+.++|.+||..||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4332110  01000000000011111 122468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-41  Score=311.36  Aligned_cols=252  Identities=26%  Similarity=0.453  Sum_probs=207.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+....      .....|+.+++.++|+||+++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4889999999999999999999999999999885431      234568999999999999999887643   2334578


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-----RSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ++|||++ ++|.+.+.........+++..++.++.||+.||.|||     +. +|+|+||+|+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            9999998 4777777765555678999999999999999999999     75 999999999999999887 89999999


Q ss_pred             CccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9887654433 33457899999999986544 8899999999999999999999998776444333322210        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                          ...++...+..+.+++.+||..+|.+|||+.++++|||+
T Consensus       227 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                011344578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-42  Score=316.56  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=205.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+..+.     ..+.+|+.+++.++|+||+++.+++..     ..++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            6889999999999999999999999999999986432     235679999999999999999988743     355889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |+||+.+ +|.+.+..     ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++ .++|+|||+++...
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 66665542     3789999999999999999999986 999999999999999887 89999999997765


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .. .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2334567788999999996654 8999999999999999999999998766444333322210              


Q ss_pred             ccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                    ....+.. ++..+.+++.+||..||++|||+.++++||||.+..
T Consensus       215 --------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 --------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             --------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                          0011222 688999999999999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-41  Score=319.90  Aligned_cols=277  Identities=24%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|++.+.||+|+||.||++.+..+|..+|+|.+..+.     ....+|+++++.++||||+++++++.     ...++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence            6999999999999999999999999999999886432     23457999999999999999999884     3345889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||++.+|+||||||+||+++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 66666653    467899999999999999999999744899999999999999887 79999999987553


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH-H-hhcCC
Q 015298          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE-I-KCMNP  303 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~-~~~~~  303 (409)
                      .. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.... ..+........... . .....
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccC
Confidence            32 23456788999999998554 488999999999999999999999976553322 22221110000000 0 00000


Q ss_pred             Cccc----cc----cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTE----FK----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~----~~----~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ....    ..    ............-...++.++.+|+.+||..||++|||+.++++||||.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            0000    00    0000000000000113678899999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.7e-42  Score=321.26  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=203.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|...+.||+|+||.||++.+..+|+.||+|.+....     ....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            5667789999999999999999999999999986432     23457888898886 9999999998743     23367


Q ss_pred             EEEeccchhHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++|||+.+++..+.... ......+++..+..++.|++.||+|||+..||+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            89999987665554332 223467999999999999999999999745999999999999999887 8999999999765


Q ss_pred             ccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..........+++.|+|||.+.+.  ..++.++|||||||++|+|++|+.||....  .....+.+.......       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~-------  229 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP-------  229 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC-------
Confidence            544444455788899999998665  368899999999999999999999997654  122222221111000       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                               .     .....+..++.++.+||.+||..||.+|||+.++++||||+....
T Consensus       230 ---------~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         230 ---------I-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             ---------c-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                     0     000112347899999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-41  Score=313.82  Aligned_cols=246  Identities=32%  Similarity=0.545  Sum_probs=199.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------------hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      +|.+...||+|++|.||+|.+..+++.+|+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            4788899999999999999999999999999885431             234578999999999999999988733   


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                        ..+.+++|||+++ +|...+..    ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence              3457899999985 66666543    46788999999999999999999986 999999999999999887 899999


Q ss_pred             cCCccccccCCC-------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015298          218 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (409)
Q Consensus       218 fg~a~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  290 (409)
                      ||.++.......       .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642211       1234578889999998654 47889999999999999999999998765544433322210


Q ss_pred             CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                                  ...++..++..+.++|.+||+.||.+||++.++++||||
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                        001344578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=319.48  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||.|+||.||++.+..++..+|+|.+....    ..+.+|+++++.++||||+++++.+.     .....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            457999999999999999999999999999999986443    23457999999999999999999884     334578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhh
Confidence            99999996 56555543   235799999999999999999999986 999999999999999887 8999999988654


Q ss_pred             ccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          225 VKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|+.||......+.+..+....  ++     
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-----  226 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP-----  226 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC-----
Confidence            3322 2234567899999999742    2346789999999999999999999998766554443332210  00     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                         ....+..++.++.++|.+||+.||.+||++.++++||||.+..
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         227 -------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             -------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                               0002335788999999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-41  Score=309.00  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=203.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488899999999999999999999999999988532      234457899999999999999998873     344588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||++ ++|.+.+...  ....++...++.++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            9999997 4777766542  246789999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------  218 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            44322 2334678899999998654 478999999999999999999999987775554444332110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                      ..++..++..+.++|.+||+.+|++||++.+++.|||+
T Consensus       219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ----------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                            01233578899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=313.89  Aligned_cols=278  Identities=34%  Similarity=0.613  Sum_probs=215.9

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhc---CCCCeecccceeeecCCCCccE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678999999999999999999899999999986321      2334577777665   6999999999987655444456


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++++|||+++++.+.+....  ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988777665422  24689999999999999999999986 999999999999999987 899999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||......+.+.++......+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            6555444455678899999999664 488999999999999999999999999888888888877665554433221100


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                       .....++......+.. ....+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 -LPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             -cchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             0000111111111111 122457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-41  Score=317.40  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=205.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||.|++|.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++.+.     ....++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence            347999999999999999999999999999999885432    34457999999999999999999874     334588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+.+ +|...+.     ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~  165 (296)
T cd06655          93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQI  165 (296)
T ss_pred             EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchhc
Confidence            99999985 5555443     34689999999999999999999986 999999999999999887 8999999998755


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+... ..+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------  234 (296)
T cd06655         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------  234 (296)
T ss_pred             ccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------
Confidence            33322 2335678899999998654 4889999999999999999999999887665544333221 0000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                      ...+..+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                            012345788999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=305.91  Aligned_cols=256  Identities=26%  Similarity=0.453  Sum_probs=199.7

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      +.||+|+|+.|--|....+|..||||++.+..    ....+|++++... .|+||+.++++|     +++..+|||||-|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVfEKm  158 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVFEKM  158 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEEecc
Confidence            57999999999999999999999999996542    4456899999988 599999999988     6666689999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCccccccC-
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKG-  227 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a~~~~~~-  227 (409)
                      .| .|+..+..    ...+++.++.++.++|+.||+|||.+ ||.||||||+|||...-.  .-||||||.+..-.... 
T Consensus       159 ~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  159 RGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             cCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            96 45554443    57899999999999999999999997 999999999999985433  25999999987543221 


Q ss_pred             -------CCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHH
Q 015298          228 -------EPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-----------QLVE  285 (409)
Q Consensus       228 -------~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----------~~~~  285 (409)
                             ....+.+|+..|||||++.    ....|..+.|.||||+|||.|+.|.+||.+....+           -...
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence                   2234678888999999872    23458899999999999999999999998654321           0111


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ++..+        +...     +.|   +...|.     .+|.+++++++.+|..|+.+|.++.++++|||++.....
T Consensus       314 LFesI--------QEGk-----YeF---PdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  314 LFESI--------QEGK-----YEF---PDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHH--------hccC-----CcC---ChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            11111        1100     011   112222     379999999999999999999999999999999976543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-41  Score=317.55  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|++|.||+|.+..++..||+|.+....    ....+|+.+++.++|+|++++++.+..     ....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            458999999999999999999999999999999886432    345679999999999999999998743     34588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+.+ +|.+.+.     ...++...+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccchhc
Confidence            99999985 6666553     34688999999999999999999986 999999999999999887 8999999998754


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+... +.+          
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----------  234 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP----------  234 (296)
T ss_pred             cccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC----------
Confidence            3322 1234567889999999865 44789999999999999999999999776554333222110 000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                     ....+..++..+.++|.+||..||.+|||+.++++||||...
T Consensus       235 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         235 ---------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                           001234578899999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-41  Score=313.31  Aligned_cols=252  Identities=26%  Similarity=0.510  Sum_probs=201.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      +|+..+.||+|++|.||++.+..+++.||+|.+....          ..+.+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4788899999999999999999999999999986432          3446799999999999999999987     344


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++|+||+.+ +|.+.+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            457899999995 66666543    45789999999999999999999986 9999999999999987765799999999


Q ss_pred             ccccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +........     .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     123457889999999865 45889999999999999999999999755433322222221100   


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                           .....++..+++++.+++.+||..||.+|||+.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 000113445789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-43  Score=334.70  Aligned_cols=248  Identities=28%  Similarity=0.491  Sum_probs=205.0

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (409)
                      +||+|.||+||-|+|..|...+|||-+...    .+-..+|+.+-+.|+|.|||++.+++     ..+.++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            799999999999999999999999998543    24456899999999999999999987     566678899999995


Q ss_pred             -hHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC-
Q 015298          154 -TVHRVVKHFNKLNQRM--PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  229 (409)
Q Consensus       154 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~-  229 (409)
                       +|..++....   +++  .+..+..+.+||++||.|||++ .|||||||-+||||+.-.+.+||+|||.++....-.+ 
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             6666665432   455  7888899999999999999997 9999999999999988777999999999887644333 


Q ss_pred             Ccccccccccccccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccc
Q 015298          230 NISYICSRYYRAPELIF-GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (409)
Q Consensus       230 ~~~~~gt~~y~aPE~l~-~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  308 (409)
                      ..++.||.-|||||++. |...|+.++|||||||++.||.||++||......+...-.....                  
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------
Confidence            34688999999999994 44569999999999999999999999997654433221111110                  


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                              .....+|+.++.+++.||.+|+.+||.+||+|.++|..||++.-
T Consensus       795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                    11223677889999999999999999999999999999999865

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-41  Score=316.51  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=202.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      -|++.+.||+|+||.||+|.+..++..+++|.+....    ....+|+++++.++|||++++++++..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788899999999999999999999999999986432    234578999999999999999998743     3457899


Q ss_pred             Eeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +||++++ +...+..   ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            9999864 4333332   245789999999999999999999986 999999999999999887 899999999865432


Q ss_pred             CC-CCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          227 GE-PNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .. ......+++.|+|||.+.    ....++.++|+|||||++|+|++|.+||...+..+....+.......        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------  227 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence            21 223456788999999984    23347789999999999999999999998776655555443321100        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        ...+..++..+.+||.+||..||.+||++.++++||||...
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                              01233478899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-41  Score=311.78  Aligned_cols=247  Identities=28%  Similarity=0.485  Sum_probs=198.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      +|.+.+.||+|+||.||+|.+ .+|+.+|+|.+....          ....+|+++++.++|+||+++.+++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            478899999999999999986 578999999885431          23567999999999999999999873     34


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+.++++||+.+ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568899999985 66666543    45789999999999999999999986 999999999999999887 899999998


Q ss_pred             ccccccC-------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          221 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       221 a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754211       112235678899999998654 4789999999999999999999999766544433322221000 


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                               ....+..++.++.++|.+||..||.+||++.++++||||
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                     011344578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-41  Score=315.26  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhc-CCCCeecccceeeecCC-CCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~  144 (409)
                      .+.|.+.+.||.|+||.||+|.+..+++.+|+|++....   .....|+.+++++ +|+||++++++++.... ....++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            457999999999999999999999999999999986543   3445688888888 79999999998764322 234568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||+++ +|.+++....  ...+++..+..++.||+.||.|||+. ||+|+||||+||+++.++ .++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchhh
Confidence            899999985 6766665422  45688888999999999999999986 999999999999999887 799999999875


Q ss_pred             cccC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      .... .......|++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   ..    
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence            4322 22334668899999999853    234788999999999999999999999765543333222110   00    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                          .......++.++.+||.+||..||.+|||+.++++||||
T Consensus       244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                001123478899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-41  Score=312.58  Aligned_cols=249  Identities=30%  Similarity=0.503  Sum_probs=198.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+....         ....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            6999999999999999999999999999999885321         235579999999999999999887643   2234


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++++||+++ +|.+.+..    ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57899999985 66666643    45688999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ......    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+..+...   +.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~---  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT---  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence            754321    11123457889999999865 44889999999999999999999999866544433322211   00   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                           ...++..+++.+.++| +||..+|++||++.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0113445788899999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-41  Score=319.28  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=204.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            358999999999999999999999999999999986432    34467899999999999999999883     344588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|...+.     ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 5655543     35688899999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... +.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~----------  233 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP----------  233 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC----------
Confidence            33322 234567889999999865 45889999999999999999999999765443222111110 000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                     ....+..++..+.+|+.+||..||.+||++.++++||||+..+..
T Consensus       234 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         234 ---------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence                           001234578899999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=329.05  Aligned_cols=251  Identities=29%  Similarity=0.526  Sum_probs=210.9

Q ss_pred             eEE--EEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           73 YMA--ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        73 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      |++  .+.||+|.||+||-|+++.+|+.||||++.+.      ......|+.||+.+.||.||.+.-.|     +....+
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv  638 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV  638 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence            544  37899999999999999999999999998542      34567899999999999999997777     333448


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC--CCcEEEeecCCcc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAK  222 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~--~~~ikl~Dfg~a~  222 (409)
                      ++|||-+.|++++.+....  .+++++...+.++.||+.||.|||-+ ||+|+||||+|||+.+.  ...+||||||+|+
T Consensus       639 FVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  639 FVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeecccccee
Confidence            8999999998888776544  68999999999999999999999986 99999999999999643  3489999999999


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ++.+.....+.+|||.|.|||+++.. .|...-|+||+|+|+|--++|..||..+.. .+++++.  .+..         
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--aFMy---------  783 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--AFMY---------  783 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc--cccc---------
Confidence            99888888899999999999999764 499999999999999999999999975533 2222211  0111         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                  +..+|.+     +++++.|||.++|+..-.+|.|.+..|.|||+++.
T Consensus       784 ------------Pp~PW~e-----is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  784 ------------PPNPWSE-----ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ------------CCCchhh-----cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                        2234443     79999999999999999999999999999999975

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=318.92  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=210.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+..+  -+.+.+|+.++++++.|++|++|+.||-..+     ++||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            488899999999999999999999999999998644  4667799999999999999999999966555     899999


Q ss_pred             ccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC-
Q 015298          150 YVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  227 (409)
Q Consensus       150 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~-  227 (409)
                      ||+ |+..+++..+   +.++++.++..+++..+.||+|||. +.=+|||||..|||++.+| ..||+|||.|....+. 
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6777776654   5789999999999999999999998 4899999999999999998 7999999999765443 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      ....+..|||.|||||++.. -.|...+||||||++..||.-|++||.+-.....+.   -.-..|++            
T Consensus       184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~PPP------------  247 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKPPP------------  247 (502)
T ss_pred             HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCCCC------------
Confidence            34567889999999999954 348999999999999999999999997644322211   11111111            


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                               .++  -|+..|.++-||+++||.++|++|.|+.++++|||+++-
T Consensus       248 ---------TF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  248 ---------TFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ---------CCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence                     111  244578899999999999999999999999999999863

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-41  Score=308.78  Aligned_cols=248  Identities=35%  Similarity=0.561  Sum_probs=202.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|+..+.||+|++|+||+|.+..+++.|++|.+....         ..+.+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4778899999999999999999899999999885432         3356799999999999999999877     3334


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++++||+++ +|.+.+..    ...+++..+..++.||+.||.|||+. ||+|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 66666543    45688999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .............++..|+|||.+.....++.++|+|||||++|+|++|..||......+....+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            76654443445678899999999855434789999999999999999999999776644433332221100         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                        ..++..+++.+.+++.+||..||.+||++.+++.|||+
T Consensus       221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                              01344578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-41  Score=310.90  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=203.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+.+..       ....+|+++++.++||||+++++++     ....+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4899999999999999999999999999999986432       3456799999999999999999887     445568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++|+||+.+ +|...+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999985 56555543    35789999999999999999999986 999999999999999888 899999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.. ....+......           
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-----------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-----------
Confidence            65544444566788999999986544 899999999999999999999999876642 11111111110           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH--HHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA--LDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~--~ell~hp~f  357 (409)
                                    ....++..++..+.++|.+||..||.+||++  .++++||||
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 --------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             --------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                          0112445578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-41  Score=310.95  Aligned_cols=245  Identities=30%  Similarity=0.494  Sum_probs=199.6

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||.|++|.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+.     ....+++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999999999999986432       34567999999999999999999773     334478999998


Q ss_pred             c-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 P-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      + ++|.+.+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            7 466666543    35689999999999999999999986 999999999999999887 8999999999876554334


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhhcCCCcccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  308 (409)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....  ..+....+.....                 
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------  211 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence            456788999999998554 48899999999999999999999998765  3333332221000                 


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCC
Q 015298          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRD  362 (409)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~  362 (409)
                                ...++...++++.++|.+||..||.+|++     +.|+++||||+++.+
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                      01134456889999999999999999999     999999999998754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4e-41  Score=310.28  Aligned_cols=255  Identities=28%  Similarity=0.434  Sum_probs=203.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||.|+||+||+|.+..++..+|+|++..+.     ....+|+++++.++|+||+++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            6999999999999999999999999999999986432     34568999999999999999988773     3345789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||++.+ +|.+.+.... ....+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 6666655322 135689999999999999999999986 999999999999999887 89999999987664


Q ss_pred             cCCCC-----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....     ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+......+....  .+.      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------  225 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP------  225 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC------
Confidence            43222     33467889999999866546899999999999999999999999876655444433321  000      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                         .+     ..       ......+++.+.+++.+||..||.+|||+.+++.||||
T Consensus       226 ---~~-----~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 ---SL-----ET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---Cc-----CC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               00     00       00012478899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-41  Score=310.42  Aligned_cols=250  Identities=30%  Similarity=0.476  Sum_probs=202.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ++|.+.+.||+|+||.||+|.+..++..+++|.+....  ..+.+|+++++.++||||+++++++..     ..++++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            47999999999999999999999889999999986543  456689999999999999999998843     34588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+++ +|.+.+..   ....+++..++.++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99995 66555542   246789999999999999999999986 999999999999999887 8999999998765443


Q ss_pred             C-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          228 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       228 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      . ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...   ..            
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------------  216 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP------------  216 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC------------
Confidence            3 22344578899999998654 5889999999999999999999999865543332221110   00            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                               .  ....+..++..+.++|.+||+.||++|||+.++|.||||
T Consensus       217 ---------~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 ---------P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ---------C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                     0  000223467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.2e-41  Score=313.64  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=191.8

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHH---hcCCCCeecccceeeecCCCCccEEEEE
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMR---LLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .||+|+||.||++.+..+|+.+|+|.+.+..       ....+|..+++   ...||||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999885432       12233443333   3479999999887733     3347899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.+ +|...+..    .+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999995 55544432    46799999999999999999999986 999999999999999887 899999999865433


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      . ......|++.|+|||.+.+...++.++|+||+||++|+|++|..||.......... +.....               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~---------------  212 (279)
T cd05633         150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL---------------  212 (279)
T ss_pred             c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh---------------
Confidence            2 22345689999999998655558899999999999999999999997543221111 111000               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN  364 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~  364 (409)
                                .....++..+++++.++|.+||..||.+|+     |+.++++||||+++...+
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence                      001113456789999999999999999999     699999999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=330.95  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             EEEEeeccCCceEEEEEEEcCCCcEEEEEEe------eccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~------~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +...+||+|+|-+||+|.|..+|..||--.+      +...  +.+..|+.+|+.|+||||+++++.|.....   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            3456899999999999999999999884332      1222  566789999999999999999998876443   5678


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +|+|.+. |+|..+++.    .+.+....++.|++||++||.|||++- .|||||||.+||+|+.+.+.|||+|+|+|..
T Consensus       120 ~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            9999998 666655554    678889999999999999999999852 3999999999999999888999999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... ....+|||.|||||+.-  ..|+..+||||||+.|+||+|+..||..-.+..++.+.......|..        
T Consensus       196 ~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s--------  264 (632)
T KOG0584|consen  196 LRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA--------  264 (632)
T ss_pred             hhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH--------
Confidence            64443 33489999999999983  56999999999999999999999999877666555543332222211        


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        +..--.+++++||.+||.. ...|+|+.|+|+||||..-
T Consensus       265 ------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 ------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                              1112368999999999999 9999999999999999863

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7e-41  Score=315.39  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=203.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+....       ....+|+++++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            6999999999999999999999999999999886432       2344789999999999999999887     344568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||++| +|...+..    ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999985 66666643    46789999999999999999999986 999999999999999887 899999998864


Q ss_pred             cccCC----------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015298          224 LVKGE----------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       224 ~~~~~----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  287 (409)
                      .....                ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+....+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21100                01123567889999998654 48999999999999999999999998776655444433


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCccCCCCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---ALDALIHPFFDELRDPN  364 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s---~~ell~hp~f~~~~~~~  364 (409)
                      ......+                          .....++.++.++|.+||+.||.+||+   +.++|+||||...+...
T Consensus       230 ~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         230 SDDIEWP--------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             hcccCCC--------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            3110000                          011246889999999999999999997   79999999998765543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-41  Score=312.83  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=198.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++.+..     ...++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEE
Confidence            347999999999999999999999999999999986432    345679999999999999999988743     34578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        83 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~  156 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKI  156 (267)
T ss_pred             EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceee
Confidence            99999985 66665543    46789999999999999999999986 999999999999999887 7999999998765


Q ss_pred             ccCC-CCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE-PNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .... ......+++.|+|||.+..  ...++.++|+|||||++|+|++|..||......+....+....           
T Consensus       157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------  225 (267)
T cd06646         157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN-----------  225 (267)
T ss_pred             cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC-----------
Confidence            3322 2234567889999998742  3346789999999999999999999996544322221111100           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                            +..+     .+.  ....++..+.+||++||..||++|||++++++|+|
T Consensus       226 ------~~~~-----~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         226 ------FQPP-----KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------CCCC-----CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                  0000     000  12246889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-41  Score=316.93  Aligned_cols=256  Identities=29%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..|.....||+|+||.||++.+..++..||||.+....    ....+|+.+++.++|+||+++++.+.     ...+.++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence            34666678999999999999999999999999885432    34567999999999999999999874     3345789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+.     .+.+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhcc
Confidence            9999986 4544443     35689999999999999999999986 999999999999999887 89999999986543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+.+..+........          
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  238 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------  238 (292)
T ss_pred             cccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------
Confidence            222 22345678999999998554 488999999999999999999999987665554443322111000          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                      ......+..+.++|.+||..||.+|||+.++++||||.....++.
T Consensus       239 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         239 ----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             ----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence                            011236889999999999999999999999999999998766653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-41  Score=313.69  Aligned_cols=240  Identities=18%  Similarity=0.224  Sum_probs=194.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      ..||+|++|.||+|..  +|+.||+|.+....       ..+.+|+.++++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5789999999999998  78999999986532       33458999999999999999999875421 22345789999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      |+++ +|.+.+..    ...+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||+++..... 
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            9995 56666653    457889999999999999999999745899999999999999887 8999999998765332 


Q ss_pred             CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          229 PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       229 ~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                       .....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+              
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence             2345678999999998542 458999999999999999999999999877666555543321111              


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                   .++...++++.+||.+||+.||++|||+.+++.
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                         123347899999999999999999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-41  Score=339.59  Aligned_cols=279  Identities=20%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCC-cEEEEE------------------Eeecc---chhhHHHHHHHHhcCCCCee
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETG-ETVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  127 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~e~~~l~~l~h~niv  127 (409)
                      ..+|++.+.||+|+||+||+|..+... ...+.|                  .+...   ...+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998765332 222222                  11111   12346799999999999999


Q ss_pred             cccceeeecCCCCccEEEEEEeccchhHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                      ++++++..     ....++|++++.+++...+.... ..........++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            99998843     33478999999887766654321 1123344667888999999999999986 99999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCC--CcHH
Q 015298          207 NPHTHQVKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL-FPGD--SGVD  281 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~--~~~~  281 (409)
                      +.++ .+||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9887 899999999986644322  2346789999999999664 489999999999999999998854 4322  3344


Q ss_pred             HHHHHHHHhCCCCHHH-------HhhcCCCccccccCcccCCCCccc-CCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          282 QLVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+.++...++....+.       +.....    ..+.... ...... ....++.++.++|.+||++||.+|||+.|+|.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~----~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDS----AEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhh----hhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            5555555444322210       000000    0000000 000001 11236788999999999999999999999999


Q ss_pred             CCCccCCC
Q 015298          354 HPFFDELR  361 (409)
Q Consensus       354 hp~f~~~~  361 (409)
                      ||||....
T Consensus       454 hp~f~~~~  461 (501)
T PHA03210        454 LPLFSAEE  461 (501)
T ss_pred             ChhhhcCC
Confidence            99998753

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-41  Score=313.25  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=200.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||+|+||+||+|.+..+|+.||+|.+...       ......|+++++.++||||+++++.+     ......++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999988542       12335799999999999999998877     3344578999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6666554322  24789999999999999999999986 999999999999999887 8999999998765444334


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4556788999999986654 889999999999999999999999765542222222111000                  


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCCC
Q 015298          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPNA  365 (409)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~~  365 (409)
                             ....++..+++.+.++|.+||+.||.+||     ++.++++||||..+.+...
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence                   00113445789999999999999999999     9999999999998876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-41  Score=312.47  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=199.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ...++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Confidence            347999999999999999999999999999999986542    234579999999999999999988743     34578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+++..    .+.+++..++.++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~  156 (267)
T cd06645          83 ICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQI  156 (267)
T ss_pred             EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEc
Confidence            99999985 66666543    46799999999999999999999986 999999999999999887 8999999998654


Q ss_pred             ccCC-CCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE-PNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .... ......|++.|+|||.+.  ....++.++|+|||||++|+|++|..||..................+.       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------  229 (267)
T cd06645         157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-------  229 (267)
T ss_pred             cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC-------
Confidence            3222 223457899999999874  233478899999999999999999999976554333222211100000       


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                                     .+.  -...++..+.++|.+||..||++|||+.++++|||
T Consensus       230 ---------------~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 ---------------KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ---------------ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                           000  01136788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-40  Score=307.76  Aligned_cols=249  Identities=29%  Similarity=0.493  Sum_probs=198.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||++.+..+|..||+|.+..+.         ....+|+.+++.+.||||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            6999999999999999999999999999999875321         234579999999999999999887632   2234


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++++|||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57899999985 66665543    35688899999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ......    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+.++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            754321    11223457889999999865 4488999999999999999999999976654443332221   110   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                           ....+..++..+.++|.+|+. +|++||++++++.|||+.
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                 011344578889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.8e-41  Score=306.76  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=203.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++||||+++.+++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            589999999999999999999999999999988532      13456799999999999999999887     3445688


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+.+ +|.+.+...  ....+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999985 666655431  234678999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------------
Confidence            43322 1234578889999998654 478899999999999999999999987766555544432110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                      ...+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                            01234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=326.72  Aligned_cols=245  Identities=30%  Similarity=0.467  Sum_probs=203.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ....|.+...+|.|+|+.|-.|.+..+++.+++|++.+......+|+.++... +||||+++.+.+     .+....++|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            45679999999999999999999999999999999988877778888776665 799999999988     666779999


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec-CCCCcEEEeecCCcccccc
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~-~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ||.+.|..  ++....  ..+.....+..|+.+|+.|+.|||.+ |+|||||||+|||++ ..+ .++|+|||.++....
T Consensus       395 ~e~l~g~e--ll~ri~--~~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGE--LLRRIR--SKPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccH--HHHHHH--hcchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence            99999752  222211  22333377788999999999999997 999999999999994 665 799999999986544


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .  ..+.+.|..|.|||++. ...|+.++||||||++||+|++|+.||......   .++.+.++.+.            
T Consensus       469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------------  530 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------------  530 (612)
T ss_pred             h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc------------
Confidence            3  44557788999999996 556999999999999999999999999877665   33444443332            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                     +...+|+.+++||++||+.||.+|+++.+++.||||
T Consensus       531 ---------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ---------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                           225689999999999999999999999999999999

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=313.02  Aligned_cols=257  Identities=27%  Similarity=0.450  Sum_probs=215.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh-------hHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY-------KNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|..+.+||.|+||+|.+|..+.|.+.||||+++++.-.       ...|-++|... +-|.++++..||-..+  
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--  423 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--  423 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh--
Confidence            3455799999999999999999999999999999999876322       12466666655 4678889998884433  


Q ss_pred             CccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                         .+|+||||++|+ |--.+++    -+++.+..+..++.+|+-||-+||++ |||+||||.+||+++.+| .|||.||
T Consensus       424 ---RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eG-HiKi~DF  494 (683)
T KOG0696|consen  424 ---RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADF  494 (683)
T ss_pred             ---heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCC-ceEeeec
Confidence               388999999975 3333333    57899999999999999999999987 999999999999999999 7999999


Q ss_pred             CCccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          219 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       219 g~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      |+.+.-. .+....+++|||.|+|||++. .+.|+.++|+||+|++||||+.|++||++.++.+..+.|+..        
T Consensus       495 GmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------  565 (683)
T KOG0696|consen  495 GMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------  565 (683)
T ss_pred             ccccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------
Confidence            9987543 344556899999999999995 456999999999999999999999999999999998888763        


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPNA  365 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~~  365 (409)
                                           ...+|..+|.++.++++.+|.+.|.+|..     -.++-.||||+.+.|...
T Consensus       566 ---------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  566 ---------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             ---------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence                                 22378889999999999999999999984     357889999999988654

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-40  Score=304.05  Aligned_cols=248  Identities=32%  Similarity=0.494  Sum_probs=205.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|+..+.||.|+||.||.+++..+++.+++|.+....      ....+|++++++++|+||+++++++.     ....++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            5899999999999999999999999999999875431      34567999999999999999999884     344588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++|||++ ++|.+.+....  ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            9999998 47776665422  45689999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4333 23345688999999998654 4788999999999999999999999887766655554321  100         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                       ..+..++.++.++|.+||..||.+||++.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0123468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-40  Score=309.01  Aligned_cols=264  Identities=26%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++++...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            6899999999999999999999999999999986432     3456899999999999999999887442   2345789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+++.........+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999984 77666665444567789999999999999999999986 999999999999999887 79999999987543


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .... ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...... ....+....+.......+      
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  228 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL------  228 (287)
T ss_pred             cccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh------
Confidence            3222 234568889999998554 5889999999999999999999999765220 000111111111000000      


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                            +.   .   .......++.+.+||.+||..||.+|||+.|++.||||++.
T Consensus       229 ------~~---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         229 ------KD---E---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             ------cc---C---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                  00   0   00011246789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=305.96  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=201.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .+|.+.+.||.|+||.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++.+..     ...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            4799999999999999999999999999999998654    2345689999999999999999988743     345889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+++ +|.+++..   ....+++..+..++.|++.||.|||++ ||+|+||+|+||+++.++ .++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 55554443   136789999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCC-CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ... ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|..||...........+....-.+..       
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------  225 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-------  225 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-------
Confidence            332 22345678899999998543  25788999999999999999999999876655444333221000000       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                                       .......+.++.+||.+||..||..|||+.+++.|||
T Consensus       226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 -----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                             0012235788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-41  Score=309.52  Aligned_cols=253  Identities=28%  Similarity=0.527  Sum_probs=201.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||+|++|.||+|.++.+++.+|+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5788899999999999999999999999999986542     234579999999999999999988743     355889


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||++ ++|.+++...   ...+++..+..++.|++.||.|||+ . |++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 5776666542   2678999999999999999999998 6 999999999999999887 8999999998755


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHH-hCCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKV-LGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~  302 (409)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+......+. ...+.        
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--------  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--------
Confidence            332222 26778899999998654 589999999999999999999999975421 1111111111 11000        


Q ss_pred             CCccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                       ...+.. ++.++.++|.+||..||++|||+.+++.||||+.+.
T Consensus       222 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         222 -----------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             -----------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                             001122 688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-40  Score=309.11  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=193.3

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHH---HHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .||+|+||.||+|.+..+++.||+|.+.+..       .....|.   ..++...||||+++.+++     .....+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4899999999999999999999999886432       1122233   344456899999998877     334458899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.| +|...+.    ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999985 4544443    246799999999999999999999986 999999999999999887 899999999875433


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      . ......|+..|+|||.+.+...++.++||||+||++|+|++|..||..................              
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  214 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------  214 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------
Confidence            2 2234578999999999875556889999999999999999999999765332211110000000              


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPNA  365 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~~  365 (409)
                                  ...++...+.++.+++.+||..||.+|+     ++.++++||||+...+...
T Consensus       215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence                        0113445789999999999999999999     9999999999998765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.4e-40  Score=303.45  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=201.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+...      .....+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            589999999999999999999999999999998542      23456899999999999999999987     3445588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999974 666665432  234578999999999999999999986 99999999999999988656799999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            43322 2234578899999988554 48899999999999999999999998766544443332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                     .......++..+.++|.+||..+|++|||+.++++||||
T Consensus       219 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ---------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                           001223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.9e-42  Score=317.97  Aligned_cols=282  Identities=32%  Similarity=0.554  Sum_probs=228.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC------CCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD------HPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+....|+|-|++|..|.+...|..||||++....   +.-.+|+++|++|+      --|+++++..|     .
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----K  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----h
Confidence            3458999999999999999999999999999999997764   33457999999995      35899999888     5


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      +..++|||+|.+.-+|.++++.+.. +..+....++.|+.|++-||..|.. |||+|.||||+|||++.....+||||||
T Consensus       505 hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCc
Confidence            6667999999999999999998765 5778999999999999999999986 7999999999999999888789999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .|....+. ..+.+..+..|.|||++.|-. |+...|+||+||+||||+||+..|++.++.+++...+..-|..+..++.
T Consensus       583 SA~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  583 SASFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             cccccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            99766443 344566688899999998865 9999999999999999999999999999999999999988888877665


Q ss_pred             hcC-------CC--ccccccCccc-------------CCCCcccCC--CCCC-------hhHHHHHHHhcccCCCCCCCH
Q 015298          300 CMN-------PN--YTEFKFPQIK-------------AHPWHKIFP--KRMP-------PEAVDLVSRLLQYSPNLRCTA  348 (409)
Q Consensus       300 ~~~-------~~--~~~~~~~~~~-------------~~~~~~~~~--~~~s-------~~l~~li~~~L~~dp~~R~s~  348 (409)
                      ...       .+  +.......+.             ...+...+-  .+++       ..+++||.+||..||.+|.|+
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            311       11  1111111110             011111110  0122       468899999999999999999


Q ss_pred             HHHhCCCCccC
Q 015298          349 LDALIHPFFDE  359 (409)
Q Consensus       349 ~ell~hp~f~~  359 (409)
                      .++|.||||..
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999974

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-40  Score=304.01  Aligned_cols=250  Identities=34%  Similarity=0.551  Sum_probs=205.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||+|++|.||+|.+..+|+.|++|++....     ....+|+.++..++|+|++++++++.     .....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence            6899999999999999999999999999999986542     34568999999999999999999884     3355889


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||||++ ++|.+.+..    ...+++..+..++.|++.||.|||+ . |++||||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 577766654    3678999999999999999999998 7 999999999999999887 8999999998766


Q ss_pred             ccCCCCc-cccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....   .+....+..   ...      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------  220 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------  220 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence            4443332 45678899999998654 588999999999999999999999977642   222222211   000      


Q ss_pred             cCCCccccccCcccCCCCcccCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                         ...+.. ++..+.++|.+||..+|++|||+.++++||||+...
T Consensus       221 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 -------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                               012233 788999999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-40  Score=312.07  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC----------------CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeec
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVS  128 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~  128 (409)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3579999999999999999998532                34579999986532     24567999999999999999


Q ss_pred             ccceeeecCCCCccEEEEEEeccc-hhHHHHHHHhhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015298          129 LKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNK---------------LNQRMPMIYVKLYAYQIFRALSYIHRSI  192 (409)
Q Consensus       129 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~  192 (409)
                      +++++..     ....++||||+. ++|.+.+.....               ....+++..+..++.||+.||.|||+. 
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            9998843     234789999997 477776654221               112467788899999999999999986 


Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML  269 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt  269 (409)
                      ||+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus       158 ~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         158 NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence            999999999999999887 899999999976533321   1223447789999998654 48999999999999999986


Q ss_pred             --CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC
Q 015298          270 --GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT  347 (409)
Q Consensus       270 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s  347 (409)
                        +..||......+.+..+..........                     .....+..++..+.+|+.+||..||.+|||
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence              668888766655554443322111000                     000123346889999999999999999999


Q ss_pred             HHHHh
Q 015298          348 ALDAL  352 (409)
Q Consensus       348 ~~ell  352 (409)
                      +.++.
T Consensus       295 ~~~i~  299 (304)
T cd05096         295 FSDIH  299 (304)
T ss_pred             HHHHH
Confidence            99984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-40  Score=306.51  Aligned_cols=252  Identities=30%  Similarity=0.545  Sum_probs=198.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--------------hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.+|+|.+....              +.+.+|+.+++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            5899999999999999999999999999999875311              1345689999999999999999877    


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                       .....+++||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||+. |++||||+|+||+++.++ .++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence             333457899999985 66665543    36789999999999999999999986 999999999999999887 89999


Q ss_pred             ecCCccccccCC---CCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          217 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       217 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|+|++|..||......+....+......
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            999987543221   122345788999999986543 4788999999999999999999999765544333322111000


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                             ..+.......++..+.++|.+||..||.+|||+.++|+||||
T Consensus       231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                   000011223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3e-40  Score=305.17  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=192.6

Q ss_pred             cceEEEEee--ccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIV--GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ++|.+.+.+  |+|+||.||++.++.++..+|+|.+...... ..|+.....+ +||||+++++++..     ...+++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEE
Confidence            356666665  9999999999999999999999998654211 2234333333 79999999988843     3358899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||++ ++|.+.+..    ...+++..+..++.||+.||.|||+. |++||||||+||+++.++..++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99997 577666653    34899999999999999999999986 9999999999999998765799999999875532


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-LVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .   ....++..|+|||++.+. .++.++|+||||+++|+|++|..||........ ...+......+            
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  226 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK------------  226 (267)
T ss_pred             C---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc------------
Confidence            2   234678899999999654 488999999999999999999999985543322 11111111000            


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-HHHHhCCCCccC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-ALDALIHPFFDE  359 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-~~ell~hp~f~~  359 (409)
                                    ...+..+++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus       227 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 --------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          0122357899999999999999999996 599999999973

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=304.71  Aligned_cols=246  Identities=31%  Similarity=0.505  Sum_probs=194.1

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHH-HHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..+|+.||+|.+.....       ....|..+ ...++|+|++++++++.     ....+++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999999864321       11233333 34458999999998883     334588999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+++ +|..++..    ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 66666543    45789999999999999999999986 999999999999999887 899999999875432 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                        .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.....                
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  210 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI----------------  210 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence              23456788999999986654 88999999999999999999999987766554444332110                


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCccCCCC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---ALDALIHPFFDELRD  362 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s---~~ell~hp~f~~~~~  362 (409)
                               .+.......+++.+.++|.+||+.||++||+   +.|++.||||+++.+
T Consensus       211 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         211 ---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                     0111122347899999999999999999995   579999999988765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.7e-40  Score=303.81  Aligned_cols=250  Identities=28%  Similarity=0.467  Sum_probs=194.4

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ......||+|+||.||+|.+..++..||+|.+....    ....+|+.+++.++|+||+++++++.     ...+.++|+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEE
Confidence            334468999999999999999999999999886432    34568999999999999999999873     345588999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRM--PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||+. ++|.+.+...   ...+  ++..+..++.||+.||.|||+. ||+||||||+||+++.+...++|+|||.+....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9998 4676666532   1334  7888889999999999999986 999999999999998744489999999987553


Q ss_pred             cCC-CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.................            
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  228 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------------  228 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc------------
Confidence            322 22334578899999998543 3478899999999999999999999975433221111000000            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                    ....++..+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus       229 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 --------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             --------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                          0011345578999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.3e-40  Score=311.07  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=202.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|.+....       ..+.+|+++++.++||||+++.+++..     ...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            46999999999999999999999999999999885321       235579999999999999999998853     334


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .++|+||+.+++.+.+...   ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999998877766432   35689999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          224 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....   ....+++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.......+...  .++       
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-------  232 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP-------  232 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC-------
Confidence            4322   34567889999998742  344788999999999999999999999876654443332211  000       


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        ...+...+..+.++|.+||..||.+||++.+++.||||..-
T Consensus       233 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         233 ------------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ------------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                              00122357889999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.2e-40  Score=301.43  Aligned_cols=250  Identities=31%  Similarity=0.478  Sum_probs=206.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||.|+||.||++.+..+++.||+|++....      ....+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            5899999999999999999999999999999986432      345679999999999999999988743     35588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+++ +|...+.........+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 77777765443357899999999999999999999986 999999999999999877 8999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||......+..........            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------  220 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence            4433 22345678899999998654 488999999999999999999999977665444443322100            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                      ..++...+..+.+++.+||..+|.+|||+.++|+||||
T Consensus       221 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ----------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            01334578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-40  Score=320.53  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-----cEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|     ..||+|.+....     ....+|+++++.+ +|+||+++++++.   
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence            3457999999999999999999865443     579999986532     2345799999999 8999999999873   


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhh----------------------------------------------------
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNK----------------------------------------------------  164 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----------------------------------------------------  164 (409)
                        ....+++||||+. |+|.+.+.....                                                    
T Consensus       113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence              3344789999998 567666643211                                                    


Q ss_pred             --------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          165 --------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       165 --------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                                    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcce
Confidence                          113478888999999999999999986 999999999999999877 8999999998765433221


Q ss_pred             ---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          231 ---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       231 ---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                         ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||........+........               
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---------------  332 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---------------  332 (374)
T ss_pred             eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc---------------
Confidence               122345679999998654 48999999999999999997 9999987654443333322110               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                  ....+...++++.++|.+||+.||.+|||+.++++
T Consensus       333 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 ------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00123346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-40  Score=308.43  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=201.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .|...+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.++||||+++++++.     +..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            5888899999999999999999999999999886432     24567999999999999999999883     3446899


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999985 6655554     35688999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------  217 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------
Confidence            3322 2234578889999998654 4899999999999999999999999876544333221110  0            


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                    ...++..++..+.+++.+||..+|++||++.+++.||||....
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                          0112334678899999999999999999999999999997653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.4e-40  Score=302.41  Aligned_cols=245  Identities=28%  Similarity=0.451  Sum_probs=199.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +|.+.+.||.|+||.||++.+..+++.+|+|.+....     ....+|+.+++.++|+||+++++.+     ....++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            4889999999999999999999999999999885322     3445789999999999999999987     34446889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+++ ++.+.+...  ....+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999984 666655432  245689999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....             
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-------------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence            322 23345688899999998554 489999999999999999999999987665554444332110             


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                     ...+..++..+.+||.+||+.||.+|||+.+++.-
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           01234578899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=320.51  Aligned_cols=248  Identities=19%  Similarity=0.264  Sum_probs=196.6

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+...+...||+|.||+||+|++..   .||||++..+.      +.+..|+.++++-+|.||+-+.|++     ..+
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p  460 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNP  460 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCC
Confidence            334456778899999999999999844   49999996542      4567899999999999999999988     444


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+ .||+-+|+| +|+..+...   ...|.....+.|++||+.|+.|||.+ +|||||||..||++.+++ .|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEecccc
Confidence            44 799999997 666666543   36788889999999999999999997 999999999999999886 999999999


Q ss_pred             cccccc---CCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVK---GEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~---~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +....-   ........|...|||||+++-  ...|++++|||||||++|||+||..||...+..+.+..+-++...|..
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            865422   222345567888999999953  234899999999999999999999999955544444433333222221


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .                        ......++++++|+..||.+++++||+..++|.
T Consensus       615 s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 S------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             h------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1                        122346789999999999999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=319.97  Aligned_cols=269  Identities=26%  Similarity=0.415  Sum_probs=231.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+..++..||-||||.|-++........+|+|++++.       ......|-++|..+..|.||++|..|     .+..|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            3567778899999999999987666556899988653       23345788999999999999999998     78888


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|+.||-|- |.++..+..    .+.+.+..++.++..+++|++|||++ |||+|||||+|.+++.+| .+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhhHH
Confidence            999999876 567766665    67899999999999999999999986 999999999999999998 89999999999


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....+....++||||.|.|||++.... ...++|.||||+++|||++|.+||.+.+....+..|.+++...         
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------  638 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------  638 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence            999999999999999999999997654 7899999999999999999999999999999999999875321         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCCCC--CCCCCCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPNAR--LPSGRFLPP  375 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~~~--~~~~~~~~~  375 (409)
                                        .+|..++..+.+||+++...+|.+|..     +.++-+|-||.+..|.-.+  ...++++|+
T Consensus       639 ------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~  700 (732)
T KOG0614|consen  639 ------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPS  700 (732)
T ss_pred             ------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcccc
Confidence                              156778999999999999999999985     8999999999998886443  233444555


Q ss_pred             CCC
Q 015298          376 LFN  378 (409)
Q Consensus       376 ~~~  378 (409)
                      +.+
T Consensus       701 va~  703 (732)
T KOG0614|consen  701 VAN  703 (732)
T ss_pred             CCC
Confidence            544

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-40  Score=310.96  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=201.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .|.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++..     ....+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            355566899999999999999999999999998532    2345578999999999999999998743     3457899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +||+++ +|...+.     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999985 5544433     35689999999999999999999986 999999999999999887 899999999865433


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+.+..+...   +..          
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~----------  235 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP----------  235 (297)
T ss_pred             ccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC----------
Confidence            22 22345688999999998654 4899999999999999999999999876655544333211   000          


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                 .  ......++..+.++|.+||+.||.+||++.++++||||.+...+
T Consensus       236 -----------~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         236 -----------K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             -----------C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence                       0  00123468899999999999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-40  Score=319.58  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=192.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|++....     ....+|+.+++.+ +||||+++++++.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            45799999999999999999974     3467789999986432     2345799999999 8999999999873    


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhh-----------------------------------------------------
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  164 (409)
                       .....++||||++ |+|.+.+.....                                                     
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             3334789999998 567666653210                                                     


Q ss_pred             ------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          165 ------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       165 ------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                                        ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              012478888999999999999999986 999999999999999876 899999999876543


Q ss_pred             CCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          227 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       227 ~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||..........+......           
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------  334 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----------  334 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-----------
Confidence            3221   122345679999999654 48999999999999999998 8999987655444333322110           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                      ....+...+.++.+||.+||+.||++|||+.++++.
T Consensus       335 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         335 ----------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                            001223457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.5e-41  Score=311.66  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .|...+.||+|+||.||+|.+..++..||+|.+....     ..+.+|+++++.++||||+++++++.     .....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            4777889999999999999999999999999886432     24568999999999999999999883     3445789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999995 5555443     35789999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3321 2234578889999998654 4889999999999999999999999765443322211110               


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                   ....+....+..+.++|.+||..+|.+|||+.++++||||.....
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         217 -------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                         000123356889999999999999999999999999999987543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-39  Score=299.63  Aligned_cols=248  Identities=31%  Similarity=0.544  Sum_probs=197.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ..+.+|+.+++.++|+||+++++.+     .....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            5899999999999999999999999999999986543      2445799999999999999998876     3344578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999984 66665543    45688999999999999999999986 999999999999999877 8999999998765


Q ss_pred             ccCCCC-----ccccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          225 VKGEPN-----ISYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       225 ~~~~~~-----~~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ......     ....+++.|+|||.+.+..  .++.++||||||+++|+|++|..||............... +.++   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            433221     1245688999999986433  3788999999999999999999999765433222221111 1000   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCC--CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                             .++.  .++..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                   0111  358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-40  Score=307.81  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=200.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|.+.+.||+|++|.||+|.+..+++.||+|.+....     ....+|+.++.+. .||||+++++++.     ...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence            3467999999999999999999999999999999986432     2234566656555 5999999999884     344


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..+++|||+++.+..++...   ...+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .++|+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            58899999988776665542   357899999999999999999999734999999999999999887 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHH
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  298 (409)
                      ............++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||..... .+.+..+...   ..    
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~----  236 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP----  236 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence            65444433445578889999998543   2378899999999999999999999965332 2222222211   00    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                  +..       .....++.++.+||.+||..||.+||++.+++.||||....
T Consensus       237 ------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         237 ------------PSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ------------CCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                        000       01113688999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.2e-40  Score=301.42  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            46999999999999999999999999999999987553   23567999999999999999998773     33447899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||++ ++|.+.+...  ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 5676666432  235688999999999999999999986 999999999999999887 899999999876543


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            3221  122235679999988554 48899999999999999998 999998766554433332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                     ....+..++.++.++|.+||..||++|||+.++++
T Consensus       223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                           01134557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=306.21  Aligned_cols=251  Identities=28%  Similarity=0.493  Sum_probs=200.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcC---CCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++.     ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            478889999999999999999999999999988543     234567889999986   999999999874     3345


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||+.+ +|.+++.     ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999985 5655543     24789999999999999999999986 999999999999999877 89999999987


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||...........+...  .         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~---------  218 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--K---------  218 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--C---------
Confidence            6644332 334568889999999876666789999999999999999999999765543322211100  0         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                              .+        .......+.++.+++.+||..||.+||++.++++||||++..
T Consensus       219 --------~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         219 --------PP--------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             --------CC--------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                    00        001112678999999999999999999999999999998654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-40  Score=306.75  Aligned_cols=255  Identities=28%  Similarity=0.422  Sum_probs=200.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+|++.+.||+|+||+||++.+..+|+.||+|++....     ..+.+|+++++.++||||+++++++.     ....++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            47999999999999999999999999999999876432     34567999999999999999999884     335588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|...+..    .+.+++..+..++.|++.||.|||+..+|+||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999995 55554433    457899999999999999999999744899999999999999887 8999999998654


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCCHHH
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-------LVEIIKVLGTPTREE  297 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~i~~~~~~~~~~~  297 (409)
                      ... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......+.       +...........   
T Consensus       155 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         155 INS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            322 22345789999999998654 588999999999999999999999986543211       011111100000   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                          ........++.++.+|+.+||+.||.+|||+.++++||||.+-
T Consensus       230 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 --------------------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             --------------------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                                0000111267889999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-40  Score=309.03  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=202.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+....    ....+|+.+++.++|||++++++.+..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            468999999999999999999999899999999985332    334678999999999999999998743     33478


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+.+ +|.+.+.     ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 6655554     24678889999999999999999986 999999999999999887 8999999987654


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+... .++.++|+|||||++|+|++|..||...+..+....+.. .+.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~----------  233 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------  233 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence            3322 22334678889999998654 478999999999999999999999976654333222111 0000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                     ....+..++..+.++|.+||..+|.+||++.+++.||||+..+
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         234 ---------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                           0002334678999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6e-40  Score=301.79  Aligned_cols=243  Identities=31%  Similarity=0.553  Sum_probs=198.0

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||+|+||.||++.+..+|+.+++|.+....       ....+|+++++.++||||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999999999999986542       2345788999999999999998877     3445588999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC--
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  228 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~--  228 (409)
                      .+ +|.+++..    ...+++..+..++.||+.||.|||+. |++||||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            85 77666654    34789999999999999999999986 999999999999999888 89999999987553331  


Q ss_pred             -------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          229 -------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       229 -------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                             ......++..|+|||.+.... .+.++|+||||+++|+|++|..||......+....+...  ...       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------  219 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE-------  219 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC-------
Confidence                   122345678899999986544 889999999999999999999999877655554443321  000       


Q ss_pred             CCCccccccCcccCCCCcccCCC--CCChhHHHHHHHhcccCCCCCCCH---HHHhCCCCccCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA---LDALIHPFFDELRD  362 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~L~~dp~~R~s~---~ell~hp~f~~~~~  362 (409)
                                          .+.  .++..+.+++.+||+.+|.+|||+   .++|+||||+++.+
T Consensus       220 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         220 --------------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             --------------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                                111  148899999999999999999999   99999999987653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=304.11  Aligned_cols=253  Identities=31%  Similarity=0.483  Sum_probs=202.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .|...+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++||||+++++++..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            4666689999999999999999999999999885332    234678999999999999999998743     3447899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +||+.+ +|.+.+..     ..++...+..++.|++.||.|||++ ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 66555542     5689999999999999999999986 999999999999999887 899999998765433


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .. ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.... .+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC-----------
Confidence            22 122356889999999986544 8899999999999999999999998766555444333210 000           


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                    ...+..++..+.+||.+||..||++|||+.++++||||++.+++
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         235 --------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             --------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                          00122367899999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.3e-40  Score=302.81  Aligned_cols=244  Identities=21%  Similarity=0.238  Sum_probs=192.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|.+.+.||+|+||.||+|.++   ..+..||+|.+....     ..+.+|+.+++.++||||+++++++..     ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence            46999999999999999999865   456789999986542     234579999999999999999998743     33


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||+++ +|.+.+...   ...+++..++.++.||+.||+|||+. |++||||||+||+++.++ .++++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            47899999996 555555431   35789999999999999999999986 999999999999999887 8999999987


Q ss_pred             cccccCCCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          222 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       222 ~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ..........  ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||...+..+.+..+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------  227 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------  227 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence            6542221111  2234578999999865 458999999999999999775 99999887766554444221100      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                            ..+..++..+.+++.+||+.+|.+|||+.++++
T Consensus       228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                  123457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.9e-40  Score=301.63  Aligned_cols=250  Identities=29%  Similarity=0.434  Sum_probs=197.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            47999999999999999999999999999999875321       234579999999999999999998743     234


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++++||+++ +|..++.........+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 77777765544456689999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhh
Q 015298          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       223 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ....... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..+.......+.++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543222 2234678899999998654 4789999999999999999999999654321 12222211111111      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                          ......+..+.++|.+||..+|.+||++.++++.
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                                0122467889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=299.24  Aligned_cols=249  Identities=28%  Similarity=0.490  Sum_probs=200.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+..+         ...+.+|+++++.++|+||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            3699999999999999999999999999999987432         12345799999999999999999876432   23


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++++||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            346799999985 66666543    35688999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ++.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++..   .+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---  225 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---  225 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC---
Confidence            8754321    112235678899999998654 478999999999999999999999987655444333221   11   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                           ....++..+++.+.++|.+||. +|..||++.++++|||.
T Consensus       226 ---------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 ---------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                 1112566789999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-40  Score=316.49  Aligned_cols=278  Identities=21%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             EeeccC--CceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ..||.|  +||+||+|.+..+|+.||+|++....      +.+.+|+.+++.++||||+++++++.     ...+.++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            356666  99999999999999999999986432      34467888999999999999999884     334578999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+.+ ++.+++....  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99984 6666665432  34689999999999999999999986 999999999999999887 8999999865332211


Q ss_pred             CCC--------ccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--
Q 015298          228 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--  296 (409)
Q Consensus       228 ~~~--------~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~--  296 (409)
                      ...        ....++..|+|||++.+. ..++.++|||||||++|+|++|..||......+............+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            110        012235669999998653 347899999999999999999999998776655544443321111100  


Q ss_pred             -------HHhhcCCCcc----cccc-----CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          297 -------EIKCMNPNYT----EFKF-----PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       297 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                             .+........    +...     .......+........++.+.+||++||+.||++|||+.++|+||||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    0000     00000111111233467889999999999999999999999999999876


Q ss_pred             CCC
Q 015298          361 RDP  363 (409)
Q Consensus       361 ~~~  363 (409)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-39  Score=303.70  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=198.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ...+|.+.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++||||+++++++.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            35689999999999999999997652     34589999875432     23456889999999999999998873    


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~  211 (409)
                       .....++||||+. |+|.+.+......      ....+...+..++.|++.||.|||++ ||+||||||+||+++.++ 
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-  156 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-
Confidence             2334789999998 5777777643211      13346678889999999999999986 999999999999999887 


Q ss_pred             cEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015298          212 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  287 (409)
                      .++|+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   1122346679999998654 48999999999999999998 789998766555443332


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC------CCCccCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI------HPFFDELR  361 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~------hp~f~~~~  361 (409)
                      .. +.+                           ..+...++.+.+++.+||+.||++|||+.++++      ||||..+.
T Consensus       236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            11 000                           023346789999999999999999999999986      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.5e-40  Score=304.08  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      -|.+.+.||+|+||.||+|.+..+++.||+|.+....     ..+.+|+.+++.++||||+++++++.     ...+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            4788899999999999999999999999999875332     34567999999999999999999883     3445789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|...+.     ...++...+..++.|++.|+.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999985 5555543     35689999999999999999999986 999999999999999887 89999999987553


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...  .+           
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP-----------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----------
Confidence            322 12234678889999998653 4788999999999999999999999765544333322110  00           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                     ..++..++.++.+++.+||..+|.+||++.++++||||.+..
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                           012345788999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-40  Score=305.84  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=197.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCC-----cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46999999999999999999976655     689999886432     23567999999999999999998873     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      ....+++|||++ ++|.+.+.....            ....+++..+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEc
Confidence            334789999998 577776654321            115688889999999999999999996 999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015298          208 PHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (409)
                      .++ .++|+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 89999999987543322   12234557889999998654 48999999999999999998 99999887766655


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ..+.+...                            ...+..+++++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            44432110                            01344578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-39  Score=296.69  Aligned_cols=250  Identities=35%  Similarity=0.537  Sum_probs=202.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|...+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++.+....   ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4888999999999999999999999999999986543      34567999999999999999988874321   25578


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +++||++ ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 566666554    34889999999999999999999996 999999999999999877 8999999998876


Q ss_pred             ccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55443   34566788999999986544 89999999999999999999999977652111  1111100          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                    ......++...+..+.+||.+||..||.+||++.+++.||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000111445678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-39  Score=303.89  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=201.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--------hhhHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|++....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999975   478999999986421        3345799999999 599999998877     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999995 56555543    46788999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCC--CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          219 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       219 g~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |++.......  ......|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+...+...  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987654322  22245678899999998543 246789999999999999999999997543322222222211000  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                             ...++..+++.+.+++.+||..||.+|+     ++.++++||||+...+.
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                                   0013445788999999999999999997     89999999999988654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=349.50  Aligned_cols=252  Identities=29%  Similarity=0.505  Sum_probs=206.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+.++.....||.|.||.||-|.+..+|+..|+|-++-.      .....+|..++..++|||+|+++++-...+.    
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek---- 1308 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK---- 1308 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH----
Confidence            345788889999999999999999999999999977422      2445689999999999999999887643332    


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                       ++|.||||. |+|.+++.+    ++..++...+.+..|++.|+.|||++ |||||||||.||+++.+| .+|++|||.|
T Consensus      1309 -v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1309 -VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGSA 1381 (1509)
T ss_pred             -HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeecccce
Confidence             678999999 577777765    55677777888999999999999998 999999999999999888 8999999999


Q ss_pred             cccccCC-----CCccccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCC
Q 015298          222 KVLVKGE-----PNISYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTP  293 (409)
Q Consensus       222 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~  293 (409)
                      ..+.+..     ......||+.|||||++.+..  ....+.||||||||+.||+||+.||...++ ...+.....+ ..|
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h~P 1460 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-HKP 1460 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-CCC
Confidence            8775543     234678999999999996543  356789999999999999999999976543 3443333221 111


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                                 .+|+++|.+.++||..||+.||++|+++.|+++|-|=+.
T Consensus      1461 ---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 ---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             ---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                                       267789999999999999999999999999999988654

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.6e-40  Score=308.84  Aligned_cols=272  Identities=21%  Similarity=0.299  Sum_probs=192.3

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccc-hhH
Q 015298           83 SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETV  155 (409)
Q Consensus        83 ~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  155 (409)
                      ++|.||++++..+++.||+|++....      ..+.+|+++++.++|+||+++++++.     .....+++|||++ +++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence            44556666666799999999986541      34568999999999999999999884     3344789999999 466


Q ss_pred             HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC------
Q 015298          156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP------  229 (409)
Q Consensus       156 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~------  229 (409)
                      .+++....  ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||.+........      
T Consensus        87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeeccccccccccc
Confidence            66665432  35689999999999999999999986 999999999999999887 899999998865432211      


Q ss_pred             --CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--HHhhcCCC
Q 015298          230 --NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--EIKCMNPN  304 (409)
Q Consensus       230 --~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~  304 (409)
                        .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||......................  ........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence              1234467789999998553 347889999999999999999999998765544333222111000000  00000000


Q ss_pred             ccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          305 YTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       305 ~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ...   ..................++.++.+|+.+||..||++|||+.++|+||||+.++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence            000   00000001111122233456789999999999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-39  Score=294.89  Aligned_cols=248  Identities=31%  Similarity=0.512  Sum_probs=202.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+++++.++|+|++++++++..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            4888999999999999999999899999999986544    456689999999999999999998743     3447899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +||++ ++|.+.+...   ...+++..+..++.|++.||.+||+. |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5666655432   25789999999999999999999986 999999999999999877 899999999877655


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+... ..+.            
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------  216 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------  216 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence            44334567788999999986544 889999999999999999999999876544444333221 0000            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                                   ......++..+.++|.+||+.||++|||+.++++|||
T Consensus       217 -------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 -------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                         0011124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-39  Score=296.61  Aligned_cols=249  Identities=28%  Similarity=0.455  Sum_probs=204.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||++.+..+++.+|+|.+...      .....+|+++++.++|+||+++.+++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            489999999999999999999999999999998642      1234578999999999999999988843     35588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+||+++ +|...+.........+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999974 67777765544457789999999999999999999986 999999999999999877 8999999999776


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            544 3334567889999999865 447889999999999999999999998776544333322110              


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                           ++         ..+...+.++.+++.+||..+|.+|||+.+++.||++
T Consensus       218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 00         0223468899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3e-39  Score=305.43  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=201.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|...+.||+|+||.||+|.+..+|+.|++|.+....       ....+|+++++.++|||++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            4777888999999999999999999999999985321       234578999999999999999998843     3457


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.+++...+..   ....+++..+..++.||+.||.|||++ ||+|+||+|+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            89999999887766543   245689999999999999999999986 999999999999999887 8999999998643


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .   ......++..|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+.... .+         
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------  238 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP---------  238 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC---------
Confidence            2   2234578889999999842  2447889999999999999999999998776555554433210 00         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                       ......++..+.+|+.+||+.+|.+||++.+++.||||+..
T Consensus       239 -----------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 -----------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                             00122357789999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-39  Score=301.90  Aligned_cols=245  Identities=33%  Similarity=0.614  Sum_probs=202.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (409)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+++++.+. ||||+++++++     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            699999999999999999999999999999998642       234457889999998 99999999887     34445


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||+. ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 677666654    45799999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCC---------------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015298          223 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (409)
Q Consensus       223 ~~~~~~~---------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (409)
                      .......                     .....++..|+|||.+... .++.++|+||||++++++++|..||.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5533221                     1234567889999998654 48899999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCc
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFF  357 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f  357 (409)
                      ....+...                             ...++..+++.+.+||.+||..||.+|||+    .++++||||
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44433321                             011345578999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-39  Score=301.60  Aligned_cols=250  Identities=22%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|.+....     ..+.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4568999999999999999999864     245789999885432     2345789999999999999999887     


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~  211 (409)
                      ......++||||+. ++|.+.+......      ...++...+..++.|++.||.|||+. |++||||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-
Confidence            33344789999998 5777776542211      12356778889999999999999986 999999999999999887 


Q ss_pred             cEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015298          212 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  287 (409)
                      .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            899999999875433221   1123446789999998654 48999999999999999999 789998776554444332


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ... .                           ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EGG-L---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCC-c---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            210 0                           01234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=294.56  Aligned_cols=246  Identities=36%  Similarity=0.608  Sum_probs=202.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+....      ....+|++++++++|+|++++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4889999999999999999999999999999986543      23567999999999999999988873     334588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++|||+++ +|.+.+..    ...+++..++.++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999985 66665543    36789999999999999999999986 999999999999999877 8999999998766


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...  .           
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  215 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--D-----------  215 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--C-----------
Confidence            44332 23456788999999986544 889999999999999999999999766544333332210  0           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                     ...++..+++.+.+++.+||..+|++|||+.+++.||||
T Consensus       216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                           011345678999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-39  Score=311.52  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=193.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence            3458999999999999999999754     345789999986432     2345699999999 899999999877532 


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhh----------------------------------------------------
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNK----------------------------------------------------  164 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------  164 (409)
                         ...++++|||+.+ +|.+.+.....                                                    
T Consensus        84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence               2347799999984 66666643211                                                    


Q ss_pred             -----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC---Ccccccc
Q 015298          165 -----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICS  236 (409)
Q Consensus       165 -----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt  236 (409)
                           ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++........   .....++
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCC
Confidence                 123688899999999999999999986 999999999999999887 899999999976533221   1223446


Q ss_pred             ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccC
Q 015298          237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  315 (409)
Q Consensus       237 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (409)
                      ..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........                       
T Consensus       239 ~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------  294 (337)
T cd05054         239 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-----------------------  294 (337)
T ss_pred             ccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-----------------------
Confidence            779999998664 48999999999999999998 99999875544433332221000                       


Q ss_pred             CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          316 HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       316 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                          ...+...++++.+++.+||+.+|.+||++.++++|
T Consensus       295 ----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 ----MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                01233467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-39  Score=303.36  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=197.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ..+.+|+++++.++|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            3469999999999999999998743     46889999986532     3456799999999999999999988433   


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhh----------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFN----------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                        ...++||||++ ++|.+.+....          .....+++..+..++.|++.||.|||++ ||+||||||+||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~  157 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGY  157 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcC
Confidence              44789999998 46766665431          1234578889999999999999999986 9999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015298          209 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (409)
Q Consensus       209 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (409)
                      ++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            87 899999999875432221   2233457789999998654 48999999999999999998 999998777665544


Q ss_pred             HHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+.....                            ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4432110                            0123357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3e-39  Score=332.97  Aligned_cols=142  Identities=26%  Similarity=0.440  Sum_probs=123.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.++||||++++.++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            357999999999999999999999999999999986532       4556789999999999999998776     3344


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      +++|||||+. ++|..++..    ...+++..++.|+.||+.||.|||.. ||+||||||+|||++.++ .+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence            5899999997 567666653    45789999999999999999999986 999999999999999887 8999999987


Q ss_pred             c
Q 015298          222 K  222 (409)
Q Consensus       222 ~  222 (409)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-39  Score=307.25  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=192.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcE--EEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+..++..  +|+|.+...     ...+.+|++++.++ +|+||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            45799999999999999999999887764  577766532     12345799999999 899999999987     334


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                      .++++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||+. ||+||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecC
Confidence            45789999997 577777654321            123688999999999999999999986 9999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015298          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       209 ~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  287 (409)
                      ++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |..||...+..+....+.
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            87 8999999998643222112222335679999988554 48899999999999999998 999998766554433221


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...                            ....+..+++++.+||.+||+.||++||++.+++.+
T Consensus       238 ~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            000223468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-39  Score=303.03  Aligned_cols=253  Identities=30%  Similarity=0.450  Sum_probs=201.0

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      |.....||+|+||.||++.+..+|+.||+|++....    ....+|+.+++.++|+||+++++.+..     ..+.++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            444568999999999999999999999999875322    235579999999999999999998843     34578999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+++ +|.+.+.     ...+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 4544432     35689999999999999999999986 999999999999999887 7999999988655332


Q ss_pred             C-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          228 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       228 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      . ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+....+....+.......             
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------  235 (292)
T ss_pred             cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence            2 2234567889999998854 447899999999999999999999998766554443332211000             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                                 +  .....++..+.+++.+||..||.+||++.+++.||||.+...++
T Consensus       236 -----------~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         236 -----------L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             -----------c--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence                       0  01124688999999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-39  Score=304.85  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=192.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc--EEEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|.+.+.||+|+||.||+|.+..++.  .+++|.++..     .+.+.+|+.++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            369999999999999999999887765  4688877632     13456799999999 7999999998873     334


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~  209 (409)
                      .+++++||++ ++|.+.+.....            ....+++..++.++.|++.||+|||++ ||+||||||+||+++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            5789999998 577777754221            123588899999999999999999986 99999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015298          210 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       210 ~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  288 (409)
                      + .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 8999999998643222111222234569999998654 48999999999999999997 9999987766555444322


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...                            ...+..++..+.+||.+||..||.+|||+.++++.
T Consensus       234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            110                            01234578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-39  Score=302.08  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=195.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||+||++.+.     .++..+|+|.+....    ....+|+++++.++||||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            347999999999999999999853     355679999886432    34567999999999999999998873     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFN---------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      ..++++||||++ ++|.+++....         .....+++..+..++.|++.||+|||++ |++||||||+||+++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC
Confidence            345789999998 57766665422         1123589999999999999999999986 999999999999999887


Q ss_pred             CcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015298          211 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  286 (409)
                       .++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+
T Consensus       158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             -cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             899999999875533221   122344678999999865 458999999999999999998 99999877665554444


Q ss_pred             HHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ......                            ..+...+.++.+|+.+||+.||.+|||+.+++.
T Consensus       236 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCCcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            331100                            023347889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.2e-39  Score=333.23  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=193.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ++|.+.++||+|+||.||+|.+..+|+.||+|++..+.       ....+|+++++.++||||+++++++.     ....
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            47999999999999999999999999999999986431       23457999999999999999998873     3445


Q ss_pred             EEEEEeccch-hHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNK-------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                      .+++|||++| +|.+.+.....       ....++...+..++.||+.||+|||++ ||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            7899999985 67777654321       123456677888999999999999986 999999999999999887 8999


Q ss_pred             eecCCccccccCC-------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015298          216 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (409)
Q Consensus       216 ~Dfg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (409)
                      +|||++.......                   .....+||+.|+|||.+.+. .++.++|||||||++|+|+||..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997651110                   01124689999999998654 489999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .........  .....|..  .                 .     -...+++.+.+++.+||..||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~~--~-----------------~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPIE--V-----------------A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChhh--c-----------------c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            543322211  11111100  0                 0     012478899999999999999999987766543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=299.29  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=195.0

Q ss_pred             eEEEEeeccCCceEEEEEEEcC---CCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           73 YMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      |.+.+.||+|+||.||+|....   ++..||+|.+..+.      ....+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998765   34789999986542      234578999999999999999987754433 3344


Q ss_pred             EEEEEEeccc-hhHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      +.++++||+. ++|...+....  .....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            5789999998 46666664432  1234689999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....  .  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~--  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R--  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C--
Confidence            9976543321   112234567999999854 458999999999999999999 999998766555443332210  0  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                              ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-39  Score=298.13  Aligned_cols=249  Identities=23%  Similarity=0.451  Sum_probs=198.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||++.+..++..+++|.++.-         ......|+.+++.++||||+++++++..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            589999999999999999999888777777766421         1234468899999999999999988743     33


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++|+||+.+ +|...+.........+++..++.++.|++.||.|||+. |++|+||+|+||+++. + .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-C-CEeecccCce
Confidence            47899999984 77777765555567899999999999999999999986 9999999999999975 3 6999999998


Q ss_pred             cccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...  ..       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~-------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT-------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence            76543322 234567889999998854 44788999999999999999999999765544433332211  00       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                         ...+..++.++.++|.+||..||.+||++.++++||||
T Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                               01234578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.9e-39  Score=312.63  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=193.8

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCC-----CcEEEEEEeeccc-----hhhHHHHHHHHhcC-CCCeecccceeee
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFS  135 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~  135 (409)
                      .....+|++.+.||+|+||.||+|.+...     +..||+|++....     ..+.+|+++++.+. ||||+++++++. 
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-  111 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT-  111 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc-
Confidence            34456899999999999999999987533     3579999986432     33457999999996 999999999883 


Q ss_pred             cCCCCccEEEEEEeccc-hhHHHHHHHhhh--------------------------------------------------
Q 015298          136 TTDKDELYLNLVLEYVP-ETVHRVVKHFNK--------------------------------------------------  164 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------------------------------------  164 (409)
                          ....++||||||+ |+|.+.+.....                                                  
T Consensus       112 ----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         112 ----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             ----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence                3445889999998 567666643211                                                  


Q ss_pred             ------------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          165 ------------------------------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       165 ------------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                                                                ....+++..+..++.||+.||.|||+. +|+||||||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~  266 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAAR  266 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChH
Confidence                                                      123478888899999999999999986 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (409)
                      ||+++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||....
T Consensus       267 Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         267 NVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             hEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            99999887 899999999876533222   1234456789999998654 48999999999999999997 999998755


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       279 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+...........                           ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus       345 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         345 VDSTFYNKIKSGYR---------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hhHHHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            43333322221000                           0123457889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4e-39  Score=295.59  Aligned_cols=243  Identities=22%  Similarity=0.304  Sum_probs=193.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||.||++..+ ++..+|+|.+...   ...+.+|+.+++.++||||+++++++.     .....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            35899999999999999999875 4567999987643   234567999999999999999998773     33447899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99998 5666655431   34688999999999999999999986 999999999999999887 899999999876533


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            2221  122345679999998654 58999999999999999999 99999887766655554331100           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                       ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             022335788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=291.55  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=213.5

Q ss_pred             CCCCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhc-CCCCeeccccee
Q 015298           62 GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCF  133 (409)
Q Consensus        62 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~  133 (409)
                      +.........+|.+.++||.|+|++|.+++.+.|.+.||+|+++++       ....+.|-.+...- +||.+|.+..||
T Consensus       241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            3344444556899999999999999999999999999999998653       22335666666554 799999999999


Q ss_pred             eecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcE
Q 015298          134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV  213 (409)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~i  213 (409)
                           ..+..+++|.||++|+  +++-+. +...+++++.++.+..+|+.||.|||++ |||+||||.+|||+|.+| .+
T Consensus       321 -----qtesrlffvieyv~gg--dlmfhm-qrqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeg-hi  390 (593)
T KOG0695|consen  321 -----QTESRLFFVIEYVNGG--DLMFHM-QRQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEG-HI  390 (593)
T ss_pred             -----cccceEEEEEEEecCc--ceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCC-ce
Confidence                 6666799999999975  333332 2367899999999999999999999997 999999999999999999 79


Q ss_pred             EEeecCCcccc-ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCCcHHHHHH
Q 015298          214 KLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-------GDSGVDQLVE  285 (409)
Q Consensus       214 kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~-------~~~~~~~~~~  285 (409)
                      ||.|+|+.+.- .++....+++|||.|.|||++++. .|+..+|+|+||++|+||+.|+.||+       ..+..+.+.+
T Consensus       391 kltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  391 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             eecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            99999998753 455667789999999999999775 49999999999999999999999996       2233344444


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC------CHHHHhCCCCccC
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC------TALDALIHPFFDE  359 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~------s~~ell~hp~f~~  359 (409)
                      ++-...                            -.+|..+|-.+..+++..|.+||++|.      ...++..|+||+.
T Consensus       470 vilekq----------------------------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  470 VILEKQ----------------------------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             HHhhhc----------------------------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            322100                            014556788889999999999999997      4678999999999


Q ss_pred             CCCCC
Q 015298          360 LRDPN  364 (409)
Q Consensus       360 ~~~~~  364 (409)
                      +.|..
T Consensus       522 idwd~  526 (593)
T KOG0695|consen  522 IDWDL  526 (593)
T ss_pred             CCHHH
Confidence            88764

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.9e-39  Score=303.52  Aligned_cols=249  Identities=29%  Similarity=0.443  Sum_probs=202.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .|...+.||+|+||.||++.+..+|..+|+|.+....       ..+.+|+++++.++|||++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            4888999999999999999999999999999986431       234578999999999999999998843     3347


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.|++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999998877665432   45689999999999999999999986 999999999999999887 8999999988654


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..   .....+++.|+|||.+..  ...++.++|+|||||++|+|++|..||...........+......+         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234567889999999742  2347889999999999999999999998766555555444321100         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        ......++.+.++|.+||+.+|.+||++.++++|+|+...
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                              0122467889999999999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-39  Score=296.14  Aligned_cols=238  Identities=21%  Similarity=0.296  Sum_probs=186.5

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      +.||+|+||.||+|.+..+++.||+|.+....     ..+.+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            36899999999999999999999999875432     345679999999999999999998743     34478999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      .+ +|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++....+....
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            85 56555542   234688999999999999999999986 999999999999999887 8999999998754332111


Q ss_pred             c---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          231 I---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       231 ~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .   ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+.....               
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence            1   11224569999998654 48899999999999999997 8999976655443332222100               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                   ...+...+..+.+|+.+||+.||++|||+.++++
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0123456889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-39  Score=295.90  Aligned_cols=245  Identities=24%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|++.++||+|+||.||+|.+. ++..||+|.+....   ....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            457999999999999999999964 56779999886532   34567999999999999999988773     3344789


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+. ++|.+.+...  ....++...+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 5777766532  245688889999999999999999986 999999999999999887 89999999997654


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------  223 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            3221  1223346679999998654 48889999999999999998 99999876655554444321110          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        .....++.++.+++.+||..||++|||++++++
T Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 ------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                              012346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-39  Score=299.12  Aligned_cols=251  Identities=21%  Similarity=0.272  Sum_probs=191.9

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCc--EEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+...      .....+|+++++.++|+||++++++++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999887775  6899987543      1334578999999999999999987654322 12234


Q ss_pred             EEEEEeccc-hhHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          144 LNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+++|||+. ++|...+....  .....+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 56665553221  1234588999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||......+....+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            986543321   1223456789999998654 58999999999999999999 8999987665544333322100     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                             ...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   00233567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-39  Score=306.66  Aligned_cols=244  Identities=24%  Similarity=0.368  Sum_probs=191.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcE----EEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGET----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++.+.||+|+||.||+|.+..+|+.    ||+|.+....     +.+.+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4799999999999999999998766654    8999885432     3455789999999999999999887432     


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                       ..+++++|+. |+|.+.+...   ...++...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEccccc
Confidence             1458999988 5666665532   34688889999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ++.........   ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+. ..+......+   
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL---  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC---
Confidence            98764433322   22335679999998654 48999999999999999997 9999987654443 2222210000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                              ..+...+.++.+++.+||..||.+|||+.+++.+
T Consensus       231 ------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    0123467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-39  Score=301.49  Aligned_cols=256  Identities=30%  Similarity=0.458  Sum_probs=207.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ...|.+.+.||+|++|.||+|.+..++..|++|.+....   ....+|+++++.++|+|++++++++...     ...++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            456999999999999999999999899999999997543   3456799999999999999999988443     45889


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ++||++ ++|.+.+....   ..++...+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence            999999 67777776522   3789999999999999999999986 999999999999999887 89999999876543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.... .+.          
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----------  235 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP----------  235 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC----------
Confidence            322 12234578889999998654 48999999999999999999999998766554444332210 000          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                     ...+..++..+.++|.+||+.+|.+|||+.+++.||||.+...
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         236 ---------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             ---------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                           0012236789999999999999999999999999999998544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=294.66  Aligned_cols=285  Identities=35%  Similarity=0.592  Sum_probs=225.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+.+-.+-||-|+||.||.+.|..+|+.||+|++..-      .+...+|+++|..++|.|++...++.-...-..-..+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3455567899999999999999999999999988532      3455689999999999999998876522211111115


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      |+++|.|..+|..++-.    .+.++...++.+.+||++||+|||+. ||.||||||.|.|++++. .+||||||+++..
T Consensus       133 YV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFGLARve  206 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEeccccccccc
Confidence            67888888887777655    67899999999999999999999986 999999999999999998 8999999999876


Q ss_pred             ccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  .+..+.|.+|+|||++.+...|+.+.||||+||++.||+..+..|...+..+++..|...+|+|..+.++...
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            44332  2345668999999999999999999999999999999999999999999999999999999999998776422


Q ss_pred             CCccc-cccCcccCCCCcccC----CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 PNYTE-FKFPQIKAHPWHKIF----PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~~~~~-~~~~~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ..-.. ..-...+...+...+    +..-..+..+++.++|.+||++|.+..+++.|++..+.+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            11110 000111111111111    223456788999999999999999999999999998764

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-39  Score=295.31  Aligned_cols=244  Identities=19%  Similarity=0.276  Sum_probs=193.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||.||+|.+.. +..+|+|.+....   ..+.+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            469999999999999999998754 4569999886542   34567999999999999999999873     23347899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.+ +|.+.+...   ...+++..++.++.||+.||.|||+. |++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999985 566655432   23689999999999999999999986 999999999999999887 899999999876543


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3221  123345679999998654 48899999999999999998 99999877665554444332110           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                       ..+...+..+.+++.+||..||.+|||+.+++.+
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0223467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-39  Score=298.72  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=196.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCC-----CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            45799999999999999999998644     4889999986442     23457899999999999999999873     


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNK------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                      .....++||||++ ++|.+.+.....      ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3345789999997 577777764322      123478888999999999999999986 999999999999999888 8


Q ss_pred             EEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015298          213 VKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  288 (409)
                      +||+|||+++......   ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            9999999987653332   12234457789999998654 48999999999999999998 9999987665554443321


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      . ..                           ..++...+.++.++|.+||+.+|++|||+.++++
T Consensus       237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 G-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0 00                           0134456899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-39  Score=304.39  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=202.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..|...+.||+|+||.||+|++..+++.+|+|.+....       ....+|+++++.++|+|++++.+++..     ...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence            35888899999999999999999999999999885321       234579999999999999999998854     334


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .++||||+.+++...+...   ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCccccee
Confidence            7899999998876665432   35689999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          224 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+..... +        
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------  232 (308)
T cd06634         165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------  232 (308)
T ss_pred             ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C--------
Confidence            533   234567889999999742  23478899999999999999999999977655444433322110 0        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                        .......+..+.+||.+||..+|.+||++.++++|||+.....
T Consensus       233 ------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         233 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence                              0012346788999999999999999999999999999987533

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=312.01  Aligned_cols=261  Identities=26%  Similarity=0.362  Sum_probs=195.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+++|.-.+.||+|+||.||+|... +|..||||++....    +.+.+|++++.+++|||+|+++||+.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            4568888999999999999999964 44899999886533    458899999999999999999999954332    36


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      +||+|||. |+|.+.+......  .+++....+|+.++++||+|||..+.  ||||||||+|||+|.+. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            89999999 6877776642211  88999999999999999999998754  99999999999999998 8999999999


Q ss_pred             ccccc-CCCCccc-cccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH-HhCCCCHH
Q 015298          222 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS--GVDQLVEIIK-VLGTPTRE  296 (409)
Q Consensus       222 ~~~~~-~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~~-~~~~~~~~  296 (409)
                      +.... ....... .||.+|+|||.... ...+.++||||||++|+||+||+.+.+...  ....+..+.. .+...   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            76544 3333333 89999999999865 348999999999999999999998887543  1111222221 11111   


Q ss_pred             HHhhcCCCccccccCcccCCCCc-ccCCC-CCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWH-KIFPK-RMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                  .+..+.+..+. ..++. ..-..+..+..+|++.+|..||+..++++
T Consensus       301 ------------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 ------------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ------------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                        11111111111 11110 11223567788999999999999999754

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-38  Score=293.99  Aligned_cols=248  Identities=32%  Similarity=0.482  Sum_probs=197.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.+...       .....+|+++++.++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            4799999999999999999999999999999988531       2345679999999999999999998843     345


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||+++ +|..++.........+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999984 77777765544456789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV--DQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  299 (409)
                      ...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......  +....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD---------  224 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC---------
Confidence            553322 22345678899999998654 4889999999999999999999999654311  1111111100         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        +........+..+.++|.+||..+|++|||+.++++
T Consensus       225 ------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         225 ------------------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------------------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                              000011246789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-39  Score=298.20  Aligned_cols=250  Identities=30%  Similarity=0.451  Sum_probs=196.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|.+.+.||+|++|.||+|.+..+|+.+|+|.+...       .....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            3688999999999999999999999999999987532       1234579999999999999999998843     335


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++|||+++ +|.+++.........+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 77777765544456789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.....  ....+.+...        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------  223 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQC--------  223 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhcC--------
Confidence            6543322 2245688899999998654 48899999999999999999999997543221  1111111000        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                             .        +....+...++.+.++|.+||..||++|||+.++++
T Consensus       224 -------~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 -------D--------YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -------C--------CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                   0        000112347889999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.7e-39  Score=297.68  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|++|.||+|.+..     ++..||+|.+....     ..+.+|+.+++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4579999999999999999999987     77899999886432     2356789999999999999999877432   


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcE
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQV  213 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~i  213 (409)
                        ...++||||+. ++|.+++.....   ....+++..+..++.||+.||.|||++ +++||||||+||+++.++  ..+
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcce
Confidence              33679999997 577777765321   123588999999999999999999986 999999999999998653  259


Q ss_pred             EEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015298          214 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV  289 (409)
Q Consensus       214 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  289 (409)
                      ||+|||+++.......   ......+..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999876532211   1122234679999998654 48999999999999999997 99999876655443322211


Q ss_pred             hCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                       ..                           ...+..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             00                           01244578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.3e-39  Score=299.84  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=193.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEc----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++.+.||+|+||+||+|.+.    .++..+|+|.+....     ..+.+|+++++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            46899999999999999999853    456789999986422     345679999999999999999988743     3


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhh-------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFN-------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      ...++||||++ ++|.+.+....             .....+++..+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEc
Confidence            34789999998 46766664221             0123478888999999999999999986 999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015298          208 PHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (409)
                      .++ .+||+|||+++......   ......++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 89999999997653322   12233456679999998654 48999999999999999998 99999876654443


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ..+.... .                           ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3332210 0                           01334578999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-39  Score=294.43  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             EeeccCCceEEEEEEEcCC---CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999866   8999999986543     345679999999999999999988743     44578999


Q ss_pred             eccc-hhHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          149 EYVP-ETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ||+. ++|.+.+......     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6777776653221     37799999999999999999999986 999999999999999887 89999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       223 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ......   ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            765432   23345568889999998654 58999999999999999999 699998876555544433210        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                          ....+..++.++.+++.+||..||.+|||+.+++++
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                111344578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=293.23  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|++.+.||+|++|.||+|.+. +++.||+|.+....   ..+.+|+.+++.++||||+++++++..     ....++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeee
Confidence            457999999999999999999975 45789999986542   345679999999999999999987632     334789


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+. ++|.+.+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIK  154 (261)
T ss_pred             eeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEcc
Confidence            999995 67777665422  35689999999999999999999986 999999999999999887 89999999998664


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+....+....+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------  223 (261)
T ss_pred             CCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32211  111223579999988654 48999999999999999999 99999877655554444321100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+..+.+++.+||+.||.+||++.+++.
T Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                              123346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=291.08  Aligned_cols=238  Identities=35%  Similarity=0.584  Sum_probs=196.0

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ||.|+||.||++.+..+++.+|+|.+....       .....|+.+++.++|+||+++++.+     ......++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999999899999999986532       2456789999999999999999887     4455689999999


Q ss_pred             c-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC-CC
Q 015298          152 P-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  229 (409)
Q Consensus       152 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~-~~  229 (409)
                      . ++|.+.+..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 677666654    34789999999999999999999986 999999999999999887 8999999998765443 22


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccc
Q 015298          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (409)
Q Consensus       230 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  309 (409)
                      .....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||......+....+..  .                  
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~------------------  208 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D------------------  208 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C------------------
Confidence            3455678899999998654 478899999999999999999999976665333333322  0                  


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH---HHHhCCCCc
Q 015298          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA---LDALIHPFF  357 (409)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~---~ell~hp~f  357 (409)
                               ...++..++..+.++|.+||..||++||++   .++++||||
T Consensus       209 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 ---------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                     001344568999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-39  Score=294.27  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=192.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .++|.+.++||+|+||.||+|.+..++ .||+|.+....   ....+|+++++.++||||+++++.+.     . .+.++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEE
Confidence            457999999999999999999986654 59999986532   34567999999999999999987652     1 22579


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~  153 (262)
T cd05071          78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  153 (262)
T ss_pred             EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeecc
Confidence            9999984 776666532  234678899999999999999999986 999999999999999887 89999999997654


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  ....++..|+|||...+. .++.++|+|||||++|+|++ |..||......+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------  222 (262)
T ss_pred             ccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------
Confidence            33221  123456679999988544 48999999999999999999 89999877665554443221100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+..++..+.+++.+||+.||.+||++.++++
T Consensus       223 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                              022346889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3e-39  Score=297.08  Aligned_cols=245  Identities=22%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||.|+||.||+|.+.. +..+|+|.+....    ....+|+.+++.++|+||+++++++.     .....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4579999999999999999999877 8899999986543    34567999999999999999988773     333478


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+...  ....++...+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 777776542  245689999999999999999999987 999999999999999887 8999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..... .....++..|+|||.+... .++.++||||||+++|+|++ |+.||...+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            33221 1123346679999998554 58899999999999999998 89999887766555554432111          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-39  Score=301.66  Aligned_cols=248  Identities=21%  Similarity=0.269  Sum_probs=194.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCC-----CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      .+|++.+.||+|+||.||+|.+..+     +..||+|++....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            3688899999999999999987543     5789999987543     23457889999999999999998873     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      ....++++||+. ++|...+....            .....+++..+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEec
Confidence            334789999988 46666654211            1124578888999999999999999986 999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015298          208 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (409)
                      .++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 899999999876533221   12234567899999986544 8899999999999999998 88999877665555


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ..+.....                            ..++..++..+.+|+.+||+.+|.+||++.+++..
T Consensus       237 ~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         237 EMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            44433110                            01345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-39  Score=294.58  Aligned_cols=244  Identities=22%  Similarity=0.302  Sum_probs=192.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+....   ..+.+|+++++.++||||+++++++     ....+.++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            36889999999999999999875 46789999886432   3456799999999999999998877     333457899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+++ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++...+
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 666665432   34689999999999999999999996 999999999999999887 899999999876543


Q ss_pred             CCCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .....  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------  219 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------
Confidence            22111  12234579999998654 48899999999999999999 8999987665554443322110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                      ...+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                            01233478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.5e-39  Score=299.69  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-----cEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||++.+...+     ..+|+|.+....     ....+|+++++++ +|+||+++++++.   
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence            3457999999999999999999976443     789999886532     2345799999999 8999999998773   


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCce
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL  204 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NI  204 (409)
                        ....++++|||+. ++|...+....            .....+++..+..++.|++.||.|||+. ||+||||||+||
T Consensus        87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Ni  163 (293)
T cd05053          87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNV  163 (293)
T ss_pred             --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeE
Confidence              3334789999998 57777765421            2345788999999999999999999986 999999999999


Q ss_pred             eecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015298          205 LVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGV  280 (409)
Q Consensus       205 li~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  280 (409)
                      +++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......
T Consensus       164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999887 899999999986543321   112234567999998855 458999999999999999997 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +....+.....                            ...+...+..+.+|+.+||..||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 ELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            54443322100                            01233468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-38  Score=298.19  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+++++.++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----D   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----c
Confidence            347999999999999999999854     345679999886543    34568999999999999999999873     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      ....++||||++ ++|.+.+.....            ....+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~  157 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVG  157 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEc
Confidence            344789999997 577777654321            124588999999999999999999986 999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015298          208 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (409)
                      .++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+..
T Consensus       158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            887 899999999875533221   2234557889999998654 48899999999999999998 99999877665544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+....  .                          ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQGR--V--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCCC--C--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            4332210  0                          0012346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-38  Score=292.66  Aligned_cols=235  Identities=24%  Similarity=0.333  Sum_probs=185.5

Q ss_pred             eeccCCceEEEEEEE--cCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           78 IVGQGSFGVVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++++.     .. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999964  4678899999986432      23457899999999999999988652     11 2578999


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      |+++ +|.+.+..    ...+++..+..++.|++.||.|||++ ||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9994 56666543    45789999999999999999999986 999999999999999887 89999999987654332


Q ss_pred             CC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          229 PN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       229 ~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..    ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||......+....+.+...            
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            21    12233578999998854 448889999999999999998 9999987766554444332110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                      ...+..+++++.++|.+||+.||.+||+++++..
T Consensus       217 ----------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ----------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                            0134457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-38  Score=295.91  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=189.6

Q ss_pred             ce-EEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           72 SY-MAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        72 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      +| .+.+.||+|+||+||++.    ...++..||+|.+....     ..+.+|+++++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 899999999999998865    34578899999986532     344579999999999999999887643   223


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..++++|||+++ +|.+.+.     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999985 5655554     24699999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCH
Q 015298          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~  295 (409)
                      +........    .....++..|+|||.+.+. .++.++||||||+++|+|++|..||......  ....... .+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            876543322    1123446679999998654 4889999999999999999999998654321  1111110 000000


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+.            ...........+...+.++.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         231 VRLI------------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhh------------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000            000000111134557899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2e-38  Score=290.90  Aligned_cols=242  Identities=22%  Similarity=0.309  Sum_probs=192.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .+|.+.+.||+|+||.||++..  .|..+|+|.+..+.  ..+.+|+.+++.++|+|+++++++++..    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            4799999999999999999986  57889999986543  3456899999999999999999876432    23368999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||++ ++|.+.+....  ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            9998 47777665321  34588899999999999999999986 999999999999999887 8999999998754332


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      .  ....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||......+....+.+..                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  233445679999998554 48899999999999999997 999997765544443332210                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                  ....+..+++.+.+++.+||..||++|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00123457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.1e-38  Score=290.39  Aligned_cols=244  Identities=25%  Similarity=0.321  Sum_probs=192.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+...||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     . ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEE
Confidence            35799999999999999999987655 459999876543   34567999999999999999987652     1 12579


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05069          78 VTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEcc
Confidence            9999985 777776542  234578899999999999999999986 999999999999999887 89999999997653


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM----------  222 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            3221  1123456779999988654 48999999999999999999 99999887665554443321100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+..+.+++.+||..||.+||++.++++
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 ------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                              123457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.2e-38  Score=295.85  Aligned_cols=256  Identities=29%  Similarity=0.477  Sum_probs=197.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--------hhhHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      +|.+.+.||+|++|.||++.+.   .+++.||+|.+....        ....+|+.+++.+ +||||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   467899999986421        2345789999999 599999998877     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+. |++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            34457899999985 55555432    45789999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCCC--CccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       219 g~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876543322  12345788999999985432 36789999999999999999999996443222212221111000  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhCCCCccCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---ALDALIHPFFDELRDP  363 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s---~~ell~hp~f~~~~~~  363 (409)
                                             ....+..++..+.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                   00134457889999999999999999998   5677999999988664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=292.62  Aligned_cols=245  Identities=23%  Similarity=0.296  Sum_probs=193.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCC---CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|.+.+.||+|+||.||+|.+..+   ...||+|.+....     ..+.+|+.+++.++||||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4699999999999999999998654   4579999886432     23456999999999999999998773     333


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+++|||+.+ +|.+.+...   .+.++...+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 666665432   34789999999999999999999986 999999999999999887 8999999999


Q ss_pred             cccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .........   ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----  227 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----  227 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            876422111   122335679999998654 48999999999999999998 99999776655544443321110     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                             ..+...++.+.+++.+||+.||++||++.+++++
T Consensus       228 -----------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 -----------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   0223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-38  Score=299.35  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcC-------CCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ...++|.+.+.||+|+||.||+|.+..       ++..+|+|.+..+.     ....+|+++++.+ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            334689999999999999999998643       23579999987532     2345689999999 7999999999873


Q ss_pred             ecCCCCccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                           .....++||||++ ++|.+.+.....            ....++...+..++.|++.||+|||+. |++||||||
T Consensus        95 -----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp  168 (307)
T cd05098          95 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAA  168 (307)
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccH
Confidence                 3334789999998 577777764321            123588889999999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +||+++.++ .++|+|||.+........   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||...
T Consensus       169 ~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         169 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             HheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            999999887 899999999875533221   1112234679999998654 48999999999999999998 88999765


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+....                            ....+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         247 PVEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CHHHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5433333222110                            001334578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-39  Score=309.13  Aligned_cols=263  Identities=27%  Similarity=0.490  Sum_probs=208.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      -|..++.||-|+||.|+++....|...||+|.+.+...       ....|-.||..-+++-||+|+-.|     .+..++
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence            37888999999999999999999999999998865432       234688899999999999997666     455568


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |+||+|++| ++-.+|-.    .+.|++..+++++.++.+|+++.|+ +|+|||||||+|||||.+| .|||.|||++.-
T Consensus       705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdG-HIKLTDFGLCTG  778 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  778 (1034)
T ss_pred             EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCC-ceeeeecccccc
Confidence            899999996 44444433    5789999999999999999999997 6999999999999999999 799999999753


Q ss_pred             cc---------cCC-----------------C-----------------CccccccccccccccccCCCCCCchhhHHHH
Q 015298          224 LV---------KGE-----------------P-----------------NISYICSRYYRAPELIFGATEYTTAIDIWSA  260 (409)
Q Consensus       224 ~~---------~~~-----------------~-----------------~~~~~gt~~y~aPE~l~~~~~~~~~~Diwsl  260 (409)
                      +.         ++.                 .                 ....+||+.|+|||++.. ..|+..+|+||.
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~  857 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSV  857 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHh
Confidence            31         100                 0                 013468999999999965 458999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCccc----CCCCCChhHHHHHHH
Q 015298          261 GCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI----FPKRMPPEAVDLVSR  336 (409)
Q Consensus       261 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~l~~li~~  336 (409)
                      |||||||+.|++||......+...++++                             |+.+    +..++|.++.++|.+
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~n-----------------------------w~~~l~~~~~~~ls~e~~~li~k  908 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVIN-----------------------------WRNFLHIPYQGNLSKEALDLIQK  908 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeee-----------------------------hhhccccccccccCHHHHHHHHH
Confidence            9999999999999988776554433322                             2222    234689999999997


Q ss_pred             hcccCCCCCC---CHHHHhCCCCccCCCCCCCCCCCCCCCCCC
Q 015298          337 LLQYSPNLRC---TALDALIHPFFDELRDPNARLPSGRFLPPL  376 (409)
Q Consensus       337 ~L~~dp~~R~---s~~ell~hp~f~~~~~~~~~~~~~~~~~~~  376 (409)
                      +. .+++.|+   -++++..||||+.+.....+.....++|..
T Consensus       909 Lc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~I  950 (1034)
T KOG0608|consen  909 LC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRI  950 (1034)
T ss_pred             Hh-cChhhhhcccchhhhhcCccccccchHhhhhccCCcCccc
Confidence            65 4778887   477899999999998877666556666654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.1e-38  Score=291.54  Aligned_cols=244  Identities=23%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|++.+.||+|+||.||+|.+. .+..+|+|.+...   ...+.+|+.+++.++|+|++++++++.     . ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEE
Confidence            347999999999999999999865 5667999998653   234568999999999999999987652     1 12579


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05070          78 VTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIE  153 (260)
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeecc
Confidence            9999984 776666531  235689999999999999999999986 999999999999999887 89999999997654


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----------  222 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32211  122345679999998554 48899999999999999999 89999877665555544321110          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+..+.+|+.+||..||.+|||+.++++
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                              123456889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3e-38  Score=297.04  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeec
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  136 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~  136 (409)
                      ...++|.+.+.||+|+||.||++.+     ..++..||+|.+....     ....+|+++++++ +||||+++++++.. 
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence            3445899999999999999999975     3356689999886532     2356799999999 79999999998733 


Q ss_pred             CCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                          ....+++|||+. ++|.+.+....  ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|
T Consensus       111 ----~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l  182 (302)
T cd05055         111 ----GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVKI  182 (302)
T ss_pred             ----CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEEE
Confidence                334789999998 56766664311  23489999999999999999999986 999999999999999777 8999


Q ss_pred             eecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          216 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+..........
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            99999875533221   11234567899999986554 8999999999999999998 9999987665544433322100


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                 ....+...++++.+|+.+||..+|++|||+.+++.
T Consensus       262 ---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 ---------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       00123346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-38  Score=296.77  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=190.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998753     23568888876432     23557999999999999999998773     33


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNK--------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlk  200 (409)
                      ...++++||+. ++|.+.+.....                    ....++...+..++.|++.||.|||+. ||+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            34678999998 567666654211                    124578889999999999999999986 99999999


Q ss_pred             CCceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015298          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG  276 (409)
Q Consensus       201 p~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  276 (409)
                      |+||+++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 899999999875433221   1223446789999988554 48999999999999999998 9999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ....+....+....                            ....+..++.++.+|+.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            65444332221110                            01123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-38  Score=298.11  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=194.2

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcC-------CCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeeccccee
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCF  133 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~  133 (409)
                      .....+|.+.+.||+|+||.||+|.+..       ....+|+|.+....     ....+|+++++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3445689999999999999999998642       34579999886432     2345789999999 699999999987


Q ss_pred             eecCCCCccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCC
Q 015298          134 FSTTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (409)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlk  200 (409)
                      .     ...+++++|||+. ++|.+.+.....            ....++...+..++.||+.||.|||++ ||+|||||
T Consensus        88 ~-----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlk  161 (314)
T cd05099          88 T-----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLA  161 (314)
T ss_pred             c-----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeecccc
Confidence            3     3345789999998 577777765321            124588889999999999999999986 99999999


Q ss_pred             CCceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015298          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG  276 (409)
Q Consensus       201 p~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  276 (409)
                      |+||+++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus       162 p~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         162 ARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             ceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 899999999976533211   1122234679999998654 48999999999999999999 8999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ....+....+....                            ....+..++.++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         240 IPVEELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            66554444332210                            00123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=287.29  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=208.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHH-HhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +.+-...||.|+||+|++..++.+|+..|||++....     +.+..|.+.. +.-+.||||++++..|...+     .+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cW  139 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CW  139 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----ee
Confidence            4455668999999999999999999999999996543     2334455543 44478999999999876554     78


Q ss_pred             EEEeccchhHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPETVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      |.||.|.-+++.+.+. +.-....+++..+-.|....+.||.||.+.++|||||+||+|||++..| .+||||||.+...
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhH
Confidence            9999999888776554 3445678999999999999999999999988999999999999999988 8999999998777


Q ss_pred             ccCCCCccccccccccccccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHhhcC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-GTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  302 (409)
                      .+.-..+.-.|-..|||||.+..... |..+||+||||++|||+.||..||.+.+.  .+.++.... |.|+.-..    
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~----  292 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF----  292 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC----
Confidence            66655566678888999999965544 88999999999999999999999987654  333333322 22221000    


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                              +.         -.-..+..+..||..||.+|-..||.-.+++++||++......
T Consensus       293 --------~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  293 --------DK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             --------cc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence                    00         0013788999999999999999999999999999998765443

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.9e-38  Score=289.68  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=193.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|++.++||+|+||.||+|... +++.||+|.+....   ..+.+|+.+++.++|+||+++++.+.     . ...++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence            457999999999999999999854 57889999987543   34567999999999999999987652     1 23679


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||+. ++|.+.+...  ....++...+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence            999997 4676665432  245688999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  .....++..|+|||.+... .++.++||||||+++|+|++ |++||.+.+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------  222 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------
Confidence            2221  1223446789999998554 47899999999999999999 99999877665554443221110          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+.++.+++.+||..||++|||+++++.
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              123456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=288.61  Aligned_cols=242  Identities=24%  Similarity=0.348  Sum_probs=194.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch---hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+.+.||.|+||.||+|..  .|+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence            34799999999999999999987  588999999976543   45679999999999999999998743     334789


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||++ ++|.+.+....  ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||.++...
T Consensus        78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~  153 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEcccccccccc
Confidence            999998 57776665321  23689999999999999999999986 999999999999999887 89999999997663


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ....  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+....              
T Consensus       154 ~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  216 (256)
T cd05039         154 QGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--------------  216 (256)
T ss_pred             cccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            3222  33345679999998654 48899999999999999997 999997765544333222110              


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                    ....+...++.+.++|.+||..+|.+|||+.++++
T Consensus       217 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 --------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                          00123457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.7e-38  Score=316.67  Aligned_cols=283  Identities=21%  Similarity=0.258  Sum_probs=182.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCC----CcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLET----GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      ...+|.+.+.||+|+||.||+|.+..+    +..||+|++...........+.++...+.++..+...+..... .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            456899999999999999999999988    9999999876432211111122222233344444333322111 33445


Q ss_pred             EEEEEeccch-hHHHHHHHhhh----------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNK----------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                      +++|+||+++ +|.+++.....                .........+..++.||+.||.|||++ ||+||||||+|||+
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl  288 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQNIIF  288 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEE
Confidence            7899999984 56666543210                001112345678999999999999986 99999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCC--CCccccccccccccccccCCC---------------------CCCchhhHHHHHHH
Q 015298          207 NPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDIWSAGCV  263 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwslG~i  263 (409)
                      +.+...+||+|||+++....+.  ......+++.|+|||.+....                     .++.++|||||||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            8654489999999997553322  234567899999999763211                     23456799999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcc--cCCCCCChhHHHHHHHhcccC
Q 015298          264 VAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFPKRMPPEAVDLVSRLLQYS  341 (409)
Q Consensus       264 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~li~~~L~~d  341 (409)
                      ||||+++..++.  .....+..+....+... ..|.......        .......  ......+..+.+||.+||++|
T Consensus       369 L~el~~~~~~~~--~~~~~~~~~l~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        369 FLQMAFPNLRSD--SNLIQFNRQLKRNDYDL-VAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHhCcCCCc--hHHHHHHHHHHhcCCcH-HHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999776543  33333333333322221 1121111000        0000000  011123456779999999999


Q ss_pred             CCCCCCHHHHhCCCCccCCCCC
Q 015298          342 PNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       342 p~~R~s~~ell~hp~f~~~~~~  363 (409)
                      |++|||+.++|+||||++....
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999875443

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.6e-38  Score=293.04  Aligned_cols=244  Identities=23%  Similarity=0.306  Sum_probs=190.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+    .||+|.+....     ....+|+.+++.+.||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3479999999999999999999877776    48999886432     2345788899999999999998877421    


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                        ..+++++|++ |++.+.+..   ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG  154 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFG  154 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCC
Confidence              2568999998 566666543   235689999999999999999999986 999999999999998877 79999999


Q ss_pred             CccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++.........   ...+++.|+|||.+.+. .++.++|||||||++|||++ |..||......+....+.. ...+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--  230 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL--  230 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC--
Confidence            998664332211   22345679999998654 48999999999999999998 9999976654443332221 1100  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ..+...+.++.+++.+||..||+.||++.+++.
T Consensus       231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     012346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.7e-38  Score=296.27  Aligned_cols=254  Identities=18%  Similarity=0.238  Sum_probs=194.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCC----------------cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETG----------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  129 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~  129 (409)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ..+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999876544                568999986542     344579999999999999999


Q ss_pred             cceeeecCCCCccEEEEEEeccc-hhHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNK-------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                      ++++..     ....+++|||+. ++|...+.....       ....+++..++.++.|++.||.|||++ ||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccch
Confidence            988733     345789999998 467666654321       122689999999999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPG  276 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  276 (409)
                      +||+++.++ .++|+|||+++......   ......+++.|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999887 89999999987543322   12234457789999998654 48999999999999999998  7788877


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ....+.+............                     ......+...+.++.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6655554444332111000                     0000123346789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.9e-38  Score=293.95  Aligned_cols=252  Identities=19%  Similarity=0.224  Sum_probs=185.4

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCC---CcEEEEEEeeccchhhH---------------HHHHHHHhcCCCCeecccce
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  132 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~e~~~l~~l~h~niv~~~~~  132 (409)
                      .+|.+.+.||+|+||+||+|.+..+   +..+|+|+.........               .+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998877   67778886533222111               12233455689999999887


Q ss_pred             eeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                      ...... ...+.+++++++..++...+..    ....++..+..++.|++.||.|||+. +|+||||||+|||++.++ .
T Consensus        92 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKRC-RMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEecC-CceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            644332 2335678889887766555543    23467888899999999999999986 999999999999999887 8


Q ss_pred             EEEeecCCccccccCC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015298          213 VKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (409)
                      ++|+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        11234689999999998654 58999999999999999999999998764332222


Q ss_pred             HHHH--HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          285 EIIK--VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       285 ~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ...+  .+......                       .......++.+.+++..|+..+|.+||+..++++
T Consensus       244 ~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEG-----------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhh-----------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2111  11100000                       0012235789999999999999999999999864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-39  Score=294.63  Aligned_cols=242  Identities=27%  Similarity=0.406  Sum_probs=188.8

Q ss_pred             EEEEeeccCCceEEEEEEEc----CCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           74 MAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+.+.||.|.||.||+|...    ..+..|+||.+...     ...+.+|++.++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    45678999999542     2455679999999999999999998863222     7


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++|+||+. |+|.+.+...  ....++...+..|+.||+.||.|||++ +|+|+||+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            89999998 6788887753  246789999999999999999999986 999999999999999888 999999999976


Q ss_pred             cccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          224 LVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       224 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ......   .....+...|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            622211   12334567899999986544 8999999999999999999 7899988877666655533211        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                          ...+..++..+.++|..||..||.+|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                0134457899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-38  Score=302.45  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=191.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||.+..+.     ....+|+.++..+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            45799999999999999999984     3567899999986532     2345799999999 689999999877432  


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhh-----------------------------------------------------
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  164 (409)
                        ...++++|||++ |+|.+.+.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              234679999998 567666653210                                                     


Q ss_pred             ----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC---Cc
Q 015298          165 ----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NI  231 (409)
Q Consensus       165 ----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~  231 (409)
                                ....++...+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                      013467888889999999999999986 999999999999999887 899999999876532211   11


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       232 ~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      ...+++.|+|||.+.+. .++.++||||||+++|+|++ |..||..................                  
T Consensus       240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  300 (343)
T cd05103         240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  300 (343)
T ss_pred             CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------
Confidence            22345679999998654 48999999999999999997 99999765443332222211000                  


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                               ...+...++++.+++.+||+.||.+|||+.++++|
T Consensus       301 ---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     00223367889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.5e-38  Score=291.22  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=192.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|.+.+.||+|+||.||+|.+..++.   .+|+|.+....     ..+.+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            479999999999999999999875543   79999886432     34567999999999999999998873     334


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      +.++||||+++ +|.+.+..   ....++...+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            47899999985 66666543   235689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ..........    ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||......+....+.+....    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----  228 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----  228 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC----
Confidence            7654432211    12224579999998654 48999999999999999886 99999877665544443321110    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                              ..+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       229 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 ------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                    012346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=289.33  Aligned_cols=228  Identities=29%  Similarity=0.361  Sum_probs=181.2

Q ss_pred             CCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch-hHHHHHH
Q 015298           82 GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK  160 (409)
Q Consensus        82 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~  160 (409)
                      |.+|.||++++..+|+.||+|.+..... ..+|...+....||||+++++++.     .....++||||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999976543 334555556667999999999873     33458899999985 6666654


Q ss_pred             HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCcccccccccc
Q 015298          161 HFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR  240 (409)
Q Consensus       161 ~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~  240 (409)
                      .    ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            3    34689999999999999999999986 999999999999999888 7999999987654332  23345577899


Q ss_pred             ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcc
Q 015298          241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  320 (409)
Q Consensus       241 aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (409)
                      |||.+.+ ..++.++|+||+|+++|+|++|..||......     + .   .            .            ...
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---~------------~------------~~~  195 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---T------------H------------TTL  195 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---c------------c------------ccc
Confidence            9998854 34789999999999999999999887432110     0 0   0            0            000


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCc
Q 015298          321 IFPKRMPPEAVDLVSRLLQYSPNLRCTA-----LDALIHPFF  357 (409)
Q Consensus       321 ~~~~~~s~~l~~li~~~L~~dp~~R~s~-----~ell~hp~f  357 (409)
                      .++..+++.++++|.+||+.||.+|+++     .++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1344578999999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-38  Score=288.33  Aligned_cols=245  Identities=24%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+.+.||+|+||.||+|.+. .+..+|+|.+..+.   ....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            457999999999999999999975 45789999986542   34568999999999999999988763     3334789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+++ +|.+.+...  ....++...+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 666666432  235689999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+....+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            3211  1122335679999998654 48999999999999999998 99999877766655554332111          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+.++.+++.+||..||.+||++.+++.
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                              123345889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-38  Score=288.42  Aligned_cols=236  Identities=26%  Similarity=0.362  Sum_probs=186.0

Q ss_pred             EeeccCCceEEEEEEEcCCC---cEEEEEEeeccch-----hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETG---ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ++||+|+||.||+|.+..++   ..+|+|.+..+..     ...+|+.+++.++|+||+++++++.     .. ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            46999999999999876555   7899999865432     4457899999999999999988652     11 257999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||++ ++|.+.+..    ...+++..+..++.|++.||.|||.+ |++||||||+||+++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            9998 467666653    34789999999999999999999986 999999999999999887 8999999998766433


Q ss_pred             CCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          228 EPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       228 ~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....    ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-----------  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-----------  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-----------
Confidence            3211    11224579999998654 48999999999999999998 9999987665444333322100           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                       ...+..++..+.++|.+||..||++||++.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-38  Score=295.57  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=194.9

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-------CCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ....+|.+.+.||+|+||.||+|++.       .++..||+|.+....     ....+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34568999999999999999999753       234579999886432     3456799999999 8999999999873


Q ss_pred             ecCCCCccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                           .....+++|||+. ++|.+.+.....            ....++...+..++.||+.||.|||++ ||+||||||
T Consensus        92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp  165 (304)
T cd05101          92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAA  165 (304)
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeeccccc
Confidence                 3345789999998 477777765321            123577888999999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +||+++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.
T Consensus       166 ~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         166 RNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999887 899999999976543221   1223446789999998654 48899999999999999998 88999776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+.....                            ...+...+..+.+|+.+||..+|.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            65554443321100                            01233578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-38  Score=291.67  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=194.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||.||+|.+..    ++..|++|.+....     ....+|+.+++.++|+||++++++++..    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4589999999999999999999876    35889999886432     3345799999999999999999876532    


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKL----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                      ....+++++|+. ++|...+......    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            233678999987 5777766543221    15689999999999999999999986 999999999999999887 8999


Q ss_pred             eecCCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          216 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|||+++........   ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+.....
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence            999999765332211   123346679999998654 48999999999999999998 9999987665443332221100


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                  ...+..+++++.+++.+||..||++|||+.+++.
T Consensus       238 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 ----------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                        0012346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.8e-38  Score=293.13  Aligned_cols=247  Identities=24%  Similarity=0.340  Sum_probs=192.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+....    ..+.+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            46889999999999999999743     356789999876432    34567999999999999999988773     23


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNK-----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~  209 (409)
                      ...+++|||+. ++|.+++.....           ....+++..+..++.||+.||.|||+. ||+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence            34789999998 567766654221           113578899999999999999999986 99999999999999987


Q ss_pred             CCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015298          210 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVE  285 (409)
Q Consensus       210 ~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  285 (409)
                      + .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 899999999875432221   1223346789999998654 48999999999999999998 9999977666555444


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      +.....                            ...+..+++.+.+||.+||+.||.+||++.+++.
T Consensus       237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332110                            0123457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=291.79  Aligned_cols=240  Identities=23%  Similarity=0.336  Sum_probs=184.9

Q ss_pred             eeccCCceEEEEEEEcCCCc--EEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEEe
Q 015298           78 IVGQGSFGVVFQAKCLETGE--TVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      .||+|+||.||+|.+..++.  .+++|.+....     ....+|+++++++ +||||+++++++.     ...+.+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence            58999999999999988876  46888876421     2445799999999 8999999999873     3344789999


Q ss_pred             ccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          150 YVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       150 ~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                      |+. ++|.+.+.....            ....+++..+..++.|++.||+|||+. |++||||||+||+++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEEC
Confidence            998 577777654321            123578999999999999999999986 999999999999999887 89999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |||++..............+..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+....     
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----  228 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----  228 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence            9999864322211222233567999999854 458999999999999999997 999997765544433322110     


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                             ....+..++.++.+++.+||..||.+|||+.+++.
T Consensus       229 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 -----------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                   00022346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.7e-38  Score=304.56  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcC-CCCeecccceeeec
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFST  136 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~  136 (409)
                      ....+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ..+.+|++++..+. ||||+++++++.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence            34457899999999999999999864     355789999997542     23457999999997 9999999988743 


Q ss_pred             CCCCccEEEEEEeccc-hhHHHHHHHhhh---------------------------------------------------
Q 015298          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNK---------------------------------------------------  164 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------------------------------------------  164 (409)
                          ...+++||||+. |+|.+.+.....                                                   
T Consensus       113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                334789999999 577777653211                                                   


Q ss_pred             -------------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          165 -------------------------------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       165 -------------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                                                                 ....+++..++.++.||+.||.|||+. +|+||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp  267 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAA  267 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCc
Confidence                                                       012466777889999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +|||++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||...
T Consensus       268 ~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         268 RNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             ceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999877 899999999976533221   2234567889999998654 48899999999999999998 89999776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+...........                           ...+..++.++.+|+.+||..+|.+||++.+++..
T Consensus       346 ~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNEQFYNAIKRGYR---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555544333221000                           01234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-39  Score=326.75  Aligned_cols=258  Identities=28%  Similarity=0.425  Sum_probs=193.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC-----
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-----  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-----  139 (409)
                      ..+|.....||+||||.||+++++-+|..||||++.-.     ...+.+|+..|.+|+|||||+++..|......     
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            45677889999999999999999999999999999654     23456899999999999999998654110000     


Q ss_pred             --------------------------------------------------------------------------------
Q 015298          140 --------------------------------------------------------------------------------  139 (409)
Q Consensus       140 --------------------------------------------------------------------------------  139 (409)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -----------------------------CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015298          140 -----------------------------DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR  190 (409)
Q Consensus       140 -----------------------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  190 (409)
                                                   ...++||-||||+.+++..+-..+....  ....+|++++||++||.|+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence                                         0157899999999866665554332111  467789999999999999999


Q ss_pred             cCCcEeecCCCCceeecCCCCcEEEeecCCccccc-------------------cCCCCccccccccccccccccCCC--
Q 015298          191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--  249 (409)
Q Consensus       191 ~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~--  249 (409)
                      . |||||||||.||++++++ .|||+|||+|+...                   +....++.+||.-|+|||++.+..  
T Consensus       716 ~-giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 Q-GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             C-ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            6 999999999999999887 89999999997621                   011345678999999999996665  


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChh
Q 015298          250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPE  329 (409)
Q Consensus       250 ~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  329 (409)
                      .|+.++||||||+||+||+.   ||..  ..+... +.+.++.+..                  +..   .-+...--+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~-iL~~LR~g~i------------------P~~---~~f~~~~~~~  846 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERAS-ILTNLRKGSI------------------PEP---ADFFDPEHPE  846 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCc--hHHHHH-HHHhcccCCC------------------CCC---cccccccchH
Confidence            69999999999999999984   3532  222222 2222221110                  000   0011122345


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          330 AVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       330 l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      -..+|+.||+.||.+||||.|+|++.||-
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            67899999999999999999999999997

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.4e-38  Score=289.06  Aligned_cols=244  Identities=23%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|...+.||+|+||.||+|.+..++.   .+|+|.+....     .....|+++++.++|+||+++.+++.     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            478999999999999999999876665   79999886432     23457899999999999999998873     333


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||+++ +|...+..   ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            47899999995 55555532   235789999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ..........    ....+..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654322111    11224569999998654 47999999999999999997 999998776655554443221111   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               .+...+.++.+++.+||..||++||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     12346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.8e-38  Score=289.48  Aligned_cols=249  Identities=20%  Similarity=0.377  Sum_probs=197.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcC-CCcEEEEEEeeccc--------------hhhHHHHHHHHh-cCCCCeecccceeee
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK--------------RYKNRELQTMRL-LDHPNVVSLKHCFFS  135 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~e~~~l~~-l~h~niv~~~~~~~~  135 (409)
                      .|.+.+.||+|+||.||+|.+.. +++.+|+|.+....              .....|+.++.. ++||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            37888999999999999999987 78899999875321              113357776654 79999999999873 


Q ss_pred             cCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                          ...+.+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+..|++|+||+|+||+++.++ .++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence                34458899999985 777777654445677999999999999999999999634899999999999999887 899


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||.+.............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            9999999866544444456788899999999654 48999999999999999999999997665544444333211111 


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                ......++.+.++|.+||+.||++||++.++..+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      0112468899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-38  Score=299.32  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=194.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCC-------CcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ....+|.+.+.||+|+||.||+|.+...       +..||+|.+....     ....+|+++++++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3445799999999999999999986432       2368999886432     3456799999999 8999999999873


Q ss_pred             ecCCCCccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                           ....+++++||++ ++|.+.+.....            ....++...+..++.|++.||.|||++ ||+||||||
T Consensus        89 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp  162 (334)
T cd05100          89 -----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAA  162 (334)
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceecccccc
Confidence                 3344789999998 477777664321            123577888899999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +||+++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       163 ~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         163 RNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999887 899999999876543221   1122334679999998654 48899999999999999998 88999876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+.....                            ...+...+.++.+++.+||..+|.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         241 PVEELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            65554433322100                            01233568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.2e-38  Score=289.36  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=192.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+....     ..+..|+.+++.++||||+++.+++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            369999999999999999999887765   59999986431     24557999999999999999988873     334


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||+++ +|.+.+...   .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            47899999985 565555432   35689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCCcc---cc---ccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          222 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       222 ~~~~~~~~~~~---~~---gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ...........   ..   .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+......  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~--  230 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL--  230 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence            76543322111   11   13479999998654 48999999999999999886 99999877665544443221100  


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       231 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 --------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      022346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.1e-38  Score=287.62  Aligned_cols=236  Identities=22%  Similarity=0.275  Sum_probs=184.1

Q ss_pred             eeccCCceEEEEEEEc--CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEec
Q 015298           78 IVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++||||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  455679999886542     23567999999999999999988762     1 236799999


Q ss_pred             cch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC
Q 015298          151 VPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (409)
Q Consensus       151 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~  229 (409)
                      +++ +|.+.+..   ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 66555542   245789999999999999999999986 999999999999999887 899999999875533321


Q ss_pred             C----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          230 N----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       230 ~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .    ....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+.+...             
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------------
Confidence            1    112235679999998654 48899999999999999996 9999987766554443322110             


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                     ...+...++++.++|.+||..||++||+..++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0133457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=294.67  Aligned_cols=254  Identities=20%  Similarity=0.248  Sum_probs=192.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCC--------------cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETG--------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH  131 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~  131 (409)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+....     ..+.+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              358999986542     23557999999999999999999


Q ss_pred             eeeecCCCCccEEEEEEeccch-hHHHHHHHhhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNK--------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       132 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                      ++.     .....++||||+.+ +|.+.+.....        ....+++..+..++.|++.||.|||++ |++||||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            874     33347899999984 67666643211        012467888899999999999999986 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPGD  277 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~  277 (409)
                      ||+++.++ .+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999887 899999999875533221   1123346789999998654 48999999999999999998  67888877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      +..+.+..+.+........                     .....+...++.+.+|+.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQ---------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhcccc---------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            6655555443321100000                     000012346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.8e-38  Score=286.37  Aligned_cols=239  Identities=26%  Similarity=0.330  Sum_probs=190.1

Q ss_pred             EeeccCCceEEEEEEEcC-CC--cEEEEEEeeccch-----hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLE-TG--ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|++|.||+|.+.. .+  ..||+|.+..+..     .+.+|+.+++.++||||+++++.+..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 33  3689999876543     45679999999999999999988743      4578999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||++ ++|.+.+....  ...+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 57777665422  15689999999999999999999986 999999999999999887 8999999998766442


Q ss_pred             CC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          228 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       228 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..    .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......          
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  219 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------  219 (257)
T ss_pred             ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence            21    1123456789999998554 48999999999999999998 99999877666655544321000          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                       ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0123346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-37  Score=285.51  Aligned_cols=244  Identities=21%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||.||++.+. ++..+|+|.+...   ...+.+|+++++.++|||++++++++.     .....+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence            36899999999999999999875 4678999988653   235668999999999999999988773     33457899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.+ +|.+.+..   ....+++..++.++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 55554432   234688999999999999999999986 999999999999999877 899999999875533


Q ss_pred             CCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-------------  218 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------
Confidence            221  1122345689999998654 48899999999999999998 999998766555444432210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                     ....+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       219 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 ---------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           001233468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.2e-38  Score=292.36  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=193.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ..+.+|+.+++.++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            457999999999999999999875     367899999986432     34567999999999999999998773     


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCC
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNK------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlk  200 (409)
                      .....+++|||++ ++|.+.+.....                  ....+++..++.++.|++.||.|||++ |++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            2334789999998 477777653211                  113477888999999999999999986 99999999


Q ss_pred             CCceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015298          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG  276 (409)
Q Consensus       201 p~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  276 (409)
                      |+||+++.++ .++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 899999999875432221   1123345679999998654 48999999999999999997 8889977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ....+....+.....                            ...+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         236 MAHEEVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            665554443322100                            0023456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-37  Score=289.93  Aligned_cols=243  Identities=21%  Similarity=0.302  Sum_probs=187.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++.+.||+|+||.||+|.+..+|+    .+++|.+....     .....|+.+++.++||||+++++++.     +.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence            479999999999999999999987776    46777764321     23345677888999999999998762     11


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                       ..++++||+. |+|.+.+..   ....+++..+..++.||+.||.|||++ |++||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2567899988 677666653   235789999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ++.......   .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+........ +......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~---  230 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERL---  230 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC---
Confidence            976543322   1233456789999998654 48999999999999999998 999998765443322 22110000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                              ..+...+.++.+++.+||..||.+|||+.++++
T Consensus       231 ------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         231 ------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                    012235678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-37  Score=285.24  Aligned_cols=242  Identities=27%  Similarity=0.389  Sum_probs=193.5

Q ss_pred             EEEEeeccCCceEEEEEEEcCCC----cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           74 MAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+.+.||.|+||.||+|.+..++    ..||+|.+....     .....|+.+++.++|+||+++++.+..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            46788999999999999998766    899999996543     245679999999999999999988743     3457


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||+++ +|.+.+....  ...+++..+..++.|++.||.+||+. |++||||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999985 6666665422  12289999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCCCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ........  ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+..+....+.+...         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  222 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------  222 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            65442221  1236788999999844 458999999999999999998 8899987665555554432110         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                         ...+...+.++.+++.+||..||.+|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                               0123347899999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=288.57  Aligned_cols=244  Identities=26%  Similarity=0.348  Sum_probs=193.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|++.+.||+|+||.||+|.++.+|+    .+|+|.+....     ....+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            4579999999999999999999877765    58999876543     234579999999999999999998753     


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                       ...++||||+. ++|.+.+..   ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCc
Confidence             23679999998 566666543   234689999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCCCcc---ccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++..........   ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||......+....+.+...    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----  229 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER----  229 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC----
Confidence            9976643332221   223567999998854 448899999999999999998 9999988765554433332100    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                              ...+...+.++.+++.+||..||+.|||+.++++
T Consensus       230 ------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                    0123346788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-38  Score=288.50  Aligned_cols=237  Identities=18%  Similarity=0.198  Sum_probs=177.6

Q ss_pred             EeeccCCceEEEEEEEcC------------CCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           77 RIVGQGSFGVVFQAKCLE------------TGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      +.||+|+||.||+|....            ....+++|.+....    ..+.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            368999999999998532            22358888875432    234568889999999999999998743     


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC------cEE
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH------QVK  214 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~------~ik  214 (409)
                      ....++||||++++..+.+..  .....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.      .++
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeE
Confidence            233679999999643333322  1245689999999999999999999986 9999999999999976542      289


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      ++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+... ....   .
T Consensus       153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---~  225 (262)
T cd05077         153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---Q  225 (262)
T ss_pred             eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc---C
Confidence            9999998654322   23457888999998865566899999999999999998 5888887654322211 1110   0


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                 .               ......++++.+||.+||+.||.+||+..+++++
T Consensus       226 -----------~---------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 -----------C---------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----------c---------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                       0               0112246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-37  Score=287.77  Aligned_cols=249  Identities=22%  Similarity=0.290  Sum_probs=193.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      .+|.+.+.||+|+||.||+|+.+.     +.+.+++|.+....     ....+|++++++++|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            479999999999999999999754     34679999885433     2356799999999999999999877     33


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                      ..+.++||||++ ++|.+.+......     ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            345789999998 5777776543211     12689999999999999999999986 999999999999999887 899


Q ss_pred             EeecCCccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          215 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       215 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      ++|||++.......  ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-  235 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-  235 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence            99999986442221  12234557789999988654 47899999999999999998 889997655544433322110 


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                +....+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus       236 --------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 --------------------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      0001234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-37  Score=292.40  Aligned_cols=254  Identities=19%  Similarity=0.255  Sum_probs=190.4

Q ss_pred             cceEEEEeeccCCceEEEEEEEcC----------------CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  129 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~  129 (409)
                      .+|.+.+.||+|+||.||++.+..                ++..+|+|.+....     ..+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986432                34579999986532     345679999999999999999


Q ss_pred             cceeeecCCCCccEEEEEEeccc-hhHHHHHHHhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKL-------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                      ++++..     ....+++|||+. ++|.+.+......       ...+++..+..++.|++.||+|||+. ||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            998743     234789999998 5777766543211       13477788999999999999999986 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPG  276 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  276 (409)
                      +||+++.++ .++|+|||++........   .....++..|+|||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 899999999875533221   1122335679999987654 48999999999999999998  7789977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+..+.+...........           ...          ....+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRDQG-----------RQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhhcc-----------ccc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            665554433222110000           000          00012346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-37  Score=288.02  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=190.0

Q ss_pred             cceEEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .+|++.+.||+|+||.||+|.    +..++..||+|.+....    ..+.+|+++++.++||||++++++++..   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            479999999999999999997    44678999999986543    2456899999999999999998876543   223


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5777666432   34689999999999999999999986 999999999999999887 8999999999


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHH
Q 015298          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG-TPTRE  296 (409)
Q Consensus       222 ~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~  296 (409)
                      .........    ....++..|+|||.+.+. .++.++|||||||++|+|++|..++..... .....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchH
Confidence            865433221    112234569999998654 488999999999999999998877643321 11110000000 00000


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+....            ........+..++.++.+|+.+||..+|++|||+.++++
T Consensus       234 ~~~~~~------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELL------------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHH------------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000000            000000123457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=297.53  Aligned_cols=265  Identities=25%  Similarity=0.400  Sum_probs=209.3

Q ss_pred             CCCCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----------hhhHHHHHHHHhcCCCCeecccce
Q 015298           64 NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHC  132 (409)
Q Consensus        64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~  132 (409)
                      .+.+....+|.+.++||.|||+.||+|.|....+.||+|+-...+           +..-+|.+|-+.|+||.||++|++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            455667789999999999999999999999999999999863221           122379999999999999999998


Q ss_pred             eeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCcEeecCCCCceeecCC-
Q 015298          133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPH-  209 (409)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~ivH~Dlkp~NIli~~~-  209 (409)
                      |....+    .+|-|+|||+| +|+-+++    ....+++.+++.|+.||+.||.||.+. -.|||-||||.|||+... 
T Consensus       536 fslDtd----sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  536 FSLDTD----SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeccc----cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            854333    37889999997 4444444    367899999999999999999999863 149999999999998532 


Q ss_pred             -CCcEEEeecCCccccccCCCC--------ccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015298          210 -THQVKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGD  277 (409)
Q Consensus       210 -~~~ikl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~l~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~  277 (409)
                       .+.|||.|||+++++......        ....||.+|++||.+.-   .++.+.++||||+|||+|.++.|+.||...
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence             237999999999988654332        34678999999999842   455789999999999999999999999876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ...+.+.+.-..+.             ..+..|+.          ...++.++++||++||++.-++|....++..||+|
T Consensus       688 qsQQdILqeNTIlk-------------AtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl  744 (775)
T KOG1151|consen  688 QSQQDILQENTILK-------------ATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL  744 (775)
T ss_pred             hhHHHHHhhhchhc-------------ceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence            65544433222221             11222222          12478999999999999999999999999999999


Q ss_pred             cC
Q 015298          358 DE  359 (409)
Q Consensus       358 ~~  359 (409)
                      ..
T Consensus       745 lP  746 (775)
T KOG1151|consen  745 LP  746 (775)
T ss_pred             cc
Confidence            75

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-37  Score=284.76  Aligned_cols=244  Identities=23%  Similarity=0.334  Sum_probs=192.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|++.+.||+|+||.||++.+. .+..+|+|.+....   ..+.+|+++++.++|+||+++++++..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            458999999999999999999854 45679999886543   345679999999999999999887632      23679


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|||++ ++|.+.+...  ....++...+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999998 5777766542  245678888999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .....  ....++..|+|||.+... .++.++|+|||||++|++++ |..||...+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----------  222 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------
Confidence            32211  123345679999998654 48889999999999999998 99999876655544433221100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ..+...+.++.+++.+||+.||++||++.++++
T Consensus       223 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                              022347889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-37  Score=283.30  Aligned_cols=237  Identities=22%  Similarity=0.358  Sum_probs=185.3

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      +.||+|+||.||+|... ++..+|+|.+....     ..+.+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            36899999999999854 68899999886542     234579999999999999999988733     33478999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      ++ +|.+.+..   ....+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            84 55555432   234678999999999999999999986 999999999999999887 8999999998754332211


Q ss_pred             c--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          231 I--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       231 ~--~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      .  ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  12335679999998554 48899999999999999998 999998776554443332210                 


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                 ....+..++..+.+++.+||..+|++||++.++++
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       00123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=284.11  Aligned_cols=237  Identities=23%  Similarity=0.346  Sum_probs=186.5

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEecc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ++||.|+||.||+|.+.. ++.||+|.+....     ..+.+|+++++.++|+||+++++++.     ...+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            368999999999999877 9999999886432     34567999999999999999998874     333478999999


Q ss_pred             ch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       152 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      .+ +|.+.+..   ....++...+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            74 56555542   235688899999999999999999987 999999999999999887 8999999998755322211


Q ss_pred             ---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          231 ---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       231 ---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                         ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence               112235569999998654 48999999999999999999 889997766544333332210                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                  ....+..++.++.+++.+||..+|.+|||+.++++
T Consensus       213 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                        00123457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-37  Score=287.28  Aligned_cols=246  Identities=20%  Similarity=0.264  Sum_probs=183.3

Q ss_pred             EeeccCCceEEEEEEEcC--CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||+|....  ....+|+|.+....     ..+.+|+++++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            368999999999996532  44578888775332     23457899999999999999998873     3344789999


Q ss_pred             ccc-hhHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          150 YVP-ETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       150 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      |++ ++|.+.+..... .....++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            998 477777654322 123456778889999999999999986 999999999999999887 8999999998654322


Q ss_pred             CC---CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          228 EP---NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       228 ~~---~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ..   .....+++.|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+......+.   
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---  230 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL---  230 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC---
Confidence            11   122344677999998742      2346889999999999999999 8899987766555444433211100   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                          .....+..++..+.+++..|+ .||.+|||+.++++
T Consensus       231 --------------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 --------------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             --------------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                001133457889999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-37  Score=289.28  Aligned_cols=235  Identities=20%  Similarity=0.222  Sum_probs=178.7

Q ss_pred             eeccCCceEEEEEEEcCC------------------------CcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecc
Q 015298           78 IVGQGSFGVVFQAKCLET------------------------GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  129 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~  129 (409)
                      .||+|+||.||+|....+                        ...||+|.+....    ..+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            689999999999975322                        2358888885432    234568889999999999999


Q ss_pred             cceeeecCCCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          130 KHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                      ++++..     ..+.++||||++++ |...+..   ....+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            998743     33478999999964 4444332   245789999999999999999999986 9999999999999975


Q ss_pred             CC------CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 015298          209 HT------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD  281 (409)
Q Consensus       209 ~~------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~  281 (409)
                      .+      ..++++|||.+......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      14899999987643222   23456788999999866566899999999999999985 6999997765433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .........                              .++...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       230 ~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KERFYEKKH------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHhcc------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            322111100                              0223356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=310.28  Aligned_cols=205  Identities=27%  Similarity=0.405  Sum_probs=170.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecC-CCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-DKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~  144 (409)
                      ..|...+.||+|+||.||+++++.+|+.||||.+...     ....-+|+++|++|+|+|||++.++-.... ..-...-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3577788999999999999999999999999998653     334458999999999999999876542211 0002224


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec--CCC-CcEEEeecCC
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--PHT-HQVKLCDFGS  220 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~--~~~-~~ikl~Dfg~  220 (409)
                      .+|||||.| +|...+... ....++++.+++.+..+++.||.|||++ ||+||||||+||++-  .+| ...||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            689999995 666666543 3357899999999999999999999997 999999999999873  222 3689999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD  277 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  277 (409)
                      |+...++....+.+||+.|.+||++-.+.+|+..+|.|||||++|+++||..||...
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999999999999999999999999864567999999999999999999999999644

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-38  Score=289.76  Aligned_cols=236  Identities=20%  Similarity=0.263  Sum_probs=181.4

Q ss_pred             EeeccCCceEEEEEEEcCCCcE-------EEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGET-------VAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~-------vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +.||+|+||.||+|.+..++..       +|+|.+....    ....+|+.+++.++||||+++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            3689999999999998665544       8888875432    3345788999999999999999988543     2367


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc-------EEEee
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-------VKLCD  217 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~-------ikl~D  217 (409)
                      +||||+++ +|...+...   ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 565555432   34688999999999999999999986 99999999999999876532       79999


Q ss_pred             cCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       218 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ||++.....   .....+++.|+|||.+.+...++.++|||||||++|+|++|. +||.......... ....       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            999865432   223567888999999976556889999999999999999984 6665444332221 1110       


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                            ...++...+.++.++|.+||+.||++|||+.++++.
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                  001334456889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.3e-37  Score=283.53  Aligned_cols=240  Identities=23%  Similarity=0.340  Sum_probs=191.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .+|.+.+.||+|+||.||++..  +++.||+|.+..+.  ....+|+.+++.++|||++++++++..     . ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence            4699999999999999999874  78899999986542  345679999999999999999887632     1 157999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+. ++|.+.+....  ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            9998 57777765422  34688999999999999999999986 999999999999999887 8999999998754322


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       228 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                        ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+.+...               
T Consensus       154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------  215 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---------------  215 (254)
T ss_pred             --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------
Confidence              1223345679999998654 48899999999999999997 9999987765554433322100               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                   ...+..+++.+.+++.+||..+|..||++.+++.
T Consensus       216 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 -------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0022357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.1e-37  Score=285.21  Aligned_cols=246  Identities=20%  Similarity=0.217  Sum_probs=182.4

Q ss_pred             EeeccCCceEEEEEEEc--CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.||+|+||.||+|...  .++..+|+|.+....     ..+.+|+.+++.++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            36899999999999854  356789999886432     24557999999999999999998773     3334789999


Q ss_pred             ccc-hhHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          150 YVP-ETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       150 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      |++ ++|.+.+..... .....+...+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 577666654322 123456677888999999999999986 999999999999999887 8999999998754332


Q ss_pred             CC---CccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          228 EP---NISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       228 ~~---~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ..   .....++..|+|||++.+.      ..++.++|+||||+++|+|++ |..||......+............    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----  229 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK----  229 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC----
Confidence            21   1234567789999998532      135789999999999999996 999998766554433222110000    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                  .       .........++.+.+++.+|+ .+|.+|||+.+++.
T Consensus       230 ------------~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         230 ------------L-------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------------C-------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                        0       000122246788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-38  Score=313.37  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=202.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      .+-...+.||+|+||+||+|+..     .....||||.++...     ..+++|++++..|+|||||+++|.+...+.  
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P--  563 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP--  563 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe--
Confidence            35667789999999999999854     234679999997543     567899999999999999999999955443  


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhh------c----CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKL------N----QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~------~----~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~  209 (409)
                         +++|+|||. |+|.+.|......      +    ..++..+...|+.||+.|+.||-++ .+|||||-..|+||..+
T Consensus       564 ---~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  564 ---LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             ---eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccc
Confidence               789999999 8888888764321      2    2378889999999999999999986 99999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015298          210 THQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVE  285 (409)
Q Consensus       210 ~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  285 (409)
                      . .|||+|||+++.....+...   ...-..+|||||.+.-+ +++++|||||+||+|||+++ |+-||.+..+.+.+..
T Consensus       640 l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  640 L-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             e-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            7 89999999998654332211   12235679999999654 59999999999999999997 9999999999999888


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                      +.++--.                            .-|++.|.++.+|+..||+.+|++||+..|+
T Consensus       718 i~~g~lL----------------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  718 IRAGQLL----------------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHcCCcc----------------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            7663110                            1467899999999999999999999999987

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.2e-37  Score=283.78  Aligned_cols=245  Identities=26%  Similarity=0.371  Sum_probs=192.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCC---CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+...   ...||+|......     ..+.+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C
Confidence            34699999999999999999987644   3568999886432     245679999999999999999987632     1


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                       ..++||||++ ++|.+.+...   ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCce
Confidence             2568999998 5676666432   34689999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          221 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       221 a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      +.........  ....++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+.+....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----  227 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-----  227 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence            8765433211  122234679999988544 58899999999999999996 99999887766555443321100     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                             ..+..++..+.++|.+||..+|.+|||+.+++..
T Consensus       228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   1234578999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-37  Score=287.50  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=188.8

Q ss_pred             ceEEEEeeccCCceEEEEEEE----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKC----LETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .|.+.+.||+|+||.||+|..    ..++..||+|.+....     ....+|+.+++.++||||+++.+++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            478999999999999999974    4578899999986432     3456799999999999999998877432   234


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCccc
Confidence            4789999997 4666655421   34689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC---
Q 015298          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT---  294 (409)
Q Consensus       222 ~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~---  294 (409)
                      .........    ....++..|+|||.+.+. .++.++|||||||++|+|+++..|+.....  ...   +..+...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccc
Confidence            765433221    234456679999998654 488999999999999999998776533211  000   0000000   


Q ss_pred             -HH-HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 -RE-EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                       .. .......             ......+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEE-------------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHc-------------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             00 0000000             00001234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=306.67  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      +..++.|.+...||.|.+|+||+++.+.+|+..|+|+...+   ...++.|.++++.+ .|||++.++++|+-.......
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34456799999999999999999999999999999998654   34556788888887 699999999999887777777


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++||||||+ |+..++++...  +.++.+..+..|++.++.||.+||.+ .++|||||-.|||++.++ .|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeeeeee
Confidence            8999999999 57777777655  88999999999999999999999987 999999999999999998 8999999988


Q ss_pred             cccccC-CCCccccccccccccccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKG-EPNISYICSRYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ...... ....+.+|||+|||||++...+    .|+..+|+||||++..||.-|.+|+-+.-..-.+..|   .+.|++ 
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP-  246 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP-  246 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc-
Confidence            655433 3456789999999999995433    3677899999999999999999999776554333322   223322 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                            ...-++..++++.+||..||.+|-.+||+..++|.|||+.+.
T Consensus       247 ----------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  247 ----------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                  111245578899999999999999999999999999999853

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.5e-37  Score=282.80  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=180.6

Q ss_pred             EeeccCCceEEEEEEEcC---CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +.||+|+||.||+|.+..   .+..+|+|.+....     ....+|+.+++.++||||+++++++...    +...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998653   34579999885321     2345788999999999999998865432    23367899


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+. ++|.+.+...   ....+...+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9998 5666665431   34467777888999999999999986 999999999999999887 8999999998754322


Q ss_pred             C-----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          228 E-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       228 ~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .     ......++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+...  .+        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence            1     11123446789999998654 58999999999999999999 56777665544433322211  00        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                        ...+..+++.+.+++.+||..+|++||++.++++.
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                              00223467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-37  Score=289.48  Aligned_cols=245  Identities=22%  Similarity=0.316  Sum_probs=189.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeeccch-----hhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|+..+.||+|+||.||+|.+..+|.    .+|+|.+.....     ...+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3468999999999999999999987776    468888765422     345789999999999999999877421    


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                        ..+++++|++ |++.+.+..   ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg  154 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFG  154 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEcccc
Confidence              1458999998 566665543   234688999999999999999999986 999999999999998877 89999999


Q ss_pred             CccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+. ..+......+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--  230 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL--  230 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC--
Confidence            99765433221   12334678999999855 448999999999999999997 9999977654333 2222211000  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                               ..+...+..+.+++.+||..||++||++.+++..
T Consensus       231 -------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 -------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     0122357889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-37  Score=284.39  Aligned_cols=242  Identities=21%  Similarity=0.305  Sum_probs=186.5

Q ss_pred             EeeccCCceEEEEEEEcCCC------cEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           77 RIVGQGSFGVVFQAKCLETG------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +.||+|+||.||+|.+...+      +.+|+|.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999986544      78999987543     2344579999999999999999988743     33478


Q ss_pred             EEEeccc-hhHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC----CcEEEee
Q 015298          146 LVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCD  217 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~----~~ikl~D  217 (409)
                      +||||++ ++|.+.+.....   ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 577777654322   124578889999999999999999986 999999999999998654    2699999


Q ss_pred             cCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          218 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       218 fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      ||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---
Confidence            999875533221   1123446789999998654 48999999999999999998 999998766555433322100   


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ....+..++..+.++|.+||..+|.+||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                     00123457889999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=280.72  Aligned_cols=245  Identities=19%  Similarity=0.254  Sum_probs=182.5

Q ss_pred             eeccCCceEEEEEEEcCC--CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEec
Q 015298           78 IVGQGSFGVVFQAKCLET--GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      .||+|+||.||++.....  ...+++|.+....     ..+.+|+.+++.++||||+++++.+.     .....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            689999999999975433  2456677665332     34567888999999999999999874     33447899999


Q ss_pred             cc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC-
Q 015298          151 VP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  228 (409)
Q Consensus       151 ~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~-  228 (409)
                      +. ++|.+.+..........+...++.++.||+.||+|||++ +|+||||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            99 477777664333334567778889999999999999986 999999999999999887 79999999976432211 


Q ss_pred             --CCccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          229 --PNISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       229 --~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                        ......++..|+|||++...      ..++.++|||||||++|+|++ |..||......+.+..+.+.....      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence              12345678899999987421      235788999999999999997 577887766666555544321100      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                       .+...+...+++.+.+++..|| .+|.+||++.++++
T Consensus       229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                             0011123346889999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-37  Score=283.25  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=190.0

Q ss_pred             eEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc-c
Q 015298           73 YMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE-L  142 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~-~  142 (409)
                      |.+.+.||+|+||.||+|.+.   .+++.||||.+..+.      ....+|+++++.++||||+++++.+........ .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999865   357899999986532      234578999999999999999987755433222 2


Q ss_pred             EEEEEEeccc-hhHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ..+++++|+. +++...+....  .....++...+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            3467889988 46555543211  1123578889999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++.......   .....+++.|++||.+.+. .++.++|||||||++|+|++ |.+||......+....+.... .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~---  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R---  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c---
Confidence            9876533221   1223345779999998554 47899999999999999999 899998766544333332210 0   


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                              ...+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       234 ------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 ------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00123467899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-37  Score=280.49  Aligned_cols=234  Identities=21%  Similarity=0.223  Sum_probs=180.5

Q ss_pred             EeeccCCceEEEEEEEcCCC----------cEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           77 RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ..+.+|+.+++.++||||+++++++.. .     .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence            36899999999999998776          358888775443   355688999999999999999998754 2     2


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC------cEEEe
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH------QVKLC  216 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~------~ikl~  216 (409)
                      .++||||+.+ +|...+...   ...++...+..++.||+.||.|||++ ||+||||||+||+++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999985 555555432   23789999999999999999999986 9999999999999986652      49999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |||++.....   .....++..|+|||.+.+. ..++.++|||||||++|+|++ |..||...+..+.......    . 
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~-  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q-  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C-
Confidence            9999876533   2234566789999998655 358999999999999999999 5788866543222211110    0 


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ...+......+.++|.+||..||.+|||+.++++
T Consensus       223 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 -------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                     0011112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=297.92  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=194.4

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCc---E-EEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGE---T-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      +-.+.++||+|+||.||+|..+..+.   . ||+|..+.+       ...+-+|+++|+.++|||||+++|+......  
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P--  235 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP--  235 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--
Confidence            34445899999999999999875432   3 899988642       2344579999999999999999997744332  


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                         ++||||+|.| +|.+.+...   .+.++..+...++.+.++||+|||++ +++||||-..|+|++.++ .+||+|||
T Consensus       236 ---l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  236 ---LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             ---cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCccc
Confidence               7799999995 666666542   23699999999999999999999986 999999999999999877 78999999


Q ss_pred             CccccccCCCCc-cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          220 SAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       220 ~a~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      +++......... ..--...|+|||.+... .|++++|||||||++||+.+ |..||.+....+....+....       
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------  379 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------  379 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-------
Confidence            987643111111 11134679999999665 69999999999999999998 889999999988888874421       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                          +....+...+.++..++.+|+..||++|||..++.+
T Consensus       380 --------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 --------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                111244567889999999999999999999998853

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=311.35  Aligned_cols=248  Identities=21%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc-----EEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+-...+.||+|+||.||.|.......     .||+|.+.+.     ...+.+|..+|+.++|||||+++++.+.... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            3456778899999999999999765433     4999988654     3455689999999999999999999976333 


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                          .+|++|||. |+|...++.-+.   ....++..+...++.||++|+.||+++ ++|||||...|+|++... .+||
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKI  843 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKI  843 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEE
Confidence                579999999 577777765321   145688999999999999999999986 999999999999999887 8999


Q ss_pred             eecCCccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          216 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|||+|+.........   ...-...|||||.+.. ..++.++|||||||+|||++| |..||.+.++.+.+......-+
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR  922 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR  922 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence            9999998443322111   1122357999999976 459999999999999999998 9999999999888776655321


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+                            .|..+++.+.++|..||+.+|++||+...+++
T Consensus       923 L~----------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LD----------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cC----------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            11                            45678999999999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-36  Score=279.15  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEc----CCCcEEEEEEeeccch-----hhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..|.+.+.||+|+||.||+|...    .+++.+|+|.+.....     .+.+|+++++.+.|+||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            35888899999999999999864    3488999999875433     45689999999999999999887633   224


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+.+++|||++ ++|.+.+...   ...++...+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            45789999997 4776666532   23689999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCH
Q 015298          221 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-GTPTR  295 (409)
Q Consensus       221 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~  295 (409)
                      +.........    ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.........  +.... +....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence            9866432211    122345669999998654 4889999999999999999999998654321100  00000 00000


Q ss_pred             HHH-hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEI-KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+ ..+...             .....+...+.++.+++.+||..||.+|||+.++++
T Consensus       233 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKEG-------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHcC-------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000 000000             000112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=291.29  Aligned_cols=273  Identities=21%  Similarity=0.262  Sum_probs=182.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc----------------CCCcEEEEEEeeccch------------------hhHHH
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL----------------ETGETVAIKKVLQDKR------------------YKNRE  114 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~e  114 (409)
                      ..++|.+.++||+|+||.||+|.+.                ..++.||||++..+..                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                3456799999864321                  11236


Q ss_pred             HHHHHhcCCCCe-----ecccceeeecCC---CCccEEEEEEeccc-hhHHHHHHHhh-----------h---------h
Q 015298          115 LQTMRLLDHPNV-----VSLKHCFFSTTD---KDELYLNLVLEYVP-ETVHRVVKHFN-----------K---------L  165 (409)
Q Consensus       115 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~l~~~~-----------~---------~  165 (409)
                      +.++.+++|.++     +++++++.....   ......++|+||++ ++|.+++....           .         .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766554     566666543211   11234689999999 46766664311           0         0


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCcc--ccccccccccc
Q 015298          166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPE  243 (409)
Q Consensus       166 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE  243 (409)
                      ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++.....+.....  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12345677889999999999999986 999999999999999887 899999999975543322222  23478999999


Q ss_pred             cccCCCC---------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          244 LIFGATE---------------------YTTAIDIWSAGCVVAELMLGKP-LFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       244 ~l~~~~~---------------------~~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .+.....                     .....|+||+||++|+|++|.. ||.........   .+.. ......|...
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~~  456 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRMY  456 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHhh
Confidence            9843211                     1124799999999999999985 77543211110   0000 0000011110


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCC---CCCCCHHHHhCCCCccC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP---NLRCTALDALIHPFFDE  359 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp---~~R~s~~ell~hp~f~~  359 (409)
                      .            ...+.-......++.++||+.+||..+|   .+|+|+.|+|+||||..
T Consensus       457 ~------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        457 K------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             c------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0            0011111233478999999999999876   68999999999999963

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=289.72  Aligned_cols=239  Identities=29%  Similarity=0.462  Sum_probs=195.7

Q ss_pred             EEEEeeccCCceEEEEEEEcCC--C--cEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           74 MAERIVGQGSFGVVFQAKCLET--G--ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~--~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...++||.|.||.||+|.....  |  -.||||..+.+     .+.+..|..+|+.++||||++++|++...      -+
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence            3456899999999999987533  3  35889988764     24456799999999999999999988421      16


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +||||.++ |.|..+++..   ...++......++.||+.||.|||+. .+|||||...|||+.+.. -+||+|||+++.
T Consensus       466 WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeecccchhhh
Confidence            89999999 6666666542   46789999999999999999999986 999999999999999887 799999999998


Q ss_pred             cccCCCCccccc--cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGEPNISYIC--SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ..+........|  ..-|||||.+ +-..++.++|||.|||.|||++. |..||.+-.+.+.+..+.++-+.|       
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-------  612 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-------  612 (974)
T ss_pred             ccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------
Confidence            766544333333  4469999998 44569999999999999999885 999999998888877776643333       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                                           .|+.+++.+..|+.+||.+||.+||...++.
T Consensus       613 ---------------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ---------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ---------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                 5677999999999999999999999877753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=9e-37  Score=279.62  Aligned_cols=282  Identities=30%  Similarity=0.509  Sum_probs=213.1

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcC---CCcEEEEEEeec--cchhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQ--DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      +.....|..+++||+|.|++||++.+..   ..+.||+|.+..  .......|+++|..+ .+.||+++.+++     ..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----cc
Confidence            3445679999999999999999999887   789999999854  345678999999998 589999999988     55


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      +...++|+||++. ...++.       ..++...++.+++.++.||.++|.+ |||||||||.|+|.+...+.-.|+|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEech
Confidence            5568999999995 333332       3577889999999999999999987 999999999999999888789999999


Q ss_pred             Ccccccc-------------------C--------------------------CCCccccccccccccccccCCCCCCch
Q 015298          220 SAKVLVK-------------------G--------------------------EPNISYICSRYYRAPELIFGATEYTTA  254 (409)
Q Consensus       220 ~a~~~~~-------------------~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~  254 (409)
                      +|.....                   +                          .......||++|+|||++...+..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9862100                   0                          001134689999999999888888999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhhcCCC-----------ccc--cccCcc-----cC
Q 015298          255 IDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTREEIKCMNPN-----------YTE--FKFPQI-----KA  315 (409)
Q Consensus       255 ~DiwslG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~-----------~~~--~~~~~~-----~~  315 (409)
                      +||||.|+|++.++++..||.. .+..+.+.++...+|.......-.+...           ..+  ..+...     ..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999854 4556667777766654332221111100           000  011111     00


Q ss_pred             --C--CCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          316 --H--PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       316 --~--~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                        .  .+.....+..+..+.+|+.+||..||.+|+||+++|+||||....
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence              0  122222334567899999999999999999999999999998543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=300.52  Aligned_cols=251  Identities=30%  Similarity=0.442  Sum_probs=192.7

Q ss_pred             eEEEEeeccCCce-EEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEEe
Q 015298           73 YMAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        73 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      |.-.+.+|.|..| .||+|..  .|+.||||++..+. ...++|+..|+.- +|||||++++.-     .+..+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            4555678999888 5799987  88899999987665 4778999999998 699999976543     67788999999


Q ss_pred             ccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CC-CcEEEeecCCccccc
Q 015298          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HT-HQVKLCDFGSAKVLV  225 (409)
Q Consensus       150 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~-~~ikl~Dfg~a~~~~  225 (409)
                      .|..+|.+++...............+.+..|++.||++||+ ++||||||||.||||+.   ++ ..++|+|||+++...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999988631111112224456778999999999998 69999999999999976   23 379999999998876


Q ss_pred             cCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .+..    ..+..||.+|+|||++.+.. -+.++|||||||++|+.++| ..||...-..  -.+|.+..          
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~----------  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGN----------  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCc----------
Confidence            5543    33567899999999997654 57799999999999999986 8999654322  22333210          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                          +.   +..         +......++.+||.+|+.+||..||+|.++|.||+|-..
T Consensus       730 ----~~---L~~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  730 ----YT---LVH---------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ----cc---eee---------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                00   000         111111289999999999999999999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.5e-35  Score=264.56  Aligned_cols=238  Identities=39%  Similarity=0.644  Sum_probs=192.4

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch-hHH
Q 015298           83 SFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVH  156 (409)
Q Consensus        83 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  156 (409)
                      +||.||+|.+..+|+.+|+|++...     .....+|++.+++++|+|++++++++..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999989999999998654     3456789999999999999999998743     3457899999997 777


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCcccccc
Q 015298          157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  236 (409)
Q Consensus       157 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt  236 (409)
                      ..+..    ...++...+..++.+++.++.+||+. +|+|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            76654    23389999999999999999999996 999999999999999887 8999999999877555445566788


Q ss_pred             ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCC
Q 015298          237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  316 (409)
Q Consensus       237 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (409)
                      ..|++||.+.+. .++.++|+||||+++|+|++|..||......+...+..........                     
T Consensus       150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------  207 (244)
T smart00220      150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------------------  207 (244)
T ss_pred             cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence            899999998643 4788999999999999999999999874443333332221100000                     


Q ss_pred             CCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          317 PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       317 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                          .....++.++.+++.+||..||++||++.++++||||
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                0011167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=248.81  Aligned_cols=215  Identities=24%  Similarity=0.420  Sum_probs=178.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHh-cCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+....+..||+|++|.|-+.++..+|...|+|.+...-     +...+|+.+..+ ...|.+|++++.++...+   
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd---  119 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD---  119 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc---
Confidence            33445566678999999999999999999999999986442     223345555444 368999999998865544   


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                        ++|.||.|..+|..+..+..+.++.+++..+-+|+..++.||.|||+++.++|||+||+||||+.+| ++|+||||.+
T Consensus       120 --vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIs  196 (282)
T KOG0984|consen  120 --VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGIS  196 (282)
T ss_pred             --EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccc
Confidence              8899999999999998888888999999999999999999999999999999999999999999998 8999999999


Q ss_pred             cccccCCCCccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQLVEIIK  288 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~  288 (409)
                      ....+.-..+...|-.-|||||.+..   +..|+-++||||||+++.||.+++.||+.. +..+++.++..
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            87766655554667777999999842   335889999999999999999999999754 45555555543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=280.98  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+....++||.|.||.||.|.++.....||||.++.+.   ..+..|..+|+.++|||+|++++++.     .+.-+
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPF  338 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPF  338 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCe
Confidence            33445667789999999999999999999999999998764   55678999999999999999999984     33337


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |||+|||. |+|++++....  ...++.-....++.||..|+.||..+ ++|||||...|.|+.++. .+|++|||+++.
T Consensus       339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhh
Confidence            89999988 88999988765  35577777888999999999999986 999999999999999876 899999999998


Q ss_pred             cccCCCCccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          224 LVKGEPNISYIC---SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       224 ~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +..+ ......|   ..-|.|||.|.- ..++.++|||+|||+|||+.| |-.||.+-+..+.+..+.+..+.       
T Consensus       415 MtgD-TYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-------  485 (1157)
T KOG4278|consen  415 MTGD-TYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-------  485 (1157)
T ss_pred             hcCC-ceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-------
Confidence            7543 2223333   456999999843 348999999999999999997 89999998877776666553221       


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                                           .-|+.+++.+.+|++.||+++|.+||+..++
T Consensus       486 ---------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  486 ---------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ---------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                                 1356799999999999999999999998886

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=280.02  Aligned_cols=252  Identities=20%  Similarity=0.288  Sum_probs=199.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...-.++++||+|-||.|.+|.- ..+..||+|.++.+.     ..+.+|+++|.+|+||||+.+++++...+.     +
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----i  610 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----L  610 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----h
Confidence            34577889999999999999995 346899999997542     556789999999999999999999865443     7


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++|+|||+ |+|...+.....  ..+......+|+.||+.|++||.+ +++|||||.+.|+|++.++ ++||+|||+++.
T Consensus       611 cmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~  686 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRN  686 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCcccccc
Confidence            89999999 677666654321  223455567799999999999997 6999999999999999998 899999999986


Q ss_pred             cccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ...+....   ..+-...|||+|.+.-+ ++++++|+|+||++|||+++  .+.||......+...+.-..+..+.....
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            64443321   23345789999999765 49999999999999999874  78999888877776665555443332211


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                           -..|.-++..+.++|.+||..|..+|||.+++-.
T Consensus       766 ---------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  766 ---------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ---------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                 1135568899999999999999999999999843

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=291.65  Aligned_cols=244  Identities=25%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .-.|.++||.|.||.||+|+.+..|   ..||||.++..     +..+..|+.||-+++||||++|.++...     ..-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence            4678899999999999999988776   46999999743     4566789999999999999999998733     233


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +.||+|||+ |.|+..|+..   .+.++..++..+++.|+.|++||-+ +|+|||||...|||++.+- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEecccccee
Confidence            679999999 6776666543   4679999999999999999999997 5999999999999999998 89999999999


Q ss_pred             ccccCC-CCccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKGE-PNISYIC---SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~~-~~~~~~g---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ...++. ...+..|   ..+|.|||.+. ..+++.++||||+|++|||.++ |+.||.+.++.+.+..|....+.|++  
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--  856 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--  856 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence            775554 2222222   35799999994 4569999999999999999775 99999999999999999988776653  


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                -+++..+.+|+..||++|-.+||...|++.+
T Consensus       857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                      4589999999999999999999999998753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.8e-34  Score=309.21  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=183.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEec
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      ..|...+.||+|+||.||+|.+..+|..||+|++.........|++++++++||||+++++++...     ...++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeC
Confidence            346677899999999999999999999999999976655556789999999999999999988433     336899999


Q ss_pred             cc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          151 VP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH---RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       151 ~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ++ |+|.+.+.       .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++ ..++. ||.......
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~  834 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT  834 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-ecccccccc
Confidence            98 56666653       3788889999999999999999   54 999999999999999776 56665 665543321


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCC-HHHHhhcCCC
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPT-REEIKCMNPN  304 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~-~~~~~~~~~~  304 (409)
                         .....+|+.|+|||++.+. .++.++|||||||++|||+||+.||..... ...+.+..+...... ...+  .++ 
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-  907 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--IDP-  907 (968)
T ss_pred             ---CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe--eCc-
Confidence               1234678999999998654 589999999999999999999999954321 111111111110000 0000  000 


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                             .+.. .  ...+.....++.+++.+||+.||++|||+.++++.
T Consensus       908 -------~~~~-~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        908 -------SIRG-D--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             -------cccC-C--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                   0000 0  00111123467789999999999999999999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=276.57  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCC-C--cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLET-G--ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...+.++||+|.||.|++|.+... |  ..||||.+..+.     ..+.+|+.+|.+|+|+|++++|++... .     -
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q-----p  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q-----P  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c-----h
Confidence            456678999999999999998753 3  468999997654     456799999999999999999998743 1     1


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +-||||.++ |+|++.+..  .....|.......++.||+.|+.||..+ ++|||||-..|+|+-... .|||+|||+.+
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeeccccee
Confidence            458999999 677777665  3467788899999999999999999987 999999999999998766 89999999999


Q ss_pred             ccccCCCCccccc----cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKGEPNISYIC----SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ....++......+    ...|.|||.+.. ..++.++|+|++||++|||+| |+.||.+....+++.+|-+....+    
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp----  335 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP----  335 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC----
Confidence            8866655443222    345999999965 459999999999999999997 899999999888877765432111    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                              -++.+++++.++++.||..+|.+|||...+.+.-+..+
T Consensus       336 ------------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  336 ------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ------------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                    24568999999999999999999999998865544443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=266.54  Aligned_cols=197  Identities=28%  Similarity=0.432  Sum_probs=171.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh------------hHHHHHHHHhcC---CCCeecccce
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY------------KNRELQTMRLLD---HPNVVSLKHC  132 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~e~~~l~~l~---h~niv~~~~~  132 (409)
                      .+..+|...+.+|+|+||+|++|.++.+...|+||.+.+++-.            .-.|+.||..|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            3455799999999999999999999999999999998765421            125999999997   9999999999


Q ss_pred             eeecCCCCccEEEEEEeccchh--HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          133 FFSTTDKDELYLNLVLEYVPET--VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      |     +++.|+||+||-.+.+  |-+++.    ....+++.++..|++|++.|+++||+. ||||||||-+||.++++|
T Consensus       638 F-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g  707 (772)
T KOG1152|consen  638 F-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNG  707 (772)
T ss_pred             e-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCC
Confidence            9     7778899999987743  444443    368899999999999999999999997 999999999999999998


Q ss_pred             CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015298          211 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (409)
                       -+||+|||.|.... ..+.-.+.||..|.|||++.+..+.+..-|||+||++||.++..+.||..
T Consensus       708 -~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  708 -FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             89999999987543 44556789999999999998888889999999999999999999999853

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=252.80  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=184.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHH--HhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTM--RLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l--~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .....+.+.||+|.||.||+|.+  .|+.||||++... ++...+|.++.  ..|+|+||+.+++.-.... ..-..++|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEE
Confidence            35688999999999999999998  7899999999654 44445666655  4679999999876543322 22335899


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcEeecCCCCceeecCCCCcEEEeec
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      |++|.+ |+|.+++..     ..++.....+++..++.||++||..+       .|.|||||..|||+.+++ ..-|+|+
T Consensus       287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeec
Confidence            999999 889888874     67899999999999999999999643       499999999999999998 8999999


Q ss_pred             CCccccccCC-----CCccccccccccccccccCCCCC-----CchhhHHHHHHHHHHHHh----C------CCCCCCCC
Q 015298          219 GSAKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TTAIDIWSAGCVVAELML----G------KPLFPGDS  278 (409)
Q Consensus       219 g~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DiwslG~il~~llt----g------~~pf~~~~  278 (409)
                      |+|.......     .....+||.+|||||+|......     -..+||||||.++||++.    |      ++||.+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9997654432     34568899999999999543321     135899999999999984    2      47776432


Q ss_pred             c----HHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          279 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       279 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .    .+.+.++.-                  ..+++......|..   ...-..+..+++-||..||.-|.||--+-+
T Consensus       441 p~DPs~eeMrkVVC------------------v~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVC------------------VQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCHHHHhccee------------------ecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            2    111111110                  00111111112211   001134567899999999999999876643

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=257.65  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=186.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHh--cCCCCeecccceeeecCCCCccEEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .-.....||+|+||.||+|..  +++.||||++... ++....|-+|.+.  ++|+||+++++.-...+. ...-++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEe
Confidence            456678899999999999987  6799999999654 4566677777765  589999998775433332 244578999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcEeecCCCCceeecCCCCcEEEeecC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--------GVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      +|.+ |+|.+++..     ..+++....+++..+++||+|||+..        .|+|||||..|||+..|. ...|+|||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9998 889888884     67999999999999999999999732        599999999999999998 89999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          220 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYT-----TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       220 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|..+..+..   ....+||.+|||||+|.+...+.     .+.||||+|.|||||++.-..+......+...-....+|
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9988765543   34578999999999997665554     468999999999999975433321111110000011111


Q ss_pred             -CCCHHHHhhc------CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          292 -TPTREEIKCM------NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       292 -~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                       .|.-+.++..      .|.+.+         .|...   .-...+++.+..||..||+.|.|+.=+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~---------~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPD---------AWRKH---AGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChh---------hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence             2222222211      111111         11111   234678999999999999999998644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-33  Score=270.35  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.....+|+|.||.||+++++.+++..|+|+++-+    ....+.|+-+++..+||||+.+++.|...+.     ++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence            45799999999999999999999999999999999754    3456789999999999999999998865444     88


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |.||||+|+-+..+.+   ..+.+++.++...++..+.||+|||+. |=+|||||-.||+++..+ .+|+.|||.+..+.
T Consensus        89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqit  163 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhhh
Confidence            9999999643333322   268899999999999999999999985 999999999999999888 89999999875543


Q ss_pred             c-CCCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 K-GEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~-~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      . -....++.||++|||||+-.  ....|...+|||++|+...|+---++|-...-....+..+.+..-.|+.-      
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l------  237 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL------  237 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc------
Confidence            2 23456899999999999872  22348899999999999999988887766555544444444432222210      


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                 +       -+.+.++.+.+|++.+|..+|++|||++.+|.|||...-
T Consensus       238 -----------k-------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  238 -----------K-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             -----------c-------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                       0       123467889999999999999999999999999998753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.9e-32  Score=263.60  Aligned_cols=241  Identities=26%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+..++||+|+||+||+|.+...|+    +||||++...     ...+.+|+-+|..++|||+++++++.....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4456799999999999999876665    5788887543     345668999999999999999999884332      


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +-||++|++ |.|.++++.   ....+.......|+.||++|+.|||++ +++||||-..|||+.+-. .+||.|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchhh
Confidence            458999999 677777665   357899999999999999999999997 999999999999999877 79999999999


Q ss_pred             ccccCCCCccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          223 VLVKGEPNISYIC---SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       223 ~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ............+   .+-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....+.-..+.+..+.      
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL------  919 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL------  919 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC------
Confidence            8866655444333   345999999854 459999999999999999997 99999988876665544443211      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                            ..|...+.++..++.+||..|+..||++.++..
T Consensus       920 ----------------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  920 ----------------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ----------------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                                  135568899999999999999999999998753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=269.62  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=190.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEc---C----CCcEEEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCL---E----TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      +..+.+.||+|.||.|++|.-.   .    ....||||.++..     .+.+..|+++|+.+ .|+||+.+.+++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            3456679999999999999743   1    1457999988643     34556899999998 59999999998843   


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhh---hh-------c--CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCcee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFN---KL-------N--QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIl  205 (409)
                        ...+++|+||+. |.|...+....   ..       .  ..++..+...++.||+.|++||++. ++|||||-..|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEE
Confidence              444789999999 78888877644   11       1  1388999999999999999999986 9999999999999


Q ss_pred             ecCCCCcEEEeecCCccccccCCCCcc--ccc--cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-c
Q 015298          206 VNPHTHQVKLCDFGSAKVLVKGEPNIS--YIC--SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS-G  279 (409)
Q Consensus       206 i~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~-~  279 (409)
                      ++.+. .+||+|||+|+...+......  ..+  ...|||||.+.. ..|+.++||||+|++|||+.| |..||.+.. .
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99886 899999999986544333221  111  234999999976 569999999999999999998 889998855 3


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       280 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+....+..+. +                           -..|...++++.++++.||..+|++||+..++.+
T Consensus       529 ~~l~~~l~~G~-r---------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGN-R---------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhcCC-C---------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            33333222211 1                           0135568999999999999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=235.76  Aligned_cols=258  Identities=23%  Similarity=0.306  Sum_probs=189.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhc-CCCCeecccceeeecCCCCccE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...+.|.+.+.||+|.||.+.+|+++.++..+++|.+...   .+.+.+|..---.| -|.||+.-++.-+...+    +
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----A   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----e
Confidence            3456799999999999999999999999999999998654   34555666544444 58999998776554333    5


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee-cCCCCcEEEeecCCc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSA  221 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli-~~~~~~ikl~Dfg~a  221 (409)
                      +++++||++ |+|...+.     ..++.+...+.++.|+++||.|||++ ++||||||.+|||| +.+..+|||||||++
T Consensus        97 YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccc
Confidence            789999999 66665554     36788999999999999999999997 99999999999997 666679999999998


Q ss_pred             cccccCCCCccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~  296 (409)
                      +.....  ....-.+..|.+||++...    -...+.+|+|+||+++|.++||.+||+.....+ .+.+.++-.+.... 
T Consensus       171 ~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-  247 (378)
T KOG1345|consen  171 RKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-  247 (378)
T ss_pred             cccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-
Confidence            754221  1112234558899987322    224678999999999999999999998544332 22333332221110 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCC---CCHHHHhCCCCccC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR---CTALDALIHPFFDE  359 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R---~s~~ell~hp~f~~  359 (409)
                             .     .|        . .-..+++.+..+.++-|..++++|   .++......-|...
T Consensus       248 -------~-----~P--------~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  248 -------A-----LP--------K-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             -------c-----Cc--------h-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence                   0     00        0 112478999999999999999999   45555566667654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.4e-29  Score=223.59  Aligned_cols=207  Identities=35%  Similarity=0.602  Sum_probs=175.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccc-
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-  152 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  152 (409)
                      ||+|.+|.||++.+..+|+.+++|++....     ....+|++.++.+.|++++++++++..     ....++++|++. 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998889999999997664     357789999999999999999988743     345789999999 


Q ss_pred             hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC-CCCcEEEeecCCccccccCC-CC
Q 015298          153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE-PN  230 (409)
Q Consensus       153 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~-~~~~ikl~Dfg~a~~~~~~~-~~  230 (409)
                      ++|...+...   ...++...++.++.+++.++.+||+. |++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            6777666532   14689999999999999999999986 9999999999999998 56 89999999987654332 12


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      ....+...|++||.+......+.++|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3355678899999986543578999999999999999                                           


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 015298          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP  355 (409)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp  355 (409)
                                       ..+.+++.+|+..||.+||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1478999999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.3e-29  Score=223.67  Aligned_cols=204  Identities=32%  Similarity=0.523  Sum_probs=167.8

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      |.+.+.||+|++|.||++.+..+++.+|+|.+...     .....+|++.++.++|+|++++++++..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56789999999999999999988999999999653     3455679999999999999999987743     2347899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +|++.+ +|.+.+...    .. +++..+..++.+++.++.+||++ +++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777766542    23 88999999999999999999986 999999999999999886 89999999988765


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCcH-HHHHHHH
Q 015298          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGV-DQLVEII  287 (409)
Q Consensus       226 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~-~~~~~i~  287 (409)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+.. +....+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            443  334566788899999884444577899999999999999999999977 4444 3444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.9e-30  Score=273.82  Aligned_cols=206  Identities=17%  Similarity=0.197  Sum_probs=145.8

Q ss_pred             hcCC-CCeecccceeeecC--CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 015298          120 LLDH-PNVVSLKHCFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (409)
Q Consensus       120 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (409)
                      .++| +||+.+++.|-...  ......+++++|+++++|.+.+..   ....+++..++.++.||+.||.|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3455 57777777652221  112234678899999988888753   235699999999999999999999986 9999


Q ss_pred             ecCCCCceeecCCC------------------CcEEEeecCCccccccCC-----------------CCccccccccccc
Q 015298          197 RDIKPQNLLVNPHT------------------HQVKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  241 (409)
Q Consensus       197 ~Dlkp~NIli~~~~------------------~~ikl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~a  241 (409)
                      |||||+||||+..+                  ..+|++|||+++......                 ......||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996432                  256677777765321100                 0112457899999


Q ss_pred             cccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCccc
Q 015298          242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  321 (409)
Q Consensus       242 PE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (409)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  ..+..+.... .++.                          
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ--------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence            99986654 8999999999999999999988875321  1111111110 0100                          


Q ss_pred             CCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          322 FPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       322 ~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      .. ...+...+++.+||.+||.+|||+.++++||||.+.
T Consensus       234 ~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        234 IL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            00 113456789999999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.2e-28  Score=210.33  Aligned_cols=166  Identities=20%  Similarity=0.197  Sum_probs=124.8

Q ss_pred             hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCcc
Q 015298          153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  232 (409)
Q Consensus       153 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~  232 (409)
                      |+|.+++...   ...+++..++.++.||+.||.|||++ +      ||+||+++.++ .+++  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4566666532   45699999999999999999999986 6      99999999887 7888  9998765432    2


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCccccccC
Q 015298          233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  311 (409)
Q Consensus       233 ~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  311 (409)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            3688999999999664 4899999999999999999999999765432 2233332221110000               


Q ss_pred             cccCCCCcccCCCCCCh--hHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          312 QIKAHPWHKIFPKRMPP--EAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       312 ~~~~~~~~~~~~~~~s~--~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                             ....+..++.  ++.++|.+||..||.+|||+.++++|+|+.
T Consensus       128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                   0000112333  699999999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=215.63  Aligned_cols=250  Identities=21%  Similarity=0.250  Sum_probs=189.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-----cEEEEEEeeccchh-----hHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDKRY-----KNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~-----~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      +..+++....+-+|.||.||.|.++...     +.|.+|.++.....     ...|--++..+.|||+..+.++.....+
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            4457888889999999999999776432     34556655544322     2356667777789999999887754322


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhh----hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcE
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFN----KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV  213 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~i  213 (409)
                          ..++++.+++ |+|...+...+    +..+.++..+...++.|++.|++|||++ |+||.||...|.+|+..- ++
T Consensus       362 ----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  362 ----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eE
Confidence                2456788888 77777766433    1234466777888999999999999987 999999999999999776 89


Q ss_pred             EEeecCCccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015298          214 KLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV  289 (409)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  289 (409)
                      ||+|=.+++-..+.....   ..--...||+||.+.. ..|+.++|+||||++||||+| |+.||..-+..++..-+.++
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999988665543321   1112346999999965 459999999999999999998 99999888877765555443


Q ss_pred             hCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+                            --.|-++|+++..++--||..+|++||+.+|+..
T Consensus       515 yR----------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 YR----------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ce----------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            21                            1135578999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5.8e-28  Score=242.99  Aligned_cols=259  Identities=23%  Similarity=0.341  Sum_probs=192.1

Q ss_pred             EEEEeeccCCceEEEEEEEcCCCcEEEEEEee----ccchh------hHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .....+|.|++|.|+.+......+.++.|.+.    .....      ...|+.+-..+.|||++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            45678999999999998888777777777553    11111      2245566677899999887766643332     


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ..-+||||+++|..++..    ...++..++-.+++|++.|++|||.. ||.||||||+|++++.++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCccee
Confidence            223499999866666554    35789999999999999999999985 999999999999999988 899999999876


Q ss_pred             cccCC-----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      .....     .....+|+..|+|||++.+..+.....||||.|+++..|++|+.||......+....-...   .     
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---~-----  541 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---S-----  541 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---c-----
Confidence            54332     2346788999999999988877778899999999999999999999765443322100000   0     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                         .    .+....-.     ..+...++.+.+.+|.+||+.||.+|.|+.++++.+||+.+...
T Consensus       542 ---~----~~~~~~~~-----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  542 ---D----QRNIFEGP-----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             ---c----ccccccCh-----HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence               0    00000000     00122468889999999999999999999999999999987643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=206.02  Aligned_cols=210  Identities=24%  Similarity=0.360  Sum_probs=173.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec--cchhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +..|+++++||+|.||.++.|.+.-+++.||||.-..  +......|.+..+.|. .+.|..++-  |.   ....+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYY--FG---qeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYY--FG---QEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceee--ec---cccchhhh
Confidence            4579999999999999999999999999999997643  3455677999999885 688888743  22   44455679


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC----CCCcEEEeecCCcc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP----HTHQVKLCDFGSAK  222 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~----~~~~ikl~Dfg~a~  222 (409)
                      |+|.++.+|.+++...   +.+|+...+..++.|++.-++|+|++ .+|.|||||+|+||..    +.+.|.|+|||+|+
T Consensus       102 VidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            9999999999998865   57899999999999999999999997 9999999999999953    33479999999999


Q ss_pred             ccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHH
Q 015298          223 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD---SGVDQLVEIIKV  289 (409)
Q Consensus       223 ~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~i~~~  289 (409)
                      .+.+...        ..+..||..||+--...+.+ -+...|+=|||-++++.|-|.+||.+.   +..+.+++|-..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~  254 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET  254 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence            8755432        34667899999988887755 789999999999999999999999875   445555555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-26  Score=194.81  Aligned_cols=208  Identities=24%  Similarity=0.334  Sum_probs=168.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCC-CCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..++|+++++||+|+||.+|+|....+|+.||||.-....  .....|..+.+.|++ ..|+.+..++     ....+-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence            3568999999999999999999999999999999886554  345678999999875 5566655544     4445567


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC--CCCcEEEeecCCccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~--~~~~ikl~Dfg~a~~  223 (409)
                      +||+.++.+|.+++...   ...++...+..++-|++.-++|+|.+ ++|||||||+|+|+.-  ..+.+.++|||+|+.
T Consensus        88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhh
Confidence            99999999998887654   46799999999999999999999997 9999999999999743  334799999999987


Q ss_pred             cccCC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 015298          224 LVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       224 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i  286 (409)
                      +.+..        ......||..|.+--...+.. .+...|+=|+|.+|.+..-|..||++.......++.
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            75432        234567899999877765543 688899999999999999999999986655444433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-24  Score=205.94  Aligned_cols=251  Identities=20%  Similarity=0.202  Sum_probs=189.3

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCC-cEEEEEEeeccc----hhhHHHHHHHHhcCC----CCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~  142 (409)
                      +|.+.+.||+|+||.||+|.+..++ +.+|+|......    .....|..++..+..    +++..+++.+.    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999998775 678999876532    146679999988873    57777766552    2445


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC----CcEEEeec
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCDF  218 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~----~~ikl~Df  218 (409)
                      +-+|||+.++.+|.++.....  .+.++...+..++.|++.+|.+||+. |++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776543  68899999999999999999999986 999999999999997553    47999999


Q ss_pred             CCcc--ccccCC--------C-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015298          219 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       219 g~a~--~~~~~~--------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  287 (409)
                      |+++  ......        . .....||..|.++.+..+. ..+.+.|+||++.++.+++.|..||..........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 2235599999999998665 48999999999999999999999997765443333322


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +.......               ..         +....+.++..+...+-..+...+|....+...
T Consensus       251 ~~~~~~~~---------------~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLT---------------DR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhcc---------------cc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            21110000               00         112345677888887777888889977766543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3e-25  Score=210.14  Aligned_cols=159  Identities=19%  Similarity=0.287  Sum_probs=120.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcC-CCcEEEEEEeecc---------chhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ...++|.+.+.||+|+||+||+|.+.. +++.+|||++...         ...+.+|+++|+.++|+|++..+..+   .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            345679999999999999999999876 6788899986422         23467899999999999998532211   1


Q ss_pred             CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecC-CCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDI-KPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dl-kp~NIli~~~~~~ikl~  216 (409)
                           ..++||||+.|..+..+   .    ...   ...++.|++.||.|||+. ||+|||| ||+|||++.++ .++|+
T Consensus        92 -----~~~LVmE~~~G~~L~~~---~----~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ikLi  154 (365)
T PRK09188         92 -----KDGLVRGWTEGVPLHLA---R----PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAAVI  154 (365)
T ss_pred             -----CcEEEEEccCCCCHHHh---C----ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEEEE
Confidence                 25799999997533221   1    111   145788999999999986 9999999 99999998777 89999


Q ss_pred             ecCCccccccCCCC---------cccccccccccccccc
Q 015298          217 DFGSAKVLVKGEPN---------ISYICSRYYRAPELIF  246 (409)
Q Consensus       217 Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~l~  246 (409)
                      |||+|+........         ....+++.|+|||.+.
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999866443211         2345678899999884

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-26  Score=222.33  Aligned_cols=237  Identities=28%  Similarity=0.417  Sum_probs=189.8

Q ss_pred             eccCCceEEEEEEE---cCCCcEEEEEEeecc------chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEEEE
Q 015298           79 VGQGSFGVVFQAKC---LETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        79 lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      +|.|.||.|++++-   ...|..+|+|+.++.      ......|-.++..++ ||.++++..++..     +..+++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHhh
Confidence            68999999988753   346778999987542      223345777888886 9999999877733     33477899


Q ss_pred             eccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       149 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      ++..|+  ++.. .......+.+.....+...++-+++++|+. +|+|||+|++||+++.+| .+++.|||+++...+..
T Consensus        77 d~~rgg--~lft-~l~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   77 DFLRGG--DLFT-RLSKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhcccc--hhhh-ccccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHhhh
Confidence            999974  2222 233356788888999999999999999985 999999999999999999 79999999998765554


Q ss_pred             CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccc
Q 015298          229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (409)
Q Consensus       229 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  308 (409)
                      ..   |||..|||||++.   ....++|.||+|+++++|+||..||..    +....|.+..                  
T Consensus       152 ~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~------------------  203 (612)
T KOG0603|consen  152 IA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE------------------  203 (612)
T ss_pred             hc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc------------------
Confidence            33   9999999999986   367899999999999999999999987    5555555421                  


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCC
Q 015298          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPN  364 (409)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~  364 (409)
                                 -.+|..++..+++++..++..+|..|.-     +.++++|+||+.+.+..
T Consensus       204 -----------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  204 -----------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             -----------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence                       1145568899999999999999999985     46889999999998873

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=2.7e-23  Score=195.79  Aligned_cols=260  Identities=34%  Similarity=0.511  Sum_probs=194.8

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCC-CeecccceeeecCCCCccEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  144 (409)
                      |.+...||.|+||.||++.+.   ..+++|.+....       ..+.+|+.+++.+.|+ +++++.+.+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            788999999999999999986   788999885432       3456788999999988 799998887     222236


Q ss_pred             EEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++++++.+. +...+...... ..++...+..++.|++.++.|+|.. +++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            7999999964 33232221100 3789999999999999999999986 9999999999999998764599999999875


Q ss_pred             cccCC-------CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 015298          224 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLG  291 (409)
Q Consensus       224 ~~~~~-------~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~  291 (409)
                      .....       ......||..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23567889999999999663  4688999999999999999999999877664   333333333222


Q ss_pred             CC-CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          292 TP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       292 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .+ ....                    ............+.+++.+++..+|..|.+..+...++|......
T Consensus       232 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         232 TPSLASP--------------------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             Ccccccc--------------------cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            21 0000                    000000112367899999999999999999999999877665433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=5.5e-25  Score=221.94  Aligned_cols=241  Identities=26%  Similarity=0.457  Sum_probs=174.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..-.+|..++.|..|+||.||.++++.+.+.+|+| +.++.-...            ||..+         .++.+  .|
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR------------nilt~---------a~npf--vv  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR------------NILTF---------AGNPF--VV  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh------------ccccc---------cCCcc--ee
Confidence            34567999999999999999999999999999994 433221111            12222         11111  12


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                           |+-..+++.    -+.++.        +++.+++|||+. ||+|||+||+|.+|+.-| .+|++|||+++.....
T Consensus       136 -----gDc~tllk~----~g~lPv--------dmvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPV--------DMVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc----CCCCcc--------hhhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhh
Confidence                 322223322    345554        337899999975 999999999999999988 7999999997654211


Q ss_pred             C----------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          228 E----------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       228 ~----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      .                .....+|||+|+|||++.- +.|+..+|+|++|+|+|+.+.|..||.++...+.+.+.+....
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1                1124589999999999964 4599999999999999999999999999999888877666322


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC---CHHHHhCCCCccCCCCCCCCCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHPFFDELRDPNARLP  368 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~---s~~ell~hp~f~~~~~~~~~~~  368 (409)
                      .-+                         +. .+.++++++++|..+|+.+|..|.   .+-++.+|+||+.+.+...=..
T Consensus       276 ~wp-------------------------E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRq  329 (1205)
T KOG0606|consen  276 EWP-------------------------EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQ  329 (1205)
T ss_pred             ccc-------------------------cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhh
Confidence            211                         11 234789999999999999999997   5678889999999988833223


Q ss_pred             CCCCCCCCCC
Q 015298          369 SGRFLPPLFN  378 (409)
Q Consensus       369 ~~~~~~~~~~  378 (409)
                      ...++|.+..
T Consensus       330 kaefvpql~~  339 (1205)
T KOG0606|consen  330 KAEFVPQLES  339 (1205)
T ss_pred             hccccccccc
Confidence            3344444433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=9.3e-25  Score=198.33  Aligned_cols=237  Identities=25%  Similarity=0.322  Sum_probs=146.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHH-------HhcC----------CCCeeccccee-
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLD----------HPNVVSLKHCF-  133 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-------~~l~----------h~niv~~~~~~-  133 (409)
                      .......||.|+++.||.+.+..||+.+|+|++........++++.+       ..+.          |-.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778899999999999999999999999999864432222122111       1111          11111111111 


Q ss_pred             -------eecCC-CCcc---EEEEEEeccchhHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCcEeecC
Q 015298          134 -------FSTTD-KDEL---YLNLVLEYVPETVHRVVKHFNKLNQR---MPMIYVKLYAYQIFRALSYIHRSIGVCHRDI  199 (409)
Q Consensus       134 -------~~~~~-~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dl  199 (409)
                             +.... ....   ..+++|+-+.++|..++.........   +.......+..|+++.+++||.. |++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccc
Confidence                   11110 1111   24789999998888877654433333   22233345668999999999986 9999999


Q ss_pred             CCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 015298          200 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSAGCVVAELMLGKP  272 (409)
Q Consensus       200 kp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~lltg~~  272 (409)
                      +|+|++++.+| .+.|+||+.........  .....+..|.+||.....       ..++.+.|.|+||+++|.|++|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 89999998776543221  113445779999977332       247889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCC
Q 015298          273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR  345 (409)
Q Consensus       273 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R  345 (409)
                      ||...........                               .|.. .. ++++.+++||.++|++||.+|
T Consensus       249 Pf~~~~~~~~~~~-------------------------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-------------------------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-------------------------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-------------------------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            9975532110000                               1111 22 589999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.6e-23  Score=188.85  Aligned_cols=195  Identities=24%  Similarity=0.395  Sum_probs=142.8

Q ss_pred             CCCCeecccceeeecC----------------------CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHH
Q 015298          122 DHPNVVSLKHCFFSTT----------------------DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY  179 (409)
Q Consensus       122 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~  179 (409)
                      +|||||++...|....                      -.....+|+||..+..+|..++..     ...+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            5999999998774321                      123456899999999998888763     5677788888999


Q ss_pred             HHHHHHHHHHhcCCcEeecCCCCceeecCCC---CcEEEeecCCccccccC-------CCCccccccccccccccccCCC
Q 015298          180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT  249 (409)
Q Consensus       180 qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~---~~ikl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~  249 (409)
                      |+++|+.|||++ ||.|||||.+|||+.-+.   ..+.|+|||.+-.....       .......|.-.-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999997 999999999999984332   36889999976433221       1123455677899999985332


Q ss_pred             C-----CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCC
Q 015298          250 E-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK  324 (409)
Q Consensus       250 ~-----~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (409)
                      .     .-.++|.|+.|.+.||+++...||.+.....  ...                ..|.+-.++.         +++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~----------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDT----------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--ech----------------hhhhhhhCCC---------Ccc
Confidence            2     2247899999999999999999997622110  000                0111212222         567


Q ss_pred             CCChhHHHHHHHhcccCCCCCCCHH
Q 015298          325 RMPPEAVDLVSRLLQYSPNLRCTAL  349 (409)
Q Consensus       325 ~~s~~l~~li~~~L~~dp~~R~s~~  349 (409)
                      .+++.+++++..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            8999999999999999999999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=3.2e-23  Score=209.56  Aligned_cols=241  Identities=31%  Similarity=0.418  Sum_probs=168.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhh---HHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYK---NRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .|...+.||++.|=+|.+|++. .| .|+||++.+..     +.+   .+|++ ...+++||++.+.-..     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            6888999999999999999974 34 49999986543     112   23444 5556899999976543     22233


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .|||-+|...+|.+.+..    ..-+...+.+.|+.|++.||..+|+. ||+|||||.+||||++=. -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            567888888888776654    44567778888999999999999986 999999999999999755 699999986543


Q ss_pred             cccCCCC----cccccc----ccccccccccCCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015298          224 LVKGEPN----ISYICS----RYYRAPELIFGAT----------EYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (409)
Q Consensus       224 ~~~~~~~----~~~~gt----~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (409)
                      ..-...+    .-+.-|    .+|.|||.+....          ..+++-||||+||+++||++ |++||.-.    ++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHH
Confidence            2111111    111112    3599999985411          15678999999999999998 78999521    111


Q ss_pred             HHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .....- .-..+..           +.            .--+..++.+|..|++.||.+|.+|++.|+.
T Consensus       246 aYr~~~-~~~~e~~-----------Le------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------LE------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------HH------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111110 0111110           00            1124578999999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=2.4e-22  Score=175.12  Aligned_cols=135  Identities=15%  Similarity=0.221  Sum_probs=102.7

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------------------------------hhHHHHHHHHhcCCCC
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  125 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n  125 (409)
                      ...||+|+||.||+|.+. +|+.||+|++.....                              ....|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999986 899999999864321                              1124889999998877


Q ss_pred             eecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCcEeecCCCCce
Q 015298          126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI-HRSIGVCHRDIKPQNL  204 (409)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~ivH~Dlkp~NI  204 (409)
                      +.......  ..   .  .+|||||++|+......   .....++...+..++.|++.+|.+| |+. ||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHE
Confidence            74433221  11   1  26999999975222111   1145789999999999999999999 675 999999999999


Q ss_pred             eecCCCCcEEEeecCCcccc
Q 015298          205 LVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       205 li~~~~~~ikl~Dfg~a~~~  224 (409)
                      +++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 4 7999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=5.4e-22  Score=175.15  Aligned_cols=171  Identities=11%  Similarity=0.141  Sum_probs=125.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chh---------hHHHHHHHHhcCCCCeecccceeee
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFS  135 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~---------~~~e~~~l~~l~h~niv~~~~~~~~  135 (409)
                      ..++|++.+.||.|+||.||++.+  ++..+|+|.+...    ...         ..+|+..+.++.|++|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            356899999999999999999765  5778999999532    111         4678889999999999999887654


Q ss_pred             cCCC---CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC
Q 015298          136 TTDK---DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (409)
Q Consensus       136 ~~~~---~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~  211 (409)
                      ....   .....+|+|||++| +|.+..        .+++    ....+++.+|..||+. |++|||+||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-
Confidence            3211   12346799999997 443321        2233    2356999999999986 999999999999998765 


Q ss_pred             cEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH
Q 015298          212 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM  268 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll  268 (409)
                       ++|+|||.............           .+.. ..+..++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence             99999998865432211111           2222 33668999999999987764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.8e-21  Score=168.96  Aligned_cols=134  Identities=17%  Similarity=0.242  Sum_probs=104.5

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------------------------------hhHHHHHHHHhcCCCC
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  125 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n  125 (409)
                      ...||+|++|+||+|.+. +|+.||||++.....                              ....|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 899999999865311                              1246788899999988


Q ss_pred             eecccceeeecCCCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCc
Q 015298          126 VVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQN  203 (409)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~N  203 (409)
                      +.....+..  . .    .+|||||++|. +......    ...++...+..++.|++.++.+||. . ||+||||||+|
T Consensus        81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe--c-C----CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            754433321  1 1    36999999975 2221111    3567888899999999999999998 6 99999999999


Q ss_pred             eeecCCCCcEEEeecCCcccc
Q 015298          204 LLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       204 Ili~~~~~~ikl~Dfg~a~~~  224 (409)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 55 8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=5.3e-21  Score=165.36  Aligned_cols=182  Identities=19%  Similarity=0.134  Sum_probs=132.8

Q ss_pred             EEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch--------hhHHHHHHHHhcC-CCCeecccceeeecCCCCccEE
Q 015298           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+...|++|+||+|+++..  .+..++.+.+.....        .+.+|+++|++|. |+++++++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            4567899999999998775  777888777754432        3578999999995 47788887641     1    5


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecC-CCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dl-kp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+|+.|..+..   ..      +.. ...++.|++.+|.++|+. ||+|||| ||+|||++.++ .++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~---~~------~~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQ---RP------PRG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHh---hh------hhh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence            79999999753211   10      111 134678999999999996 9999999 79999999877 799999999985


Q ss_pred             cccCCCC--------------ccccccccccccccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 015298          224 LVKGEPN--------------ISYICSRYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDS  278 (409)
Q Consensus       224 ~~~~~~~--------------~~~~gt~~y~aPE~l~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~  278 (409)
                      .......              .-..+++.|+.|+.-.--...+ ...++++.|+.+|.++|+..|+..+.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            5433211              0112467788887653222233 56789999999999999998876544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.5e-21  Score=169.96  Aligned_cols=237  Identities=16%  Similarity=0.229  Sum_probs=181.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      +..+..+|.+...|..|+|++  .|..+++|++...      .+.+.+|.-.|+.+.||||+.+++.+     ..+..+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            344566889999999999998  6667788877432      35677899999999999999999988     5556688


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee-cCCCCceeecCCCCcEEEe--ecCCc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR-DIKPQNLLVNPHTHQVKLC--DFGSA  221 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~-Dlkp~NIli~~~~~~ikl~--Dfg~a  221 (409)
                      ++..||+ |+|..++...  .+-.....++.+++.++++|++|||+--.++-| -|....++||.+- +.+|.  |--++
T Consensus       264 ~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            9999999 7888887643  244567788999999999999999974344444 6888899999876 55543  32222


Q ss_pred             cccccCCCCccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .      ........|.||+||.+...+.  .-.++|+|||++++|||.|.+.||......+.-.++.-.          
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------  404 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------  404 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----------
Confidence            1      2233456889999999955443  345799999999999999999999988877655444321          


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                                       -++..+|..++..+..|++-|+..||.+||..+.+
T Consensus       405 -----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  405 -----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             -----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence                             12334788899999999999999999999987765

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.6e-20  Score=193.33  Aligned_cols=192  Identities=25%  Similarity=0.398  Sum_probs=149.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh-hHHHHHHHHhcC---CCCeecccceeeecCCCCccE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY-KNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+..|.|.+.||.|+||+||+|.... |+.||+|+-+..... +.==.+++.+|+   -+.|.++..++...+.     
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----
Confidence            445689999999999999999999876 999999988765422 211234445554   2345555554433222     


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC------CCCcEEEe
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP------HTHQVKLC  216 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~------~~~~ikl~  216 (409)
                      -+||++|.+ |+|.+++.    ..+.+++..+..++.|++..++.||.. +|||+||||+|.||..      +...++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEE
Confidence            358999999 88888876    478899999999999999999999985 9999999999999842      22269999


Q ss_pred             ecCCcccc---ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 015298          217 DFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK  271 (409)
Q Consensus       217 Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~  271 (409)
                      |||.+.-+   .++......++|-.+-.+|.+.|. .+++++|.|.|+.+++.||+|+
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence            99987543   334344566778899999998664 5999999999999999999997

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.8e-19  Score=157.35  Aligned_cols=134  Identities=18%  Similarity=0.247  Sum_probs=101.3

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhc-----CCCCeecccceeeecCCCCccE-E
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTDKDELY-L  144 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~  144 (409)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++....  +..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence            346899999999995  6667665 69988643    34567899999999     6799999999885432  2233 3


Q ss_pred             EEEEeccc---hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCcEeecCCCCceeecCCC---CcEEEee
Q 015298          145 NLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL-SYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCD  217 (409)
Q Consensus       145 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~ivH~Dlkp~NIli~~~~---~~ikl~D  217 (409)
                      .+|+||++   ++|.+++..     ..+++.  ..++.|++.++ +|||++ +|+||||||+|||++..+   ..++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47999955   588887753     345555  35678888888 999997 999999999999997432   2799999


Q ss_pred             cCCc
Q 015298          218 FGSA  221 (409)
Q Consensus       218 fg~a  221 (409)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=2.6e-20  Score=176.70  Aligned_cols=179  Identities=28%  Similarity=0.471  Sum_probs=132.6

Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ..|++|.|++|. ++|.+.+.. .......+......++.|+..|++|   + |.+|+|+||.||++..+. .+||+|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhh
Confidence            446889999999 466665543 4445667788889999999999999   5 999999999999998777 89999999


Q ss_pred             CccccccCC-------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          220 SAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       220 ~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +........       ..+...||..||+||.+.++. |+.++||||||++|+||++ -...|...   .....+..  +
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~--g  475 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRD--G  475 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhhc--C
Confidence            987765555       456788999999999997765 9999999999999999997 22222110   00111111  0


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                      ..++.                         +.. -.++-.+|+..||...|.+||++.+.-.|+|.
T Consensus       476 ~ip~~-------------------------~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIPPE-------------------------FLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCChH-------------------------Hhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            00000                         000 12455699999999999999988888888775

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=4.1e-19  Score=160.05  Aligned_cols=138  Identities=15%  Similarity=0.160  Sum_probs=104.1

Q ss_pred             ceEEEEeeccCCceEEEEEE-EcCCCcEEEEEEeeccc----------------------------hhhHHHHHHHHhcC
Q 015298           72 SYMAERIVGQGSFGVVFQAK-CLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLD  122 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~e~~~l~~l~  122 (409)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++....                            ....+|++.++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999999 67799999999986431                            11346889999987


Q ss_pred             CCCeecccceeeecCCCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-cEeecCC
Q 015298          123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-VCHRDIK  200 (409)
Q Consensus       123 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-ivH~Dlk  200 (409)
                      +.. +.+...+.. . .    .++||||++|. +....    .....+....+..++.||+.++.+||+. | |+|||||
T Consensus       109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            532 222222211 1 1    36999999984 22221    1134456666788999999999999986 9 9999999


Q ss_pred             CCceeecCCCCcEEEeecCCccc
Q 015298          201 PQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       201 p~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 899999999864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=6.3e-18  Score=163.35  Aligned_cols=204  Identities=25%  Similarity=0.361  Sum_probs=148.9

Q ss_pred             HHhcCCCCeecccceeeecCCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc-E
Q 015298          118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV-C  195 (409)
Q Consensus       118 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~i-v  195 (409)
                      |+.+.|.|+.++++..+..     ..+++|.+||. |+|.+.+..   ....++......++++|+.||.|||.+ .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence            3568999999999988654     33789999999 788777764   356778888888999999999999987 55 9


Q ss_pred             eecCCCCceeecCCCCcEEEeecCCccccccC---CCCccccccccccccccccCCCC------CCchhhHHHHHHHHHH
Q 015298          196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATE------YTTAIDIWSAGCVVAE  266 (409)
Q Consensus       196 H~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DiwslG~il~~  266 (409)
                      |+.|++.|.+++... .+||+|||+.......   .......-..-|.|||.+.....      .+.+.|+||+|++++|
T Consensus        72 hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999988 8999999998765321   11111122445999999965321      4667999999999999


Q ss_pred             HHhCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCC
Q 015298          267 LMLGKPLFPGDSGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP  342 (409)
Q Consensus       267 lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp  342 (409)
                      +++...||......    +.+..+.+....+....+..                      ...+.+++..++..||..+|
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~----------------------~~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL----------------------LNELPPELLLLVARCWEEIP  208 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh----------------------hhhcchHHHHHHHHhcccCh
Confidence            99999999763322    23333322111111110000                      01356689999999999999


Q ss_pred             CCCCCHHHHhC
Q 015298          343 NLRCTALDALI  353 (409)
Q Consensus       343 ~~R~s~~ell~  353 (409)
                      ..||++.++-.
T Consensus       209 ~~rPs~~~i~~  219 (484)
T KOG1023|consen  209 EKRPSIEQIRS  219 (484)
T ss_pred             hhCccHHHHHh
Confidence            99999998743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.7e-19  Score=179.45  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcC-CCcEEEEEEeeccc------hhhHHHHHHHHhcC-CCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..|.+.+.||+|.|+.|-.+.... +...+|.|.+....      .....|..+-+.+. |.|++++++..     .+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            468888999999999999888743 44566777664332      12234777777776 99999998877     5555


Q ss_pred             EEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       143 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      +.+++++|..|+ +..-+.  .......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||+
T Consensus        95 ~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             ccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchh
Confidence            678999997753 222221  111225677788899999999999999 75 9999999999999997764699999999


Q ss_pred             cccccc-CC---CCccccc-cccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVK-GE---PNISYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~-~~---~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |..... ..   .....+| ++.|+|||.+.+........|+||+|+++..+++|..|+......+....          
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~----------  241 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS----------  241 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce----------
Confidence            987655 22   2335677 99999999997766678999999999999999999999976554331100          


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                   .+.... ..........++....+++.+++..+|..|.+..++..+||+..
T Consensus       242 -------------~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 -------------SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -------------eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                         000000 01111233457889999999999999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=2.9e-17  Score=144.59  Aligned_cols=132  Identities=17%  Similarity=0.176  Sum_probs=98.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--------------------------hhhHHHHHHHHhcCCCC
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  125 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~e~~~l~~l~h~n  125 (409)
                      .|.+.+.||+|+||.||++... +|+.||||++....                          .....|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888899999999999999864 79999999875422                          11346788888887774


Q ss_pred             --eecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCc
Q 015298          126 --VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (409)
Q Consensus       126 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~N  203 (409)
                        ++..++.         ...++||||++|.....+.      .   ......++.+++.++.++|.. ||+||||||+|
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~------~---~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVR------V---LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFN  155 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhcc------c---cccHHHHHHHHHHHHHHHHHC-CCCcCCCCccc
Confidence              3333221         1247899999974222111      0   133567888999999999986 99999999999


Q ss_pred             eeecCCCCcEEEeecCCcccc
Q 015298          204 LLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       204 Ili~~~~~~ikl~Dfg~a~~~  224 (409)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999877 8999999999644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=6.6e-17  Score=143.76  Aligned_cols=129  Identities=19%  Similarity=0.330  Sum_probs=100.8

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +.||+|++|.||+|.+  +|..+++|+.....            ....+|++++..+.|++++....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5789999999999987  77889999764321            12457889999999998877655543322     25


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|||++| +|.+.+...       .. ....++.+++.+|.+||+. |++|||++|.||+++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 565555421       11 6778899999999999986 999999999999999 55 799999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.7e-16  Score=139.87  Aligned_cols=125  Identities=18%  Similarity=0.328  Sum_probs=93.9

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .||+|++|.||++..  +|..+++|......            ....+|+++++.+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999985  67889999864321            22346999999998887554433332211     246


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +||||++| ++.+.+...    ..       .++.|++.+|.+||+. |++|||++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 454443321    10       6788999999999986 999999999999999 55 899999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=3.3e-16  Score=158.37  Aligned_cols=131  Identities=18%  Similarity=0.299  Sum_probs=98.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------------chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ..|...+.||+|+||.||++.+.  +..+++|+....            .....+|+++++.++|++++....+..... 
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-
Confidence            34677899999999999999874  334454443211            123457999999999999887655443221 


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                          ..++||||++| +|.+.+.            ....++.|++.+|.+||+. ||+||||||+||+++ ++ .++|+|
T Consensus       410 ----~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liD  470 (535)
T PRK09605        410 ----EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLID  470 (535)
T ss_pred             ----CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEe
Confidence                25699999986 5544443            2456889999999999986 999999999999994 44 799999


Q ss_pred             cCCccc
Q 015298          218 FGSAKV  223 (409)
Q Consensus       218 fg~a~~  223 (409)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.3e-16  Score=135.83  Aligned_cols=131  Identities=21%  Similarity=0.232  Sum_probs=90.4

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhh----------------------------HHHHHHHHhcCCCC--
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  125 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~e~~~l~~l~h~n--  125 (409)
                      .+.||+|+||+||+|.+. +|+.||||++.......                            ..|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 89999999986532110                            13444444443322  


Q ss_pred             eecccceeeecCCCCccEEEEEEeccchhH-H-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCc
Q 015298          126 VVSLKHCFFSTTDKDELYLNLVLEYVPETV-H-RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (409)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~N  203 (409)
                      +.+.+.+.         ..++||||++++. . ..+....     . ...+..++.+++.++.++|.+.||+||||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            22322211         1479999999721 1 1111111     1 156788999999999999982399999999999


Q ss_pred             eeecCCCCcEEEeecCCcccc
Q 015298          204 LLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       204 Ili~~~~~~ikl~Dfg~a~~~  224 (409)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 55 8999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=4.4e-15  Score=134.09  Aligned_cols=133  Identities=15%  Similarity=0.236  Sum_probs=97.0

Q ss_pred             Eeec-cCCceEEEEEEEcCCCcEEEEEEeecc-----------------chhhHHHHHHHHhcCCCCe--ecccceeeec
Q 015298           77 RIVG-QGSFGVVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFST  136 (409)
Q Consensus        77 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  136 (409)
                      ..|| .||.|+||.+..  .+..++||.+...                 .....+|++++..|.|++|  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 888899998876  4788999987431                 1224579999999998875  5555543221


Q ss_pred             CCCCccEEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          137 TDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                      . ......++|||+++|  +|.+.+.     ...+++..    +.||+.+|.+||+. ||+||||||+|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CEE
Confidence            1 111123599999996  5555543     23455543    56899999999996 999999999999999877 899


Q ss_pred             EeecCCccc
Q 015298          215 LCDFGSAKV  223 (409)
Q Consensus       215 l~Dfg~a~~  223 (409)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.6e-15  Score=146.84  Aligned_cols=254  Identities=25%  Similarity=0.259  Sum_probs=189.9

Q ss_pred             CccccceEEEEeecc--CCceEEEEEEE--cCCCcEEEEEEeec------cchhhHHHHHHHHhc-CCCCeecccceeee
Q 015298           67 PKQTISYMAERIVGQ--GSFGVVFQAKC--LETGETVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (409)
                      ......+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.      ......+|+...+.+ .|+|.++.+..+  
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--  187 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--  187 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--
Confidence            334456788899999  99999999998  88999999997432      223345677776666 489999866666  


Q ss_pred             cCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHH----HHHHHHhcCCcEeecCCCCceeecCCCC
Q 015298          136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~ivH~Dlkp~NIli~~~~~  211 (409)
                         ......++-+|+|+..+......   ...-++...++....+...    ||..+|.. +|+|-|+||+||++..+..
T Consensus       188 ---e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  188 ---EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             ---ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccc
Confidence               44555789999999766554433   2344788888999999999    99999986 9999999999999999844


Q ss_pred             cEEEeecCCccccccCCCCc------cccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHH
Q 015298          212 QVKLCDFGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD--SGVDQL  283 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~~~~~------~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~  283 (409)
                      ..+++|||+...+.++....      ...+...|++||++.+  -++...|++++|.+..+..+|..+....  ....++
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            89999999988776554221      2256777999999843  4799999999999999999887655332  221111


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       284 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .++.                              ....+-...+..+...+..|+..+|..|++++.+++|+++....
T Consensus       339 r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  339 RQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             cccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            1100                              00012233566777799999999999999999999999998643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=2.8e-15  Score=125.34  Aligned_cols=131  Identities=18%  Similarity=0.228  Sum_probs=101.7

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCC--CCeecccceeeecCCCCccEEEEEEec
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      +.+.||+|.++.||++...  +..+++|......  ....+|+.+++.+.|  .++++++..+.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            4578999999999999973  4789999986654  356789999999976  47777766552     22346799999


Q ss_pred             cchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS--IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       151 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +.+.....          ++......++.+++.++.+||..  .+++|+|++|+||++++.+ .++++|||.+..
T Consensus        75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            98742111          14455667789999999999973  2699999999999999865 899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.9e-15  Score=153.72  Aligned_cols=269  Identities=24%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+.+.+-+-+|.++.++.+.-..+|...++|.......       ....+-.++-...+|-++..   ++..  ....
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~---~~s~--~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRS---FPSF--PCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecc---cCCC--CCCC
Confidence            3457777889999999999999888887777765533221       11112222222234555543   2221  1222


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      -.+|+++|.++ ++...+..    .+..+.+.++.++..+..++++||.. .+.|+|++|.|+++..++ ..++.|||..
T Consensus       878 P~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t~  951 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGTL  951 (1205)
T ss_pred             CcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCccccc
Confidence            25689999975 44333332    34677777888888999999999975 799999999999999888 7999999843


Q ss_pred             cccccC--------------------------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 015298          222 KVLVKG--------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML  269 (409)
Q Consensus       222 ~~~~~~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt  269 (409)
                      ....--                                .......+|+.|.+||.+.+.. ....+|+|++|+++++.++
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence            221000                                0012345789999999997655 7889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH
Q 015298          270 GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL  349 (409)
Q Consensus       270 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~  349 (409)
                      |.+||......+....|.+.....+                         . -+...+.++++++..+|..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~f~ni~~~~~~~p-------------------------~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNRDIPWP-------------------------E-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhccccCCCCCC-------------------------C-CccccChhhhhhhhhhhccCchhccCcc
Confidence            9999998887777665554321111                         0 2345789999999999999999999887


Q ss_pred             ---HHhCCCCccCCCCCCCCCCCCCCCCCC
Q 015298          350 ---DALIHPFFDELRDPNARLPSGRFLPPL  376 (409)
Q Consensus       350 ---ell~hp~f~~~~~~~~~~~~~~~~~~~  376 (409)
                         ++-.||||+.+.+.+.......++|..
T Consensus      1085 ~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred             cccccccCCccCCCCccccccccCccCCCC
Confidence               888999999999887776666555544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5.8e-15  Score=132.54  Aligned_cols=241  Identities=20%  Similarity=0.232  Sum_probs=160.9

Q ss_pred             EEEEEEEcCCCcEEEEEEee----cc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccc-hhHH
Q 015298           86 VVFQAKCLETGETVAIKKVL----QD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVH  156 (409)
Q Consensus        86 ~V~~~~~~~~~~~vaiK~~~----~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  156 (409)
                      .||++-++..|..|+--.+.    ++    ......-+.-|-.+.|.|||+++.++......+.....++.|||. |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            46777776666655432211    11    111111223455568999999998886666556667789999999 7787


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CcEeecCCCCceeecCCCCcEEEeecCCcccc-----ccCCCC
Q 015298          157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPN  230 (409)
Q Consensus       157 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~-----~~~~~~  230 (409)
                      ..|+...+....+......+|+.||+.||.|||+.- -|+|+++..+.|++..++ -||++--.-...-     ......
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhh
Confidence            888877777778899999999999999999999731 399999999999999887 6777632211100     000111


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  309 (409)
                      ....+-++|.+||.=. ....+.++|||++|+...+|..|+.--. ..+..+.-..+.+.+                   
T Consensus       240 ~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-------------------  299 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-------------------  299 (458)
T ss_pred             hccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence            2234567899999642 2346778999999999999998875422 221111111111110                   


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                  + .--...-++++.+||+..|+.||++.+++.||.+-++
T Consensus       300 ------------~-~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  300 ------------I-GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             ------------e-eccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence                        0 0012223589999999999999999999999997765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=1.3e-12  Score=128.20  Aligned_cols=165  Identities=24%  Similarity=0.325  Sum_probs=121.0

Q ss_pred             EEEEcCCCcEEEEEEeeccch----hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhh
Q 015298           89 QAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK  164 (409)
Q Consensus        89 ~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~  164 (409)
                      .|..+.++.+|.|...+....    ...+-++.|+.++||||+++++.+     .....+|||+|.+.. |...++.   
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~---  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE---  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH---
Confidence            456677888888888765443    245677889999999999999988     444468999999873 2234443   


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC-Cccccccccccccc
Q 015298          165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPE  243 (409)
Q Consensus       165 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE  243 (409)
                          +....+...++||+.||.|||+.++++|++|.-+.|+++..| ..||++|.++........ .....---.|..|+
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~  175 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPE  175 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence                225666677899999999999778999999999999999998 899999998754322211 11111122366777


Q ss_pred             cccCCCCCCchhhHHHHHHHHHHHHhC
Q 015298          244 LIFGATEYTTAIDIWSAGCVVAELMLG  270 (409)
Q Consensus       244 ~l~~~~~~~~~~DiwslG~il~~lltg  270 (409)
                      ....   -.-..|.|.|||++++++.|
T Consensus       176 ~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  176 EIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcCc---cccchhhhhHHHHHHHHhCc
Confidence            5522   12457999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=3.3e-12  Score=125.35  Aligned_cols=137  Identities=22%  Similarity=0.311  Sum_probs=87.6

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhh-------------------------------------------
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYK-------------------------------------------  111 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~-------------------------------------------  111 (409)
                      .+.||+|++|+||+|+. .+|+.||||+..... ...                                           
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            35799999999999986 479999999985431 011                                           


Q ss_pred             HHHHHHHHhc----CCCCeecccceeeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHH-HH
Q 015298          112 NRELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR-AL  185 (409)
Q Consensus       112 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~l  185 (409)
                      .+|.+.+.++    +|.+-+.+...+.....    ..+|||||++| .+.+.... .  .....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~-~--~~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAAL-D--EAGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHH-H--hcCCC---HHHHHHHHHHHHH
Confidence            1233333333    23333333333322111    14799999997 44333321 1  11122   2345555555 46


Q ss_pred             HHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       186 ~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ..+|.. |++|+|++|.||+++.++ .++++|||++....
T Consensus       271 ~ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            788986 999999999999999887 89999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=3.1e-13  Score=131.16  Aligned_cols=248  Identities=20%  Similarity=0.197  Sum_probs=174.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-CCCcEEEEEEeeccch------hhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-ETGETVAIKKVLQDKR------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|..+..||.|.|+.|+.+... .++..|++|...+...      +...|+-+...+ .|.+++.++..|+....  
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--
Confidence            4567889999999999999988755 6788999998765432      223455555555 58888887777744333  


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                         .++-.|||++....+-.   .....+.+...+++..|++.++.++|+. .++|+|+||+||++..++...+++|||.
T Consensus       341 ---~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 ---GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ---ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccccc
Confidence               55888999864333322   2245677788889999999999999985 9999999999999988644799999999


Q ss_pred             ccccccCCCCcccccccccc-ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLVKGEPNISYICSRYYR-APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +....-  ........-+++ .+|++.....+..+.|++|||..+.+.++|.+.-........   +...          
T Consensus       414 ~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~~----------  478 (524)
T KOG0601|consen  414 WTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRSG----------  478 (524)
T ss_pred             ccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eecc----------
Confidence            864211  111222333444 366665666788999999999999999999754332221111   1000          


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                               ..+          .......+++.+.+.++..++..|+.+.++..|.=|..
T Consensus       479 ---------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 ---------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ---------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                     000          11123477889999999999999999999999876654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=1.6e-12  Score=129.12  Aligned_cols=141  Identities=20%  Similarity=0.280  Sum_probs=87.6

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh--------------------------------------hHH
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY--------------------------------------KNR  113 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~~~  113 (409)
                      .|.. +.||+|++|+||+|+.+.+|+.||||+.......                                      ..+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 7899999999999999888999999998643100                                      011


Q ss_pred             ------HHHHHHhc----CCCCeecccceeeecCCCCccEEEEEEeccchh-HHHHHHHhhhhc---CCCCHHHHHHHHH
Q 015298          114 ------ELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLN---QRMPMIYVKLYAY  179 (409)
Q Consensus       114 ------e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~---~~l~~~~~~~i~~  179 (409)
                            |+.-+.++    .+.+.+.+-.+|....    ...+|||||+.|. +.+. ......+   ..+.+..+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHHHHH
Confidence                  22222222    2333333333332111    1246999999973 3332 1111111   1244444555555


Q ss_pred             HHHHHHHHHHhcCCcEeecCCCCceeecCCC---CcEEEeecCCcccccc
Q 015298          180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLVK  226 (409)
Q Consensus       180 qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~---~~ikl~Dfg~a~~~~~  226 (409)
                      |++       .. |++|+|+||.||+++.++   ..++++|||++.....
T Consensus       275 Qif-------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF-------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            655       35 999999999999998765   3799999999876533

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=6.1e-12  Score=107.65  Aligned_cols=124  Identities=15%  Similarity=0.186  Sum_probs=89.5

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCee-cccceeeecCCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      .+.|+.|.++.||++..  .+..|++|......   ....+|+.+++.+.+.+++ +++...     ...  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            46789999999999986  47889999876543   3457899999988655544 333322     111  25899999


Q ss_pred             chhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----EeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          152 PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV-----CHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       152 ~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~i-----vH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|......        ..   ....+..+++.+|..||.. ++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 ~G~~l~~~--------~~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE--------DF---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc--------cc---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            97421100        01   1133567999999999975 75     9999999999999 44 79999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=5.6e-11  Score=113.42  Aligned_cols=214  Identities=21%  Similarity=0.252  Sum_probs=154.0

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch--hHHH
Q 015298           84 FGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHR  157 (409)
Q Consensus        84 ~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  157 (409)
                      -.+.|+|....+|..|++|++.-++    ...-.-+++++++.|+|+|++.++|. ....+...+++|++|.++  +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHH
Confidence            3578999999999999999994332    12235689999999999999999886 334567778999999995  5544


Q ss_pred             HHHHh-----------hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          158 VVKHF-----------NKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       158 ~l~~~-----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      ..-.-           ...+...++..+|.++.|+..||.++|++ |+..+-|.|.+|+++.+. +++|+..|......+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            42211           11244578899999999999999999997 999999999999999887 899998887765543


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCcHHH-HHHHHHHhCCCCHHHHhhcCCC
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQ-LVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      +.           .  |.+.    -..+-|.=.||.+++.|.||..--.. ....+. +..                   
T Consensus       446 d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------------------  489 (655)
T KOG3741|consen  446 DP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------------------  489 (655)
T ss_pred             CC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------------------
Confidence            32           0  1121    12456999999999999999632111 111111 111                   


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                       +....+.+++++|.-+...++++ -++.+++.|
T Consensus       490 -----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 -----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             -----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                             12236778888888888887776 677776643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=1e-11  Score=107.50  Aligned_cols=131  Identities=18%  Similarity=0.222  Sum_probs=93.0

Q ss_pred             EeeccCCceEEEEEEEcC------CCcEEEEEEeecc--------------ch------------h----hHHHHHHHHh
Q 015298           77 RIVGQGSFGVVFQAKCLE------TGETVAIKKVLQD--------------KR------------Y----KNRELQTMRL  120 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~--------------~~------------~----~~~e~~~l~~  120 (409)
                      ..||.|--+.||.|....      .+..+|||+.+..              .+            .    ..+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      3579999987311              00            0    1268888888


Q ss_pred             cCC--CCeecccceeeecCCCCccEEEEEEeccchh-H-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCcE
Q 015298          121 LDH--PNVVSLKHCFFSTTDKDELYLNLVLEYVPET-V-HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI-HRSIGVC  195 (409)
Q Consensus       121 l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~iv  195 (409)
                      +..  -++++++.+.     .    -+|||||++++ + ...+.     ...++...+..+..+++.+|..| |+. ||+
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~-glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC-NLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            843  4555554431     1    36899999863 1 11122     23455566677889999999998 875 999


Q ss_pred             eecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       196 H~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||||++.||+++. + .+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            9999999999974 4 6999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=1.4e-12  Score=128.38  Aligned_cols=157  Identities=24%  Similarity=0.336  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC--------Ccc--ccccccccccccccCCC
Q 015298          180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--------NIS--YICSRYYRAPELIFGAT  249 (409)
Q Consensus       180 qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~--------~~~--~~gt~~y~aPE~l~~~~  249 (409)
                      +++.|+.|+|++.++||++|.|++|.++..+ ..||+.|+.+........        ...  ..-...|.|||.+.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3449999999999999999999999999988 899999998754433111        011  111446999999966 4


Q ss_pred             CCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCCh
Q 015298          250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP  328 (409)
Q Consensus       250 ~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  328 (409)
                      ..+.++|+||+||++|.+. .|+..+..................                         -...+...++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcH
Confidence            5789999999999999999 566666554333222211111000                         01113467899


Q ss_pred             hHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          329 EAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       329 ~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ++++=|.++|..++..||++..++..|||.+..-+
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK  274 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence            99999999999999999999999999999875433

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=2.3e-10  Score=95.57  Aligned_cols=139  Identities=19%  Similarity=0.274  Sum_probs=96.7

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEee-cc-----------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVL-QD-----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ....|-+|+-+.|+++.+  .|+.+.||.-. +.           .+...+|++.|.++.--.|.-..-+|.....    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            456788999999999987  88888888532 11           2334568888887743233222222222111    


Q ss_pred             EEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcE--EEeec
Q 015298          143 YLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDF  218 (409)
Q Consensus       143 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~i--kl~Df  218 (409)
                       -+|+|||++|  ++.+.+....  ...........++.+|=+.+.-||.+ +|+|+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEee
Confidence             3589999998  6666555432  22333333367888999999999997 999999999999998877654  89999


Q ss_pred             CCccc
Q 015298          219 GSAKV  223 (409)
Q Consensus       219 g~a~~  223 (409)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=9.2e-10  Score=92.40  Aligned_cols=126  Identities=15%  Similarity=0.304  Sum_probs=83.7

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeec-c-----------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQ-D-----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+++|+-+.++.+..  -|..+++|.=.+ .           .....+|++++.++.--.|...+-+++....     .
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            3578899999999865  455566664321 1           1223468888888754333322222222221     4


Q ss_pred             EEEEeccchhHHH-HHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .|+|||++|.+.. .+..    .   .    ..++..+=.-+.-||.. ||+|+||.++||++..+  ++.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            5899999985443 3332    1   1    34556677777889987 99999999999999854  499999999974

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.1e-09  Score=94.61  Aligned_cols=121  Identities=23%  Similarity=0.312  Sum_probs=76.5

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccc------------------------------hhhHHHHHHHHhcCCC--Ceeccccee
Q 015298           86 VVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQTMRLLDHP--NVVSLKHCF  133 (409)
Q Consensus        86 ~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~~~l~~l~h~--niv~~~~~~  133 (409)
                      .||.|.. ..|..+|+|+.....                              ....+|.+.|.++..-  ++++++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888885 567899999874210                              1124699999999765  456665432


Q ss_pred             eecCCCCccEEEEEEeccc--hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH-HHhcCCcEeecCCCCceeecCCC
Q 015298          134 FSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY-IHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                           .    -+|||||++  |.....+..     ..++......++.+++..+.. +|. .||+|+||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 2    258999999  643333332     122234456677788885555 566 599999999999999865 


Q ss_pred             CcEEEeecCCcccc
Q 015298          211 HQVKLCDFGSAKVL  224 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~  224 (409)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             6999999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.00  E-value=3.5e-09  Score=94.56  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=90.4

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCC--CeecccceeeecCCCCccEEEEEEe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHP--NVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      +.|+.|..+.||++... +|+.+++|.....     .....+|+++++.+.+.  ++++++.+.....  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999863 3688999987643     24567899999999763  3455554332111  1123569999


Q ss_pred             ccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015298          150 YVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR--------------------------------------  190 (409)
Q Consensus       150 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------------------------------------  190 (409)
                      |++|. +...+.     ...++......++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99873 211110     0234444444555555555555552                                      


Q ss_pred             -----------------cCCcEeecCCCCceeecCC-CCcEEEeecCCccc
Q 015298          191 -----------------SIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (409)
Q Consensus       191 -----------------~~~ivH~Dlkp~NIli~~~-~~~ikl~Dfg~a~~  223 (409)
                                       ...++|+|+.|.||+++.+ ...+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1257999999999999973 22689999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=1.2e-08  Score=93.35  Aligned_cols=110  Identities=12%  Similarity=0.158  Sum_probs=77.1

Q ss_pred             hHHHHHHHHhcCCCCeecc--cceeeecCCCCccEEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015298          111 KNRELQTMRLLDHPNVVSL--KHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS  186 (409)
Q Consensus       111 ~~~e~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~  186 (409)
                      ..+|...+.+|..-+|...  +.++....+.....-+||||++++  ++.+++....  ....+......++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            5688888888754344333  333322121212235689999997  5666664332  244566777889999999999


Q ss_pred             HHHhcCCcEeecCCCCceeecCC------CCcEEEeecCCccc
Q 015298          187 YIHRSIGVCHRDIKPQNLLVNPH------THQVKLCDFGSAKV  223 (409)
Q Consensus       187 ~LH~~~~ivH~Dlkp~NIli~~~------~~~ikl~Dfg~a~~  223 (409)
                      -||.. ||+|+|+++.|||++.+      ...+.++||+.+..
T Consensus       153 ~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        153 DMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99997 99999999999999752      23799999998853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=2.3e-08  Score=93.62  Aligned_cols=195  Identities=15%  Similarity=0.211  Sum_probs=128.5

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhc-CCCCeec----ccceeeecCCCCccEEEEEE
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVS----LKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~----~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ..+.||+|+-+.+|-.-.  -+ ..+.|++.... ....+-+..|... .||-+-.    -....+..+  ....+-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~--~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGR--RGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hh-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCC--ccceeEEec
Confidence            346799999999986542  22 23457665443 2222334444333 4543322    111111111  122266788


Q ss_pred             eccchh--HHHHHH--HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          149 EYVPET--VHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       149 e~~~~~--l~~~l~--~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +.+.|.  ...++.  ...+......+..+.+.++.++.+.+-||.+ |.+-+|++++|+|++.++ .+.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEcccceeec
Confidence            888862  222221  1122234467788899999999999999997 999999999999999777 8999986554444


Q ss_pred             ccCCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLG-KPLFPG  276 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg-~~pf~~  276 (409)
                      .++......+|.+.|.+||.-.    ..-..+...|.|.||+++++++.| +.||.+
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            5555556678899999999753    112356789999999999999987 899975

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=4.8e-08  Score=87.02  Aligned_cols=132  Identities=20%  Similarity=0.191  Sum_probs=92.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--------------------------chhhHHHHHHHHhcCCC-
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------------------------KRYKNRELQTMRLLDHP-  124 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~e~~~l~~l~h~-  124 (409)
                      -+.+...||-|--+.||.|.+. .|..+|||.=...                          ....++|.++|.+|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4667889999999999999964 7899999954210                          11235799999998644 


Q ss_pred             -CeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCc
Q 015298          125 -NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (409)
Q Consensus       125 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~N  203 (409)
                       .+++.++.-         .-++|||+++|..+.  .      -++..+....++..|+.-+..+-. .||||+|+.+-|
T Consensus       171 ~~VP~P~~~n---------RHaVvMe~ieG~eL~--~------~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN  232 (304)
T COG0478         171 VKVPKPIAWN---------RHAVVMEYIEGVELY--R------LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN  232 (304)
T ss_pred             CCCCCccccc---------cceeeeehcccceee--c------ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence             666654422         246999999984211  1      112334444455555555555544 499999999999


Q ss_pred             eeecCCCCcEEEeecCCccc
Q 015298          204 LLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       204 Ili~~~~~~ikl~Dfg~a~~  223 (409)
                      |+++++| .+.++||-.+..
T Consensus       233 IlV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCC-CEEEEeCccccc
Confidence            9999998 799999987753

>PRK09902 hypothetical protein; Provisional

Probab=98.70  E-value=5.6e-07  Score=78.37  Aligned_cols=138  Identities=12%  Similarity=0.083  Sum_probs=95.3

Q ss_pred             ccCCceEEEEEEEcCCCcEEEEEEeec----------cchhhHHHHHHHHhcCCCC--eecccceeeecCCCCccEEEEE
Q 015298           80 GQGSFGVVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        80 g~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      |.||.+.|+....  .|+.+-+|.-..          ...-+.+|+..++.|..-+  ++++. ++-.........-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5578888888765  455688886531          1344578999888885333  44444 2222222334446799


Q ss_pred             Eeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC-cEEEeecCCccc
Q 015298          148 LEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (409)
Q Consensus       148 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~-~ikl~Dfg~a~~  223 (409)
                      +|-++|  +|.+.+....  -.+.+......++.+++.++.-||+. |+.|+|+.+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  6666554311  23456677778999999999999996 9999999999999986651 399999987754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=3.8e-07  Score=80.63  Aligned_cols=108  Identities=17%  Similarity=0.289  Sum_probs=76.3

Q ss_pred             hhHHHHHHHHhcCCCC--eecccceeeecCCCCccEEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH
Q 015298          110 YKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL  185 (409)
Q Consensus       110 ~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l  185 (409)
                      ...+|...+..|..-.  .++.+.+........ ...++|+|++++  +|.+.+...    ...+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            3457888777774333  333444333322222 445789999986  465555542    2266667788999999999


Q ss_pred             HHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCccc
Q 015298          186 SYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  223 (409)
Q Consensus       186 ~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a~~  223 (409)
                      .-||.. ||+|+|+++.|||++.++  ..+.++||+.++.
T Consensus       132 ~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999997 999999999999998764  3689999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.59  E-value=6.7e-07  Score=79.04  Aligned_cols=133  Identities=15%  Similarity=0.188  Sum_probs=90.6

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccch----------------------------hhHHHHHHHHhcC--CCCe
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR----------------------------YKNRELQTMRLLD--HPNV  126 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~e~~~l~~l~--h~ni  126 (409)
                      ..|.+|--+.||+|.. .++..+|+|++.....                            ...+|+.-|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3788888899999984 5688999999853211                            1124666666663  3334


Q ss_pred             ecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       127 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                      ++.+.+.     .    -.|||||++...   ...-.-..-.+...++..+..+++..+.-|-...++||+||..=|||+
T Consensus       133 P~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         133 PEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             CCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            4444333     1    358999998430   000000123344446778888999999888764699999999999999


Q ss_pred             cCCCCcEEEeecCCcccc
Q 015298          207 NPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~  224 (409)
                      . ++ .+.|+|||.|...
T Consensus       201 ~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         201 H-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             E-CC-eEEEEECcccccc
Confidence            9 55 7999999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=2.6e-07  Score=91.65  Aligned_cols=138  Identities=22%  Similarity=0.286  Sum_probs=81.8

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccchh--------------------------------------------hH
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY--------------------------------------------KN  112 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~  112 (409)
                      .-|++++-|+||+|+.+ +|+.||||+....-+.                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999965 5999999988543110                                            01


Q ss_pred             HHHHHHHhc----CCCCeecccceeeecCCCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 015298          113 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY  187 (409)
Q Consensus       113 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~  187 (409)
                      +|..-+.++    .+..-+.+-.+|......    -.|+|||+.|. +.+.... .  ...++...+.....++.  +..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l-~--~~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAAL-K--SAGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHH-H--hcCCCHHHHHHHHHHHH--HHH
Confidence            233333333    222223333334322222    46999999983 3333211 1  13444333222211111  111


Q ss_pred             HHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       188 LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      +-.. |++|.|..|.||+++.++ .+.+.|||+.....+
T Consensus       281 ~~~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhc-CccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence            2224 999999999999999998 899999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.55  E-value=2.2e-06  Score=75.00  Aligned_cols=137  Identities=15%  Similarity=0.259  Sum_probs=87.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhh-------------HHHHHHHHhcCCCCeecccceeeec
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMRLLDHPNVVSLKHCFFST  136 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~e~~~l~~l~h~niv~~~~~~~~~  136 (409)
                      .++|.+.+.+-......|.+..-  +|+.+++|.........             .+++..+..+....+..+...+...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45788889998888888877765  78899999876543222             2344444444332222222212111


Q ss_pred             ---CCCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          137 ---TDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       137 ---~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                         ........+|+|||++|- +.+..        .+++.    +...+..++.-||+. |++|+|..|.|++++.+  .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~--~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN--G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC--c
Confidence               112223356899999983 22211        12222    345677889999986 99999999999999955  4


Q ss_pred             EEEeecCCccc
Q 015298          213 VKLCDFGSAKV  223 (409)
Q Consensus       213 ikl~Dfg~a~~  223 (409)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.52  E-value=1.1e-06  Score=92.00  Aligned_cols=205  Identities=19%  Similarity=0.292  Sum_probs=136.1

Q ss_pred             HHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015298          112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR  190 (409)
Q Consensus       112 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  190 (409)
                      +-|++.+..+.|+|++.++.+.......+ ..+.+..++|.. .+...+.+    -..++...++.+..++++||.|+|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            45777788889999999876554332221 111233345553 33333333    4678899999999999999999998


Q ss_pred             cCCcEeecCCCC---ceeecCCCCcEEEe--ecCCccccccCCCCccccccccccccccccCCC-CCCchhhHHHHHHHH
Q 015298          191 SIGVCHRDIKPQ---NLLVNPHTHQVKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVV  264 (409)
Q Consensus       191 ~~~ivH~Dlkp~---NIli~~~~~~ikl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il  264 (409)
                      . ...|.-|..+   +...+.++ .+.++  ||+.+.................+.+||...... ..+...|+|++|..+
T Consensus       305 ~-~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 L-SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             h-ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            6 6666655555   44445555 56666  888887766655555556667788888774322 123346999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC
Q 015298          265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL  344 (409)
Q Consensus       265 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~  344 (409)
                      ..+..|..+-.....      ...                                +++........+++.+|+.-++++
T Consensus       383 ~~~~~~~~i~~~~~~------~~~--------------------------------~l~~~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV------PVS--------------------------------LLDVLSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             hhhhhcCcccccccc------hhh--------------------------------hhccccchhhhhhhhhhcchhhhh
Confidence            999988643321110      000                                011112227889999999999999


Q ss_pred             CCCHHHHhCCCCccCCC
Q 015298          345 RCTALDALIHPFFDELR  361 (409)
Q Consensus       345 R~s~~ell~hp~f~~~~  361 (409)
                      |+++.+++.|||.+--.
T Consensus       425 Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFPT  441 (1351)
T ss_pred             ccchhhhhhchhccccc
Confidence            99999999999987543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.46  E-value=2.9e-08  Score=97.44  Aligned_cols=245  Identities=18%  Similarity=0.168  Sum_probs=161.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCC-eecccceeeecCCCCccEEEEEEec
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      -|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++     +...+.+..+++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhh
Confidence            4555677899999999999987666555 6666544 44456899999999999 333332     33667778899999


Q ss_pred             cchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCC
Q 015298          151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (409)
Q Consensus       151 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~  230 (409)
                      +.++-.. ..........+.......+++.-++++++||+. -=+|+|    ||+..+.  ..+..||+...........
T Consensus       316 ~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccc-cccCChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccccc--ccccccccCCcccCccccc
Confidence            9854000 000011112233444555677778899999974 458888    8888753  6999999998777666566


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       231 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      .+..+++.++|||+.... .+....|.|++|.--.+|.-|.+|-......      ...++..         +     ..
T Consensus       388 ~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~---------p-----~s  446 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNG---------P-----NS  446 (829)
T ss_pred             ccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCccc------cCCCCCC---------C-----Cc
Confidence            778899999999988554 4788899999998777777777665331100      0000000         0     00


Q ss_pred             CcccC-CCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          311 PQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       311 ~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                      +.+.. ..|...++       .++...|+...|..|+....++.|.+|..
T Consensus       447 ~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  447 PMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            00000 11211111       15778899999999999999998888875

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=1.2e-05  Score=72.22  Aligned_cols=74  Identities=20%  Similarity=0.208  Sum_probs=49.5

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCC--eecccceeeecCCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +++++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4678999999999999744  58999988655  345567888888885332  44554322  1122233468899999


Q ss_pred             ch
Q 015298          152 PE  153 (409)
Q Consensus       152 ~~  153 (409)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            86

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.17  E-value=2.4e-05  Score=70.07  Aligned_cols=69  Identities=17%  Similarity=0.149  Sum_probs=45.5

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCe--ecccceeeecCCCCccEEEEEEeccc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEYVP  152 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~  152 (409)
                      ..||+|..+.||+.    .|..+++|.....  .....+|.++++.+..-.+  ++.+++.     .......+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            46899999999974    2556788987543  2345789999988854333  3443333     22222567999999


Q ss_pred             hh
Q 015298          153 ET  154 (409)
Q Consensus       153 ~~  154 (409)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=2.4e-05  Score=77.58  Aligned_cols=138  Identities=21%  Similarity=0.280  Sum_probs=80.9

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhh-----------------------------------------HHH
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----------------------------------------NRE  114 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~e  114 (409)
                      .+-||....|+|++|+.+. |+.||||+-+..-+..                                         .+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3578999999999999665 9999999875431100                                         012


Q ss_pred             HH----HHHhcCCCC---eecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 015298          115 LQ----TMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY  187 (409)
Q Consensus       115 ~~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~  187 (409)
                      .+    +.+.+.|-+   -|.+-.+|.....    .-+|+||||+|.-.+.+....  ...++...+..   .+.++...
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~---~l~~~~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAID--KRGISPHDILN---KLVEAYLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHH--HcCCCHHHHHH---HHHHHHHH
Confidence            22    122234444   1223333322221    257999999972111111111  24455554333   33332221


Q ss_pred             -HHhcCCcEeecCCCCceeecC---CCCcEEEeecCCcccc
Q 015298          188 -IHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVL  224 (409)
Q Consensus       188 -LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg~a~~~  224 (409)
                       +-.. |++|+|=.|.||++++   .+..+.+-|||+....
T Consensus       316 qIf~~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  316 QIFKT-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHhc-CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence             2224 9999999999999984   2348999999998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.04  E-value=1.9e-05  Score=66.20  Aligned_cols=126  Identities=21%  Similarity=0.336  Sum_probs=84.1

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeec-ccceeeecCCCCccEEEEEEe
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVS-LKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      -++.+.||+|.+|.||++.+  .|..+|+|+-..+  ...+..|+++|..++..++-. ++.  +.   .    .++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~--yg---~----~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYF--YG---E----DFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEE--ec---h----hhhhhh
Confidence            34567899999999999998  6779999988655  356678999999997665543 222  11   1    246799


Q ss_pred             ccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC-C-ceeecCCCCcEEEeecCCccc
Q 015298          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP-Q-NLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       150 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp-~-NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |+.| .|.+...       ..+...    ...+++..--|- .+||-|+.|.- . ||++. +. .+.|+||..|++
T Consensus        93 ~i~G~~L~~~~~-------~~~rk~----l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEI-------GGDRKH----LLRVLEKAYKLD-RLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhh-------cccHHH----HHHHHHHHHHHH-HhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence            9998 4333221       112222    234555533344 45999999864 3 56665 44 699999999974

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.99  E-value=0.00015  Score=62.89  Aligned_cols=126  Identities=26%  Similarity=0.367  Sum_probs=88.8

Q ss_pred             cceEEEEeeccCCc-eEEEEEEEcCCCcEEEEEEeec---c------------c----------hhhHHHHHHHHhc---
Q 015298           71 ISYMAERIVGQGSF-GVVFQAKCLETGETVAIKKVLQ---D------------K----------RYKNRELQTMRLL---  121 (409)
Q Consensus        71 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~------------~----------~~~~~e~~~l~~l---  121 (409)
                      .++...+.||.|.- |.||+++.  .|+.||+|.+..   .            .          ..+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 99999987  888999999421   0            0          1123566665555   


Q ss_pred             CCCCe--ecccceeeecCC-------------CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015298          122 DHPNV--VSLKHCFFSTTD-------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS  186 (409)
Q Consensus       122 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~  186 (409)
                      .+.++  |+.+++.....+             .......||.||+...-            .+....    +.+|++-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            45566  888887754421             12233568888877531            222222    457888899


Q ss_pred             HHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       187 ~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+|.. ||+-+|+++.|..      .-+|+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc------CCEEEecccC
Confidence            99984 9999999999986      3489999965

>PLN02876 acyl-CoA dehydrogenase

Probab=97.92  E-value=0.00013  Score=78.00  Aligned_cols=77  Identities=18%  Similarity=0.191  Sum_probs=49.3

Q ss_pred             EEeeccCCceEEEEEEEcCCC--cEEEEEEeecc-----chhhHHHHHHHHhcC-CCCe--ecccceeeecCCCCccEEE
Q 015298           76 ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  145 (409)
                      .+.++.|.++.+|+......+  ..+++|+....     .....+|+++++.+. |.++  ++++.++...  ......+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            467788999999988764332  46778876432     245678999999995 6665  4444333111  1112356


Q ss_pred             EEEeccchh
Q 015298          146 LVLEYVPET  154 (409)
Q Consensus       146 lv~e~~~~~  154 (409)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.87  E-value=0.00024  Score=62.01  Aligned_cols=127  Identities=19%  Similarity=0.321  Sum_probs=81.4

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccc--------------------hhhHHHHHHHHhcC------CCCeeccc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK  130 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~e~~~l~~l~------h~niv~~~  130 (409)
                      ..||+|+.-.||.--   .....+||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            468999999988543   34457889886554                    34456777666665      78899988


Q ss_pred             ceeeecCCCCccEEEEEEeccc---hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          131 HCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      |...+..+     ..+|+|.+.   |.....+..+.. .+.++. ...   ..+-.-..||-++ +|+.+||+|.||++.
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~---~~L~~f~~~l~~~-~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELR---QALDEFKRYLLDH-HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHH---HHHHHHHHHHHHc-CCeecCCCcccEEEE
Confidence            87644333     567777654   333333333332 345665 332   3344445667776 999999999999995


Q ss_pred             CCC--C-cEEEee
Q 015298          208 PHT--H-QVKLCD  217 (409)
Q Consensus       208 ~~~--~-~ikl~D  217 (409)
                      ...  . .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            433  2 567776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.84  E-value=0.00019  Score=65.17  Aligned_cols=68  Identities=18%  Similarity=0.127  Sum_probs=41.8

Q ss_pred             eccCCc-eEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEEEEeccch
Q 015298           79 VGQGSF-GVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (409)
Q Consensus        79 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (409)
                      |..|.. +.||++..  .+..+.+|+.... .....+|+++++.+. +--+++++.+...     ....++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCC
Confidence            334444 78998875  3467888877543 234567999988884 3234444443311     1235689999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.72  E-value=0.00026  Score=66.28  Aligned_cols=134  Identities=16%  Similarity=0.271  Sum_probs=94.8

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------c------------------------hhhHHHHHHHHhcCCC
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------K------------------------RYKNRELQTMRLLDHP  124 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------------------------~~~~~e~~~l~~l~h~  124 (409)
                      +..+|..|--+.||.|. ..+|..+|||+++..      .                        -..++|++-|++|...
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            44578888889999998 568888999987421      0                        1123677788888665


Q ss_pred             CeecccceeeecCCCCccEEEEEEeccchh--HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          125 NVVSLKHCFFSTTDKDELYLNLVLEYVPET--VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       125 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                      .|+...-+.. ..      -+|||++++..  -.-.|+     ...++...+..+-.|++.-+.-|-+.|++||.||.-=
T Consensus       227 GIP~PePIlL-k~------hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  227 GIPCPEPILL-KN------HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             CCCCCCceee-ec------ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            5443322221 11      35899999842  111122     4567777788888888888888887889999999999


Q ss_pred             ceeecCCCCcEEEeecCCccc
Q 015298          203 NLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |+|+- +| .+.|+|.+.+..
T Consensus       295 N~Lyh-dG-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  295 NLLYH-DG-KLYIIDVSQSVE  313 (520)
T ss_pred             hheEE-CC-EEEEEEcccccc
Confidence            99997 44 799999998753

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.71  E-value=0.0006  Score=61.39  Aligned_cols=69  Identities=19%  Similarity=0.311  Sum_probs=43.9

Q ss_pred             EEeeccCCceEEEEEEEcC-CCcEEEEEEeeccch---hhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEEEEEEec
Q 015298           76 ERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      .+.|..|-...+|++.... .++.|++|+......   ...+|+.+++.+....+ ++++...   ..      .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence            4567888888999987533 357888997754321   23478889988854333 3333221   11      269999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            886

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.59  E-value=0.00062  Score=61.39  Aligned_cols=30  Identities=37%  Similarity=0.476  Sum_probs=25.0

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+|+.+.||+++.+. ..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence            589999999999998553 456999998853

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.56  E-value=5.7e-05  Score=73.30  Aligned_cols=171  Identities=19%  Similarity=0.236  Sum_probs=110.6

Q ss_pred             HHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015298          112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS  191 (409)
Q Consensus       112 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  191 (409)
                      .-...+++.+.|+|...++++--    .......+|||+++.++.+.+....     +-..       +++       .+
T Consensus        30 lgr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~~   86 (725)
T KOG1093|consen   30 LGRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------AH   86 (725)
T ss_pred             hhhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------cc
Confidence            34567888899999998766442    2233377999999998887766421     1111       111       11


Q ss_pred             CCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 015298          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK  271 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~  271 (409)
                       |+.|-     |        .++++| .++..               |  |-      ...+++|||++|.++.++..|.
T Consensus        87 -~~~~~-----~--------~~~~td-~~~t~---------------~--~~------~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   87 -GVLHL-----N--------IIYITD-HFLTK---------------Y--PS------PIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -cccee-----h--------hhhccc-ccccc---------------C--CC------CCCcchhhhhHHHHHHHHHHhh
Confidence             22222     1        344444 11110               0  11      1124999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          272 PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       272 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                      ..+......++...+.+....+.......+..                 .+...++..+..++.+|+-..|..||...++
T Consensus       129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  129 SLEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            88888777777777777654443322111110                 1222367788999999999999999999999


Q ss_pred             hCCCCccCC
Q 015298          352 LIHPFFDEL  360 (409)
Q Consensus       352 l~hp~f~~~  360 (409)
                      .+++-|.++
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999999876

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.49  E-value=0.00068  Score=62.01  Aligned_cols=132  Identities=18%  Similarity=0.245  Sum_probs=72.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeeccch----hhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEEEEEEeccch
Q 015298           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEYVPE  153 (409)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (409)
                      +..|-.+.+|+..  .+++.+++|.......    ...+|.++++.+....+ ++++...     .    -++||+|++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777888886  3667888887644322    34678999998864333 2332211     1    1479999887


Q ss_pred             hHHH------------HHHHhhhh------cCCCCHH-HHHHHHHHH---------HHHHHHHHh-------cCCcEeec
Q 015298          154 TVHR------------VVKHFNKL------NQRMPMI-YVKLYAYQI---------FRALSYIHR-------SIGVCHRD  198 (409)
Q Consensus       154 ~l~~------------~l~~~~~~------~~~l~~~-~~~~i~~qi---------~~~l~~LH~-------~~~ivH~D  198 (409)
                      ....            +.....+.      ...++.. .+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            2211            11111100      1111211 111221111         111222211       12589999


Q ss_pred             CCCCceeecCCCCcEEEeecCCccc
Q 015298          199 IKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       199 lkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +.|.||+++.++  +.|+||..+..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999998765  78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.48  E-value=0.00034  Score=60.65  Aligned_cols=98  Identities=22%  Similarity=0.221  Sum_probs=75.2

Q ss_pred             HHHHHHHHhcCC-CCeecccceeeecCCCCccEEEEEEeccch-hHHHH---HHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015298          112 NRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRV---VKHFNKLNQRMPMIYVKLYAYQIFRALS  186 (409)
Q Consensus       112 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~---l~~~~~~~~~l~~~~~~~i~~qi~~~l~  186 (409)
                      ..|.-+++.+.+ +++++++|.+     .    -+++.||.+. .+...   +.+    -...++..+.+|+.+++..+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHH
Confidence            358888999976 6999998877     2    2468999884 33211   111    234678889999999999999


Q ss_pred             HHHh---cCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          187 YIHR---SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       187 ~LH~---~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +|+.   . .+.-.|++++|+.++.++ ++|++|...+...
T Consensus        74 ~l~~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   74 ELDHGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             HHhcCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            9986   3 477889999999999887 8999999977544

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.44  E-value=0.0019  Score=60.71  Aligned_cols=144  Identities=13%  Similarity=0.081  Sum_probs=76.9

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCC--eecccceeeec-CCCCccEEEEEEec
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEY  150 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~  150 (409)
                      .+.++.|....+|++..  ++..+++|+....  ......|++++..|....  +++++...-.. ........+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45677777789998864  3346788987553  344556778887774322  33333211000 00112345789999


Q ss_pred             cchhH------------HHHHHHhhhhcCCC--------CHH-H----HH----------HHHHHHHHHHHHHHh-----
Q 015298          151 VPETV------------HRVVKHFNKLNQRM--------PMI-Y----VK----------LYAYQIFRALSYIHR-----  190 (409)
Q Consensus       151 ~~~~l------------~~~l~~~~~~~~~l--------~~~-~----~~----------~i~~qi~~~l~~LH~-----  190 (409)
                      ++|.-            ...+...-.....+        ... .    ..          .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            87621            11111110000110        000 0    00          001122334555532     


Q ss_pred             -cCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          191 -SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       191 -~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                       ..+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence             24899999999999999776 57899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.40  E-value=0.0031  Score=61.05  Aligned_cols=71  Identities=21%  Similarity=0.335  Sum_probs=47.1

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeec-----------cchhhHHHHHHHHhcC---CCCeecccceeeecCCCCc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~  141 (409)
                      .+.||.|.++.||++.+...++.++||.-..           .......|.+.|+.+.   ..++++++.+.     .. 
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~-  104 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EE-  104 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CC-
Confidence            4678999999999999854446899997431           1223456778887763   34566665432     11 


Q ss_pred             cEEEEEEeccch
Q 015298          142 LYLNLVLEYVPE  153 (409)
Q Consensus       142 ~~~~lv~e~~~~  153 (409)
                       ..++||||+++
T Consensus       105 -~~~lVME~L~~  115 (401)
T PRK09550        105 -LAVTVMEDLSD  115 (401)
T ss_pred             -CCEEEEecCCC
Confidence             14589999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.34  E-value=0.0023  Score=59.76  Aligned_cols=144  Identities=11%  Similarity=0.018  Sum_probs=77.3

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeec-cchhhHHHHHHHHhcCCCC--eecccceeeec-CCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~  151 (409)
                      .+.|..|....+|+...  .+..+++|+... .......|+++++.+.+..  +++++...-.. ........+++++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677787789998864  445788998764 3344567888888884332  34433211000 001112356899999


Q ss_pred             chhHH------------HHHHHhhhhcCCC--------CHHHHHH------------HHHHHHHHHHHHHh------cCC
Q 015298          152 PETVH------------RVVKHFNKLNQRM--------PMIYVKL------------YAYQIFRALSYIHR------SIG  193 (409)
Q Consensus       152 ~~~l~------------~~l~~~~~~~~~l--------~~~~~~~------------i~~qi~~~l~~LH~------~~~  193 (409)
                      +|...            +.+...-.....+        .......            ....+..++.++..      ..+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            76211            1111110000000        0000000            11112233344432      137


Q ss_pred             cEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       194 ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            99999999999999765 56899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.30  E-value=0.0049  Score=58.26  Aligned_cols=29  Identities=31%  Similarity=0.339  Sum_probs=25.1

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            899999999999998554 45799999885

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.18  E-value=8.1e-05  Score=80.46  Aligned_cols=156  Identities=14%  Similarity=0.001  Sum_probs=106.7

Q ss_pred             HHHHHHhcCCCCeecccceeeecCCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015298          114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI  192 (409)
Q Consensus       114 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  192 (409)
                      |...++...|+++.....-..   .......+..++|+. |.+...+-........+....+.....+.+.+..-+|..-
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            444555668988887543221   122222456888887 4555555544444445555555555555466666666532


Q ss_pred             C----cEeecCCCCceeecCCCCcEEEeecCCccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 015298          193 G----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (409)
Q Consensus       193 ~----ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~l  267 (409)
                      +    -+|++||+-|.+|..+. +++++++|+.++..+. .......+++.|++|++.. ...++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence            3    58999999999999887 8999999999843332 2234567788999999874 34578889999999999999


Q ss_pred             HhCCCCC
Q 015298          268 MLGKPLF  274 (409)
Q Consensus       268 ltg~~pf  274 (409)
                      .-|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9888777

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.17  E-value=0.00055  Score=63.09  Aligned_cols=130  Identities=17%  Similarity=0.172  Sum_probs=85.8

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec----------cc----------------hhhHHHHHHHHhcC-C-
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----------DK----------------RYKNRELQTMRLLD-H-  123 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~----------------~~~~~e~~~l~~l~-h-  123 (409)
                      -|.+++.||-|--+.||.+-+ ..|.+.++|.-.-          ..                -...+|+..|+.|. | 
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            477889999999999999986 4678888884310          00                11236888888774 2 


Q ss_pred             CCeecccceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCc
Q 015298          124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (409)
Q Consensus       124 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~N  203 (409)
                      --+++.+++         ...++|||++.|--...+.+         ...+..+...+..-+--|-.+ |+||+|+.-=|
T Consensus       172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~---------v~d~~~ly~~lm~~Iv~la~~-GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH---------VEDPPTLYDDLMGLIVRLANH-GLIHGDFNEFN  232 (465)
T ss_pred             CCCCCcccc---------cceeeHHHhhcccceeeeee---------cCChHHHHHHHHHHHHHHHHc-Cceecccchhe
Confidence            223344332         22578999988731111111         112233445555666667776 99999999999


Q ss_pred             eeecCCCCcEEEeecCCcc
Q 015298          204 LLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       204 Ili~~~~~~ikl~Dfg~a~  222 (409)
                      |+++.++ .++++||-...
T Consensus       233 imv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eEEecCC-CEEEeechHhh
Confidence            9999777 79999998543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.07  E-value=0.011  Score=55.36  Aligned_cols=30  Identities=30%  Similarity=0.542  Sum_probs=26.4

Q ss_pred             CCcEeecCCCCceeecCC----CCcEEEeecCCcc
Q 015298          192 IGVCHRDIKPQNLLVNPH----THQVKLCDFGSAK  222 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~----~~~ikl~Dfg~a~  222 (409)
                      ..++|+|+.+.||+++.+    + .+.++||..+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            368999999999999874    5 79999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.05  E-value=0.01  Score=55.53  Aligned_cols=75  Identities=7%  Similarity=-0.001  Sum_probs=50.0

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeec--cchhhHHHHHHHHhcCC---CCeecccceeeecCCCCccEEEEEEe
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDH---PNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      -.+.||+|..+.||....  ++..+++|..+.  ....+..|.+.|+.|..   -.++++++.+....  ....-+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEe
Confidence            356799999999999864  333577787654  23577899999998853   34666665442211  1122578999


Q ss_pred             ccch
Q 015298          150 YVPE  153 (409)
Q Consensus       150 ~~~~  153 (409)
                      +++|
T Consensus        94 ~i~G   97 (297)
T PRK10593         94 RLRG   97 (297)
T ss_pred             ccCC
Confidence            9885

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.87  E-value=0.019  Score=53.94  Aligned_cols=29  Identities=31%  Similarity=0.600  Sum_probs=25.2

Q ss_pred             CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            37999999999999986 4 68999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.73  E-value=0.023  Score=54.01  Aligned_cols=69  Identities=20%  Similarity=0.170  Sum_probs=43.0

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc-----------chhhHHHHHHHHhcC--CC-CeecccceeeecCCCCccE
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~  143 (409)
                      .||.|....||++.+...++.|+||.-...           .....-|.+.|+...  -| .+++++.+-       ...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence            579999999999997544468999965311           122345777776653  23 455554321       112


Q ss_pred             EEEEEeccch
Q 015298          144 LNLVLEYVPE  153 (409)
Q Consensus       144 ~~lv~e~~~~  153 (409)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3589999863

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.66  E-value=0.032  Score=53.39  Aligned_cols=31  Identities=26%  Similarity=0.649  Sum_probs=26.4

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .++|+|+++.||+++.+...+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986434799999998863

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.57  E-value=0.047  Score=51.88  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=25.9

Q ss_pred             cEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       194 ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++|+|+.+.||+++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975544799999999854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.53  E-value=0.03  Score=52.43  Aligned_cols=31  Identities=26%  Similarity=0.463  Sum_probs=27.6

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      .++|+|+.+.|++++.++ -+-+.||+++..-
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence            489999999999999887 5999999999754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.43  E-value=0.051  Score=51.15  Aligned_cols=30  Identities=13%  Similarity=0.199  Sum_probs=26.9

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+|+.++||+++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            799999999999999877 799999998853

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.38  E-value=0.008  Score=56.50  Aligned_cols=76  Identities=17%  Similarity=0.287  Sum_probs=61.0

Q ss_pred             CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      .+..|.|++|++.++.+...        .....+++..++.+.+..++-+-.+...-|||+..+||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            35677889999988764321        22456677888889999888888877899999999999999 77 8999999


Q ss_pred             CCcccc
Q 015298          219 GSAKVL  224 (409)
Q Consensus       219 g~a~~~  224 (409)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.31  E-value=0.04  Score=53.07  Aligned_cols=70  Identities=17%  Similarity=0.169  Sum_probs=45.0

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeec----------cchhhHHHHHHHHhcC--CC-CeecccceeeecCCCCcc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~  142 (409)
                      .+.||.|.-..||++.+...++.|+||.-..          +.....-|.+.|+...  -| ++++++.+-       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            5678999999999999854467899996531          1123345777777663  23 455554321       11


Q ss_pred             EEEEEEeccc
Q 015298          143 YLNLVLEYVP  152 (409)
Q Consensus       143 ~~~lv~e~~~  152 (409)
                      ...+|||+++
T Consensus       107 ~~~~vMEdL~  116 (409)
T PRK12396        107 MNCCVMEDLS  116 (409)
T ss_pred             HhhHHHHhCc
Confidence            2357999886

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.17  E-value=0.11  Score=47.99  Aligned_cols=31  Identities=29%  Similarity=0.531  Sum_probs=25.6

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .++|+|+.|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999996553456999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PTZ00384 choline kinase; Provisional

Probab=95.86  E-value=0.21  Score=48.35  Aligned_cols=29  Identities=28%  Similarity=0.382  Sum_probs=24.7

Q ss_pred             CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ...+|.|+-+.||+.+.+  .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            368999999999998644  59999999885

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.40  E-value=0.34  Score=47.09  Aligned_cols=70  Identities=19%  Similarity=0.242  Sum_probs=45.7

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeec-----------cchhhHHHHHHHHhcC---CCCeecccceeeecCCCC
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  140 (409)
                      ..+.||.|....||+..+  .+..++||.-..           +......|.+.|+.+.   ..++++++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            467889999999999886  345688997541           2223345677776653   24666766544     21


Q ss_pred             ccEEEEEEeccch
Q 015298          141 ELYLNLVLEYVPE  153 (409)
Q Consensus       141 ~~~~~lv~e~~~~  153 (409)
                      .  -+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  3578999965

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.07  E-value=0.48  Score=43.97  Aligned_cols=73  Identities=15%  Similarity=0.141  Sum_probs=43.8

Q ss_pred             EEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhcC---CCCeecccceeeecCCCCccEEEEEEe
Q 015298           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      .-.+.++.|....+|+..  .+++.+.+|.-... ...+..|.+-|+.|.   --.+++++.+......     -+||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEE
Confidence            345678889999999887  57889999987643 455678998888883   3345566655432222     268999


Q ss_pred             ccch
Q 015298          150 YVPE  153 (409)
Q Consensus       150 ~~~~  153 (409)
                      |++.
T Consensus        93 ~l~~   96 (288)
T PF03881_consen   93 FLEM   96 (288)
T ss_dssp             ----
T ss_pred             eecC
Confidence            9873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.63  E-value=0.1  Score=50.02  Aligned_cols=61  Identities=31%  Similarity=0.296  Sum_probs=39.8

Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~  209 (409)
                      ..|+-+|..| ++...++.     ...+++...+++.-.+.|+.-+----+++|.|+.|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4566677776 55555543     4455566666666666665543322289999999999998543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.39  E-value=0.89  Score=43.08  Aligned_cols=27  Identities=26%  Similarity=0.357  Sum_probs=23.5

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ++||+|+.+.||+++ +  .+.|+||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            789999999999995 3  47899999875

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.31  E-value=0.13  Score=47.28  Aligned_cols=49  Identities=27%  Similarity=0.440  Sum_probs=36.2

Q ss_pred             HHHHHHHHHHHHHHHHhc-CCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          174 VKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       174 ~~~i~~qi~~~l~~LH~~-~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ....+..+-.++.-.+.. +-++|+|+.|+|++.++.+ .++|+||..|..
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            334455555555555532 2489999999999999866 799999998864

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.74  E-value=0.092  Score=45.20  Aligned_cols=29  Identities=24%  Similarity=0.324  Sum_probs=25.0

Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      -.+|+|+.|.||+++.++  ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998654  89999999864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.72  E-value=0.095  Score=46.24  Aligned_cols=30  Identities=43%  Similarity=0.734  Sum_probs=20.1

Q ss_pred             CcEeecCCCCceee-cCCCCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli-~~~~~~ikl~Dfg~a~~  223 (409)
                      .++|+||.|.||++ +.++ .++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            58999999999999 5455 899999999864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.37  E-value=0.21  Score=46.90  Aligned_cols=80  Identities=21%  Similarity=0.268  Sum_probs=43.9

Q ss_pred             EEEEeccchhHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHH---HHHhcCCcEeecCCCCceeec-CCC---------
Q 015298          145 NLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRALS---YIHRSIGVCHRDIKPQNLLVN-PHT---------  210 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~---~LH~~~~ivH~Dlkp~NIli~-~~~---------  210 (409)
                      .||++...++..++-... ...+-..-.+-++.++.||+.-.-   -|-...+.+|-||||+|||+= ++.         
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            478887765433322211 111122223456667777765431   122122799999999999973 211         


Q ss_pred             -------CcEEEeecCCcccc
Q 015298          211 -------HQVKLCDFGSAKVL  224 (409)
Q Consensus       211 -------~~ikl~Dfg~a~~~  224 (409)
                             -..+|.||.+++..
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             EEEecccceeeecccCHHHhc
Confidence                   13567788877643

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=92.18  E-value=2.9  Score=41.42  Aligned_cols=70  Identities=13%  Similarity=0.122  Sum_probs=42.2

Q ss_pred             EEEeeccCCceEEEEEEEcC--------CCcEEEEEEeeccch---hhHHHHHHHHhcCCCCee-cccceeeecCCCCcc
Q 015298           75 AERIVGQGSFGVVFQAKCLE--------TGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDEL  142 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~  142 (409)
                      -.+.|..|-...+|++....        .++.|.+++.-....   ....|..+++.+..-.|- ++++.+     .   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~---  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----S---  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----C---
Confidence            56677778888899887542        256788988754322   234688888777543333 333333     1   


Q ss_pred             EEEEEEeccch
Q 015298          143 YLNLVLEYVPE  153 (409)
Q Consensus       143 ~~~lv~e~~~~  153 (409)
                       -..|.+|++|
T Consensus       181 -gg~I~efi~g  190 (442)
T PTZ00296        181 -GGRIEEWLYG  190 (442)
T ss_pred             -CCEEEEeeCC
Confidence             1246777764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	409
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-141
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-141
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-141
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-141
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-141
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-140
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-140
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-139
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-139
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-139
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-139
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-139
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-138
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-138
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-138
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-137
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-137
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-137
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-137
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-137
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-135
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-132
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-96
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-87
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-46
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-46
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-46
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-46
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-46
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-45
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-45
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-45
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-45
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-45
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-45
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-45
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-45
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-45
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-45
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-45
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-45
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-45
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-45
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-45
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-45
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-45
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-45
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-45
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-45
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-45
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-45
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-45
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-45
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-45
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-45
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-45
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-45
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-45
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-44
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-44
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-44
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-44
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-44
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-44
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-44
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-44
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-44
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-44
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-43
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-43
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-43
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-43
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-43
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-43
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-43
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-43
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-43
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-43
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-43
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-43
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-43
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-43
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-43
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-43
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-43
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-43
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-43
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-43
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-43
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-43
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-42
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-42
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-42
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-41
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-41
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-41
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-40
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-40
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-39
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-38
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-38
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-38
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-38
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-38
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-38
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-38
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-38
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-38
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-38
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-38
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-38
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-38
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-38
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-38
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-38
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-38
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-38
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-38
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-38
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-38
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-38
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-38
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-38
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-38
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-38
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-38
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-38
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-38
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-38
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-38
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-38
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-38
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-38
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-38
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-38
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-38
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-37
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-37
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-37
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-37
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-37
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-37
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-37
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-36
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-36
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-36
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-35
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-35
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-34
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-34
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-34
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-34
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-34
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-33
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-33
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-33
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-33
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-33
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-33
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-33
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-33
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-33
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-33
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-33
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-33
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-33
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-33
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-33
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-33
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-33
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-33
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-32
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-32
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-32
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-32
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-31
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-31
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-31
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-31
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-31
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-31
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-31
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-31
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-30
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-30
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-30
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-30
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-30
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-30
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-30
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-30
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-30
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-30
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-30
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-30
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-29
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-29
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-28
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-28
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-28
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-28
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-28
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-27
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-27
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-26
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-26
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-25
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-24
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-23
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-20
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-20
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-20
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-19
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-19
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-19
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-17
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-17
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-16
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-16
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-16
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-16
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-15
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-15
3soa_A	444	Full-Length Human Camkii Length = 444		2e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-13
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-07
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		5e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-04

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/380 (63%), Positives = 297/380 (78%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 20  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 68
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 368 SSNP-PLATILIPPHARIQA 386

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/380 (63%), Positives = 297/380 (78%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 14  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 62
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 63  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 122
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 181
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 242 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 361
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 362 SSNP-PLATILIPPHARIQA 380

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/380 (63%), Positives = 297/380 (78%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 24  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 72
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 73  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 132
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 191
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 252 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 371
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 372 SSNP-PLATILIPPHARIQA 390

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/380 (63%), Positives = 297/380 (78%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 22  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 70
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 71  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 130
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 189
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 250 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 369
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 370 SSNP-PLATILIPPHARIQA 388

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/380 (63%), Positives = 297/380 (78%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 65  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 113
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 114 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 173
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 232
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 293 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 412
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 413 SSNP-PLATILIPPHARIQA 431

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  494 bits (1273), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 241/380 (63%), Positives = 296/380 (77%), Gaps = 14/380 (3%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 20  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 68
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
           R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367
Query: 385 KSVPVEILVKLIPEHARKQC 404
            S P  +   LIP HAR Q 
Sbjct: 368 SSNP-PLATILIPPHARIQA 386

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  493 bits (1269), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 291/360 (80%), Gaps = 5/360 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 345 RCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQC 404
           R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q 
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 365

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  493 bits (1268), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 235/352 (66%), Positives = 287/352 (81%), Gaps = 6/352 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 8   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 67
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 128 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           YICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQC 404
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q 
Sbjct: 307 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 357

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  491 bits (1263), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 290/360 (80%), Gaps = 5/360 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 345 RCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQC 404
           R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 364

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 240/377 (63%), Positives = 295/377 (78%), Gaps = 14/377 (3%)
Query: 29  MNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVF 88
              MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFGVV+
Sbjct: 1   FGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVY 49
Query: 89  QAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLV 147
           QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLV
Sbjct: 50  QAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 109
Query: 148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN 207
           L+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 168
Query: 208 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           P T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL
Sbjct: 169 PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP 327
           +LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R P
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 288
Query: 328 PEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSV 387
           PEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL S 
Sbjct: 289 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 348
Query: 388 PVEILVKLIPEHARKQC 404
           P  +   LIP HAR Q 
Sbjct: 349 P-PLATILIPPHARIQA 364

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 290/360 (80%), Gaps = 5/360 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 345 RCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQC 404
           R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q 
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 371

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  490 bits (1261), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 290/360 (80%), Gaps = 5/360 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 345 RCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQC 404
           R T L+A  H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q 
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 360

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 234/349 (67%), Positives = 286/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           YICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  487 bits (1253), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 234/351 (66%), Positives = 286/351 (81%), Gaps = 6/351 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ 403
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  486 bits (1251), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 285/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 7   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 66
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 127 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 306 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 353

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 285/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  485 bits (1249), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 285/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 4   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 63
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 124 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 303 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 350

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  484 bits (1245), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 232/349 (66%), Positives = 284/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           YICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  483 bits (1243), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 232/351 (66%), Positives = 284/351 (80%), Gaps = 6/351 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           YICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ 403
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  483 bits (1243), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 232/349 (66%), Positives = 284/349 (81%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K D +YLNLVL+YVPETV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  477 bits (1227), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 229/349 (65%), Positives = 281/349 (80%), Gaps = 6/349 (1%)
Query: 57  VTTIGGRNGQPK---QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
           VTT+    GQ     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI 172
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVP TV+RV +H+++  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           YVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            H FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  469 bits (1207), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 225/350 (64%), Positives = 284/350 (81%), Gaps = 5/350 (1%)
Query: 55  IIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE 114
           I V    G+ G+ ++ I+Y   +++G GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
           LQ MR++ HPNVV LK  F+S  DK DE++LNLVLEYVPETV+R  +H+ KL Q MPM+ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +KLY YQ+ R+L+YIH SIG+CHRDIKPQNLL++P +  +KL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           ICSRYYRAPELIFGAT YTT IDIWS GCV+AELM G+PLFPG+SG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
           +RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+SRLL+Y+P+ R TA++AL 
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 354 HPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ 403
           HPFFDELR   AR+P+GR LPPLFN+   EL SV  +++ +L+P+HA  +
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEEL-SVRPDLISRLVPQHAEAE 370

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  349 bits (896), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 168/369 (45%), Positives = 245/369 (66%), Gaps = 43/369 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 133 FFSTTDKD---------------------------------ELYLNLVLEYVPETVHRVV 159
           F++T D++                                   YLN+++EYVP+T+H+V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           K F +  + +PM  + +Y YQ+FRA+ +IH S+G+CHRDIKPQNLLVN   + +KLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LGKPLF G++ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQ 339
           +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI P+  P  A+DL+ ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 340 YSPNLRCTALDALIHPFFDELRDP-------NARLPSG--RFLPPLFNFKSHELKSVPVE 390
           Y P+LR    +A+ HPFFD LR+        N+  P G  + +P LFNF  +EL  +P  
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 391 ILVKLIPEH 399
           +L +++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  320 bits (819), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 160/339 (47%), Positives = 227/339 (66%), Gaps = 10/339 (2%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LLDHP 124
           K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 125 NVVSLKHCFFSTTDKD--ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           N+V L+  F++  ++D  ++YLN+V+EYVP+T+HR  +++ +     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 183 RALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
           R++  +H  S+ VCHRDIKP N+LVN     +KLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PELIFG   YTTA+DIWS GC+ AE+MLG+P+F GD+   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 302 NPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    +AL HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 359 ELRDPNARLPSGRFLPP-LFNFKSHELKSVPVEILVKLI 396
           EL DP  +LP+ + LP  LF F  +E++ +      KL+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 172/297 (57%), Gaps = 26/297 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     E  L LV E++ + + +V+   NK   +   I  K+Y YQ+ R +++ H+  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQI--KIYLYQLLRGVAHCHQH- 138
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
             F   +  PW  I P     E +DL+S +L + PN R +A DA+ HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 172/297 (57%), Gaps = 26/297 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     E  L LV E++ + + +V+   NK   +   I  K+Y YQ+ R +++ H+  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQI--KIYLYQLLRGVAHCHQH- 138
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
             F   +  PW  I P     E +DL+S +L + PN R +A DA+ HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 112/315 (35%), Positives = 177/315 (56%), Gaps = 28/315 (8%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------REL 115
           G  G P+   ++     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIY 173
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K F   +    +P+  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +K Y +Q+ + L++ H S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
              + + +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 291 GTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           GTP       +   P+Y    FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 285
Query: 349 LDALIHPFFDELRDP 363
             AL HPFF ++  P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 192/345 (55%), Gaps = 29/345 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 352 LIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
           L HP+     DPN   P G  +PP F    H  +++  + L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  181 bits (459), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 112/315 (35%), Positives = 177/315 (56%), Gaps = 28/315 (8%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------REL 115
           G  G P+   ++     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIY 173
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K F   +    +P+  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +K Y +Q+ + L++ H S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
              + + +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 291 GTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           GTP       +   P+Y    FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 285
Query: 349 LDALIHPFFDELRDP 363
             AL HPFF ++  P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 194/345 (56%), Gaps = 29/345 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH---PNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+       +  R L+ +++L H    N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----EPN------ISYIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 352 LIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
           L HP+     DPN   P G  +PP F    H  +++  + L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 116/349 (33%), Positives = 195/349 (55%), Gaps = 36/349 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 127
           Y   + +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            ++    ++T +    + +V + +   +++++K     +Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 243
           IH S  V HRD+KP NLL+N  T  +K+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IH-SANVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 302 --NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
               NY +   P      W K+FPK    +A+DL+ R+L ++PN R T  +AL HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 360 LRDPN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLI-PEHARKQ 403
             DP     A  P        F F + EL  +P E L +LI  E AR Q
Sbjct: 336 YYDPTDEPVAEEP--------FTF-AMELDDLPKERLKELIFQETARFQ 375

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 110/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + LS+ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 110/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E VH+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 124
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 242 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 124
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 242 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 108/296 (36%), Positives = 170/296 (57%), Gaps = 24/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E+V + + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 125
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 109/345 (31%), Positives = 191/345 (55%), Gaps = 29/345 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA +A
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 352 LIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
           L HP+     DPN   P G  +PP F    H  +++  + L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 171/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 169/294 (57%), Gaps = 28/294 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF +
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 170/298 (57%), Gaps = 28/298 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 103/333 (30%), Positives = 177/333 (53%), Gaps = 57/333 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTM-RLLDHPNVVSLKH 131
           +G+G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N+V+L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              +  D+D   + LV +Y+   +H V++        +  ++ +   YQ+ + + Y+H S
Sbjct: 77  VLRADNDRD---VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH-S 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK---------------------GEPN 230
            G+ HRD+KP N+L+N   H VK+ DFG ++  V                       +P 
Sbjct: 128 GGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 231 IS-YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E++ GKP+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFPKRMPP-----EAV 331
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 332 DLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           DL+ +LLQ++PN R +A DAL HPF     +PN
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 323 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 169/296 (57%), Gaps = 24/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 123
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 168/296 (56%), Gaps = 24/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   +   +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 124
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 242 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 169/296 (57%), Gaps = 24/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 125
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 168/296 (56%), Gaps = 24/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   +   +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 125
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 112/347 (32%), Positives = 187/347 (53%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + LV   +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 164
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 339 PSDEPIAEAP--------FKFDM-ELDDLPKEKLKELIFEETARFQP 376

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 323 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 319 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 356

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 152
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 327 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 319 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 149
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 324 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 150
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 325 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 141
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 316 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 323 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 321 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 164
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 339 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 376

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 142
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 317 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 354

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 102/301 (33%), Positives = 166/301 (55%), Gaps = 22/301 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 133 FFSTTDKDEL-YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              T    E   + +VL+ +   +H+++      +Q + + +V+ + YQ+ R L Y+H S
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH-S 176
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIF 246
             V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+ 
Sbjct: 177 AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              EYT AID+WS GC+  E++  + LFPG + V QL  I+ VLGTP+   I+ +     
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295
Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                  P  +  PW  ++P     +A+ L+ R+L++ P+ R +A  AL HPF  +  DP
Sbjct: 296 RAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354
Query: 364 N 364
           +
Sbjct: 355 D 355

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 319 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 356

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 102/301 (33%), Positives = 166/301 (55%), Gaps = 22/301 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 133 FFSTTDKDEL-YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              T    E   + +VL+ +   +H+++      +Q + + +V+ + YQ+ R L Y+H S
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH-S 177
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIF 246
             V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+ 
Sbjct: 178 AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              EYT AID+WS GC+  E++  + LFPG + V QL  I+ VLGTP+   I+ +     
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 296
Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                  P  +  PW  ++P     +A+ L+ R+L++ P+ R +A  AL HPF  +  DP
Sbjct: 297 RAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 355
Query: 364 N 364
           +
Sbjct: 356 D 356

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/346 (31%), Positives = 185/346 (53%), Gaps = 39/346 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC---MNP 303
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                  P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 364 N----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           +    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 322 SDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 358

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 110/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 323 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 187/347 (53%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 142
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 317 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 354

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 188/347 (54%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 323 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 187/347 (53%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 321 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 358

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/311 (35%), Positives = 170/311 (54%), Gaps = 23/311 (7%)
Query: 58  TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYK 111
             +G  N   +    Y    +VG+GS+G+V + +  +TG  VAIKK L+       K+  
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMP 170
            RE++ ++ L H N+V+L         K   YL  V E+V  T+   ++ F N L+ ++ 
Sbjct: 72  MREIKLLKQLRHENLVNLLEV---CKKKKRWYL--VFEFVDHTILDDLELFPNGLDYQV- 125
Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEP 229
              V+ Y +QI   + + H S  + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE 
Sbjct: 126 ---VQKYLFQIINGIGFCH-SHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV 180
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
               + +R+YRAPEL+ G  +Y  A+D+W+ GC+V E+ +G+PLFPGDS +DQL  I+  
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 290 LGT--PTREEIKCMNPNYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           LG   P  +E+   NP +   + P+IK   P  + +PK +    +DL  + L   P+ R 
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRP 299
Query: 347 TALDALIHPFF 357
              + L H FF
Sbjct: 300 FCAELLHHDFF 310

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 186/344 (54%), Gaps = 35/344 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 249
           V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----NPNY 305
            YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN- 364
                P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  DP+ 
Sbjct: 268 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 365 ---ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
              A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 326 EPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/344 (31%), Positives = 186/344 (54%), Gaps = 35/344 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 149
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 249
           V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----NPNY 305
            YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN- 364
                P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  DP+ 
Sbjct: 269 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 365 ---ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
              A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 327 EPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 361

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 111/347 (31%), Positives = 186/347 (53%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMN 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 319 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 356

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 167/296 (56%), Gaps = 25/296 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     + +  L+LV EY     H V+   ++  + +P   VK   +Q  +A+++ H+  
Sbjct: 71  F-----RRKRRLHLVFEYCD---HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
              HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G T
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDT 178
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 307
           +Y   +D+W+ GCV AEL+ G PL+PG S VDQL  I K LG   P  +++   N  ++ 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 308 FKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            K P  +   P    FP    P A+ L+   L   P  R T    L HP+F+ +R+
Sbjct: 239 VKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 163/304 (53%), Gaps = 23/304 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 125
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 126 VVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+ L   F   +     Y   LV+ ++   + ++      +  +     ++   YQ+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLKG 138
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 243
           L YIH S GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +N 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              +      PQ     + ++FP R  P+A DL+ ++L+   + R TA  AL HPFF+  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 361 RDPN 364
           RDP 
Sbjct: 313 RDPE 316

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 162/304 (53%), Gaps = 23/304 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 125
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 126 VVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+ L   F   +     Y   LV+ ++   + ++      +        ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGMEFSEEKIQYLVYQMLKG 156
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 243
           L YIH S GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +N 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              +      PQ     + ++FP R  P+A DL+ ++L+   + R TA  AL HPFF+  
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330
Query: 361 RDPN 364
           RDP 
Sbjct: 331 RDPE 334

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 170/308 (55%), Gaps = 23/308 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L H    T    E  L LV EY+ + +    ++ +     + M  VKL+ +Q+ R L+
Sbjct: 63  VTL-HDIIHT----EKSLTLVFEYLDKDLK---QYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           N  +  + +P+ +A       P R+  +  DL+++LLQ+    R +A DA+ HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 362 DPNARLPS 369
           +   +LP 
Sbjct: 290 ERIHKLPD 297

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 105/295 (35%), Positives = 161/295 (54%), Gaps = 31/295 (10%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
            +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   ++     ++LV +++   +  ++K  N L   +   ++K Y     + L Y+
Sbjct: 77  LLDAFGHKSN-----ISLVFDFMETDLEVIIKD-NSL--VLTPSHIKAYMLMTLQGLEYL 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H+   + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+
Sbjct: 129 HQHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELL 184
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI--KCMNP 303
           FGA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT E+    C  P
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 304 NYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           +Y  FK FP I   P H IF      + +DL+  L  ++P  R TA  AL   +F
Sbjct: 245 DYVTFKSFPGI---PLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 110/347 (31%), Positives = 185/347 (53%), Gaps = 41/347 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMN 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 363 PN----ARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
           P+    A  P        F F   EL  +P E L +LI E   +  P
Sbjct: 319 PSDEPIAEAP--------FKF-DMELDDLPKEKLKELIFEETARFQP 356

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 166/302 (54%), Gaps = 36/302 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S  DK    L LV E+  + +    K+F+  N  +    VK + +Q+ + L + H S 
Sbjct: 70  LHS--DKK---LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SR 120
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 309 KFPQIKAHPWH-------KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           K P  K +P +        + PK +     DL+  LL+ +P  R +A +AL HP+F +  
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
Query: 362 DP 363
            P
Sbjct: 291 PP 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 165/302 (54%), Gaps = 36/302 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S  DK    L LV E+  + +    K+F+  N  +    VK + +Q+ + L + H S 
Sbjct: 70  LHS--DKK---LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SR 120
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            Y+T+ID+WSAGC+ AEL    +PLFPG+   DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 309 KFPQIKAHPWH-------KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           K P  K +P +        + PK +     DL+  LL+ +P  R +A +AL HP+F +  
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
Query: 362 DP 363
            P
Sbjct: 291 PP 292

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 159/300 (53%), Gaps = 24/300 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL  V   +   ++ +VK     +Q +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IH-SAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
                 P +       IF +   P A+DL+ R+L    + R +A +AL H +F +  DP 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 164/296 (55%), Gaps = 34/296 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 158/300 (52%), Gaps = 24/300 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL  V   +   ++ +VK      Q +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IH-SAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
                 P +       IF +   P A+DL+ R+L    + R +A +AL H +F +  DP 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 164/296 (55%), Gaps = 34/296 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 164/296 (55%), Gaps = 34/296 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA  AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 157/300 (52%), Gaps = 24/300 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL  V   +   ++ +VK      Q +   +V+   YQ+ R L Y
Sbjct: 86  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 138
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN    ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 139 IH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 194
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 254
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
                 P +       IF +   P A+DL+ R+L    + R +A +AL H +F +  DP 
Sbjct: 255 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F   T  +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 171
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 172 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
               PQ+    +  +F     P AVDL+ ++L    + R TA +AL HP+F +  DP+
Sbjct: 289 N-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPD 344

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 157/295 (53%), Gaps = 22/295 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 132
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D+     LV+ ++   + +++KH     +++    ++   YQ+ + L YIH +
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-A 146
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP NL VN    ++K+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 307
           T  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ +      NY +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
              P+++   +  I      P AV+L+ ++L      R TA +AL HP+F+ L D
Sbjct: 264 -GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 266 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 162 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 279 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 152
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 153 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 270 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK     +Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 166 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 280 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 166 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 162 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 279 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 141
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 259 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 140
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 258 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 256 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK       ++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 24/298 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
           +    Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 159/312 (50%), Gaps = 30/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------------LQDKRYKNRELQTMRL 120
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 121 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVK 175
           L+H   PN++ L+  F    +     L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            + Y I   L  +H + GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 296 EEIKCMNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
           E++   +     +Y       + A  W  + P    P A+DL++++L+++P  R +   A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 352 LIHPFFDELRDP 363
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 159/312 (50%), Gaps = 30/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------------LQDKRYKNRELQTMRL 120
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 121 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVK 175
           L+H   PN++ L+  F    +     L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            + Y I   L  +H + GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 296 EEIKCMNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
           E++   +     +Y       + A  W  + P    P A+DL++++L+++P  R +   A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 352 LIHPFFDELRDP 363
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 165/312 (52%), Gaps = 23/312 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR 366
              F    A P  K F   +     DL+ + L ++P  R +A  AL HP+F +L      
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 309
Query: 367 LPSGRFLPPLFN 378
           L S   LPP  N
Sbjct: 310 LDS--HLPPSQN 319

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 159/294 (54%), Gaps = 21/294 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              F    A P  K F   +     DL+ + L ++P  R +A  AL HP+F +L
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 100/310 (32%), Positives = 165/310 (53%), Gaps = 38/310 (12%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 127
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 128 ----------SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
                      L     S T+ + +Y+  V EY+   +  V++    L +     + +L+
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQGPLLEE-----HARLF 125
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---- 233
            YQ+ R L YIH S  V HRD+KP NL +N     +K+ DFG A+++   +P+ S+    
Sbjct: 126 MYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHL 181
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL---VEII 287
              + +++YR+P L+     YT AID+W+AGC+ AE++ GK LF G   ++Q+   +E I
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            V+    R+E+  + P Y      +    P  ++ P  +  EAVD + ++L +SP  R T
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTE-PHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLT 299
Query: 348 ALDALIHPFF 357
           A +AL HP+ 
Sbjct: 300 AEEALSHPYM 309

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 102/291 (35%), Positives = 157/291 (53%), Gaps = 21/291 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              F    A P  K F   +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/300 (32%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRALSYIHRS 191
            +     E  L LV E++   + + +      N  + + +  VK + +Q+ + L++ H +
Sbjct: 73  HT-----ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y+T+IDIWS GC++AE++ GKPLFPG +  +QL  I  ++GTP     + + P+ T+ 
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKL 239
Query: 309 -KF-PQIKAHPWHKIFPKRMP-------PEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
            K+ P I+  P   +     P          +D +  LLQ +P++R +A  AL HP+F E
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/306 (32%), Positives = 160/306 (52%), Gaps = 31/306 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++SL + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + LV+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+     + K+FP  + P           +A DL+S++L   P  R +  DAL HP+ 
Sbjct: 263 R-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 358 DELRDP 363
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 309 LQHPYINVWYDP 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 99/306 (32%), Positives = 160/306 (52%), Gaps = 31/306 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++SL + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + LV+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+     + K+FP  + P           +A DL+S++L   P  R +  DAL HP+ 
Sbjct: 263 R-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 358 DELRDP 363
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 158/294 (53%), Gaps = 28/294 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                      L+L+ EY    +    K +   N  + M  +K + YQ+   +++ H S 
Sbjct: 102 IHHNH-----RLHLIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCH-SR 151
Query: 193 GVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
              HRD+KPQNLL++      T  +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--P 303
            G+  Y+T++DIWS  C+ AE+++  PLFPGDS +DQL +I +VLG P       +   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           ++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A +AL HP+F
Sbjct: 270 DWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 317 LQHPYINVWYDP 328

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 162/307 (52%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 177
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 138
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 139 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 256 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 315 LQHPYINVWYDP 326

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 317 LQHPYINVWYDP 328

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 177
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 309 LQHPYINVWYDP 320

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 310 LQHPYINVWYDP 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +  DA
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 352 LIHPFFDELRDP 363
           L HP+ +   DP
Sbjct: 310 LQHPYINVWYDP 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 99/314 (31%), Positives = 164/314 (52%), Gaps = 35/314 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 304 -NYTEF--KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTAL 349
            NY E   K+P IK   + ++FP  + P           +A DL+S++L   P+ R +  
Sbjct: 257 RNYVENRPKYPGIK---FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 313
Query: 350 DALIHPFFDELRDP 363
           +AL HP+     DP
Sbjct: 314 EALRHPYITVWYDP 327

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 162/307 (52%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 161/307 (52%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYLL-----YQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 161/312 (51%), Gaps = 31/312 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 137
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
            NY E + P      + ++FP  + P           +A DL+S++L   P+ R +  +A
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 352 LIHPFFDELRDP 363
           L HP+     DP
Sbjct: 314 LRHPYITVWYDP 325

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 161/307 (52%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 97/301 (32%), Positives = 158/301 (52%), Gaps = 31/301 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++SL + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + LV+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+     + K+FP  + P           +A DL+S++L   P  R +  DAL HP+ 
Sbjct: 263 R-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 358 D 358
           +
Sbjct: 322 N 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 163/313 (52%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 161/307 (52%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 163/313 (52%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 152/299 (50%), Gaps = 25/299 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 129
            Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 250 EYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKCMN 302
            Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ ++
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LD 266
Query: 303 PNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+F
Sbjct: 267 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 163/313 (52%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 141
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+        + ++ +RYYRAPE+I
Sbjct: 142 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 200 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 259 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 318 LQHPYINVWYDPS 330

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 162/313 (51%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 258 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 317 LQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 162/313 (51%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 162/313 (51%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 144
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 145 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 262 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 321 LQHPYINVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 162/313 (51%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 310 LQHPYINVWYDPS 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 161/313 (51%), Gaps = 31/313 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDA 351
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +  +A
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 352 LIHPFFDELRDPN 364
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 157
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 331 LEAMTHPYFQQVR 343

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 108/360 (30%), Positives = 167/360 (46%), Gaps = 87/360 (24%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y+ + ++G+GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 126 VVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L            DELY+  VLE     + ++ K    L +     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNI----------- 231
             ++IH S G+ HRD+KP N L+N     VK+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 232 -----------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL--MLGK------- 271
                      S++ +R+YRAPELI     YT +IDIWS GC+ AEL  ML         
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 272 --PLFPGD-----------------SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
             PLFPG                  S  DQL  I  ++GTPT +++K +N        P+
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-------PE 311
Query: 313 IKAHPWHKIFPKRMP-----------PEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           +    + K+FP R P            + ++L+  +L+++PN R T   AL HP+  ++R
Sbjct: 312 VIK--YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/311 (29%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N+L++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 324 FYTVVKDQARM 334

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 138
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 251
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 312 LEAMTHPYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 250
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 LDALIHPFFDELR 361
           L+A+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 159/307 (51%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP    +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 110/367 (29%), Positives = 161/367 (43%), Gaps = 95/367 (25%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 126
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 127 VSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V +            DELY+  VLE       ++ +    L +    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------------ 232
           + Y+H S G+ HRD+KP N LVN     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 233 ----------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL--MLGK--- 271
                           ++ +R+YRAPELI     YT AID+WS GC+ AEL  M+ +   
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 272 ------PLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 305
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE- 345
Query: 306 TEFKFPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                    A  + +IFPKR              +A+ L+ R+L ++PN R T  + L H
Sbjct: 346 --------DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 355 PFFDELR 361
           PFF E+R
Sbjct: 398 PFFKEVR 404

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 18/289 (6%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLD---HPNVVSL 129
           +G G++G V++A+   +G  VA+K V      +       RE+  +R L+   HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 130 KH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R L ++
Sbjct: 72  MDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFL 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  +
Sbjct: 129 HANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRG 244
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP     P   + P+ M      L+  +L ++P+ R +A  AL H + 
Sbjct: 245 AFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 18/289 (6%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLD---HPNVVSL 129
           +G G++G V++A+   +G  VA+K V      +       RE+  +R L+   HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 130 KH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R L ++
Sbjct: 72  MDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFL 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  +
Sbjct: 129 HANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRG 244
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP     P   + P+ M      L+  +L ++P+ R +A  AL H + 
Sbjct: 245 AFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 159/307 (51%), Gaps = 31/307 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNVVSLKHC 132
           +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N++ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      +E   + +V+E +   + +V++     ++RM  +      YQ+   + ++H S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGIKHLH-S 144
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I G   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 308
              +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 309 KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + P+   + + K+FP  + P           +A DL+S++L    + R +  +AL HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 358 DELRDPN 364
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 147/289 (50%), Gaps = 18/289 (6%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLD---HPNVVSL 129
           +G G++G V++A+   +G  VA+K V      +       RE+  +R L+   HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 130 KH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R L ++
Sbjct: 72  MDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFL 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE++  +
Sbjct: 129 HANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +    
Sbjct: 187 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRG 244
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            FP     P   + P+ M      L+  +L ++P+ R +A  AL H + 
Sbjct: 245 AFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 148/296 (50%), Gaps = 29/296 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLD--- 122
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 123 HPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           HPNVV L   C  S TD+ E+ + LV E+V + +   +         +P   +K    Q 
Sbjct: 73  HPNVVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQF 129
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            R L ++H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRA
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 245
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + +     FP     P   + P+ M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 156/313 (49%), Gaps = 29/313 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARLPS 369
           F  +    AR+ S
Sbjct: 324 FYTVVKDQARMGS 336

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/314 (29%), Positives = 156/314 (49%), Gaps = 29/314 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARLPSG 370
           F  +    AR+ S 
Sbjct: 324 FYTVVKDQARMGSS 337

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLRQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 324 FYTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 151
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 269
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 270 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 329 FYTVVKDQARM 339

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 324 FYTVVKDQARM 334

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 264 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 323 FYTVVKDQARM 333

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 324 FYTVVKDQARM 334

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 155/311 (49%), Gaps = 29/311 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 FDELRDPNARL 367
           F  +    AR+
Sbjct: 324 FYTVVKDQARM 334

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/333 (27%), Positives = 168/333 (50%), Gaps = 53/333 (15%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPK------------------RMPPEA--------- 330
            K ++ +     F   K +P +                       R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 331 ------VDLVSRLLQYSPNLRCTALDALIHPFF 357
                 +D + + L++ P +R T   AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 93/333 (27%), Positives = 169/333 (50%), Gaps = 53/333 (15%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHPWH------------------KIFPKRMPPEA--------- 330
            K ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 331 ------VDLVSRLLQYSPNLRCTALDALIHPFF 357
                 +D + + L++ P +R T   AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 109/367 (29%), Positives = 163/367 (44%), Gaps = 92/367 (25%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y  + ++G+GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 126 VVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L            DELY+  VLE     + ++ K    L ++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------------ 231
              +IH S G+ HRD+KP N L+N     VK+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 232 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGK---- 271
                          S++ +R+YRAPELI     YT +IDIWS GC+ AEL+ + K    
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 272 ------PLFPGD-----------------SGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
                 PLFPG                  S  DQL  I  V+GTP  E++KC+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCIT------ 313
Query: 309 KFPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           K   IK   + K+FP R           +  E +DL+  +L+++   R T   AL HP+ 
Sbjct: 314 KQEVIK---YIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYL 370
Query: 358 DELRDPN 364
            ++R  N
Sbjct: 371 KDVRKEN 377

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 94  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 144
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 145 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 262
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 263 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 357 F 357
           F
Sbjct: 322 F 322

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 F 357
           F
Sbjct: 324 F 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 263
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 264 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 357 F 357
           F
Sbjct: 323 F 323

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 F 357
           F
Sbjct: 324 F 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA +A+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 357 F 357
           F
Sbjct: 324 F 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 118/225 (52%), Gaps = 24/225 (10%)
Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           LV EY+  T       F +L Q +    ++ Y Y++ +AL Y H S G+ HRD+KP N++
Sbjct: 117 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 169
Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVA 265
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC++A
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 266 ELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 316
            ++  + P F G    DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 317 PWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            W           + PEA+DL+ +LL+Y    R TA +A+ HP+F
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 118/225 (52%), Gaps = 24/225 (10%)
Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           LV EY+  T       F +L Q +    ++ Y Y++ +AL Y H S G+ HRD+KP N++
Sbjct: 112 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 164
Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVA 265
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC++A
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 266 ELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 316
            ++  + P F G    DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 317 PWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            W           + PEA+DL+ +LL+Y    R TA +A+ HP+F
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 151/299 (50%), Gaps = 28/299 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + DAL H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 154/297 (51%), Gaps = 24/297 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL-KH 131
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 132 CFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           C    +  ++ +  + LV ++     H +    + +  +  +  +K     +   L YIH
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPEL 244
           R+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL
Sbjct: 143 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           + G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++ N
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-N 259
Query: 305 YTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           Y  ++  ++      K+  +       P A+DL+ +LL   P  R  + DAL H FF
Sbjct: 260 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 151/299 (50%), Gaps = 28/299 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + DAL H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 151/299 (50%), Gaps = 28/299 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + DAL H FF
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 166/333 (49%), Gaps = 53/333 (15%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHPWH------------------KIFPKRMPPEA--------- 330
            K ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 331 ------VDLVSRLLQYSPNLRCTALDALIHPFF 357
                 +D + + L++ P +R T   AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/284 (33%), Positives = 141/284 (49%), Gaps = 42/284 (14%)
Query: 113 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQ 167
           RE+  +R L HPNV+SL+  F S  D+    + L+ +Y    +  ++K       NK   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL 224
           ++P   VK   YQI   + Y+H +  V HRD+KP N+LV    P   +VK+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 225 ---VKGEPNIS-YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF------ 274
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 275 ---PGDSGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPWH 319
                    DQL  I  V+G P     E+IK M  + T  K F +        IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 320 KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
           K+ P     +A  L+ +LL   P  R T+  A+  P+F  L DP
Sbjct: 303 KVKPDS---KAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 101/357 (28%), Positives = 164/357 (45%), Gaps = 49/357 (13%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 125 N--------VVSLKHCF-----FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           N         +   H       F+    + +++ +V E + E +  ++K +   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 226
           IYVK  + Q+   L Y+HR  G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------V 280
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 281 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FPKRMP 327
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 328 PEAVDLVSRLLQYSPNLRCTALDALIHPFF------DELRDPNARL-PSGRFLPPLF 377
            E  D +S +LQ  P  R  A   + HP+       +E+R P+  L  SG  +P  F
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 101/357 (28%), Positives = 164/357 (45%), Gaps = 49/357 (13%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 125 N--------VVSLKHCF-----FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           N         +   H       F+    + +++ +V E + E +  ++K +   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 226
           IYVK  + Q+   L Y+HR  G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------V 280
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 281 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FPKRMP 327
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 328 PEAVDLVSRLLQYSPNLRCTALDALIHPFF------DELRDPNARL-PSGRFLPPLF 377
            E  D +S +LQ  P  R  A   + HP+       +E+R P+  L  SG  +P  F
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 161/348 (46%), Gaps = 61/348 (17%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 139
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPW--------------------HKIF-------PK 324
            P    I    P   +F F ++    W                    H I          
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 325 RMPPEA----------VDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
           R   E+           DL+ R+L Y P  R     AL H FF +  D
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 362

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 161/348 (46%), Gaps = 61/348 (17%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 158
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPW--------------------HKIF-------PK 324
            P    I    P   +F F ++    W                    H I          
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 325 RMPPEA----------VDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
           R   E+           DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 161/348 (46%), Gaps = 61/348 (17%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 158
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPW--------------------HKIF-------PK 324
            P    I    P   +F F ++    W                    H I          
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 325 RMPPEA----------VDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
           R   E+           DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DAL H +
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DAL H +
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DAL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A DAL H +
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 139/295 (47%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           +  L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A DAL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/311 (29%), Positives = 147/311 (47%), Gaps = 70/311 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 201 VSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 249
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----I 353
                  E+ FP+       K FPK     A DLV +L  L  +  L C  ++       
Sbjct: 250 -------EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKA 290
Query: 354 HPFFDELRDPN 364
           HPFF+ +   N
Sbjct: 291 HPFFESVTWEN 301

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 144/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 209 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 251 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298
Query: 361 RDPN 364
              N
Sbjct: 299 TWEN 302

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 146/305 (47%), Gaps = 58/305 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
             +   ++ D+W+ GC++ +L+ G P F  G+ G+    +IIK+                
Sbjct: 208 EKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKL---------------- 249
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDE 359
            E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ 
Sbjct: 250 -EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 360 LRDPN 364
           +   N
Sbjct: 297 VTWEN 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 142/304 (46%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             CF    D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 154
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 155 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 213 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 254
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 255 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302
Query: 361 RDPN 364
              N
Sbjct: 303 TWEN 306

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 144/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 205 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 246
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 247 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294
Query: 361 RDPN 364
              N
Sbjct: 295 TWEN 298

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 144/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 247
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 248 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 361 RDPN 364
              N
Sbjct: 296 TWEN 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 146/305 (47%), Gaps = 58/305 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
             +   ++ D+W+ GC++ +L+ G P F  G+ G+    +IIK+                
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKL---------------- 249
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDE 359
            E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ 
Sbjct: 250 -EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 360 LRDPN 364
           +   N
Sbjct: 297 VTWEN 301

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 209 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 251 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298
Query: 361 RDPN 364
              N
Sbjct: 299 TWEN 302

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 249
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 250 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 361 RDPN 364
              N
Sbjct: 298 TWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 247
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 248 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 361 RDPN 364
              N
Sbjct: 296 TWEN 299

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 249
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 250 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 361 RDPN 364
              N
Sbjct: 298 TWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 247
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 248 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 361 RDPN 364
              N
Sbjct: 296 TWEN 299

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 249
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 250 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 361 RDPN 364
              N
Sbjct: 298 TWEN 301

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 124
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 183 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 224
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 225 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272
Query: 361 RDPN 364
              N
Sbjct: 273 TWEN 276

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 126
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 185 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 226
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 227 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274
Query: 361 RDPN 364
              N
Sbjct: 275 TWEN 278

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 80  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 131
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 132 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 190 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 231
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 232 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279
Query: 361 RDPN 364
              N
Sbjct: 280 TWEN 283

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 146/311 (46%), Gaps = 70/311 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 139
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 140 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 198 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 246
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----I 353
                  E+ FP+       K FPK     A DLV +L  L  +  L C  ++       
Sbjct: 247 -------EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKA 287
Query: 354 HPFFDELRDPN 364
           HPFF+ +   N
Sbjct: 288 HPFFESVTWEN 298

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 125
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 184 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 225
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 226 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
Query: 361 RDPN 364
              N
Sbjct: 274 TWEN 277

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 146/311 (46%), Gaps = 70/311 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 76  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 120
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 121 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 179 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 227
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----I 353
                  E+ FP+       K FPK     A DLV +L  L  +  L C  ++       
Sbjct: 228 -------EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKA 268
Query: 354 HPFFDELRDPN 364
           HPFF+ +   N
Sbjct: 269 HPFFESVTWEN 279

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 142/304 (46%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 247
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP+       K FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 248 EYDFPE-------KFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 361 RDPN 364
              N
Sbjct: 296 TWEN 299

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 49/308 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
             PQ     W  I       +A DL+ ++L + P+LR TA   L HP+   ++  ++  P
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 369 SGRFLPPL 376
           +   LP L
Sbjct: 289 TISDLPSL 296

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/304 (28%), Positives = 141/304 (46%), Gaps = 56/304 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +F+  D ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 152
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 246
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 153 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             +   ++ D+W+ GC++ +L+ G P F   +      +IIK+                 
Sbjct: 211 EKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 252
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL--LQYSPNLRCTALDAL----IHPFFDEL 360
           E+ FP          FPK     A DLV +L  L  +  L C  ++       HPFF+ +
Sbjct: 253 EYDFPA-------AFFPK-----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300
Query: 361 RDPN 364
              N
Sbjct: 301 TWEN 304

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             PQ     W  I       +A DL+ ++L + P+LR TA   L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 38/286 (13%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 133
           ++G+G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H +  
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 251
           + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
             A DIWS GC + E+  GKP F                        +   P    FK  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 239
Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             K HP     P+ M  EA   + +  +  P+ R  A D L+  F 
Sbjct: 240 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             PQ     W  I       +A DL+ ++L + P+LR TA   L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 38/286 (13%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 133
           ++G+G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H +  
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELI-FGATEY 251
           + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
             A DIWS GC + E+  GKP F                        +   P    FK  
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 225
Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             K HP     P+ M  EA   + +  +  P+ R  A D L+  F 
Sbjct: 226 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F  +T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKKVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + R++KHF K  + +P   V  Y  Q+  
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           AL ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 H-SKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 120
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 42/293 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   TD   +YL + L    E   RVV H     +      +K     +  A++Y 
Sbjct: 71  LYETFEDNTD---IYLVMELCTGGELFERVV-HKRVFRESDAARIMK----DVLSAVAYC 122
Query: 189 HRSIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H+ + V HRD+KP+N L   +     +KL DFG A     G+   + + + YY +P+++ 
Sbjct: 123 HK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    D WSAG ++  L+ G P F   +  + +++I +  GT              
Sbjct: 182 GL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-------------- 223
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
            F FP+     W  +      P+A  L+ RLL  SP  R T+L AL H +F++
Sbjct: 224 -FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 127
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 42/293 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   TD   +YL + L    E   RVV H     +      +K     +  A++Y 
Sbjct: 88  LYETFEDNTD---IYLVMELCTGGELFERVV-HKRVFRESDAARIMK----DVLSAVAYC 139
Query: 189 HRSIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H+ + V HRD+KP+N L   +     +KL DFG A     G+   + + + YY +P+++ 
Sbjct: 140 HK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    D WSAG ++  L+ G P F   +  + +++I +  GT              
Sbjct: 199 GL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-------------- 240
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
            F FP+     W  +      P+A  L+ RLL  SP  R T+L AL H +F++
Sbjct: 241 -FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 151 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 127 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/325 (28%), Positives = 151/325 (46%), Gaps = 57/325 (17%)
Query: 68  KQTISYMAERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMR 119
           K  +S M +R+  +G G++G V   +   T    AIK + +     +       E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVL----EYVPETVHRVVKHFNKLNQRMPMIYVK 175
           LLDHPN++ L + FF   DK   YL +      E   E +HR+     K N+    + +K
Sbjct: 92  LLDHPNIMKL-YDFFE--DKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIK 143
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISY 233
               Q+   ++Y+H+   + HRD+KP+NLL+        +K+ DFG + V    +     
Sbjct: 144 ----QVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ  EI++     
Sbjct: 199 LGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----- 247
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                K     YT F  P+     W     K +   A DL+ ++LQ+    R +A  AL 
Sbjct: 248 -----KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
Query: 354 HPFFDELRDPNARLPSGRFLPPLFN 378
           HP+  E+    ++  SG  LP L N
Sbjct: 292 HPWIKEM---CSKKESGIELPSLAN 313

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 64/295 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-------SAKVLVKGEPNISYICSRYYRA 241
           H S  V HRDIKP+NLL+     ++K+ DFG       S +  + G  +        Y  
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   +   +D+WS G +  E ++GKP F  ++  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                EF FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGAT 249
            V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+   DIWS G  + EL + +  FP DS            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             Q+   P  ++   +   E VD  S+ L+ +   R T  + + HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 H-SKRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P   V++ ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 248
            V HRD+KP N+L+N    QVK+CDFG +  LV     +I   C + Y APE I      
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQ 187
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y+   DIWS G  + EL + +  FP DS            GTP ++            
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------ 222
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              Q+   P  ++   +   E VD  S+ L+ +   R T  + + HPFF
Sbjct: 223 -LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P   V++ ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++P+ R    + L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 260
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 146/306 (47%), Gaps = 56/306 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 246
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 237 R-YYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  +AL 
Sbjct: 354 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 399
Query: 354 HPFFDE 359
           HP+  +
Sbjct: 400 HPWLQD 405

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 147/326 (45%), Gaps = 54/326 (16%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F  
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               +      ++ +V E +  + +  +K    L  R+   +++  AYQI ++++++H S
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLH-S 136
Query: 192 IGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPN 230
             + H D+KP+N+L                     +NP    +K+ DFGSA      E +
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHH 191
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
            + + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++L
Sbjct: 192 STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 291 GTPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFPKR--------MPPEAV------DLVS 335
           G   +  I K     Y          H     +  R        M  + V      DL+ 
Sbjct: 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310
Query: 336 RLLQYSPNLRCTALDALIHPFFDELR 361
           ++L+Y P  R T  +AL HPFFD L+
Sbjct: 311 KMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  ++ +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++ + R T  + L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 184 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 229
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           YT                PK + P A  L+ R+L  +P  R +  + +   +F
Sbjct: 230 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 50/288 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  ++ +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            FP              +   A DL+SRLL+++ + R T  + L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/326 (26%), Positives = 146/326 (44%), Gaps = 54/326 (16%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F  
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               +      ++ +V E +  + +  +K    L  R+   +++  AYQI ++++++H S
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLH-S 136
Query: 192 IGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPN 230
             + H D+KP+N+L                     +NP    +K+ DFGSA      E +
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHH 191
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
            + +  R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++L
Sbjct: 192 STLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 291 GTPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFPKR--------MPPEAV------DLVS 335
           G   +  I K     Y          H     +  R        M  + V      DL+ 
Sbjct: 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310
Query: 336 RLLQYSPNLRCTALDALIHPFFDELR 361
           ++L+Y P  R T  +AL HPFFD L+
Sbjct: 311 KMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 61  GGRN-GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---- 113
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 114 -ELQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMP 170
            E+Q M+ L+HPNVVS +           ++L L L +EY      R  K+ N+      
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 118
Query: 171 MIY--VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVK 226
           +    ++     I  AL Y+H +  + HRD+KP+N+++ P   ++  K+ D G AK L +
Sbjct: 119 LKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFP 275
           GE    ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 178 GELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 183 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 228
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           YT                PK + P A  L+ R+L  +P  R +  + +   +F
Sbjct: 229 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 178 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 223
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           YT                PK + P A  L+ R+L  +P  R +  + +   +F
Sbjct: 224 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 61  GGRN-GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---- 113
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 114 -ELQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMP 170
            E+Q M+ L+HPNVVS +           ++L L L +EY      R  K+ N+      
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 117
Query: 171 MIY--VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVK 226
           +    ++     I  AL Y+H +  + HRD+KP+N+++ P   ++  K+ D G AK L +
Sbjct: 118 LKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFP 275
           GE    ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 177 GELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 174 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 219
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           YT                PK + P A  L+ R+L  +P  R +  + +   +F
Sbjct: 220 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 130/297 (43%), Gaps = 52/297 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + +D     + +V+EYV   E    + K     N R+     +    QI 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y HR + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y AP
Sbjct: 127 SGVDYCHRHM-VVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAP 184
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+I G       +DIWS+G ++  L+ G   F  D               PT  +  C  
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKICDG 231
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
             YT                P+ + P  + L+  +LQ  P  R T  D   H +F +
Sbjct: 232 IFYT----------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY+P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY+P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K +E    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 147/346 (42%), Gaps = 90/346 (26%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 122
           Y  +  +GQGS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV------------------------------- 151
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 152 -----PETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN 203
                 E ++  +  F +     QR  +I   +   QIF AL Y+H   G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMR--QIFSALHYLHNQ-GICHRDIKPEN 198
Query: 204 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE-YTTAID 256
            L + + + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 257 IWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 316
            WSAG ++  L++G   FPG +  D + +++        +++   NPNY           
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN---------- 301
Query: 317 PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
                    + P A DL+S LL  + + R  A+ AL HP+  +  D
Sbjct: 302 --------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPE 204
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 143/315 (45%), Gaps = 51/315 (16%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 126 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 238 -YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ APELI     Y   +DIWS G +V E++ G+P +                  P  +
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLK 227
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            +K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF
Sbjct: 228 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 276
Query: 357 FDELRDPNARLPSGR 371
             +   P + +P  R
Sbjct: 277 LAKAGPPASIVPLMR 291

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 90/313 (28%), Positives = 141/313 (45%), Gaps = 48/313 (15%)
Query: 67  PKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMR 119
           P    SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 69  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 126
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              H NVV + + +      DEL++  V+E++       +    ++N+      +     
Sbjct: 127 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 177
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-Y 238
            + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +    Y
Sbjct: 178 AVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APELI     Y   +DIWS G +V E++ G+P +                  P  + +
Sbjct: 236 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAM 279
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF  
Sbjct: 280 KMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328
Query: 359 ELRDPNARLPSGR 371
           +   P + +P  R
Sbjct: 329 KAGPPASIVPLMR 341

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 143/315 (45%), Gaps = 51/315 (16%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 81
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 82  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 132
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 133 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 190
Query: 238 -YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ APELI     Y   +DIWS G +V E++ G+P +                  P  +
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLK 234
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            +K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF
Sbjct: 235 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 283
Query: 357 FDELRDPNARLPSGR 371
             +   P + +P  R
Sbjct: 284 LAKAGPPASIVPLMR 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 143/315 (45%), Gaps = 51/315 (16%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 79
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 80  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 130
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 131 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 188
Query: 238 -YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ APELI     Y   +DIWS G +V E++ G+P +                  P  +
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLK 232
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            +K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF
Sbjct: 233 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 281
Query: 357 FDELRDPNARLPSGR 371
             +   P + +P  R
Sbjct: 282 LAKAGPPASIVPLMR 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 143/315 (45%), Gaps = 51/315 (16%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 122 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 238 -YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ APELI     Y   +DIWS G +V E++ G+P +                  P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLK 223
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            +K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF
Sbjct: 224 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 357 FDELRDPNARLPSGR 371
             +   P + +P  R
Sbjct: 273 LAKAGPPASIVPLMR 287

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 142/322 (44%), Gaps = 50/322 (15%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR +  + L   FF
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 358 DELRDPNARLPSGRF-LPPLFN 378
                P  RLP+    +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 141/310 (45%), Gaps = 48/310 (15%)
Query: 67  PKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMR 119
           P    SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 203
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              H NVV + + +      DEL++  V+E++       +    ++N+      +     
Sbjct: 204 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 254
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRY 238
            + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P     + + Y
Sbjct: 255 AVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 312
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APELI     Y   +DIWS G +V E++ G+P +                  P  + +
Sbjct: 313 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAM 356
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           K +  N      P++K    HK+      P     + RLL   P  R TA + L HPF  
Sbjct: 357 KMIRDNLP----PRLKN--LHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405
Query: 359 ELRDPNARLP 368
           +   P + +P
Sbjct: 406 KAGPPASIVP 415

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 133
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  
Sbjct: 134 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPE 189
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 190 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 236

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 141/322 (43%), Gaps = 50/322 (15%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR +  + L   FF
Sbjct: 228 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 280
Query: 358 DELRDPNARLPSGRF-LPPLFN 378
                P  RLP+    +PP F+
Sbjct: 281 TSGYAP-MRLPTSCLTVPPRFS 301

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 141/322 (43%), Gaps = 50/322 (15%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR +  + L   FF
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 358 DELRDPNARLPSGRF-LPPLFN 378
                P  RLP+    +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K +E    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 127
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +   F    D   +Y+ +      E + R+V    +  + +   YV     Q+  AL+Y
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 188 IHRSIGVCHRDIKPQNLL---VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
            H S  V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FH-SQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                + T   DIWSAG V+  L+ G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           Y       ++  P        + P+AVDL+ ++L   P  R +A   L H +F +
Sbjct: 244 YA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 141/322 (43%), Gaps = 50/322 (15%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR +  + L   FF
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 358 DELRDPNARLPSGRF-LPPLFN 378
                P  RLP+    +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 46/298 (15%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDH 123
           ++T  +M   ++G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V+L+  + STT     YL + L    E   R+++      +   ++       Q+  
Sbjct: 66  ENIVTLEDIYESTT---HYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 184 ALSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSR-YYR 240
           A+ Y+H + G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE +     Y+ A+D WS G +   L+ G P F  ++   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
               Y EF+ P          F   +   A D +  LL+  PN R T   AL HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH 123
           QP++    + +  +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           P+VV     +F  TD     L +V+EY    +V  +++  NK    +    +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTL 135
Query: 183 RALSYIH--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRYY 239
           + L Y+H  R I   HRDIK  N+L+N   H  KL DFG A  L       +  I + ++
Sbjct: 136 KGLEYLHFMRKI---HRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I     Y    DIWS G    E+  GKP +        +  +  +   PT     
Sbjct: 192 MAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT----- 239
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             NP  T F+ P++    W   F         D V + L  SP  R TA   L HPF
Sbjct: 240 --NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 168
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 223
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           + ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 140
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           + ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           + ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMAE----RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           +  + ++ P +V L+   FS  D   LY  +VLEY P     +  H  ++  R    + +
Sbjct: 94  RIQQAVNFPFLVKLE---FSFKDNSNLY--MVLEYAPGG--EMFSHLRRIG-RFSEPHAR 145
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 171
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 140
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 139/308 (45%), Gaps = 51/308 (16%)
Query: 62  GRNGQPKQTISYMAERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ 113
           GR     Q +S   +R+  +G G++G V   K   TG   AIK + +             
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 114 -ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK--LNQRMP 170
            E+  ++ LDHPN++ L   F    DK   YL  V+E     V+R  + F++  L Q+  
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFS 119
Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 228
            +   +   Q+    +Y+H+   + HRD+KP+NLL+   +    +K+ DFG +     G 
Sbjct: 120 EVDAAVIMKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 178
Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
                + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ     +
Sbjct: 179 KMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----E 229
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +L    + +     P++T+                  +  EA  LV  +L Y P+ R +A
Sbjct: 230 ILKRVEKGKFSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISA 271
Query: 349 LDALIHPF 356
            +AL HP+
Sbjct: 272 EEALNHPW 279

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 143/302 (47%), Gaps = 46/302 (15%)
Query: 64  NGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMR 119
           +G  +  +S  +  E  +G+G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L HPN++ LK  F + T+     ++LVLE V   E   R+V+     ++R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK-- 155
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQ-VKLCDFGSAKVLVKGEPNISYIC 235
             QI  A++Y+H + G+ HRD+KP+NLL   P     +K+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
               Y APE++ G   Y   +D+WS G +   L+ G   F  + G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
           R  + C      E+ F      PW       +   A DLV +L+   P  R T   AL H
Sbjct: 261 RRILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 355 PF 356
           P+
Sbjct: 307 PW 308

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 115/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 137/314 (43%), Gaps = 48/314 (15%)
Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKR 109
           H IVT    + G      +     I+G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQ 167
               E+  M  LDH N++ L   F S  D     + LV+EYV   E   R++     L +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVK 226
              ++++K    QI   + ++H+ + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 227 GEPNISYICSRYYRAPELI-FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
            E       +  + APE++ +    + T  D+WS G +   L+ G   F GD+  + L  
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           I+        EE                          + +  EA + +S+LL    + R
Sbjct: 300 ILACRWDLEDEEF-------------------------QDISEEAKEFISKLLIKEKSWR 334
Query: 346 CTALDALIHPFFDE 359
            +A +AL HP+  +
Sbjct: 335 ISASEALKHPWLSD 348

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYV      +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVAGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + TD       +V+EYV   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            A+ Y HR + V HRD+KP+N+L++ H    K+ DFG + ++  GE   +   S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG 270
           E+I G       +DIWS G ++  L+ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 132
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 133/311 (42%), Gaps = 59/311 (18%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------- 113
           R  + K   SY   R +G G++G V   K        AIK + + +  K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 114 --------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFN 163
                   E+  ++ LDHPN++ L   F     +D+ Y  LV E+    E   +++   +
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINR-H 141
Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSA 221
           K ++      +K    QI   + Y+H+   + HRDIKP+N+L+        +K+ DFG +
Sbjct: 142 KFDECDAANIMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               K       + + YY APE++    +Y    D+WS G ++  L+ G P F G +  D
Sbjct: 197 SFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            + ++ K                Y +F       + W     K +  EA +L+  +L Y 
Sbjct: 255 IIKKVEK-------------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYD 289
Query: 342 PNLRCTALDAL 352
            N RCTA +AL
Sbjct: 290 YNKRCTAEEAL 300

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + TD       +V+EYV   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            A+ Y HR + V HRD+KP+N+L++ H    K+ DFG + ++  GE       S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG 270
           E+I G       +DIWS G ++  L+ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 134/315 (42%), Gaps = 53/315 (16%)
Query: 59  TIGGRNGQPKQTISYMAERI---------VGQGSFGVVFQAKCLETGETVAIK----KVL 105
           ++   NG+   +    AE I         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 106 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFN 163
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R+V K F 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK--LCDFGSA 221
                  +I       Q+  A+ Y+HR +G+ HRD+KP+NLL      + K  + DFG +
Sbjct: 118 TEKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           K+  KG+   +   +  Y APE +     Y+ A+D WS G +   L+ G P F  ++   
Sbjct: 171 KMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
              +I+K                  EF  P      W  I        A D +  L++  
Sbjct: 230 LFEQILKA---------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKD 264
Query: 342 PNLRCTALDALIHPF 356
           PN R T   A  HP+
Sbjct: 265 PNKRYTCEQAARHPW 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 125
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK--LNQRMPMIYVKLYAYQIFR 183
           ++ L   F    DK   YL  V+E     V+R  + F++  L Q+   +   +   Q+  
Sbjct: 66  IMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +Y+H+   + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY A
Sbjct: 116 GTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++    +Y    D+WS G ++  L+ G P F G +  DQ     ++L    + +    
Sbjct: 175 PEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFD 225
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            P++T+                  +  EA  LV  +L Y P+ R +A +AL HP+
Sbjct: 226 PPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 142/312 (45%), Gaps = 57/312 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           Y+    +G+GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L     + TD     + +V+EY   E    +V+      +RM     + +  QI  A
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVE-----KKRMTEDEGRRFFQQIICA 120
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ + + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 121 IEYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +++G+   P D   D+ +                  PN
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR--LPFD---DEFI------------------PN 215
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
              FK    K +    + P  + P A  L+ R++   P  R T  +    P+F      N
Sbjct: 216 L--FK----KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF------N 263
Query: 365 ARLPSGRFLPPL 376
             LP   +L P+
Sbjct: 264 VNLPD--YLRPM 273

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 93/352 (26%), Positives = 155/352 (44%), Gaps = 75/352 (21%)
Query: 30  NDMKIRDDKEME---ATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAE----RIVGQG 82
           + +K ++++EM+    +  D +G E   + +        +PK  ++ M E    +++G+G
Sbjct: 111 DGLKKQEEEEMDFRSGSPSDNSGAEEMEVSL-------AKPKHRVT-MNEFEYLKLLGKG 162
Query: 83  SFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +FG V   K   TG          E +  K  +     +NR LQ  R   HP + +LK+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYS 219
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL Y+H   
Sbjct: 220 F-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y
Sbjct: 272 NVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDY 329
Query: 252 TTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
             A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+           
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----------- 370
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                      FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 371 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 76  ERI--VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 126
           ERI  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V     F+S  +     +++ +E++   ++ +V+K      +R+P   +   +  + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
            G T Y+   DIWS G  + EL +G+ P+ P D+
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGRYPIPPPDA 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 123
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 181
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 228
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                            FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 229 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 136/316 (43%), Gaps = 50/316 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 83  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 136 N-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 192
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 227
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 228 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 282
Query: 369 SGRFLPPLFNFKSHEL 384
           +   +PP F+     L
Sbjct: 283 TCLTIPPXFSIAPSSL 298

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 43/289 (14%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+  A+K++       + KR       + R +D P  V+    
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + +  E    ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 248
            V HRD+KP N+L+N    QVK CDFG +  LV     +I   C + Y APE I      
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQ 214
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y+   DIWS G    EL + +  FP DS            GTP ++            
Sbjct: 215 KGYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------ 249
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              Q+   P  ++   +   E VD  S+ L+ +   R T  +   HPFF
Sbjct: 250 -LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 124
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 182
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 229
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                            FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 230 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 122
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 180
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 227
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                            FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 228 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 150/313 (47%), Gaps = 64/313 (20%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA-----YQIFR 183
            ++    TTD+   +L + LE     +  +V+  N  ++ + +   K Y       QI  
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 144
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 231
            ++++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 232 SYIC-----SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                    +  +RAPEL+  +T+   T +IDI+S GCV    +L K   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLHD--------------------RSLIAEATDLISQMIDHDPLK 300
Query: 345 RCTALDALIHPFF 357
           R TA+  L HP F
Sbjct: 301 RPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 150/313 (47%), Gaps = 64/313 (20%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA-----YQIFR 183
            ++    TTD+   +L + LE     +  +V+  N  ++ + +   K Y       QI  
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 144
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 231
            ++++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 232 SYIC-----SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                    +  +RAPEL+  +T+   T +IDI+S GCV    +L K   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLHD--------------------RSLIAEATDLISQMIDHDPLK 300
Query: 345 RCTALDALIHPFF 357
           R TA+  L HP F
Sbjct: 301 RPTAMKVLRHPLF 313

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 138/294 (46%), Gaps = 56/294 (19%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 124
           +++G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIF 182
            +V+L + F     + E  L+L+L+Y+        + F  L+QR       V++Y  +I 
Sbjct: 120 FLVTLHYAF-----QTETKLHLILDYINGG-----ELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 240
            AL ++H+ +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C    Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 241 APELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           AP+++ G  + +  A+D WS G ++ EL+ G   F  D   +   EI       +R  +K
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 280
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDA 351
              P                  +P+ M   A DL+ RLL   P  R  C   DA
Sbjct: 281 SEPP------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 60/298 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 262
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 320
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 367
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF 357
                            FP+ + PEA  L+S LL+  P  R       A + + H FF
Sbjct: 368 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 136/304 (44%), Gaps = 47/304 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 135 STTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               +D+  + ++ E++   E   +V    NK+++   + Y++    Q+ + L ++H + 
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 193 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 250
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y T  D+WS G +   L+ G   F G++  + L              +K  + N  +  F
Sbjct: 335 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 380
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP--NARLP 368
             I               +  D + +LL   PN R T   AL HP+      P  ++++P
Sbjct: 381 SGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427
Query: 369 SGRF 372
           S R+
Sbjct: 428 SSRY 431

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 136/316 (43%), Gaps = 50/316 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 83  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 136 N-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 192
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 227
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 228 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 282
Query: 369 SGRFLPPLFNFKSHEL 384
           +   +PP F+     L
Sbjct: 283 TCLTIPPRFSIAPSSL 298

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 136/316 (43%), Gaps = 50/316 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 87  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 140 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 196
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 231
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 232 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 286
Query: 369 SGRFLPPLFNFKSHEL 384
           +   +PP F+     L
Sbjct: 287 TCLTIPPRFSIAPSSL 302

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 142/303 (46%), Gaps = 39/303 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           Y+   DIWS G  + E+ +G+ P+ P D+   +L+   +V G       +   P     K
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 310 FPQIKAHPWHKIF----------PKRMPP-----EAVDLVSRLLQYSPNLRCTALDALIH 354
           F  + + P   IF          P ++P      E  D V++ L  +P  R      ++H
Sbjct: 267 F-GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 355 PFF 357
            F 
Sbjct: 326 AFI 328

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 136/304 (44%), Gaps = 47/304 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 135 STTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               +D+  + ++ E++   E   +V    NK+++   + Y++    Q+ + L ++H + 
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 193 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 250
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y T  D+WS G +   L+ G   F G++  + L              +K  + N  +  F
Sbjct: 229 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 274
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP--NARLP 368
             I               +  D + +LL   PN R T   AL HP+      P  ++++P
Sbjct: 275 SGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 321
Query: 369 SGRF 372
           S R+
Sbjct: 322 SSRY 325

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P++   Y+A  I +G+GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV +   +      DEL++  V+E++       +    ++N+      +   
Sbjct: 96  MRDYHHDNVVDMYSSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
              + RALSY+H   GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 238 -YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE+I     Y T +DIWS G +V E++ G+P
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 184
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L + F     + E  L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y  ++ +G+G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 123
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQ 282
           Y+   DIWS G  + E+ +G+ P+ P D+  D 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 135/316 (42%), Gaps = 50/316 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 104
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 105 HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 158 N-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 214
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 249
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 250 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 304
Query: 369 SGRFLPPLFNFKSHEL 384
           +   +PP F+     L
Sbjct: 305 TCLTIPPRFSIAPSSL 320

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 135/316 (42%), Gaps = 50/316 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 106
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 107 HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 160 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 216
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 251
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 252 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 306
Query: 369 SGRFLPPLFNFKSHEL 384
           +   +PP F+     L
Sbjct: 307 TCLTIPPRFSIAPSSL 322

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 47/297 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +      +EL++  ++E++       +    +LN+      +      + +AL+Y+H   
Sbjct: 111 YLVG---EELWV--LMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
           GV HRDIK  ++L+     +VKL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
            T +DIWS G +V E++ G+P +  DS V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
           ++K    HK+      P   D + R+L   P  R TA + L HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 181
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  Y 
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKGYN 237
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 90  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 91  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFAEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 50/299 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DH 123
            ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           P    L H F +   K+ L+   V+EY+      ++ H    + +  +     YA +I  
Sbjct: 78  P---FLTHMFCTFQTKENLF--FVMEYL--NGGDLMYHIQSCH-KFDLSRATFYAAEIIL 129
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 242
            L ++H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y AP
Sbjct: 130 GLQFLH-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G  +Y  ++D WS G ++ E+++G+  F G    +                I+  N
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDN 234
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDEL 360
           P Y                 P+ +  EA DL+ +L    P  R     D   HP F E+
Sbjct: 235 PFY-----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 108 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 161
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 216
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADEPI-QIYEKI 250

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 91/310 (29%), Positives = 134/310 (43%), Gaps = 50/310 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 81  HGFFEDND----FVFVVLELCRR---RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 134 N-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 190
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 225
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP- 368
             +IK + +    PK + P A  L+ ++LQ  P  R T  + L   FF     P ARLP 
Sbjct: 226 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPI 280
Query: 369 SGRFLPPLFN 378
           +   +PP F+
Sbjct: 281 TCLTIPPRFS 290

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 94  EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 147
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 148 DLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 181
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 236
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKGYN 216
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 139/299 (46%), Gaps = 55/299 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           R++G+GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  C F T D+    L  V+E+V      ++ H  K ++R      + YA +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFV--NGGDLMFHIQK-SRRFDEARARFYAAEIISALMFL 140
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H   G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  A+D W+ G ++ E++ G   F  ++  D L E I        +E+         
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV--------- 241
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA------LIHPFFDEL 360
                        ++P  +  +A  ++   +  +P +R  +L        L HPFF E+
Sbjct: 242 -------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKGYN 216
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 102 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 155
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 156 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 210
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 245

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+    
Sbjct: 93  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 143
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 144 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 200
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
              DIWS G  + E+ +G+      SG   + E++
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 19/207 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 253 TAIDIWSAGCVVAELMLGK-PLFPGDS 278
              DIWS G  + E+ +G+ P+ P D+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 19/207 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 253 TAIDIWSAGCVVAELMLGK-PLFPGDS 278
              DIWS G  + E+ +G+ P+ P D+
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 57/293 (19%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 130
           ++G+GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 131 HCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + F     +D  Y+ LVLE      +   +   VK F++   R  M       +QI   +
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM-------HQIITGM 125
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPEL 244
            Y+H S G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE 
Sbjct: 126 LYLH-SHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE- 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I   + +    D+WS GC+   L++G+P F  D+  + L +++                 
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----------------- 225
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
             +++ P              +  EA DL+ +LL+ +P  R +    L HPF 
Sbjct: 226 LADYEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 149/317 (47%), Gaps = 68/317 (21%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA-----YQIFR 183
            ++    TTD+   +L + LE     +  +V+  N  ++ + +   K Y       QI  
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 231
            ++++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 232 SYIC-----SRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLGKPLFPGDSGV 280
                    +  +RAPEL+  +    T      +IDI+S GCV    +L K   P     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQY 340
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLHD--------------------RSLIAEATDLISQMIDH 282
Query: 341 SPNLRCTALDALIHPFF 357
            P  R TA+  L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ ++  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQPI-QIYEKI 250

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 50/294 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP    
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L H F +   K+ L+   V+EY+      ++ H    + +  +     YA +I   L ++
Sbjct: 81  LTHMFCTFQTKENLF--FVMEYL--NGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 135
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G
Sbjct: 136 H-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
             +Y  ++D WS G ++ E+++G+  F G    +                I+  NP Y  
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFY-- 238
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDEL 360
                          P+ +  EA DL+ +L    P  R     D   HP F E+
Sbjct: 239 ---------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 62/300 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 129
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F     +D   + ++++Y+   E    + K     +QR P    K YA ++  AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSR-YYRAPELI 245
           +H S  + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C    Y APE++
Sbjct: 122 LH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                Y  +ID WS G ++ E++ G   F  DS   +  E  K+L    R          
Sbjct: 176 -STKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYE--KILNAELR---------- 221
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL-----QYSPNLRCTALDALIHPFFDEL 360
                           FP     +  DL+SRL+     Q   NL+    D   HP+F E+
Sbjct: 222 ----------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 50/290 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L H 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 88
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  A+ + H+
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 139
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
            +GV HRD+KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 196
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 239
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + FP  +   W  +      PEA DL++++L  +P+ R TA +AL HP+
Sbjct: 240 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------R 113
           G + QP    +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPM 171
           E++ M++L+HPN+V L         + E  L L++EY    E    +V H      RM  
Sbjct: 61  EVRIMKILNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKE 110
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
              +    QI  A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           ++  S  Y APEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 93/357 (26%), Positives = 154/357 (43%), Gaps = 77/357 (21%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC-LETG--ETVAIKKVLQDKR--YKNRELQTMRLL 121
           P+ +  +  E  +G+G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 122 D-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
               NV+ +K+CF     +   ++ + + Y+        + F  +   +    V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEH------ESFLDILNSLSFQEVREYMLN 125
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----------VLVKGEP- 229
           +F+AL  IH+  G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 230 ------NISYIC-SRY-----------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGK 271
                 N   IC SR            +RAPE++      TTAID+WSAG +   L+ G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 272 -PLFPGDSGVDQLVEIIKVLGTPTREEIK-----------------------CMNPNYTE 307
            P +     +  L +I+ + G  +RE I+                       C      +
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302
Query: 308 FKFPQ----IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              P+    I+ H  +      +P EA DL+ +LL  +P  R TA +AL+HPFF ++
Sbjct: 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 117/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 127
           +++GQGSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L + F     + E  L L+L+++     R    F +L++ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     ++ + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 148/317 (46%), Gaps = 68/317 (21%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA-----YQIFR 183
            ++    TTD+   +L + LE     +  +V+  N  ++ + +   K Y       QI  
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 231
            ++++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 232 SYIC-----SRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLGKPLFPGDSGV 280
                    +  +RAPEL+  +    T      +IDI+S GCV    +L K   P     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQY 340
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLHD--------------------RSLIAEATDLISQMIDH 282
Query: 341 SPNLRCTALDALIHPFF 357
            P  R TA+  L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L    F   + ++  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +   + TG+  A K +       +D +   RE +  RLL HPN+V L H 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 70
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  ++++ H 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILESVNHCHL 121
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
           + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  +  Y +PE + 
Sbjct: 122 N-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VL 178
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 221
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + FP  +   W  +      PEA DL++++L  +P  R TA +AL HP+
Sbjct: 222 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVA-----IKKVLQDKRYKNRELQTMRLLDHPNVV 127
           YM    +G+G FG+V   +C+ET          +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L   F S  +     L ++ E++   +   R+     +LN+R  + YV    +Q+  AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
            ++H S  + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +      +TA D+WS G +V  L+ G   F  ++   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 305 YT--EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           YT  E  F +I               EA+D V RLL      R TA +AL HP+  +
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +   + TG+  A K +       +D +   RE +  RLL HPN+V L H 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 70
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  ++++ H 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILESVNHCHL 121
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
           + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  +  Y +PE + 
Sbjct: 122 N-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VL 178
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 221
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + FP  +   W  +      PEA DL++++L  +P  R TA +AL HP+
Sbjct: 222 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 139/310 (44%), Gaps = 58/310 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            + F    D+  +YL  +LE+ P   +++ ++   + +++    +++    ++  AL Y 
Sbjct: 81  YNYFH---DRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T +   +D+W AG +  E ++G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
           KFP              +   + DL+S+LL+Y P  R      + HP+         +  
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW--------VKAN 270
Query: 369 SGRFLPPLFN 378
           S R LPP++ 
Sbjct: 271 SRRVLPPVYQ 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 139/310 (44%), Gaps = 58/310 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            + F    D+  +YL  +LE+ P   +++ ++   + +++    +++    ++  AL Y 
Sbjct: 80  YNYFH---DRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T +   +D+W AG +  E ++G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
           KFP              +   + DL+S+LL+Y P  R      + HP+         +  
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW--------VKAN 269
Query: 369 SGRFLPPLFN 378
           S R LPP++ 
Sbjct: 270 SRRVLPPVYQ 279

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/336 (25%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLD-----HPNVVSLK 130
           +G+G+FG V Q  C++    G  VA+K +   ++YK      + +L+      P+  +L 
Sbjct: 41  LGEGTFGRVVQ--CVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLC 98
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              F   D    ++ +  E +  +    +K  N L    P+  V+  A+Q+ +A+ ++H 
Sbjct: 99  VQMFDWFDY-HGHMCISFELLGLSTFDFLKDNNYLP--YPIHQVRHMAFQLCQAVKFLHD 155
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ------------------VKLCDFGSAKVLVKGEPNIS 232
           +  + H D+KP+N+L     ++                  V++ DFGSA      E + +
Sbjct: 156 N-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHST 212
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG- 291
            + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG 
Sbjct: 213 IVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGP 271
Query: 292 TPTREEIKC------------MNPNYTEFKFPQIKAHPWHKIFPKRMPP--EAVDLVSRL 337
            P+R   K              + N +  ++ +    P  +          +  DL+  +
Sbjct: 272 IPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESM 331
Query: 338 LQYSPNLRCTALDALIHPFFDELRD--PNARLPSGR 371
           L+Y P  R T  +AL HPFF  LR   PN    S R
Sbjct: 332 LEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 94/385 (24%), Positives = 165/385 (42%), Gaps = 69/385 (17%)
Query: 19  TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERI 78
           + GVD   E +    ++  K    +V D    + GH+ V  IG           ++ ER 
Sbjct: 8   SSGVDLGTENLYFQSMQSSKRSSRSVED---DKEGHL-VCRIG----------DWLQERY 53
Query: 79  -----VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 130
                +G+G+FG V   +CL+       VA+K +    +Y+      + +L        +
Sbjct: 54  EIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKE 111
Query: 131 HCFFSTTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + F      D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL 
Sbjct: 112 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALR 169
Query: 187 YIHRSIGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGE 228
           ++H +  + H D+KP+N+L          N H            +++ DFGSA      E
Sbjct: 170 FLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHE 226
Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
            + + + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K
Sbjct: 227 HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 289 VLG-------TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAV---D 332
           +LG         TR++          + N ++ ++ +    P  K +  +   E V   D
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFD 344
Query: 333 LVSRLLQYSPNLRCTALDALIHPFF 357
           L+ R+L++ P  R T  +AL+HPFF
Sbjct: 345 LMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L L++EY    E    +V H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQI 123
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 44/292 (15%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K                
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             EF  P      W  I        A D +  L++  P  R T   AL HP+
Sbjct: 234 EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 57  VTTIGGRNGQPKQTISYMAERI-----VGQGSFGVVFQAKCLETGETVAIKKVLQ--DKR 109
           + + G     P+Q   + AE +     +G+G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 110 YKNRELQ----TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH-FNK 164
            + + L      MR  D P +V      F   D       + +E +  +  +  K+ ++ 
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
           L+  +P   +        +AL+++  ++ + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 225 VKGEPNISYICSRYYRAPELIFGATE---YTTAIDIWSAGCVVAELMLGKPLFP-GDSGV 280
           V           R Y APE I  +     Y    D+WS G  + EL  G+  +P  +S  
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 281 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFPK 324
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++ +
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 325 R 325
           R
Sbjct: 295 R 295

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L    F   + ++  L LV+EY    E    +V H       M     +    QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFRQI 115
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+    
Sbjct: 77  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 127
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+
Sbjct: 128 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYS 184
Query: 253 TAIDIWSAGCVVAELMLGK 271
              DIWS G  + E+ +G+
Sbjct: 185 VQSDIWSMGLSLVEMAVGR 203

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 142/320 (44%), Gaps = 50/320 (15%)
Query: 79  VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H +
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 192 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 233
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG-- 291
           + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG  
Sbjct: 209 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 292 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAV---DLVSRL 337
                  TR++          + N ++ ++ +    P  K +  +   E V   DL+ R+
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 326
Query: 338 LQYSPNLRCTALDALIHPFF 357
           L++ P  R T  +AL+HPFF
Sbjct: 327 LEFDPAQRITLAEALLHPFF 346

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 142/320 (44%), Gaps = 50/320 (15%)
Query: 79  VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H +
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 192 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 233
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG-- 291
           + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG  
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 292 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAV---DLVSRL 337
                  TR++          + N ++ ++ +    P  K +  +   E V   DL+ R+
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 317
Query: 338 LQYSPNLRCTALDALIHPFF 357
           L++ P  R T  +AL+HPFF
Sbjct: 318 LEFDPAQRITLAEALLHPFF 337

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 137/297 (46%), Gaps = 48/297 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY-T 306
             +Y  ++D W+ G ++ E+M G+  F              ++G+         NP+  T
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPF-------------DIVGSSD-------NPDQNT 234
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL------DALIHPFF 357
           E    Q+      +I P+ M  +A  ++   L   P  R   L      D   HPFF
Sbjct: 235 EDYLFQVILEKQIRI-PRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF 290

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 50/290 (17%)
Query: 79  VGQGSFGVVFQ-AKCLETGETVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +  K L   E  A+     K   +D +   RE +  RLL HPN+V L H 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 77
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  A+ + H+
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 128
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
            +GV HR++KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 185
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 228
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + FP  +   W  +      PEA DL++++L  +P+ R TA +AL HP+
Sbjct: 229 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 228
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 229 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 44/292 (15%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K                
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK---------------- 232
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             E++F    +  W  I        A D +  L++  P  R T   AL HP+
Sbjct: 233 -AEYEF---DSPYWDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 123/292 (42%), Gaps = 44/292 (15%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K                
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
             EF  P      W  I        A D +  L++  P  R T   AL HP+
Sbjct: 234 EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 136/313 (43%), Gaps = 48/313 (15%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHP +V L   ++         L +++E+ P      +    +L++ +    +++ 
Sbjct: 62  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 114
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL+++H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I +
Sbjct: 115 CRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++       T Y    DIWS G  + E+   +P                    
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 212
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P   + P +   E  D +   L  +P  R +A   L
Sbjct: 213 PHHE----LNPMRVLLKIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 266
Query: 353 IHPFFDELRDPNA 365
            HPF   +    A
Sbjct: 267 EHPFVSSITSNKA 279

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 226
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 227 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVVSLKHC 132
           ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           + S      LYL + L    E   R+V K F        +I+      Q+  A+ Y+H  
Sbjct: 85  YESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLH-D 134
Query: 192 IGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +    
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQK 193
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+ A+D WS G +   L+ G P F  ++      +I+K                  EF 
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------EYEFD 238
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            P      W  I        A D +  L++  P  R T   AL HP+
Sbjct: 239 SPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 178
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 179 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 234
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 235 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 27/230 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L  C F    +D+ YL +V+EY+P  + V+ +       N  +P  + K Y  ++ 
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVV 184
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNI-SYICSRYYR 240
            AL  IH S+G+ HRD+KP N+L++ H H +KL DFG+  K+   G  +  + + +  Y 
Sbjct: 185 LALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYI 242
Query: 241 APELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 65/300 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFF 357
                              FP+ + PEA  L++ LL+  P  R       A + + H FF
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 136/313 (43%), Gaps = 48/313 (15%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHP +V L   ++         L +++E+ P      +    +L++ +    +++ 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 122
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL+++H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I +
Sbjct: 123 CRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++       T Y    DIWS G  + E+   +P                    
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 220
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P   + P +   E  D +   L  +P  R +A   L
Sbjct: 221 PHHE----LNPMRVLLKIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274
Query: 353 IHPFFDELRDPNA 365
            HPF   +    A
Sbjct: 275 EHPFVSSITSNKA 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 239
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 240 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 130/304 (42%), Gaps = 48/304 (15%)
Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G+FGVV   +C+E  TG     K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 133 FFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           F     +D+  + L+LE++   E   R+     K+++   + Y++    Q    L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 191 SIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
              + H DIKP+N++        VK+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
                 D+W+ G +   L+ G   F G+  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD-ELRDPNARLP 368
           F  +              PEA D +  LLQ  P  R T  DAL HP+   +  +  +R+P
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 369 SGRF 372
           S R+
Sbjct: 321 SSRY 324

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 117/228 (51%), Gaps = 31/228 (13%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 125
           R++G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK----LYAYQI 181
           +V L + F  T  K    L L+LEY+        + F +L +    I+++     Y  +I
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGG-----ELFMQLEREG--IFMEDTACFYLAEI 130
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYR 240
             AL ++H+  G+ +RD+KP+N+++N H   VKL DFG  K  +  G    ++  +  Y 
Sbjct: 131 SMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           APE++   + +  A+D WS G ++ +++ G P F G++    + +I+K
Sbjct: 189 APEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 239
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 240 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 123
           T  Y     +G+G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            N+V L H   S      L  +LV   E   + V R  +++++ +    +        QI
Sbjct: 63  SNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 237
             A+ + H+ +GV HRD+KP+NLL+        VKL DFG A + V+G+      +  + 
Sbjct: 113 LEAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y +PE +     Y   +DIW+ G ++  L++G P F  D    +L + IK         
Sbjct: 171 GYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKA-------- 220
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                     + FP   +  W  +      PEA +L++++L  +P  R TA +AL HP+
Sbjct: 221 --------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 141/324 (43%), Gaps = 59/324 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 248 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 297
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 298 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 414
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVS 335
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 415 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 470
Query: 336 RLLQYSPNLRCTALDALIHPFFDE 359
                 P     A DA     FDE
Sbjct: 471 -----PPRGEVNAADAFDIGSFDE 489

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 44/283 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           R +G+GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALSY 187
              ++S  D++++++ + L    +  + + +  HF +         VKL+  ++  AL Y
Sbjct: 81  ---WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFICELVMALDY 130
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +     + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 248 --ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP--------TREE 297
                Y+ A+D WS G    EL+ G+  +   S      EI+    T         ++E 
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEM 247
Query: 298 I----KCMNPN----YTEF----KFPQIKAHPWHKIFPKRMPP 328
           +    K + PN    +++      FP +    W  +F KR+ P
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 125
           R++G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK----LYAYQI 181
           +V L + F  T  K    L L+LEY+        + F +L +    I+++     Y  +I
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGG-----ELFMQLEREG--IFMEDTACFYLAEI 130
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YR 240
             AL ++H+  G+ +RD+KP+N+++N H   VKL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           APE++   + +  A+D WS G ++ +++ G P F G++    + +I+K
Sbjct: 189 APEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 122
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 141/324 (43%), Gaps = 59/324 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVS 335
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 336 RLLQYSPNLRCTALDALIHPFFDE 359
                 P     A DA     FDE
Sbjct: 472 -----PPRGEVNAADAFDIGSFDE 490

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 141/324 (43%), Gaps = 59/324 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVS 335
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 336 RLLQYSPNLRCTALDALIHPFFDE 359
                 P     A DA     FDE
Sbjct: 472 -----PPRGEVNAADAFDIGSFDE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 141/324 (43%), Gaps = 59/324 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVS 335
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP  +    
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI---- 471
Query: 336 RLLQYSPNLRCTALDALIHPFFDE 359
                 P     A DA     FDE
Sbjct: 472 -----PPRGEVNAADAFDIGSFDE 490

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 136/308 (44%), Gaps = 60/308 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F+   D+  +YL  +LEY P  E    + K      QR   I  +L       AL Y
Sbjct: 89  YNYFY---DRRRIYL--ILEYAPRGELYKELQKSCTFDEQRTATIMEELAD-----ALMY 138
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CH-GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              +   +D+W  G +  EL++G P F   S  +    I+KV       ++K        
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------DLK-------- 239
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL 367
                         FP  +P  A DL+S+LL+++P+ R        HP+         R 
Sbjct: 240 --------------FPASVPTGAQDLISKLLRHNPSERLPLAQVSAHPW--------VRA 277
Query: 368 PSGRFLPP 375
            S R LPP
Sbjct: 278 NSRRVLPP 285

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 84/358 (23%), Positives = 156/358 (43%), Gaps = 70/358 (19%)
Query: 34  IRDDKEMEATVV-------DGNGTETGHIIVTTIGGRNGQPKQTIS------YMAERIVG 80
           +RDD    A ++       D     T ++   ++G  +  P    +      Y  + ++G
Sbjct: 44  LRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIG 103
Query: 81  QGSFGVV-----------FQAKCLE-TGETVAIKKVLQDKRYKNRELQTMR-LLDHPNVV 127
           +G   VV           F  K +E T E ++ +++ + +    RE   +R +  HP+++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
           +L   + S++     ++ LV + +     R  + F+ L +++ +     +     +  A+
Sbjct: 164 TLIDSYESSS-----FMFLVFDLM-----RKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           S++H +  + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++
Sbjct: 214 SFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 246 FGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             + +     Y   +D+W+ G ++  L+ G P F     +  L  I              
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI-------------- 317
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           M   Y +F  P+     W             DL+SRLLQ  P  R TA  AL HPFF+
Sbjct: 318 MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 29/240 (12%)
Query: 48  NGTETGHIIVTTIGGRNGQPK-QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ 106
           +G +TG++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 107 DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTDKDELYLNLVLEYVPETVHRVV 159
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           K   ++   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFG 170
Query: 220 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFP 275
            +  LV  +          Y APE I        +Y    D+WS G  + EL  G+  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 131/299 (43%), Gaps = 38/299 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +++EY    E   R+         R      + +  Q+   +SY H S+ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 253 TAI-DIWSAGCVVAELMLG-----KPLFPGD--SGVDQLVEIIKVLGTPTREEIKC---- 300
             I D+WS G  +  +++G      P  P D    + +++ +   +    R   +C    
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 301 ----MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS-PNLRCTALDALIH 354
               +    T    P+IK H W   F K +P + ++  +   Q+  P     +LD ++ 
Sbjct: 256 SRIFVADPATRISIPEIKTHSW---FLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 169
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++ G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N+L++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 77  RIVGQGSFGVVFQAK--------CLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 128
           +++G+GSFG V  A+         ++  +  AI K  ++K   +     ++ + HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L H  F T DK    L  VL+Y+   E  + + +    L  R      + YA +I  AL 
Sbjct: 104 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 153
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C    Y APE +
Sbjct: 154 YLH-SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-V 210
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLF 274
                Y   +D W  G V+ E++ G P F
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++G+G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                KD+  LN + EY+     R +     ++ + P      +A  I   ++Y+H S+ 
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLH-SMN 128
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPN-------------ISYICSRY 238
           + HRD+   N LV  + + V + DFG A+++V  K +P               + + + Y
Sbjct: 129 IIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           + APE+I G + Y   +D++S G V+ E++
Sbjct: 188 WMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 34/216 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLD-HPNVVSLKH 131
           R++ +G F  V++A+ + +G   A+K++L ++  KNR    E+  M+ L  HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 132 CFFSTTDKDELYLNLVLEYVPET---VHRVVKHFNKLNQRMPM---IYVKLYAYQIFRAL 185
           C  ++  K+E       E++  T     ++V+   K+  R P+     +K++ YQ  RA+
Sbjct: 92  CSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAV 149
Query: 186 SYIHRSI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
            ++HR    + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEE 207
Query: 238 -------YYRAPELIFGATEYTTA--IDIWSAGCVV 264
                   YR PE+I   + +      DIW+ GC++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 21/219 (9%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P      YA +I   L ++H
Sbjct: 86  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEPQ--AVFYAAEISIGLFFLH 137
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGA 248
           +  G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I   
Sbjct: 138 KR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AY 194
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 57/309 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 129
           +++G+G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     +DE YL LV+EY       ++   +K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 247
           R +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 248 ATEYTTAI------DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
                         D W+ G    E+  G+  F  DS  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TALDALIHPFF- 357
                       K H    +  + +P EA D + RLL   P  R     A D   HPFF 
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
Query: 358 ----DELRD 362
               D LRD
Sbjct: 333 GLDWDGLRD 341

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
               + I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV EY    E    +V H      R      +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAH-----GRXKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 40/305 (13%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y  + ++G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFR 183
           S    F     KDEL+L + L     +V  ++KH     +    +     +     ++  
Sbjct: 77  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 237
            L Y+H++ G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP---- 244
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                        P ++     K   K+       ++S  LQ  P  R TA + L H FF
Sbjct: 245 -------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
Query: 358 DELRD 362
            + ++
Sbjct: 292 QKAKN 296

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 128
           R +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QI + + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRA 241
             +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 G-TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE +   ++++ A D+WS G V+ EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 164 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 140 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 136 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 190
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 51/286 (17%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 129
           + ++ +G+GSF +    KC+      A    +  KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSIC--RKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRAL 185
              F      D+L+  LV+E +   E   R+ K  HF++      M        ++  A+
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-------RKLVSAV 119
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 242
           S++H  +GV HRD+KP+NLL        ++K+ DFG A++       +   C + +Y AP
Sbjct: 120 SHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGV--DQLVEIIKVLGTPTREEIK 299
           EL+     Y  + D+WS G ++  ++ G+ P    D  +     VEI+K +         
Sbjct: 179 ELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------- 230
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                  +F F   +   W     K +  EA DL+  LL   PN R
Sbjct: 231 ------GDFSF---EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 137
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 151 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 136/308 (44%), Gaps = 50/308 (16%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 128
           +   ++G+G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRAL 185
           L   F     +D+    LV E +      ++ H  K    N+R     V+     +  AL
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGG--SILAHIQKQKHFNEREASRVVR----DVAAAL 124
Query: 186 SYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDF--GSAKVLVKG-----EPNISYIC- 235
            ++H + G+ HRD+KP+N+L         VK+CDF  GS   L         P ++  C 
Sbjct: 125 DFLH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 236 SRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIK 288
           S  Y APE++      AT Y    D+WS G V+  ++ G P F G  G D      E+ +
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCR 243
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           V      E I+       +++FP      W  I       EA DL+S+LL      R +A
Sbjct: 244 VCQNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSA 290
Query: 349 LDALIHPF 356
              L HP+
Sbjct: 291 AQVLQHPW 298

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 151 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 40/304 (13%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y  + ++G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFR 183
           S    F     KDEL+L + L     +V  ++KH     +    +     +     ++  
Sbjct: 72  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 237
            L Y+H++ G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P    
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP---- 239
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                        P ++     K   K+       ++S  LQ  P  R TA + L H FF
Sbjct: 240 -------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286
Query: 358 DELR 361
            + +
Sbjct: 287 QKAK 290

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    D   +YL   L    E + ++++   K        +V    + I + + Y+H S
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFV---LHTIGKTVEYLH-S 139
Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y    DIWS G ++  ++ G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
               KF  +    W+ +        A DLVS++L   P+ R TA   L HP+  +
Sbjct: 244 ----KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L + +EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 43/292 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    D   +YL   L    E + ++++   K        +V    + I + + Y+H S
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFV---LHTIGKTVEYLH-S 139
Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y    DIWS G ++  ++ G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
               KF  +    W+ +        A DLVS++L   P+ R TA   L HP+
Sbjct: 244 ----KFT-LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 52/305 (17%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 128
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV--KHFNKLNQRMPMIYVKLYAYQIFRA 184
           LK  +      D  Y+ +V E +   E + +++  K F++      +       + I + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-------FTITKT 128
Query: 185 LSYIHRSIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRY 238
           + Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  
Sbjct: 129 VEYLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE +     Y  A DIWS G ++  ++ G   F  +   D   EI+  +G+      
Sbjct: 186 FVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSG----- 238
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-- 356
                     KF  +    W+ +        A DLVS++L   P+ R TA   L HP+  
Sbjct: 239 ----------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
Query: 357 -FDEL 360
            +D+L
Sbjct: 283 HWDQL 287

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 137/304 (45%), Gaps = 60/304 (19%)
Query: 70  TISYMAERIVGQGSFGVV-----------FQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
           T  Y     +G+G+F VV           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKL 176
           RLL HPN+V L H   S      L  +LV   E   + V R  +++++ +    +     
Sbjct: 85  RLLKHPNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI----- 136
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--IS 232
             +QI  ++++IH+   + HRD+KP+NLL+        VKL DFG A + V+GE      
Sbjct: 137 --HQILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG 192
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           +  +  Y +PE +     Y   +DIW+ G ++  L++G P F  D    +L + IK    
Sbjct: 193 FAGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKA--- 247
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                          + FP   +  W  +      PEA +L++++L  +P  R TA  AL
Sbjct: 248 -------------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQAL 286
Query: 353 IHPF 356
            HP+
Sbjct: 287 KHPW 290

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L + +EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 24/226 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y+  + +G+GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIF 182
           V  +  F    +   LY+  V++Y           F ++N +  +++    +  +  QI 
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGG-----DLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 241
            AL ++H    + HRDIK QN+ +      V+L DFG A+VL    E   + I + YY +
Sbjct: 136 LALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           PE I     Y    DIW+ GCV+ EL   K  F   S  + +++II
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 272
Query: 366 RLP 368
           + P
Sbjct: 273 KRP 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 92/365 (25%), Positives = 143/365 (39%), Gaps = 88/365 (24%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 124
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQ 180
           N   VV L    F  +  + +++ +V E +    H ++K   K N Q +P+  VK    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLG---HHLLKWIIKSNYQGLPVRCVKSIIRQ 148
Query: 181 IFRALSYIHRSIGVCHRDIKPQN------------------------------------- 203
           + + L Y+H    + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 204 ---LLVNP------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
              LLVNP         +VK+ D G+A  + K       I +R YR+ E++ GA  Y+T 
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 255 IDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            DIWS  C+  EL  G  LF   SG       D +  II++LG+  R     ++  Y+  
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRH--FALSGKYSRE 323
Query: 309 KFPQ-------IKAHPWHKI--------FPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
            F +        K  PW           +P     +  D +  +L+  P  R +A + L 
Sbjct: 324 FFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLR 383
Query: 354 HPFFD 358
           HP+ +
Sbjct: 384 HPWLN 388

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HR++  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 134 KRYI-HRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 124
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 125 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 128
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSY 187
           LK  +    D   +Y+   L    E + ++++  F    +   +++       I + + Y
Sbjct: 81  LKDVY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT------ITKTVEY 131
Query: 188 IHRSIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           +H + GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + A
Sbjct: 132 LH-AQGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y  A DIWS G ++   + G   F  +   D   EI+  +G+         
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSG-------- 238
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF---FD 358
                  KF  +    W+ +        A DLVS+ L   P+ R TA   L HP+   +D
Sbjct: 239 -------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 359 EL 360
           +L
Sbjct: 286 QL 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 32/223 (14%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 127
           E I+G G FG V++A     G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L+          E  L LV+E+     ++RV+       +R+P   +  +A QI R ++
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 187 YIHRS--IGVCHRDIKPQNLLV-------NPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           Y+H    + + HRD+K  N+L+       +     +K+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
            + APE+I  A+ ++   D+WS G ++ EL+ G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 272
Query: 366 RLP 368
           + P
Sbjct: 273 KRP 275

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 103/415 (24%), Positives = 161/415 (38%), Gaps = 101/415 (24%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGR-NGQPKQTISYMAERIVGQGSF 84
           PE+  ++   DD E E    D N    G   +  IG   NG+      Y   R +G G F
Sbjct: 1   PEQEEEILGSDDDEQE----DPNDYCKGGYHLVKIGDLFNGR------YHVIRKLGWGHF 50
Query: 85  GVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHPN---VVSLKHCF 133
             V+ +  ++  + VA+K V   + Y    L  +RLL        + PN   VV L   F
Sbjct: 51  STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQIFRALSYIHRSI 192
              +  +  ++ +V E +    H ++K   K N Q +P+  VK    Q+ + L Y+H   
Sbjct: 111 -KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 193 GVCHRDIKPQNLLV---------------------------------------------- 206
            + H DIKP+N+L+                                              
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 207 --NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
             N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y T  DIWS  C+ 
Sbjct: 227 PKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA 283
Query: 265 AELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ------ 312
            EL  G  LF   SG       D +  II++LG   R+ I  +   Y++  F +      
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSKEFFTKKGDLKH 341
Query: 313 -IKAHPWHKI--------FPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
             K  PW           + +       D +  +L+  P  R TA + L HP+ +
Sbjct: 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 366 RLP 368
           + P
Sbjct: 274 KRP 276

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +     +R+  I +  Y  QI + + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
              + HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 KRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR 366
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A+
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 367 LP 368
            P
Sbjct: 275 RP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR 366
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A+
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 367 LP 368
            P
Sbjct: 275 RP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNAR 366
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A+
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 367 LP 368
            P
Sbjct: 275 RP 276

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 272
Query: 366 RLP 368
           + P
Sbjct: 273 KRP 275

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 130/308 (42%), Gaps = 55/308 (17%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----- 118
           N   K + +Y  +  +G+G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 119 --RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIY 173
             R L HPN+V L         ++E +  LV + V   E    +V + F         I 
Sbjct: 81  ICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNI 231
                 QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E   
Sbjct: 136 ------QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
            +  +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L        
Sbjct: 189 GFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL-------- 238
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTAL 349
                             + QIKA  +    P+   + PEA  L+  +L  +P  R TA 
Sbjct: 239 ------------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD 280
Query: 350 DALIHPFF 357
            AL  P+ 
Sbjct: 281 QALKVPWI 288

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/339 (24%), Positives = 148/339 (43%), Gaps = 66/339 (19%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE------LQTMRLLDHPN 125
           +++  R +G G+FG V   + ++  +  A+K V   K+Y          L+ ++  D  N
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 126 VVSLK-HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
              +K H  F   D    ++ L+ E +  +++ ++   N     +  I  KLY  +I +A
Sbjct: 96  NNIVKYHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDI--KLYCIEILKA 149
Query: 185 LSYIHRSIGVCHRDIKPQNLLVN-PHTHQ-----------------------VKLCDFGS 220
           L+Y+ R + + H D+KP+N+L++ P+  +                       +KL DFG 
Sbjct: 150 LNYL-RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  G  LF     +
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 281 DQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ-----------IKAHPWH 319
           + L  +  ++           T T    K +N +  +  +P+            K  P +
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 320 KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
           KI    +     D +  +LQ  P LR +  + L H F +
Sbjct: 325 KIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 61/308 (19%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L   + S        L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP+N+L+    ++  VKL DFG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTP 197
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           ++ APE++     Y   +D+W  G ++  L+ G   F G    ++L E I       + +
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 248
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            K MNP              W  I        A DLV R+L   P  R T  +AL HP+ 
Sbjct: 249 YK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 358 DELRDPNA 365
            E RD  A
Sbjct: 291 KE-RDRYA 297

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 366 RLP 368
           + P
Sbjct: 274 KRP 276

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 119
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 216
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 217 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 271
Query: 366 RLP 368
           + P
Sbjct: 272 KRP 274

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           Y+  + +G+G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L  +C      K E +L L   +   T+   ++        +    +      I R L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS---AKVLVKGEPNISYI-------CSR 237
           IH + G  HRD+KP N+L+      V L D GS   A + V+G      +       C+ 
Sbjct: 150 IH-AKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 238 YYRAPELIFGATEYTTA---IDIWSAGCVVAELMLGK 271
            YRAPEL F    +       D+WS GCV+  +M G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 50/285 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 257

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 257

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 257

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 258

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 135
           ++G G FG VF+AK    G+T  I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 136 ---TTDKDELYLNLVLEYVPETVHRVVKHFNK-----------------LNQRMPMIYVK 175
               T  D L  +   +Y PE      +   K                 + +R      K
Sbjct: 79  YDPETSDDSLESS---DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 176 LYAYQIF----RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           + A ++F    + + YIH S  + HRD+KP N+ +   T QVK+ DFG    L       
Sbjct: 136 VLALELFEQITKGVDYIH-SKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               +  Y +PE I  + +Y   +D+++ G ++AEL+
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 124
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HR+IK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 125 ECLQALEFLH-SNQVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 257

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           V HRD+K +N L++     ++K+ DFG +K  V      S + +  Y APE++       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 135/311 (43%), Gaps = 62/311 (19%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMR---------- 119
           +Y  + I+G+G   VV +     T +  A+K   V     +   E+Q +R          
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 120 --LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
             +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 78  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 125
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE   S 
Sbjct: 126 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLRSV 183
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I  
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-- 241
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       M+ NY +F  P+   +               DLVSR L   P  R TA
Sbjct: 242 ------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTA 278
Query: 349 LDALIHPFFDE 359
            +AL HPFF +
Sbjct: 279 EEALAHPFFQQ 289

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 145/323 (44%), Gaps = 48/323 (14%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 118
           QP    ++   R++G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++   VVSL + + +   KD L L L L    +    +  H  +     P      YA
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHIY-HMGQAG--FPEARAVFYA 292
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L  +HR   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y APE++     YT + D W+ GC++ E++ G+  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALI 353
           + +           +K  P  + + +R  P+A  L S+LL   P  R      +A +   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 354 HPFFDELRDPNARLPSGRFLPPL 376
           HP F +L     RL +G   PP 
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPPF 465

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 135
           ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 136 ----TTDKDELY-----LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
               T+ K+        L + +E+  + T+ + ++   +  +++  +       QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGV 135
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            YIH S  + +RD+KP N+ +   T QVK+ DFG    L           +  Y +PE I
Sbjct: 136 DYIH-SKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 246 FGATEYTTAIDIWSAGCVVAELM 268
             + +Y   +D+++ G ++AEL+
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 145/323 (44%), Gaps = 48/323 (14%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 118
           QP    ++   R++G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++   VVSL + + +   KD L L L L    +    +  H  +     P      YA
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHIY-HMGQAG--FPEARAVFYA 292
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L  +HR   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y APE++     YT + D W+ GC++ E++ G+  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALI 353
           + +           +K  P  + + +R  P+A  L S+LL   P  R      +A +   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 354 HPFFDELRDPNARLPSGRFLPPL 376
           HP F +L     RL +G   PP 
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPPF 465

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 217
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++    
Sbjct: 218 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
Query: 364 NARLP 368
            A+ P
Sbjct: 272 GAKRP 276

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           ++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 50/303 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G+ G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
           +++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++     A
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 272
Query: 366 RLP 368
           + P
Sbjct: 273 KRP 275

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++    
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 270
Query: 364 NARLP 368
            A+ P
Sbjct: 271 GAKRP 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +   S+I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++   T     Y    D+WS G  + E+   +P                    
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP-------------------- 238
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P     P R      D + + L+ + + R T    L
Sbjct: 239 PHHE----LNPMRVLLKIA--KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 292
Query: 353 IHPF 356
            HPF
Sbjct: 293 QHPF 296

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +   S+I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++   T     Y    D+WS G  + E+   +P                    
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP-------------------- 238
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P     P R      D + + L+ + + R T    L
Sbjct: 239 PHHE----LNPMRVLLKIA--KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 292
Query: 353 IHPF 356
            HPF
Sbjct: 293 QHPF 296

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK-NRELQTMRLLDHPNVVSLKHCFF 134
           +VG G++G V++ + ++TG+  AIK   V  D+  +  +E+  ++   H   ++  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 135 STTD----KDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +     D+L+  LV+E+    +V  ++K  N     +   ++     +I R LS++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 246
           +   V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 247 ----GATEYTTAIDIWSAGCVVAELMLGKP 272
                AT Y    D+WS G    E+  G P
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 90/367 (24%), Positives = 143/367 (38%), Gaps = 90/367 (24%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 124
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQ 180
           N   VV L   F   +  +  ++ +V E +    H ++K   K N Q +P+  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---------------------------------- 206
           + + L Y+H    + H DIKP+N+L+                                  
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 207 --------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
                         N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEIKCMNPNYT 306
           T  DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y+
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYS 313
Query: 307 EFKFPQ-------IKAHPWHKI--------FPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
           +  F +        K  PW           + +       D +  +L+  P  R TA + 
Sbjct: 314 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 373
Query: 352 LIHPFFD 358
           L HP+ +
Sbjct: 374 LRHPWLN 380

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 215
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA  AL 
Sbjct: 216 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261
Query: 354 HPF 356
            P+
Sbjct: 262 VPW 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++    
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 270
Query: 364 NARLP 368
            A+ P
Sbjct: 271 GAKRP 275

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 72  SYMAERIVGQGSFGVV-----------FQAKCLET--GETVAIKKVLQDKRYKNRELQTM 118
           +Y  + I+G+G   VV           +  K ++   G + + ++V + +    +E+  +
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 119 RLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           R +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 65  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 112
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE     
Sbjct: 113 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREV 170
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I  
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-- 228
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       M+ NY +F  P+   +               DLVSR L   P  R TA
Sbjct: 229 ------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTA 265
Query: 349 LDALIHPFFDE 359
            +AL HPFF +
Sbjct: 266 EEALAHPFFQQ 276

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 139/304 (45%), Gaps = 51/304 (16%)
Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 128
           IS+  + ++G G+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKLYAYQIFRALS 186
                +  T+KD  +  + +E    T+   V  K F  L    P+  ++    Q    L+
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQ----QTTSGLA 132
Query: 187 YIHRSIGVCHRDIKPQNLLVN-PHTH---QVKLCDFGSAKVLVKGEPNISYIC----SRY 238
           ++H S+ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  
Sbjct: 133 HLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 239 YRAPELIFGATEY--TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
           + APE++    +   T  +DI+SAGCV    ++ +   P    + +   I+  LG  +  
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS-- 246
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + C++P   E                      A +L+ +++   P  R +A   L HPF
Sbjct: 247 -LDCLHPEKHEDVI-------------------ARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 357 FDEL 360
           F  L
Sbjct: 287 FWSL 290

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T  D     ++++    
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 270
Query: 364 NARLP 368
            A+ P
Sbjct: 271 GAKRP 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 72  SYMAERIVGQGSFGVV-----------FQAKCLET--GETVAIKKVLQDKRYKNRELQTM 118
           +Y  + I+G+G   VV           +  K ++   G + + ++V + +    +E+  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 119 RLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           R +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 78  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 125
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE     
Sbjct: 126 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREV 183
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I  
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-- 241
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       M+ NY +F  P+   +               DLVSR L   P  R TA
Sbjct: 242 ------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQKRYTA 278
Query: 349 LDALIHPFFDE 359
            +AL HPFF +
Sbjct: 279 EEALAHPFFQQ 289

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 215
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA  AL 
Sbjct: 216 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261
Query: 354 HPF 356
            P+
Sbjct: 262 VPW 264

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-----YAYQIFRALSYI 188
            +        + LV+EY           +N L+   P+ Y        +  Q  + ++Y+
Sbjct: 72  LNP-------VCLVMEYAEGG-----SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 189 H--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H  +   + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
             + Y+   D++S G ++ E++  +  F
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 129/303 (42%), Gaps = 55/303 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 61  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 111
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 112 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 168
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 169 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 214
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA  AL 
Sbjct: 215 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 260
Query: 354 HPF 356
            P+
Sbjct: 261 VPW 263

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-----YAYQIFRALSYI 188
            +        + LV+EY           +N L+   P+ Y        +  Q  + ++Y+
Sbjct: 71  LNP-------VCLVMEYAEGG-----SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 189 H--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H  +   + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
             + Y+   D++S G ++ E++  +  F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 52/286 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 244
             IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL
Sbjct: 122 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPEL 177
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     +   +D+WS G V+  ++ G+   P D   D   E                   
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------- 216
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
           Y+++K  +   +PW KI         + L+ ++L  +P+ R T  D
Sbjct: 217 YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPD 257

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 122 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++          D+WS G +   L+ G   F G++  + L  I              +N
Sbjct: 181 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVN 227
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            ++ E  F                   A D + RLL   P  R T   +L H +   +R 
Sbjct: 228 YDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
Query: 363 PNAR 366
            N R
Sbjct: 275 RNVR 278

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 48/304 (15%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +    +I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++   T     Y    D+WS G  + E+   +P                    
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP-------------------- 238
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
           P  E    +NP     K    K+ P     P R      D + + L+ + + R T    L
Sbjct: 239 PHHE----LNPMRVLLKIA--KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 292
Query: 353 IHPF 356
            HPF
Sbjct: 293 QHPF 296

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 94  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 148 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 252
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 253 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 304
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 305 PLHTSRVL 312

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 132 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 189
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 236
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 289 PLHTSRVL 296

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 86  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 140 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 244
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 245 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 296
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 297 PLHTSRVL 304

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 136/313 (43%), Gaps = 48/313 (15%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 133 FFSTTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR---- 183
           +      + LY     L +V+E +        + F+++  R    + +  A +I +    
Sbjct: 130 Y------ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
           A+ Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY A
Sbjct: 179 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE + G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +   
Sbjct: 238 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM--- 287
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDEL 360
                +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     
Sbjct: 288 ----GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 335
Query: 361 RDPNARLPSGRFL 373
           + P   L + R L
Sbjct: 336 KVPQTPLHTSRVL 348

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 136/313 (43%), Gaps = 48/313 (15%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 133 FFSTTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR---- 183
           +      + LY     L +V+E +        + F+++  R    + +  A +I +    
Sbjct: 80  Y------ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
           A+ Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY A
Sbjct: 129 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE + G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +   
Sbjct: 188 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM--- 237
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDEL 360
                +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     
Sbjct: 238 ----GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285
Query: 361 RDPNARLPSGRFL 373
           + P   L + R L
Sbjct: 286 KVPQTPLHTSRVL 298

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 79  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 133 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 190
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 237
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 238 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 289
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 290 PLHTSRVL 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 136/313 (43%), Gaps = 48/313 (15%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 133 FFSTTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR---- 183
           +      + LY     L +V+E +        + F+++  R    + +  A +I +    
Sbjct: 124 Y------ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
           A+ Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY A
Sbjct: 173 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE + G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +   
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM--- 281
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDEL 360
                +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     
Sbjct: 282 ----GQYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
Query: 361 RDPNARLPSGRFL 373
           + P   L + R L
Sbjct: 330 KVPQTPLHTSRVL 342

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 39/295 (13%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K      T+     + L++E++P    +  + K+ NK+N +  +     YA QI + +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL----KYAVQICKGM 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRA 241
            Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLG-SRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +   +++  A D+WS G  + EL     L   DS    +   +K++G PT  ++   
Sbjct: 198 PECLM-QSKFYIASDVWSFGVTLHEL-----LTYCDSDSSPMALFLKMIG-PTHGQMTVT 250
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
               T     + K  P     P   P E   L+ +  ++ P+ R T+   LI  F
Sbjct: 251 RLVNT---LKEGKRLP----CPPNCPDEVYQLMRKCWEFQPSNR-TSFQNLIEGF 297

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 84  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 138 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 195
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 242
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 243 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 294
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 295 PLHTSRVL 302

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 85  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 139 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 196
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 243
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 244 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 295
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 296 PLHTSRVL 303

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 134 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 238
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 290
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 291 PLHTSRVL 298

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L +  EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HR++KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 39/295 (13%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K      T+     + L++E++P    +  + K+ NK+N +  +     YA QI + +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL----KYAVQICKGM 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRA 241
            Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLG-SRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +   +++  A D+WS G  + EL     L   DS    +   +K++G PT  ++   
Sbjct: 186 PECLM-QSKFYIASDVWSFGVTLHEL-----LTYCDSDSSPMALFLKMIG-PTHGQMTVT 238
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
               T     + K  P     P   P E   L+ +  ++ P+ R T+   LI  F
Sbjct: 239 RLVNT---LKEGKRLP----CPPNCPDEVYQLMRKCWEFQPSNR-TSFQNLIEGF 285

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 125
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 182
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 145
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 134/308 (43%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK             + YY APE + 
Sbjct: 132 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VL 189
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 236
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 289 PLHTSRVL 296

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 131
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                 ++D+ Y  LV+EY+   T+   ++    L+    + +      QI   + + H 
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAH- 128
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 246
            + + HRDIKPQN+L++ +   +K+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 129 DMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 247 G-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           G AT+  T  DI+S G V+ E+++G+P F G++ V
Sbjct: 186 GEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHP 124
           Y+   ++G+GS+G V +    ET    A+K +           +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           NV+ L    ++  +K ++Y+  V+EY    +  ++    +  +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDG 121
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRA 241
           L Y+H S G+ H+DIKP NLL+      +K+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLH-SQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 242 PELIFGATEYTT-AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV--------LGT 292
           PE+  G   ++   +DIWSAG  +  +  G   F GD+ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 293 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFPKRMPP 328
           P  + +K M    P    F   QI+ H W   F K+ PP
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 90  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 140
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 141 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 197
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 198 SKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 125
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 182
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            + YY +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTM-RLLDHPNVVSLKH 131
           +G GS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    +   LYL   L         + +H       +P   V  Y      AL+++H S
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-S 175
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 243
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 176 QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
           L+ G+  Y TA D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+ E V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            + +  F    A              A D + RLL   P  R T  D+L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 125/304 (41%), Gaps = 54/304 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 143 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 201
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++          D+WS G +   L+ G   F G++  + L  I              +N
Sbjct: 202 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVN 248
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            ++ E  F                   A D + RLL   P  R     +L H +   +R 
Sbjct: 249 YDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295
Query: 363 PNAR 366
            N R
Sbjct: 296 RNVR 299

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +  K C     D+ E  L LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H S    HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLH-SQHYIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 185 FWYAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 117/253 (46%), Gaps = 38/253 (15%)
Query: 137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQR----MPMIYVKLYAYQIFRALSYIHRS 191
           T+ DE+Y+  + EY+  +++ +  ++F  L++     +P+  +K     +  + SYIH  
Sbjct: 113 TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
             +CHRD+KP N+L++ +  +VKL DFG ++ +V  +   S   +  +  PE     + Y
Sbjct: 171 KNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSY 228
Query: 252 TTA-IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
             A +DIWS G  +  +     + P    +  LVE+   + T   E             +
Sbjct: 229 NGAKVDIWSLGICLYVMFYN--VVPFSLKI-SLVELFNNIRTKNIE-------------Y 272
Query: 311 PQIKAHPWHKIFPKR-------MPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-----D 358
           P  + H  + +  K+       +  E +D +   L+ +P  R T+ DAL H +      +
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332
Query: 359 ELRDPNARLPSGR 371
           +LR+ +  L   R
Sbjct: 333 DLREFSKELYKKR 345

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++ H  ++  R    +   YA +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL-Q 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y  ++D W+ G ++ E++ G+  F G+   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 126/308 (40%), Gaps = 38/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K  LQD     RE++   R    P++V +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           +      + LY       +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 124 Y------ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 178 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D WS G +   L+ G P F  + G      +    G  TR     +     
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR-----IRXGQY 284
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE-LRDPNA 365
           EF  P+     W ++       E   L+  LL+  P  R T  +   HP+  +  + P  
Sbjct: 285 EFPNPE-----WSEV-----SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQT 334
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 335 PLHTSRVL 342

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +  K C     D+ E  L LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 185 FWYAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++ H  ++  R    +   YA +I   L ++ +
Sbjct: 408 HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL-Q 459
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y  ++D W+ G ++ E++ G+  F G+   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 137/311 (44%), Gaps = 46/311 (14%)
Query: 69  QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRLL----DH 123
           + +  + E ++G+G+   V     L T +  A+K +  Q    ++R  + + +L     H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 124 PNVVSLKHCFFSTTDKDELYL---NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            NV+ L        ++D  YL    +    +   +H+  +HFN+L          +    
Sbjct: 71  RNVLELI---EFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELE-------ASVVVQD 119
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 230
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 231 ISYIC-SRYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
           +   C S  Y APE++   +E    Y    D+WS G ++  L+ G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 346 CTALDALIHPF 356
            +A   L HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            + YY +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            + YY +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L      T   D + L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 93  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + 
Sbjct: 143 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 199
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           ++ APE++     Y   +D+W  G ++  L+ G   F G    ++L E I       + +
Sbjct: 200 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 250
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            K MNP              W  I        A DLV R+L   P  R T  +AL HP+ 
Sbjct: 251 YK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWL 292
Query: 358 DELRDPNA 365
            E RD  A
Sbjct: 293 KE-RDRYA 299

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 132 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +     +   L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 128
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 129 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 145 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L      T   D + L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 91  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 197
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           ++ APE++     Y   +D+W  G ++  L+ G   F G    ++L E I       + +
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 248
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            K MNP              W  I        A DLV R+L   P  R T  +AL HP+ 
Sbjct: 249 YK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 358 DELRDPNA 365
            E RD  A
Sbjct: 291 KE-RDRYA 297

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 138/313 (44%), Gaps = 44/313 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +DE +L LV++Y       ++   +K   ++P    + Y  ++  A+  IH+ +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+                N+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 313
Query: 307 E-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL-QYSPNLRCTAL-DALIHPFFDELRDP 363
           E F+FP              +  EA DL+ RL+      L    + D   H FF+ L   
Sbjct: 314 ERFQFPS---------HVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 364
Query: 364 NARLPSGRFLPPL 376
           N R     ++P +
Sbjct: 365 NIRNLEAPYIPDV 377

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLS-SRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             RE ++   P Y+  +  QI    WH+   +R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 174
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 138/313 (44%), Gaps = 44/313 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +DE +L LV++Y       ++   +K   ++P    + Y  ++  A+  IH+ +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+                N+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 297
Query: 307 E-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL-QYSPNLRCTAL-DALIHPFFDELRDP 363
           E F+FP              +  EA DL+ RL+      L    + D   H FF+ L   
Sbjct: 298 ERFQFPS---------HVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 348
Query: 364 NARLPSGRFLPPL 376
           N R     ++P +
Sbjct: 349 NIRNLEAPYIPDV 361

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 77/331 (23%), Positives = 130/331 (39%), Gaps = 75/331 (22%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-------- 113
           G +G   Q   Y  +  +G+GS+GVV  A   E   T    KVL  K+   +        
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 114 -----------------------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY 150
                                  E+  ++ LDHPNVV L        D +E +L +V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFEL 119
Query: 151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT 210
           V +     V     L++       + Y   + + + Y+H    + HRDIKP NLLV    
Sbjct: 120 VNQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDG 174
Query: 211 HQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTT--AIDIWSAGCVVAEL 267
           H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +   
Sbjct: 175 H-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKR-- 325
           + G+  F                     E I C++         +IK+      FP +  
Sbjct: 234 VFGQCPF-------------------MDERIMCLH--------SKIKSQALE--FPDQPD 264
Query: 326 MPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           +  +  DL++R+L  +P  R    +  +HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K C     D+ E  + LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 73  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 179 FWYAPECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 190
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K C     D+ E  + LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 74  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 180 FWYAPECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ ++VK    L +   + Y+     Q    L Y+H S  + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLH-SRRILHG 209
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +D+WS+ C++  ++ G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   K     +  A+K + + +  K  E    R    +L + +   +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            ++  D + LYL  V++Y       ++   +K   R+P    + Y  ++  A+  +H+ +
Sbjct: 140 HYAFQDDNNLYL--VMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-L 194
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           G   Y    D WS G  + E++ G+  F  +S V+   +I+ 
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 136/308 (44%), Gaps = 39/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++++++G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIH 189
            +        L +++E +        + F+++ +R    + +  A +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
            S  + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 127 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 182
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  ++G        + +    +  I+       
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 229
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE-LRDPNA 365
           ++ FP  +   W ++       +A  L+  LL+  P  R T    + HP+ ++ +  P  
Sbjct: 230 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 281
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 282 PLHTARVL 289

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 136/308 (44%), Gaps = 39/308 (12%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++++++G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIH 189
            +        L +++E +        + F+++ +R    + +  A +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
            S  + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 201
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  +Y  + D+WS G ++  L+ G P F  ++G        + +    +  I+       
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 248
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE-LRDPNA 365
           ++ FP  +   W ++       +A  L+  LL+  P  R T    + HP+ ++ +  P  
Sbjct: 249 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 301 PLHTARVL 308

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             +T      L +++EY+       +     L +     Y+     +I + L Y+H    
Sbjct: 87  LKSTK-----LWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSERK 137
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++     VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 138 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 194
Query: 253 TAIDIWSAGCVVAELMLGKP 272
              DIWS G    EL  G+P
Sbjct: 195 FKADIWSLGITAIELAKGEP 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM 118
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 119 RL-------LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN----- 166
            L       ++H N++ +   F     +++ +  LV+E          KH + L+     
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVME----------KHGSGLDLFAFI 121
Query: 167 QRMPMIYVKLYAY---QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223
            R P +   L +Y   Q+  A+ Y+ R   + HRDIK +N+++      +KL DFGSA  
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYL-RLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAY 179
Query: 224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML 269
           L +G+   ++  +  Y APE++ G       +++WS G  +  L+ 
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 143/315 (45%), Gaps = 68/315 (21%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 129
           +G+G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 130 KHCFF--STTDK-----DELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            + +   +TT+K      ++YL + ++    E +   +     + +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QI 127
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY- 233
             A+ ++H S G+ HRD+KP N+        VK+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 234 -----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
                + ++ Y +PE I G + Y+  +DI+S G ++ EL     L+P  + ++++  +  
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTD 239
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           V                   KFP         +F ++ P E V +V  +L  SP  R  A
Sbjct: 240 V----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPMERPEA 274
Query: 349 LDALIHPFFDELRDP 363
           ++ + +  F++L  P
Sbjct: 275 INIIENAVFEDLDFP 289

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 188
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 247
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 248 DAKVDIWSSCCMMLHMLNG 266

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 46/311 (14%)
Query: 69  QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRLL----DH 123
           + +  + E ++G+G+   V     L T +  A+K +  Q    ++R  + + +L     H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 124 PNVVSLKHCFFSTTDKDELYL---NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            NV+ L        ++D  YL    +    +   +H+  +HFN+L          +    
Sbjct: 71  RNVLELI---EFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELE-------ASVVVQD 119
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 230
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 231 ISYIC-SRYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
           +   C S  Y APE++   +E    Y    D+WS G ++  L+ G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 346 CTALDALIHPF 356
            +A   L HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 65  GQPKQTIS---YMAERIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE---- 114
           G P+  I+    +  RI+G+G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 115 -LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
               M+ LDHP++V L        +++  ++ + L    E  H + ++ N L     ++ 
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLT 126
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           + LY+ QI +A++Y+  SI   HRDI  +N+LV      VKL DFG ++  ++ E     
Sbjct: 127 LVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKA 183
Query: 234 ICSRY---YRAPELIFGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
             +R    + +PE I     +TTA D+W  A C+   L  GK P F
Sbjct: 184 SVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ ++VK    L +   + Y+     Q    L Y+H S  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLH-SRRILHG 190
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +D+WS+ C++  ++ G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 129
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 130 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 188 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 279 GVDQ-LVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
            + +  V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 144
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 145 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 202
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-LVEI 286
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  + +  V  
Sbjct: 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262
Query: 287 IKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
            + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 54/294 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 129 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++          D+WS G +   L+ G   F G++  + L              I  +N
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVN 234
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            ++ E  F                   A D + RLL   P  R     +L H +
Sbjct: 235 YDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKLNQRMPM 171
           +L               + C F        YL     E+VP     + K F  L      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDFLTLE----- 148
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 149 -HLIXYSFQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXV 205
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEII 287
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 257
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 125
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 126 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 183
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 130
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 131 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 189 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 279 G-VDQLVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
             +   V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 248 EIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 129
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 130 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 188 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 279 GV 280
            +
Sbjct: 247 EI 248

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 124
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 125 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 182
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 183 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALS 186
           L   + + TD     + L+LE V        + F+ L Q+  +   +  ++  QI   ++
Sbjct: 80  LHDVYENRTD-----VVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                      ++ + + F  +    A D + +LL      R T  +AL HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 117
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 118 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 176 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 234
Query: 279 GV 280
            +
Sbjct: 235 EI 236

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 125
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 126 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 183
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 144
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 145 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 203 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261
Query: 279 GV 280
            +
Sbjct: 262 EI 263

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 130
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 131 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 189 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 279 G-VDQLVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
             +   V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 248 EIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 129
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 130 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 188 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 279 G-VDQLVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
             +   V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 EIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 116
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 117 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 175 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 233
Query: 279 GV 280
            +
Sbjct: 234 EI 235

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 129
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 130 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 188 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 279 G-VDQLVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
             +   V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 EIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 144
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 145 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 203 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 261
Query: 279 GVDQ-LVEIIKVLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
            + +  V   + + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 262 EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 130
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 131 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 189 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 279 GV 280
            +
Sbjct: 248 EI 249

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 107 PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 149
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 150 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 208 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 266
Query: 279 GV 280
            +
Sbjct: 267 EI 268

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL------ 115
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 ---------------QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVK 160
                            +RLLD          +F   D       L+LE  PE V  +  
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL-- 130
Query: 161 HFNKLNQRMPMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
            F+ + +R  +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DF
Sbjct: 131 -FDFITERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           GS   L+K      +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D 
Sbjct: 189 GSG-ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 279 GV 280
            +
Sbjct: 248 EI 249

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTM 118
           P + +   ++R++G+G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           R L+HPNV++L            + L       P   H  +  F +  QR P +   + +
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ R + Y+     V HRD+  +N +++  +  VK+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 238 YYRAPELIFGATE------YTTAIDIWSAGCVVAELM 268
           + R P + + A E      +TT  D+WS G ++ EL+
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 77  RIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 128
           RI+G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L        +++  ++ + L    E  H + ++ N L     ++ + LY+ QI +A++Y+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLTLVLYSLQICKAMAYL 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 245
             SI   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I
Sbjct: 130 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 186
Query: 246 FGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
                +TTA D+W  A C+   L  GK P F
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RS 191
            F         L++V EY+       + H +   +++        AY + + ++Y+H R+
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 245
             + HRD+K  NLLV+   + VK+CDFG +++         ++ S+       + APE++
Sbjct: 158 PPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEVL 211
Query: 246 FGATEYTTAIDIWSAGCVVAEL 267
                   + D++S G ++ EL
Sbjct: 212 RDEPSNEKS-DVYSFGVILWEL 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 77  RIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 128
           RI+G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L        +++  ++ + L    E  H + ++ N L     ++ + LY+ QI +A++Y+
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLTLVLYSLQICKAMAYL 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 245
             SI   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I
Sbjct: 126 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 182
Query: 246 FGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
                +TTA D+W  A C+   L  GK P F
Sbjct: 183 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 127
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRAL 185
           S         D  E   + VL  + E +  V   F+ + +R  +     + + +Q+  A+
Sbjct: 70  SGFSGVIRLLDWFERPDSFVL--ILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 128 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +  +WS G ++ +++ G   F  D  +
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 113/297 (38%), Gaps = 67/297 (22%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLK 130
           ERI G+GSFG VF+     T + VAIK +       +     +E+  +   D   V    
Sbjct: 29  ERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             +   +      L +++EY+       +      ++      +K    +I + L Y+H 
Sbjct: 88  GSYLKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHS 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGAT 249
              + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   +
Sbjct: 139 EKKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQS 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y +  DIWS G    EL  G+P                                     
Sbjct: 196 AYDSKADIWSLGITAIELAKGEP------------------------------------- 218
Query: 310 FPQIKAHPWHKIF--PKRMPPEAV--------DLVSRLLQYSPNLRCTALDALIHPF 356
            P    HP   +F  PK  PP  V        + +   L   P+ R TA + L H F
Sbjct: 219 -PNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD---------- 122
           Y    ++G+G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 123 ---------HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
                    HP V+ L   F    +  E ++ LVLE  P     +   F+ + ++ P+  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDL---FDYITEKGPLGE 138
Query: 174 --VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
              + +  Q+  A+ + H S GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
            +  +R Y  PE I     +     +WS G ++ +++ G
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RS 191
            F         L++V EY+       + H +   +++        AY + + ++Y+H R+
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 245
             + HR++K  NLLV+   + VK+CDFG +++        +++ S+       + APE++
Sbjct: 158 PPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEVL 211
Query: 246 FGATEYTTAIDIWSAGCVVAEL 267
                   + D++S G ++ EL
Sbjct: 212 RDEPSNEKS-DVYSFGVILWEL 232

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      ++      L LV +Y+P    +  V +H   L    P + +  +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALG---PQLLLN-WGVQIAKGM 146
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 243 ELI-FGATEYTTAIDIWSAGCVVAELM 268
           E I FG  +YT   D+WS G  V ELM
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SLKHCFFSTTDKDELYLNLVLE---------YVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           +L         K    L +++E         Y+    +  V + +     + + ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 239 ---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 306

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 456 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 507 LE-SKRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 561
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 562 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      ++      L LV +Y+P    +  V +H   L    P + +  +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALG---PQLLLN-WGVQIAKGM 128
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 243 ELI-FGATEYTTAIDIWSAGCVVAELM 268
           E I FG  +YT   D+WS G  V ELM
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      TT + ++   L++E+ P      V         +P     +    +   +++
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 188 IHRSIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + R  G+ HR+IKP N++  +      V KL DFG+A+ L   E  +S   +  Y  P++
Sbjct: 128 L-RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 245 IFGAT-------EYTTAIDIWSAGCVVAELMLG 270
              A        +Y   +D+WS G        G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 70  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 111
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 112 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 169
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 127
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRAL 185
           S         D  E   + VL  + E    V   F+ + +R  +     + + +Q+  A+
Sbjct: 93  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 150
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 151 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 208
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +  +WS G ++ +++ G   F  D  +
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 243

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 71  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 112
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 113 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 170
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L     S T      + LV + +P        H +K N    ++    +  QI + + Y
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 155
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 244
           +     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A E 
Sbjct: 156 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 245 IFGATEYTTAIDIWSAGCVVAELML--GKP 272
           I    ++T   D+WS G  + ELM   GKP
Sbjct: 214 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 71  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 112
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 113 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 170
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 127
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRAL 185
           S         D  E   + VL  + E    V   F+ + +R  +     + + +Q+  A+
Sbjct: 71  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 129 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +  +WS G ++ +++ G   F  D  +
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FG V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGV 75
Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHRSIGV 194
            T +   Y  ++ E++  T   ++ +  + N++     V LY A QI  A+ Y+ +    
Sbjct: 76  CTREPPFY--IITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NF 130
Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEY 251
            HRD+  +N LV    H VK+ DFG ++ L+ G+   ++  +++   + APE +    ++
Sbjct: 131 IHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNKF 187
Query: 252 TTAIDIWSAGCVVAEL-MLGKPLFPG 276
           +   D+W+ G ++ E+   G   +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 66  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 107
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 108 QEELARSFFWQVLEAVRHCH-NXGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 165
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 69  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 110
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 111 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 168
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 169 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 46/272 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 66  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 107
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 108 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 165
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-LVEIIK 288
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  + +  V   +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 289 VLGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 318
            + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----------------- 115
           Y    ++G G FG V+    +     VAIK V +D+     EL                 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 116 ----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
                 +RLLD          +F   D       L+LE  PE V  +   F+ + +R  +
Sbjct: 66  SGFSGVIRLLD----------WFERPDS----FVLILER-PEPVQDL---FDFITERGAL 107
Query: 172 I--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K   
Sbjct: 108 QEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 165
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
              +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L     S T      + LV + +P        H +K N    ++    +  QI + + Y
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 132
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 244
           +     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A E 
Sbjct: 133 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 245 IFGATEYTTAIDIWSAGCVVAELML--GKP 272
           I    ++T   D+WS G  + ELM   GKP
Sbjct: 191 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 54/295 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVP-ETVHRVVKHFNKLNQRMP 170
           +L               + C F        YL     E+VP +T   + K F  L     
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKTPEDLYKDFLTLE---- 148
Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 230
             ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    
Sbjct: 149 --HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDX 204
Query: 231 ISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEI 286
           +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKI 256
Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
            +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      TT + ++   L++E+ P      V         +P     +    +   +++
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 188 IHRSIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + R  G+ HR+IKP N++  +      V KL DFG+A+ L   E  +    +  Y  P++
Sbjct: 128 L-RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 245 IFGAT-------EYTTAIDIWSAGCV 263
              A        +Y   +D+WS G  
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVT 212

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +          D+WS G +   L+ G   F GD+  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                     ++ + + F  +    A D + +LL      R T  +AL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 456 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 507 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 561
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 562 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 81  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 132 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 186
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 187 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +          D+WS G +   L+ G   F GD+  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                     ++ + + F  +    A D + +LL      R T  +AL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +          D+WS G +   L+ G   F GD+  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                     ++ + + F       A D + +LL      R T  +AL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 73  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 124 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 178
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 179 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 79  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 130 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 184
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 185 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 78  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 129 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 183
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 184 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 121/293 (41%), Gaps = 52/293 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALS 186
           L   + + TD     + L+LE V        + F+ L Q+  +   +  ++  QI   ++
Sbjct: 80  LHDVYENRTD-----VVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++          D+WS G +   L+ G   F GD+  + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                      ++ + + F       A D + +LL      R T  +AL HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 104 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 155 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 209
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 210 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F      +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDF------L 136
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            + ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
           E I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVP--ETVHRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  E    + K F  L    
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKEAPEDLYKDFLTLE--- 150
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 151 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 205
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 257
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 258 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 312

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDF------L 136
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            + ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +          D+WS G +   L+ G   F GD+  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                     ++ + + F       A D + +LL      R T  +AL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           Y  +  + APEL+ G  EY  ++D ++ G                     L E+I   G 
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVT-------------------LYEMIAARGP 388
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP----NLRCTA 348
                 K  N    +    Q         +P +  P + D    LLQ  P      R  +
Sbjct: 389 FRARGEKVENKELKQRVLEQA------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 349 LDAL-IHPFFDELRDPNAR-LPSGRFLPPL 376
            D L  HP F   RD + R L +G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           Y  +  + APEL+ G  EY  ++D ++ G                     L E+I   G 
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVT-------------------LYEMIAARGP 388
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP----NLRCTA 348
                 K  N    +    Q         +P +  P + D    LLQ  P      R  +
Sbjct: 389 FRARGEKVENKELKQRVLEQA------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 349 LDAL-IHPFFDELRDPNAR-LPSGRFLPPL 376
            D L  HP F   RD + R L +G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 126
           +  + +G+G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++L   + +T++     + L+LEY    E     +    ++     +I +     QI   
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           + Y+H++  + H D+KPQN+L++       +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E I      TTA D+W+ G +   L+     F G+   +  + I +V            N
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------N 249
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
            +Y+E  F  +                A D +  LL  +P  R TA   L H +  +
Sbjct: 250 VDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           Y  +  + APEL+ G  EY  ++D ++ G                     L E+I   G 
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVT-------------------LYEMIAARGP 388
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP----NLRCTA 348
                 K  N    +    Q         +P +  P + D    LLQ  P      R  +
Sbjct: 389 FRARGEKVENKELKQRVLEQA------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 349 LDAL-IHPFFDELRDPNAR-LPSGRFLPPL 376
            D L  HP F   RD + R L +G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           Y  +  + APEL+ G  EY  ++D ++ G                     L E+I   G 
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVT-------------------LYEMIAARGP 388
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP----NLRCTA 348
                 K  N    +    Q         +P +  P + D    LLQ  P      R  +
Sbjct: 389 FRARGEKVENKELKQRVLEQA------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 349 LDAL-IHPFFDELRDPNAR-LPSGRFLPPL 376
            D L  HP F   RD + R L +G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 185
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 186 ---HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 240
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 292
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 347

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDF------L 136
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            + ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ER++G G FG V   +    G+    VAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  +   +V+E++      +     K + +  +I +      I   + Y
Sbjct: 108 HLEGVV--TRGKPVM---IVIEFMENGA--LDAFLRKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LA-DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--------VKGEPNISYICSRYY 239
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +         KG+  I ++     
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM----- 179
Query: 240 RAPELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPGDSGVDQLVEI 286
            APE I     +T+A D+W  G C+   LM G   F G    D +  I
Sbjct: 180 -APESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDF------L 136
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            + ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 137 TLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+ + +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLITQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 205 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 263 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 314
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 315 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 362

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 203 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 261 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 312
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 313 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 360

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 196 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 254 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 305
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 306 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 353

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 198 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 256 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 307
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 355

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMEN--GSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LS-DMSAVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SLKHCFFSTTDKDELYLNLVLE---------YVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           +L         K    L +++E         Y+    +  V + +     + + ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+ + + ++  S    HRD+  +N+L++   + VK+ DFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 239 ---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRL 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 306

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L +  V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 126
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ER++G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENG--SLDTFLKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 154
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 155 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 213 LESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 128
           +++G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 129 --LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
             L  C  ST       + LV + +P     ++ H  +   R+    +  +  QI + +S
Sbjct: 83  RLLGICLTST-------VQLVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 134 YLE-DVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            I     +T   D+WS G  V ELM
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           HP++V + +    T    +    +V+EYV     +  K      Q++P+     Y  +I 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEIL 192
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSR 237
            ALSY+H SIG+ + D+KP+N+++     Q+KL D G+   +     + G P        
Sbjct: 193 PALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ++APE++   T  T A DI++ G  +A L L  P   G   VD L E   VL T
Sbjct: 243 -FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L +  V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 138
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LS-DMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LS-DMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 148
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 149 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA 206
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 207 LRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 148
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 149 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA 206
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 207 LRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 142
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 143 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA 200
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 201 LRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             +ST  +    L +V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 138
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMEN--GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMEN--GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 44/290 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           +G+GSF  V+  K L+T  TV +    LQD++    E Q        ++ L HPN+V   
Sbjct: 34  IGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH- 189
             + ST    +  + +       T+   +K F     ++    ++ +  QI + L ++H 
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV----LRSWCRQILKGLQFLHT 147
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           R+  + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE      
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EE 204
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +Y  ++D+++ G    E    +  +                        +C N       
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYS-----------------------ECQNAAQI--- 238
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           + ++ +      F K   PE  +++   ++ + + R +  D L H FF E
Sbjct: 239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 71  ISYMA-ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 121
           +SY+  E ++G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQ 180
           +HPN++ L+         + + + ++ E++    +  +  F +LN  +  +I +      
Sbjct: 73  EHPNIIRLEGVV-----TNSMPVMILTEFME---NGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 237
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 238 ---YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               + APE I    ++T+A D WS G V+ E+M
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/348 (20%), Positives = 132/348 (37%), Gaps = 56/348 (16%)
Query: 78  IVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
           ++G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F +    +EL++             +  HF      + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 190 RSIGVCHRDIKPQNLLVNPHT--------HQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII-------------- 287
             L      Y    DI+S G    EL  G   F        L+E +              
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 288 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 249 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVEQC 301
Query: 338 LQYSPNLRCTALDALIHPFFDEL-RDPNARLPS-GRFLPPLFNFKSHE 383
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+  +
Sbjct: 302 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQ 349

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 128/308 (41%), Gaps = 59/308 (19%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           + +     +  L +V+E +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK    GE                  
Sbjct: 134 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE------------------ 173
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              +Y  + D+WS G ++  L+ G P F  + G      +    G  TR  +        
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 217
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF-FDELRDPNA 365
           +++FP  +   W ++       E   L+  LL+  P  R T  + + HP+     + P  
Sbjct: 218 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269
Query: 366 RLPSGRFL 373
            L + R L
Sbjct: 270 PLHTSRVL 277

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G GSFG V++ K       V I KV+     Q + ++N E+  +R   H N++     F
Sbjct: 44  IGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----LF 97
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                KD L   +V ++   +   + KH +    +  M  +   A Q  + + Y+H +  
Sbjct: 98  MGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKN 152
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELIFGATE 250
           + HRD+K  N+ ++     VK+ DFG A V  +  G   +     S  + APE+I     
Sbjct: 153 IIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 251 --YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             ++   D++S G V+ ELM G+  +   +  DQ++ ++
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/348 (20%), Positives = 132/348 (37%), Gaps = 56/348 (16%)
Query: 78  IVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
           ++G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F +    +EL++             +  HF      + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 190 RSIGVCHRDIKPQNLLVNPHT--------HQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII-------------- 287
             L      Y    DI+S G    EL  G   F        L+E +              
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 288 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVEQC 317
Query: 338 LQYSPNLRCTALDALIHPFFDEL-RDPNARLPS-GRFLPPLFNFKSHE 383
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+  +
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQ 365

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNRE-----LQ 116
           P++ + +   +++G G+FG V  A      +T     VA+K + +      RE     L+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 117 TM-RLLDHPNVVSL--------------KHCFFSTT-----DKDELYLNLVLEYVPETVH 156
            M +L  H N+V+L              ++C +         K E +    +EY  +   
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC 216
              +  N L     + +    AYQ+ + + ++     V HRD+  +N+LV  H   VK+C
Sbjct: 161 EEEEDLNVLTFEDLLCF----AYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKIC 214
Query: 217 DFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKP 272
           DFG A+ ++     +    +R    + APE +F    YT   D+WS G ++ E+  LG  
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVN 273
Query: 273 LFPG 276
            +PG
Sbjct: 274 PYPG 277

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 131
           G+G FGVV++     T  TVA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSYI 188
             FS+   D   L LV  Y P     ++   + L+   P+ +    K+ A      ++++
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSWHXRCKI-AQGAANGINFL 140
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 141 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKP 272
            G  E T   DI+S G V+ E++ G P
Sbjct: 199 RG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----QTMRLL 121
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
                +     F    D + L ++L+   + +        FN  ++++ +  V + A Q+
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-------FNFCSRKLSLKTVLMLADQM 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              + ++H S    HRDIKP N L  +    +QV + DFG AK
Sbjct: 113 INRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             +ST  +    L +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 248
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 249 TE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L+        +  L + +V EY+   ++   ++  +     M ++ +        R LS
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRA 241
                +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 169 ----DLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE I   T +++A D+WS G V+ E++
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+++G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     +T      + ++ E++    +  +  F + N  +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLA-DMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 166 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 224 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 168 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 226 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 150 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 208 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 71  ISYMA-ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 121
           +SY+  E ++G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQ 180
           +HPN++ L+         + + + ++ E++    +  +  F +LN  +  +I +      
Sbjct: 75  EHPNIIRLEGVV-----TNSMPVMILTEFME---NGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 237
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 238 ---YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               + APE I    ++T+A D WS G V+ E+M
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 118/262 (45%), Gaps = 32/262 (12%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-RELQTMRLLDHPNVVSLKHCFFST 136
           ++G+G +G V++    E    V +      + + N + +  + L++H N+          
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 137 TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI---- 192
           T    +   LV+EY P   +  +  +  L+    +   +L A+ + R L+Y+H  +    
Sbjct: 80  TADGRMEYLLVMEYYP---NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRGD 135
Query: 193 ----GVCHRDIKPQNLLVNPHTHQVKLCDFG-----SAKVLVK-GEPN---ISYICSRYY 239
                + HRD+  +N+LV      V + DFG     +   LV+ GE +   IS + +  Y
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 240 RAPELIFGATEYTTA------IDIWSAGCVVAEL-MLGKPLFPGDSGVD-QLVEIIKVLG 291
            APE++ GA            +D+++ G +  E+ M    LFPG+S  + Q+    +V  
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254
Query: 292 TPTREEIKCMNPNYTEF-KFPQ 312
            PT E+++ +     +  KFP+
Sbjct: 255 HPTFEDMQVLVSREKQRPKFPE 276

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 52/239 (21%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDKRYK-----NRELQ 116
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 117 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNK 164
            M   D+PN+V L          C    + +  D +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 165 LNQRMP----MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220
           ++   P           A Q+   ++Y+     V HRD+  +N LV      VK+ DFG 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIADFGL 220
Query: 221 AKVLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
           ++ +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 221 SRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEI 269

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 125
           ++++G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           ++ L+             + ++ EY+      + K   + +    ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYR 240
            Y+  ++   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           +   HPNV+SL         + E    +VL Y+    H  +++F +     P +   + +
Sbjct: 85  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 137
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    +  + 
Sbjct: 138 GLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 238 Y-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
                 + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++    
Sbjct: 196 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 250
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
               +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 251 ----QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 290

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 104 KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 155
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 156 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 209
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 210 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 269
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 270 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 309

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 105 KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 156
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 157 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 210
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 211 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 270
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 271 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 310

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 35/258 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP +V     F+ 
Sbjct: 16  LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK----FYG 70
Query: 136 TTDKDELYLNLVLEYVPE--TVHRVVKHFNKL--NQRMPMIYVKLYAYQIFRALSYIHRS 191
              K E  + +V EY+     ++ +  H   L  +Q + M       Y +   ++++  S
Sbjct: 71  VCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM------CYDVCEGMAFL-ES 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 248
               HRD+  +N LV+     VK+ DFG  + ++  +  +S + +++   + APE +F  
Sbjct: 123 HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPE-VFHY 179
Query: 249 TEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            +Y++  D+W+ G ++ E+  LGK   P D   +  V ++KV      +  +   P+   
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGK--MPYDLYTNSEV-VLKV-----SQGHRLYRPHLAS 231
Query: 308 FKFPQIKAHPWHKIFPKR 325
               QI    WH++  KR
Sbjct: 232 DTIYQIMYSCWHELPEKR 249

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 138 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 191
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 54/295 (18%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 115 LQTMRLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
              M+   HPNV+SL   C  S            L  +P   H  +++F +     P + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 174 VKL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
             + +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 131 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 184
Query: 233 YICSRYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL 283
           Y         +L             ++TT  D+WS G ++ ELM  G P +P  +  D  
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
           V ++        +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 245 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 288

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L+        +  L + +V EY+   ++   ++  +     M ++ +        R LS
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRA 241
                +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 169 ----DLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE I   T +++A D+WS G V+ E++
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 129/287 (44%), Gaps = 38/287 (13%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           +   HPNV+SL         + E    +VL Y+    H  +++F +     P +   + +
Sbjct: 87  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 139
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ ++  E +  +  + 
Sbjct: 140 GLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 238 Y-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
                 + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++    
Sbjct: 198 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 252
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
               +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 253 ----QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 292

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           +   HPNV+SL         + E    +VL Y+    H  +++F +     P +   + +
Sbjct: 84  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 136
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y    
Sbjct: 137 GLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 190
Query: 238 YYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK 288
                +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++ 
Sbjct: 191 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 249
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                  +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 250 -------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 289

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMSLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           +   HPNV+SL         + E    +VL Y+    H  +++F +     P +   + +
Sbjct: 81  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 133
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y    
Sbjct: 134 GLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 187
Query: 238 YYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK 288
                +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++ 
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 246
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                  +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 247 -------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 286

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 78  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 129
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 130 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 183
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 184 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 243
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 244 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 283

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 54/295 (18%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 115 LQTMRLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
              M+   HPNV+SL   C  S            L  +P   H  +++F +     P + 
Sbjct: 81  GIIMKDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVK 132
Query: 174 VKL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
             + +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 133 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 186
Query: 233 YICSRYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL 283
           Y         +L             ++TT  D+WS G ++ ELM  G P +P  +  D  
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 246
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
           V ++        +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 247 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 138 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 191
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 135 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 192
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 193 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 86
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 87  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 139
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 140 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 197
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 198 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 256
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 257 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 296

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+++G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     +T      + ++ E++    +  +  F + N  +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLA-DMNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 141 GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 193
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 194 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 251
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 252 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 311 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 350

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 82
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 83  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 135
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 136 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 193
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 194 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 253 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 82  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 134
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 135 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 192
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 193 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------------E 114
           P   I +  E ++G+G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
              M+   HPNV+SL         + E    +VL Y+    H  +++F +     P +  
Sbjct: 80  GIIMKDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKD 132
Query: 175 KL-YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
            + +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +
Sbjct: 133 LIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVH 190
Query: 234 ICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             +       + A E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 191 NKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 249
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 250 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 289

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 80  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV  + +  K+ DFG ++   V VK    
Sbjct: 134 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KT 189
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 190 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 90  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV  + +  K+ DFG ++   V VK    
Sbjct: 144 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KT 199
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 200 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +          + VLE  P         F   N  +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTLST 163
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHCFF 134
           +  +G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N++       
Sbjct: 31  VKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 135 STTDKD-ELYLNLVLE---YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             T  D +L+L         + + +   V  +N+L            A  + R L+Y+H 
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH---------IAETMARGLAYLHE 139
Query: 191 SI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRY 238
            I          + HRDIK +N+L+  +     + DFG A     G+        + +R 
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 239 YRAPELIFGATEYTT----AIDIWSAGCVVAEL 267
           Y APE++ GA  +       ID+++ G V+ EL
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 86  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 138 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 193
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGD 277
              DI++  CV+ E + G P + GD
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 125
           ++  + I+G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY--AYQIFR 183
           ++ L+    + T++  +Y  +    V   +        +   + P+ + K    A    R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 184 ALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 239
            L+Y+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            APE +    + +   D++  G ++ EL+ G+  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 124
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 125
           ++  + I+G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY--AYQIFR 183
           ++ L+    + T++  +Y  +    V   +        +   + P+ + K    A    R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 184 ALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 239
            L+Y+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            APE +    + +   D++  G ++ EL+ G+  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 183
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 80  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 132 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 183
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +          + VLE  P         F   N     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTAST 163
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 80  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 132 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 86  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 244
             S    HRD+  +NLL+      VK+ DFG  + L + + +      R     + APE 
Sbjct: 138 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 245 IFGATEYTTAIDIWSAGCVVAEL 267
           +   T ++ A D W  G  + E+
Sbjct: 196 LKTRT-FSHASDTWMFGVTLWEM 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 244
             S    HRD+  +NLL+      VK+ DFG  + L + + +      R     + APE 
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 186 LKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 136/355 (38%), Gaps = 109/355 (30%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 129
           +G+G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 130 KHCFFST------TDKDELYL-NLVLEY---------VPETVHRVVKHF---NKLNQRMP 170
            + +  T       + DE++L +   ++          P    R +  F   N + Q  P
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 171 -----MIYVKLYAYQ-------IFRALSYIHRSIGVC--------------------HRD 198
                 +Y+++   +       + R  S   R  GVC                    HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAPELI 245
           +KP N+        VK+ DFG    + + E       P  +Y      + ++ Y +PE I
Sbjct: 190 LKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQI 248
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G   Y+  +DI+S G ++ EL+               +E ++++             + 
Sbjct: 249 HG-NNYSHKVDIFSLGLILFELLY---------SFSTQMERVRIIT------------DV 286
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              KFP         +F ++ P E + +V  +L  SP  R  A D + +  F+ L
Sbjct: 287 RNLKFPL--------LFTQKYPQEHM-MVQDMLSPSPTERPEATDIIENAIFENL 332

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 87  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HR++  +N+LV  + +  K+ DFG ++   V VK    
Sbjct: 141 LLHFAADVARGMDYLSQKQFI-HRNLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KT 196
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 197 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    +  GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 71  RWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 124
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    +  GE VAIK      ++    +++         V +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 69  RWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 122
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 308
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 77/344 (22%), Positives = 137/344 (39%), Gaps = 70/344 (20%)
Query: 49  GTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK 108
           GTE  +    ++ GR         Y   + +G G    VFQ    E  +  AIK V  ++
Sbjct: 14  GTENLYFQSMSVKGR--------IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEE 64
Query: 109 -------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH 161
                   Y+N      +L  H + + ++   +  TD+   Y+ +V+E     ++  +K 
Sbjct: 65  ADNQTLDSYRNEIAYLNKLQQHSDKI-IRLYDYEITDQ---YIYMVMECGNIDLNSWLKK 120
Query: 162 FNKLN--QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
              ++  +R      K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG
Sbjct: 121 KKSIDPWER------KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFG 171
Query: 220 SAKVLVKGEPNI---SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAE 266
            A  +     ++   S + +  Y  PE I   +            +   D+WS GC++  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 267 LMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM 326
           +  GK  F       Q++  I  L          ++PN+ E +FP I         P++ 
Sbjct: 232 MTYGKTPF------QQIINQISKLHA-------IIDPNH-EIEFPDI---------PEK- 267
Query: 327 PPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSG 370
             +  D++   L+  P  R +  + L HP+      P  ++  G
Sbjct: 268 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 308
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 308
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 261
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 264
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 220
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
           Q++  I  L          ++PN+ E +FP I         P++   +  D++   L+  
Sbjct: 221 QIINQISKLHA-------IIDPNH-EIEFPDI---------PEK---DLQDVLKCCLKRD 260
Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSG 370
           P  R +  + L HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 133/314 (42%), Gaps = 69/314 (21%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 132 C-----FFSTTDKDELYLNLVLEYVPETVHRVVKHF---------NKLNQRMPMIYVKL- 176
           C           K +  L +V+E +    H  +K +         N   +  P +   + 
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 233
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ +     
Sbjct: 193 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV----- 245
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                   M+  Y +               P   P    DL+    Q++PN+R T L+ +
Sbjct: 246 --------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 353 ------IHPFFDEL 360
                 +HP F E+
Sbjct: 284 NLLKDDLHPSFPEV 297

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 77/344 (22%), Positives = 136/344 (39%), Gaps = 70/344 (20%)
Query: 49  GTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK 108
           GTE  +    ++ GR         Y   + +G G    VFQ    E  +  AIK V  ++
Sbjct: 14  GTENLYFQSMSVKGR--------IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEE 64
Query: 109 -------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH 161
                   Y+N      +L  H + + ++   +  TD+   Y+ +V+E     ++  +K 
Sbjct: 65  ADNQTLDSYRNEIAYLNKLQQHSDKI-IRLYDYEITDQ---YIYMVMECGNIDLNSWLKK 120
Query: 162 FNKLN--QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
              ++  +R      K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG
Sbjct: 121 KKSIDPWER------KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFG 171
Query: 220 SAKVLVKGEPNI---SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAE 266
            A  +      +   S + +  Y  PE I   +            +   D+WS GC++  
Sbjct: 172 IANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 267 LMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM 326
           +  GK  F       Q++  I  L          ++PN+ E +FP I         P++ 
Sbjct: 232 MTYGKTPF------QQIINQISKLHA-------IIDPNH-EIEFPDI---------PEK- 267
Query: 327 PPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSG 370
             +  D++   L+  P  R +  + L HP+      P  ++  G
Sbjct: 268 --DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +         +     +K + R P+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLR-------RKAEADLDKEDGR-PL 157
Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++    
Sbjct: 158 ELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 215
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            I    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 57  VTTIGGRNGQPKQTISYMAERIV-----GQGSFGVVFQAKCLETGETVAIK---KVLQDK 108
           +TT G  +G P      +A  IV     G+G FG V++ K    GE VA+K      +  
Sbjct: 23  MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS 80
Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE---LYLNLVLEYVPETVHRVVKHFNKL 165
            ++  E+    +L H N++     F +  +KD      L LV +Y     H     F+ L
Sbjct: 81  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDY-----HEHGSLFDYL 131
Query: 166 NQRMPMI--YVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLC 216
           N+    +   +KL A      L+++H  I        + HRD+K +N+LV  +     + 
Sbjct: 132 NRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 189
Query: 217 DFG------SAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVA 265
           D G      SA   +   PN   + ++ Y APE++  +      E     DI++ G V  
Sbjct: 190 DLGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 266 EL 267
           E+
Sbjct: 249 EI 250

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL---QDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           VG+G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--- 192
           T+      L L+  Y     H  +  F +     P + ++L A      L+++H  I   
Sbjct: 73  TSRNSSTQLWLITHYHE---HGSLYDFLQRQTLEPHLALRL-AVSAACGLAHLHVEIFGT 128
Query: 193 ----GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 243
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 244 LI--------FGATEYTTAIDIWSAGCVVAEL 267
           ++        F + ++T   DIW+ G V+ E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 163 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 220
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +         +     +K + R P+
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLR-------RKAEADLDKEDGR-PL 149
Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++    
Sbjct: 150 ELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 207
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            I    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 57  VTTIGGRNGQPKQTISYMAERIV-----GQGSFGVVFQAKCLETGETVAIK---KVLQDK 108
           +TT G  +G P      +A  IV     G+G FG V++ K    GE VA+K      +  
Sbjct: 10  MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS 67
Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE---LYLNLVLEYVPETVHRVVKHFNKL 165
            ++  E+    +L H N++     F +  +KD      L LV +Y     H     F+ L
Sbjct: 68  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDY-----HEHGSLFDYL 118
Query: 166 NQRMPMI--YVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLC 216
           N+    +   +KL A      L+++H  I        + HRD+K +N+LV  +     + 
Sbjct: 119 NRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 176
Query: 217 DFG------SAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVA 265
           D G      SA   +   PN   + ++ Y APE++  +      E     DI++ G V  
Sbjct: 177 DLGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235
Query: 266 EL 267
           E+
Sbjct: 236 EI 237

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 51/226 (22%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIY 173
           V     +    D D L   +V EY+             P+ +  V     +    + +  
Sbjct: 80  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++           
Sbjct: 135 MLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR---------DV 183
Query: 234 ICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
             + YYR             PE I    ++TT  D+WS G ++ E+
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEI 228

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T K  +Y  +V+E V             L      + VK     +  A + +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGG-----DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 194 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 247
            C  HRD+  +N LV    + +K+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 248 ATEYTTAIDIWSAGCVVAE-LMLGKPLFPGDS 278
              Y++  D+WS G ++ E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 136/323 (42%), Gaps = 87/323 (26%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 79
Query: 132 C-----FFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMP------MIYVKL 176
           C           K +  L +V+E +     ++  R ++   + N   P      MI +  
Sbjct: 80  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM-- 136
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
            A +I   ++Y++    V HR++  +N +V  H   VK+ DFG  + + +         +
Sbjct: 137 -AAEIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 184
Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
            YYR            APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 242
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
           ++ +             M+  Y +               P   P    DL+    Q++PN
Sbjct: 243 LKFV-------------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPN 275
Query: 344 LRCTALDAL------IHPFFDEL 360
           +R T L+ +      +HP F E+
Sbjct: 276 MRPTFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 136/323 (42%), Gaps = 87/323 (26%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 132 C-----FFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMP------MIYVKL 176
           C           K +  L +V+E +     ++  R ++   + N   P      MI +  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM-- 135
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
            A +I   ++Y++    V HR++  +N +V  H   VK+ DFG  + + +         +
Sbjct: 136 -AAEIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 183
Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
            YYR            APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
           ++ +             M+  Y +               P   P    DL+    Q++PN
Sbjct: 242 LKFV-------------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPN 274
Query: 344 LRCTALDAL------IHPFFDEL 360
           +R T L+ +      +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 135/323 (41%), Gaps = 87/323 (26%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 77
Query: 132 C-----FFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMP------MIYVKL 176
           C           K +  L +V+E +     ++  R ++   + N   P      MI +  
Sbjct: 78  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM-- 134
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + +         +
Sbjct: 135 -AAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 182
Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
            YYR            APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 183 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 240
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
           ++ +             M+  Y +               P   P    DL+    Q++P 
Sbjct: 241 LKFV-------------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPK 273
Query: 344 LRCTALDAL------IHPFFDEL 360
           +R T L+ +      +HP F E+
Sbjct: 274 MRPTFLEIVNLLKDDLHPSFPEV 296

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 72/314 (22%), Positives = 132/314 (42%), Gaps = 69/314 (21%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 75
Query: 132 C-----FFSTTDKDELYLNLVLEYVPETVHRVVKHF---------NKLNQRMPMIYVKL- 176
           C           K +  L +V+E +    H  +K +         N   +  P +   + 
Sbjct: 76  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 131
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 233
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 132 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 189
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ +     
Sbjct: 190 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV----- 242
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                   M+  Y +               P   P    DL+    Q++P +R T L+ +
Sbjct: 243 --------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 353 ------IHPFFDEL 360
                 +HP F E+
Sbjct: 281 NLLKDDLHPSFPEV 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 72/314 (22%), Positives = 132/314 (42%), Gaps = 69/314 (21%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 132 C-----FFSTTDKDELYLNLVLEYVPETVHRVVKHF---------NKLNQRMPMIYVKL- 176
           C           K +  L +V+E +    H  +K +         N   +  P +   + 
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 233
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ +     
Sbjct: 193 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV----- 245
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                   M+  Y +               P   P    DL+    Q++P +R T L+ +
Sbjct: 246 --------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 353 ------IHPFFDEL 360
                 +HP F E+
Sbjct: 284 NLLKDDLHPSFPEV 297

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T K  +Y  +V+E V             L      + VK     +  A + +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGG-----DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 194 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
            C  HRD+  +N LV    + +K+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 251 -----YTTAIDIWSAGCVVAE-LMLGKPLFPGDS 278
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 135/323 (41%), Gaps = 87/323 (26%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 132 C-----FFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMP------MIYVKL 176
           C           K +  L +V+E +     ++  R ++   + N   P      MI +  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM-- 135
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + +         +
Sbjct: 136 -AAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 183
Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
            YYR            APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 184 AYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
           ++ +             M+  Y +               P   P    DL+    Q++P 
Sbjct: 242 LKFV-------------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPK 274
Query: 344 LRCTALDAL------IHPFFDEL 360
           +R T L+ +      +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 135/323 (41%), Gaps = 87/323 (26%)
Query: 77  RIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 132 C-----FFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMP------MIYVKL 176
           C           K +  L +V+E +     ++  R ++   + N   P      MI +  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM-- 135
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
            A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + +         +
Sbjct: 136 -AAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 183
Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
            YYR            APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
           ++ +             M+  Y +               P   P    DL+    Q++P 
Sbjct: 242 LKFV-------------MDGGYLD--------------QPDNCPERVTDLMRMCWQFNPK 274
Query: 344 LRCTALDAL------IHPFFDEL 360
           +R T L+ +      +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 70
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 71  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 124
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 182
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 67
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 68  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 121
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 179
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 65
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 66  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 119
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 177
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	409
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-101
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-100
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-99
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-99
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-98
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-96
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-96
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-92
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-90
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-90
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-90
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-90
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-90
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-89
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-89
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-81
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-65
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-63
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-63
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-61
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-60
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-59
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-59
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-58
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-57
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-57
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-57
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-55
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-55
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-54
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-53
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-53
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-53
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-53
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-52
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-52
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-51
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-51
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-51
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-50
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-50
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-50
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-50
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-50
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-49
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-49
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-49
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-49
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-48
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-48
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-47
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-47
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-46
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-46
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-44
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-43
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-43
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-41
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-40
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-39
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-38
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-38
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-38
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-37
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-37
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-37
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-36
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-36
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-35
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-35
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-34
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-34
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-34
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-33
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-33
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-33
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-33
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-31
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-19
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  635 bits (1639), Expect = 0.0
 Identities = 239/394 (60%), Positives = 299/394 (75%), Gaps = 14/394 (3%)

Query: 13  RESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS 72
             S   +    + P     MK+  DK         +G++   ++ T   G+     Q +S
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDK---------DGSKVTTVVATP--GQGPDRPQEVS 55

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 133 FFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-S 174

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           T++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFP
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGR 371
           QIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A  H FFDELRDPN +LP+GR
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGR 354

Query: 372 FLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
             P LFNF + EL S P  +   LIP HAR Q  
Sbjct: 355 DTPALFNFTTQELSSNP-PLATILIPPHARIQAA 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  625 bits (1615), Expect = 0.0
 Identities = 227/374 (60%), Positives = 291/374 (77%), Gaps = 5/374 (1%)

Query: 37  DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG 96
           +  +    ++        I V    G+ G+ ++ I+Y   +++G GSFGVVFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 97  ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETV 155
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  DK DE++LNLVLEYVPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
           +R  +H+ KL Q MPM+ +KLY YQ+ R+L+YIH SIG+CHRDIKPQNLL++P +  +KL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT IDIWS GCV+AELM G+PLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS 335
           G+SG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 336 RLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKL 395
           RLL+Y+P+ R TA++AL HPFFDELR   AR+P+GR LPPLFN+   EL SV  +++ +L
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEEL-SVRPDLISRL 362

Query: 396 IPEHARKQCPFLGL 409
           +P+HA  +    G+
Sbjct: 363 VPQHAEAELLSRGI 376

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  597 bits (1542), Expect = 0.0
 Identities = 161/358 (44%), Positives = 230/358 (64%), Gaps = 12/358 (3%)

Query: 53  GHIIVTTIGGRNGQP--KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY 110
           G ++         +   K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 111 KNRELQTMRLL---DHPNVVSLKHCFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKL 165
           +NRELQ M+ L    HPN+V L+  F++    D+ ++YLN+V+EYVP+T+HR  +++ + 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 166 NQRMPMIYVKLYAYQIFRALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               P I +K++ +Q+ R++  +H  S+ VCHRDIKP N+LVN     +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
              EPN++YICSRYYRAPELIFG   YTTA+DIWS GC+ AE+MLG+P+F GD+   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYS 341
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 342 PNLRCTALDALIHPFFDELRDPNARLPSGRFLPP-LFNFKSHELKSVPVEILVKLIPE 398
           P  R    +AL HP+FDEL DP  +LP+ + LP  LF F  +E++ +      KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  581 bits (1499), Expect = 0.0
 Identities = 170/382 (44%), Positives = 247/382 (64%), Gaps = 43/382 (11%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 125 NVVSLKHCFFSTTDK---------------------------------DELYLNLVLEYV 151
           N++ L   F++T D+                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 152 PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH 211
           P+T+H+V+K F +  + +PM  + +Y YQ+FRA+ +IH S+G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 212 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK 271
            +KLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LGK
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 272 PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAV 331
           PLF G++ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI P+  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 332 DLVSRLLQYSPNLRCTALDALIHPFFDELRDP-------NARLPSG--RFLPPLFNFKSH 382
           DL+ ++L+Y P+LR    +A+ HPFFD LR+        N+  P G  + +P LFNF  +
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 383 ELKSVPVEILVKLIPEHARKQC 404
           EL  +P  +L +++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  302 bits (775), Expect = e-101
 Identities = 102/296 (34%), Positives = 159/296 (53%), Gaps = 21/296 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+++ H+  
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 251
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 309
              +D+W+ GCV AEL+ G PL+PG S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 310 FPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
            P  +   P    FP  +   A+ L+   L   P  R T    L HP+F+ +R+  
Sbjct: 241 IPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  299 bits (768), Expect = e-100
 Identities = 94/315 (29%), Positives = 156/315 (49%), Gaps = 34/315 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 126
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 127 VSLKHCF-----------FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           V +                S T+ + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLLEEHAR 123

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 232
           L+ YQ+ R L YIH S  V HRD+KP NL +N     +K+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 233 -YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             + +++YR+P L+     YT AID+W+AGC+ AE++ GK LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 292 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL 349
               E+ + +      +          P  ++ P  +  EAVD + ++L +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 350 DALIHPFFDELRDPN 364
           +AL HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  299 bits (767), Expect = 2e-99
 Identities = 107/348 (30%), Positives = 184/348 (52%), Gaps = 37/348 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 125
           +  + ++G+G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 126 VVSLKHCFFSTTDKD--ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++++ +     + ++  E+Y+  + E +   +HRV+       Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 232
           A+  +H    V HRD+KP NLL+N     +K+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 293 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           P  +       +P   E+    P   A P  K+FP+ + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            +AL HP+     DPN         P  F F  H  +++  + L KLI
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEPIPPSFFEF-DHYKEALTTKDLKKLI 347

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  297 bits (763), Expect = 3e-99
 Identities = 103/295 (34%), Positives = 156/295 (52%), Gaps = 21/295 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 K   YL  V E+V  T+   ++ F      +    V+ Y +QI   + + H   
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 251
            + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 309
             A+D+W+ GC+V E+ +G+PLFPGDS +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 310 FPQIKAH-PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
            P+IK   P  + +PK +    +DL  + L   P+ R    + L H FF      
Sbjct: 263 LPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  295 bits (757), Expect = 3e-98
 Identities = 104/329 (31%), Positives = 174/329 (52%), Gaps = 36/329 (10%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 122
           +Y+    +G+G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           H N+V+L         +  L L  V EY+      + ++ +     + M  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 239
           R L+Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--- 296
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            I      +  + +P+ +A       P R+  +  DL+++LLQ+    R +A DA+ HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHAP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 357 FDELRDPNARLPSGRFLPPLFNFKSHELK 385
           F  L +   +LP       +F  K  +L+
Sbjct: 285 FLSLGERIHKLPD---TTSIFALKEIQLQ 310

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  292 bits (750), Expect = 1e-96
 Identities = 106/340 (31%), Positives = 181/340 (53%), Gaps = 33/340 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 125
           Y     +G+G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 126 VVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ +       +     ++Y+  V + +   +++++K      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYY 239
            L YIH S  V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 300 CM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           C+ N     +    P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 357 FDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            ++  DP+   P        F F   EL  +P E L +LI
Sbjct: 317 LEQYYDPS-DEPI---AEAPFKF-DMELDDLPKEKLKELI 351

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  291 bits (748), Expect = 2e-96
 Identities = 98/347 (28%), Positives = 161/347 (46%), Gaps = 40/347 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------------RELQT 117
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 118 MRLLDHPNVVSLKHCF--FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM--IY 173
           +    HPN++ L+  F  F      +LYL  V E +   + +V+       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHD-----QRIVISPQH 135

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 294 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL 349
             E++    +P   +Y       + A  W  + P    P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 350 DALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            AL HP+F+ L DP   L           F   +     V  + K+ 
Sbjct: 313 QALRHPYFESLFDPL-DLTE----GLSERF-HFDESVTDVYDMHKIF 353

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  290 bits (745), Expect = 2e-96
 Identities = 89/303 (29%), Positives = 149/303 (49%), Gaps = 23/303 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 129
           Y   R +G+G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +       V E+V  T       F +L Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 250 EYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEI--KCMNPNYT 306
            Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 307 EFK--FPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
            F     +     W +         + PEA+D + +LL+Y    R TA +A+ HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 361 RDP 363
              
Sbjct: 327 VKD 329

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  290 bits (745), Expect = 3e-96
 Identities = 105/322 (32%), Positives = 156/322 (48%), Gaps = 36/322 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 129
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     K  + L  V +++      +       +  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
           +   + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI---KCMNP 303
           GA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
           +Y    F      P H IF      + +DL+  L  ++P  R TA  AL   +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 364 NARLPSGRFLPPLFNFKSHELK 385
                      P  N     LK
Sbjct: 300 GPTPGC---QLPRPNCPVETLK 318

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  287 bits (736), Expect = 3e-95
 Identities = 104/294 (35%), Positives = 168/294 (57%), Gaps = 27/294 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +  L L  V E++      + K  ++    +    +K+Y YQ+ R +++ H+  
Sbjct: 88  I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 306
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           +  F   +  PW  I P     E +DL+S +L + PN R +A DA+ HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSIIP-GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  288 bits (739), Expect = 4e-95
 Identities = 105/337 (31%), Positives = 170/337 (50%), Gaps = 32/337 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y++   VG G++G V  A    +GE VAIKK+          +   REL  ++ + H NV
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 127 VSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           + L   F   +      + YL  V+ ++   + +++        +     ++   YQ+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 242
            L YIH S GV HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIH-SAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           E+I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ + 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           +     +    PQ     + ++FP+   P+A DL+ ++L+   + R TA  AL HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            RDP             F+  S E + + V+   + I
Sbjct: 312 FRDPE-EETE---AQQPFDD-SLEHEKLTVDEWKQHI 343

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  286 bits (733), Expect = 1e-94
 Identities = 90/298 (30%), Positives = 157/298 (52%), Gaps = 30/298 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                    L+L  + EY    + + +      N  + M  +K + YQ+   +++ H   
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 193 GVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
              HRD+KPQNLL++         +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMN 302
            G+  Y+T++DIWS  C+ AE+++  PLFPGDS +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A +AL HP+F   
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  284 bits (729), Expect = 1e-94
 Identities = 100/294 (34%), Positives = 157/294 (53%), Gaps = 28/294 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 K  L L  V E++      + K  +     +  +  K +  Q+   ++Y H   
Sbjct: 69  I---HTKKRLVL--VFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 306
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
           +  F   +  PW       +    +DL+S++L+  PN R TA  AL H +F E 
Sbjct: 235 DPNFTVYEPLPWESFLK-GLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  286 bits (733), Expect = 4e-94
 Identities = 101/337 (29%), Positives = 171/337 (50%), Gaps = 32/337 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 127 VSLKHCFF---STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           + L   F    +  D  + YL  V+ ++   + +++K     ++++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 242
            L YIH + G+ HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           E+I     YT  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
           +     +    P+++   +  I      P AV+L+ ++L      R TA +AL HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 360 LRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
           L D     P        ++  S +     ++   ++ 
Sbjct: 314 LHDTEDE-PQ----VQKYDD-SFDDVDRTLDEWKRVT 344

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  282 bits (723), Expect = 9e-93
 Identities = 92/326 (28%), Positives = 152/326 (46%), Gaps = 28/326 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 130
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 131 -HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                S  ++ +  + LV ++     H +    + +  +  +  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 244
           R+  + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCM 301
           + G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 302 NPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
              Y + +  + +              P A+DL+ +LL   P  R  + DAL H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKS 386
            DP      G  +         E  +
Sbjct: 318 -DPMPSDLKG--MLSTHLTSMFEYLA 340

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  282 bits (723), Expect = 1e-92
 Identities = 106/339 (31%), Positives = 172/339 (50%), Gaps = 36/339 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           NV+ L   F      +   ++YL  V   +   ++ +VK      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVKC-----QKLTDDHVQFLIYQI 141

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYR 240
            R L YIH S  + HRD+KP NL VN    ++K+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIH-SADIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE++     Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 301 M-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 358 DELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            +  DP+   P        ++  S E + + ++    L 
Sbjct: 316 AQYHDPDDE-PV----ADPYDQ-SLESRDLLIDEWKSLT 348

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  278 bits (714), Expect = 3e-92
 Identities = 103/298 (34%), Positives = 160/298 (53%), Gaps = 28/298 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                   +L L  V E+       + K+F+  N  +    VK + +Q+ + L + H   
Sbjct: 70  L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNY 305
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
             +            + P ++     DL+  LL+ +P  R +A +AL HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVVP-KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  278 bits (713), Expect = 9e-92
 Identities = 91/306 (29%), Positives = 157/306 (51%), Gaps = 36/306 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 129
           +G G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRALSY 187
                    +++L L  V E++   + + +      N  + + +  VK + +Q+ + L++
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 244
            H +  + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCM 301
           + G+  Y+T+IDIWS GC++AE++ GKPLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 302 NPNYTEFKFPQIKAHPWHKIFPK----RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            P Y      Q       ++        +    +D +  LLQ +P++R +A  AL HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 358 DELRDP 363
            E    
Sbjct: 298 AEYYHH 303

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  280 bits (717), Expect = 2e-90
 Identities = 101/348 (29%), Positives = 167/348 (47%), Gaps = 41/348 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N++SL + F      +   ++YL  V+E +   + +V++        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 302 NPNYTEF--KFPQIKAHPWHKIFP-----------KRMPPEAVDLVSRLLQYSPNLRCTA 348
            P    +    P+     + K+FP           K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            DAL HP+ +   DP          P +++    + +   +E   +LI
Sbjct: 351 DDALQHPYINVWYDPAEVEAPP---PQIYDK-QLDEREHTIEEWKELI 394

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  279 bits (714), Expect = 3e-90
 Identities = 108/396 (27%), Positives = 165/396 (41%), Gaps = 87/396 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 125 NVVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +VV +            DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 232
             + Y+H S G+ HRD+KP N LVN     VK+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 233 ------------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML----- 269
                             ++ +R+YRAPELI     YT AID+WS GC+ AEL+      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 270 ------GKPLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCM-N 302
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 303 PNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
            +   +   FP+ +     + FP     +A+ L+ R+L ++PN R T  + L HPFF E+
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPA-SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
           R       +            ++  ++    L    
Sbjct: 404 RIAEVETNA----TEKVRLPFNDWMNMDEPQLRYAF 435

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  274 bits (702), Expect = 6e-90
 Identities = 99/326 (30%), Positives = 156/326 (47%), Gaps = 37/326 (11%)

Query: 79  VGQGSFGVVFQAK-CLETGETVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 127
           +G+G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 244
           +H    V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 305 YTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
                   F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 362 DPNARLPSGRFLPPLFNFKS-HELKS 386
                L        L   ++  EL +
Sbjct: 305 RCKENLD-----SHLPPSQNTSELNT 325

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  275 bits (705), Expect = 6e-90
 Identities = 97/348 (27%), Positives = 169/348 (48%), Gaps = 41/348 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N++ L + F      +   ++Y+  V+E +   + +V++        +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQ------MELDHERMSYLLYQM 136

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMP-----------PEAVDLVSRLLQYSPNLRCTA 348
            P    +    P+   + + K+FP  +             +A DL+S++L    + R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            +AL HP+ +   DP+    +    P + +    + +   +E   +LI
Sbjct: 314 DEALQHPYINVWYDPS-EAEA--PPPKIPDK-QLDEREHTIEEWKELI 357

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  275 bits (706), Expect = 9e-90
 Identities = 107/373 (28%), Positives = 187/373 (50%), Gaps = 65/373 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL---QD----KR-YKNRELQTMRLL-DH 123
           Y   + +G+G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V+L +   +  D+D +YL  V +Y+   +H V++        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 232
            + Y+H S G+ HRD+KP N+L+N   H VK+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 233 -----------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E++ GKP+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 282 QLVEIIKVLGTPTREEIKCMN-----------------PNYTEFKFPQIKAHPWHKIFPK 324
           QL  II V+  P+ E+++ +                      +        +   KI PK
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 325 R-MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHE 383
                EA+DL+ +LLQ++PN R +A DAL HPF     +PN   P+      +     ++
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN-EEPN---CDHIITIPIND 354

Query: 384 LKSVPVEILVKLI 396
                ++    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  277 bits (709), Expect = 1e-89
 Identities = 103/388 (26%), Positives = 164/388 (42%), Gaps = 79/388 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQD-KR-YKNRELQTMRLLDHP 124
           Y+ + ++G+GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 125 NVVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            ++ L            DELY+  VLE     + ++ K        +   ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKT----PIFLTEEHIKTILYNLL 139

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 232
              ++IH   G+ HRD+KP N L+N     VK+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 233 -------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG--------- 270
                        ++ +R+YRAPELI     YT +IDIWS GC+ AEL+           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 271 --KPLFPGDSG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 308
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
            FP  K     + +P  +  + ++L+  +L+++PN R T   AL HP+  ++R       
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376

Query: 369 SGRFLPPLFNFKSHELKSVPVEILVKLI 396
           S             +   +    L  + 
Sbjct: 377 S----TKKIILPFDDWMVLSETQLRYIF 400

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  272 bits (698), Expect = 1e-89
 Identities = 87/304 (28%), Positives = 145/304 (47%), Gaps = 32/304 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 126
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLD 134

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           ++H +  + HRD+KP+N+LV      VKL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                    FP     P   + P  M      L+  +L ++P+ R +A  AL H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVP-EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 361 RDPN 364
            + N
Sbjct: 304 -EGN 306

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  253 bits (647), Expect = 7e-81
 Identities = 96/344 (27%), Positives = 155/344 (45%), Gaps = 46/344 (13%)

Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S  D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 190 RSIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYR 240
            +  V HRD+KP N+LV    P   +VK+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---------GVDQLVEIIKVLG 291
           APEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 292 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
            P  +         E   +  ++    +       + +    +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 343 NLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKS 386
             R T+  A+  P+F E  DP        F      +   E  +
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDV--FAGCQIPYPKREFLT 362

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  213 bits (543), Expect = 5e-65
 Identities = 89/330 (26%), Positives = 153/330 (46%), Gaps = 57/330 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DH 123
           Y   +++G+GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 124 PNVVSLKHCFFSTTDKDELYLN---LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            NV+ +   F         + N   +  E +   ++ ++K      Q   +  V+ +A+ 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208

Query: 181 IFRALSYIHRSIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           I + L  +H++  + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 300 -----------CMNPNYTEFKFPQIKAHPWHKIFPKR----MPPEA-------------- 330
                         P Y         +   +    +R     PPE+              
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 331 -VDLVSRLLQYSPNLRCTALDALIHPFFDE 359
            +D + + L++ P +R T   AL HP+   
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  208 bits (530), Expect = 1e-63
 Identities = 98/369 (26%), Positives = 157/369 (42%), Gaps = 74/369 (20%)

Query: 46  DGNGTETGHIIVT---TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK 102
           DG   +    IV        R         Y  + ++G+GSFG V +A      E VAIK
Sbjct: 35  DGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK 85

Query: 103 KVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEY 150
            +   K + N    E++ + L+          +V LK  F         + N   LV E 
Sbjct: 86  IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--------FRNHLCLVFEM 137

Query: 151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQN-LLVNP 208
           +   ++ ++++ N   + + +   + +A Q+  AL ++    + + H D+KP+N LL NP
Sbjct: 138 LSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               +K+ DFGS+     G+    YI SR+YR+PE++ G   Y  AID+WS GC++ E+ 
Sbjct: 196 KRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMH 252

Query: 269 LGKPLFPGDSGVDQLVEIIKVLGTPTREEIK-----------CMNPNYTEFKFPQIKAH- 316
            G+PLF G + VDQ+ +I++VLG P    +              +  +   K    K   
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312

Query: 317 --PWHKIFP-----KRMPPEA----------------VDLVSRLLQYSPNLRCTALDALI 353
             P  +        +   P                   DL+ R+L Y P  R     AL 
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372

Query: 354 HPFFDELRD 362
           H FF +  D
Sbjct: 373 HSFFKKTAD 381

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  207 bits (529), Expect = 2e-63
 Identities = 84/336 (25%), Positives = 145/336 (43%), Gaps = 42/336 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL-----DHP 124
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 125 NVVSLKHC-----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           + +   H       F+    + +++ +V E + E +  ++K +   ++ +P+IYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSAKVLVKGEPNISYI 234
           Q+   L Y+HR  G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIK 288
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 289 VLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFPKRMP------PEAVDLVS 335
           +LG      +          N         ++K  P   +  ++         E  D +S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 336 RLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGR 371
            +LQ  P  R  A   + HP+  +           R
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  199 bits (509), Expect = 9e-61
 Identities = 79/363 (21%), Positives = 146/363 (40%), Gaps = 78/363 (21%)

Query: 51  ETGHIIV---TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           E  H        +            ++  R +G G+FG V   + ++  +  A+K V   
Sbjct: 21  EIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71

Query: 108 KRYKN---RELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYLN---LVLEYVPETVH 156
           K+Y      E   ++ +     ++ N+V     F        +Y +   L+ E +  +++
Sbjct: 72  KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF--------MYYDHMCLIFEPLGPSLY 123

Query: 157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN-LLVNPHTH---- 211
            ++   N       +  +KLY  +I +AL+Y+ + + + H D+KP+N LL +P+      
Sbjct: 124 EIITRNNY--NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLI 180

Query: 212 -------------------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
                               +KL DFG A    K + + S I +R YRAPE+I     + 
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWD 237

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI---------KCMNP 303
            + D+WS GCV+AEL  G  LF     ++ L  +  ++    +  +         K +N 
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEA--------VDLVSRLLQYSPNLRCTALDALIHP 355
           +  +  +P+  +        K+  P           D +  +LQ  P LR +  + L H 
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357

Query: 356 FFD 358
           F +
Sbjct: 358 FLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  198 bits (506), Expect = 2e-60
 Identities = 81/361 (22%), Positives = 143/361 (39%), Gaps = 72/361 (19%)

Query: 52  TGHIIVTT---IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQD 107
           + H+I  +   +  R         Y     +G+G+FG V +    + G   VA+K V   
Sbjct: 1   SMHLICQSGDVLSAR---------YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV 51

Query: 108 KRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEYVPETV 155
            RY      E+Q +  L           V +   F         +     +V E +  + 
Sbjct: 52  DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--------HHGHICIVFELLGLST 103

Query: 156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-------- 207
           +  +K          + +++  AYQI ++++++H    + H D+KP+N+L          
Sbjct: 104 YDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAY 160

Query: 208 ----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDI 257
                          +K+ DFGSA      E + + + +R+YRAPE+I     ++   D+
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDV 217

Query: 258 WSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKA 315
           WS GC++ E  LG  +FP     + L  + ++LG   +  I K     Y    +    + 
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277

Query: 316 HPWHKIFPKRMPP-------------EAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
               +   +   P                DL+ ++L+Y P  R T  +AL HPFFD L+ 
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

Query: 363 P 363
            
Sbjct: 338 S 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  196 bits (500), Expect = 2e-59
 Identities = 84/387 (21%), Positives = 143/387 (36%), Gaps = 85/387 (21%)

Query: 34  IRDDKEMEATVVDGNGTETGHIIVT---TIGGRNGQPKQTISYMAERIVGQGSFGVVFQA 90
           + DDKE             GH++      +  R         Y     +G+G+FG V + 
Sbjct: 1   VEDDKE-------------GHLVCRIGDWLQER---------YEIVGNLGEGTFGKVVEC 38

Query: 91  KCLETG-ETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKD 140
                G   VA+K +    +Y+     E+  ++ +      +    V +   F       
Sbjct: 39  LDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF------- 91

Query: 141 ELYLN---LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
             +     +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H    + H 
Sbjct: 92  -NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHT 147

Query: 198 DIKPQNLLVN------------------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           D+KP+N+L                         +++ DFGSA      E + + + +R+Y
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHY 205

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           R PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG      I 
Sbjct: 206 RPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264

Query: 300 CM---------NPNYTEFKFPQIKAHPWHKIFPKRMPPEA------VDLVSRLLQYSPNL 344
                         + E            K     M  ++       DL+ R+L++ P  
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324

Query: 345 RCTALDALIHPFFDELRDPNARLPSGR 371
           R T  +AL+HPFF  L        + R
Sbjct: 325 RITLAEALLHPFFAGLTPEERSFHTSR 351

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  194 bits (495), Expect = 3e-59
 Identities = 69/293 (23%), Positives = 106/293 (36%), Gaps = 49/293 (16%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHP 124
           S+     +G GS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             V L+  +    +   LY  L  E    ++    +H       +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L+++H S G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLH-SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y TA D++S G  + E+     L  G  G  QL +                   
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                            F   +  E   ++  +L+  P LR TA   L  P  
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  191 bits (488), Expect = 4e-58
 Identities = 63/319 (19%), Positives = 116/319 (36%), Gaps = 60/319 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 242 PELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
                    ++PN+   +            FP     +  D++   L+  P  R +  + 
Sbjct: 253 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 352 LIHPFFDELRDPNARLPSG 370
           L HP+      P  ++  G
Sbjct: 291 LAHPYVQIQTHPVNQMAKG 309

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  190 bits (485), Expect = 5e-58
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 42/300 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
            ++G+G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            +  +  +  ++ + +E VP  ++  +++  +  L      I    Y  QI   L Y+H 
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 249
           +  + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 250 E-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  A DIWS GC + E+  GKP F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
           K    K HP     P+ M  EA   + +  +  P+ R  A D L+  F           P
Sbjct: 237 KVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  190 bits (484), Expect = 2e-57
 Identities = 63/319 (19%), Positives = 115/319 (36%), Gaps = 60/319 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 242 PELIFG----------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
                    ++PN+   +            FP     +  D++   L+  P  R +  + 
Sbjct: 234 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 352 LIHPFFDELRDPNARLPSG 370
           L HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  191 bits (487), Expect = 3e-57
 Identities = 63/319 (19%), Positives = 115/319 (36%), Gaps = 60/319 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 242 PELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
                    ++PN+   +            FP     +  D++   L+  P  R +  + 
Sbjct: 281 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

Query: 352 LIHPFFDELRDPNARLPSG 370
           L HP+      P  ++  G
Sbjct: 319 LAHPYVQIQTHPVNQMAKG 337

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  192 bits (489), Expect = 4e-57
 Identities = 67/301 (22%), Positives = 123/301 (40%), Gaps = 51/301 (16%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 128
           IS+  + ++G G+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVH-RVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                     KD  +  + +E    T+   V +         P+  ++    Q    L++
Sbjct: 83  YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 188 IHRSIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGEPNISY---IC-SRYY 239
           +H S+ + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 240 RAPELIFGATE--YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            APE++    +   T  +DI+SAGCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
           +   +               P            A +L+ +++   P  R +A   L HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 357 F 357
           F
Sbjct: 287 F 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  188 bits (479), Expect = 2e-56
 Identities = 44/350 (12%), Positives = 93/350 (26%), Gaps = 65/350 (18%)

Query: 63  RNGQPKQTIS--------YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--- 111
                    S              +  G   VVF  + +E  E  A+K            
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 112 ----NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN---------------------L 146
               +        L   +    +         D + +                      L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 147 VLEYVPETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN 203
           ++      +  +    + +        ++ + +   Q+ R  + +    G+ H    P N
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDN 224

Query: 204 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGC 262
           L + P    + L D  +   +  G    +      Y   E +      +T A++ W  G 
Sbjct: 225 LFIMPDGR-LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 263 VVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 322
            +  +      F   +   +       L  P  +                          
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGS 321

Query: 323 PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD-PNARLPSGR 371
              +P     L+ R L +    R   L+A+  P F +L++  ++ L +G+
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  186 bits (475), Expect = 3e-56
 Identities = 69/326 (21%), Positives = 112/326 (34%), Gaps = 56/326 (17%)

Query: 57  VTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKN 112
           +  I  ++        Y+  + +G+G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 113 RELQTMRLLDHPNVVSLKHCFF-STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMP 170
           RE    RL +HPN++ L          K E +  L+L +    T+   ++        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--- 227
              +      I R L  IH + G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 228 -------EPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
                  +   +  C+  YRAPEL             D+WS GCV+  +M G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                V +  V                 +   PQ            R       L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284

Query: 339 QYSPNLRCTALDALIHPFFDELRDPN 364
              P+ R      L      +   P 
Sbjct: 285 TVDPHQRPHIPLLLSQLEALQPPAPG 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  185 bits (471), Expect = 4e-56
 Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 45/299 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V          D+    L +V+EY     +  V+    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 186 SYIHR----SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 240
              HR       V HRD+KP N+ ++     VKL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
                 E KF +I         P R   E  ++++R+L      R +  + L +P   E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  184 bits (469), Expect = 3e-55
 Identities = 58/304 (19%), Positives = 111/304 (36%), Gaps = 27/304 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      TT      L  ++E+ P       + +  N     +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 186 SYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           +++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 243 ELIFGAT-------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK--VLGTP 293
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
           +               +      P      + +      +++ +L+              
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 354 HPFF 357
               
Sbjct: 303 ETSD 306

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  186 bits (473), Expect = 9e-55
 Identities = 85/352 (24%), Positives = 146/352 (41%), Gaps = 66/352 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 130
            ++E+I+G GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY- 74

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVH-RVVKH--FNKLNQRMPMIYVKLYAYQIFRALSY 187
           +C  +      LY+   LE     +   V      ++  +            QI   +++
Sbjct: 75  YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGE----PNI 231
           +H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 232 SYIC-SRYYRAPELIFGATE------YTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
           +    +  +RAPEL+  +         T +IDI+S GCV   ++  GK  F       + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 344 LRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKL 395
            R TA+  L HP F      + +L    FL  + +    E +  P  +L+K 
Sbjct: 286 KRPTAMKVLRHPLF---WPKSKKLE---FLLKVSDRLEIENRDPPSALLMKF 331

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  183 bits (466), Expect = 9e-55
 Identities = 64/315 (20%), Positives = 120/315 (38%), Gaps = 48/315 (15%)

Query: 51  ETGHIIVTTIGGRNGQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDK 108
             G ++   +   + + ++ +     +  VG+GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQ 167
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ +++K    L +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
                    Y  Q    L Y+H +  + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 228 EPNISYICSR------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               S +          + APE++ G       +DIWS+ C++  ++ G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
             ++I      P   EI                        P    P     +   L+  
Sbjct: 264 LCLKIAS--EPPPIREI------------------------PPSCAPLTAQAIQEGLRKE 297

Query: 342 PNLRCTALDALIHPF 356
           P  R +A++      
Sbjct: 298 PVHRASAMELRRKVG 312

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  186 bits (473), Expect = 4e-54
 Identities = 74/316 (23%), Positives = 127/316 (40%), Gaps = 48/316 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L   F     +D+    LV+E     E    ++    K N+        +   Q+   
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHR-MKFNEV----DAAVIIKQVLSG 148

Query: 185 LSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY AP
Sbjct: 149 VTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++    +Y    D+WS G ++  L+ G P F G +  DQ  EI+         +++   
Sbjct: 208 EVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKGK 253

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
             +            W  +        A DL+ ++LQ+    R +A  AL HP+  E+  
Sbjct: 254 YTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

Query: 363 PNARLPSGRFLPPLFN 378
                     L     
Sbjct: 301 KKESGIELPSLANAIE 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  179 bits (455), Expect = 1e-53
 Identities = 65/297 (21%), Positives = 119/297 (40%), Gaps = 56/297 (18%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH- 189
            + ST    +  + LV E +   T+   +K F      M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT 147

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 242
           R+  + HRD+K  N+ +   T  VK+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
                ++       P    F K   PE  +++   ++ + + R +  D L H FF E
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  179 bits (456), Expect = 2e-53
 Identities = 69/313 (22%), Positives = 112/313 (35%), Gaps = 61/313 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
           +    ++GQG+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 130 KHCFFSTTDKDEL--------YLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              +    +  +          L + +EY         +       N             
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 237
           QI  ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK + +    +        
Sbjct: 124 QILEALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 238 -------------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                         Y A E++ G   Y   ID++S G +  E++   P   G       V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
            I+K L +                +FP     P    F          ++  L+ + PN 
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274

Query: 345 RCTALDALIHPFF 357
           R  A   L   + 
Sbjct: 275 RPGARTLLNSGWL 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  183 bits (467), Expect = 2e-53
 Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 49/296 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     E    ++    + ++            Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-KRFSEV----DAARIIRQVLS 137

Query: 184 ALSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              +            W K+        A DL+ ++L Y P++R +A DAL H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  177 bits (451), Expect = 4e-53
 Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 53/311 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +    ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 133 F-----------FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           +            +++      L + +E+  + T+ + ++   +  +++  +       Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           I + + YIH S  + +RD+KP N+ +   T QVK+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIH-SKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           +PE I    +Y   +D+++ G ++AEL+ +    F            ++           
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSK----FFTDLR----------- 232

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-D 358
                                I       +   L+ +LL   P  R    + L       
Sbjct: 233 -------------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

Query: 359 ELRDPNARLPS 369
           +  + N R  +
Sbjct: 274 KSPEKNERHTA 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  182 bits (465), Expect = 5e-53
 Identities = 75/316 (23%), Positives = 132/316 (41%), Gaps = 48/316 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y    ++G+GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L         +D     +V E     E    ++K   + ++            Q+F  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKR-KRFSEH----DAARIIKQVFSG 133

Query: 185 LSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY AP
Sbjct: 134 ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G   Y    D+WSAG ++  L+ G P F G +  +   +I+        + ++   
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETGK 238

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
             +            W  I       +A DL+ ++L + P+LR TA   L HP+  +   
Sbjct: 239 YAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

Query: 363 PNARLPSGRFLPPLFN 378
               +     L     
Sbjct: 286 ETPTISDLPSLESAMT 301

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  178 bits (454), Expect = 1e-52
 Identities = 74/313 (23%), Positives = 118/313 (37%), Gaps = 47/313 (15%)

Query: 54  HIIVTTIGGRNGQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQ 106
           H       G      Q++  Y+  + +G+GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 107 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKL 165
           ++    RE+  +  + HPN+V  +  F    +   LY  +V++Y     + + +      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
                   +  +  QI  AL ++H    + HRDIK QN+ +      V+L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 226 KGEPNISYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                      + YY +PE+      Y    DIW+ GCV+ EL   K  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
             I                      FP +               +   LVS+L + +P  
Sbjct: 235 LKII------------------SGSFPPV---------SLHYSYDLRSLVSQLFKRNPRD 267

Query: 345 RCTALDALIHPFF 357
           R +    L   F 
Sbjct: 268 RPSVNSILEKGFI 280

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  177 bits (450), Expect = 1e-52
 Identities = 78/302 (25%), Positives = 121/302 (40%), Gaps = 60/302 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 125
           +  E+ +G+G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+     F    + +EL +  VLE      + R++KHF K  + +P   V  Y  Q+  A
Sbjct: 94  VIKYYASFI---EDNELNI--VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYIC 235
           L ++H S  V HRDIKP N+ +      VKL D G  +           + G P      
Sbjct: 149 LEHMH-SRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPT 294
             YY +PE I     Y    DIWS GC++ E+   +  F GD   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                       +  +P +               E   LV+  +   P  R         
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 355 PF 356
             
Sbjct: 292 AK 293

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  181 bits (462), Expect = 2e-52
 Identities = 78/306 (25%), Positives = 129/306 (42%), Gaps = 59/306 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------------REL 115
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY 173
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   +++   +K ++      
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINR-HKFDEC----D 147

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNI 231
                 QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
               ++++     +          + W  I       EA +L+  +L Y  N RCTA +A
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 352 LIHPFF 357
           L   + 
Sbjct: 300 LNSRWI 305

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  175 bits (445), Expect = 4e-52
 Identities = 84/332 (25%), Positives = 130/332 (39%), Gaps = 68/332 (20%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 119
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L H +VV     F    D D ++  +VLE       +    +      + +     + Y
Sbjct: 71  SLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKRR-----KALTEPEARYY 120

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE-------- 228
             QI     Y+HR+  V HRD+K  NL +N    +VK+ DFG + KV   GE        
Sbjct: 121 LRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           PN        Y APE++     ++  +D+WS GC++  L++GKP F   S + +    IK
Sbjct: 179 PN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIK 228

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                           Y+                PK + P A  L+ ++LQ  P  R T 
Sbjct: 229 -------------KNEYS---------------IPKHINPVAASLIQKMLQTDPTARPTI 260

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFK 380
            + L   FF     P     +   +PP F+  
Sbjct: 261 NELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  177 bits (450), Expect = 9e-52
 Identities = 62/309 (20%), Positives = 115/309 (37%), Gaps = 32/309 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      TT      L  ++E+ P       + +  N     +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           +++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 243 ELIFGAT-------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK--VLGTP 293
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
           +               +      P      + +      +++ +L+              
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWG-----F 297

Query: 354 HPFFDELRD 362
             FF E  D
Sbjct: 298 DQFFAETSD 306

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  173 bits (441), Expect = 1e-51
 Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 66/297 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D   +YL  +LEY P       + K       +        Y  ++  ALSY
Sbjct: 75  YGYFH---DATRVYL--ILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 240
            H S  V HRDIKP+NLL+      +K+ DFG +            G  +        Y 
Sbjct: 125 CH-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE+I G   +   +D+WS G +  E ++GKP F  ++  +    I +V           
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                 EF FP      +       +   A DL+SRLL+++P+ R    + L HP+ 
Sbjct: 223 ------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  174 bits (443), Expect = 3e-51
 Identities = 83/332 (25%), Positives = 128/332 (38%), Gaps = 68/332 (20%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 119
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L H +VV     F    D D ++  +VLE       +    +      + +     + Y
Sbjct: 97  SLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKRR-----KALTEPEARYY 146

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE-------- 228
             QI     Y+HR+  V HRD+K  NL +N    +VK+ DFG + KV   GE        
Sbjct: 147 LRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGT 204

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           PN        Y APE++     ++  +D+WS GC++  L++GKP F        L E   
Sbjct: 205 PN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYL 251

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     +     Y+                PK + P A  L+ ++LQ  P  R T 
Sbjct: 252 ----------RIKKNEYS---------------IPKHINPVAASLIQKMLQTDPTARPTI 286

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFK 380
            + L   FF     P     +   +PP F+  
Sbjct: 287 NELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  172 bits (438), Expect = 4e-51
 Identities = 74/321 (23%), Positives = 137/321 (42%), Gaps = 68/321 (21%)

Query: 65  GQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQ 116
               + I  +    ++G+GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYV 174
               L HP+++ L + F    D + +Y  LVLE     E    +       ++       
Sbjct: 64  IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE----- 228
           + + +QI   + Y+H S G+ HRD+   NLL+  +   +K+ DFG + ++ +  E     
Sbjct: 115 RHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTL 172

Query: 229 ---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
              PN        Y +PE+    + +    D+WS GC+   L++G+P F  D+  + L +
Sbjct: 173 CGTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           ++                   +++ P      +       +  EA DL+ +LL+ +P  R
Sbjct: 224 VVLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADR 254

Query: 346 CTALDALIHPFFDELRDPNAR 366
            +    L HPF        ++
Sbjct: 255 LSLSSVLDHPFMSRNSSTKSK 275

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  175 bits (445), Expect = 4e-51
 Identities = 81/338 (23%), Positives = 133/338 (39%), Gaps = 46/338 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L   F    DK E+ L  +LE++   E   R+     K+++   + Y++    Q    L 
Sbjct: 113 LHDAF---EDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 187 YIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           ++H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE I
Sbjct: 164 HMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                     D+W+ G V+  ++L G   F G+  ++ L  + +                
Sbjct: 222 VDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGEDDLETLQNVKRC--------------- 265

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-DELRDP 363
             +++F       +  +      PEA D +  LLQ  P  R T  DAL HP+   +  + 
Sbjct: 266 --DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315

Query: 364 NARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            +R+PS R+       K         +  +  I   + 
Sbjct: 316 TSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSS 353

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  172 bits (437), Expect = 8e-51
 Identities = 67/325 (20%), Positives = 123/325 (37%), Gaps = 60/325 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 127
           +   + +G+G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 128 SLKHCFF-------STTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              + +              ++YL + ++    E +   +       +            
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFL 125

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 237
           QI  A+ ++H S G+ HRD+KP N+        VK+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 238 -----------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
                       Y +PE I G   Y+  +DI+S G ++ EL+   P F       + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           ++                    KFP +           +  P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272

Query: 347 TALDALIHPFFDELRDPNARLPSGR 371
            A++ + +  F++L  P   +   R
Sbjct: 273 EAINIIENAVFEDLDFPGKTVLRQR 297

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  171 bits (435), Expect = 1e-50
 Identities = 85/305 (27%), Positives = 134/305 (43%), Gaps = 48/305 (15%)

Query: 65  GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM 118
           G  K  I+  Y  E  +G+GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL 176
           + LDHPN++ L   F     +D   + LV+E     E   RVV       +      +K 
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMK- 113

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYI 234
               +  A++Y H  + V HRD+KP+N L    +    +KL DFG A     G+   + +
Sbjct: 114 ---DVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            + YY +P+++ G   Y    D WSAG ++  L+ G P F   +  + +++I +      
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG----- 222

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                        F FP      W  +      P+A  L+ RLL  SP  R T+L AL H
Sbjct: 223 ------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEH 262

Query: 355 PFFDE 359
            +F++
Sbjct: 263 EWFEK 267

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  179 bits (456), Expect = 1e-50
 Identities = 79/336 (23%), Positives = 131/336 (38%), Gaps = 21/336 (6%)

Query: 61  GGRNGQPKQTI--SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----R 113
           GGR+          +  +  +G G FG V +    +TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEYVP--ETVHRVVKHFNKLNQRMP 170
           E+Q M+ L+HPNVVS +             L  L +EY    +    + +  N     + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLK 119

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 228
              ++     I  AL Y+H +  + HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F  +    Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                + E I   +      KF  +   P H         +    +  +L +    R T 
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTD 292

Query: 349 LDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHEL 384
                   F  L    +               ++ +
Sbjct: 293 PQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPV 328

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  172 bits (439), Expect = 1e-50
 Identities = 66/328 (20%), Positives = 126/328 (38%), Gaps = 52/328 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN----------------REL 115
           R + QG F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHF---NKLNQRMP 170
           Q +  + +   ++ +      T+ DE+Y+  + EY+     +      F         +P
Sbjct: 95  QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 230
           +  +K     +  + SYIH    +CHRD+KP N+L++ +   VKL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 231 ISYIC-SRYYRAPELIFGATEY-TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           I     +  +  PE     + Y    +DIWS G  +  +      F     + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  + I+   P      F     +         +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 349 LDALIHPFF-----DELRDPNARLPSGR 371
            DAL H +      ++LR+ +  L   R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  174 bits (443), Expect = 2e-50
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 56/306 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRL 120
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYA 178
           L+HP ++ +K+ F    D ++ Y+  VLE +   E   +VV +  +L +       KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGN-KRLKEAT----CKLYF 245

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC- 235
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 236 SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  Y APE++       Y  A+D WS G ++   + G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                        ++ F       W ++       +A+DLV +LL   P  R T  +AL 
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 354 HPFFDE 359
           HP+  +
Sbjct: 400 HPWLQD 405

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  177 bits (451), Expect = 2e-50
 Identities = 83/390 (21%), Positives = 151/390 (38%), Gaps = 49/390 (12%)

Query: 8   PTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQP 67
           PT+ V               +     +R    + +   +             +  ++   
Sbjct: 96  PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155

Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDH 123
                Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L H
Sbjct: 156 LDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           P +V+L   F    D +E+ +  + E++   E   +V    NK+++   + Y++    Q+
Sbjct: 214 PTLVNLHDAF---EDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QV 264

Query: 182 FRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
            + L ++H      H D+KP+N++     ++++KL DFG    L   +       +  + 
Sbjct: 265 CKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 323

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           APE+  G        D+WS G V++ ++L G   F G++  +            T   +K
Sbjct: 324 APEVAEG-KPVGYYTDMWSVG-VLSYILLSGLSPFGGENDDE------------TLRNVK 369

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-- 357
             + N  +  F  I               +  D + +LL   PN R T   AL HP+   
Sbjct: 370 SCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416

Query: 358 DELRDPNARLPSGRFLPPLFNFKSHELKSV 387
                 ++++PS R+     + K+      
Sbjct: 417 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 446

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  172 bits (437), Expect = 2e-50
 Identities = 87/348 (25%), Positives = 139/348 (39%), Gaps = 84/348 (24%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL---------QDKRYKNRELQTMRLLDH 123
           Y  +  +GQGS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL----- 176
           PN+  L   +     +DE Y+ LV+E       + ++    +    +  M  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 177 ------------------------------YAYQIFRALSYIHRSIGVCHRDIKPQN-LL 205
                                            QIF AL Y+H + G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQGICHRDIKPENFLF 201

Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDIWS 259
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 260 AGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 319
           AG ++  L++G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 320 KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL 367
            +      P A DL+S LL  + + R  A+ AL HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  170 bits (433), Expect = 5e-50
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 129
           YM    +G+G FG+V +     + +T     +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F      +EL +  + E++   +   R+     +LN+R  + YV     Q+  AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 188 IHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           +H S  + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                 +TA D+WS G  +  ++L G   F  ++  +Q  +II        E I      
Sbjct: 175 HQHDVVSTATDMWSLG-TLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYT 221

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
           + E  F +I               EA+D V RLL      R TA +AL HP
Sbjct: 222 FDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  168 bits (429), Expect = 9e-50
 Identities = 75/297 (25%), Positives = 124/297 (41%), Gaps = 66/297 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D+  +YL  +LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFH---DRKRIYL--MLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 240
            H    V HRDIKP+NLL+      +K+ DFG +            G  +        Y 
Sbjct: 130 CH-ERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE+I G   +   +D+W AG +  E ++G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                 + KFP     P+       +   + DL+S+LL+Y P  R      + HP+ 
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  168 bits (427), Expect = 2e-49
 Identities = 78/317 (24%), Positives = 133/317 (41%), Gaps = 46/317 (14%)

Query: 54  HIIVTTIGGRNGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQ 106
           H    + G  N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 107 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNK 164
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R+V    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK 222
             + +   YV     Q+  AL+Y H S  V H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
           +    E + +   +  Y APE+     + T   DIWSAG V+  L+ G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
             +                     E  +               + P+AVDL+ ++L   P
Sbjct: 234 QQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLTKDP 267

Query: 343 NLRCTALDALIHPFFDE 359
             R +A   L H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  168 bits (428), Expect = 3e-49
 Identities = 84/345 (24%), Positives = 148/345 (42%), Gaps = 60/345 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN--------RELQTMRL 120
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYA 178
           L+HP ++ +K+ F    D ++ Y+  VLE +   E   +VV +  +L +       KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGN-KRLKEA----TCKLYF 120

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC- 235
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 236 SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  Y APE++       Y  A+D WS G ++   + G P F        L + I   G  
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 235

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                        ++ F       W ++       +A+DLV +LL   P  R T  +AL 
Sbjct: 236 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 274

Query: 354 HPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPE 398
           HP+  +  D   +      L    N  +   + +      +  P 
Sbjct: 275 HPWLQD-EDMKRKFQD---LLSEENESTALPQVLAQPSTSRKRPR 315

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  167 bits (426), Expect = 3e-49
 Identities = 54/327 (16%), Positives = 98/327 (29%), Gaps = 90/327 (27%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHPN 125
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           VV     +    + D + +    EY    ++   +    ++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPH------------------THQVKLCDFGSAKVL-- 224
           L YIH S+ + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 225 ---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               +G+          + A E++     +    DI++    V      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---- 234

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP-------EAVDLV 334
                                               WH+I   R+P        E  +L+
Sbjct: 235 ----------------------------------DQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 335 SRLLQYSPNLRCTALDALIHPFFDELR 361
             ++   P  R +A+  + H       
Sbjct: 261 KVMIHPDPERRPSAMALVKHSVLLSAS 287

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  167 bits (425), Expect = 3e-49
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 48/297 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y    ++G+GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L         +D     +V E     E    ++K   + ++      +K    Q+F  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSG 133

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY AP
Sbjct: 134 ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G   Y    D+WSAG ++  L+ G P F G +  D L  +                
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-------------- 236

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
               ++ F       W  I       +A DL+ ++L + P+LR TA   L HP+  +
Sbjct: 237 ---GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  167 bits (425), Expect = 6e-49
 Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 48/307 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 128
           ++   ++G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L+  +         Y  LV++ V   E   R+++      ++   + ++    Q+  A+ 
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILER-GVYTEKDASLVIQ----QVLSAVK 120

Query: 187 YIHRSIGVCHRDIKPQNLLV-NPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y APE
Sbjct: 121 YLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            +     Y+ A+D WS G +   L+ G P F  ++      +I +               
Sbjct: 178 -VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------- 222

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               ++F    +  W  I        A D +  LL+  PN R T   AL HP+ D     
Sbjct: 223 ---YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271

Query: 364 NARLPSG 370
           +  +   
Sbjct: 272 HRDIYPS 278

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  166 bits (422), Expect = 7e-49
 Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 56/311 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPN+++L   F    +K ++ L  +LE V   E    + +    L +     ++K    Q
Sbjct: 67  HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEK-ESLTEDEATQFLK----Q 116

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   + Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G      I  +
Sbjct: 117 ILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGT 174

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F G++  + L  I  V      
Sbjct: 175 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGETKQETLTNISAV------ 226

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                       + F       +           A D + RLL   P  R T   +L H 
Sbjct: 227 -----------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEHS 267

Query: 356 FFDELRDPNAR 366
           +   +R  N R
Sbjct: 268 WIKAIRRRNVR 278

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  167 bits (426), Expect = 2e-48
 Identities = 80/334 (23%), Positives = 142/334 (42%), Gaps = 46/334 (13%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNREL 115
           +  + G      +     I+G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY 173
             M  LDH N++ L   F     K+++ L  V+EYV   E   R++     L +   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           +K    QI   + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
              +  + APE +      +   D+WS G V+A ++L G   F GD+  + L  I+    
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVG-VIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA 351
                           +         +  I       EA + +S+LL    + R +A +A
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 352 LIHPFFDELRDPNARLPSGRFLPPLFNFKSHELK 385
           L HP+  +    ++RL + +      + +    K
Sbjct: 341 LKHPWLSD-HKLHSRLSAQKKKNRGSDAQDFVTK 373

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  165 bits (420), Expect = 5e-48
 Identities = 73/327 (22%), Positives = 125/327 (38%), Gaps = 57/327 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           H NV++L   +    ++ ++ L  +LE V   E    + +    L++     ++K    Q
Sbjct: 74  HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQK-ESLSEEEATSFIK----Q 123

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   ++Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G      I  +
Sbjct: 124 ILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  I  V      
Sbjct: 182 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                       + F       +           A D + +LL      R T  +AL HP
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 356 FFDELRDPNARLPSGRFLPPLFNFKSH 382
           +     D    +     +  L NF+  
Sbjct: 275 WITP-VDNQQAMVRRESVVNLENFRKQ 300

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (419), Expect = 7e-48
 Identities = 76/331 (22%), Positives = 128/331 (38%), Gaps = 57/331 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPNV++L   +    +K ++ L  +LE V   E    + +    L +     ++K    Q
Sbjct: 73  HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEK-ESLTEEEATEFLK----Q 122

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   + Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  +  V      
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANVSAV------ 232

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                       ++F       +           A D + RLL   P  R T  D+L HP
Sbjct: 233 -----------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

Query: 356 FFDELRDPNARLPSGRFLPPLFNFKSHELKS 386
           +    +D    L        +  FK    + 
Sbjct: 274 WIKP-KDTQQALSRKASAVNMEKFKKFAARK 303

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  165 bits (419), Expect = 1e-47
 Identities = 80/325 (24%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 123
           Y    ++G+G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLY 177
           P++V L   +       +  L +V E++   +    +VK           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC 235
             QI  AL Y H    + HRD+KP   LL +   +  VKL  FG A  L +         
Sbjct: 136 MRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 236 -SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            + ++ APE +     Y   +D+W  G ++  L+ G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                       ++K        W  I        A DLV R+L   P  R T  +AL H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 355 PFFDELRDPNARLPSGRFLPPLFNF 379
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (418), Expect = 2e-47
 Identities = 74/331 (22%), Positives = 129/331 (38%), Gaps = 57/331 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPN+++L   +    ++ ++ L  +LE V   E    + +    L++     ++K    Q
Sbjct: 74  HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQK-ESLSEEEATSFIK----Q 123

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   ++Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G      I  +
Sbjct: 124 ILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  I  V      
Sbjct: 182 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANITAV------ 233

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                       + F       + +         A D + +LL      R T  +AL HP
Sbjct: 234 -----------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 356 FFDELRDPNARLPSGRFLPPLFNFKSHELKS 386
           +     D    +     +  L NFK   ++ 
Sbjct: 275 WITP-VDTQQAMVRRESVVNLENFKKQYVRR 304

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  166 bits (422), Expect = 3e-47
 Identities = 75/318 (23%), Positives = 129/318 (40%), Gaps = 48/318 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L       +++   YL  + + V   E    +V      ++      ++    QI  A
Sbjct: 73  VRLHDSI---SEEGHHYL--IFDLVTGGELFEDIVAR-EYYSEADASHCIQ----QILEA 122

Query: 185 LSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           + + H  +GV HR++KP+NLL  +      VKL DFG A  +   +        +  Y +
Sbjct: 123 VLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y   +D+W+ G ++  L++G P F  +       +I               
Sbjct: 182 PE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------- 227

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
                 + FP   +  W  +      PEA DL++++L  +P+ R TA +AL HP+     
Sbjct: 228 ----GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275

Query: 362 DPNARLPSGRFLPPLFNF 379
              + +     +  L  F
Sbjct: 276 TVASCMHRQETVDCLKKF 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  164 bits (417), Expect = 4e-47
 Identities = 76/317 (23%), Positives = 125/317 (39%), Gaps = 47/317 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y  +  +G+G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L        ++   YL  V + V   E    +V      ++      ++    QI  +
Sbjct: 91  VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAR-EFYSEADASHCIQ----QILES 140

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +P
Sbjct: 141 IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E +     Y+  +DIW+ G ++  L++G P F  +       +I                
Sbjct: 200 E-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------- 245

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
                + +P   +  W  +      PEA  L+  +L  +P  R TA  AL  P+      
Sbjct: 246 ----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293

Query: 363 PNARLPSGRFLPPLFNF 379
             + +     +  L  F
Sbjct: 294 VASAIHRQDTVDCLKKF 310

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  161 bits (410), Expect = 5e-47
 Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 49/296 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y  +  +G+G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L        ++   YL  V + V   E    +V      ++      ++    QI  +
Sbjct: 68  VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAR-EFYSEADASHCIQ----QILES 117

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           ++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E        +  Y +
Sbjct: 118 IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLS 175

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y+  +DIW+ G ++  L++G P F  +       +I               
Sbjct: 176 PE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 222

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                 + +P   +  W  +      PEA  L+  +L  +P  R TA  AL  P+ 
Sbjct: 223 -----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  163 bits (414), Expect = 5e-47
 Identities = 72/343 (20%), Positives = 127/343 (37%), Gaps = 62/343 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 127
               R++ +G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 128 SLKHCFF-----STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
                       S T + E    L+ E     +   +K   +    +    V    YQ  
Sbjct: 90  QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146

Query: 183 RALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------------E 228
           RA+ ++H +   + HRD+K +NLL++     +KLCDFGSA  +                E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 229 PNISYICSRYYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
             I+   +  YR PE+I  +         DIW+ GC++  L   +  F   +     + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           +                   ++  P                     L+  +LQ +P  R 
Sbjct: 262 VNG-----------------KYSIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 347 TALDALIHPF-FDELRDPNARLPSGRFLPPLFNFKSHELKSVP 388
           +  + +         R+ N + P    L     + S  L   P
Sbjct: 295 SIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  162 bits (412), Expect = 9e-47
 Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 49/296 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +      D  Y+ +V E +   E + ++++   F++      +       + I + + Y
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-------FTITKTVEY 131

Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           +H + GV HRD+KP N+L    + +   +++CDFG AK L      +   C +  + APE
Sbjct: 132 LH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVL-GTPTREEIKCM 301
            +     Y  A DIWS G V+   ML G   F           + ++  G          
Sbjct: 191 -VLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSG---------- 238

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                +F         W+ +        A DLVS++L   P+ R TA   L HP+ 
Sbjct: 239 -----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  162 bits (412), Expect = 1e-46
 Identities = 83/301 (27%), Positives = 132/301 (43%), Gaps = 46/301 (15%)

Query: 64  NGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMR 119
           +G  +  +S  +  E  +G+G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L HPN++ LK  F       E+ L  VLE V   E   R+V+     ++R     VK  
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEK-GYYSERDAADAVK-- 155

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  A++Y+H   G+ HRD+KP+NLL   P     +K+ DFG +K++      +  +C
Sbjct: 156 --QILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC 211

Query: 236 -SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            +  Y APE I     Y   +D+WS G +   L+ G   F  + G   +   I       
Sbjct: 212 GTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------ 264

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                C      E+ F    +  W ++        A DLV +L+   P  R T   AL H
Sbjct: 265 ----NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQH 306

Query: 355 P 355
           P
Sbjct: 307 P 307

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  161 bits (409), Expect = 2e-46
 Identities = 72/309 (23%), Positives = 128/309 (41%), Gaps = 41/309 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTD 138
           G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +    
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VYENMH 95

Query: 139 KDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
             +  L +++E +   E   R+  +      +R     ++     I  A+ ++H S  + 
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR----DIGTAIQFLH-SHNIA 150

Query: 196 HRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYT 252
           HRD+KP+NLL  +      +KL DFG AK   +    +   C + YY APE + G  +Y 
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKYD 207

Query: 253 TAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
            + D+WS G V+  ++L G P F  ++G      + +         I+       ++ FP
Sbjct: 208 KSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QYGFP 253

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-DELRDPNARLPSG 370
                 W ++       +A  L+  LL+  P  R T    + HP+    +  P   L + 
Sbjct: 254 ---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305

Query: 371 RFLPPLFNF 379
           R L    + 
Sbjct: 306 RVLQEDKDH 314

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  162 bits (413), Expect = 2e-46
 Identities = 79/324 (24%), Positives = 134/324 (41%), Gaps = 45/324 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
            +  +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFRAL 185
             +         L +V+E +   E        F+++  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 186 SYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            Y+H SI + HRD+KP+NLL  +   +  +KL DFG AK         +   + YY APE
Sbjct: 175 QYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            + G  +Y  + D+WS G V+  ++L G P F  + G+     +           I+   
Sbjct: 234 -VLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 280

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
               +++FP      W ++       E   L+  LL+  P  R T  + + HP+  +   
Sbjct: 281 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

Query: 363 -PNARLPSGRFLPPLFNFKSHELK 385
            P   L + R L      +  ++K
Sbjct: 331 VPQTPLHTSRVL-KEDKERWEDVK 353

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  160 bits (406), Expect = 5e-46
 Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 52/309 (16%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 126
           +  + +G+G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFR 183
           ++L   +    +  E+ L  +LEY    E     + +    +++   +  +K    QI  
Sbjct: 92  INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSENDVIRLIK----QILE 142

Query: 184 ALSYIHRSIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 240
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           APE I      TTA D+W+ G ++A ++L     F G+   +  + I +V          
Sbjct: 201 APE-ILNYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
                     +       +  +        A D +  LL  +P  R TA   L H +  +
Sbjct: 249 -------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

Query: 360 LRDPNARLP 368
               N   P
Sbjct: 294 WDFENLFHP 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  159 bits (405), Expect = 7e-46
 Identities = 71/310 (22%), Positives = 137/310 (44%), Gaps = 40/310 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 130
            + ++ +G+GSF +  +    ++ +  A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F      D+L+  LV+E +   E   R+ K     ++      ++    ++  A+S++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMR----KLVSAVSHM 122

Query: 189 HRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           H  +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE +
Sbjct: 123 H-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-L 180

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y  + D+WS G V+   ML G+  F            ++++     ++IK     
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG--- 231

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD-P 363
             +F F       W  +       EA DL+  LL   PN R        + +  +     
Sbjct: 232 --DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281

Query: 364 NARLPSGRFL 373
           +  L +   L
Sbjct: 282 SNPLMTPDIL 291

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  160 bits (405), Expect = 2e-45
 Identities = 61/366 (16%), Positives = 115/366 (31%), Gaps = 93/366 (25%)

Query: 56  IVTTIGGRNGQPKQTISYMAE--------RIVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           +V+T     GQP +  S + E         ++GQ       +A   ETGE+  +      
Sbjct: 50  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 109

Query: 108 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 135
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
                  +L   ++   +T   V+   +  ++ +          Q+ R L+ +H   G+ 
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLV 228

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---------- 245
           H  ++P +++++     V L  F      V+    +    SR +  PEL           
Sbjct: 229 HTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHR 284

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
              T  T + D W+ G V+  +         D+ +                         
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------------------------ 320

Query: 306 TEFKFPQIKAHPWHKIF--PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                          IF   K +P     L+   L+Y    R   L A+  P +++LR  
Sbjct: 321 -----------GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369

Query: 364 -NARLP 368
            +A LP
Sbjct: 370 LSAALP 375

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  157 bits (398), Expect = 4e-45
 Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 60/309 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK------------KVLQDKRYK-NRELQTMR 119
           Y  + I+G+G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 120 LLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL 176
            +  HPN++ LK  +     +   +  LV + +   E    + +    L+++      + 
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEK----ETRK 128

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC- 235
               +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C 
Sbjct: 129 IMRALLEVICALH-KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVCG 185

Query: 236 SRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
           +  Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I+   
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 244

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
                            ++F    +  W             DLVSR L   P  R TA +
Sbjct: 245 ----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAEE 280

Query: 351 ALIHPFFDE 359
           AL HPFF +
Sbjct: 281 ALAHPFFQQ 289

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (394), Expect = 6e-44
 Identities = 67/311 (21%), Positives = 121/311 (38%), Gaps = 31/311 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +   ++        RELQ +   + P +V     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +S  +     +++ +E++       +    K   R+P   +   +  + + L+Y+     
Sbjct: 101 YSDGE-----ISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G   Y+ 
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH-YSV 209

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
             DIWS G  + E+ +G+   P     +  +     +     E                +
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 314 KAHPWHKIF---------------PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD 358
            + P   IF                     E  D V++ L  +P  R      ++H F  
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329

Query: 359 ELRDPNARLPS 369
                      
Sbjct: 330 RSDAEEVDFAG 340

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  153 bits (389), Expect = 1e-43
 Identities = 83/325 (25%), Positives = 134/325 (41%), Gaps = 55/325 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 130
           E ++G+G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALS 186
             F     ++E    LV E +     +  + K  HFN+L   + +         +  AL 
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-------QDVASALD 125

Query: 187 YIHRSIGVCHRDIKPQNLL-VNP-HTHQVKLCDFGSAKVLVKGE-------PNISYIC-S 236
           ++H + G+ HRD+KP+N+L  +P     VK+CDF     +           P +   C S
Sbjct: 126 FLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
             Y APE++      A+ Y    D+WS G V+  ++L G P F G  G D   +  +   
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 292 TPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  E I+       +++FP      W  I        A DL+S+LL      R +A
Sbjct: 244 ACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSA 290

Query: 349 LDALIHPFFDELRDPNARLPSGRFL 373
              L HP+      P   LP+   L
Sbjct: 291 AQVLQHPWVQG-CAPENTLPTPMVL 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  154 bits (390), Expect = 3e-43
 Identities = 74/307 (24%), Positives = 135/307 (43%), Gaps = 61/307 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----------KVLQDKRYK-NRELQTMRL 120
           Y  + ++G+G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 121 L-DHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
           +  HP++++L   +        ++L  V + +   E    + +    L+++      +  
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMFL--VFDLMRKGELFDYLTEK-VALSEK----ETRSI 205

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              +  A+S++H +  + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C +
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCGT 262

Query: 237 RYYRAPELIFGATE-----YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVL 290
             Y APE++  + +     Y   +D+W+ G V+   +L G P F     +  L  I++  
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
                           +++F    +  W             DL+SRLLQ  P  R TA  
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQ 356

Query: 351 ALIHPFF 357
           AL HPFF
Sbjct: 357 ALQHPFF 363

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  155 bits (392), Expect = 3e-43
 Identities = 56/355 (15%), Positives = 107/355 (30%), Gaps = 85/355 (23%)

Query: 56  IVTTIGGRNGQPKQTISYMAER--------IVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           +V+T     GQP +  S + ER        ++GQ       +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 108 KRYKNRELQTMR-----------------------------LLDHPNVVSLKHCFFSTTD 138
           +R  +  ++ M+                             L+  P    +        D
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 139 KDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
              L    +   +    +T   V+   +  ++ +          Q+ R L+ +H   G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLV 233

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 248
           H  ++P +++++     V L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 249 -TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            T  T A D W+ G  +  +         D+ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
                     W     K +P     L+   L+Y    R   L A+  P +++LR 
Sbjct: 327 ---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  151 bits (384), Expect = 4e-43
 Identities = 76/320 (23%), Positives = 125/320 (39%), Gaps = 62/320 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN---RELQTMRLLDHP 124
           Y+   ++G+GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           NV+ L    ++   +  +Y  +V+EY      E +  V +       R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SR 237
           +   L Y+H S G+ H+DIKP NLL+      +K+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLH-SQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 238 YYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            ++ PE+  G   ++   +DIWSAG  +  +  G   F GD+        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
            I         +  P                P   DL+  +L+Y P  R +      H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 357 FDELRDPNARLPSGRFLPPL 376
           F        + P      P+
Sbjct: 267 F------RKKHPPAEAPVPI 280

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  151 bits (384), Expect = 6e-43
 Identities = 81/308 (26%), Positives = 123/308 (39%), Gaps = 72/308 (23%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D ++LY    L Y    E +     +  K          + Y  +I  AL Y
Sbjct: 96  YFTF---QDDEKLY--FGLSYAKNGELLK----YIRK-IGSFDETCTRFYTAEIVSALEY 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------YICSRY 238
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             +PEL+        + D+W+ GC++ +L+ G P F                        
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAG--------------------- 235

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP------NLRCTALDAL 352
              N       F +I    +   FP++  P+A DLV +LL                    
Sbjct: 236 ---NEYLI---FQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 353 IHPFFDEL 360
            HPFF+ +
Sbjct: 288 AHPFFESV 295

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  151 bits (383), Expect = 2e-42
 Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K    + T    L   +++EY    E   R+         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           SY H S+ +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 245 IFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +    EY     D+WS G  +  +++G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
              ++  P             R+ PE   L+SR+    P  R +  +   H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  147 bits (374), Expect = 1e-41
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 41/288 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---AT 249
            V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+   DIWS G  + EL + +  +       Q ++ + V                    
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS---------------- 231

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            PQ+ A  +          E VD  S+ L+ +   R T  + + HPFF
Sbjct: 232 -PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  146 bits (372), Expect = 1e-41
 Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
                          Y  L LEY    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 242
            Y+H  IG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 243 ELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           EL+    E+    +D+WS G V+  ++ G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                          PW K     +    + L+ ++L  +P+ R T  D     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  147 bits (372), Expect = 3e-41
 Identities = 73/324 (22%), Positives = 125/324 (38%), Gaps = 66/324 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
            +  +++G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFRAL 185
             +         L +V+E +   E        F+++  R    +           I  A+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 186 SYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            Y+H SI + HRD+KP+NLL  +   +  +KL DFG AK                     
Sbjct: 131 QYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE---------------- 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
                 +Y  + D+WS G V+  ++L G P F  + G+     +           I+   
Sbjct: 174 ------KYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 215

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
               +++FP      W ++       E   L+  LL+  P  R T  + + HP+  +   
Sbjct: 216 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265

Query: 363 -PNARLPSGRFLPPLFNFKSHELK 385
            P   L + R L      +  ++K
Sbjct: 266 VPQTPLHTSRVL-KEDKERWEDVK 288

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  147 bits (372), Expect = 3e-41
 Identities = 69/320 (21%), Positives = 121/320 (37%), Gaps = 73/320 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--------------- 112
           Y  +  +G+GS+GVV  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 113 ----------RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVK 160
                     +E+  ++ LDHPNVV L        ++D LY+  V E V     V  V  
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGP-VMEVPT 130

Query: 161 HFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220
                 + +     + Y   + + + Y+H    + HRDIKP NLLV      +K+ DFG 
Sbjct: 131 L-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG-EDGHIKIADFGV 183

Query: 221 AKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDIWSAGCVVAELMLGKPLFPGD 277
           +      +  +S    +  + APE +      ++  A+D+W+ G  +   + G+  F  +
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             +  L   IK                    +FP     P        +  +  DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD---QPD-------IAEDLKDLITRM 276

Query: 338 LQYSPNLRCTALDALIHPFF 357
           L  +P  R    +  +HP+ 
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  147 bits (373), Expect = 3e-41
 Identities = 70/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
                          Y  L LEY    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 242
            Y+H  IG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 243 ELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           EL+    E+    +D+WS G V+  ++ G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                          PW K     +    + L+ ++L  +P+ R T  D     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  146 bits (371), Expect = 7e-41
 Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 57/309 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           N+V L     +        L L++EY    E    +V H      RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            A+ Y H+   + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 242 PELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           PEL  G  +Y    +D+WS G ++  L+ G   F G + + +L E +             
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
               Y                 P  M  +  +L+ R L  +P  R T    +   + +  
Sbjct: 228 -RGKYR---------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

Query: 361 RDPNARLPS 369
            + +   P 
Sbjct: 272 HEEDELKPF 280

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  147 bits (372), Expect = 2e-40
 Identities = 71/298 (23%), Positives = 135/298 (45%), Gaps = 54/298 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           R +G+GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D+++++  +V++ +   +  +    H  + N       VKL+  ++  AL Y
Sbjct: 81  WYSF---QDEEDMF--MVVDLLLGGDLRY----HLQQ-NVHFKEETVKLFICELVMALDY 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 246
           +  +  + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQ-NQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 247 -GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--VDQLVEIIKVLGTPTREEIKCMNP 303
                Y+ A+D WS G    EL+ G+  +   S     ++V   +         +     
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE------TTVVT---- 238

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI-HPFFDEL 360
                             +P     E V L+ +LL+ +P+ R + L  +   P+ +++
Sbjct: 239 ------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  145 bits (367), Expect = 2e-40
 Identities = 62/314 (19%), Positives = 111/314 (35%), Gaps = 66/314 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 122
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 123 H--PNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLY 177
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
            +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 237 RYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           R Y  PE I     Y   +  +WS G ++ +++ G   F  D                  
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------- 253

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                           +I        F +R+  E   L+   L   P+ R T  +   HP
Sbjct: 254 ----------------EIIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 356 FFDELRDPNARLPS 369
           +  ++  P      
Sbjct: 296 WMQDVLLPQETAEI 309

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  143 bits (363), Expect = 3e-40
 Identities = 80/307 (26%), Positives = 130/307 (42%), Gaps = 52/307 (16%)

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------R 113
           G ++    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPM 171
           E+Q ++L  HP+++ L     + TD    +  +V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICKH-----GRVEE 110

Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           +  +    QI  A+ Y HR   V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 232 SYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
              C S  Y APE+I G       +DIWS G ++  L+ G   F  +         +  L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL 219

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
                ++I+        F  P      +       +      L+  +LQ  P  R T  D
Sbjct: 220 ----FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258

Query: 351 ALIHPFF 357
              H +F
Sbjct: 259 IREHEWF 265

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  145 bits (368), Expect = 3e-40
 Identities = 39/315 (12%), Positives = 94/315 (29%), Gaps = 64/315 (20%)

Query: 72  SYMAERIVGQGSFGVVFQAKC-----LETGETVAIK----KVLQDKRYKNRELQTMRLLD 122
                 ++G+G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
               +           ++   L  V E       ++ +  + N   + MP   V  +A +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ----------VKLCDFGSA---KVLVKG 227
           +   +  +H    + H DIKP N ++     +          + L D G +   K+  KG
Sbjct: 181 MLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               +   +  ++  E++     +   ID +     V  ++ G  +   + G        
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290

Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                    + + +                W++ F              +L         
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFF------------HVMLNIPDCHHLP 325

Query: 348 ALDALIHPFFDELRD 362
           +LD L        + 
Sbjct: 326 SLDLLRQKLKKVFQQ 340

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  142 bits (360), Expect = 2e-39
 Identities = 68/301 (22%), Positives = 124/301 (41%), Gaps = 39/301 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKHC 132
           +G+G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   D       + +E +  +  +  K+ ++ L+  +P   +        +AL+++  +
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
           + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 251 --YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WS G  + EL  G+  +P  + V   +  + V G P               
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP--------------- 247

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP 368
             PQ+          +   P  ++ V+  L    + R    + L HPF     +    + 
Sbjct: 248 --PQLSNSE-----EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVA 300

Query: 369 S 369
            
Sbjct: 301 C 301

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  142 bits (359), Expect = 3e-39
 Identities = 72/323 (22%), Positives = 117/323 (36%), Gaps = 68/323 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 122
           Y    ++G+G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 123 ----HPNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVK 175
               HP V+ L   +F T  ++   L  VLE      +    + +        +     +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK-----GPLGEGPSR 142

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            +  Q+  A+ + H   GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 236 -SRYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
            +R Y  PE I    +Y      +WS G ++ +++ G   F  D                
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ--------------- 243

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                             +I     H  FP  + P+   L+ R L   P+ R +  + L+
Sbjct: 244 ------------------EILEAELH--FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 354 HPFFDELRDPNARLPSGRFLPPL 376
            P+     +     PS     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  148 bits (374), Expect = 3e-39
 Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 58/302 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 125
           RI+G+G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +V + + F      D+L    +L+ +   +  + + +H            ++ YA +I  
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L ++H +  V +RD+KP N+L++ H H V++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y ++ D +S GC++ +L+ G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFFD 358
                              P    PE   L+  LLQ   N R  C    A      PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 359 EL 360
            L
Sbjct: 455 SL 456

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  140 bits (356), Expect = 9e-39
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 46/302 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKHC 132
           +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V     
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F + TD     + + +E +     ++ K   ++   +P   +      I +AL Y+    
Sbjct: 93  FITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FGA 248
           GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I       
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCMNPNYTE 307
            +Y    D+WS G  + EL  G+  +       + L ++++    P              
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP-------------- 247

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL 367
              P +               +    V   L      R      L H F          +
Sbjct: 248 ---PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDV 297

Query: 368 PS 369
            S
Sbjct: 298 AS 299

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  140 bits (356), Expect = 1e-38
 Identities = 82/332 (24%), Positives = 142/332 (42%), Gaps = 59/332 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 125
           Y+    +G+GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L     + TD   +   +V+EY   E    +V+      +RM     + +  QI  A
Sbjct: 71  IIKLYDVITTPTD---IV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           + Y HR   + HRD+KP+NLL++ +   VK+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHRH-KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I G       +D+WS G V+  +++G+  F  +  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
               +  P      +       + P A  L+ R++   P  R T  +    P+F      
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF------ 262

Query: 364 NARLPSGRFLPPLFNFKSHELKSVPVEILVKL 395
           N  LP   +L P+   +     S  V  L + 
Sbjct: 263 NVNLP--DYLRPMEEVQGSYADSRIVSKLGEA 292

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  142 bits (360), Expect = 2e-38
 Identities = 82/362 (22%), Positives = 140/362 (38%), Gaps = 71/362 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +++G+G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D + LY  LV++Y    + +       +K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF---QDDNNLY--LVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 245
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VH-QLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 246 ----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
                G   Y    D WS G  + E++ G+  F  +S + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL---IHPFF- 357
           N     F+FP              +   A DL+ RL+  S   R           HPFF 
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343

Query: 358 ----DELRDPNARLPSGRFLPPL------FNFKSHELKSVPVEILV-KLIPEHARKQCPF 406
               D +R+  A  P   ++P +       NF   +      E +        +    PF
Sbjct: 344 GIDWDNIRNCEA--P---YIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPF 398

Query: 407 LG 408
           +G
Sbjct: 399 VG 400

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  143 bits (363), Expect = 4e-38
 Identities = 72/319 (22%), Positives = 126/319 (39%), Gaps = 55/319 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           R++G+G FG VF  +   TG+  A  K L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L + F +   K +L   LV+  +   +  +  + + ++ N          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLC--LVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           ++H    + +RD+KP+N+L++   + V++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G  EY  ++D ++ G  + E++  +  F                     +E+       
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARG------------EKVENKEL------- 401

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFFDEL 360
                 ++        +P +  P + D    LLQ  P  R             HP F   
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF--- 452

Query: 361 RDPN-ARLPSGRFLPPLFN 378
           RD +  +L +G   PP   
Sbjct: 453 RDISWRQLEAGMLTPPFVP 471

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  141 bits (356), Expect = 4e-38
 Identities = 86/375 (22%), Positives = 133/375 (35%), Gaps = 90/375 (24%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +++G+G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D++ LY  LV+EY    + +       +K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 239
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VH-RLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 240 RAPELI------FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
            +PE++       G   Y    D W+ G    E+  G+  F  DS   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL- 352
                  ++        P            + +P EA D + RLL   P  R     A  
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324

Query: 353 --IHPFF-----DELRDPNARLPSGRFLPPL------FNF------KSHELKSVPVEILV 393
              HPFF     D LRD     P   F P         NF       +  +      +  
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP--P---FTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSD 379

Query: 394 KLIPEHARKQCPFLG 408
                      PF+G
Sbjct: 380 IREGAPLGVHLPFVG 394

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (349), Expect = 8e-38
 Identities = 67/359 (18%), Positives = 124/359 (34%), Gaps = 105/359 (29%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 128 SLKHCF----------------------------------------------------FS 135
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 136 TTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
                ++YL + ++    E +   +     L  R   + + ++  QI  A+ ++H S G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF-IQIAEAVEFLH-SKGL 185

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------------VKGEPNISYICSRYYRA 241
            HRD+KP N+        VK+ DFG    +                  +   + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE I G   Y+  +DI+S G ++ EL+     F       +++  ++             
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR------------- 287

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                  KFP +           +  P+   +V  +L  SP  R  A D + +  F+ L
Sbjct: 288 -----NLKFPLL---------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  139 bits (352), Expect = 9e-38
 Identities = 62/339 (18%), Positives = 116/339 (34%), Gaps = 49/339 (14%)

Query: 73  YMAERIVGQG--SFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHP 124
           Y    ++G+G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           N+V  +  F +    +EL+  +V  ++   +   ++         M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLK 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--------KVLVKGEPNISYIC 235
           AL YIH   G  HR +K  ++L++    +V L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 236 SRYYRAPELIF-GATEYTTAIDIWSAGCVVAELMLGKP----------LF-------PGD 277
              + +PE++      Y    DI+S G    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
                +      +          ++ + T               + +   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 338 LQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPL 376
           LQ +P+ R +A   L H FF        +  +   LP L
Sbjct: 318 LQRNPDARPSASTLLNHSFFK-----QIKRRASEALPEL 351

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  139 bits (351), Expect = 1e-37
 Identities = 79/364 (21%), Positives = 138/364 (37%), Gaps = 84/364 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLL-----DHP 124
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N   VV L   F  +      ++ +V E +   + + +   N   Q +P+  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLV----------------------------------- 206
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 207 -------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
                        N    +VK+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEI-------KC 300
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMP------PEAVDLVSRLLQYSPNLRCTALDALIH 354
                      ++K     ++  ++            D +  +L+  P  R TA + L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 355 PFFD 358
           P+ +
Sbjct: 393 PWLN 396

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  141 bits (357), Expect = 3e-37
 Identities = 85/316 (26%), Positives = 135/316 (42%), Gaps = 58/316 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           R++G+G FG V   +   TG+  A  K L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRM-PMIYVKLYAYQIFRAL 185
           L + + +   KD L   LVL  +   +       H   + Q   P      YA +I   L
Sbjct: 249 LAYAYET---KDALC--LVLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
             +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++
Sbjct: 300 EDLH-RERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                YT + D W+ GC++ E++ G+  F                    REE+       
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFFDEL 360
                  +K  P  + + +R  P+A  L S+LL   P  R  C    A     HP F   
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF--- 448

Query: 361 RDPN-ARLPSGRFLPP 375
           +  N  RL +G   PP
Sbjct: 449 KKLNFKRLGAGMLEPP 464

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  139 bits (351), Expect = 7e-37
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 52/295 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 125
           Y+    +G G+FG V   K   TG  VA+K     K+          RE+Q ++L  HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L     + +D   ++  +V+EYV   E    + K+      R+     +    QI  
Sbjct: 78  IIKLYQVISTPSD---IF--MVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILS 127

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 242
            + Y HR   V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C S  Y AP
Sbjct: 128 GVDYCHRH-MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAP 184

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+I G       +DIWS+G ++  L+ G   F  D  V  L + I               
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-------------- 229

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                F  P      +       + P  + L+  +LQ  P  R T  D   H +F
Sbjct: 230 --DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  136 bits (344), Expect = 9e-37
 Identities = 79/306 (25%), Positives = 126/306 (41%), Gaps = 74/306 (24%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--E--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +  F     KD   L +V+EYV   E  +  R +  F+           + YA QI    
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPH-----ARFYAAQIVLTF 154

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYY 239
            Y+H S+ + +RD+KP+NLL++   + +++ DFG AK +        G P          
Sbjct: 155 EYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------A 204

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I     Y  A+D W+ G ++ E+  G P F  D    Q+ E I         +++
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI------VSGKVR 256

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP-----NLRCTALDALIH 354
                                 FP     +  DL+  LLQ        NL+    D   H
Sbjct: 257 ----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294

Query: 355 PFFDEL 360
            +F   
Sbjct: 295 KWFATT 300

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  136 bits (345), Expect = 3e-36
 Identities = 88/355 (24%), Positives = 148/355 (41%), Gaps = 65/355 (18%)

Query: 22  VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS-YMAERIVG 80
              +    + +K +   EM+     G+ ++        +     + + T++ +   +++G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFR--SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLG 157

Query: 81  QGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLK 130
           +G+FG V   K   TG   A+K      ++           NR LQ  R   HP + +LK
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALK 214

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           + F  T D+  L    V+EY    E    + +      +       + Y  +I  AL Y+
Sbjct: 215 YSF-QTHDR--LCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYL 264

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
             +Y  A+D W  G V+ E+M G+  F      ++L E+I        EEI+        
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL------MEEIR-------- 367

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFF 357
                         FP+ + PEA  L+S LL+  P  R    + DA     H FF
Sbjct: 368 --------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  132 bits (335), Expect = 6e-36
 Identities = 81/312 (25%), Positives = 123/312 (39%), Gaps = 57/312 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 130
           E I G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+VS  
Sbjct: 21  EVI-GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 131 HCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             F     KDEL+  LV++      V + +  +V      +  +    +     ++   L
Sbjct: 80  TSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSR------- 237
            Y+H   G  HRD+K  N+L+      V++ DFG SA +   G+   +    R       
Sbjct: 135 EYLH-KNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFVGTP 190

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP----LFPGDSGVDQLVEIIKVLG-T 292
            + APE++     Y    DIWS G    EL  G        P           +KVL  T
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----------MKVLMLT 239

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                    +P       P ++     K   K+       ++S  LQ  P  R TA + L
Sbjct: 240 LQN------DP-------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

Query: 353 IHPFFDELRDPN 364
            H FF + ++  
Sbjct: 287 RHKFFQKAKNKE 298

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  133 bits (336), Expect = 7e-36
 Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 74/306 (24%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--E--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
              F     +D   + ++++Y+   E  ++ R  + F   N        K YA ++  AL
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPV-----AKFYAAEVCLAL 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYY 239
            Y+H S  + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y
Sbjct: 120 EYLH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------Y 169

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE++     Y  +ID WS G ++ E++ G   F   +   +  E I         E++
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKI------LNAELR 221

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP-----NLRCTALDALIH 354
                                 FP     +  DL+SRL+         NL+    D   H
Sbjct: 222 ----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259

Query: 355 PFFDEL 360
           P+F E+
Sbjct: 260 PWFKEV 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  133 bits (336), Expect = 7e-36
 Identities = 67/308 (21%), Positives = 118/308 (38%), Gaps = 66/308 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-------RELQTMRL 120
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLY 177
           ++H N++ +   F    ++      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
             Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 237 RYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
                          P              +  E + LVS LLQ  P  R T    +  P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 356 FFDELRDP 363
           +  +  + 
Sbjct: 277 WVTQPVNL 284

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  132 bits (334), Expect = 2e-35
 Identities = 78/296 (26%), Positives = 127/296 (42%), Gaps = 57/296 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           K+  F T D+  L    V+EY    E    + +      +       + Y  +I  AL Y
Sbjct: 71  KYA-FQTHDR--LC--FVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 246
           +H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              +Y  A+D W  G V+ E+M G+  F      ++L E+I        EEI+       
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL------MEEIR------- 223

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFF 357
                          FP+ + PEA  L++ LL+  P  R      DA     H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  132 bits (334), Expect = 7e-35
 Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 68/307 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +D+ YL +V+EY+P  + V+      +     +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVN----LMSN--YDVPEKWARFYTAEVVLALDA 183

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 239
           IH S+G  HRD+KP N+L++   H +KL DFG+   + K              YI     
Sbjct: 184 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 240 RAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            +PE++    G   Y    D WS G  + E+++G   F  DS    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL---I 353
             K MN       FP              +  EA +L+   L     +R           
Sbjct: 284 --KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329

Query: 354 HPFFDEL 360
           H FF   
Sbjct: 330 HLFFKND 336

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  128 bits (325), Expect = 3e-34
 Identities = 74/298 (24%), Positives = 129/298 (43%), Gaps = 59/298 (19%)

Query: 77  RIVGQGSFGVVFQAK---CLETGETVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 127
           +++GQGSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L + F  T  K  LYL  +L+++   +   R+ K             VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     +T + D WS G ++ E++ G   F G     + + +I       + ++      
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMI------LKAKLG----- 244

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFF 357
                             P+ + PEA  L+  L + +P  R             H FF
Sbjct: 245 -----------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  128 bits (325), Expect = 3e-34
 Identities = 79/302 (26%), Positives = 132/302 (43%), Gaps = 65/302 (21%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQ----DKRYKNRELQTM---RLL---DH 123
           R++G+G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           P +V L + F  T  K  LYL  +LEY+   E   ++ +                Y  +I
Sbjct: 81  PFIVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEI 130

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YR 240
             AL ++H   G+ +RD+KP+N+++N   H VKL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLH-QKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE++   + +  A+D WS G ++ +++ G P F G++   + ++ I       + ++  
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKLN- 239

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHP 355
                                 P  +  EA DL+ +LL+ +   R      DA     HP
Sbjct: 240 ---------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278

Query: 356 FF 357
           FF
Sbjct: 279 FF 280

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  127 bits (321), Expect = 7e-34
 Identities = 74/311 (23%), Positives = 129/311 (41%), Gaps = 52/311 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS- 191
               +     + LV+EY    +++ V+ H  +        +   +  Q  + ++Y+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 192 -IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP NLL+      +K+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y+   D++S G ++ E++  +  F    G      I+  +   TR               
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTR--------------- 222

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR------CTALDALIHPFFDELRDPN 364
           P +          K +P     L++R     P+ R         +  L+  F     D  
Sbjct: 223 PPL---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA--DEP 271

Query: 365 ARLPSGRFLPP 375
            + P    LPP
Sbjct: 272 LQYPCQHSLPP 282

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  128 bits (323), Expect = 9e-34
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 63/300 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
           R++G+GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  L+   V+E+V   + +  + K      +R      + YA +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISA 136

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H   G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLH-DKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y  A+D W+ G ++ E++ G   F  ++  D L E I        +E+     
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI------LNDEVV---- 242

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDALI----HPFF 357
                             +P  +  +A  ++   +  +P +R              HPFF
Sbjct: 243 ------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  127 bits (322), Expect = 1e-33
 Identities = 74/299 (24%), Positives = 120/299 (40%), Gaps = 62/299 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
            ++G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  LY   V+EYV   + ++ + +       R    +   YA +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIG 133

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++  S G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y  ++D W+ G ++ E++ G+  F G+   D+L + I          +     
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNVA---- 239

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFF 357
                             +PK M  EAV +   L+   P  R  C          H FF
Sbjct: 240 ------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  127 bits (321), Expect = 2e-33
 Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 58/302 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           R++G+GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V L  C F T  +  L+   V+EYV   + +  + +      +++P  + + Y+ +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEIS 120

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            AL+Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D W+ G ++ E+M G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDALI----HP 355
                   F  I         P+ +  +A  ++   L   P  R  C           HP
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

Query: 356 FF 357
           FF
Sbjct: 278 FF 279

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  127 bits (321), Expect = 2e-33
 Identities = 78/303 (25%), Positives = 137/303 (45%), Gaps = 59/303 (19%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNREL--QTM---RLL----DHP 124
           +++G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V+L + F     + +L+L  +L+Y+   E    + +      +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYR 240
            AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLH-KLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 241 APELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           AP+++ G    +  A+D WS G ++ EL+ G   F  D   +   EI + +    + E  
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKSEPP 284

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IH 354
                                 +P+ M   A DL+ RLL   P  R  C   DA     H
Sbjct: 285 ----------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322

Query: 355 PFF 357
            FF
Sbjct: 323 LFF 325

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  127 bits (321), Expect = 2e-33
 Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 59/297 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 127
           +++G+GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L    F T DK  LY   VL+Y+   E  + + +      +       + YA +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            Y+H S+ + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y   +D W  G V+ E++ G P F   +   ++ + I        + ++     
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL------NKPLQ----- 257

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR----CTALDALIHPFF 357
                                +   A  L+  LLQ     R       ++   H FF
Sbjct: 258 -----------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  126 bits (318), Expect = 3e-33
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 62/297 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           +++G+GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +  +    F T +   L+   V+EY+   + ++ +         +  +     YA +I 
Sbjct: 79  FLTHMFCT-FQTKEN--LF--FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEII 128

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 241
             L ++H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLH-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D WS G ++ E+++G+  F G    ++L   I+       +     
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------MDNPF-- 236

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFF 357
                               +P+ +  EA DL+ +L    P  R     D   HP F
Sbjct: 237 --------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (315), Expect = 5e-33
 Identities = 71/312 (22%), Positives = 120/312 (38%), Gaps = 68/312 (21%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +     +G+GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                +   T      L +++EY+   +   +++    L++      +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDET----QIATILREILKGLD 133

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 245
           Y+H S    HRDIK  N+L++    +VKL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLH-SEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
             +  Y +  DIWS G    EL  G+P                                 
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------------------- 217

Query: 306 TEFKFPQIKAHPWHKIF--PKRMPP--------EAVDLVSRLLQYSPNLRCTALDALIHP 355
                P  + HP   +F  PK  PP           + V   L   P+ R TA + L H 
Sbjct: 218 -----PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272

Query: 356 FFDELRDPNARL 367
           F        + L
Sbjct: 273 FILRNAKKTSYL 284

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  126 bits (318), Expect = 8e-33
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 58/302 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           R++G+GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V L  C F T  +  L+   V+EYV   + +  + +      +++P  + + Y+ +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEIS 163

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            AL+Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D W+ G ++ E+M G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDALI----HP 355
                   F  I         P+ +  +A  ++   L   P  R  C           HP
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320

Query: 356 FF 357
           FF
Sbjct: 321 FF 322

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  125 bits (315), Expect = 1e-32
 Identities = 76/296 (25%), Positives = 125/296 (42%), Gaps = 53/296 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +  + C+            LV+EY   +   +++   K    +  + +    +   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+H S  + HRD+K  N+L++     VKL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI--IKVLGTPTREEIKCM 301
               E  Y   +D+WS G    EL   KP  P       L  +  +  L       I   
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP--P-------LFNMNAMSAL-----YHIAQN 268

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                    P +++  W + F         + V   LQ  P  R T+   L H F 
Sbjct: 269 ES-------PALQSGHWSEYF--------RNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (310), Expect = 2e-32
 Identities = 76/310 (24%), Positives = 127/310 (40%), Gaps = 67/310 (21%)

Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR 119
            G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYA 178
              +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 237
            +  +AL ++H S  V HRDIK  N+L+      VKL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP----------LFPGDSGVDQLVEII 287
           Y+ APE++     Y   +DIWS G +  E++ G+P          L+           +I
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----------LI 228

Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
              GTP  +                          P+++     D ++R L+     R +
Sbjct: 229 ATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGS 263

Query: 348 ALDALIHPFF 357
           A + L H F 
Sbjct: 264 AKELLQHQFL 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  122 bits (307), Expect = 8e-32
 Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 65/295 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G+GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                +EL+  +++E++    +  +V        R+    +      + +AL+Y+H + G
Sbjct: 113 V---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH-AQG 161

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           V HRDIK  ++L+     +VKL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 253 TAIDIWSAGCVVAELMLGKP----------LFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           T +DIWS G +V E++ G+P          +             ++    P  +      
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-----------RLRDSPPPKLKN----- 263

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                                 ++ P   D + R+L   P  R TA + L HPF 
Sbjct: 264 --------------------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  120 bits (303), Expect = 1e-31
 Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 55/288 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           N+V L        +       +V+E+VP   ++  +         +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIAL 133

Query: 184 ALSYIH-RSIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRY 238
            + Y+  ++  + HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 239 YRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           + APE I    E YT   D +S   ++  ++ G+  F   S   ++  I  +     R  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGLR-- 248

Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        P I         P+  PP   +++       P  R
Sbjct: 249 -------------PTI---------PEDCPPRLRNVIELCWSGDPKKR 274

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  125 bits (314), Expect = 2e-31
 Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 62/299 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
            ++G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  LY   V+EYV   + ++ + +       R    +   YA +I   
Sbjct: 405 TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIG 454

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++  S G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y  ++D W+ G ++ E++ G+  F G+   D+L + I          +     
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNVA---- 560

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR--CTALDAL---IHPFF 357
                             +PK M  EAV +   L+   P  R  C          H FF
Sbjct: 561 ------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (302), Expect = 3e-31
 Identities = 72/315 (22%), Positives = 124/315 (39%), Gaps = 70/315 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   ++         L +++E+ P   V  ++   ++    +    +++   Q+  AL++
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 246
           +H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LH-SKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 247 GAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
             T     Y    DIWS G  + E+   +P                              
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP------------------------------ 220

Query: 303 PNYTEFKFPQIKAHPWHKIF--PKRMPP----------EAVDLVSRLLQYSPNLRCTALD 350
                   P  + +P   +    K  PP          E  D +   L  +P  R +A  
Sbjct: 221 --------PHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272

Query: 351 ALIHPFFDELRDPNA 365
            L HPF   +    A
Sbjct: 273 LLEHPFVSSITSNKA 287

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (299), Expect = 1e-30
 Identities = 79/299 (26%), Positives = 125/299 (41%), Gaps = 45/299 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 130
           +     +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             +F  TD     L +V+EY    +V  +++  NK    +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 248
             +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 -FMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI--IKVLGTPTREEIKCMNPNYT 306
             Y    DIWS G    E+  GKP  P         +I  ++ +       I    P   
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKP--P-------YADIHPMRAI-----FMIPTNPP--- 242

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA 365
               P  +        P+       D V + L  SP  R TA   L HPF    +  + 
Sbjct: 243 ----PTFRK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  122 bits (307), Expect = 3e-30
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 46/236 (19%)

Query: 58  TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQD-------KR 109
             + G+         Y  +  +  G  G ++ A      G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEYVP-ETVHRVVKHFNKLNQ 167
               E Q +  + HP++V +   F   TD+    +  +V+EYV  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRS------KGQ 177

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--- 224
           ++P+     Y  +I  ALSY+H  IG+ + D+KP+N+++     Q+KL D G+   +   
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234

Query: 225 --VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
             + G P         ++APE++      T A DI++ G  +A L L  P   G  
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  117 bits (295), Expect = 3e-30
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
                + T    L   +V EY+   +++R++ H +   +++        AY + + ++Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 189 H-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 246
           H R+  + HR++K  NLLV+   + VK+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
                    D++S G ++ EL   +  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (296), Expect = 3e-30
 Identities = 71/307 (23%), Positives = 125/307 (40%), Gaps = 42/307 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 128
           +    +VG G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 129 LKHCFF-STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               F        +  L LV+E+    +V  ++K  N     +   ++     +I R LS
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 245
           ++H    V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLH-QHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 246 ----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           NP       P++K+  W K F           +   L  + + R      + HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKF--------QSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 362 DPNARLP 368
           +      
Sbjct: 295 NERQVRI 301

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  115 bits (291), Expect = 6e-30
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 36/221 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 127
           E I+G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 128 SLK-HCFFSTTDKDELYLNLVLEYVPE-TVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRA 184
           +L+  C      +  L   LV+E+     ++RV+       +  +        A QI R 
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARG 117

Query: 185 LSYIHRS--IGVCHRDIKPQNLLVN-------PHTHQVKLCDFGSAKVLVKGEPNISYIC 235
           ++Y+H    + + HRD+K  N+L+             +K+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
           +  + APE+I  +  ++   D+WS G ++ EL+ G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (292), Expect = 9e-30
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 131
             ++G+G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 132 CFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                     L    + EY+        +  +   +   +QR+        A  I   ++
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDSQYP-WSQRVSF------AKDIASGMA 122

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--------- 237
           Y+H S+ + HRD+   N LV      V + DFG A+++V  +     + S          
Sbjct: 123 YLH-SMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 238 ------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
                 Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  113 bits (286), Expect = 4e-29
 Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 58/297 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   +   +L   +V ++    +++  +        +  M  +   A Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLA--IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H +  + HRD+K  N+ ++   + VK+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
                  Y+   D+++ G V+ ELM G+  +   +  DQ   II+++G  +         
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL-------- 243

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                        P         P     L++  L+   + R         P F  +
Sbjct: 244 ------------SPDLSKVRSNCPKRMKRLMAECLKKKRDER---------PSFPRI 279

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 1e-28
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 39/241 (16%)

Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------ 107
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 108 ---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFN 163
              KR++ RE+     L H N+VS+        + D  YL  V+EY+   T+   ++   
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTLSEYIES-- 104

Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223
             +  + +     +  QI   + + H    + HRDIKPQN+L++     +K+ DFG AK 
Sbjct: 105 --HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 224 LVKGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           L   E +++     + +  Y +PE   G        DI+S G V+ E+++G+P F G++ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 280 V 280
           V
Sbjct: 218 V 218

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  112 bits (283), Expect = 1e-28
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYK---NRELQTMRLLDHP 124
           Y   R+VG+G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +VV +           +LY+   +  +    +  +++        +          QI  
Sbjct: 95  HVVPI---HDFGEIDGQLYV--DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGS 145

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYY 239
           AL   H + G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            APE    +   T   DI++  CV+ E + G P + GD 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (283), Expect = 2e-28
 Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 37/239 (15%)

Query: 58  TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKN 112
           + +  R         Y    I+G G    V  A+ L     VA+K VL     +D  +  
Sbjct: 8   SHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYL 57

Query: 113 R---ELQTMRLLDHPNVVSLKHCFF---STTDKDELYLNLVLEYVP-ETVHRVVKHFNKL 165
           R   E Q    L+HP +V++    +              +V+EYV   T+  +V      
Sbjct: 58  RFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---- 109

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
              M             +AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ + 
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIA 167

Query: 226 KGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               +++     I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS V
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  112 bits (282), Expect = 4e-28
 Identities = 43/216 (19%), Positives = 86/216 (39%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
            + +G+G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIH 189
               T    +LYL  + +Y    +++  +K         + +      AY     L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKL------AYSSVSGLCHLH 151

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAELM 268
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  110 bits (278), Expect = 6e-28
 Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
              VG+G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              S     +L+L  +  Y    +++  +          + +         I   L+++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 238 YYRAPELI-----FGATEYTTAIDIWSAGCVVAELM 268
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  108 bits (273), Expect = 2e-27
 Identities = 27/215 (12%), Positives = 72/215 (33%), Gaps = 30/215 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
              + +   G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 130 KHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
                        +  L+  ++P       +H         +Q +        A  + R 
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF------ALDMARG 123

Query: 185 LSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           ++++H     +    +  ++++++      ++                  + +  + APE
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPE 178

Query: 244 LIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
            +          + D+WS   ++ EL+  +  F  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (272), Expect = 6e-27
 Identities = 43/225 (19%), Positives = 87/225 (38%), Gaps = 41/225 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
             ++G+G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 130 K-HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              C         L +  +       T++ VV+        + +   +  A +I + + Y
Sbjct: 95  MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--------Y 239
           +H + G+ H+D+K +N+  +     V + DFG     + G         +         +
Sbjct: 146 LH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200

Query: 240 RAPELIFGATE--------YTTAIDIWSAGCVVAELMLGKPLFPG 276
            APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  107 bits (270), Expect = 2e-26
 Identities = 46/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
           +  +G+G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVK-HFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +L+L  V +Y    ++   +  +   +   + +      A      L+++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKL------ALSTASGLAHLH 156

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAELM 268
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (269), Expect = 2e-26
 Identities = 55/255 (21%), Positives = 106/255 (41%), Gaps = 39/255 (15%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 126
           ++      +  +G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 127 VS-LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK-HFNKLNQRMPMIYVKLYAYQIFR 183
           +  +      T+   +L+L  +  +  + ++   +K +    N+   +      A  + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHI------AETMAR 132

Query: 184 ALSYIHRSI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
            L+Y+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 235 CSRY------YRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
            +        Y APE++ GA     +    ID+++ G V+ EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 285 EIIKVLGTPTREEIK 299
              ++   P+ E+++
Sbjct: 249 FEEEIGQHPSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 4e-25
 Identities = 50/254 (19%), Positives = 96/254 (37%), Gaps = 39/254 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 132
             ++G+G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 133 FFSTTDKDELYLNLVLEYVPET--VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
               T    +   LV+EY P       +  H +       +      A+ + R L+Y+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL------AHSVTRGLAYLHT 129

Query: 191 SI--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---------PNISY 233
            +         + HRD+  +N+LV        + DFG +  L               IS 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 234 ICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD--QLVE 285
           + +  Y APE++ GA            +D+++ G +  E+ +          V   Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 286 IIKVLGTPTREEIK 299
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 40/233 (17%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            R +G+G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +  K C     D     L LV+EYVP      ++ +      + +  + L+A QI   ++
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+H +    HRD+  +N+L++ +   VK+ DFG AK + +G          YYR      
Sbjct: 149 YLH-AQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198

Query: 241 ------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEI 286
                 APE +     +  A D+WS G  + EL+          +   +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 52/238 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
             L   C         +   L+ + +P      +  + + ++  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           ++Y+   R +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    A E ++     YT   D+WS G  V ELM  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 41/351 (11%), Positives = 76/351 (21%), Gaps = 88/351 (25%)

Query: 35  RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLE 94
           R+     +   D      G        GR         Y      G       +QA    
Sbjct: 7   REPDRESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTA 54

Query: 95  TGETVAIKKVL----QDKRYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 147
               VA+  V                    +  +D P V  +         +    +  V
Sbjct: 55  LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--V 109

Query: 148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV 206
            E++   ++  V       +     +        +  A    HR+ GV      P  + V
Sbjct: 110 AEWIRGGSLQEV------ADTSPSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRV 162

Query: 207 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAE 266
           +     V L                                        DI   G  +  
Sbjct: 163 SI-DGDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYA 194

Query: 267 LMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM 326
           L++ +   P       L    +                                I    +
Sbjct: 195 LLVNRWPLPEAGVRSGLAPAERDTAGQPI---------------------EPADIDR-DI 232

Query: 327 PPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLF 377
           P +   + +R +Q    +R  +         + ++   A       L P+ 
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 42/216 (19%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K             L L++EY+P       + KH  +++    +     Y  QI + 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL----QYTSQICKG 126

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  +    HRD+  +N+LV  + ++VK+ DFG  KVL + +         +++    
Sbjct: 127 MEYLG-TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVKEP 176

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM 268
                   APE +   ++++ A D+WS G V+ EL 
Sbjct: 177 GESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 40/215 (18%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 127
            + +G+G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 128 SLKHCFFSTTDKDE-LYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
             K      +     L   L++EY+P   +  ++ + + ++ R+  I +  Y  QI + +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  +    HRD+  +N+LV    ++VK+ DFG  KVL + +         YY+     
Sbjct: 159 EYLG-TKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM 268
                  APE +   ++++ A D+WS G V+ EL 
Sbjct: 209 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 48/232 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
            R++G+G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYA 178
             L      S          ++L ++            R+ ++   L  +  ++    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             I   + Y+  S    HRD+  +N ++      V + DFG ++ +  G+         Y
Sbjct: 144 VDIACGMEYLS-SRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------Y 192

Query: 239 YR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           YR            A E L      YT   D+W+ G  + E+M  G+  + G
Sbjct: 193 YRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 41/216 (18%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            R +G+G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K      T+     + L++E++P       + K+ NK+N +  +     YA QI + 
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL----KYAVQICKG 138

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +         YY     
Sbjct: 139 MDYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKDD 188

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM 268
                   APE +  +  +  A D+WS G  + EL+
Sbjct: 189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.6 bits (220), Expect = 8e-20
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 40/215 (18%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
              +G+G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V  +        +  L   LV+EY+P      ++ F + ++ R+    + LY+ QI + +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  S    HRD+  +N+LV      VK+ DFG AK+L   +         YY      
Sbjct: 141 EYLG-SRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM 268
                  APE +     ++   D+WS G V+ EL 
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 56/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            + +G G+FG V +A        +   TVA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPM 171
           N+V+L       T        ++ EY                 +          +  + +
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++YQ+ + ++++  S    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                    Y             APE IF    YT   D+WS G  + EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 277 DSGVDQLVEIIK 288
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 29/224 (12%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
               T +   Y  ++ E++    +  +  + +   R  +  V L   A QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
                HR++  +N LV    H VK+ DFG ++++        Y      +      APE 
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG--DSGVDQLVE 285
           +     ++   D+W+ G ++ E+   G   +PG   S V +L+E
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 46/231 (19%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
            +I+G+G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           + L       + +      ++L ++            R+      +  +  ++    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
            I   + Y+  +    HRD+  +N ++      V + DFG +K +  G+         YY
Sbjct: 155 DIALGMEYLS-NRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YY 203

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R            A E L      YT+  D+W+ G  + E+   G   +PG
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 48/232 (20%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 125
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V +        + +     LV+E         +  + + N+ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                    APE + +   ++++  D+WS G ++ E    G+  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 86.5 bits (213), Expect = 5e-19
 Identities = 50/330 (15%), Positives = 91/330 (27%), Gaps = 74/330 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRE--------------------LQT 117
           +G+G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIY-- 173
                    + L            L L     Y     + +     F      + + +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 174 -----------------VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC 216
                             K   +Q+  +L+    S+   HRD+   N+L+   +   KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL-KKLH 204

Query: 217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 277 DSGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIFP--KRMP 327
           D   D   +I +++           +P       +Y   K  +          P  K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 328 PEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
            +  +    +L +S     +A D L     
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 45/223 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 130
              +G+G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 131 H--CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALSY 187
              C    T K  +Y  +V+E V          F +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------- 240
           +  S    HRD+  +N LV    + +K+ DFG ++    G          Y         
Sbjct: 229 LE-SKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                APE L +G   Y++  D+WS G ++ E   LG   +P 
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 53/249 (21%)

Query: 77  RIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 125
           + +G+G+FG V +A         T  TVA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMI 172
           VV+L      T     L   +++E+               E V   V   +     + + 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 233 YICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG 279
                 Y             APE IF    YT   D+WS G ++ E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 280 VDQLVEIIK 288
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 50/237 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
             L   C         +   L+ + +P      +  + + ++  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           ++Y+   R +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 241 ---------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    A E I     YT   D+WS G  V ELM  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  +V EY+       +  F K      +   +L   A QI   ++Y+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 298 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG--DSGVDQLVE 285
                 +T   D+WS G ++ EL   G+  +PG  +  V   VE
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.0 bits (211), Expect = 7e-19
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHRS 191
               +K  LY  +V EY+       +  + +   R  +    L  ++  +  A+ Y+   
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 135

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 244
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 136 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                +++T  D+WS G ++ E+   G+  +P 
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHRS 191
               +K  LY  +V EY+       +  + +   R  +    L  ++  +  A+ Y+   
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 307

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 244
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 308 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                +++T  D+WS G ++ E+   G+  +P 
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.1 bits (211), Expect = 8e-19
 Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 129
           Y   R +G+GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +       ++ L+  LV++ +  ++       +   ++  +  V + A Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 190 RSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 46/233 (19%), Positives = 80/233 (34%), Gaps = 46/233 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-------VAIKKVLQDKRYKN----RELQTMRLLDHP 124
              +GQG+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 125 NVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIF 182
           ++V     C       DE    LV E+V       +  + K N+    I  KL  A Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLVKGEPNISYIC 235
            A+ ++     + H ++  +N+L+     +       +KL D G +  ++  +       
Sbjct: 124 AAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 236 SRYYR------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
               +       PE I        A D WS G  + E+   G           
Sbjct: 176 --ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
               T +   Y  ++ E++    +  +  + +   R  +  V L   A QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE- 243
                HRD+  +N LV  + H VK+ DFG ++++        Y      +      APE 
Sbjct: 129 KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  +V EY+       +  F K      +   +L   A QI   ++Y+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 381 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                 +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 45/226 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALS 186
           SL         +      +VL Y+    H  +++F +     P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRD+  +N +++     VK+ DFG A+ +   E         YY       
Sbjct: 143 YLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNKTG 191

Query: 241 --------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   A E L     ++TT  D+WS G ++ ELM  G P +P 
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 126
           R +GQGSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           V L       +        +++E +            R     N +     +  +   A 
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           +I   ++Y++ +    HRD+  +N +V      VK+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
           R            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 286 IIK 288
            + 
Sbjct: 252 FVM 254

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G FG V +   +  GE     V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L            L   LV +Y+P      +    + ++  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+    G+ HR++  +N+L+     QV++ DFG A +L   +     +     +     
Sbjct: 129 YYLE-EHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPIKW 183

Query: 241 -APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
            A E I     YT   D+WS G  V ELM  G   + G    +   L+E
Sbjct: 184 MALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 16/157 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 129
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +           Y  +VLE +  ++      F+  ++   +  V + A Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLE---DLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 190 RSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
            S  + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 49/238 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L          + L   LV+E         +  F    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    APE + F   ++++  D+WS G  + E +  G+  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 45/235 (19%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTM 118
           P + +   ++R++G+G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           R L+HPNV++L          + L   ++L Y+    H  +  F +  QR P +   + +
Sbjct: 77  RGLNHPNVLALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ R + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E         
Sbjct: 130 GLQVARGMEYLA-EQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE--------- 178

Query: 238 YYR--------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           YY               A E L      +TT  D+WS G ++ EL+  G P +  
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 129
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C       +  Y  +V+E +  ++      FN  +++  +  V L A Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLE---DLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 190 RSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK 222
            S    HRD+KP N L+      + V + DFG AK
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FGVV   K       VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C    + +  +Y  +V EY+    +  + ++ + + +       L   Y +   ++++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE- 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
           S    HRD+  +N LV+     VK+ DFG  + ++  +         Y            
Sbjct: 122 SHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKW 171

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            APE   +   +Y++  D+W+ G ++ E+  LGK  +  
Sbjct: 172 SAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 61/257 (23%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            +++G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPM 171
           N+V+L       T    +Y  L+ EY               +     +++ N+       
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 172 IYVKL-------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               L       +AYQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 225 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
           +             Y             APE +F    YT   D+WS G ++ E+  LG 
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 272 PLFPGDSGVDQLVEIIK 288
             +PG        ++I+
Sbjct: 273 NPYPGIPVDANFYKLIQ 289

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 43/230 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E+ +G G FG V+ A   +    VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
                 K+ +Y  ++ E++       +  F K ++       KL  ++ QI   +++I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
                HRD++  N+LV+      K+ DFG A+V+   E         Y            
Sbjct: 302 QRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
            APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 14/155 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 129
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +         +  Y  LV++ +  ++      FN  ++++ +  V + A Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLE---DLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 190 RSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK 222
            S    HRDIKP N L+      +QV + DFG AK
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 44/228 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            RI+G+G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L        +++  +  +++E  P   +  + H+ + N+  + ++ + LY+ QI +A++
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  SI   HRDI  +N+LV      VKL DFG ++ +   +         YY+      
Sbjct: 128 YLE-SINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVTRL 176

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                +PE + F    +TTA D+W     + E++  GK  F      D
Sbjct: 177 PIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 43/225 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK---LYAYQIFRA 184
           SL         +      +VL Y+    H  +++F  +        VK    +  Q+ + 
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF--IRNETHNPTVKDLIGFGLQVAKG 204

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +        +     
Sbjct: 205 MKFLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGA 256

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                  A E L     ++TT  D+WS G ++ ELM  G P +P 
Sbjct: 257 KLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 47/232 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L          + L   LV+E         +  F    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                    APE + F   ++++  D+WS G  + E +  G+  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
              +G G FG V+          VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  ++ EY+    +  +  F K    + +   KL   A QI   +++I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
                HRD++  N+LV+      K+ DFG A+++   E         Y            
Sbjct: 127 ERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            APE + +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK---LYAYQIFR 183
            L+       T    +   +V EY+    +  +  F  L +      V         I  
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSF--LRKHDAQFTVIQLVGMLRGIAS 158

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            + Y+   +G  HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 159 GMKYLS-DMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 241 --------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                   +PE + +   ++T+A D+WS G V+ E+M  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C     ++  +   LV E++    H  +  + +  + +      L     +   ++Y+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-E 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
              V HRD+  +N LV  +   +K+ DFG  + ++  +         Y            
Sbjct: 122 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKW 171

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +PE   F    Y++  D+WS G ++ E+   GK  +  
Sbjct: 172 ASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 45/230 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRAL 185
            L+       T        +V EY+    +  +  F + +     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+   +G  HRD+  +N+LV+ +    K+ DFG ++VL                     
Sbjct: 165 RYLS-DLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTTGG 214

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                  APE + F    +++A D+WS G V+ E++  G+  +   +  D
Sbjct: 215 KIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 44/228 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L         ++ ++  +++E         ++ F ++ +  + +  + LYAYQ+  AL+
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 131 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 179

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                APE + F    +T+A D+W  G  + E++  G   F G    D
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 62/257 (24%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            + +G+G FG V +A            TVA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-------------------ETVHRVVKHFNKLN 166
           V+ L       +    L   L++EY                      +            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 167 QRMPMIYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               +    L  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 225 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
            + +          Y             A E +F    YTT  D+WS G ++ E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 272 PLFPGDSGVDQLVEIIK 288
             +PG    ++L  ++K
Sbjct: 251 NPYPGIP-PERLFNLLK 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 57/258 (22%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQT 117
            ++ I     R +G+G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNK 164
           +  L H ++V          D D L   +V EY+             P+ +  V     +
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               + +  +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDV 183

Query: 225 VKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LG 270
              +         YYR             PE +++   ++TT  D+WS G ++ E+   G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232

Query: 271 KPLFPGDSGVDQLVEIIK 288
           K  +   S   +++E I 
Sbjct: 233 KQPWFQLS-NTEVIECIT 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 46/234 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L         ++ ++  +++E         ++ F ++ +  + +  + LYAYQ+  AL+
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 506 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 554

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG--VDQLVE 285
                APE + F    +T+A D+W  G  + E++  G   F G     V   +E
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 52/248 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP---------ETVHRVVKHFNKLNQRMPMIYVK 175
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 176 L--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           L  ++ Q+ + ++++  S    HRD+  +N+L+    H  K+ DFG A+ ++        
Sbjct: 166 LLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218

Query: 234 ICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
                Y             APE IF    YT   D+WS G ++ E+  LG   +PG    
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273

Query: 281 DQLVEIIK 288
            +  +++K
Sbjct: 274 SKFYKLVK 281

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 44/230 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           ++++G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRA 184
           + L+       +    +   ++ EY+    +  +  F +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  ++   HRD+  +N+LVN +    K+ DFG ++VL              Y     
Sbjct: 160 MKYLA-NMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTSGG 210

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                  APE + +    +T+A D+WS G V+ E+M  G+  +   S  +
Sbjct: 211 KIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 52/239 (21%)

Query: 76  ERIVGQGSFGVVFQAKC-LETGET--VAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
              +G GSFGVV + +    +G+T  VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
           ++ L    +       +   +V E  P      +    + +Q    +  +  YA Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           + Y+   R I   HRD+  +NLL+      VK+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 241 ----------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                     APE L      ++ A D W  G  + E+   G+  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRM 169
           H N+++L       T    LY  +++EY              P  +           ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               +    YQ+ R + Y+  S    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 54/248 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +  +G+G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP----------ETVHRVVKHFNKLNQRMPMIYVKL 176
           V         T+   L   +V EY+                 +    +     P+   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 177 --YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
              A Q+   + Y+   +   HRD+  +N LV      VK+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 235 CSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
              YYR             PE +++   ++TT  D+WS G V+ E+   GK  +   S  
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLS-N 266

Query: 281 DQLVEIIK 288
            + ++ I 
Sbjct: 267 TEAIDCIT 274

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 37/190 (19%), Positives = 61/190 (32%), Gaps = 33/190 (17%)

Query: 53  GHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQA-----KCLETGETVAIKKVLQD 107
           G II                +     +GQG FG ++ A     + + +     +K    D
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76

Query: 108 KRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEYVPE 153
                 EL+  +    P  +                           + Y  ++++    
Sbjct: 77  NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136

Query: 154 TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQ 212
            +    K +    +R     V   + +I   L YIH      H DIK  NLL+N  +  Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQ 192

Query: 213 VKLCDFGSAK 222
           V L D+G A 
Sbjct: 193 VYLVDYGLAY 202

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G+FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRM 169
           H N+++L       T    LY  +++EY              P  +           ++M
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               +    YQ+ R + Y+  S    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C    T +  ++  ++ EY+    +  + ++ +  +        L     +  A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-E 137

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
           S    HRD+  +N LVN     VK+ DFG ++ ++  E         Y            
Sbjct: 138 SKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRW 187

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
             PE L++   ++++  DIW+ G ++ E+  LGK  +  
Sbjct: 188 SPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 36/189 (19%), Positives = 65/189 (34%), Gaps = 32/189 (16%)

Query: 52  TGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK 111
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 112 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEYVPET 154
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQV 213
           +    K   + N       V     ++   L YIH      H DIK  NLL+   +  QV
Sbjct: 138 LQ---KISGQ-NGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQV 192

Query: 214 KLCDFGSAK 222
            L D+G + 
Sbjct: 193 YLADYGLSY 201

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP-----------ETVHRVVKHFNKLNQRMPM 171
           H N+++L       T    LY  +++EY                     +    N    +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L   AYQ+ R + Y+  S    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 54/250 (21%), Positives = 89/250 (35%), Gaps = 56/250 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
              +G+  FG V++         E  + VAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMI 172
           VV L       T    L   ++  Y              P +          +   +   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
                  QI   + Y+  S  V H+D+  +N+LV      VK+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 233 YICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDS 278
                YY+            APE +++G  +++   DIWS G V+ E+   G   + G S
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235

Query: 279 GVDQLVEIIK 288
               +VE+I+
Sbjct: 236 -NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 66/267 (24%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 116
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFN 163
            M   D+PN+V L            + L  + EY+             P TV  +     
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 164 KLNQRMPMIYVKL--------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
               R+                A Q+   ++Y+       HRD+  +N LV  +   VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 216 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSAGC 262
            DFG ++ +   +         YY+             PE + +    YTT  D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 263 VVAELM-LGKPLFPGDSGVDQLVEIIK 288
           V+ E+   G   + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQPYYGMA-HEEVIYYVR 290

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           +V        +      +  +++E +      +  R  +        + M+ +   A  I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYY 239
                Y+       HRDI  +N L+         K+ DFG A+ + +           YY
Sbjct: 150 ACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R             PE  + G   +T+  D WS G ++ E+  LG   +P 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           +V        +      +  ++LE +      +  R  +        + M+ +   A  I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYY 239
                Y+       HRDI  +N L+         K+ DFG A+ + +           YY
Sbjct: 191 ACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R             PE  + G   +T+  D WS G ++ E+  LG   +P 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 47/220 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 130
           + ++G G FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
            C     +++E+   L+ +Y+        ++        +   QR+  I          R
Sbjct: 103 FC----DERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRL-EI-----CIGAAR 150

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 238
            L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       
Sbjct: 151 GLHYLHTR-AIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQ--THLSTVVKGTLG 206

Query: 239 YRAPELIFGATEY------TTAIDIWSAGCVVAELMLGKP 272
           Y  P       EY      T   D++S G V+ E++  + 
Sbjct: 207 YIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 56/236 (23%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIYV 174
           +L         +  LY  L +EY                         N     +    +
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             +A  + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 145 LHFAADVARGMDYLS-QKQFIHRDLAARNILVGEN-YVAKIADFGLSRG----------- 191

Query: 235 CSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 33/191 (17%), Positives = 66/191 (34%), Gaps = 33/191 (17%)

Query: 52  TGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG--------ETVAIKK 103
           TG ++    G +         +  +    + + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 104 VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTDKDELYLNLVLEYVP 152
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTH 211
            ++   +    K    +    V   A ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPEDQS 198

Query: 212 QVKLCDFGSAK 222
           QV L  +G A 
Sbjct: 199 QVTLAGYGFAF 209

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 130
           + I+G+G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFR 183
                 T  + L   LV  Y+        +    +    L+  +R   I     A    R
Sbjct: 94  GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ-RI-----ALGSAR 142

Query: 184 ALSYIHRSIGVC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 238
            L+Y+H        HRD+K  N+L++    +  + DFG AK++   +   +++ +     
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGT 198

Query: 239 --YRAPE-LIFG-ATEYTTAIDIWSAGCVVAELMLGK 271
             + APE L  G ++E T   D++  G ++ EL+ G+
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 52/221 (23%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 129
            +G+G FGVV++   +    TVA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 130 K-HCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPM-------IYVKLYAYQ 180
                   +D D+L L  V  Y+P  ++       + L+   P+       I     A  
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRCKI-----AQG 141

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
               ++++H +    HRDIK  N+L+           K+ DFG A+   K     + + S
Sbjct: 142 AANGINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTS 193

Query: 237 R----Y-YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           R      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 194 RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 25/125 (20%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K          
Sbjct: 198 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247

Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
             Y             APE IF    YT   D+WS G ++ E+  LG   +PG    ++ 
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

Query: 284 VEIIK 288
              +K
Sbjct: 306 CRRLK 310

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 7e-05
 Identities = 49/407 (12%), Positives = 117/407 (28%), Gaps = 138/407 (33%)

Query: 75  AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV---SLKH 131
           A+ ++  G  G         +G+T     V    + + +             +   +LK+
Sbjct: 150 AKNVLIDGVLG---------SGKTWVALDVCLSYKVQCK---------MDFKIFWLNLKN 191

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           C     +  E     VLE + + ++++  ++   +     I +++++ Q    L  +   
Sbjct: 192 C-----NSPE----TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRL--- 237

Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPEL 244
             +  +      LLV     N         +    K+L+  + +    ++ +       L
Sbjct: 238 --LKSKP-YENCLLVLLNVQNAKA--WNAFNLSC-KILLTTRFKQVTDFLSAATTTHISL 291

Query: 245 IFGATEYTT--AIDIWS--AGCVVAEL-------------MLGKPL--FPG------DSG 279
              +   T      +      C   +L             ++ + +              
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP-PEAV------- 331
            D+L  II+         +  + P      F ++       +FP     P  +       
Sbjct: 352 CDKLTTIIES-------SLNVLEPAEYRKMFDRL------SVFPPSAHIPTILLSLIWFD 398

Query: 332 -------DLVSRLLQYS------PNLRCT----ALDALIHPFFDELRDPNARL------- 367
                   +V++L +YS           +     L+  +    +     +  +       
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL--ENEYALHRSIVDHYNIP 456

Query: 368 ---PSGRFLPP-----LFNFKSHELKSVPVEILVKLIPEHARKQCPF 406
               S   +PP      ++   H LK++          EH  +   F
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNI----------EHPERMTLF 493

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	409
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.95
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.13
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.12
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.77
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.33
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.28
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.28
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.27
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.89
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.51
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.3
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.02

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-63  Score=456.33  Aligned_cols=250  Identities=28%  Similarity=0.459  Sum_probs=204.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ..+.+|+++++.++|||||++++++     ....
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            468999999999999999999999999999999986432       3456899999999999999999988     3445


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+|||||||+|+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            6899999999988887764    57899999999999999999999997 999999999999999888 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .........+.+||+.|||||++.+..+++.++|||||||++|+|+||+.||.+.+..+....+.+...           
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-----------  229 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-----------  229 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            776666666789999999999998766567899999999999999999999998877776666654210           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                        .++..+|+++++||.+||+.||++|||+.|+++||||+.
T Consensus       230 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                              145568999999999999999999999999999999973

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-63  Score=459.78  Aligned_cols=255  Identities=31%  Similarity=0.531  Sum_probs=222.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|     .+..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            4799999999999999999999999999999999643       23467899999999999999999988     44556


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|||||||+| +|.+.+..    .+.+++..++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla~  180 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  180 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence            8999999985 78777764    46899999999999999999999996 999999999999999888 89999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ......   ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.++.+.-         
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------  250 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---------  250 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            764332   34567999999999999764 48999999999999999999999999988888877776521         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHH------HhCCCCccCCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD------ALIHPFFDELRDPNAR  366 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~e------ll~hp~f~~~~~~~~~  366 (409)
                                          -.++..+|+++++||.+||++||++|+|+.|      +++||||+++.+....
T Consensus       251 --------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          251 --------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             --------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                                0145668999999999999999999999987      5899999999887654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-62  Score=470.84  Aligned_cols=319  Identities=33%  Similarity=0.613  Sum_probs=251.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.|+|||||++++++..... .+..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999996432      334579999999999999999998754321 2345


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+|||||||+|+|.+.+..    .+.+++..++.|++||+.||.|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus       133 ~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceee
Confidence            6889999999988777653    57899999999999999999999996 999999999999999888 89999999998


Q ss_pred             ccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .....     ....+.+||+.|||||++.+..+++.++||||+||++|||++|++||.+.+..+++..|....+.|+...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65332     2345679999999999998877789999999999999999999999999999999999999999998765


Q ss_pred             HhhcCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCC
Q 015298          298 IKCMNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLP  374 (409)
Q Consensus       298 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~  374 (409)
                      +.........   ..++.....+|...++ .+++++++||.+||++||.+|||+.|+|+||||++..++.....    ..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~----~~  361 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD----CA  361 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC----CS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC----CC
Confidence            5433211111   1222223334444433 47999999999999999999999999999999999877654322    22


Q ss_pred             CCCCCCcccccCCCHHHHhhcChHHH
Q 015298          375 PLFNFKSHELKSVPVEILVKLIPEHA  400 (409)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (409)
                      +.+++.. +....+.+.+..++...+
T Consensus       362 ~~~~~~~-~~~~~~~~~~k~~i~~ei  386 (398)
T 4b99_A          362 PPFDFAF-DREALTRERIKEAIVAEI  386 (398)
T ss_dssp             SCCCCHH-HHSCCCHHHHHHHHHHHH
T ss_pred             CCCCCcc-chhhcCHHHHHHHHHHHH
Confidence            3334332 224455666666655443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.2e-62  Score=458.09  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=217.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...|.+.++||+|+||+||+|+++.+|+.||||++...    ...+.+|+++|+.++|||||+++++|..     ...+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            34699999999999999999999999999999999543    3456789999999999999999999844     34589


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||||||+| +|.+++.     ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+..
T Consensus       148 ivmEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~  220 (346)
T 4fih_A          148 VVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQV  220 (346)
T ss_dssp             EEECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceec
Confidence            99999995 6766664     35799999999999999999999996 999999999999999988 8999999999876


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+........         
T Consensus       221 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------  290 (346)
T 4fih_A          221 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------  290 (346)
T ss_dssp             CSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC---------
T ss_pred             CCCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---------
Confidence            543 345578999999999999654 589999999999999999999999999888777776655221100         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                       ..+..+|+++++||.+||+.||++|||+.|+|+||||++...+
T Consensus       291 -----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          291 -----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             -----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence                             0123479999999999999999999999999999999875443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-61  Score=457.93  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=211.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....      ..+.+|+++++.|+|||||+++++|.     +...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence            458999999999999999999999999999999996432      34568999999999999999999884     3455


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +|||||||+ |+|.+.+...  ....+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEcccccce
Confidence            899999998 5788877642  245689999999999999999999996 999999999999999988 89999999998


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...... ...+.+||+.|||||++.+. .|+.++|||||||+||+|+||++||.+.+..+.+.++.+....         
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------  243 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---------  243 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred             eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence            764332 23456899999999999764 5899999999999999999999999999888888777653110         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                         .++..+|+++++||.+||+.||++|||+.|+|+||||++
T Consensus       244 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 -------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                               134468999999999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-60  Score=441.62  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |++.++||+|+||+||+|.++.++..||+|++....      ..+.+|+++++.|+|||||+++++|.... ....+++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            478889999999999999999999999999986432      34568999999999999999999885433 23456889


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecC-CCCcEEEeecCCcc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAK  222 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~-~~~~ikl~Dfg~a~  222 (409)
                      |||||+ |+|.+++..    ...+++..++.|+.||+.||+|||++ |  ||||||||+|||++. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            999999 577777764    46899999999999999999999986 8  999999999999985 55 89999999997


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||+||+|+||+.||.+......+.........|.        
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--------  249 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--------  249 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--------
Confidence            54 3344557789999999999854  489999999999999999999999987666555443332111110        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                        .++...++++++||.+||+.||++|||+.|+|+||||++
T Consensus       250 ------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 ------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                              123447889999999999999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-60  Score=460.24  Aligned_cols=254  Identities=29%  Similarity=0.429  Sum_probs=217.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...|.+.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|..     ...+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEE
Confidence            35799999999999999999999999999999999643    3456789999999999999999999854     34589


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||||||+| +|.+++.     ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+..
T Consensus       225 iVmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~  297 (423)
T 4fie_A          225 VVMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceEC
Confidence            99999995 6766664     35799999999999999999999996 999999999999999988 8999999999876


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.......          
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------  366 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------  366 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred             CCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------
Confidence            443 345578999999999999654 58999999999999999999999999988877777665421100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                      ...+..+|+++++||.+||+.||++|||+.|+|+||||++...
T Consensus       367 ----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          367 ----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             ----------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence                            0123458999999999999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-61  Score=446.82  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++.+.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++++.++|||||+++++|.     +.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence            47999999999999999999974   46889999998643      234568999999999999999999884     34


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+|||||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            45899999999 577777764    56899999999999999999999996 999999999999999988 899999999


Q ss_pred             cccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      |+.... .....+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+.+..  +      
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------  243 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------  243 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C------
Confidence            986543 3345578899999999999764 58999999999999999999999999988888877776521  0      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPN  364 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~  364 (409)
                                           .++..+|+++++||.+||+.||++|||     ++|+++||||+++++..
T Consensus       244 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          244 ---------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence                                 145568999999999999999999998     57999999999886543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-60  Score=448.86  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=215.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEEe
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (409)
                      ...|.+.++||+|+||+||+|+++.+|+.||||++..+. ...+|+.+++.++|||||++++++.     +..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            457999999999999999999999999999999997643 3457999999999999999999884     3455899999


Q ss_pred             ccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          150 YVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       150 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      ||+ |+|.+++..    .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999 578887764    46799999999999999999999986 999999999999999887569999999998764432


Q ss_pred             C------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          229 P------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       229 ~------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .      ....+||+.|||||++.+. .|+.++|||||||+||||+||++||.+.+..+.+.++...  .++        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------
T ss_pred             cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------
Confidence            1      2235799999999999764 5899999999999999999999999887776666666542  110        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH-------------hCCCCccCCCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA-------------LIHPFFDELRDPN  364 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el-------------l~hp~f~~~~~~~  364 (409)
                                      ...++..+|+++.+||.+||+.||.+|||+.|+             |+|||+.+..+|.
T Consensus       275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                            011456789999999999999999999999997             6899999887664

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.1e-59  Score=456.48  Aligned_cols=334  Identities=68%  Similarity=1.176  Sum_probs=297.3

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCC-CCccEEE
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLN  145 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  145 (409)
                      .....+|.+.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||++++++++.... .+..+++
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            345668999999999999999999999999999999998877777899999999999999999998865433 4566788


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||+++++...+..+......+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++...
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9999999998888887777778999999999999999999999986 999999999999999776579999999998776


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++.++.+.++.|..+.+..+++.+
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            66666778899999999999776679999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCccccc
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELK  385 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (409)
                      .++.++.+...+|...++..+++++.+||.+||++||.+|||+.|+++||||+++.++....+.....|.+++|...++.
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS  368 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhc
Confidence            99999999999999999999999999999999999999999999999999999999888777777778899999988876


Q ss_pred             CCCHHHHhhcChHHHhh
Q 015298          386 SVPVEILVKLIPEHARK  402 (409)
Q Consensus       386 ~~~~~~~~~~~~~~~~~  402 (409)
                      +.+ +....++|++.+.
T Consensus       369 ~~~-~~~~~~~~~~~~~  384 (420)
T 1j1b_A          369 SNP-PLATILIPPHARI  384 (420)
T ss_dssp             TCG-GGHHHHSCTTTTC
T ss_pred             cCh-hHHHhhCCHhhhh
Confidence            644 4444455555443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-59  Score=455.01  Aligned_cols=332  Identities=51%  Similarity=0.993  Sum_probs=288.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCC----------
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD----------  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----------  138 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++..+.....+|+++++.++||||++++++++....          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            3458999999999999999999999999999999998887777899999999999999999998866443          


Q ss_pred             -----------------------CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcE
Q 015298          139 -----------------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC  195 (409)
Q Consensus       139 -----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~iv  195 (409)
                                             .+..++++||||++++|.+.+..+......+++..++.++.||+.||.|||++ ||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~  163 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GIC  163 (383)
T ss_dssp             -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEE
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cCc
Confidence                                   34556889999999999999888777788999999999999999999999986 999


Q ss_pred             eecCCCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 015298          196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP  275 (409)
Q Consensus       196 H~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~  275 (409)
                      ||||||+||+++.+.+.+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence            99999999999854448999999999877666667778899999999999776679999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 015298          276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP  355 (409)
Q Consensus       276 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp  355 (409)
                      +.+..+.+..+.+.++.|..+.+..+++.+.+..++......|...++..+++++.+||.+||++||.+|||+.|+|+||
T Consensus       244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (383)
T 3eb0_A          244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP  323 (383)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCC-------CCCCCCCC--CCCCCCCCCCcccccCCCHHHHhhcChHHHh
Q 015298          356 FFDELRD-------PNARLPSG--RFLPPLFNFKSHELKSVPVEILVKLIPEHAR  401 (409)
Q Consensus       356 ~f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (409)
                      ||+++++       +....+..  ..+|.+++|...+++..+.+...+++|.+..
T Consensus       324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            9998754       22333333  6688999999999998888999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-58  Score=449.62  Aligned_cols=330  Identities=66%  Similarity=1.167  Sum_probs=299.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCC-CCccEEEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLV  147 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv  147 (409)
                      ...+|.+.+.||+|+||+||+|++..+++ +|+|++..+.....+|+++++.++||||++++++++.... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            45689999999999999999999887766 9999998877777899999999999999999999876654 556678899


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec-CCCCcEEEeecCCcccccc
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~-~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+++++...+..+......+++..++.++.||+.||.|||++ ||+||||||+|||++ .++ .+||+|||+++....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            99999988888877777788999999999999999999999986 999999999999999 555 899999999988766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcc
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  306 (409)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|..+.+..+++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            76777888999999999997776799999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 015298          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKS  386 (409)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (409)
                      ...++.....++...++..+++++.+||.+||++||.+|||+.++++||||+++++.....+....+|++++|+..++..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV  354 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence            88999998899999999999999999999999999999999999999999999999888888888899999999988776


Q ss_pred             CCHHHHhhcChHHHhh
Q 015298          387 VPVEILVKLIPEHARK  402 (409)
Q Consensus       387 ~~~~~~~~~~~~~~~~  402 (409)
                      .+ +.+..++|.+.+.
T Consensus       355 ~~-~~~~~~~~~~~~~  369 (394)
T 4e7w_A          355 RP-DLISRLVPQHAEA  369 (394)
T ss_dssp             CG-GGHHHHSCGGGCS
T ss_pred             CH-HHHHhhccHhhhh
Confidence            55 7788888877643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.2e-58  Score=436.88  Aligned_cols=281  Identities=27%  Similarity=0.462  Sum_probs=215.9

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--hhhHHHHHHHHhc-CCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...++|++.+.||+|+||+||+|+++   .+++.||+|++....  ....+|+++|+.+ +||||++++++|.     ..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----EC
Confidence            34567999999999999999999875   467899999986543  3456899999998 6999999999884     44


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++|||||||+| +|.+.+       ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||+|||+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            568999999984 665554       3589999999999999999999986 9999999999999998755899999999


Q ss_pred             ccccccCC-----------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 015298          221 AKVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK  271 (409)
Q Consensus       221 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~  271 (409)
                      |+......                             ...+.+||+.|+|||++.+...|+.++||||+||++|+|++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            97543221                             1234579999999999987777999999999999999999999


Q ss_pred             CCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCC-------cc--------------ccccCcc----cCCCCcccCCCC
Q 015298          272 PLFP-GDSGVDQLVEIIKVLGTPTREEIKCMNPN-------YT--------------EFKFPQI----KAHPWHKIFPKR  325 (409)
Q Consensus       272 ~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~~----~~~~~~~~~~~~  325 (409)
                      .||. +.+..+++..|.+..|.+...........       ..              ....+..    ............
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9985 55677888888888876544332211000       00              0000000    000001112345


Q ss_pred             CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          326 MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       326 ~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      +|++++|||++||++||++|+|+.|+|+||||+++.
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            899999999999999999999999999999999763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-57  Score=422.48  Aligned_cols=261  Identities=24%  Similarity=0.393  Sum_probs=192.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCC-------
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-------  138 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------  138 (409)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++....     ..+.+|+++|+.|+|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999986432     345689999999999999999998865442       


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ....++|||||||. |+|.+.+.... .....+...++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            23456899999998 47777765421 122345667889999999999999997 999999999999999888 899999


Q ss_pred             cCCccccccCCC-------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015298          218 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (409)
Q Consensus       218 fg~a~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (409)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||...  .+...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence            999987644321             2346799999999999764 58999999999999999996   77543  22222


Q ss_pred             HHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      .+........+..                         ....++.+.+||.+||+.||.+|||+.|+|+||||+++.++.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222211111000                         012467789999999999999999999999999999887664


Q ss_pred             C
Q 015298          365 A  365 (409)
Q Consensus       365 ~  365 (409)
                      .
T Consensus       291 ~  291 (299)
T 4g31_A          291 K  291 (299)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.8e-57  Score=453.62  Aligned_cols=272  Identities=25%  Similarity=0.370  Sum_probs=218.4

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHH---HHHHHHhcCCCCeecccceeeec
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFST  136 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---e~~~l~~l~h~niv~~~~~~~~~  136 (409)
                      +...++|.+.+.||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            344678999999999999999999999999999999996431       12223   35566677999999999988   


Q ss_pred             CCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          137 TDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                        .+..++|||||||+| +|...+..    .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.+| .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEEe
Confidence              455568999999995 77777654    57899999999999999999999986 999999999999999998 7999


Q ss_pred             eecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||+||+|++|.+||.+.+..+...........+  
T Consensus       334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--  410 (689)
T 3v5w_A          334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--  410 (689)
T ss_dssp             CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--
T ss_pred             cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--
Confidence            999999876443 34567999999999999765669999999999999999999999997654322221111111110  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCCCC--CCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDPNA--RLP  368 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~~~--~~~  368 (409)
                                              ..++..+|+++++||.+||+.||.+|++     +.|+++||||+++.|...  +..
T Consensus       411 ------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~  466 (689)
T 3v5w_A          411 ------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY  466 (689)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCS
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCC
Confidence                                    1156678999999999999999999998     799999999999987643  222


Q ss_pred             CCCCCCCC
Q 015298          369 SGRFLPPL  376 (409)
Q Consensus       369 ~~~~~~~~  376 (409)
                      .++++|+.
T Consensus       467 ~pP~~P~~  474 (689)
T 3v5w_A          467 PPPLIPPR  474 (689)
T ss_dssp             CCSCCCCT
T ss_pred             CcCccCCC
Confidence            34455543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-55  Score=444.91  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=222.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|++....    ....+|+.+|+.|+|||||+++++|     .+...++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            368999999999999999999999999999999986543    3456899999999999999999998     4455689


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-CCcEEEeecCCccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-~~~ikl~Dfg~a~~  223 (409)
                      ||||||.| +|.+.+.   .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985 6655553   2346799999999999999999999996 99999999999999864 23899999999998


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..........+||+.|||||++.+. .|+.++|||||||+||+|++|.+||.+.+..+.+..+.+.....+.        
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  377 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  377 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS--------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc--------
Confidence            8766666778999999999999764 5899999999999999999999999999888887777653221111        


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                                       .....+|+++++||.+||+.||.+|||+.|+|+||||+...++.
T Consensus       378 -----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          378 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                             12235899999999999999999999999999999999876654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.6e-55  Score=406.44  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||+||+|++.     .+|..||||++....    +.+.+|+++|++++|||||++++++..     
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence            457999999999999999999875     368899999996542    346689999999999999999999843     


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFN---------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      ...++||||||+ |+|.+.+....         .....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCC
Confidence            334789999998 68888886532         2245799999999999999999999996 999999999999999888


Q ss_pred             CcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015298          211 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  286 (409)
                       .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             899999999986544322   2235689999999999764 49999999999999999998 99999998887777766


Q ss_pred             HHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      .+....                            ..|..+|+++.+||.+||+.||++|||+.++  |+|++++
T Consensus       244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            553110                            1355689999999999999999999999999  5677654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-54  Score=407.49  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=200.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.++||+|+||+||+|+++     .++..||||++....    +.+.+|+++|++++|||||++++++..     
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence            457999999999999999999865     468899999996542    446789999999999999999999843     


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNK-----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                      ...++||||||+ |+|.+++.....           ....+++..+..|+.||+.||.|||++ +||||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECC
Confidence            334889999999 578887764321           235699999999999999999999986 9999999999999998


Q ss_pred             CCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015298          209 HTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (409)
Q Consensus       209 ~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (409)
                      ++ .+||+|||+|+......   .....+||+.|||||++.+. .++.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            88 89999999998654332   22346789999999999664 58999999999999999999 999999988877776


Q ss_pred             HHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+.+....                            ..|..+++++.+||.+||+.||++|||+.|++++
T Consensus       272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66543111                            1455689999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-54  Score=403.67  Aligned_cols=249  Identities=22%  Similarity=0.273  Sum_probs=205.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..++++.++||+|+||+||+|...     .+++.||||++...     .+.+.+|+.++++++|||||++++++..    
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence            346889999999999999999863     46789999998643     2456789999999999999999998843    


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                       ...++||||||+ |+|.+++....            .....+++..+..|+.||+.||.|||++ +||||||||+|||+
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence             333789999998 68888876432            1235689999999999999999999986 99999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015298          207 NPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQ  282 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  282 (409)
                      +.++ .+||+|||+|+......   .....+||+.|||||++.+. .++.++|||||||+||||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9888 89999999998654332   23456789999999999765 49999999999999999998 8999999887777


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +..+......                            ..|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       257 ~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6665432111                            1355689999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-53  Score=419.10  Aligned_cols=329  Identities=31%  Similarity=0.523  Sum_probs=244.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++.........
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            346899999999999999999999999999999998653      23456899999999999999999988665444445


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||++++|..++..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++
T Consensus       131 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             eEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccch
Confidence            6889999999988877754    56799999999999999999999986 999999999999999988 89999999998


Q ss_pred             ccccCC----------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-----
Q 015298          223 VLVKGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-----  269 (409)
Q Consensus       223 ~~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-----  269 (409)
                      ......                            .....+||++|+|||++.....++.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654221                            22456789999999987666679999999999999999999     


Q ss_pred             ------CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhhcCCCccc---cccCcccCCCCcc
Q 015298          270 ------GKPLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHK  320 (409)
Q Consensus       270 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  320 (409)
                            |.++|.+..                    ..+++..+...++.|..+.+.........   ..++......+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  778887654                    35778889999999998876654321110   0112222223333


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCcccccCCCHHHHhhcChHHH
Q 015298          321 IFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHA  400 (409)
Q Consensus       321 ~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (409)
                      .++ ..++++.+||.+||++||.+|||+.|+|+||||+++.++...........  +.|+  +....+.+.+..++.+.+
T Consensus       365 ~~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~e~  439 (458)
T 3rp9_A          365 RFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR--LPFN--DWMNMDEPQLRYAFVKEI  439 (458)
T ss_dssp             GST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--CSSC--TTSCCCHHHHHHHHHHHH
T ss_pred             HCC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--CCcc--ccccCCHHHHHHHHHHHH
Confidence            333 46999999999999999999999999999999999987765433322222  2233  234567788888888888


Q ss_pred             hhhCCCCC
Q 015298          401 RKQCPFLG  408 (409)
Q Consensus       401 ~~~~~~~~  408 (409)
                      .+.+|-+.
T Consensus       440 ~~~~~~~~  447 (458)
T 3rp9_A          440 QRYHPEIQ  447 (458)
T ss_dssp             TTTCTTCC
T ss_pred             HHhCcccc
Confidence            87776543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-54  Score=398.89  Aligned_cols=248  Identities=23%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...++.+.++||+|+||+||+|++.   ..||||+++..      .+.+.+|++++++++|||||++++++..    +  
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--  104 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--  104 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--
Confidence            3457889999999999999999863   35999998632      2345689999999999999999997621    1  


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++||||||+ |+|.+.+..   ....+++..+..|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGla  179 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLA  179 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSSC
T ss_pred             eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccCc
Confidence            2579999999 577776653   246799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCC---CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +......   .....+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||.+.+..+.+..+......++. 
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-  258 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-  258 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-
Confidence            8654322   23456899999999999643  34899999999999999999999999988777666555442111100 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                            ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       259 ----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          259 ----------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             ----------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ----------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                  01134568999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.3e-53  Score=404.95  Aligned_cols=317  Identities=47%  Similarity=0.890  Sum_probs=257.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch---hhHHHHHHHHhcCCCCeecccceeeecCC--CCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTD--KDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~  144 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++..+..   ...++++.++.++||||+++++++.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            4589999999999999999999999999999999866543   34456777788899999999998876543  445568


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCcEeecCCCCceeecC-CCCcEEEeecCCc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--RSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSA  221 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~ivH~Dlkp~NIli~~-~~~~ikl~Dfg~a  221 (409)
                      ++||||+++++...+.........+++..++.++.||+.||.|||  +. ||+||||||+|||++. ++ .+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADG-TLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence            899999999988887776666788999999999999999999999  86 9999999999999997 55 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            87766666667789999999999977666899999999999999999999999999999999999999999999988888


Q ss_pred             CCCccccccCcccCCCCcccCCC---CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCC-CCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLP-PLF  377 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~---~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~-~~~  377 (409)
                      .+......+......+|...++.   ..++++.+||.+||+.||.+|||+.|+|+||||+++.++....+....+| ..+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  339 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLF  339 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGG
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHH
Confidence            77766666555555555555443   36789999999999999999999999999999999988877666555555 445


Q ss_pred             CCCcccccCCC
Q 015298          378 NFKSHELKSVP  388 (409)
Q Consensus       378 ~~~~~~~~~~~  388 (409)
                      .|...+.....
T Consensus       340 ~~~~~~~~~~~  350 (360)
T 3e3p_A          340 RFLPNEIEVMS  350 (360)
T ss_dssp             CCCHHHHHHSC
T ss_pred             HcCchHHHHHH
Confidence            55555544443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-53  Score=410.15  Aligned_cols=320  Identities=30%  Similarity=0.595  Sum_probs=238.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcC-CCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence            45899999999999999999999999999999998543      233457999999997 99999999987542   233


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||++++|...+..     ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            5789999999988877763     5799999999999999999999986 999999999999999988 89999999997


Q ss_pred             ccccC----------------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 015298          223 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (409)
Q Consensus       223 ~~~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (409)
                      .....                      ......+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      12234689999999999977667999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCccccccCc------ccCCCCccc------------CCCCCChhHHHHHHHhcccCC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ------IKAHPWHKI------------FPKRMPPEAVDLVSRLLQYSP  342 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------------~~~~~s~~l~~li~~~L~~dp  342 (409)
                      +++..+...++.|..+.+......+.......      .....+...            ....+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            99999999999998877654432211100000      000111111            123578999999999999999


Q ss_pred             CCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCcccccCCCHHHHhhcChHHHhhh
Q 015298          343 NLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ  403 (409)
Q Consensus       343 ~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (409)
                      .+|||+.|+|+||||+.+.++.............+  .  .....+++.+..++...+...
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~  374 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPI--N--DNVKHSIDDYRNLVYSEISRR  374 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC----------CCHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCc--c--ccccCCHHHHHHHHHHHHHHh
Confidence            99999999999999998877665443333332222  2  122345677776666655443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-52  Score=409.26  Aligned_cols=327  Identities=31%  Similarity=0.497  Sum_probs=251.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999653      234568999999999999999999886543333345


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            889999999988887754    56799999999999999999999996 999999999999999888 899999999987


Q ss_pred             cccCC-----------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-----------
Q 015298          224 LVKGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-----------  269 (409)
Q Consensus       224 ~~~~~-----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-----------  269 (409)
                      .....                       .....+||++|+|||++.....++.++|||||||++|+|++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            64332                       12567889999999997666679999999999999999998           


Q ss_pred             CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCCCcccc---ccCcccCCCCcccCCCCCChh
Q 015298          270 GKPLFPGDS-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFPKRMPPE  329 (409)
Q Consensus       270 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~  329 (409)
                      |.++|.+.+                 ..+++..+...+|.|..+.+..........   .++.....++...+ ..++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence            455555543                 367888899999999988776543211100   11111112222222 348999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCcccccCCCHHHHhhcChHHHhhhCCCC
Q 015298          330 AVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCPFL  407 (409)
Q Consensus       330 l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (409)
                      +.+||.+||++||.+|||+.|+|+||||+++.++...........  +.|+  .....+.+.+..++...+...+|-+
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~e~~~~~~~~  411 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKII--LPFD--DWMVLSETQLRYIFLKEVQSFHPEL  411 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCC--CSSC--TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCC--CChh--hcccCCHHHHHHHHHHHHHHhCccc
Confidence            999999999999999999999999999999988765433222222  2233  2245667888888888887777654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-52  Score=416.17  Aligned_cols=286  Identities=32%  Similarity=0.567  Sum_probs=227.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            45899999999999999999999999999999999653      2345589999999999999999998854332 2334


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||+++++...+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            578999999998766553      4589999999999999999999996 999999999999999988 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            77666566678999999999999765 58999999999999999999999999999999999999999999887765543


Q ss_pred             CCcccc--ccCcccCCCCcccCCCC-----------CChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          303 PNYTEF--KFPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       303 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      .....+  ..+......+...++..           .++++++||.+||++||.+|||+.|+|+||||+.+.++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence            221111  01111111122222221           156799999999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.1e-52  Score=387.95  Aligned_cols=282  Identities=34%  Similarity=0.561  Sum_probs=227.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            47999999999999999999999999999999996432      344589999999999999999998843     3458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+++++...+..   ..+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            89999999987776553   256799999999999999999999996 999999999999999888 8999999999865


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL-FPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            433 2334567899999999997766689999999999999999987766 66777788888899988888776554332


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      ........+..............+++++++||.+||+.||.+|||+.|+|+||||+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            111111111111111122233458999999999999999999999999999999997653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.3e-53  Score=401.08  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=205.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCC-----CcEEEEEEeeccc-----hhhHHHHHHHHhcCC-CCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDH-PNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  138 (409)
                      ..+|.+.+.||+|+||+||+|.+..+     ++.||||.+....     +.+.+|+++|+.++| ||||++++++...  
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~--  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence            46899999999999999999997654     4689999986532     345689999999976 8999999987432  


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCcee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIl  205 (409)
                        ...++||||||+ |+|.+++......            ...+++..+..++.||+.||.|||++ +||||||||+|||
T Consensus       141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  217 (353)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCcccee
Confidence              223679999999 6888888754321            34589999999999999999999996 9999999999999


Q ss_pred             ecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015298          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (409)
Q Consensus       206 i~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (409)
                      ++.++ .+||+|||+|+.......   ....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99888 899999999986644332   2346789999999999764 59999999999999999998 999999877655


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+..+......+                           ..|..+++++.+||.+||+.||.+|||+.++++|
T Consensus       296 ~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555444321111                           1455689999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-51  Score=391.10  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=220.4

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+++++.++||||+++++++.     ..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            44668999999999999999999999999999999986532      23458999999999999999999883     34


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||++ ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~  160 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFGF  160 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeeccC
Confidence            45889999997 477776654    46799999999999999999999996 999999999999999888 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....         
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------  231 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---------  231 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            98776666666788999999999998766556899999999999999999999998887776666554210         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                          .++..+++++.+||.+||+.||.+|||+.++++||||+...+.
T Consensus       232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                                1344579999999999999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8e-52  Score=389.64  Aligned_cols=281  Identities=36%  Similarity=0.665  Sum_probs=227.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++....      ....+|+++++.++||||+++++++     ....
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence            3468999999999999999999985 58999999986432      3456899999999999999999988     3444


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ++++||||+++++.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCce
Confidence            5889999999988777653   245699999999999999999999986 999999999999999888 89999999998


Q ss_pred             ccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          223 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       223 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+...++.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            65433 23345678999999999977667899999999999999999999999999999999999999888876554432


Q ss_pred             CCC--ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          302 NPN--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       302 ~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ...  +....+......++.. +...+++++.+||.+||++||.+|||+.|+|+||||+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            211  0011111112222222 2345789999999999999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-51  Score=394.23  Aligned_cols=320  Identities=31%  Similarity=0.549  Sum_probs=244.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+++++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            357999999999999999999999999999999985431      334689999999999999999998854322 1123


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||++++|..++..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeeccc
Confidence            4679999998888877763     5799999999999999999999986 999999999999999888 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.|+.+.+....
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6533  34457889999999999775679999999999999999999999999999999999999999999887765543


Q ss_pred             CCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      .....   ..++......+... ....++.+.+||.+||+.||.+|||+.++|+||||+.+.++.......     .+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-----~~~~  328 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-----KYDD  328 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-----CCCC
T ss_pred             hHHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-----CCCC
Confidence            22111   11222333344433 345799999999999999999999999999999999987765432211     2333


Q ss_pred             CcccccCCCHHHHhhcChHHHhhhCC
Q 015298          380 KSHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      ...+ .....+.|.+.+.......+|
T Consensus       329 ~~~~-~~~~~~~~~~~~~~~~~~~~~  353 (367)
T 1cm8_A          329 SFDD-VDRTLDEWKRVTYKEVLSFKP  353 (367)
T ss_dssp             C------CCHHHHHHHHHHHHHTCCC
T ss_pred             Chhh-hcCCHHHHHHHHHHHHHHhcc
Confidence            2222 244567788877777666554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=386.47  Aligned_cols=285  Identities=31%  Similarity=0.531  Sum_probs=230.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhc---CCCCeecccceeeecC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~  137 (409)
                      ..+|++.+.||+|+||+||+|++..+|+.||+|++....         ....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            458999999999999999999999999999999986322         2455788777766   4999999999887665


Q ss_pred             CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ......+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEee
Confidence            55556789999999998888776422  34499999999999999999999996 999999999999999887 899999


Q ss_pred             cCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       218 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998776666666788999999999997654 89999999999999999999999999999999999999988887655


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      +..... .....++.....++.. ....+++++.+||.+||++||.+|||+.++|+||||++..
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            432211 1111122111122222 2345899999999999999999999999999999998643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.5e-51  Score=391.42  Aligned_cols=323  Identities=31%  Similarity=0.604  Sum_probs=252.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....     ....+|+++++.++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            458999999999999999999999999999999996432     345689999999999999999998865544444568


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEec
Confidence            89999999988887753     5799999999999999999999996 999999999999999888 8999999999865


Q ss_pred             ccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....    .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43322    24468899999999987766789999999999999999999999999999999999999999998877654


Q ss_pred             cCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCC
Q 015298          301 MNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLF  377 (409)
Q Consensus       301 ~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  377 (409)
                      .......   ...+.....+|... ...+++++.+||.+||++||.+|||+.++|+||||++..++....    .....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~  333 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  333 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHh-CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence            3211000   01111122222222 235789999999999999999999999999999999886554322    122233


Q ss_pred             CCCcccccCCCHHHHhhcChHHHhhhCC
Q 015298          378 NFKSHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      .++ .++..++.+.+..++.....+..|
T Consensus       334 ~~~-~~~~~~~~~~~~~~~~~e~~~~~~  360 (364)
T 3qyz_A          334 KFD-MELDDLPKEKLKELIFEETARFQP  360 (364)
T ss_dssp             CCC------CCHHHHHHHHHHHTGGGCC
T ss_pred             Ccc-cccccCCHHHHHHHHHHHHHHhhh
Confidence            333 244567777777777665554443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-51  Score=388.36  Aligned_cols=289  Identities=31%  Similarity=0.554  Sum_probs=218.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++     .....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            47999999999999999999999999999999986432     3456899999999999999999988     4445688


Q ss_pred             EEEeccchhHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          146 LVLEYVPETVHRVVKHFNK--LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +||||++++|.+.+.....  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999998888775432  224689999999999999999999986 999999999999999888 899999999986


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            5432 233456789999999999766668999999999999999999999999999999999999988887765443321


Q ss_pred             C--CccccccCcccCCCC----cccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCC
Q 015298          303 P--NYTEFKFPQIKAHPW----HKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL  367 (409)
Q Consensus       303 ~--~~~~~~~~~~~~~~~----~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~  367 (409)
                      .  .+.. .+.......+    .......+++++.+||.+||+.||.+|||+.|+|+||||++....+...
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~  307 (317)
T 2pmi_A          238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMG  307 (317)
T ss_dssp             GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-----
T ss_pred             hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhcc
Confidence            1  0000 0000001111    1123346889999999999999999999999999999999987765443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=391.03  Aligned_cols=292  Identities=33%  Similarity=0.630  Sum_probs=230.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.....     ...+|+++++.++||||+++++++..     ...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            479999999999999999999999999999999864322     33469999999999999999998843     34478


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      +||||++++|...+...   ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999888777642   45699999999999999999999986 999999999999999888 89999999987654


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 2335678999999999977667899999999999999999999999999999999999999998877655432211


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCC
Q 015298          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFL  373 (409)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~  373 (409)
                        +....++......+.. ....+++++.+||.+||+.||.+|||+.|+|+||||.++.......+.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~  301 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI  301 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence              1111112111111111 2345789999999999999999999999999999999987766555444433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.6e-51  Score=380.84  Aligned_cols=277  Identities=35%  Similarity=0.660  Sum_probs=221.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+|.+.+.||+|+||+||+|.+ .+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4799999999999999999998 679999999985432      345689999999999999999998843     3348


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            899999999887776542   36799999999999999999999996 999999999999999888 8999999998765


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            432 223456789999999999766668999999999999999999999999999999999999888877654443211 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                       +.+. ..+......+|.. +...+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       231 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYD-PNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCC-TTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccc-cccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             0000 0111112222322 334689999999999999999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=393.25  Aligned_cols=254  Identities=27%  Similarity=0.489  Sum_probs=211.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|..+++.+ +||||+++++++     ..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence            3468999999999999999999999999999999997532       3345788999988 799999999988     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DFG  169 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFG  169 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEcccc
Confidence            4568999999985 66666654    46799999999999999999999996 999999999999999888 89999999


Q ss_pred             Cccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  240 (353)
T 3txo_A          170 MCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------  240 (353)
T ss_dssp             TCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             ceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            997533 23344567899999999999654 48999999999999999999999999988888777776521        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------LDALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~------~ell~hp~f~~~~~~  363 (409)
                                           ..++..+++++.+||++||+.||.+||++      .++++||||+++.+.
T Consensus       241 ---------------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          241 ---------------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                                 11455689999999999999999999998      899999999998654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-51  Score=399.11  Aligned_cols=303  Identities=26%  Similarity=0.406  Sum_probs=234.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++     ...
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            356899999999999999999999999999999998642       23466899999999999999999988     445


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++++||||++ |+|..++.     ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEeccce
Confidence            56899999997 57777664     25699999999999999999999986 999999999999999888 899999999


Q ss_pred             ccccccCCC--CccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++.......  ....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+..+...++.......  
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  292 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--  292 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--
Confidence            976544322  33678999999999996543   27789999999999999999999999988888877776532100  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCCCC--CCCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRDPN--ARLPSGR  371 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~~~--~~~~~~~  371 (409)
                                   .++          ....+++++++||.+||+.+|.+  |+++.++++||||+++.+..  .+....+
T Consensus       293 -------------~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p  349 (410)
T 3v8s_A          293 -------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP  349 (410)
T ss_dssp             -------------CCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCS
T ss_pred             -------------cCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCC
Confidence                         000          11257999999999999999988  99999999999999986643  2333344


Q ss_pred             CCCCC------CCCCcccccCCCHHHHhhcChHHHhhhCCCCCC
Q 015298          372 FLPPL------FNFKSHELKSVPVEILVKLIPEHARKQCPFLGL  409 (409)
Q Consensus       372 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (409)
                      ++|.+      .+|+...-...+.+ ....-+.....|.+|.||
T Consensus       350 ~~p~~~~~~d~~~fd~~~~~~~~~~-~~~~~~~~~~~~~~f~~f  392 (410)
T 3v8s_A          350 VVPDLSSDIDTSNFDDLEEDKGEEE-TFPIPKAFVGNQLPFVGF  392 (410)
T ss_dssp             CCCCCSSTTCCTTSCCCCSCCSCCC-CCCCCSSCCCTTGGGTTC
T ss_pred             CCCcCCCccchhhcCCccccccccc-cCCCchhhcccccccccc
Confidence            45544      34554332111110 000011123468889886

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-51  Score=401.51  Aligned_cols=273  Identities=24%  Similarity=0.398  Sum_probs=225.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|..+++.++||||+++++++     ....
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            45899999999999999999999999999999999642       23367899999999999999999988     4445


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+. |+|...+..   ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            6899999997 577776653   246799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCC--Ccccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          222 KVLVKGEP--NISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       222 ~~~~~~~~--~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +.......  ....+||+.|+|||++.    +...++.++|||||||++|||++|+.||.+.+..+...++.......  
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--  300 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--  300 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc--
Confidence            76544333  23468999999999986    23458999999999999999999999999988888877776431100  


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCC--CCCHHHHhCCCCccCCCCCCCCCCCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTALDALIHPFFDELRDPNARLPSGRFL  373 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~--R~s~~ell~hp~f~~~~~~~~~~~~~~~~  373 (409)
                                   .++.         ....+++++++||++||+.+|++  |+++.++++||||+++.+...+....+++
T Consensus       301 -------------~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~  358 (437)
T 4aw2_A          301 -------------QFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI  358 (437)
T ss_dssp             -------------CCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred             -------------cCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCC
Confidence                         0000         12347999999999999998888  99999999999999999887755555555


Q ss_pred             CCC
Q 015298          374 PPL  376 (409)
Q Consensus       374 ~~~  376 (409)
                      |.+
T Consensus       359 P~~  361 (437)
T 4aw2_A          359 PEV  361 (437)
T ss_dssp             CCC
T ss_pred             CcC
Confidence            544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-50  Score=388.36  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=218.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||+|++....          ..+.+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4567999999999999999999999999999999996532          3456899999999999999999988     


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEE
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ik  214 (409)
                      .....+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEE
Confidence            34455889999997 577666643    56799999999999999999999986 9999999999999987653   699


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999999877666666678899999999999654 589999999999999999999999999887777776654322211


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ..                         +...+++++++||.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            11                         1234789999999999999999999999999999998654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.9e-51  Score=392.75  Aligned_cols=319  Identities=31%  Similarity=0.545  Sum_probs=236.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998643      2344589999999999999999998754321 11234


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++|+|+++++|.+++..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            679999999888777653     6799999999999999999999986 999999999999999888 899999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            533  234578899999999997756799999999999999999999999999999999999999999998877655432


Q ss_pred             Cccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCC
Q 015298          304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFK  380 (409)
Q Consensus       304 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  380 (409)
                      ....   ..++..+...+...+ ...++.+.+||.+||++||.+|||+.++|+||||+++.++......     ..+.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~-----~~~~~~  333 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-----DPYDQS  333 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCC-----CCCCGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCC-----CCCCcc
Confidence            2111   011222223333333 3478999999999999999999999999999999998776543221     123332


Q ss_pred             cccccCCCHHHHhhcChHHHhhhCC
Q 015298          381 SHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      . +......+.+..++........|
T Consensus       334 ~-~~~~~~~~~~~~~~~~e~~~~~~  357 (367)
T 2fst_X          334 L-ESRDLLIDEWKSLTYDEVISFVP  357 (367)
T ss_dssp             G-SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             h-hhccCCHHHHHHHHHHHHHHhcc
Confidence            2 22355678888888877766554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.2e-51  Score=388.57  Aligned_cols=285  Identities=31%  Similarity=0.563  Sum_probs=224.6

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            34568999999999999999999999999999999986432      234589999999999999999998843     3


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC----CcEEEee
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCD  217 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~----~~ikl~D  217 (409)
                      ..+++||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            45889999999988887764    56799999999999999999999996 999999999999995332    2699999


Q ss_pred             cCCccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          218 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       218 fg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999765432 233456789999999999776668999999999999999999999999999999999999988887765


Q ss_pred             HHhhcCCC-ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          297 EIKCMNPN-YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       297 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .+...... .....++......+...++..+++++.+||.+||+.||.+|||+.|+|+||||++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            44322100 0001122222222333334447899999999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.1e-50  Score=382.53  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=215.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            45899999999999999999999999999999999653       23456799999999999999999988     3444


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58899999985 66666553    46799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  221 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            7643 33345567899999999999654 58999999999999999999999998887766666554310          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                         ..++..+++++.+||.+||+.||.+||     ++.++++||||+.+.+.
T Consensus       222 -------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          222 -------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                               014556899999999999999999999     99999999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.5e-51  Score=387.86  Aligned_cols=254  Identities=26%  Similarity=0.483  Sum_probs=215.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||.||+|+++.+|+.||+|++.+..       .....|..+++.+ +||||+++++++     ..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            3458999999999999999999999999999999996532       3345788888876 999999999988     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeECh
Confidence            4558999999974 77766654    46799999999999999999999996 999999999999999888 89999999


Q ss_pred             Ccccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  234 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  234 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9976432 2334567899999999999664 48999999999999999999999999888777666654410        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~-ell~hp~f~~~~~~  363 (409)
                                           ..++..+++++.+||.+||+.||.+||++. ++++||||+++.+.
T Consensus       235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                                 114456899999999999999999999998 99999999988654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-50  Score=385.23  Aligned_cols=285  Identities=33%  Similarity=0.582  Sum_probs=228.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++...         .....+|+.+++.++||||+++++++.     .
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----H   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----e
Confidence            45799999999999999999999999999999998642         134568999999999999999999883     3


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...+++||||+++++...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            344789999999987766543   245689999999999999999999996 999999999999999888 899999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            9866433 234456789999999999766668999999999999999999999999999999999999988888776554


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      ..........+......++.. +...+++++.+||.+||+.||.+|||+.|+|+||||++...+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            332211111111111112222 12457899999999999999999999999999999998765543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-51  Score=391.47  Aligned_cols=253  Identities=27%  Similarity=0.457  Sum_probs=214.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence            3456899999999999999999999999999999998643       235678999999999999999999884     3


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...+++||||++|++.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEecc
Confidence            345889999999888877764    46799999999999999999999997 999999999999999887 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+...                
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------  218 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------  218 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence            9877666666678899999999999776655889999999999999999999997643211100                


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                 .+.  .....++..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       219 -----------~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          219 -----------KVN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             -----------CCC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             -----------HHH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                       000  01112456689999999999999999999999999999999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-50  Score=381.30  Aligned_cols=251  Identities=26%  Similarity=0.463  Sum_probs=216.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            45899999999999999999999999999999999643       23445799999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCcc
Confidence            68899999985 77776654    56799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      +....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....           
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  219 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  219 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            86533  34467899999999999654 58999999999999999999999999888777776665421           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                        ..++..+++++.+||.+||..||.+|+     ++.++++||||+++.+.
T Consensus       220 ------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 ------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                              014456899999999999999999999     99999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.4e-50  Score=388.66  Aligned_cols=255  Identities=26%  Similarity=0.468  Sum_probs=210.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|.+.+.||+|+||+||+|+++.+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence            34568999999999999999999999999999999997532       2356788888876 899999999988     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-CEEEeec
Confidence            44568999999985 66666553    46799999999999999999999986 999999999999999988 8999999


Q ss_pred             CCcccc-ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHH-HHHHH
Q 015298          219 GSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV--------DQL-VEIIK  288 (409)
Q Consensus       219 g~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------~~~-~~i~~  288 (409)
                      |+++.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......        +.+ ..+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            999863 334455678899999999999664 5899999999999999999999999643221        111 11211


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCccCCCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------LDALIHPFFDELRD  362 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~------~ell~hp~f~~~~~  362 (409)
                      .                             ...++..+++++++||++||+.||.+|+++      .++++||||+++.+
T Consensus       277 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             C-----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c-----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            0                             011456689999999999999999999985      79999999999876


Q ss_pred             C
Q 015298          363 P  363 (409)
Q Consensus       363 ~  363 (409)
                      .
T Consensus       328 ~  328 (396)
T 4dc2_A          328 D  328 (396)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=393.68  Aligned_cols=272  Identities=28%  Similarity=0.452  Sum_probs=223.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|..++..++||||+++++++     ....
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence            46899999999999999999999999999999999642       23456899999999999999999988     4455


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ++++||||++ |+|..++...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechhh
Confidence            6899999996 5777776542   35799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCC--CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          222 KVLVKGEP--NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       222 ~~~~~~~~--~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      +.......  ....+||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+..+...++.......
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  289 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL  289 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence            86644332  234689999999999962      3458999999999999999999999999988888777776421000


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCC---CCHHHHhCCCCccCCCCCCCCCCCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR---CTALDALIHPFFDELRDPNARLPSG  370 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R---~s~~ell~hp~f~~~~~~~~~~~~~  370 (409)
                                     .++         .++..+|+++++||++||+ +|.+|   +++.++++||||+.+.+........
T Consensus       290 ---------------~~p---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~  344 (412)
T 2vd5_A          290 ---------------SLP---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP  344 (412)
T ss_dssp             ---------------CCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCC
T ss_pred             ---------------CCC---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCC
Confidence                           000         0224589999999999999 99998   5999999999999999887765555


Q ss_pred             CCCCCC
Q 015298          371 RFLPPL  376 (409)
Q Consensus       371 ~~~~~~  376 (409)
                      +++|.+
T Consensus       345 p~~p~~  350 (412)
T 2vd5_A          345 PFTPDF  350 (412)
T ss_dssp             SCCCC-
T ss_pred             CCCCcC
Confidence            666644

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-50  Score=390.99  Aligned_cols=320  Identities=28%  Similarity=0.506  Sum_probs=233.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357999999999999999999999999999999986532      334589999999999999999998754321 2234


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||+++++.+.+.      ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC--
T ss_pred             ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeeccc
Confidence            678999999998777664      4589999999999999999999996 999999999999999888 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            76555445567899999999999764 58999999999999999999999999999999999999988888877655433


Q ss_pred             CCcccc--ccCcccCCCCcccCC-----C------CCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCC
Q 015298          303 PNYTEF--KFPQIKAHPWHKIFP-----K------RMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPS  369 (409)
Q Consensus       303 ~~~~~~--~~~~~~~~~~~~~~~-----~------~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~  369 (409)
                      +....+  ..+......+...++     .      ..++++++||.+||+.||.+|||+.++|+||||+.+.++......
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~  334 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP  334 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCC
Confidence            211100  000000111111111     1      125789999999999999999999999999999987665332221


Q ss_pred             CCCCCCCCCCCcccccCCCHHHHhhcChHHHhh
Q 015298          370 GRFLPPLFNFKSHELKSVPVEILVKLIPEHARK  402 (409)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (409)
                      .+..|   ..... ......+.+..+++..+.+
T Consensus       335 ~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          335 PPKIP---DKQLD-EREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             CCCCC---TTTTC-CCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCC---Chhhc-cccCcHHHHHHHHHHHHHH
Confidence            22222   22222 2344567788887776654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.6e-50  Score=384.64  Aligned_cols=318  Identities=32%  Similarity=0.565  Sum_probs=243.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCC-Ccc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357999999999999999999999999999999996532      3445899999999999999999988544321 112


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||+.++|...+      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++
T Consensus       121 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC-
T ss_pred             eEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCccc
Confidence            24799999998876554      34699999999999999999999996 999999999999999888 89999999997


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+....
T Consensus       193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            6533  33456789999999999775678999999999999999999999999999999999999999998877665443


Q ss_pred             CCcccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      ......   ..+......+.. +...+++++.+||.+||+.||.+|||+.++|+||||+.+.++............    
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~----  345 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD----  345 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC----
T ss_pred             hhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc----
Confidence            221111   111111112222 234579999999999999999999999999999999988766543322222111    


Q ss_pred             CcccccCCCHHHHhhcChHHHhhh
Q 015298          380 KSHELKSVPVEILVKLIPEHARKQ  403 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~  403 (409)
                       ..+......+.+...+.....+.
T Consensus       346 -~~~~~~~~~~~~~~~~~~~~~~~  368 (371)
T 4exu_A          346 -SLEHEKLTVDEWKQHIYKEIVNF  368 (371)
T ss_dssp             -TTSSCCCCHHHHHHHHHHHHHHC
T ss_pred             -chhhcccchHHHHHHHHHHHHhc
Confidence             11234456677777666655443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-49  Score=380.73  Aligned_cols=321  Identities=32%  Similarity=0.607  Sum_probs=244.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++..........
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3468999999999999999999999999999999986432     23458999999999999999998775433333456


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      .++||||+.++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEecccccc
Confidence            889999999988877763     5799999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCCC-----------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          224 LVKGEP-----------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       224 ~~~~~~-----------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      ......           .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543211           223578999999999866566899999999999999999999999999988888888888877


Q ss_pred             CCHHHHh-hcCCC-ccc--cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCC
Q 015298          293 PTREEIK-CMNPN-YTE--FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLP  368 (409)
Q Consensus       293 ~~~~~~~-~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~  368 (409)
                      +...... ..... ..+  ...+......+.. ....+++++.+||.+||+.||.+|||+.++|+||||+...++.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  320 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE  320 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence            6532111 00000 000  0011111111111 22358999999999999999999999999999999999887765544


Q ss_pred             CCCCCCCCCCCCcccccCCCHHHHhhcChH
Q 015298          369 SGRFLPPLFNFKSHELKSVPVEILVKLIPE  398 (409)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (409)
                      .....+..+.|+..+ .....+.+.++++.
T Consensus       321 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  349 (353)
T 2b9h_A          321 GEPIPPSFFEFDHYK-EALTTKDLKKLIWN  349 (353)
T ss_dssp             CCCCCGGGGGGGCCS-SCCCHHHHHHHHHH
T ss_pred             cCCCCcceeeecchh-hcCCHHHHHHHHHH
Confidence            444444445554433 34455666655544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-50  Score=386.46  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=214.6

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++.     .
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34568999999999999999999999999999999986432       34568999999999999999999883     4


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            4458899999975 66665543    56799999999999999999999986 999999999999999888 89999999


Q ss_pred             CccccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~~~~  294 (409)
                      ++............+||+.|+|||++.+  ...++.++|||||||++|+|++|..||.......   ....+...     
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  235 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----  235 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence            9988766666678899999999999864  2348899999999999999999999997543322   22222110     


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-HHHHhCCCCccCCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-ALDALIHPFFDELRDP  363 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-~~ell~hp~f~~~~~~  363 (409)
                                              ...++..+++++.+||.+||+.||.+||+ +.++++||||+++.+.
T Consensus       236 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          236 ------------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             ------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence                                    01145568999999999999999999998 8999999999988764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=372.57  Aligned_cols=284  Identities=35%  Similarity=0.624  Sum_probs=219.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+++++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            47999999999999999999999999999999985542      334579999999999999999998843     3457


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+++++...+.   .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            8999999975433332   2256799999999999999999999986 999999999999999887 8999999999865


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  302 (409)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.+.++........... 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            432 223456789999999999776678999999999999999999999999999999988888888776654433211 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                       ..+.....+..............+++++.+||.+||+.||.+|||+.++|+||||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence             11111111111111111111235789999999999999999999999999999999887654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-49  Score=390.36  Aligned_cols=282  Identities=29%  Similarity=0.528  Sum_probs=228.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhc------CCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++....   ....+|+++++.+      +|+||+++++++..    
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence            3457999999999999999999999999999999997654   3345688888877      57799999998843    


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC-cEEEeec
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~-~ikl~Df  218 (409)
                       ...+++||||+.++|.+.+....  ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++. .+||+||
T Consensus       171 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 -RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             -TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             -CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeec
Confidence             34588999999999888877532  35699999999999999999999997 9999999999999998772 2999999


Q ss_pred             CCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       219 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      |++....  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|+...+
T Consensus       247 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            9997543  3344678999999999997654 899999999999999999999999999999999999999999988765


Q ss_pred             hhcCCCc--------ccc----------------------ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH
Q 015298          299 KCMNPNY--------TEF----------------------KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (409)
Q Consensus       299 ~~~~~~~--------~~~----------------------~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~  348 (409)
                      .......        ...                      .........|...++...++++.+||.+||++||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence            4322100        000                      0000112234444555678999999999999999999999


Q ss_pred             HHHhCCCCccCCC
Q 015298          349 LDALIHPFFDELR  361 (409)
Q Consensus       349 ~ell~hp~f~~~~  361 (409)
                      .|+|+||||++..
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-50  Score=384.80  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=215.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||+||+|+++.+|+.||+|++.+..       .....|..++..+ .||||+++++++     ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            3458999999999999999999999999999999996532       3345788888887 799999999988     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++| +|...+..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  166 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence            4568999999985 77776654    46799999999999999999999996 999999999999999888 89999999


Q ss_pred             Cccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  237 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  237 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 23345567899999999999654 48999999999999999999999999888777777665521        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDPN  364 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~~  364 (409)
                                           ..++..+++++.+||.+||+.||.+||     ++.++++||||+.+.+..
T Consensus       238 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          238 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence                                 014556899999999999999999999     479999999999887653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-49  Score=372.61  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=213.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...+|++.+.||+|+||+||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence            345899999999999999999999999999999998543    2345689999999999999999998854     3347


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. ++|.+.+..     ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            89999997 577776653     4699999999999999999999997 999999999999999888 899999999876


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........        
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  236 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------  236 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------
T ss_pred             cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            54433 33456899999999999765 489999999999999999999999988877766665544321110        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                        ..+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 ------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             ------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                              12345789999999999999999999999999999998543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-50  Score=379.68  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=216.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+....   ....+|+.+++.++||||+++++++..     ...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            458999999999999999999999999999999986543   345689999999999999999998843     345889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC--CCCcEEEeecCCccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKV  223 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~--~~~~ikl~Dfg~a~~  223 (409)
                      ||||++| +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.  ++ .+||+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence            9999985 66665532   235799999999999999999999986 9999999999999986  44 899999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...........+     
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----  227 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-----  227 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-----
T ss_pred             CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh-----
Confidence            7665555667899999999999654 4799999999999999999999999998888777777664333222211     


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                          ..+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       228 --------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                2478999999999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-49  Score=381.21  Aligned_cols=289  Identities=31%  Similarity=0.595  Sum_probs=227.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------------hhhHHHHHHHHhcCCCCeecccceee
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFF  134 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~~~~~~  134 (409)
                      .++|.+.+.||+|+||.||+|.+.. |+.||||++....               ....+|+++++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4579999999999999999999755 9999999985421               34568999999999999999999987


Q ss_pred             ecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                      .........+++||||+++++.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEE
Confidence            766566667899999999988777663   245799999999999999999999996 999999999999999887 899


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+.
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999998665555556678899999999997756689999999999999999999999999999999999999999888


Q ss_pred             HHHHhhcCCC----ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          295 REEIKCMNPN----YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       295 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                      ...+......    +............|.. .....++.+.+||.+||+.||.+|||+.++|+||||+.+.++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            7654332211    0001111112222222 23457899999999999999999999999999999999866543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-49  Score=378.29  Aligned_cols=252  Identities=28%  Similarity=0.422  Sum_probs=216.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     ...
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            3568999999999999999999999999999999986432       3456799999999999999999888     344


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||++ ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFg~  187 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEccccc
Confidence            56899999997 577776654    46799999999999999999999986 999999999999999888 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       188 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  254 (350)
T 1rdq_E          188 AKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------  254 (350)
T ss_dssp             CEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            986533  33467899999999999654 48999999999999999999999999888777766665421          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                         ..++..+++++.+||.+||+.||.+||+     +.++++||||+.+.+.
T Consensus       255 -------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          255 -------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence                               0144568999999999999999999998     9999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=374.40  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=216.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----------chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            456799999999999999999999999999999998643          234668999999999999999999883    


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEE
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ik  214 (409)
                       ....+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++.   .+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEE
Confidence             3445889999997 577766643    56799999999999999999999986 9999999999999987652   699


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+........
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            9999999877655555667899999999998654 589999999999999999999999998887777666654322111


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ..                         ....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11                         1234789999999999999999999999999999998643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-50  Score=376.67  Aligned_cols=257  Identities=20%  Similarity=0.221  Sum_probs=187.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-hh--HHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-YK--NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~--~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..++|||||++++++..... ....++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence            4699999999999999999987  789999999965432 22  345555677899999999998865432 23457899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-------IGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ||||+ |+|.+.+..     ..+++..+..++.|++.||+|||++       .+|+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99999 578777753     5799999999999999999999963       2899999999999999988 89999999


Q ss_pred             CccccccCCC-----CccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------
Q 015298          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD--------  281 (409)
Q Consensus       220 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------  281 (409)
                      +|+.......     ....+||+.|||||++.+..     .++.++|||||||+||||+||.+||......+        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            9987654332     22457999999999996532     36779999999999999999987764322110        


Q ss_pred             ---HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 ---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                         ....+.+.+...      ...+....            .......+..+.+|+.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~------~~rp~~p~------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQ------KLRPNIPN------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTS------CCCCCCCG------------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcc------cCCCCCCc------------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               001111110000      00000000            00011133578899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-49  Score=378.64  Aligned_cols=259  Identities=27%  Similarity=0.380  Sum_probs=212.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---------chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||.||+|.++.+|+.||||++...         .....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            356899999999999999999999999999999998532         2446789999999999999999998843    


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEe
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLC  216 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~  216 (409)
                       ...+++||||+. ++|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+||+
T Consensus        98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEe
Confidence             345889999998 577777766555556799999999999999999999986 999999999999998654  249999


Q ss_pred             ecCCccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          217 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       217 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+.+.......
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence            9999987654332 3456799999999999654 48999999999999999999999998743 3334444332111111


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      ..                         ...+++++.+||.+||..||.+|||+.++|+||||++.
T Consensus       254 ~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 RQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            11                         12478999999999999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.4e-49  Score=375.97  Aligned_cols=290  Identities=29%  Similarity=0.485  Sum_probs=226.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC---C
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  139 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3568999999999999999999999999999999985432      234689999999999999999998865332   1


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ....+++||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            13457899999999877776532   35799999999999999999999996 999999999999999888 89999999


Q ss_pred             CccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ++......     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765422     2234567899999999997766689999999999999999999999999999999999988888776


Q ss_pred             HHHHhhcCCCc--cccccCcccCCCCcccC-CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          295 REEIKCMNPNY--TEFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       295 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ...+.......  ................+ ....++.+.+||.+||+.||.+|||+.|+|+||||.....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            55443221100  00000000000000000 00136789999999999999999999999999999865444

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-49  Score=381.32  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=214.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            3457999999999999999999999999999999996532      3456899999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecC
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg  219 (409)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+||+|||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            58899999985 66665543    46799999999999999999999996 999999999999998654  259999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+..   
T Consensus       177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---  252 (362)
T 2bdw_A          177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---  252 (362)
T ss_dssp             TCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred             cceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence            99877655555667899999999999654 58999999999999999999999999888777666665532111110   


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                            ....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       253 ----------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          253 ----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ----------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ----------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                  012368999999999999999999999999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.6e-49  Score=376.59  Aligned_cols=255  Identities=26%  Similarity=0.470  Sum_probs=209.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc-CCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|.+.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence            34568999999999999999999999999999999997542       2345789999887 899999999988     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DF  154 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  154 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEEec
Confidence            44568999999985 77666654    46799999999999999999999986 999999999999999888 8999999


Q ss_pred             CCccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HH-HHHHHHH
Q 015298          219 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VD-QLVEIIK  288 (409)
Q Consensus       219 g~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~-~~~~i~~  288 (409)
                      |+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....        .+ ....+..
T Consensus       155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            9997533 33345567899999999999664 589999999999999999999999975321        11 1111211


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH------HHHhCCCCccCCCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------LDALIHPFFDELRD  362 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~------~ell~hp~f~~~~~  362 (409)
                      .                             ...++..++.++.+||.+||+.||.+||++      .++++||||+++.+
T Consensus       234 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          234 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             C-----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             C-----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            0                             001455689999999999999999999995      89999999998875


Q ss_pred             C
Q 015298          363 P  363 (409)
Q Consensus       363 ~  363 (409)
                      .
T Consensus       285 ~  285 (345)
T 3a8x_A          285 D  285 (345)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=386.27  Aligned_cols=292  Identities=30%  Similarity=0.499  Sum_probs=214.0

Q ss_pred             ccceEE-EEeeccCCceEEEEEEEc--CCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMA-ERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...|.+ .++||+|+||.||+|.++  .+++.||+|++...  .....+|+.+++.++||||+++++++...   ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence            345777 458999999999999966  57899999999654  34567899999999999999999988652   23458


Q ss_pred             EEEEeccchhHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee----cCCCCcEEE
Q 015298          145 NLVLEYVPETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKL  215 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli----~~~~~~ikl  215 (409)
                      ++||||++++|...+......     ...+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            899999999988887654322     23599999999999999999999996 99999999999999    4455 8999


Q ss_pred             eecCCccccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHH
Q 015298          216 CDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQ  282 (409)
Q Consensus       216 ~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~  282 (409)
                      +|||+++.....    ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999866432    2234567899999999997766699999999999999999999999976554         478


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCccc---------cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          283 LVEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      +..+...++.|....|.........         ..+.......+........++.+.+||.+||++||.+|||+.|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            8889999998877655432110000         0000000000011112234789999999999999999999999999


Q ss_pred             CCCccCCCCCCCC
Q 015298          354 HPFFDELRDPNAR  366 (409)
Q Consensus       354 hp~f~~~~~~~~~  366 (409)
                      ||||.+...+...
T Consensus       334 hp~f~~~~~~~~~  346 (405)
T 3rgf_A          334 DPYFLEDPLPTSD  346 (405)
T ss_dssp             SGGGTSSSCCCSS
T ss_pred             ChhhccCCCCccc
Confidence            9999987665443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=387.37  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=212.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            4568999999999999999999999999999999986542      3456899999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC--CCcEEEeecC
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~--~~~ikl~Dfg  219 (409)
                      ..++||||+.| +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+  ++.+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            68899999985 67666654    56799999999999999999999996 99999999999999842  2379999999


Q ss_pred             CccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+.   
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---  234 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS---  234 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc---
Confidence            9976654332 3457899999999999654 5899999999999999999999999988887777776653211111   


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                            .....+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       235 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          235 ----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                  0123479999999999999999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-49  Score=374.94  Aligned_cols=283  Identities=29%  Similarity=0.530  Sum_probs=220.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++...   ...+.++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEE
Confidence            35799999999999999999999999999999999644 455678999999997 99999999987532   23457899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+.+ +|...+       ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999995 444433       2489999999999999999999986 9999999999999997766899999999987766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHH-hhcCCC
Q 015298          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-GDSGVDQLVEIIKVLGTPTREEI-KCMNPN  304 (409)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~  304 (409)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|..||. +....+.+..+....+.+..... ......
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            6666677899999999999775679999999999999999999999995 44556666666666654332221 111100


Q ss_pred             ccc---cccCcccCCCCcccCC----CCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          305 YTE---FKFPQIKAHPWHKIFP----KRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       305 ~~~---~~~~~~~~~~~~~~~~----~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ...   ..........|.....    ..+++++.+||.+||++||.+|||+.++|+||||+++...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence            000   0011111222222222    2378999999999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7e-49  Score=364.92  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=208.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|..+|+|++....     ....+|+++++.++||||+++++++     .....
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            3468999999999999999999999999999999986543     4457899999999999999999988     34445


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEeecC
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFG  219 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg  219 (409)
                      .++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence            8899999985 78888876666678899999999999999999999996 9999999999999943   34 79999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.......      
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  244 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------  244 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred             cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------
Confidence            9987666555667789999999999843  48999999999999999999999998877655544433211000      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                          ......+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       245 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 --------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                0011236899999999999999999999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=370.51  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             CCccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------------------------hhhHHHH
Q 015298           66 QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------------------------RYKNREL  115 (409)
Q Consensus        66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~  115 (409)
                      .....++|.+.+.||+|+||.||+|.+..+|+.||+|++....                              ....+|+
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A            8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            3345678999999999999999999999999999999986432                              3456899


Q ss_pred             HHHHhcCCCCeecccceeeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 015298          116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV  194 (409)
Q Consensus       116 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~i  194 (409)
                      ++++.++||||+++++++...   ....+++||||+++ +|.+.     .....+++..++.++.||+.||.|||++ ||
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i  158 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHYQ-KI  158 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             HHHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHHC-Ce
Confidence            999999999999999987532   24468899999985 44332     1246799999999999999999999996 99


Q ss_pred             EeecCCCCceeecCCCCcEEEeecCCccccccCCC-CccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCC
Q 015298          195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGK  271 (409)
Q Consensus       195 vH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwslG~il~~lltg~  271 (409)
                      +||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|.
T Consensus       159 vH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             ECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             eccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            9999999999999888 899999999986544322 335678999999999865442  478899999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          272 PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       272 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                      .||...........+......                 ++          ....+++++.+||.+||+.||.+|||+.++
T Consensus       238 ~pf~~~~~~~~~~~~~~~~~~-----------------~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~  290 (298)
T 2zv2_A          238 CPFMDERIMCLHSKIKSQALE-----------------FP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEI  290 (298)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCC-----------------CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCCccHHHHHHHHhcccCC-----------------CC----------CccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            999887665554444331100                 00          123578999999999999999999999999


Q ss_pred             hCCCCccC
Q 015298          352 LIHPFFDE  359 (409)
Q Consensus       352 l~hp~f~~  359 (409)
                      ++||||++
T Consensus       291 l~hp~~~~  298 (298)
T 2zv2_A          291 KLHPWVTR  298 (298)
T ss_dssp             TTCHHHHC
T ss_pred             hcCccccC
Confidence            99999963

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.7e-48  Score=366.61  Aligned_cols=290  Identities=34%  Similarity=0.570  Sum_probs=234.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-CCCcEEEEEEeeccc------hhhHHHHHHHHhc---CCCCeecccceeeecC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-ETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~  137 (409)
                      ....+|.+.+.||+|+||.||+|.+. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            44568999999999999999999995 678999999986432      2455788877766   8999999999886444


Q ss_pred             CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ......+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECS
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CEEEec
Confidence            44566789999999999888876532  34599999999999999999999996 999999999999999888 899999


Q ss_pred             cCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       218 fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+....+.+....
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            9999866544444567789999999999654 489999999999999999999999999999999999999888887665


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      +...... ....+........ ..+...+++.+.+||.+||..||.+|||+.++++||||+++....
T Consensus       243 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          243 WPRDVAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             SCTTCSS-CGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             Ccccccc-chhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            5321110 1111111111111 224456899999999999999999999999999999999886554

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-49  Score=380.22  Aligned_cols=256  Identities=24%  Similarity=0.399  Sum_probs=210.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-------hhHHHHHH-HHhcCCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|.+.+.||+|+||+||+|+++.+++.||+|++.+...       ...+|..+ ++.++||||+++++++     .
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            345689999999999999999999999999999999965431       22344444 4667999999999888     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeC
Confidence            44568999999985 66666654    46799999999999999999999986 999999999999999888 8999999


Q ss_pred             CCccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          219 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       219 g~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      |+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....       
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  255 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------  255 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------
Confidence            9998643 33345567899999999999654 58999999999999999999999999888777777665420       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhCCCCccCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----LDALIHPFFDELRDPN  364 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~----~ell~hp~f~~~~~~~  364 (409)
                                            ..++..+++++.+||.+||+.||.+|+++    .++++||||+.+.+..
T Consensus       256 ----------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          256 ----------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             ----------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             ----------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                                  01345689999999999999999999986    6999999999887653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-49  Score=378.83  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=198.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..++|.+.+.||+|+||+||+|++..+|+.||+|++....   ....+|+.+++.++||||+++++++.     ....++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            3568999999999999999999999999999999997543   45678999999999999999999884     344588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC-cEEEeecCCccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~-~ikl~Dfg~a~~  223 (409)
                      +||||+. ++|...+..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++. .+||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999997 477666654    46799999999999999999999986 9999999999999986652 499999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+...+....         
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  238 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC---------
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC---------
Confidence            55555556678999999999997766445559999999999999999999987554333333322211000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                    +.......+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       239 --------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          239 --------------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             --------------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             --------------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence                          00001224789999999999999999999999999999997653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-48  Score=362.08  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=218.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            3568999999999999999999999999999999986543      3456799999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecC
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg  219 (409)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            57899999985 66565554    46799999999999999999999996 999999999999998655  249999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+.......+.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  228 (284)
T 3kk8_A          154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----  228 (284)
T ss_dssp             TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred             eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence            99877655555567899999999999654 4899999999999999999999999988777766665543211110    


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL  367 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~  367 (409)
                                           .....+++++.+||.+||+.||.+|||+.++|+||||++........
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~  275 (284)
T 3kk8_A          229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI  275 (284)
T ss_dssp             ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred             ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence                                 01234789999999999999999999999999999999876554443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=374.31  Aligned_cols=316  Identities=32%  Similarity=0.576  Sum_probs=241.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCC-CccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  143 (409)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47999999999999999999999999999999986532      3345799999999999999999987543221 1123


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++||||+.++|.+.+      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998765543      34699999999999999999999996 999999999999999887 899999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+.....
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            532  234567899999999997756689999999999999999999999999999999999999999888776654432


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCC
Q 015298          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFK  380 (409)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  380 (409)
                      .....   ..+......+.. ....+++++.+||.+||+.||.+|||+.++|+||||+.+.++........    .+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~----~~~~~  328 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ----PFDDS  328 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS----CCCCT
T ss_pred             HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC----CCccc
Confidence            21110   111111222222 23457999999999999999999999999999999998876544322211    12221


Q ss_pred             cccccCCCHHHHhhcChHHHhh
Q 015298          381 SHELKSVPVEILVKLIPEHARK  402 (409)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~  402 (409)
                       .+...++.+.+...+.....+
T Consensus       329 -~~~~~~~~~~~~~~~~~~~~~  349 (353)
T 3coi_A          329 -LEHEKLTVDEWKQHIYKEIVN  349 (353)
T ss_dssp             -TTTCCCCHHHHHHHHHHHHHT
T ss_pred             -hhhccCCHHHHHHHHHHHHHh
Confidence             123456677777776665544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.5e-48  Score=374.72  Aligned_cols=274  Identities=26%  Similarity=0.429  Sum_probs=220.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC-----CCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~  141 (409)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.     ||||+++++++..     .
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----Y  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----T
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----C
Confidence            468999999999999999999999999999999996533   34457999999986     9999999998854     3


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC-------------
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-------------  208 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~-------------  208 (409)
                      ..+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcc
Confidence            3588999999889888877532  34699999999999999999999986 9999999999999975             


Q ss_pred             ------------CCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015298          209 ------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (409)
Q Consensus       209 ------------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (409)
                                  ++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        44 899999999976433  33456789999999999765 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCC--------------------CCCChhHHHHHHH
Q 015298          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFP--------------------KRMPPEAVDLVSR  336 (409)
Q Consensus       277 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~s~~l~~li~~  336 (409)
                      .+..+.+..+....+.++...+...........+   ........++                    ...++.+.+||.+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV---NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGE---ETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCcccc---CcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            9999988888888887776654432211110000   0000000011                    1234788899999


Q ss_pred             hcccCCCCCCCHHHHhCCCCcc
Q 015298          337 LLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       337 ~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      ||++||.+|||+.|+|+||||+
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-49  Score=375.98  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=210.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||+|++.+......+|++++.++ +||||+++++++     .+..++++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            45689999999999999999999999999999999988777778899999888 799999999988     445568999


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEEEeecCCccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKV  223 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ikl~Dfg~a~~  223 (409)
                      |||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||+..+.+   .+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999985 67666653    56799999999999999999999996 9999999999999854322   499999999986


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHh
Q 015298          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD---SGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       224 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...   ...+....+.....        
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--------  240 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--------  240 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--------
Confidence            5443 334567889999999998653 4889999999999999999999999763   22333333332100        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                       .+...+...+++++.+||.+||..||.+|||+.++++||||.++.
T Consensus       241 -----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          241 -----------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             -----------------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             -----------------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                             001112345899999999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-49  Score=371.80  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=208.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++     .....
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            346899999999999999999999999999999998543     24567899999999999999999987     34455


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~  153 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLAT  153 (323)
T ss_dssp             EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccc
Confidence            7899999985 5555443    356799999999999999999999986 999999999999999888 89999999997


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ......   ......||+.|+|||++.+...++.++|||||||++|+|++|..||....................     
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----  228 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----  228 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-----
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-----
Confidence            653322   234568899999999997766568899999999999999999999987654332222211100000     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                      .     ....+++.+.+||.+||+.||.+|||+.|+++||||++...
T Consensus       229 ----------------~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          229 ----------------N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ----------------T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ----------------C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                            0     11247899999999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-48  Score=379.87  Aligned_cols=288  Identities=21%  Similarity=0.326  Sum_probs=210.6

Q ss_pred             ccccceEEEEeeccC--CceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...++|++.+.||+|  +||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            446789999999999  99999999999999999999996542      345579999999999999999998853    


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                       ...+++||||+. ++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEccc
Confidence             345889999998 57777765422  36799999999999999999999986 999999999999999888 8999999


Q ss_pred             CCccccccC--------CCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015298          219 GSAKVLVKG--------EPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (409)
Q Consensus       219 g~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  289 (409)
                      |.+......        .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987644322        112234789999999999763 45899999999999999999999999887766665544332


Q ss_pred             hCCCC-------HHHHhh-c-----CCCcccc----ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          290 LGTPT-------REEIKC-M-----NPNYTEF----KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       290 ~~~~~-------~~~~~~-~-----~~~~~~~----~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                      .....       ...+.. .     .......    .............++..+++++.+||.+||+.||.+|||+.++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            11000       000000 0     0000000    00000000111124456899999999999999999999999999


Q ss_pred             CCCCccCCCCCC
Q 015298          353 IHPFFDELRDPN  364 (409)
Q Consensus       353 ~hp~f~~~~~~~  364 (409)
                      +||||+++....
T Consensus       333 ~hp~f~~~~~~~  344 (389)
T 3gni_B          333 NHSFFKQIKRRA  344 (389)
T ss_dssp             TSGGGGGC---C
T ss_pred             cCHHHHHHhhcc
Confidence            999999886543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.8e-49  Score=388.10  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=217.4

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++.     .
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            34568999999999999999999999999999999996432       34568999999999999999999884     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||+. ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG  161 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFG  161 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEecc
Confidence            345889999997 566665542    56799999999999999999999986 999999999999999888 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....        
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  233 (476)
T 2y94_A          162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------  233 (476)
T ss_dssp             SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------
T ss_pred             chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------
Confidence            998776666666788999999999997766568899999999999999999999998877776665543210        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                           ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       234 ---------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 ---------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                 1344578999999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.1e-49  Score=372.29  Aligned_cols=283  Identities=34%  Similarity=0.600  Sum_probs=224.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            44668999999999999999999999999999999985432      23457999999999999999999884     34


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ...++||||+++++...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence            45789999999765444432   246799999999999999999999996 999999999999999888 8999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ...... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.........
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765432 2334567899999999997766789999999999999999999999999999999999888888776654322


Q ss_pred             --cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 --MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 --~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                        ..+.+.....+..............+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence              222222233333322222222234579999999999999999999999999999999853

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.7e-49  Score=364.32  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=199.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------hhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...++...++.++||||+++++++..     ..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence            45689999999999999999999999999999999865421      12234445777899999999998853     33


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++||||+++++.+.+.........+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            47899999999988888877666788999999999999999999999844999999999999999887 89999999998


Q ss_pred             ccccCCCCccccccccccccccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHH
Q 015298          223 VLVKGEPNISYICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  298 (409)
                      ............||+.|+|||++   .....++.++|||||||++|+|++|..||..... ...+...... ..+     
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-----  232 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSP-----  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCC-----
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCC-----
Confidence            77665555566899999999997   2445589999999999999999999999986433 3333332221 000     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                           ......+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 ---------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ---------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ---------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                                 01223578999999999999999999999999999999854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-48  Score=368.88  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeeccc--------hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|++.   .+|+.||+|++.+..        ....+|+.+++.++||||+++++++..  
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence            3568999999999999999999985   689999999986531        234579999999999999999998843  


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                         ...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus        93 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           93 ---GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             ---SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEEE
Confidence               344889999998 577666654    46789999999999999999999996 999999999999999888 89999


Q ss_pred             ecCCccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          217 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       217 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |||+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+...    
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----  238 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----  238 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----
Confidence            99998754332 233456799999999999654 489999999999999999999999998887777766654210    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                               .++..+++++.+||.+||..||.+||     ++.++++||||+.+.+.
T Consensus       239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence                                     13456799999999999999999999     89999999999987653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=380.45  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=207.0

Q ss_pred             ceEE--EEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           72 SYMA--ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        72 ~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++...    ...+.+|+++++.++||||+++++++.     ....++
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~  162 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIV  162 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            3555  67899999999999999999999999999754    345668999999999999999999884     344588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee--cCCCCcEEEeecCCcc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK  222 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli--~~~~~~ikl~Dfg~a~  222 (409)
                      +||||+++ +|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||+  +.++ .+||+|||+++
T Consensus       163 lv~E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~  237 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAK-QIKIIDFGLAR  237 (373)
T ss_dssp             EEEECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTT-EEEECCCSSCE
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCC-cEEEEeCCCce
Confidence            99999984 676666432   35689999999999999999999986 99999999999999  4444 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........       
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------  309 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------  309 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-------
T ss_pred             ecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-------
Confidence            7766555566789999999999865 45899999999999999999999999998888777777653211110       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                        .....+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       310 ------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 ------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                              01134789999999999999999999999999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-48  Score=375.21  Aligned_cols=257  Identities=26%  Similarity=0.376  Sum_probs=214.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++.     ....++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            45799999999999999999999999999999998654    234568999999999999999999883     345588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-CCcEEEeecCCccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-~~~ikl~Dfg~a~~  223 (409)
                      +||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985 66555432   245799999999999999999999986 99999999999999753 23799999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......          
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------  269 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----------  269 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            7655555567899999999999654 58999999999999999999999999887777666655421100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                     .......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       270 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          270 ---------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ---------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ---------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                           0112235799999999999999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.3e-48  Score=365.14  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=216.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....          ..+.+|+.+++.++||||+++++++.    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   85 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----   85 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            3457999999999999999999999999999999986532          34568999999999999999999883    


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEE
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ik  214 (409)
                       ....+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+|
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEE
Confidence             3445889999997 577777653    56789999999999999999999996 9999999999999987763   699


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            9999999877665555667899999999998654 589999999999999999999999998877776666554321111


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      ..                         +...+++.+.+||.+||..||.+|||+.++++||||....+
T Consensus       239 ~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          239 EE-------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HH-------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             hh-------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            11                         12347899999999999999999999999999999986643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=370.41  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=196.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...  .....+|+++++.++||||+++++++.     ....++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence            3456799999999999999999999999999999999754  344568999999999999999999884     344588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEeecCCc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg~a  221 (409)
                      +||||+. ++|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.   ++ .+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCccc
Confidence            9999998 476665543    56799999999999999999999986 9999999999999975   55 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhh
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~  300 (409)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.. ..+......        
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------  269 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------  269 (349)
T ss_dssp             --------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--------
T ss_pred             cccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--------
Confidence            876555445567899999999999654 4899999999999999999999999877665533 333221100        


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                       +.......++.++.+||.+||+.||++|||+.++|+||||.+..
T Consensus       270 -----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          270 -----------------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -----------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -----------------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                             00012245789999999999999999999999999999998643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.2e-49  Score=386.89  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=209.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++..     
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----  219 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----  219 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence            34568999999999999999999999999999999986431       234578889999999999999998843     


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ...+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ . ||+||||||+|||++.++ .+||+||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DF  293 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDF  293 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccC
Confidence            3458899999985 66665543    4679999999999999999999997 6 999999999999999888 8999999


Q ss_pred             CCcccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          219 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       219 g~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      |+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....       
T Consensus       294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------  365 (446)
T 4ejn_A          294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------  365 (446)
T ss_dssp             CCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred             CCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------
Confidence            99976432 3334567899999999999664 48999999999999999999999999887776666654421       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                            ..++..+++++.+||.+||+.||.+||     |+.++++||||+++.+.
T Consensus       366 ----------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 ----------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                                  014556899999999999999999999     99999999999988654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-48  Score=358.09  Aligned_cols=255  Identities=30%  Similarity=0.453  Sum_probs=216.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..++|.+.+.||+|+||.||+|.+..++..+|+|++...    .....+|+++++.++||||+++++++.     .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence            346899999999999999999999999999999998643    345678999999999999999999883     44558


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee---cCCCCcEEEeecCC
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGS  220 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli---~~~~~~ikl~Dfg~  220 (409)
                      ++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||++ ||+||||||+||++   +.++ .++|+|||+
T Consensus        82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~  155 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGL  155 (277)
T ss_dssp             EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEeccc
Confidence            899999985 66666654    46799999999999999999999996 99999999999999   6555 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.............||+.|+|||++.+  .++.++||||||+++|+|++|..||......+....+.......+...+  
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  231 (277)
T 3f3z_A          156 AARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--  231 (277)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--
T ss_pred             ceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--
Confidence            987766666667789999999999854  3899999999999999999999999988877777766654322222111  


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                             ..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus       232 -----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          232 -----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             -----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                   13689999999999999999999999999999998653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.1e-48  Score=387.33  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=216.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----------------hhhHHHHHHHHhcCCCCeecccc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------------RYKNRELQTMRLLDHPNVVSLKH  131 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~  131 (409)
                      ...+|.+.+.||+|+||+||+|.++.+++.||+|++....                 ....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3568999999999999999999999999999999986432                 33568999999999999999999


Q ss_pred             eeeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       132 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      ++     ....++++|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTT
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCC
Confidence            88     445568999999985 67666654    46799999999999999999999996 999999999999998765


Q ss_pred             C--cEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015298          211 H--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       211 ~--~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  288 (409)
                      .  .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            3  699999999987766666667889999999999853  489999999999999999999999999888887777765


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .........+                         ..+++++++||.+||++||.+|||+.++|+||||++....
T Consensus       262 ~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          262 GKYYFDFNDW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCCCCCHHHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCCCcccc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            3222221111                         2478999999999999999999999999999999976543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-48  Score=387.54  Aligned_cols=258  Identities=27%  Similarity=0.457  Sum_probs=214.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||+||+|.+..+|+.||||++...      .....+|+++++.++||||+++++++     ....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            456899999999999999999999999999999998532      34566899999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecC
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg  219 (409)
                      .+++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            58899999985 66666654    46799999999999999999999996 999999999999996432  279999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++............+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..........   
T Consensus       170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  244 (486)
T 3mwu_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---  244 (486)
T ss_dssp             CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG---
T ss_pred             cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence            9987766666667789999999999965  48999999999999999999999999988877777765532111110   


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                            ....+|+++++||.+||+.||.+|||+.++|+||||++....
T Consensus       245 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          245 ----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             ----------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             ----------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence                                  112478999999999999999999999999999999976543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-48  Score=392.98  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=214.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+|.+.+.||+|+||.||+|.++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++     ..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            4456899999999999999999999999999999998643       23346799999999999999999888     33


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++ |+|...+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEecc
Confidence            446899999997 57766665321  34599999999999999999999996 999999999999999888 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHH
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~  296 (409)
                      +++...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...   .+.+.......      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            99877666555667899999999999664 489999999999999999999999987543   22222222111      


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                            ...++..+++++++||.+||+.||.+||     ++.++++||||+++.+.
T Consensus       405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                                  0114556899999999999999999999     89999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=365.67  Aligned_cols=288  Identities=30%  Similarity=0.502  Sum_probs=220.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecC--------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT--------  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  137 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+++++.++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            458999999999999999999999999999999986543    34568999999999999999998763221        


Q ss_pred             -CCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 -DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 -~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                       .......++||||++++|.+.+.     .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++..+||+
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEc
Confidence             12345678999999998877764     36799999999999999999999986 999999999999998555589999


Q ss_pred             ecCCccccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          217 DFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       217 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |||++......    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999865332    12334567899999999876567899999999999999999999999999988888888887766


Q ss_pred             CCHHHHhhcCCCccccccCc--ccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQ--IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                      +...................  ....++. .+...+++++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLT-QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHH-HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChh-HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            65554432211111000000  0001111 12345899999999999999999999999999999999876553

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=365.67  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=197.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------hhHHHHHHHHh-cCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|++.++||+|+||+||+|.+..+|+.||||++.....      ....|+..+.. .+||||+++++++.     ...
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence            3689999999999999999999999999999999854321      12234444444 49999999999884     344


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||++++|...+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++.
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~  205 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLV  205 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCE
T ss_pred             EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeee
Confidence            58899999999888776643   46799999999999999999999996 999999999999999888 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...   ...+...  ..+        
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~~--------  270 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YLP--------  270 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CCC--------
T ss_pred             ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CCC--------
Confidence            7765555566779999999999865  489999999999999999999776654322   1111110  000        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                       ..++..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       271 -----------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 -----------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                             1123457899999999999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-48  Score=401.55  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=217.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||+||+|+++.+++.||||++.+.       ......|..++..+ .||+|+++++++     ..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            356899999999999999999999999999999998653       23345688888877 799999999887     44


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...++|||||++| +|...+..    .+.+++..++.|+.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecc
Confidence            5568999999985 67666654    46799999999999999999999996 999999999999999988 89999999


Q ss_pred             Cccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       220 ~a~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +++... ........+||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.+..+.+..|....        
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------  558 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  558 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 33445567899999999999654 58999999999999999999999999988877777665421        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH-----HHHhCCCCccCCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----LDALIHPFFDELRDPN  364 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~-----~ell~hp~f~~~~~~~  364 (409)
                                           ..++..+++++.+||++||+.||.+|+++     .++++||||+.+.+..
T Consensus       559 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          559 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                                 11456789999999999999999999997     9999999999987653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-47  Score=358.03  Aligned_cols=270  Identities=29%  Similarity=0.419  Sum_probs=221.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence            4568999999999999999999999999999999986532       33467999999999999999999883     34


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEeccC
Confidence            45889999998 466665543    46799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +...... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||......+....+....         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------  231 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  231 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------
Confidence            9765432 233456789999999998654 48999999999999999999999998877666554443210         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                                          ..++..+++.+.++|.+||+.||.+|||+.++++||||.....+..........|+.|.+
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (294)
T 2rku_A          232 --------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI  291 (294)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCS
T ss_pred             --------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCccc
Confidence                                013456789999999999999999999999999999999876665444344444555544

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-48  Score=389.56  Aligned_cols=258  Identities=30%  Similarity=0.501  Sum_probs=217.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++     ..
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            3456899999999999999999999999999999998543       23456899999999999999999988     44


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec---CCCCcEEEe
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN---PHTHQVKLC  216 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~---~~~~~ikl~  216 (409)
                      ..++++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++   .++ .+||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~-~~kl~  171 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDA-NIRII  171 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEEC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCC-cEEEE
Confidence            5568899999984 66665543    56799999999999999999999996 999999999999994   444 89999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||++............+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+........
T Consensus       172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             CTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred             eeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            9999987766665667789999999999965  48999999999999999999999999988887777766532111110


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                               ....+++++++||.+||++||.+|||+.++|+||||+.....
T Consensus       250 -------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          250 -------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             -------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence                                     112478999999999999999999999999999999976543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-48  Score=385.98  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=214.4

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+|.+.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||+++++++     ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            34568999999999999999999999999999999996432       3356799999999999999999887     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++| +|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecc
Confidence            4558899999984 77776665444456799999999999999999999986 999999999999999988 89999999


Q ss_pred             CccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG----VDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~  294 (409)
                      +++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...    .+....+...     
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----  408 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----  408 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence            9987654433 3346899999999999664 589999999999999999999999987542    2232322221     


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                              ...++..+++++.+||.+||+.||.+||+     +.++++||||+.+.+.
T Consensus       409 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          409 ------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             ------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence                                    01145568999999999999999999995     5899999999987654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=367.58  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=208.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeec
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFST  136 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~  136 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++....            ....+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            3468999999999999999999999999999999986542            2345799999999999999999988   


Q ss_pred             CCCCccEEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          137 TDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                        .....+++||||+.+  +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  170 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIK  170 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEE
Confidence              344568899999864  66665543    56799999999999999999999996 999999999999999887 899


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..      
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------  238 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------  238 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT------
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh------
Confidence            999999987766666667789999999999977665588999999999999999999999652210      00      


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                             .....+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       239 -----------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 -----------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                                   0001234579999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-47  Score=366.75  Aligned_cols=252  Identities=28%  Similarity=0.438  Sum_probs=211.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...|.+.+.||+|+||+||+|.+..+|+.||||++....       ..+.+|+++++.++||||+++++++..     ..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            346999999999999999999999999999999986432       235689999999999999999998854     33


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      ..++||||+.|++.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  202 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCB
T ss_pred             eEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCce
Confidence            57899999999887776532   46799999999999999999999996 999999999999999887 89999999997


Q ss_pred             ccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ....   .....||+.|+|||++.+  ...++.++|||||||++|+|++|..||...+..+.+..+..... +       
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~-------  271 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P-------  271 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C-------
Confidence            6533   235678999999999852  34588999999999999999999999988877666655543210 0       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                         ...+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       272 -------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          272 -------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                               012335789999999999999999999999999999997543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.9e-48  Score=373.27  Aligned_cols=284  Identities=27%  Similarity=0.418  Sum_probs=220.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC--------CCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~~  138 (409)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            468999999999999999999999999999999997643   34567999999885        788999999875332 


Q ss_pred             CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--------
Q 015298          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--------  210 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--------  210 (409)
                      ....++++||||+++++...+...  ....+++..++.++.||+.||.|||+++||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            245568899999998887776642  2367999999999999999999999844999999999999998664        


Q ss_pred             ----------------------------------------CcEEEeecCCccccccCCCCccccccccccccccccCCCC
Q 015298          211 ----------------------------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  250 (409)
Q Consensus       211 ----------------------------------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  250 (409)
                                                              ..+||+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    26999999999765432  34567899999999997654 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCccccc----cCcccC-CCCc
Q 015298          251 YTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKA-HPWH  319 (409)
Q Consensus       251 ~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~  319 (409)
                      ++.++|||||||++|+|++|..||...+      ..+.+..+....+.++...+.........+.    ...... .+|.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998655      4566777888888887765432221100000    000000 0000


Q ss_pred             --------ccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          320 --------KIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       320 --------~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                              ..++...++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                    0012234567899999999999999999999999999973

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-47  Score=367.13  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            57999999999999999999999999999999986432            2345799999999 8999999999873   


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                        .....++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence              34458899999986 77776654    46799999999999999999999986 999999999999999887 89999


Q ss_pred             ecCCccccccCCCCccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||......+.+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766666667889999999999853     23478899999999999999999999988777666666554322


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                      ......+                         ..++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus       323 ~~~~~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPEW-------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHHH-------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            2211111                         246889999999999999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.5e-48  Score=384.75  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=212.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|++.+.||+|+||+||+|.++.++..||+|++...      .....+|+.+++.++||||+++++++     .....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            45799999999999999999999999999999998643      24456899999999999999999988     34455


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCC
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~  220 (409)
                      +++|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999985 66666554    46799999999999999999999986 999999999999997643  2599999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +............+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+.+..+..........    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence            987766666667889999999999853  48999999999999999999999999988877777766532221111    


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                           ....+++.+++||.+||+.||.+|||+.++|+||||++.
T Consensus       260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                 113478999999999999999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-47  Score=355.49  Aligned_cols=252  Identities=30%  Similarity=0.472  Sum_probs=209.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence            456899999999999999999999999999999998543       234567999999999999999999883     34


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Dfg~  155 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGW  155 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSCCE
T ss_pred             CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEeccc
Confidence            458899999984 67666654    36799999999999999999999986 999999999999999888 899999998


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +...... ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+....          
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------  223 (279)
T 3fdn_A          156 SVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----------  223 (279)
T ss_dssp             ESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred             cccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC----------
Confidence            8654332 33456789999999998654 58899999999999999999999999887766666554421          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                         ..++..+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus       224 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 -------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                               0134557899999999999999999999999999999987543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.9e-47  Score=354.96  Aligned_cols=260  Identities=25%  Similarity=0.372  Sum_probs=215.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------------hhhHHHHHHHHhcC-CCCeeccccee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCF  133 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~  133 (409)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||+|++....             ....+|+++++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34568999999999999999999999999999999986432             23457999999995 99999999988


Q ss_pred             eecCCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          134 FSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                           ......++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~  162 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-N  162 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-C
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-c
Confidence                 34456889999998 577777654    46799999999999999999999986 999999999999999888 8


Q ss_pred             EEEeecCCccccccCCCCcccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015298          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  287 (409)
                      +||+|||++.............+|+.|+|||++.     ....++.++||||||+++|+|++|..||...+..+....+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  242 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  242 (298)
T ss_dssp             EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence            9999999998776665566678999999999984     23457899999999999999999999998877766665554


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ........                         .....+++.+.+||.+||+.||.+|||+.++++||||++....
T Consensus       243 ~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          243 SGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             HTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cCCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            42111100                         0112468899999999999999999999999999999977544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-47  Score=368.60  Aligned_cols=281  Identities=32%  Similarity=0.549  Sum_probs=218.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC-CC-----CeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||+||+|.+..+|+.||||++....   ....+|+.+++.++ |+     +|+++++++..    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence            3568999999999999999999999999999999997653   33456888888875 55     48888887743    


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCceeecC--CCCcEEEe
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNP--HTHQVKLC  216 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~NIli~~--~~~~ikl~  216 (409)
                       ...+++||||++++|.+.+....  ...+++..++.++.||+.||.|||. ..||+||||||+|||++.  ++ .+||+
T Consensus       128 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~  203 (382)
T 2vx3_A          128 -RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIV  203 (382)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEEC
T ss_pred             -CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEE
Confidence             34588999999999888887532  3569999999999999999999994 249999999999999954  44 79999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++..
T Consensus       204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999986533  34467889999999999765 48999999999999999999999999999999999999999888876


Q ss_pred             HHhhcCCCccccccCcccCCCCc--------------------ccCCC-----------------CCChhHHHHHHHhcc
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWH--------------------KIFPK-----------------RMPPEAVDLVSRLLQ  339 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~-----------------~~s~~l~~li~~~L~  339 (409)
                      .+...... .. .+..+....|.                    ..+..                 ..++++.+||.+||+
T Consensus       281 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          281 ILDQAPKA-RK-FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHTTCTTH-HH-HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHhhHHH-HH-HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence            55322100 00 00000000000                    00000                 001478999999999


Q ss_pred             cCCCCCCCHHHHhCCCCccCCCC
Q 015298          340 YSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       340 ~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      +||.+|||+.|+|+||||++..+
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC---
T ss_pred             CChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-48  Score=368.67  Aligned_cols=263  Identities=31%  Similarity=0.482  Sum_probs=209.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....         ....+|+++++.++||||+++++++     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            468999999999999999999999999999999986431         3456799999999999999999988     34


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhh------------------------------------cCCCCHHHHHHHHHHHHH
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKL------------------------------------NQRMPMIYVKLYAYQIFR  183 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~  183 (409)
                      ....++||||++ ++|.+.+..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            456889999997 5676665321100                                    122467788899999999


Q ss_pred             HHHHHHhcCCcEeecCCCCceeecCCCC-cEEEeecCCccccccCC-----CCccccccccccccccccCC-CCCCchhh
Q 015298          184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTTAID  256 (409)
Q Consensus       184 ~l~~LH~~~~ivH~Dlkp~NIli~~~~~-~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~~D  256 (409)
                      ||.|||++ ||+||||||+||+++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999996 9999999999999986542 69999999998653322     13456789999999998642 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHH
Q 015298          257 IWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSR  336 (409)
Q Consensus       257 iwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~  336 (409)
                      ||||||++|+|++|+.||.+....+....+..........                         ....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHH
Confidence            9999999999999999999988877777666532111100                         112368999999999


Q ss_pred             hcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          337 LLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       337 ~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ||+.||.+|||+.++|+||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-47  Score=353.93  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=204.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence            4568999999999999999999999999999999986432       24568999999999999999999873     34


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeeccc
Confidence            45889999997 477777754    45789999999999999999999997 999999999999999887 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.............+|+.|+|||.+.+....+.++||||||+++|+|++|..||......+....+....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------  227 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------  227 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence            9876555445566789999999999765545789999999999999999999998876665555443311          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                         ..++..++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       228 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 -------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                               01344578999999999999999999999999999999853

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-47  Score=363.52  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=186.7

Q ss_pred             cceEEE---EeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAE---RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+|.+.   +.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.+. ||||+++++++     .+....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            467775   78999999999999999999999999997643 45678999999997 99999999988     3445588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC--cEEEeecCCcc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK  222 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~--~ikl~Dfg~a~  222 (409)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 77776654    56899999999999999999999986 9999999999999976542  69999999998


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 015298          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-------DQLVEIIKVLGTPT  294 (409)
Q Consensus       223 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~  294 (409)
                      ...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......       +.+..+........
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence            654332 33456789999999998654 5899999999999999999999999765432       22222211100000


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .                         .....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       237 ~-------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          237 G-------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             S-------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             c-------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            0                         01124789999999999999999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-47  Score=360.92  Aligned_cols=252  Identities=29%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..|...+.||+|+||.||+|.+..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            45888899999999999999999999999999986432    3456899999999999999999988543     34789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||+.+ +|.+++.     ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999985 6655543     35799999999999999999999996 999999999999999887 89999999987654


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+........          
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  261 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL----------  261 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc----------
Confidence            432 33456899999999999654 589999999999999999999999988777666555443210000          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                      .....+++.+.+||.+||+.||.+|||+.++++||||.+..
T Consensus       262 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 ----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             ----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                            01224688999999999999999999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.8e-47  Score=361.47  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=215.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence            3458999999999999999999999999999999986532       34567999999999999999999883     34


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||+.+ +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            568899999984 66666543    46799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       221 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+....         
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  257 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  257 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence            9865432 234456789999999999654 48999999999999999999999998877666655544311         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                          ..++..+++.+.+||.+||+.||.+|||+.++++||||.....+..
T Consensus       258 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~  303 (335)
T 2owb_A          258 --------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  303 (335)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence                                0134457899999999999999999999999999999997665543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.7e-47  Score=351.81  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...|.+.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+..+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence            346999999999999999999999999999999986432      33567999999999999999999875443 34566


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeec-CCCCcEEEeecC
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVN-PHTHQVKLCDFG  219 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~-~~~~~ikl~Dfg  219 (409)
                      +++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+. |  |+||||||+||+++ .++ .+||+|||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg  177 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLG  177 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTS-CEEECCTT
T ss_pred             EEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCC-CEEEeeCC
Confidence            8899999975 77777754    46799999999999999999999986 8  99999999999998 455 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++..... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||..................+      
T Consensus       178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  248 (290)
T 1t4h_A          178 LATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------  248 (290)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------
T ss_pred             Ccccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------
Confidence            9975432 33445678999999999853  48999999999999999999999998866655444332211111      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                          ..++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus       249 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 --------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                0123346789999999999999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-47  Score=360.92  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=199.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCC------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD------  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  138 (409)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++....     ....+|+++++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999999999999999986432     345689999999999999999998755332      


Q ss_pred             ----------------------------------------------CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCH
Q 015298          139 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPM  171 (409)
Q Consensus       139 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~  171 (409)
                                                                    ....++++||||+.+ +|.+.+.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                          223458899999985 7777665422 2334566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC-------------CCcccccccc
Q 015298          172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------------PNISYICSRY  238 (409)
Q Consensus       172 ~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~-------------~~~~~~gt~~  238 (409)
                      ..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            67899999999999999986 999999999999999887 89999999998765432             2234578999


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCC
Q 015298          239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  318 (409)
Q Consensus       239 y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (409)
                      |+|||++.+. .++.++|||||||++|+|++|..|+..     ....+..........                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            9999999764 489999999999999999998766421     111111111111000                      


Q ss_pred             cccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          319 HKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       319 ~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                         .....++++.+||.+||+.||.+|||+.++|+||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               011246788999999999999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-47  Score=371.62  Aligned_cols=260  Identities=25%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             cccceEEE-EeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHH-HhcCCCCeecccceeeecCCCCccEEEE
Q 015298           69 QTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        69 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ...+|.+. +.||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..+++|
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            45578877 7899999999999999999999999998653 4556788887 5568999999999875322 23556889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEeecCCcc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAK  222 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg~a~  222 (409)
                      ||||+.| +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||+++
T Consensus       137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence            9999984 777777542  134699999999999999999999986 9999999999999987   44 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHH
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD----QLVEIIKVLGTPTREEI  298 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  298 (409)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....    ....+....        
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~--------  283 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------  283 (400)
T ss_dssp             ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC--------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc--------
Confidence            7655555567789999999999855 458999999999999999999999997654322    122222110        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                               +.++        ......+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       284 ---------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          284 ---------YEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ---------CCCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---------ccCC--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                     0000        00123579999999999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-47  Score=362.22  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=210.9

Q ss_pred             cccceEEE-EeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcC-CCCeecccceeeecCCCC
Q 015298           69 QTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  140 (409)
                      ..++|.+. +.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.+. ||||+++++++     ..
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~  100 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----EN  100 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ee
Confidence            34578888 8999999999999999999999999998643      234568999999995 69999999988     34


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEe
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLC  216 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~  216 (409)
                      ...+++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEe
Confidence            4558899999986 55554422  2246799999999999999999999996 9999999999999987   45 89999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+......... 
T Consensus       177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-  254 (327)
T 3lm5_A          177 DFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-  254 (327)
T ss_dssp             CGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred             eCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-
Confidence            99999877655555667899999999999654 5899999999999999999999999988877776666553221111 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNA  365 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~  365 (409)
                                              .....+++.+.+||.+||+.||.+|||+.++|+||||+++.+...
T Consensus       255 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          255 ------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             ------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             ------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence                                    122357899999999999999999999999999999998876554

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=357.75  Aligned_cols=259  Identities=26%  Similarity=0.413  Sum_probs=213.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||++++++++..   ..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence            45799999999999999999999999999999998643        23456899999999999999999987532   23


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ...++||||+.+++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            3478999999988777766533  46799999999999999999999997 999999999999999887 8999999999


Q ss_pred             cccccCC---CCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .......   ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence            7654321   223456899999999986533 24789999999999999999999999877666555544310       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                                            ..++..+++.+.+||.+||..||.+|||+.++++||||++...+.
T Consensus       230 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 ----------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ----------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ----------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                                  013445789999999999999999999999999999999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-47  Score=353.87  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=210.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----------chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.     
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence            35799999999999999999999999999999998643          234578999999999999999999884     


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEEE
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVKL  215 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ikl  215 (409)
                      .....++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEE
Confidence            3445889999997 577777654    46799999999999999999999986 9999999999999987652   6999


Q ss_pred             eecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +|||++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+.........
T Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             CCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            999999876555555566789999999998654 5899999999999999999999999988776665555432111111


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                               .....+++.+.+||.+||..||.+|||+.++++||||+.++..
T Consensus       233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          233 -------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             -------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                                     1123478999999999999999999999999999999976543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-47  Score=375.53  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=197.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....            ....+|+.+++.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            468999999999999999999999999999999986532            23568999999999999999999762   


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEE
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVK  214 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ik  214 (409)
                        .. .+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+|
T Consensus       211 --~~-~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cC-ceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEE
Confidence              11 25799999985 5544332    357899999999999999999999986 999999999999997544  2599


Q ss_pred             EeecCCccccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |+|||+++...........+||+.|+|||++.+  ...++.++|||||||++|+|++|..||........+.........
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987765555567789999999999853  345788999999999999999999999865543333322221111


Q ss_pred             -CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          293 -PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       293 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                       ....                         ....+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       363 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NFIPE-------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CCCch-------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence             1110                         113478999999999999999999999999999999853

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-47  Score=369.01  Aligned_cols=253  Identities=24%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcC--CCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||++....      ..+.+|+.+++.++  ||||+++++++.     ..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence            3469999999999999999999765 8999999986432      34568999999997  599999999874     33


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++ .+||+|||++
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~-~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SS-CEEECCCSSS
T ss_pred             CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CC-eEEEEecCcc
Confidence            45889999877888887765    45789999999999999999999986 999999999999996 45 7999999999


Q ss_pred             cccccCCC---CccccccccccccccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 015298          222 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEII  287 (409)
Q Consensus       222 ~~~~~~~~---~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~  287 (409)
                      +.......   ....+||+.|+|||++.+          ...++.++|||||||++|+|++|..||...... ..+..+.
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            86644322   235679999999999864          135889999999999999999999999865432 2222221


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .   ..                        ....++...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       282 ~---~~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 D---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             C---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             C---cc------------------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            1   00                        011134446889999999999999999999999999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-47  Score=351.38  Aligned_cols=253  Identities=20%  Similarity=0.253  Sum_probs=205.3

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456899999999999999999999999999999998753      23345788888888 99999999998843     


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC---------
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---------  210 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~---------  210 (409)
                      ....++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3458899999975 89888887666568899999999999999999999996 999999999999998432         


Q ss_pred             ---------CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015298          211 ---------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (409)
Q Consensus       211 ---------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (409)
                               ..+||+|||.+......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     26999999999865432   2346899999999997765677899999999999999999987754422  


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                       ...+...  .                          ...++..+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       237 -~~~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQG--R--------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTT--C--------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcC--C--------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             2222110  0                          011445689999999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4e-47  Score=358.01  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             cccceEEE-EeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ....|.+. +.||+|+||.||+|.+..+|+.||||++....    ....+|+++++++ +||||+++++++..     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence            34579985 78999999999999999999999999996542    3456899999885 79999999998843     34


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC--cEEEeecC
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~--~ikl~Dfg  219 (409)
                      .+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            5889999998 577777654    46799999999999999999999997 9999999999999987662  39999999


Q ss_pred             CccccccCC--------CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------
Q 015298          220 SAKVLVKGE--------PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-------  280 (409)
Q Consensus       220 ~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------  280 (409)
                      ++.......        .....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+....       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987553221        1224568999999999853    134788999999999999999999999865431       


Q ss_pred             --------HHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          281 --------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       281 --------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                              .....+.......+..                         ....+++++++||.+||+.||.+|||+.++|
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEFPDK-------------------------DWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhccCcccCch-------------------------hcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                    1122222110000000                         0124789999999999999999999999999


Q ss_pred             CCCCccCCCC
Q 015298          353 IHPFFDELRD  362 (409)
Q Consensus       353 ~hp~f~~~~~  362 (409)
                      +||||++...
T Consensus       295 ~hp~~~~~~~  304 (316)
T 2ac3_A          295 QHPWVQGCAP  304 (316)
T ss_dssp             HSTTCC----
T ss_pred             cChhhcCCCC
Confidence            9999997643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=361.53  Aligned_cols=254  Identities=23%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCC--CCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+ .+++.||+|++....      ..+.+|+.+++.++|  |||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            45799999999999999999997 468999999986432      345679999999987  99999999873     44


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++++|||+.+++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            56889999888888888765    56899999999999999999999996 999999999999997 45 7999999999


Q ss_pred             cccccCCC---CccccccccccccccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015298          222 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       222 ~~~~~~~~---~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  288 (409)
                      +.......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||........  .+..
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~  232 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHA  232 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--HHHH
Confidence            86644322   235679999999999853          24588999999999999999999999976543221  1111


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .+..                        .....++...++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       233 ~~~~------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          233 IIDP------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HHCT------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             HhcC------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            1110                        0111244556789999999999999999999999999999986443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.9e-47  Score=350.33  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=212.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+++++.++||||+++++++.     .
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----D   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----c
Confidence            3456899999999999999999999999999999998543       234568999999999999999999883     3


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ....++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEeccc
Confidence            4458899999974 77777654    35799999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ++..... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||......+....+....         
T Consensus       160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  228 (284)
T 2vgo_A          160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------  228 (284)
T ss_dssp             TCEECSS-SCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ccccCcc-cccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------
Confidence            9865433 233456789999999999654 48999999999999999999999998877666555443210         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                          ..++..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       229 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 --------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                013456799999999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-47  Score=350.73  Aligned_cols=256  Identities=25%  Similarity=0.320  Sum_probs=206.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            457999999999999999999999999999999986432     345689999999999999999998743     3457


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999985 6655443    246799999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....   ......||+.|+|||++.+...++.++|||||||++|+|++|..||...................       
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  227 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  227 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-------
Confidence            53322   23456789999999999766555789999999999999999999998765432221111100000       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                         ......+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          228 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             -------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                               0011247899999999999999999999999999999986543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=352.06  Aligned_cols=252  Identities=28%  Similarity=0.475  Sum_probs=186.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            457999999999999999999999999999999996432       34568999999999999999999883     345


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            68899999974 66666553   236799999999999999999999996 999999999999999887 8999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ...... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            765432 223456789999999998654 488999999999999999999999987654332221100            


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                     .  ...++..++.++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       227 ---------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ---------------A--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ---------------S--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ---------------c--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                           0  0113455789999999999999999999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-46  Score=352.41  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=210.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            458999999999999999999999999999999996542    34568999999999999999999873     344588


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee---cCCCCcEEEeecCCc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA  221 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli---~~~~~~ikl~Dfg~a  221 (409)
                      +||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            9999997 477776654    45799999999999999999999996 99999999999999   5555 8999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+......         
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------  225 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------  225 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred             eecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            754322 33456789999999998654 5899999999999999999999999888776666655542111         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                      +.......+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       226 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          226 ----------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ----------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                            0111334578999999999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=361.91  Aligned_cols=277  Identities=19%  Similarity=0.286  Sum_probs=209.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++....     ....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            458999999999999999999999999999999986432     3456899999999999999999887542   23357


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee----cCCCCcEEEeecC
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  219 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli----~~~~~~ikl~Dfg  219 (409)
                      ++||||+. ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+||++    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 57777776432 234599999999999999999999996 99999999999998    6555 79999999


Q ss_pred             CccccccCCCCccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHH
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG----VDQLVEIIK  288 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~  288 (409)
                      +++............||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9988766666667789999999999852       34589999999999999999999999975433    344444443


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                      .........+........  .+..  ..+....+...+++.+.+||.+||+.||.+|||+.|+|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPI--DWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCE--EEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCcc--ccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            321111111110000000  0000  000111122345678999999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-46  Score=361.79  Aligned_cols=289  Identities=29%  Similarity=0.489  Sum_probs=220.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC-----------CCCeeccccee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCF  133 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~  133 (409)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||||++..+.   ....+|+.+++.++           ||||+++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            34568999999999999999999999999999999997543   34567899888876           89999999988


Q ss_pred             eecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC---
Q 015298          134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---  210 (409)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~---  210 (409)
                      .... ....++++||||++++|.+++....  ...+++..++.++.||+.||.|||+++||+||||||+|||++.++   
T Consensus        96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            6543 2345688999999889888887543  456999999999999999999999844999999999999995321   


Q ss_pred             --CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHH
Q 015298          211 --HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQ  282 (409)
Q Consensus       211 --~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~  282 (409)
                        ..+||+|||++......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||....      ..+.
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence              27999999999765432  3456789999999999765 48999999999999999999999998654      4566


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCcccc-------ccCcccCCCC------cccCCCCCChhHHHHHHHhcccCCCCCCCHH
Q 015298          283 LVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPW------HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL  349 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~  349 (409)
                      +..+...++.++...+.........+       ........+.      ...++...++++.+||.+||+.||.+|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            77788888887765443211000000       0000000000      0012234567899999999999999999999


Q ss_pred             HHhCCCCccCCCC
Q 015298          350 DALIHPFFDELRD  362 (409)
Q Consensus       350 ell~hp~f~~~~~  362 (409)
                      ++|+||||++...
T Consensus       330 ell~hp~f~~~~~  342 (373)
T 1q8y_A          330 GLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHTCGGGTTCTT
T ss_pred             HHhhChhhhcccC
Confidence            9999999998644

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-46  Score=356.53  Aligned_cols=281  Identities=26%  Similarity=0.469  Sum_probs=220.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEE-cCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCC------CeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKC-LETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|+||.||+|.+ ..+|+.||+|++....   ....+|+.+++.++|+      +++++++++.     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----
Confidence            45899999999999999999998 5688999999997543   3456799999888665      4889888773     


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC-----------
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-----------  208 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~-----------  208 (409)
                      ....+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.           
T Consensus        88 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           88 HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcc
Confidence            334588999999989888876532  34689999999999999999999996 9999999999999986           


Q ss_pred             --------CCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 015298          209 --------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (409)
Q Consensus       209 --------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (409)
                              ++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus       165 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    33 699999999976433  33456889999999999654 4899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCcc----ccccCcc---------cCCCCcc--cCCCCCChhHHHHHHHhcccCCCCC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYT----EFKFPQI---------KAHPWHK--IFPKRMPPEAVDLVSRLLQYSPNLR  345 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~R  345 (409)
                      +....+.+..+..+...+........    ...+...         ...++..  ......++++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            88888888888777665543221100    0000000         0000000  0112245789999999999999999


Q ss_pred             CCHHHHhCCCCccCCCC
Q 015298          346 CTALDALIHPFFDELRD  362 (409)
Q Consensus       346 ~s~~ell~hp~f~~~~~  362 (409)
                      ||+.|+++||||+.++.
T Consensus       321 pt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          321 ITLREALKHPFFDLLKK  337 (339)
T ss_dssp             CCHHHHTTSGGGGGGGC
T ss_pred             cCHHHHhcCHHHHHHhc
Confidence            99999999999997653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-48  Score=377.77  Aligned_cols=255  Identities=18%  Similarity=0.240  Sum_probs=195.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHH---HHHhcCCCCeecccceeeecC-
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLKHCFFSTT-  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~-  137 (409)
                      ...+|.+.+.||+|+||+||+|.+..+|+.||||++...       ...+.+|+.   +++.++||||+++++.+.... 
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            356899999999999999999999999999999998632       134567884   455558999999985443111 


Q ss_pred             ---------------CCCcc---EEEEEEeccchhHHHHHHHhhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 015298          138 ---------------DKDEL---YLNLVLEYVPETVHRVVKHFNKLNQ---RMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (409)
Q Consensus       138 ---------------~~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (409)
                                     +....   ..++||||++|+|.+.+........   .+++..++.++.||+.||+|||++ ||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence                           11111   2689999999999988876432211   234577888999999999999996 9999


Q ss_pred             ecCCCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCC----------CCCCchhhHHHHHHHHHH
Q 015298          197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTTAIDIWSAGCVVAE  266 (409)
Q Consensus       197 ~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~  266 (409)
                      |||||+|||++.++ .+||+|||+++..  +......+| +.|+|||++.+.          ..++.++|||||||++|+
T Consensus       230 rDikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          230 TYLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             SCCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            99999999999887 8999999999753  223345667 999999999654          258999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC
Q 015298          267 LMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC  346 (409)
Q Consensus       267 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~  346 (409)
                      |++|+.||.+....+....+.                                 .....+++++.+||.+||+.||.+||
T Consensus       306 lltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             HHHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCC
Confidence            999999996544211111000                                 01245799999999999999999999


Q ss_pred             CHHHHhCCCCccCCC
Q 015298          347 TALDALIHPFFDELR  361 (409)
Q Consensus       347 s~~ell~hp~f~~~~  361 (409)
                      |+.++++||||+++.
T Consensus       353 t~~e~l~hp~f~~~~  367 (377)
T 3byv_A          353 LPLQAMETPEYEQLR  367 (377)
T ss_dssp             CHHHHHTSHHHHHHH
T ss_pred             CHHHHhhChHHHHHH
Confidence            999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-46  Score=346.85  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=213.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ..+.+|+.+++.++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            4568999999999999999999999999999999996432      3456899999999999999999977542   234


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cEeecCCCCceeecCCCCcEEEe
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-----VCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-----ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                      .+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+. |     |+||||||+||+++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            57899999985 88888877665566799999999999999999999997 8     99999999999999887 89999


Q ss_pred             ecCCccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          217 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       217 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.....    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  233 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----  233 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence            9999876543321 2245689999999999664 489999999999999999999999988876665555443210    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                              ..++..+++++.++|.+||..||.+|||+.++++|+|+.+-
T Consensus       234 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 ------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                    01344678999999999999999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-46  Score=356.03  Aligned_cols=256  Identities=30%  Similarity=0.465  Sum_probs=204.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+++++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            457999999999999999999999999999999985432            235689999999999999999987732  


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC--cEE
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVK  214 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~--~ik  214 (409)
                         .. .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEE
Confidence               11 6799999985 66665542    56899999999999999999999986 9999999999999987652  499


Q ss_pred             EeecCCccccccCCCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+.........
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998764433334567899999999973  3455889999999999999999999999765543322222221111


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      ...                        ......+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus       238 ~~~------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NFI------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CCC------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ccC------------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            000                        00123478999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-47  Score=363.17  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=206.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeecc--------chhhHHHHHHHHhc-CCCCeecccceeee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (409)
                      ....+|.+.+.||+|+||.||+|++.   .+|+.||||++...        .....+|+++++.+ .||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34568999999999999999999985   58999999998542        23455799999999 69999999988843


Q ss_pred             cCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                           ...+++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus       131 -----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  199 (355)
T 1vzo_A          131 -----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVV  199 (355)
T ss_dssp             -----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEE
T ss_pred             -----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cEE
Confidence                 3458899999985 77777654    45799999999999999999999986 999999999999999888 899


Q ss_pred             EeecCCccccccCC--CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          215 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       215 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      |+|||+++......  .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+...+.
T Consensus       200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            99999997653222  23346789999999999653 3478999999999999999999999975433222222222110


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                      ..                         ...++..++..+.+||.+||..||.+||     |+.++++||||+++.+.
T Consensus       280 ~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          280 KS-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             HC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             cc-------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            00                         0114456889999999999999999999     99999999999987653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-47  Score=367.16  Aligned_cols=266  Identities=14%  Similarity=0.147  Sum_probs=189.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhc--CCCCeecccceee------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF------  134 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l--~h~niv~~~~~~~------  134 (409)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.|  +||||++++..++      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999997643       2334675544444  6999888654332      


Q ss_pred             -ecCC------------CCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHH------HHHHHHHHHHHHHHHhcCCcE
Q 015298          135 -STTD------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV------KLYAYQIFRALSYIHRSIGVC  195 (409)
Q Consensus       135 -~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~iv  195 (409)
                       ....            .....++|||||++++|.+++.....   .++....      ..++.||+.||+|||++ ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCc
Confidence             1110            01145789999999999998876532   3344444      56779999999999986 999


Q ss_pred             eecCCCCceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 015298          196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLF  274 (409)
Q Consensus       196 H~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltg~~pf  274 (409)
                      ||||||+|||++.++ .+||+|||+++....  ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999888 899999999986532  2225667799999999964 145899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       275 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+......                    ..+............+.......+++.+.+||.+||+.||.+|||+.++|+|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            76532100                    0000001111111111111224689999999999999999999999999999


Q ss_pred             CCccCCCC
Q 015298          355 PFFDELRD  362 (409)
Q Consensus       355 p~f~~~~~  362 (409)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-46  Score=357.68  Aligned_cols=282  Identities=26%  Similarity=0.441  Sum_probs=219.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCC-cEEEEEEeeccc---hhhHHHHHHHHhcCCCC------eecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  139 (409)
                      .++|.+.+.||+|+||+||+|.+..++ +.||+|++....   ....+|+.+++.++|++      ++.+++++.     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----
Confidence            458999999999999999999998877 789999997543   34567999999987665      777777663     


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee-------------
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV-------------  206 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli-------------  206 (409)
                      ....+++||||+++++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||+             
T Consensus        93 ~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           93 FHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence            334588999999988877766422  35799999999999999999999986 99999999999999             


Q ss_pred             ------cCCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 015298          207 ------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (409)
Q Consensus       207 ------~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (409)
                            +.++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus       170 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  4455 899999999976433  33456889999999999654 4899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCcccc----ccCcc---------cCCCCccc--CCCCCChhHHHHHHHhcccCCCCC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQI---------KAHPWHKI--FPKRMPPEAVDLVSRLLQYSPNLR  345 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~---------~~~~~~~~--~~~~~s~~l~~li~~~L~~dp~~R  345 (409)
                      +.+..+.+..+..+...+..........    .++..         ...++...  .....+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            8888888888887776554322110000    00000         00000000  111234689999999999999999


Q ss_pred             CCHHHHhCCCCccCCCCC
Q 015298          346 CTALDALIHPFFDELRDP  363 (409)
Q Consensus       346 ~s~~ell~hp~f~~~~~~  363 (409)
                      ||+.++|+||||+++.+.
T Consensus       326 pt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CCHHHHTTSGGGGGCCHH
T ss_pred             cCHHHHhcChhhcCCChh
Confidence            999999999999987543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-46  Score=348.91  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=212.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...      ...+.+|+++++.++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            45899999999999999999999999999999998543      234568999999999999999999873     3445


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCC
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~  220 (409)
                      .++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            789999997 466666553    35799999999999999999999996 999999999999997643  2699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.............+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.........     
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  243 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-----  243 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence            987655555556678999999999854  3899999999999999999999999988776666555442111000     


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                          .....+++++.+||.+||..||.+|||+.++|+||||++..+
T Consensus       244 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 --------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                                011347899999999999999999999999999999987643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.3e-47  Score=356.17  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....       ..+.+|+.+++.++||||+++++++..... ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CC
Confidence            3568999999999999999999999999999999996542       234578899999999999999998755432 23


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+.++||||++ ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence            45689999997 577777654    46799999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +........    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+......+.. 
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-  240 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-  240 (311)
T ss_dssp             C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-
Confidence            976543322    2345689999999999764 4899999999999999999999999988877666655443221111 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                              .....+++++.+||.+||+.||.+||++.+++.|+|++...
T Consensus       241 ------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          241 ------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                                    01234789999999999999999999999999999998543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=350.00  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=207.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhc-CCCCeecccceeeecCC-CCcc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++...   .....+|+.+++.+ +||||+++++++..... ....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3456899999999999999999999999999999998643   34567899999998 89999999998865432 1245


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  176 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  176 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCCTTT
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeCcCc
Confidence            67899999985 8887776532  45799999999999999999999996 999999999999999887 8999999998


Q ss_pred             cccccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ....... ......||+.|+|||++..    ...++.++|||||||++|+|++|..||......+....+.... .    
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~----  251 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-A----  251 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C----
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-c----
Confidence            7654322 2345678999999999852    3458899999999999999999999998877665554433210 0    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                            .......+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus       252 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 ----------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ----------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ----------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                  011234578999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.5e-46  Score=348.46  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+++++.++||||+++++++..     ...+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence            3568999999999999999999999999999999985432    345679999999999999999998853     2347


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence            899999985 56555543   246799999999999999999999996 999999999999999887 899999998754


Q ss_pred             ccc-CCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          224 LVK-GEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       224 ~~~-~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      ... ........||+.|+|||++.    ....++.++|||||||++|+|++|..||...+..+....+.......     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  241 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-----  241 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----
Confidence            321 12233457899999999984    34458899999999999999999999999887766655554421100     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                           ...+..++..+.+||.+||..||.+|||+.++++||||+.+..
T Consensus       242 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          242 ---------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             ---------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ---------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                 0123346889999999999999999999999999999987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=347.62  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=206.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+....  ....+|+.+++.++||||+++++++..     ...+++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence            457999999999999999999999999999999997543  456789999999999999999998854     3347899


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+++ +|.+++..   ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence            999985 77776653   256899999999999999999999986 999999999999999887 899999999976543


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       227 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..... +          . 
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------~-  244 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P----------T-  244 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C----------C-
T ss_pred             hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c----------c-
Confidence            32 23456789999999998654 489999999999999999999999987766554443322110 0          0 


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                    ...+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       245 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          245 --------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             --------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             --------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                          001234688999999999999999999999999999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-46  Score=359.48  Aligned_cols=283  Identities=24%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++..     ...
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  105 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE  105 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence            3568999999999999999999999999999999987542     345689999999999999999998853     344


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+.+ +|.+.+..    ...+++..+..++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus       106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  180 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  180 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence            8899999985 88777764    457999999999999999999999733899999999999999888 89999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CCHHHHh--
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT-PTREEIK--  299 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~--  299 (409)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...... .......  
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            55332 23456789999999999654 5899999999999999999999999887655543322111100 0000000  


Q ss_pred             hcCCCccccc------------cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          300 CMNPNYTEFK------------FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       300 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      ........+.            ...+............++.++.+||.+||+.||.+|||+.++|+||||++....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence            0000000000            000000011111233478999999999999999999999999999999976433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.8e-46  Score=348.40  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ....+|++.+.||+|+||+||+|.+  +|+.||+|++....      ..+.+|+++++.++||||+++++++.     ..
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            4456899999999999999999987  78899999986542      23457999999999999999999883     33


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeec
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ..+++||||+.+ +|.+.+.... ....+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            347899999985 7777766421 123489999999999999999999986 9  99999999999999887 8999999


Q ss_pred             CCccccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          219 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       219 g~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      |+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......     
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             CCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence            9997553332 23456789999999999654 4899999999999999999999999888776655544321110     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCccC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI--HPFFDE  359 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~--hp~f~~  359 (409)
                                            ..++..+++++.+||.+||..||.+|||+.++++  +++++.
T Consensus       258 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                  1145568999999999999999999999999987  566554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.7e-46  Score=354.78  Aligned_cols=268  Identities=21%  Similarity=0.335  Sum_probs=187.2

Q ss_pred             CCccccceEEEE-eeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           66 QPKQTISYMAER-IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        66 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .....++|.+.+ .||+|+||+||+|.+..+|+.||||++........+....++.++||||+++++++.... ....++
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~  101 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL  101 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence            334567899965 699999999999999999999999999876655555556678889999999999875433 235567


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSA  221 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a  221 (409)
                      ++||||+.+ +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            899999985 787777642  235799999999999999999999996 999999999999998643  25999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...............+...        
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (336)
T 3fhr_A          179 KETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG--------  248 (336)
T ss_dssp             EEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             eecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc--------
Confidence            765432 3345678999999999854 448899999999999999999999997665433322111111000        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                           ...        ........+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       249 -----~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 -----QYG--------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------C--------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -----ccc--------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                 000        0001123579999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-45  Score=344.82  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=209.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence            346999999999999999999999999999999986432     455789999999999999999998843     3357


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+++.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~  168 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeeccccee
Confidence            899999985 6666553     36799999999999999999999996 999999999999999887 899999999976


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...  .+         
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------  236 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP---------  236 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC---------
T ss_pred             cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC---------
Confidence            54432 23456789999999999654 4889999999999999999999999887765554443321  00         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                       ..++..++..+.+||.+||..||.+|||+.++++||||...
T Consensus       237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                             11344678999999999999999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-46  Score=352.14  Aligned_cols=269  Identities=26%  Similarity=0.408  Sum_probs=192.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++....     .
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----E   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----C
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----C
Confidence            345899999999999999999999999999999988543     234457889999999999999999885433     3


Q ss_pred             EEEEEeccc-hhHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNK----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      .++||||+. ++|.+++.....    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEec
Confidence            789999997 578777765432    245689999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCC------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015298          219 GSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (409)
Q Consensus       219 g~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  292 (409)
                      |++.......      ......||+.|+|||++.+...++.++|||||||++|+|++|..||......+.........  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--  243 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--  243 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--
Confidence            9987553321      12345789999999998654458999999999999999999999998876655443332211  


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      +..                 .............+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       244 ~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          244 PPS-----------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCC-----------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCc-----------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            000                 000000111334578999999999999999999999999999999976544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-45  Score=344.50  Aligned_cols=256  Identities=24%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....       ..+.+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            458999999999999999999999999999999985421       3456899999999999999999987     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||++| +|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            58899999985 77777654    46799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          222 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       222 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .......  ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+....+......... .+.     
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~-----  231 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN-----  231 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC-----
T ss_pred             cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC-----
Confidence            7654332  22345789999999999764 48999999999999999999999998877665544433211 010     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                        .....+..+++.+.++|.+||..||.+||+..+.+.+.|..-+.
T Consensus       232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                              01113456899999999999999999999766677776655443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=342.82  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=200.9

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      |.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++..     ....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            333458999999999999999999999999986542    345689999999999999999998843     34578999


Q ss_pred             eccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||++ ++|.+++... .....+++..++.++.||+.||.|||++ ||+||||||+||+++...+.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9997 5777776542 2234567889999999999999999996 99999999999999873338999999999765432


Q ss_pred             C-CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCc
Q 015298          228 E-PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (409)
Q Consensus       228 ~-~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  305 (409)
                      . ......||+.|+|||++.+. ..++.++||||||+++|+|++|..||..................             
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  243 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence            2 23456789999999998543 23789999999999999999999999765443322211111111             


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                   ...++..+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                         11144568999999999999999999999999999999986543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-45  Score=348.54  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcC--CCCeecccceeeec
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST  136 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~  136 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++....          ....+|+.+++.++  |+||+++++++.  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--  118 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--  118 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence            3568999999999999999999999999999999986532          34457999999996  599999999884  


Q ss_pred             CCCCccEEEEEEeccc--hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEE
Q 015298          137 TDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                         .....++|||++.  ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.+|
T Consensus       119 ---~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 ---RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             ---CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEE
T ss_pred             ---cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEE
Confidence               3445789999987  677777654    46799999999999999999999986 9999999999999984434899


Q ss_pred             EeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||....      .+...     
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-----  258 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----  258 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-----
Confidence            9999999865432 33456789999999998766656789999999999999999999996531      11110     


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                                              ...++..+++++.+||.+||+.||.+|||+.++++||||++...+
T Consensus       259 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          259 ------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             ------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                                    001345689999999999999999999999999999999976543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5e-46  Score=355.26  Aligned_cols=272  Identities=21%  Similarity=0.316  Sum_probs=207.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------------------hhhHHHHHHHHhcCCCCeec
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVVS  128 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~e~~~l~~l~h~niv~  128 (409)
                      .++|.+.+.||+|+||.||+|.+  +|+.||+|++....                     ..+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999998  99999999986431                     55678999999999999999


Q ss_pred             ccceeeecCCCCccEEEEEEeccch-hHHHHHHH----hhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCC
Q 015298          129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKH----FNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQ  202 (409)
Q Consensus       129 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~ivH~Dlkp~  202 (409)
                      +++++..     ...+++||||+++ +|.+.+..    .......+++..++.++.||+.||.|||+ + ||+||||||+
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~  181 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPS  181 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChH
Confidence            9998843     3458899999986 66554211    01115679999999999999999999998 6 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCc-H
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT-AIDIWSAGCVVAELMLGKPLFPGDSG-V  280 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~-~  280 (409)
                      ||+++.++ .+||+|||.+...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||..... .
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999888 8999999999865433 3345678999999999976544555 99999999999999999999988766 4


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      +....+.......+.        ....+ ...... .........+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       260 ~~~~~i~~~~~~~~~--------~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKNIEYPL--------DRNHF-LYPLTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCCCCCCC--------SSSSS-TTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccCcCCcc--------chhhh-hccccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            444433221100000        00000 000000 00011224689999999999999999999999999999999865


Q ss_pred             C
Q 015298          361 R  361 (409)
Q Consensus       361 ~  361 (409)
                      .
T Consensus       330 ~  330 (348)
T 2pml_X          330 N  330 (348)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=343.17  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=190.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------hhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||||++.....      ...++..+++.++||||+++++++..     .
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~   96 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----N   96 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----C
Confidence            345689999999999999999999999999999999965421      22234456788899999999998843     3


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+++||||+++.+..+...   ....+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            45889999997655444432   2567999999999999999999999723999999999999999888 8999999999


Q ss_pred             cccccCCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~  296 (409)
                      .............+|+.|+|||++.    ....++.++|||||||++|+|++|+.||..... .+.+..+....  +.  
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~--  248 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP--  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC--
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC--
Confidence            7765555555667899999999985    234588999999999999999999999987443 34444333311  00  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                             .     .          .....+++++.+||.+||..||.+|||+.++++||||++..
T Consensus       249 -------~-----~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 -------L-----L----------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -------C-----C----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -------C-----C----------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                   0     0          01124789999999999999999999999999999998653

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-45  Score=346.79  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=187.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-----hhHHHHH-HHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++.....     ....|+. +++.++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence            34689999999999999999999999999999999965421     2233444 6677899999999998843     34


Q ss_pred             EEEEEEeccchhHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..++||||+.++|.+++..... ....+++..+..++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            5789999999988887765332 3578999999999999999999999844999999999999999887 8999999999


Q ss_pred             cccccCCCCcccccccccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  297 (409)
                      .............||+.|+|||++.   ....++.++|||||||++|+|++|..||...... +.+..+.          
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------  243 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----------  243 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----------
Confidence            8765554445567899999999983   2345889999999999999999999999764321 1100000          


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                               .     .....+.......+++.+.+||.+||..||.+|||+.++++||||....
T Consensus       244 ---------~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          244 ---------K-----GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---------C-----SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ---------c-----CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                     0     0000111112345789999999999999999999999999999998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.3e-45  Score=339.45  Aligned_cols=258  Identities=26%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCC--------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTD--------  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--------  138 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            457999999999999999999999999999999996543   345679999999999999999988754321        


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      .....+++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            235668899999974 887777642   34678899999999999999999997 999999999999999888 899999


Q ss_pred             cCCccccccC---------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Q 015298          218 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-  281 (409)
Q Consensus       218 fg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-  281 (409)
                      ||++......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||....... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345689999999999765568999999999999999998   554322211 


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      ....+...            .             ..+...++...++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       237 ~~~~~~~~------------~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSV------------S-------------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHST------------T-------------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhcccc------------c-------------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            11111110            0             001112345577889999999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.3e-45  Score=350.26  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-------CCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ....+|.+.+.||+|+||.||+|.+.       .++..||+|++....     ..+.+|+.+++.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            34578999999999999999999975       345689999996542     3456899999999 8999999999883


Q ss_pred             ecCCCCccEEEEEEeccch-hHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                           ....+++||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||++ ||+||||||
T Consensus       158 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp  231 (370)
T 2psq_A          158 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  231 (370)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCG
T ss_pred             -----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccch
Confidence                 33347899999985 88887765321            124589999999999999999999996 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       232 ~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          232 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999888 89999999998654332   22334567899999999764 48999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+.....                            ...+..+++++.++|.+||..||.+|||+.+++++
T Consensus       310 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          310 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CGGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76655544332110                            11345678999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-44  Score=343.38  Aligned_cols=249  Identities=18%  Similarity=0.204  Sum_probs=201.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++...  .....+|+++++.+ +||||+++++++..     ..+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccE
Confidence            345899999999999999999999999999999998643  34567899999999 99999999988743     34578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc-----EEEeecCC
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGS  220 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~-----ikl~Dfg~  220 (409)
                      +||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .     +||+|||+
T Consensus        82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~  156 (330)
T 2izr_A           82 MVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCTT
T ss_pred             EEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEccc
Confidence            99999988888887653   46899999999999999999999996 999999999999999776 5     99999999


Q ss_pred             ccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHH
Q 015298          221 AKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---DQLVEIIKV  289 (409)
Q Consensus       221 a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~  289 (409)
                      ++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....   +.+..+...
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            986544322        2467889999999999764 4899999999999999999999999875433   333333222


Q ss_pred             hCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ....+...                        .....+ ++.++|.+||..||.+||++.++++
T Consensus       236 ~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          236 KRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111110                        111234 8999999999999999999998864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-44  Score=340.09  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=197.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcC--CCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|++....      ....+|+.+++.++  ||||+++++++.     ..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence            457999999999999999999975 58999999986432      34467999999997  599999999873     34


Q ss_pred             cEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       142 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++++|||+.+++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeecccc
Confidence            45889999888888888765    46789999999999999999999996 9999999999999974 4 8999999999


Q ss_pred             cccccCCC---CccccccccccccccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH
Q 015298          222 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEII  287 (409)
Q Consensus       222 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~  287 (409)
                      ........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||....... .+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            86543322   2345789999999998541          358889999999999999999999997654332 222111


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .   .                        .....++...++++.+||.+||..||.+|||+.++++||||+....
T Consensus       254 ~---~------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          254 D---P------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             C---T------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             h---c------------------------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            1   0                        0011134456889999999999999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=352.12  Aligned_cols=256  Identities=20%  Similarity=0.225  Sum_probs=205.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEE-----EcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ....+|.+.+.||+|+||.||+|.     +..+++.||||++...     .....+|+.+++.++||||+++++++..  
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            345689999999999999999999     4567889999998543     2345679999999999999999998843  


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--C
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--H  211 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~  211 (409)
                         ....++||||+. ++|.+++.....   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  .
T Consensus       146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCc
Confidence               333679999997 588888776432   224689999999999999999999996 999999999999998544  2


Q ss_pred             cEEEeecCCccccccC---CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015298          212 QVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  287 (409)
                      .+||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5999999999754322   223345678999999998654 48999999999999999998 999999887766665554


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      .....                            ..+..+++.+.+||.+||+.||.+|||+.++++|.++.
T Consensus       301 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            32110                            12445789999999999999999999999999997765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-45  Score=343.35  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=190.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||.||+|.+..++.   .||+|++...      ...+.+|+++++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35589999999999999999999887775   8999998643      23456899999999999999999988654332


Q ss_pred             C-ccEEEEEEeccch-hHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          140 D-ELYLNLVLEYVPE-TVHRVVKHFNK--LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       140 ~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                      + ....++||||+.+ +|.+.+.....  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEEE
Confidence            1 1224799999985 77777764332  123689999999999999999999996 999999999999999887 8999


Q ss_pred             eecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          216 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999976544322   2234567789999998654 48999999999999999999 9999998877766655543211


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-------HHHHhCCCCccCCCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-------ALDALIHPFFDELRD  362 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-------~~ell~hp~f~~~~~  362 (409)
                                                  ...+..+++++.+||.+||+.||.+|||       +.+++.|||+.....
T Consensus       258 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          258 ----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             ----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence                                        0134457899999999999999999999       777889999986543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.8e-44  Score=333.93  Aligned_cols=251  Identities=20%  Similarity=0.226  Sum_probs=203.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++...  .....+|+.+++.+ +|+|++++++++.     .....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence            45799999999999999999999999999999998643  34567899999999 7999999998773     3445789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC----cEEEeecCCcc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAK  222 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~----~ikl~Dfg~a~  222 (409)
                      ||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.    .+||+|||++.
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999988888887643   35699999999999999999999986 9999999999999987651    39999999998


Q ss_pred             ccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhC
Q 015298          223 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---GVDQLVEIIKVLG  291 (409)
Q Consensus       223 ~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~  291 (409)
                      .......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..   ..+.+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            6654322        3456789999999998654 48999999999999999999999998743   3333343333221


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+....                        ....+++++.++|.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          239 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             CccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111111                        123478999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=343.32  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=201.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|.+.+.||+|+||.||+|.+..+|+   .||||++...     ...+.+|+.+++.++||||+++++++     .
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            345689999999999999999999986665   4999999753     23456799999999999999999988     3


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      .....++||||+++ +|.+++..   ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCC
Confidence            34457899999975 77777643   246799999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       219 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      |+++.......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+...... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence            99986644322    1223457789999999654 48999999999999999999 99999888877766655442111 


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                 ..+..+++.+.+||.+||..||.+|||+.++++
T Consensus       274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       134468999999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-44  Score=333.71  Aligned_cols=246  Identities=20%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|.+.+.||+|+||.||+|.+. +++.||+|++...   .....+|+++++.++||||+++++++.     .....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence            4468999999999999999999986 5778999999754   345678999999999999999999883     334478


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999985 67666643   245689999999999999999999986 999999999999999887 8999999999765


Q ss_pred             ccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....  ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  225 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence            3321  22345567889999998654 48999999999999999999 9999998877766665543211          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                        ...+...++.+.++|.+||+.||.+|||+.++++|
T Consensus       226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              11344578999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-45  Score=339.81  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=210.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecC-----------
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----------  137 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++........+|+++++.++||||+++++++....           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            346899999999999999999999999999999999888788889999999999999999999874311           


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                      ......+++||||+++ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  164 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIG  164 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEEC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEEC
Confidence            1224557899999995 8888776532  46799999999999999999999986 999999999999999887 89999


Q ss_pred             ecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...  ......+..        
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~--------  233 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD--------  233 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--------
T ss_pred             cchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--------
Confidence            99999877665555667899999999999664 4899999999999999999999887421  111111100        


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                             ..++..++..+.++|.+||..||.+|||+.++++|.+.-.
T Consensus       234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                   0133457899999999999999999999999999987543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=339.21  Aligned_cols=250  Identities=24%  Similarity=0.454  Sum_probs=200.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||+||+|.+..+|+.||+|++...    ...+.+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            45899999999999999999999999999999988543    2345689999999999999999998853     34478


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999985 777776542   46799999999999999999999996 999999999999999887 8999999999765


Q ss_pred             ccCCCC---------------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHH
Q 015298          225 VKGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL--VEII  287 (409)
Q Consensus       225 ~~~~~~---------------~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~i~  287 (409)
                      ......               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........  ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            433221               14678999999999965 45899999999999999999999998653221100  0000


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      .                            ......+..+++.+.++|.+||+.||.+|||+.++++  |++.+
T Consensus       238 ~----------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          238 G----------------------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             H----------------------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             c----------------------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            0                            0011134568899999999999999999999999986  55544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-44  Score=346.53  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             cccceEEEEeeccCCceEEEEEE-----EcCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ..++|.+.+.||+|+||.||+|.     +..+++.||||++....     ....+|+++++.+ +||||+++++++... 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            35689999999999999999999     55677999999996532     3456899999999 789999999987432 


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhh---------------------------------------------------
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL---------------------------------------------------  165 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  165 (409)
                         ...+++||||+.+ +|.+.+......                                                   
T Consensus        99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence               2236799999984 787777653221                                                   


Q ss_pred             -----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCC---Cc
Q 015298          166 -----------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NI  231 (409)
Q Consensus       166 -----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~  231 (409)
                                 ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence                       12289999999999999999999996 999999999999999887 899999999976543322   23


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccccc
Q 015298          232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (409)
Q Consensus       232 ~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  310 (409)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+...........+                 
T Consensus       254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  315 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  315 (359)
T ss_dssp             -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence            45678899999998654 48999999999999999998 999998877655555444432111                 


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                      1344578999999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=340.76  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=198.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhc----CCCCeecccceee
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFF  134 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l----~h~niv~~~~~~~  134 (409)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.+    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4568999999999999999999999999999999986432          2344799999998    8999999999874


Q ss_pred             ecCCCCccEEEEEEec-cc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec-CCCC
Q 015298          135 STTDKDELYLNLVLEY-VP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTH  211 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~-~~~~  211 (409)
                      .     ....++|||+ +. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++ .++ 
T Consensus       109 ~-----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          109 T-----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTT-
T ss_pred             c-----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCC-
Confidence            3     3346789998 44 677777764    45799999999999999999999997 999999999999998 555 


Q ss_pred             cEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015298          212 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       212 ~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      .+||+|||++...... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence            8999999999866433 34456789999999998765545668999999999999999999996531      11110  


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                                 ...++..++..+.+||.+||+.||.+|||+.++++||||+...+
T Consensus       249 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                                       00134568999999999999999999999999999999997654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=358.00  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=191.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .+|.+.+.||+|+||+|+. ....+|+.||||++... .....+|+.+++.+ +||||+++++++     ....+++|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            3699999999999999763 44568999999998654 34567899999999 799999999877     3445588999


Q ss_pred             eccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC----CcEEEeecCCcccc
Q 015298          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAKVL  224 (409)
Q Consensus       149 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~----~~ikl~Dfg~a~~~  224 (409)
                      ||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ..+||+|||+++..
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999988877642   23455556778999999999999986 999999999999995322    25889999999866


Q ss_pred             ccCC----CCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          225 VKGE----PNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       225 ~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||.......... +   .+....  
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~--  247 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSL--  247 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCC--
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCc--
Confidence            4432    2345679999999999964  3457889999999999999999 999996554332211 1   111000  


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                   ..     .  ......+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus       248 -------------~~-----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          248 -------------DC-----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             -------------TT-----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             -------------cc-----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                         00     0  0011235668999999999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.6e-44  Score=331.00  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----------hhhHHHHHHHHhcCCCCeecccceeeec
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  136 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~  136 (409)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....           ....+|+.+++.++||||+++++++   
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   92 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---   92 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence            34568999999999999999999999999999999985322           3456899999999999999999987   


Q ss_pred             CCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCC--
Q 015298          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTH--  211 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~--  211 (409)
                        ....  ++||||+. ++|.+.+..   ....+++..++.++.|++.||.|||++ |  |+||||||+||+++.++.  
T Consensus        93 --~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           93 --HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             --TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTC
T ss_pred             --cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCC
Confidence              2232  48999998 566665543   246799999999999999999999986 9  999999999999987662  


Q ss_pred             --cEEEeecCCccccccCCCCccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHH
Q 015298          212 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEII  287 (409)
Q Consensus       212 --~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~i~  287 (409)
                        .+||+|||+++....  ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+.. ....
T Consensus       165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence              299999999975432  3445678999999999843 334788999999999999999999999876544332 1111


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ...+                          +...++..+++.+.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          243 REEG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHSC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1111                          111245568999999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=344.38  Aligned_cols=251  Identities=21%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCC-------CcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ...++|.+.+.||+|+||.||+|.+..+       +..||+|++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            4457899999999999999999997543       3579999996542     3356899999999 9999999999884


Q ss_pred             ecCCCCccEEEEEEeccch-hHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                      .     ...+++||||+.+ +|.+.+.....            ....+++..++.++.||+.||.|||++ ||+||||||
T Consensus       146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  219 (382)
T 3tt0_A          146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA  219 (382)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCG
T ss_pred             c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCc
Confidence            3     3347899999985 88888775431            124699999999999999999999996 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 89999999998654332   23345668899999999764 48999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+.....                            ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76665554433210                            11344689999999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=340.99  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=186.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcC-CCCeecccceeeecCC---CCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD---KDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~~~  142 (409)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999985543    33467999999996 9999999998754332   4455


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecCC
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .+++||||++|+|.+.+.... ....+++..++.++.||+.||.|||++ |  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            688999999999888887543 246799999999999999999999986 9  99999999999999887 899999999


Q ss_pred             ccccccCCC-------------Ccccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015298          221 AKVLVKGEP-------------NISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE  285 (409)
Q Consensus       221 a~~~~~~~~-------------~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  285 (409)
                      +........             .....||+.|+|||++.  ....++.++|||||||++|+|++|..||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            986643322             11456899999999983  334578999999999999999999999975443221110


Q ss_pred             HHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCC
Q 015298          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP  355 (409)
Q Consensus       286 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp  355 (409)
                      .                               +....+...+..+.+||.+||+.||.+|||+.++++|-
T Consensus       265 ~-------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          265 K-------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             c-------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            0                               00012234678899999999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.6e-44  Score=329.14  Aligned_cols=246  Identities=20%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++     ......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            3568999999999999999999875 5678999999654   34467899999999999999999988     3444478


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||++ ++|.+.+...   ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 4677776543   34699999999999999999999996 999999999999999888 8999999999765


Q ss_pred             ccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      .....  .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR----------  223 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence            44322  2234456789999998654 48899999999999999999 9999988877766555433211          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                        ...+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              11234578999999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=343.15  Aligned_cols=250  Identities=23%  Similarity=0.297  Sum_probs=203.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ..++|.+.+.||+|+||.||+|.+.     .+++.||+|++....     ..+.+|+.+++.++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            3568999999999999999999987     456899999997542     345689999999999999999998843   


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKL--------------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (409)
                        ...+++||||+.+ +|.+++......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence              3347899999985 888887653211                    26799999999999999999999996 99999


Q ss_pred             cCCCCceeecCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 015298          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPL  273 (409)
Q Consensus       198 Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~p  273 (409)
                      ||||+||+++.++ .+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999887 89999999997653321   22345678899999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       274 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      |.+....+....+.....                            ...+..+++.+.++|.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            988877665554433110                            0134568899999999999999999999999986


Q ss_pred             C
Q 015298          354 H  354 (409)
Q Consensus       354 h  354 (409)
                      +
T Consensus       329 ~  329 (343)
T 1luf_A          329 I  329 (343)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.1e-44  Score=336.93  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=202.9

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ....+|.+.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+++++.++||||+++++++.   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---   96 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---   96 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe---
Confidence            34568999999999999999999983     456899999996542     34567999999999999999999873   


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNK--------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (409)
                        .....++||||+. ++|.+.+.....                    ....+++..++.++.||+.||.|||++ ||+|
T Consensus        97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH  173 (314)
T 2ivs_A           97 --QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVH  173 (314)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             --cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcc
Confidence              3334789999998 688888775432                    123489999999999999999999996 9999


Q ss_pred             ecCCCCceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 015298          197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKP  272 (409)
Q Consensus       197 ~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~  272 (409)
                      |||||+||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus       174 ~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          174 RDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999887 899999999976543322   2334567889999998654 48999999999999999999 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       273 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                      ||.+....+....+....                            ....+..+++.+.++|.+||+.||.+|||+.+++
T Consensus       252 p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~  303 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS  303 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            998877655544333211                            0113456899999999999999999999999998


Q ss_pred             CC
Q 015298          353 IH  354 (409)
Q Consensus       353 ~h  354 (409)
                      ++
T Consensus       304 ~~  305 (314)
T 2ivs_A          304 KD  305 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.2e-44  Score=342.32  Aligned_cols=258  Identities=17%  Similarity=0.152  Sum_probs=197.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCC-----CcEEEEEEeeccchhhHHHHH---------------HHHhcCCCCeecc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVVSL  129 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~e~~---------------~l~~l~h~niv~~  129 (409)
                      ..+|.+.+.||+|+||.||+|.+..+     ++.||+|++........+|++               .++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            44799999999999999999998765     588999999776544444444               4455679999999


Q ss_pred             cceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec--
Q 015298          130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--  207 (409)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~--  207 (409)
                      ++++.... .+..+.+|||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++  
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESS
T ss_pred             Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecC
Confidence            99886543 234668899999988888877642   46799999999999999999999996 999999999999998  


Q ss_pred             CCCCcEEEeecCCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 015298          208 PHTHQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG  279 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  279 (409)
                      .++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus       189 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 NPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             CTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            666 899999999976543221        1334589999999999665 489999999999999999999999986433


Q ss_pred             HHHHHHHHH-HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          280 VDQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       280 ~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ......... .............                   .....+++++.+||..||..||.+||++.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKC-------------------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHH-------------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHh-------------------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            333322222 1111111111000                   012357899999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-44  Score=348.23  Aligned_cols=247  Identities=20%  Similarity=0.272  Sum_probs=201.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|.+....     ..+.+|+++++.++||||+++++++..     ..
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence            44568999999999999999999999999999999986542     345689999999999999999998833     33


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG~s  260 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFGMS  260 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence            4789999998 5777776542   34689999999999999999999996 999999999999999887 8999999999


Q ss_pred             cccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      +.......   .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+.+...      
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------  333 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------  333 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC------
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            75433211   1122356789999999654 48999999999999999998 9999988776665444332111      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       334 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ----------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  0134557899999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.5e-44  Score=328.57  Aligned_cols=243  Identities=27%  Similarity=0.450  Sum_probs=189.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+  +|+.||+|++....        ....+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            45799999999999999999998  58899999985431        34568999999999999999999883     34


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---cEeecCCCCceeecCC-------C
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG---VCHRDIKPQNLLVNPH-------T  210 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~---ivH~Dlkp~NIli~~~-------~  210 (409)
                      ...++||||+.+ +|.+.+.     ...+++..++.++.|++.||.|||++ |   |+||||||+||+++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            447899999974 5655543     56899999999999999999999996 8   9999999999999862       2


Q ss_pred             CcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015298          211 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  290 (409)
                      +.+||+|||++....... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            379999999997654332 3356789999999998654 48999999999999999999999998877655544433210


Q ss_pred             CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                 .....+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                       0111345688999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-44  Score=352.97  Aligned_cols=259  Identities=28%  Similarity=0.388  Sum_probs=190.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhc-CCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ...|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     ....++++|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            3467888999999999998754 5689999999987653 3456899999876 899999998877     344568899


Q ss_pred             EeccchhHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC------------Cc
Q 015298          148 LEYVPETVHRVVKHFNKLNQR---MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT------------HQ  212 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~------------~~  212 (409)
                      |||++++|.+++.........   .++..++.++.||+.||.|||++ ||+||||||+|||++.++            ..
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceE
Confidence            999999998888753221111   13334577999999999999986 999999999999997532            37


Q ss_pred             EEEeecCCccccccCCC-----CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015298          213 VKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGV  280 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  280 (409)
                      +||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987654322     224578999999999965      2458999999999999999999 99999765543


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       281 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                      +  ..+......                 .+.     ........+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       247 ~--~~i~~~~~~-----------------~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRGIFS-----------------LDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHTCCC-----------------CCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcCCCC-----------------ccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            3  222221100                 000     000011234688999999999999999999999999999964

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.9e-44  Score=331.77  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=206.1

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .....+|.+.+.||+|+||.||+|.+..++..||+|++..+.   ....+|+.+++.++||||+++++++.     ....
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   83 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP   83 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence            345678999999999999999999999999999999997654   34568999999999999999999873     3344


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+. ++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++.
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~  159 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSR  159 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGGG
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCccce
Confidence            789999998 58877776422  45699999999999999999999997 999999999999999887 89999999998


Q ss_pred             ccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .......  .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------  229 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------  229 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------
T ss_pred             eccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---------
Confidence            6543322  2234567889999999654 48999999999999999999 999998877665554443311         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                         ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus       230 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 -------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                               11134568899999999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.5e-44  Score=330.34  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=200.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++     .....+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            44568999999999999999999875 6778999999754   34567899999999999999999988     334447


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 5777766532   35699999999999999999999996 999999999999999887 899999999976


Q ss_pred             cccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....  ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....         
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------  239 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------  239 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred             ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence            53321  22334567889999999654 48999999999999999998 9999998887766665544211         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                         ...+...++.+.++|.+||+.||.+|||+.++++|
T Consensus       240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 -------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                               11344578999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=355.46  Aligned_cols=273  Identities=21%  Similarity=0.311  Sum_probs=202.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||||++....     ....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            458999999999999999999999999999999986432     3456899999999999999999887532   23347


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee----cCCCCcEEEeecC
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  219 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli----~~~~~~ikl~Dfg  219 (409)
                      ++||||+. ++|.+.+.... ....+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999997 57777665422 234499999999999999999999996 99999999999998    6555 79999999


Q ss_pred             CccccccCCCCccccccccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHH
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSAGCVVAELMLGKPLFPGD----SGVDQLVEIIK  288 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~i~~  288 (409)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||...    ...+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99876655555567899999999998531       34788999999999999999999999643    23344444433


Q ss_pred             HhCCCCHHHHhhcCC-CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          289 VLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .  .|. ..+..... ....+.+..  ..+....+...+++.+.++|.+||+.||++|||+.++++
T Consensus       242 ~--~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 G--KPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             S--CCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             C--CCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            2  221 11110000 000000000  000011122335678899999999999999999999854

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.4e-44  Score=334.75  Aligned_cols=264  Identities=24%  Similarity=0.392  Sum_probs=195.2

Q ss_pred             cccceEEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|++.+.||+|+||.||+|+    +..+|+.||+|++....    ..+.+|+++++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            35689999999999999999998    56789999999986543    34568999999999999999999875422   


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            223679999997 5887777643   34589999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++........    .....++..|+|||++.+. .++.++|||||||++|+|++|..||......     .....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccc
Confidence            9986644321    2234567789999999654 4899999999999999999999998643211     1111111110


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ......       ..............+..+++++.+||.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQMIVF-------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             THHHHH-------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHH-------HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000000       000000000011135568999999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.9e-43  Score=328.31  Aligned_cols=250  Identities=21%  Similarity=0.250  Sum_probs=201.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++...  .....+|+.+++.++|++++..+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            46899999999999999999999999999999998643  3456789999999999988777665543    23357899


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec---CCCCcEEEeecCCcccc
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~---~~~~~ikl~Dfg~a~~~  224 (409)
                      |||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            999988888887632   45799999999999999999999996 999999999999994   555 8999999999876


Q ss_pred             ccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC
Q 015298          225 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLGTP  293 (409)
Q Consensus       225 ~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~  293 (409)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....   .+.+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            54332        2456789999999999664 489999999999999999999999986432   23333333321111


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      +..                        .....+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111                        022457899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-43  Score=333.02  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=203.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++..  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            356899999999999999999985     4578899999997542     3456899999999 99999999998843  


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNK--------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                         ....++||||+.+ +|.+.+.....              ....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus        99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~  174 (313)
T 1t46_A           99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (313)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccc
Confidence               3346899999985 88887765321              123589999999999999999999996 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (409)
                      ||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus       175 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999887 899999999986654432   2234567889999998654 48999999999999999999 999998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       279 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ..+...........                           ...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            65555554442111                           11234578999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.4e-44  Score=339.86  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEE--EEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||.||+|.+..+|..+  |+|.+...     .....+|+++++.+ +||||+++++++.     .
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~   97 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H   97 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence            3468999999999999999999999998865  99988642     24466899999999 8999999999884     3


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~  207 (409)
                      ...+++||||+++ +|.+.+....            .....+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVG  176 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEc
Confidence            3458899999974 8888776432            2235799999999999999999999986 999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015298          208 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       208 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  286 (409)
                      .++ .+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+
T Consensus       177 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          177 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            887 8999999999754443344455678899999998654 48999999999999999998 99999887765554433


Q ss_pred             HHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ....                            ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       255 ~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2210                            011334578999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.3e-43  Score=327.76  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=198.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.++|++++..+..+..    ...+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence            45899999999999999999999999999999987543  3456789999999999988887766543    23457899


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee---cCCCCcEEEeecCCcccc
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli---~~~~~~ikl~Dfg~a~~~  224 (409)
                      |||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            999988888877632   45799999999999999999999996 99999999999999   5665 8999999999876


Q ss_pred             ccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCC
Q 015298          225 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---DQLVEIIKVLGTP  293 (409)
Q Consensus       225 ~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~  293 (409)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   +.+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            54322        2356789999999999664 4899999999999999999999999864432   2223222211111


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      +..                        .....+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            110                        012357899999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-43  Score=332.83  Aligned_cols=256  Identities=19%  Similarity=0.263  Sum_probs=195.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcC---CCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ....+|.+.+.||+|+||.||+|.+..   ++..||+|++....      ....+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345689999999999999999998765   56689999986432      335679999999999999999998866544


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                      ......++||||+.+ +|...+....  .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEE
Confidence            434456899999985 7777765432  2346799999999999999999999986 999999999999999887 8999


Q ss_pred             eecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015298          216 CDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (409)
Q Consensus       216 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  291 (409)
                      +|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            9999997654332   12234567889999999654 58999999999999999999 9999988777665554433211


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                  ...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        01344678999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.1e-44  Score=338.43  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=197.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcE----EEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|++.+.||+|+||+||+|.+..+++.    ||+|.+...     .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            345899999999999999999999988876    667766432     234568999999999999999999762     


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      + ...++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             C-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECCC
Confidence            1 22679999998 5776666532   35789999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          219 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       219 g~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....   
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---  235 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---  235 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence            99987644332   2345567899999999654 48999999999999999999 9999988776655544432110   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                               ...+..++.++.++|.+||..||.+|||+.++++|
T Consensus       236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     11334468889999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=337.80  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|++...     .....+|+.+++.+ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            4568999999999999999999973     46678999998643     24456899999999 89999999998843  


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKL-------------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (409)
                         ...+++||||++ ++|.+.+......                   ...+++..++.++.||+.||.|||++ ||+||
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~  196 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHR  196 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence               334789999997 4888877653211                   13479999999999999999999996 99999


Q ss_pred             cCCCCceeecCCCCcEEEeecCCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 015298          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPL  273 (409)
Q Consensus       198 Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~p  273 (409)
                      ||||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999887 8999999999866444322   234567889999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       274 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      |.+....+....+......                           ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9887765555444432110                           1134457899999999999999999999999998


Q ss_pred             CC
Q 015298          354 HP  355 (409)
Q Consensus       354 hp  355 (409)
                      |-
T Consensus       328 ~l  329 (344)
T 1rjb_A          328 FL  329 (344)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5e-44  Score=338.07  Aligned_cols=268  Identities=20%  Similarity=0.239  Sum_probs=197.5

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch---hhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|++.+.||+|+||+||+|++  .++.||||++.....   ...+|+.+++.++||||+++++++..... ....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence            345899999999999999999987  489999999965432   33458888999999999999998865432 234578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------CcEeecCCCCceeecCCCCcEE
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI----------GVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                      +||||+.+ +|.+++..     ..+++..++.++.||+.||.|||+ .          ||+||||||+|||++.++ .+|
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEE
Confidence            99999985 88877753     569999999999999999999996 5          999999999999999887 899


Q ss_pred             EeecCCccccccCCC---CccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015298          215 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (409)
Q Consensus       215 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  287 (409)
                      |+|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+...........
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976644332   2346789999999999653    235668899999999999999999997654322211111


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccC-CCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .....+....+......       ......+...+ ....++++.+||.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVH-------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTT-------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhc-------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11222222222110000       00000000000 1113456999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-43  Score=332.83  Aligned_cols=247  Identities=25%  Similarity=0.307  Sum_probs=190.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....       ..+.+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            3458999999999999999999999999999999986532       345679999999999999999998843     3


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence            458899999985 77777764    46799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          221 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       221 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      +.......  ......||+.|+|||++.+. .++.++||||||+++|+|++|..||........ ....... .+     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~-~~-----  252 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQA-IP-----  252 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSC-CC-----
T ss_pred             CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccC-CC-----
Confidence            87654332  22356789999999998654 589999999999999999999999987654322 2222110 00     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-CHHHHhC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TALDALI  353 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-s~~ell~  353 (409)
                                         .....+..+++++.++|.+||..||.+|| |+.++++
T Consensus       253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                               01123456899999999999999999999 7777764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-43  Score=330.17  Aligned_cols=249  Identities=18%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-------cEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-------ETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++..  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence            3468999999999999999999998877       479999986433    345689999999999999999998843  


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc----
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ----  212 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~----  212 (409)
                         ....++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .    
T Consensus        84 ---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~~~~  155 (289)
T 4fvq_A           84 ---GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREE-DRKTG  155 (289)
T ss_dssp             ---TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECC-BGGGT
T ss_pred             ---CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCC-ccccc
Confidence               333679999998 5887777642   23489999999999999999999996 999999999999998776 4    


Q ss_pred             ----EEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHH
Q 015298          213 ----VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEII  287 (409)
Q Consensus       213 ----ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~  287 (409)
                          +||+|||++.....   .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||....... .....
T Consensus       156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~  231 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFY  231 (289)
T ss_dssp             BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH
T ss_pred             ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHh
Confidence                99999999865422   234567899999999976566899999999999999999955 5554444333 22222


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      ...                             ..++...++++.+||.+||+.||.+|||+.++++|  |+++-.
T Consensus       232 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          232 EDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             HTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             hcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            210                             01334467889999999999999999999999986  444433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-43  Score=334.98  Aligned_cols=257  Identities=22%  Similarity=0.286  Sum_probs=207.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (409)
                      ....+|.+.+.||+|+||.||+|.+.     .+++.||+|.+....     ..+.+|+.+++.++||||+++++++.   
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---   98 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---   98 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc---
Confidence            44568999999999999999999876     467899999986542     23457999999999999999999883   


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                        .....++||||+.+ +|.+.+......      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++
T Consensus        99 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC
T ss_pred             --cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCC
Confidence              33346899999984 888887654321      25679999999999999999999996 999999999999999887


Q ss_pred             CcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015298          211 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  286 (409)
                       .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             899999999976543321   2234568899999998654 48999999999999999999 89999887766655544


Q ss_pred             HHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC------CCccCC
Q 015298          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH------PFFDEL  360 (409)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h------p~f~~~  360 (409)
                      .....                            ...+..+++.+.+||.+||..||.+|||+.++++|      ++|+++
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          254 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            33110                            01234578999999999999999999999999976      666544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-43  Score=329.03  Aligned_cols=248  Identities=26%  Similarity=0.359  Sum_probs=191.3

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCC---CcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      .....+|.+.+.||+|+||.||+|.+..+   +..||+|.+...     ...+.+|+.+++.++||||+++++++.    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----
Confidence            34567899999999999999999998654   457999998643     234567999999999999999998762    


Q ss_pred             CCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                       + ...++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        87 -~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  159 (281)
T 1mp8_A           87 -E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGD  159 (281)
T ss_dssp             -S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC
T ss_pred             -c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEECc
Confidence             1 125799999985 777776532   35699999999999999999999996 999999999999999887 899999


Q ss_pred             cCCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          218 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       218 fg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ||++........  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---  235 (281)
T 1mp8_A          160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred             cccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---
Confidence            999986644322  2234557889999998654 48999999999999999997 9999998877666555433110   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                               ..++..+++.+.++|.+||..||.+|||+.+++++
T Consensus       236 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     01345689999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.9e-44  Score=335.27  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=199.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+++++.++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            34799999999999999999999999999999988543    234568999999999999999999886432 2344578


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~  184 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence            99999995 88888887666678899999999999999999999996 999999999999999887 8999999998754


Q ss_pred             ccCCC----------CccccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhC
Q 015298          225 VKGEP----------NISYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLG  291 (409)
Q Consensus       225 ~~~~~----------~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~  291 (409)
                      .....          .....||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... +........  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            22111          12345689999999986433  2688999999999999999999999531100 000000000  


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                               ......+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       263 -------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 -------------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -------------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                                     00001123578999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-43  Score=335.35  Aligned_cols=251  Identities=21%  Similarity=0.299  Sum_probs=203.9

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCc-----EEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++..  
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence            45689999999999999999999987664     79999986542     3456899999999 89999999998843  


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL----------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli  206 (409)
                         ...+++||||+++ +|.+.+......          ...+++..++.++.||+.||.|||++ ||+||||||+||++
T Consensus       122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLL  197 (333)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEE
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEE
Confidence               3347899999985 888887754321          45689999999999999999999996 99999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015298          207 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQ  282 (409)
Q Consensus       207 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  282 (409)
                      +.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.
T Consensus       198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9887 899999999986544332   2234567889999998654 48999999999999999998 9999988776665


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+......+                           ..+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            55544432111                           1234568999999999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-43  Score=329.30  Aligned_cols=252  Identities=30%  Similarity=0.454  Sum_probs=191.8

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            345899999999999999999999999999999998642       1335689999999999999999998854     3


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+.+ +|.+++.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999985 88888887666678899999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 015298          221 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       221 a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  298 (409)
                      +....... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.... ..+.........+     
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  256 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-----  256 (310)
T ss_dssp             ----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-----
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-----
Confidence            87654332 23345789999999998654 5899999999999999999999999764321 1111111111000     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                           ......+++++.+||.+||..||.+|||+.+++++
T Consensus       257 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          257 ---------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ---------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                 01124578999999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.7e-43  Score=345.63  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ....+|.+.+.||+|+||.||+|.+  +|+.||||++..+  .+.+.+|+.+++.++||||+++++++....    ..++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence            4456899999999999999999998  5789999999764  345678999999999999999999875422    2378


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+.+ +|.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            99999984 8888776532  33479999999999999999999996 999999999999999887 8999999999754


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.+...            
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------  404 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------  404 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            322  2234668899999999654 48999999999999999998 9999988776665554433211            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                      ...+..+++.+.+||.+||..||.+|||+.++++
T Consensus       405 ----------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ----------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            1134568999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=335.39  Aligned_cols=258  Identities=15%  Similarity=0.140  Sum_probs=193.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC---CCcEEEEEEeeccchh---------------hHHHHHHHHhcCCCCeecccc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKH  131 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~e~~~l~~l~h~niv~~~~  131 (409)
                      .++|.+.+.||+|+||.||+|.+..   ++..+|+|++......               ..+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999987   8889999998764322               235667778889999999999


Q ss_pred             eeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC-
Q 015298          132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT-  210 (409)
Q Consensus       132 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~-  210 (409)
                      ++.... .+..++++||||++++|.+++..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ 
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSST
T ss_pred             cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCC
Confidence            886533 23566889999997787776653    34799999999999999999999986 999999999999998654 


Q ss_pred             CcEEEeecCCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHH
Q 015298          211 HQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVD  281 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~  281 (409)
                      ..+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            2799999999976533211        1345789999999999764 4899999999999999999999999653 2222


Q ss_pred             HHHHHHHHh-CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 QLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ......... ...+.......                    -...+++++.++|.+||..||.+|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            222222221 11111111100                    012478999999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.9e-43  Score=332.88  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEc-------CCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceee
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (409)
                      ....+|.+.+.||+|+||.||+|.+.       .++..||+|++....     ....+|+++++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34568999999999999999999976       467889999997542     3356799999999 8999999999883


Q ss_pred             ecCCCCccEEEEEEeccch-hHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCC
Q 015298          135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (409)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp  201 (409)
                           ....+++||||+.+ +|.+.+.....            ....+++..++.++.||+.||.|||++ ||+||||||
T Consensus       112 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  185 (334)
T 2pvf_A          112 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  185 (334)
T ss_dssp             -----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSG
T ss_pred             -----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCcc
Confidence                 33347899999985 88887765321            123589999999999999999999996 999999999


Q ss_pred             CceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015298          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (409)
Q Consensus       202 ~NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (409)
                      +||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999887 899999999976544321   2334567889999998654 48999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       278 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+.....                            ...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76665554443211                            01344578999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.7e-43  Score=329.34  Aligned_cols=254  Identities=21%  Similarity=0.297  Sum_probs=194.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHh--cCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..++|.+.+.||+|+||+||+|.+  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            456899999999999999999987  79999999996543 334567777776  79999999998865433 3345678


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--------RSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                      +||||+++ +|.+.+.     ...+++..++.++.||+.||.|||        +. ||+||||||+|||++.++ .+||+
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEEC
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEEe
Confidence            99999985 7777763     467999999999999999999999        76 999999999999999887 89999


Q ss_pred             ecCCccccccCCC-----CccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 015298          217 DFGSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLG----------KPLFPG  276 (409)
Q Consensus       217 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltg----------~~pf~~  276 (409)
                      |||+++.......     .....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999976544332     22347899999999996543     244789999999999999999          888865


Q ss_pred             CCc----HHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          277 DSG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       277 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                      ...    .+............+                 .    .....++...++.+.+||.+||+.||.+|||+.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRP-----------------N----IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCC-----------------C----CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCC-----------------C----CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            322    122222111100000                 0    000011223567899999999999999999999998


Q ss_pred             C
Q 015298          353 I  353 (409)
Q Consensus       353 ~  353 (409)
                      +
T Consensus       295 ~  295 (301)
T 3q4u_A          295 K  295 (301)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-43  Score=352.19  Aligned_cols=248  Identities=21%  Similarity=0.331  Sum_probs=204.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+..++..||||.+..+.   ..+.+|+.+++.++||||+++++++..     ...+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence            34568999999999999999999999999999999997543   456689999999999999999998843     3347


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +|||||+. |+|.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  367 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSRL  367 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred             EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeeccccee
Confidence            89999998 58888776432  35689999999999999999999996 999999999999999887 899999999986


Q ss_pred             cccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ......  .....+++.|+|||++... .++.++|||||||+||+|++ |..||.+.+..+....+.+..          
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------  436 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------  436 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            543221  2234456789999999654 48999999999999999999 999999877665554443211          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       437 ------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                              01134568999999999999999999999999976

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5e-43  Score=324.54  Aligned_cols=248  Identities=26%  Similarity=0.337  Sum_probs=198.2

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcC---CCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      .....+|.+.+.||+|+||.||+|.+..   ++..||+|.+...     ...+.+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence            3456789999999999999999998654   3456999998754     2345679999999999999999997631   


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                        .. .++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 --~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  156 (281)
T 3cc6_A           85 --EP-TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLGD  156 (281)
T ss_dssp             --SS-CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEECC
T ss_pred             --CC-CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeCc
Confidence              11 468999998 5777776542   45689999999999999999999986 999999999999999887 899999


Q ss_pred             cCCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          218 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       218 fg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ||++........  .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......  
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--  233 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--  233 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--
Confidence            999976543321  2334567889999998654 48999999999999999998 99999877766655544432111  


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                ..+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       234 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 --------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                      1234578999999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-43  Score=334.96  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=193.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEE----EEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||+||+|.+..+|+.+    |+|.+...     ...+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            3468999999999999999999998888765    77766432     24566899999999999999999988531   


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                        . .++|++|+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             --C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEccC
Confidence              1 567888888 5776666532   46799999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          219 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       219 g~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |+++........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+......  
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--  238 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--  238 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence            999866443322   234457889999999754 48999999999999999999 99999887765554433321110  


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 --------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                      1234578999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-44  Score=340.96  Aligned_cols=265  Identities=21%  Similarity=0.244  Sum_probs=198.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++....    ..+.+|+.+++.++||||+++++++.     .....
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  110 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEM  110 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCC
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence            456899999999999999999996 478999999886542    34568999999999999999999873     33447


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  188 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGISKK  188 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeecccccc
Confidence            899999984 66665543222234689999999999999999999996 999999999999999887 899999999976


Q ss_pred             cccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.........     ...  
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~--  260 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ESH--  260 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HHH--
T ss_pred             cccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hcc--
Confidence            43221   22345689999999998654 48999999999999999999999997654322111100000     000  


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...     .+...........++...+..+.+++.+||+.||.+|||+.++++|
T Consensus       261 ~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          261 NNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000     0111111111222233456789999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.6e-43  Score=322.44  Aligned_cols=245  Identities=14%  Similarity=0.203  Sum_probs=199.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ...+|.+.+.||+|+||.||+|.+  +|+.||+|++....      ..+.+|+.+++.++||||+++++++...   ...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            456899999999999999999998  58899999986532      3456799999999999999999987432   124


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecC
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ..++||||+++ +|.+.+...  ....+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEecc
Confidence            46899999984 888777642  123589999999999999999999986 9  99999999999999887 79999888


Q ss_pred             CccccccCCCCccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      ++...    ......||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......     
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            77543    2234578999999999965432  334899999999999999999999988776665554432111     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                            ..++..+++++.++|.+||+.||.+|||+.++++
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  1145568999999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.9e-44  Score=337.05  Aligned_cols=266  Identities=20%  Similarity=0.275  Sum_probs=200.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++....     ..+.+|+++++.++||||+++++++..     ...
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSC
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCc
Confidence            345899999999999999999984 468999999986532     245789999999999999999998843     333


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--GVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      .++||||+.+ +|.+.+.........+++..++.++.|++.||.|||++.  ||+||||||+||+++.++ .+||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  180 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL  180 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSS
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCcc
Confidence            6799999985 888887765555566999999999999999999999732  999999999999999887 899999999


Q ss_pred             ccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCC
Q 015298          221 AKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD----SGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       221 a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~i~~~~~~~~  294 (409)
                      +........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...    .............    
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  255 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----  255 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT----
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH----
Confidence            986643322  23455899999999986544 899999999999999999999999521    1000011111100    


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                                .................++...+..+.+++.+||+.||.+|||+.++++|-.
T Consensus       256 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          256 ----------LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             ----------TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ----------hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                      0001111111111122223334578999999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-44  Score=351.89  Aligned_cols=254  Identities=20%  Similarity=0.220  Sum_probs=193.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCC-CCeecccce---------
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLKHC---------  132 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h-~niv~~~~~---------  132 (409)
                      ...|...+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+.| .|...+..+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34699999999999999999999999999999998632       2345689999998877 322211111         


Q ss_pred             ------------eeecCCCCccEEEEEEeccchhHHHHHHHhh---hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 015298          133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFN---KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (409)
Q Consensus       133 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (409)
                                  +..........++++|+++.++|.+++....   .....+++..+..++.||+.||.|||++ ||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence                        1000001123367899999998888876432   2244577888889999999999999986 99999


Q ss_pred             cCCCCceeecCCCCcEEEeecCCccccccCCCCcccccccccccccccc---------CCCCCCchhhHHHHHHHHHHHH
Q 015298          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTTAIDIWSAGCVVAELM  268 (409)
Q Consensus       198 Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwslG~il~~ll  268 (409)
                      ||||+|||++.++ .+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999988 7999999998765333  345567 9999999983         3345888999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCH
Q 015298          269 LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (409)
Q Consensus       269 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~  348 (409)
                      +|+.||...+..+....+                       +.          ....+++++.+||.+||+.||.+|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999765432111100                       00          112478999999999999999999999


Q ss_pred             HHHhCCCCccCCC
Q 015298          349 LDALIHPFFDELR  361 (409)
Q Consensus       349 ~ell~hp~f~~~~  361 (409)
                      .++++||||+++.
T Consensus       359 ~~~l~~~~~~~~~  371 (413)
T 3dzo_A          359 LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHTTSHHHHHHH
T ss_pred             HHHHhCHHHHHHH
Confidence            9999999998753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.5e-43  Score=324.40  Aligned_cols=243  Identities=23%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             ccceEEEE-eeccCCceEEEEEEE--cCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAER-IVGQGSFGVVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||+|++...      ...+.+|+.+++.++||||+++++++ ..    
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC----
Confidence            45799998 999999999999954  567899999998654      23456899999999999999999977 21    


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                       ...++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             -CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccCC
Confidence             12679999998 577777654    46799999999999999999999996 999999999999999887 89999999


Q ss_pred             CccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      ++.........    ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+.....   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  238 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---  238 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence            99766443321    223456889999998654 47899999999999999999 9999988776655444332110   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ..++..+++.+.++|.+||..||.+|||+.++++
T Consensus       239 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     0134568999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-43  Score=334.22  Aligned_cols=255  Identities=19%  Similarity=0.225  Sum_probs=199.8

Q ss_pred             cccceEEEEeeccCCceEEEEEE-----EcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (409)
                      ...+|.+.+.||+|+||.||+|.     +..++..||+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence            45689999999999999999999     5568889999998543     2345679999999999999999998843   


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--Cc
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQ  212 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~  212 (409)
                        ....++||||++ ++|.+++......   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..
T Consensus       105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcce
Confidence              333689999996 6888887754321   24589999999999999999999986 999999999999998433  26


Q ss_pred             EEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015298          213 VKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  288 (409)
                      +||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543322   22345678899999998654 48999999999999999998 9999988776655544433


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                      ...                            ...+..+++.+.++|.+||..||.+|||+.++++|.|+.
T Consensus       261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            110                            012345789999999999999999999999999998865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=326.11  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=187.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      ..+|.+.+.||+|+||.||+|.+  .++.||+|++....  ..+.+|+++++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            45799999999999999999997  57899999996543  44568999999999999999998763     22  4689


Q ss_pred             Eeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR---SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       148 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      |||+++ +|.+.+.... ....++...+..++.|++.||.|||+   + ||+||||||+||+++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999985 7777765321 12357889999999999999999998   5 8999999999999988774589999999975


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+..          
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  222 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------  222 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------
Confidence            5332  2345689999999999654 58999999999999999999999997654322211111110100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                      ...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       223 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 ----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            0123457899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.6e-43  Score=322.01  Aligned_cols=245  Identities=20%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|++....   ....+|+++++.++||||+++++++..     ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            458999999999999999999986 67889999997543   456789999999999999999998843     334789


Q ss_pred             EEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      ||||++ ++|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            999998 4777776542   35689999999999999999999986 999999999999999887 89999999987653


Q ss_pred             cC--CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          226 KG--EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       226 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..  .......+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+.....           
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----------  223 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------  223 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence            22  112334567889999998654 48999999999999999999 8999988777666555443211           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                       ...+...++.+.++|.+||..||.+|||+.+++++
T Consensus       224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             11234578999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-43  Score=330.11  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=201.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEE-----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      ..+|.+.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45899999999999999999985     4577899999997542     2356899999999 789999999987432  


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCcee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIl  205 (409)
                        ...+++||||+. ++|.+.+......            ...+++..++.++.||+.||.|||++ ||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEE
Confidence              233679999998 4887777653211            12388999999999999999999996 9999999999999


Q ss_pred             ecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015298          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (409)
Q Consensus       206 i~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (409)
                      ++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99887 899999999976544322   1235568899999998654 48999999999999999998 999998876555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...........+                           ..+..+++.+.++|.+||..||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444433321110                           1344578999999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-42  Score=323.95  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=188.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...++|++.+.||+|+||.||+|.+.   ..||+|++....      ..+.+|+.+++.++||||++++++..      .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence            34568999999999999999999853   359999986432      34568999999999999999988541      1


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  166 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFGL  166 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC-
T ss_pred             CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEcccee
Confidence            22579999998 466555532   246799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccC---CCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKG---EPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~---~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +......   .......||+.|+|||++.  ....++.++|||||||++|+|++|+.||......+.+.........+..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD  246 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence            8755331   2223457899999999985  2345788999999999999999999999987777666655543221110


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                             .......+++.+.+||.+||..||.+|||+.++++
T Consensus       247 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 -----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             -----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   01123457899999999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.1e-43  Score=323.97  Aligned_cols=246  Identities=21%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             CccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .....+|.+.+.||+|+||.||+|.+  +|+.||+|++..+.  +.+.+|+.+++.++||||+++++++...    ...+
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~   90 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL   90 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence            34567899999999999999999987  58899999997543  4456899999999999999999976432    2246


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+++ +|.+.+....  ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~  166 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKE  166 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred             EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeecccccc
Confidence            799999985 8888776532  23488999999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||......+....+....            
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------  231 (278)
T 1byg_A          167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------
T ss_pred             cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence            4332  2344678899999998654 48999999999999999998 999998776655444332210            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                      ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                            11134568999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=337.33  Aligned_cols=258  Identities=14%  Similarity=0.136  Sum_probs=197.4

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCC--------CcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeee-------
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLET--------GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-------  135 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  135 (409)
                      ++|.+.+.||+|+||.||+|.+..+        ++.||+|++... ....+|+++++.++||||+++++.+..       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4799999999999999999999874        889999999765 567789999999999999985332110       


Q ss_pred             ----cCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC-
Q 015298          136 ----TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT-  210 (409)
Q Consensus       136 ----~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~-  210 (409)
                          .......+.++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ 
T Consensus       121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCCEEEEETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEETTEE
T ss_pred             chhhccccCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcCCCC
Confidence                0001245678999999889988887532  36799999999999999999999997 999999999999999765 


Q ss_pred             CcEEEeecCCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHH
Q 015298          211 HQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVD  281 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~  281 (409)
                      ..+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ..+
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence            2699999999976543221        2345789999999999654 58999999999999999999999998764 333


Q ss_pred             HHHHHHHHh-CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          282 QLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       282 ~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+....... ..+..         ...           .......+++++.+||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~---------~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          277 DIMKQKQKFVDKPGP---------FVG-----------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHSCCC---------EEC-----------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhccCChhh---------hhh-----------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333333221 11100         000           00011246899999999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-43  Score=339.54  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=189.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|.+.+.||+|+||.||+|++.   .++..||||++...     ...+.+|+.+++.++||||+++++++.     .
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----K  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----e
Confidence            4568999999999999999999987   46778999998643     234568999999999999999999883     3


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||++ ++|.+++..   ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECcCc
Confidence            334789999997 577777653   245799999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      +++........    ....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......  
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--  269 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--  269 (373)
T ss_dssp             ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99866433211    122346789999999654 48999999999999999998 99999888776655544332111  


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                ..+..++..+.++|.+||+.||.+|||+.++++
T Consensus       270 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 --------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                      123357899999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=328.72  Aligned_cols=247  Identities=21%  Similarity=0.289  Sum_probs=194.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC----cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||+|++....     ..+.+|+.+++.++||||+++++++.     
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----
Confidence            4458999999999999999999987654    459999986532     23557999999999999999999873     


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      .....++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCC
Confidence            33447899999985 77777653   246799999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       219 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      |++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+...... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-  269 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-  269 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-
Confidence            99986543321    1223457789999999654 48999999999999999999 99999887766655544332111 


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                 ..+..+++.+.++|.+||+.||.+||++.+++++
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       1234578999999999999999999999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=331.72  Aligned_cols=244  Identities=24%  Similarity=0.352  Sum_probs=191.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEE----EEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|++.+.||+|+||.||+|.+..+++.+    |+|.+...     ...+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            458999999999999999999999888766    55655322     24556899999999999999999987532    


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                       . .++|++|+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             1 567888887 5776666542   46799999999999999999999996 999999999999999887 89999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            9986643322   2234457789999999654 48999999999999999999 99999887766655444332110   


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ..+..++.++.+||.+||..||.+|||+.++++
T Consensus       239 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 -------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     134457899999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.3e-43  Score=344.92  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=202.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+.+++.++||||+++++++.     . ..+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----~-~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----C-Ccc
Confidence            44568999999999999999999975 4678999999754   345678999999999999999998763     1 126


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. |+|.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCceE
Confidence            79999998 58888776432  34688999999999999999999996 999999999999999887 899999999986


Q ss_pred             cccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....  ......+++.|+|||++... .++.++|||||||++|||++ |+.||.+.+..+....+......+       
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------  405 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------  405 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------
T ss_pred             cCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            53221  12234457789999999654 48999999999999999999 999999888777766655432111       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                           .+..+++++.+||.+||..||.+|||+.++++
T Consensus       406 ---------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 ---------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                 24457899999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-42  Score=325.00  Aligned_cols=261  Identities=22%  Similarity=0.345  Sum_probs=196.4

Q ss_pred             ccceEEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|++.+.||+|+||.||+|.    +..+++.||+|++....     ....+|+.+++.++||||+++++++...   .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            3469999999999999999999    57789999999986432     4457899999999999999999987542   2


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECccc
Confidence            2347899999985 777776432   46799999999999999999999996 999999999999999887 89999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++........    .....+|..|+|||++.+. .++.++|||||||++|+|++|..|+....     .......+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc
Confidence            9987654432    2345678889999998654 47899999999999999999998864221     111111111110


Q ss_pred             HH-HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EE-IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .. ......         ..........+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVN---------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHH---------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHH---------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00 000000         00000011134568999999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=322.69  Aligned_cols=247  Identities=25%  Similarity=0.292  Sum_probs=199.7

Q ss_pred             ccceEEEE-eeccCCceEEEEEEEc--CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAER-IVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||+|++....     ....+|+++++.++||||+++++++. ..    
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~----   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE----   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS----
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC----
Confidence            45687777 9999999999999864  467889999997532     34568999999999999999999872 11    


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                       ..++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECcccc
Confidence             26899999985 67666542   246799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+.....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~----  231 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----  231 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence            986643322    2234557899999998654 48999999999999999998 9999988877665554433110    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF  356 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~  356 (409)
                                              ..++..+++++.++|.+||..||.+|||+.++++|.+
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                    1134568999999999999999999999999998743

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.3e-43  Score=330.69  Aligned_cols=264  Identities=23%  Similarity=0.304  Sum_probs=200.8

Q ss_pred             ccccceEEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|++....    ..+.+|+++++.++||||++++++++.   .
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence            345689999999999999999999    56789999999996543    335689999999999999999988754   2


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      +...+++||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  171 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKIADF  171 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEEccc
Confidence            3455789999996 5777777643   24699999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       219 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .......+.
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~  249 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPA  249 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccccccccc
Confidence            99986643332    2345678889999998654 47999999999999999999999986533211100 000000000


Q ss_pred             HHHH-hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          295 REEI-KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       295 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+ ....             .......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          250 LSRLLELLE-------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhh-------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000 0000             000111345689999999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-42  Score=319.34  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=199.6

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++..     . ..
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~   82 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PI   82 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-Cc
Confidence            44568999999999999999999975 5678999999654   3456689999999999999999987631     1 25


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. ++|.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~  158 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARL  158 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCccccc
Confidence            79999997 57777665321  23689999999999999999999986 999999999999999887 899999999986


Q ss_pred             cccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ......  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+....          
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------  227 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------  227 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred             ccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc----------
Confidence            643321  2234567889999998654 48999999999999999999 999998877766555443311          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                        ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       228 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              01134467899999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.2e-44  Score=362.21  Aligned_cols=284  Identities=25%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++..... .....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            46899999999999999999999999999999998654     2345679999999999999999887643211 12444


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC--cEEEeecCC
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS  220 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~--~ikl~Dfg~  220 (409)
                      .++||||+. ++|.+++.... ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.  .+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            679999996 57777766422 234689999999999999999999986 9999999999999987652  489999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...........   ............
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccchhhhh
Confidence            9887666666677899999999998654 589999999999999999999999976543321110   000000000000


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      .........+..  ..+....+...+++.+.+||.+||.+||.+|||+.++++||||+.+.
T Consensus       247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            000000011111  11111223334678999999999999999999999999999999764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-42  Score=325.24  Aligned_cols=245  Identities=23%  Similarity=0.333  Sum_probs=188.2

Q ss_pred             ccccceEEE-EeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHH-HhcCCCCeecccceeeecCCCCccEEE
Q 015298           68 KQTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        68 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...++|.+. +.||+|+||.||+|.+..+|+.||+|++... ....+|+.++ +.++||||+++++++.... ....+++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~   91 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL   91 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence            345678887 7899999999999999999999999999654 4556788887 6679999999999875422 2355688


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEeecCCc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg~a  221 (409)
                      +||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCC-cEEEeccccc
Confidence            99999985 8887776522  35799999999999999999999996 9999999999999997   45 7999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....                      ...++.++|||||||++|+|++|..||......+....+...            
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~------------  213 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------------  213 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS------------
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH------------
Confidence            6431                      134788999999999999999999999765432211100000            


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                            ...   ....+.......+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       214 ------~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          214 ------IRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ------SCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ------Hhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                  000   000000001135799999999999999999999999999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-42  Score=342.52  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+++++.++||||+++++++..      ..+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            345689999999999999999999864 4679999997543   456789999999999999999987632      225


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||+. |+|.+.+...  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       254 ~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~  329 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARL  329 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred             EEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence            79999998 4787777542  245689999999999999999999996 999999999999999887 899999999986


Q ss_pred             cccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ......  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......        
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------  400 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------  400 (452)
T ss_dssp             -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred             cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            543221  2234557889999998654 48999999999999999999 99999988877766655432111        


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCccC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI--HPFFDE  359 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~--hp~f~~  359 (409)
                                          ..+..+++.+.+||.+||..||.+|||+.++++  ..++..
T Consensus       401 --------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                                134467899999999999999999999999986  355543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-42  Score=344.36  Aligned_cols=259  Identities=20%  Similarity=0.231  Sum_probs=203.6

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++...  .....+|+++++.+.|++.+..+..+..    ...+.+|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEE
Confidence            456899999999999999999999999999999987643  3456789999999988665555444432    2345789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceee---cCCCCcEEEeecCCccc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli---~~~~~~ikl~Dfg~a~~  223 (409)
                      ||||++++|.+++...   ...+++..++.|+.||+.||.|||++ ||+||||||+||||   +.++ .+||+|||+++.
T Consensus        81 vme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~  155 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK  155 (483)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence            9999988888887643   46799999999999999999999986 99999999999999   4555 899999999987


Q ss_pred             cccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 015298          224 LVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---DQLVEIIKVLGT  292 (409)
Q Consensus       224 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~  292 (409)
                      ......        .....||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+....   +.+..+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            654332        2256789999999999664 4899999999999999999999999875442   333333322111


Q ss_pred             CCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh----------CCCCccCCC
Q 015298          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL----------IHPFFDELR  361 (409)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell----------~hp~f~~~~  361 (409)
                      .....                        +...+++++.+||.+||..||.+||++.+++          .++|+..+.
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~d  289 (483)
T 3sv0_A          235 TSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD  289 (483)
T ss_dssp             SCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCH
T ss_pred             ccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcC
Confidence            11111                        1234789999999999999999999999875          466665543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-42  Score=322.05  Aligned_cols=246  Identities=21%  Similarity=0.332  Sum_probs=194.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCC---cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+..++   ..+|+|.+....     ....+|+.+++.++||||++++++++..    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            457999999999999999999976443   468999886432     3456899999999999999999976432    2


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECcccc
Confidence            346799999986 77777653   246689999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCC-----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          221 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       221 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      +.......     ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+.....   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  250 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence            97653321     22345667889999999654 48999999999999999999 6777877666555444433211   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ...+..+++.+.++|.+||..||.+|||+.++++
T Consensus       251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     1134457899999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-42  Score=319.21  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=194.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...|.+.+.||+|+||.||+|.+..++.   .||+|.+....     ..+.+|+.+++.++||||+++++++....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            4468889999999999999999765554   79999986432     34458999999999999999999885322    


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||+. ++|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence            22468999986 577666643   246789999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          221 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       221 a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      +......     .......+++.|+|||.+.+. .++.++|||||||++|+|++| .+||...+..+....+.....   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---  246 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---  246 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---
Confidence            9754322     223345678899999999654 489999999999999999995 555655555444443332111   


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               ...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       247 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 -------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                     0134457899999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=328.09  Aligned_cols=272  Identities=20%  Similarity=0.274  Sum_probs=193.9

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-hhHHHHHH--HHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-YKNRELQT--MRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...++|.+.+.||+|+||.||+|.+  +++.||||++..... ....|.++  +..++||||+++++.+..........+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3456899999999999999999987  789999999965432 22334444  445899999999987665555566678


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcEeecCCCCceeecCCCCcEE
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI---------GVCHRDIKPQNLLVNPHTHQVK  214 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------~ivH~Dlkp~NIli~~~~~~ik  214 (409)
                      ++||||++ ++|.+++..     ...++..++.++.||+.||.|||+ .         ||+||||||+|||++.++ .+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEE
Confidence            89999997 588777753     456889999999999999999997 5         999999999999999887 899


Q ss_pred             EeecCCccccccCC---------CCccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCC-C
Q 015298          215 LCDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELMLGKPLFPGD-S  278 (409)
Q Consensus       215 l~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~-~  278 (409)
                      |+|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||... .
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999997654321         12345789999999999652      23567899999999999999997665432 2


Q ss_pred             cHHHHHHHHHHh-CCCCHHHHhhcCCCccccccCcccCCCCcccCCC------CCChhHHHHHHHhcccCCCCCCCHHHH
Q 015298          279 GVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK------RMPPEAVDLVSRLLQYSPNLRCTALDA  351 (409)
Q Consensus       279 ~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~s~~l~~li~~~L~~dp~~R~s~~el  351 (409)
                      ..+....+.... ..+....+......           ......++.      ..++.+.+||.+||+.||++|||+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSR-----------EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTT-----------SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcc-----------cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence            111111111111 11222111110000           000011111      134579999999999999999999999


Q ss_pred             h------CCCCccC
Q 015298          352 L------IHPFFDE  359 (409)
Q Consensus       352 l------~hp~f~~  359 (409)
                      +      .++|-++
T Consensus       310 l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          310 EERMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHHHCCCC-
T ss_pred             HHHHHHHHHHHHhc
Confidence            4      5667654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.6e-43  Score=327.03  Aligned_cols=257  Identities=23%  Similarity=0.281  Sum_probs=196.0

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .|...+.||+|+||.||+|.+  +++.||+|++...        ...+.+|+.+++.++||||+++++++..     ...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence            355668999999999999986  6889999998642        2345689999999999999999998843     334


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .++||||++ ++|.+.+... .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeeccccc
Confidence            789999997 5777776643 3346799999999999999999999986 999999999999999887 89999999997


Q ss_pred             ccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      .......   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......+....+.............
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            6543322   234578999999999854  37899999999999999999999998765544333333322111100000


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ......              ...+...++.+.+++.+||..||.+|||+.+++++
T Consensus       260 ~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          260 YIDKKM--------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HSCSSC--------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hccccc--------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000000              00122345789999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=331.38  Aligned_cols=244  Identities=16%  Similarity=0.208  Sum_probs=190.9

Q ss_pred             ccceEEEEeeccCCceEEEEE-----EEcCCCcEEEEEEeeccc-hhhHHHHHHHHhcC---CCCeecccceeeecCCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQA-----KCLETGETVAIKKVLQDK-RYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  140 (409)
                      ..+|.+.+.||+|+||+||+|     .+..+++.||+|++.... ....+|+++++.+.   |+||+++++++....   
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~---  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN---  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence            457999999999999999999     467889999999997543 45567888888887   899999999885433   


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC----------
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP----------  208 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~----------  208 (409)
                        ..++||||++ |+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.          
T Consensus       141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC-----
T ss_pred             --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccc
Confidence              3789999998 688888876543 356799999999999999999999986 9999999999999987          


Q ss_pred             -CCCcEEEeecCCccccc---cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015298          209 -HTHQVKLCDFGSAKVLV---KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (409)
Q Consensus       209 -~~~~ikl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (409)
                       ++ .+||+|||+++...   ........+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             56 89999999996543   222334567999999999997654 8999999999999999999999995432100   


Q ss_pred             HHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       285 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                             .....    .+.   ....++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       293 -----------------------~~~~~----~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 -----------------------CKPEG----LFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -----------------------EEECS----CCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -----------------------eeech----hcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                   00000    000   01246788999999999999999766555544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=333.40  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=188.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC---cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ....|.+.+.||+|+||.||+|.+..++   ..||+|.+....     ..+.+|+.+++.++||||++++++++..    
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----  162 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----  162 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence            3456999999999999999999976443   468999886432     3456799999999999999999976432    


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ....++||||+.+ +|.+.+..   ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeecc
Confidence            2236799999985 77777653   245688999999999999999999996 999999999999999887 89999999


Q ss_pred             CccccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       220 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      +++.......     .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+..+....+.....  
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence            9976533221     2234567889999998654 48999999999999999999 7888887665554444332110  


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                ...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      01344578999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3e-42  Score=325.22  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=193.6

Q ss_pred             ccce-EEEEeeccCCceEEEEEEE----cCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISY-MAERIVGQGSFGVVFQAKC----LETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+| ++.+.||+|+||+||++..    ..+|+.||+|++....     ..+.+|+++++.++||||+++++++...   
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---
Confidence            3455 9999999999999988753    4588999999997542     3356899999999999999999988542   


Q ss_pred             CccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      +...+++||||+++ +|.+.+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  178 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDF  178 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCG
T ss_pred             CCceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCc
Confidence            23457899999985 7766654     34599999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       219 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      |++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......     ........
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~  252 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQ  252 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCC
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccc
Confidence            99987654332    2345578889999999654 47899999999999999999999996532210     00001110


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ......        ..............+..+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          253 GQMTVL--------RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHH--------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhHH--------HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            000000        000000000011134568999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=345.70  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ....+|.+.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+++++.++||||+++++++..      ..+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            345689999999999999999999864 4679999997543   456789999999999999999987632      226


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +|||||+.+ +|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  412 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARL  412 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTT
T ss_pred             eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEccccccee
Confidence            799999984 7877775422  35689999999999999999999986 999999999999999887 899999999976


Q ss_pred             cccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....  ......++..|+|||++... .++.++|||||||+||+|++ |..||.+....+.+..+......        
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------  483 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------  483 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred             cCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            53221  12234457789999998654 48999999999999999999 99999988877766655432111        


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC--CCccC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH--PFFDE  359 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h--p~f~~  359 (409)
                                          ..+..+++.+.+||.+||..||++|||+.++++.  .+|..
T Consensus       484 --------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                                1344678999999999999999999999999863  45543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-42  Score=319.09  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=190.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC-CCc--EEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|++.+.||+|+||.||+|.+.. +++  .||+|++...       .....+|+++++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            4589999999999999999998643 333  6899988643       13456899999999999999999987432   


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                        . .++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEccc
Confidence              1 568999998 5777776543   35689999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       219 g~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      |++........    .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+...... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-  243 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-  243 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence            99976644332    2234567789999998654 47899999999999999999 99999888776665554331100 


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                ...+..+++++.++|.+||..||.+|||+.+++++
T Consensus       244 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          244 --------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                      01234578999999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-41  Score=348.98  Aligned_cols=240  Identities=23%  Similarity=0.303  Sum_probs=192.9

Q ss_pred             eEE-EEeeccCCceEEEEEEE--cCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           73 YMA-ERIVGQGSFGVVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        73 y~~-~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      +.+ .+.||+|+||.||+|.+  ..+++.||||+++...      ..+.+|+++++.++||||+++++++..     . .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~-~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C-C
Confidence            444 35899999999999954  4677899999996532      345689999999999999999997731     1 1


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            679999998 467777653    56799999999999999999999986 999999999999999887 89999999998


Q ss_pred             ccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          223 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       223 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+....+......     
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  591 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  591 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6644322    2234457889999999654 48999999999999999998 99999988877766555442111     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                             ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   134568999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-42  Score=324.54  Aligned_cols=253  Identities=19%  Similarity=0.279  Sum_probs=187.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch-hhHHHHHHHHhc--CCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL--DHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++..... ...+|.+++..+  +||||+++++++..... ....+++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence            45899999999999999999998  489999999865432 334556665554  89999999998755321 2245789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcEeecCCCCceeecCCCCcEEEee
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--------GVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ||||+.+ +|.+.+..     ..+++..++.++.|++.||.|||+ .        ||+||||||+||+++.++ .+||+|
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~D  185 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIAD  185 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEe
Confidence            9999985 88877753     579999999999999999999996 4        999999999999999887 899999


Q ss_pred             cCCccccccCCCC-----ccccccccccccccccCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCC
Q 015298          218 FGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLG----------KPLFPG  276 (409)
Q Consensus       218 fg~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~------~~DiwslG~il~~lltg----------~~pf~~  276 (409)
                      ||++.........     ....||+.|+|||++.+.. ...      ++|||||||++|+|++|          ..||..
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            9999765433221     2457899999999996544 333      49999999999999999          677754


Q ss_pred             CCc----HHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 015298          277 DSG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL  352 (409)
Q Consensus       277 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell  352 (409)
                      ...    .+...........         .+..            ........+++++.+||.+||+.||.+|||+.+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~---------~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKL---------RPSF------------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCC---------CCCC------------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhcc---------Cccc------------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence            322    1111111110000         0000            00001123567799999999999999999999998


Q ss_pred             CC
Q 015298          353 IH  354 (409)
Q Consensus       353 ~h  354 (409)
                      +|
T Consensus       324 ~~  325 (337)
T 3mdy_A          324 KT  325 (337)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=319.46  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=196.5

Q ss_pred             cccceEEEEeeccCCceEEEEEE----EcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      ...+|++.+.||+|+||.||+|.    +..+|+.||+|++....    ..+.+|+++++.++||||+++++++....   
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---
Confidence            45679999999999999999998    46789999999986543    34568999999999999999998875422   


Q ss_pred             ccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Dfg  190 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  190 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecCc
Confidence            2346799999985 887777642   35699999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          220 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       220 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++........    .....++..|+|||++.+. .++.++|||||||++|+|++|..||.....     ......+....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~  264 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQ  264 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCC
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccc
Confidence            9987644332    2234567789999998654 478999999999999999999998854211     11111111110


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ......       ..............+..+++++.++|.+||..||.+|||+.++++
T Consensus       265 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          265 GQMIVF-------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             THHHHH-------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhhHH-------HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000000       000000000001134568999999999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=344.64  Aligned_cols=244  Identities=25%  Similarity=0.293  Sum_probs=194.2

Q ss_pred             ccceEEEE-eeccCCceEEEEEEEc--CCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAER-IVGQGSFGVVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++.+.+ .||+|+||.||+|.++  .++..||||++...     ...+.+|+++++.++||||+++++++..      
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------  407 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------  407 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------
Confidence            34566666 8999999999999876  35677999999653     2446789999999999999999998742      


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGl  482 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGL  482 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCST
T ss_pred             CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccC
Confidence            127899999985 66666542   246799999999999999999999996 999999999999999887 899999999


Q ss_pred             ccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++........    ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+...    
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----  557 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----  557 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC----
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            9865433221    123346789999999654 58999999999999999998 9999999888776665543211    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                              ..++..+++++.+||.+||..||.+|||+.++++
T Consensus       558 ------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    0134568999999999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.1e-41  Score=319.65  Aligned_cols=254  Identities=20%  Similarity=0.238  Sum_probs=194.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHh--cCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      ..+|.+.+.||+|+||.||+|.+  +|+.||+|++.... ....+|.++++.  ++||||+++++++..... ....+++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~l  117 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL  117 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEE
Confidence            35799999999999999999998  68999999996543 345678888887  799999999998754331 1235789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcEeecCCCCceeecCCCCcEEEee
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--------RSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ||||+.+ +|.+.+..     ..+++..++.++.||+.||.|||        +. ||+||||||+||+++.++ .+||+|
T Consensus       118 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~D  190 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIAD  190 (342)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECC
T ss_pred             EEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEE
Confidence            9999985 88887753     47999999999999999999999        75 999999999999999888 899999


Q ss_pred             cCCccccccCCC-----CccccccccccccccccCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 015298          218 FGSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLG----------KPLFPGD  277 (409)
Q Consensus       218 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~  277 (409)
                      ||++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999976654432     245578999999999965432     23689999999999999999          7888654


Q ss_pred             Cc----HHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          278 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       278 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..    .+.+.........         .+...            ........++.+.+||.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~---------~~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKL---------RPNIP------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCC---------CCCCC------------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHh---------CCCCc------------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            32    1222211110000         00000            00011124567999999999999999999999987


Q ss_pred             C
Q 015298          354 H  354 (409)
Q Consensus       354 h  354 (409)
                      |
T Consensus       330 ~  330 (342)
T 1b6c_B          330 T  330 (342)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=318.21  Aligned_cols=251  Identities=20%  Similarity=0.252  Sum_probs=195.2

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ....+|.+.+.||+|+||.||+|.+..   .+|+|++...      ...+.+|+.+++.++||||+++++++..     .
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            345689999999999999999999753   4999998643      2345679999999999999999998853     3


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++ ++ .+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeecCC
Confidence            34789999998 566666542   234799999999999999999999996 999999999999998 55 799999999


Q ss_pred             cccccc------CCCCccccccccccccccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 015298          221 AKVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI  286 (409)
Q Consensus       221 a~~~~~------~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i  286 (409)
                      +.....      ........||+.|+|||++.+        ...++.++|||||||++|+|++|..||......+....+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            865421      122334568999999999864        234789999999999999999999999887766655544


Q ss_pred             HHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                      ..... +                          ......++.++.++|.+||..||.+|||+.++++.  ++.+.
T Consensus       256 ~~~~~-~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~  301 (319)
T 2y4i_B          256 GTGMK-P--------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLP  301 (319)
T ss_dssp             HTTCC-C--------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC-
T ss_pred             ccCCC-C--------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHH
Confidence            33110 0                          01122478899999999999999999999999873  44443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.4e-43  Score=334.27  Aligned_cols=248  Identities=19%  Similarity=0.174  Sum_probs=183.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcC---------CCCeec
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS  128 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~---------h~niv~  128 (409)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999998  78999999997542            45678999999886         555554


Q ss_pred             -----------------ccceeeecC--------CCCccEEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHH
Q 015298          129 -----------------LKHCFFSTT--------DKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIF  182 (409)
Q Consensus       129 -----------------~~~~~~~~~--------~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~  182 (409)
                                       ++++|....        ......++|||||+.++ +.+.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence                             444443210        01245588999999753 444332     36789999999999999


Q ss_pred             HHHHHHH-hcCCcEeecCCCCceeecCCC-------------------CcEEEeecCCccccccCCCCcccccccccccc
Q 015298          183 RALSYIH-RSIGVCHRDIKPQNLLVNPHT-------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAP  242 (409)
Q Consensus       183 ~~l~~LH-~~~~ivH~Dlkp~NIli~~~~-------------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  242 (409)
                      .||.||| +. ||+||||||+|||++.++                   ..+||+|||+|+.....    ..+||+.|+||
T Consensus       172 ~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            9999999 87 999999999999998764                   27999999999876432    45899999999


Q ss_pred             ccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcc
Q 015298          243 ELIFGATEYTTAIDIWSAGCV-VAELMLGKPLFPGDSGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  320 (409)
Q Consensus       243 E~l~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (409)
                      |++.+..  +.++||||||++ .+++++|..||....... ....+......+..                      ...
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~  302 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK----------------------CNT  302 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC----------------------CCS
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc----------------------cch
Confidence            9997543  889999998777 778889999984321111 11122211110000                      000


Q ss_pred             cCCCCCChhHHHHHHHhcccCCCCCCCHHHHh-CCCCcc
Q 015298          321 IFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL-IHPFFD  358 (409)
Q Consensus       321 ~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell-~hp~f~  358 (409)
                      ..+..+++++++||.+||++|     |+.|+| +||||+
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            011236789999999999987     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-40  Score=340.81  Aligned_cols=246  Identities=26%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCC---CcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ....+|.+.+.||+|+||.||+|.+..+   +..||+|.+....     ..+.+|+.+++.++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            4557899999999999999999998654   4679999886432     345689999999999999999987621    


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                        ..+++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       463 --~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          463 --NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             --CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEec
Confidence              12579999998 5777776532   34689999999999999999999996 999999999999999887 8999999


Q ss_pred             CCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       219 g~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      |+++.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......   
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---  611 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  611 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99986643322  2234557889999999654 58999999999999999997 99999988877776665542111   


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                               .++..+++.+.+||.+||..||.+|||+.++++
T Consensus       612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     134568899999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=345.54  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcC-CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|++.+.||+|+||.||+|.+.. +|+.||||++....     ..+.+|+.+++.++||||+++++++......+..
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            34689999999999999999999976 79999999986432     2345799999999999999999988766554455


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ..+|||||++| +|.+.+      ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+  .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccc
Confidence            57899999985 554433      23799999999999999999999996 99999999999999864  7999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      +.....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.....          .+..      
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~------  287 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED------  287 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT------
T ss_pred             hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc------
Confidence            865433   456799999999998653  4899999999999999999999886421100          0000      


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                    .     .....++.+.+||.+||+.||.+||+..+.+.|+|+.-
T Consensus       288 --------------~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          288 --------------D-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --------------C-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------------c-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                          0     00013678999999999999999999999999998864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.6e-40  Score=304.51  Aligned_cols=223  Identities=15%  Similarity=0.066  Sum_probs=174.4

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....       ..+.+|+.+++.++||||+++++++..     .
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  103 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R  103 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence            4468999999999999999999999999999999996542       345689999999999999999998843     3


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...++||||++ ++|.+++.      .......+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+++| 
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~-  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA-  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC-
T ss_pred             CcEEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc-
Confidence            45889999998 47766653      1245667888999999999999996 999999999999999887 79998543 


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                                        |++        .++.++|||||||++|+|++|+.||.+.+..+.+....+.           
T Consensus       175 ------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------  217 (286)
T 3uqc_A          175 ------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-----------  217 (286)
T ss_dssp             ------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-----------
T ss_pred             ------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-----------
Confidence                              332        2789999999999999999999999876532211000000           


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                               . . ........+...+++++.+||.+||+.||.+| |+.++++.
T Consensus       218 ---------~-~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          218 ---------T-A-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             ---------T-T-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ---------h-c-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                     0 0 00000111234689999999999999999999 99999863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.2e-33  Score=279.53  Aligned_cols=179  Identities=16%  Similarity=0.091  Sum_probs=125.7

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeeccc--------------hhhHHHHHHHHhc-CCCCeecccceeeecCCCCcc
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+.|++|.+..++...+|+.||+|++.++.              +.+.+|+++|+++ .|+||+++++++     +++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            4677888888888888899999999996541              3356799999999 799999999988     5556


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+||||||++| +|.+.+..    .+.+++.   .|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccC
Confidence            68999999996 77777764    4667664   4789999999999997 999999999999999988 8999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 015298          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP  272 (409)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~  272 (409)
                      +..... ....+.+||+.|+|||++.+  .+..++|+||+|+++++|.++..
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            866443 33456789999999999965  36778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.5e-27  Score=237.03  Aligned_cols=178  Identities=16%  Similarity=0.242  Sum_probs=132.7

Q ss_pred             EEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------------hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ...+.||+|+||.||+|.  ..+..+++|+.....            +.+.+|++++++++||||+++..++....   .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---N  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT---T
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC---c
Confidence            446789999999999994  467889999864321            22468999999999999996544443222   2


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                        .+|||||++ ++|.+.+..            +..++.||+.||.|||++ ||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999998 677665542            567899999999999986 9999999999999997   699999999


Q ss_pred             ccccccCCC--------CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 015298          221 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLF  274 (409)
Q Consensus       221 a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwslG~il~~lltg~~pf  274 (409)
                      ++.......        .....||+.|+|||++... ..|+..+|+|+..+-..+.+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            987644221        1356889999999999531 23677889999999998888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1e-23  Score=194.71  Aligned_cols=139  Identities=16%  Similarity=0.189  Sum_probs=109.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------------------hhhHHHHHHHHhcCCCCeecc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSL  129 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~  129 (409)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|.+....                      ....+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            456669999999999999999 889999999985321                      23568999999999  5 666


Q ss_pred             cceeeecCCCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                      .+++..      ...++||||++| +|.+ +          .......++.||+.||.|||+. ||+||||||+|||++ 
T Consensus       167 ~~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-  227 (282)
T 1zar_A          167 PKVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             CCEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-
T ss_pred             CeEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-
Confidence            665421      124799999986 5544 2          1123457899999999999986 999999999999999 


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccccccccccccc
Q 015298          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  246 (409)
Q Consensus       209 ~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~  246 (409)
                      ++ .+||+|||+++.            +..++|||.+.
T Consensus       228 ~~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EE-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TT-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CC-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            76 899999999963            34478899873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=7.5e-21  Score=173.31  Aligned_cols=133  Identities=17%  Similarity=0.233  Sum_probs=102.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcE--EEEEEeeccc----------------------------hhhHHHHHHHHhc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDK----------------------------RYKNRELQTMRLL  121 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~e~~~l~~l  121 (409)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998788999  9999864321                            1356799999999


Q ss_pred             CCCCe--ecccceeeecCCCCccEEEEEEeccch------hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hcC
Q 015298          122 DHPNV--VSLKHCFFSTTDKDELYLNLVLEYVPE------TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RSI  192 (409)
Q Consensus       122 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~  192 (409)
                      .|+++  +.++..    .     ..+|||||+++      .|.+...       ..++..+..++.||+.||.||| +. 
T Consensus       128 ~~~~i~~p~~~~~----~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~-  190 (258)
T 1zth_A          128 KEAGVSVPQPYTY----M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA-  190 (258)
T ss_dssp             HHTTCCCCCEEEE----E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS-
T ss_pred             HhCCCCCCeEEEc----C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC-
Confidence            88764  222221    1     14699999953      3433321       1234567789999999999999 75 


Q ss_pred             CcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||+||||||+|||++.   .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            9999999999999986   6999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=2.7e-18  Score=163.05  Aligned_cols=141  Identities=12%  Similarity=0.094  Sum_probs=92.9

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch------------------hhHHHHHHHHhcCCCCeeccccee
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKHCF  133 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~~~~~~  133 (409)
                      -|.+...||+|++|.||+|.+ .+|+.||||+++....                  ....+.++.....|+|+.+++...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            499999999999999999997 4799999998743210                  011223333333445554443322


Q ss_pred             eecCCC-CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC-
Q 015298          134 FSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-  211 (409)
Q Consensus       134 ~~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~-  211 (409)
                      ...... .....+|||||++|....   .      ......+..++.||+.+|.+||+. |||||||||.|||++.++. 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~---~------l~~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMR---Q------VSSVPDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGG---G------CCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECS
T ss_pred             CCCCeeeeccCceEEEEecCCccHh---h------hcccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCc
Confidence            111000 000025899999974211   1      112223567889999999999986 9999999999999986652 


Q ss_pred             --------cEEEeecCCccc
Q 015298          212 --------QVKLCDFGSAKV  223 (409)
Q Consensus       212 --------~ikl~Dfg~a~~  223 (409)
                              .+.|+||+.+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                    288999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1.4e-11  Score=111.95  Aligned_cols=135  Identities=15%  Similarity=0.090  Sum_probs=100.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeec----cchhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..|.+...++.|+.+.||++..  .+..+++|+...    ......+|+++++.+. +..++++++++.     .....+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceE
Confidence            3588999999999999999975  468999999863    3345788999999985 566777776653     234478


Q ss_pred             EEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 015298          146 LVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS---------------------------------  191 (409)
Q Consensus       146 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------------------------------  191 (409)
                      +||||++|. +...+         .+......++.++..+|..||+-                                 
T Consensus        87 lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            999999984 32221         11122346778999999999970                                 


Q ss_pred             -------------------------CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          192 -------------------------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       192 -------------------------~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                                               ..++|+|++|.||+++.+. .+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                     2589999999999998543 56799999885

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=3.7e-10  Score=101.97  Aligned_cols=133  Identities=16%  Similarity=0.076  Sum_probs=88.7

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhcCCCC--eecccceeeecCCCCccEEEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      .|.+....+.|..+.||++.. .+|..+++|+.... .....+|+.+++.+.+.+  +++++.+...     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            466655545666799999964 56788999987654 244678999999886544  4456655422     22367999


Q ss_pred             eccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 015298          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-------------------------------------  191 (409)
Q Consensus       149 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------  191 (409)
                      ||++|.-.. .       ....   ...++.+++..|..||+.                                     
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999974212 0       0111   123455666666666652                                     


Q ss_pred             --------------------CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          192 --------------------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       192 --------------------~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                                          .+++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                0299999999999998654 56799999985

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=4.7e-10  Score=106.71  Aligned_cols=140  Identities=15%  Similarity=0.157  Sum_probs=98.8

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEee--cc-----chhhHHHHHHHHhcCC--CCeecccceeeecCCCCccEEE
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ..+.|+.|.++.||++..  .+..+++|+..  ..     .....+|+.+++.|..  ..+++++..+...  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            456789999999999885  34678898776  22     3456789999999974  4466666554221  1112356


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-----------------------------------  190 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-----------------------------------  190 (409)
                      +||||++|....     ......++......++.+++.+|..||.                                   
T Consensus       118 ~vme~v~G~~l~-----~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLW-----DQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCC-----CTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecC-----CCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            899999974210     0112346777888899999999999996                                   


Q ss_pred             ----------------------cCCcEeecCCCCceeecCCCC-cEEEeecCCccc
Q 015298          191 ----------------------SIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (409)
Q Consensus       191 ----------------------~~~ivH~Dlkp~NIli~~~~~-~ikl~Dfg~a~~  223 (409)
                                            ..+++|||++|.||+++.++. .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  136999999999999987652 368999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.95  E-value=5.1e-10  Score=103.91  Aligned_cols=182  Identities=13%  Similarity=0.164  Sum_probs=110.1

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcC-CCCe--ecccceeeecCCCCccEEEEEEecc
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      +.++.|....||++.     ..+++|+....  .....+|.++++.+. +..+  ++++...  .........++||+++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEccc
Confidence            458899999999864     46889986543  245678999998884 3332  2332211  1111112346899999


Q ss_pred             chh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 015298          152 PET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS---------------------------------------  191 (409)
Q Consensus       152 ~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------------------------------------  191 (409)
                      +|. +.....      ..++......++.|++..|..||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            973 222111      2456666666777777777777740                                       


Q ss_pred             ------------------CCcEeecCCCCceeecCC-CCcEEEeecCCccccccCCCC---ccc---cccc-------cc
Q 015298          192 ------------------IGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPN---ISY---ICSR-------YY  239 (409)
Q Consensus       192 ------------------~~ivH~Dlkp~NIli~~~-~~~ikl~Dfg~a~~~~~~~~~---~~~---~gt~-------~y  239 (409)
                                        ..++|+|++|.||+++.+ +..+.|+||+.+.........   ...   .+..       .|
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              147999999999999974 436889999998653221000   000   0000       01


Q ss_pred             --cc-cccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 015298          240 --RA-PELIFGATEYTTAIDIWSAGCVVAELMLGKPLF  274 (409)
Q Consensus       240 --~a-PE~l~~~~~~~~~~DiwslG~il~~lltg~~pf  274 (409)
                        .. |+...   ......+.|++|.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~---r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLE---KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHH---HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHH---HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              11 22211   0122368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.42  E-value=2.4e-06  Score=79.07  Aligned_cols=69  Identities=13%  Similarity=-0.007  Sum_probs=45.4

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCC---CeecccceeeecCCCCccEEEEEEec
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHP---NVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      .+.++.|....||+.     |..+++|+-...  .....+|.++|+.|.+.   .+.+++.+..    ......++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence            345788888899988     567889985432  23456899999999753   2334433322    112235699999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus        95 i~G   97 (306)
T 3tdw_A           95 VQG   97 (306)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=1.4e-05  Score=72.17  Aligned_cols=129  Identities=15%  Similarity=0.118  Sum_probs=80.2

Q ss_pred             ccCCce-EEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhcCC-CCeecccceeeecCCCCccEEEEEEeccchh-H
Q 015298           80 GQGSFG-VVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPET-V  155 (409)
Q Consensus        80 g~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l  155 (409)
                      ..|..| .||+......+..+++|+-.... ....+|...|+.+.. --+.+++.+...     ....++||++++|. +
T Consensus        33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           33 NVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             ECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEEH
T ss_pred             cCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCccc
Confidence            334444 78988877777889999875432 345679999988842 224455544422     23467999999873 3


Q ss_pred             HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 015298          156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR---------------------------------------------  190 (409)
Q Consensus       156 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------------  190 (409)
                      .+....        .......+..++...|.-||.                                             
T Consensus       108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            222211        011122334444455555553                                             


Q ss_pred             ------c------CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          191 ------S------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       191 ------~------~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                            .      ..++|+|+.+.||+++.++ .+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                  0      0279999999999998654 56799999885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=7.6e-06  Score=76.57  Aligned_cols=72  Identities=14%  Similarity=0.289  Sum_probs=40.2

Q ss_pred             EeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCC--CCeecccce----eeecCCCCccEEEEEEec
Q 015298           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--PNVVSLKHC----FFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~----~~~~~~~~~~~~~lv~e~  150 (409)
                      +.|+.|..+.||++..  .+..+++|+..........|..+++.|..  -.+++++..    .+.   ......+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEEe
Confidence            4566677889999875  33459999987654444556777666631  123333321    110   012346789999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus       113 i~G  115 (346)
T 2q83_A          113 IEG  115 (346)
T ss_dssp             CCC
T ss_pred             ecC
Confidence            986

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.07  E-value=2.5e-05  Score=74.90  Aligned_cols=72  Identities=17%  Similarity=0.159  Sum_probs=44.9

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----------chhhHHHHHHHHhcCC--C-CeecccceeeecCCCC
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLDH--P-NVVSLKHCFFSTTDKD  140 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~  140 (409)
                      ..+.||.|..+.||++....+++.+++|.....           ......|.++++.+..  + .+++++.+  .   ..
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TE  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CC
Confidence            356789999999999976666788999975421           1233678888887742  3 33344322  1   11


Q ss_pred             ccEEEEEEeccch
Q 015298          141 ELYLNLVLEYVPE  153 (409)
Q Consensus       141 ~~~~~lv~e~~~~  153 (409)
                      .  .++|||++++
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            1  3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=1.8e-05  Score=74.63  Aligned_cols=78  Identities=10%  Similarity=0.070  Sum_probs=49.2

Q ss_pred             EEEEee-ccCCceEEEEEEEc--C----CCcEEEEEEeeccc-------hhhHHHHHHHHhcCC---CCeecccceeeec
Q 015298           74 MAERIV-GQGSFGVVFQAKCL--E----TGETVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFST  136 (409)
Q Consensus        74 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~~~~~  136 (409)
                      ...+.| +.|..+.+|++...  .    ++..+++|+.....       ....+|+.+++.|..   -.+++++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88888999988753  0    26688999875432       456789999888842   2455555443211


Q ss_pred             CCCCccEEEEEEeccch
Q 015298          137 TDKDELYLNLVLEYVPE  153 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~~  153 (409)
                        ......++||||++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              101224579999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.77  E-value=0.00042  Score=59.63  Aligned_cols=98  Identities=16%  Similarity=0.108  Sum_probs=63.8

Q ss_pred             hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCccc
Q 015298          154 TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  233 (409)
Q Consensus       154 ~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~  233 (409)
                      +|.++|..+   +.+++++++|.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            677887765   689999999999999999987762211212333456888998888 676663 1110           


Q ss_pred             cccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 015298          234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML  269 (409)
Q Consensus       234 ~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt  269 (409)
                      .....+.|||.+.  ...+.+.=|+|||+++|..+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1123467888762  345788899999999999884

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00058  Score=62.63  Aligned_cols=65  Identities=15%  Similarity=0.093  Sum_probs=40.6

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEEEEEEecc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEYV  151 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~  151 (409)
                      .+.|+.|....+|++      ..+++|+.....   ....+|+.+++.+....+ .+++...     ...  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            677888999999998      468889875432   223578888877743222 3443322     111  14789999


Q ss_pred             -ch
Q 015298          152 -PE  153 (409)
Q Consensus       152 -~~  153 (409)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.33  E-value=0.0013  Score=60.71  Aligned_cols=142  Identities=13%  Similarity=0.070  Sum_probs=75.4

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeec--cchhhHHHHHHHHhcCCCC--eecccceeeecCCC----CccEEEE
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDK----DELYLNL  146 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~----~~~~~~l  146 (409)
                      -.+.|+.|....+|++..  ++..+++|+...  .......|+.+++.|....  +++++...   .+.    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~---~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK---DGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT---TCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEe--CCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC---CCCEEEEECCEEEE
Confidence            456778888899999875  233688998865  3455667888888774222  33333210   000    0123578


Q ss_pred             EEeccchhH------------HHHHHHhhhhcCC--------CCHHHHHH---------------HHHHHHHHHHHHHhc
Q 015298          147 VLEYVPETV------------HRVVKHFNKLNQR--------MPMIYVKL---------------YAYQIFRALSYIHRS  191 (409)
Q Consensus       147 v~e~~~~~l------------~~~l~~~~~~~~~--------l~~~~~~~---------------i~~qi~~~l~~LH~~  191 (409)
                      +++|++|.-            ...+...-.....        ........               +...+...+..+...
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999988621            1111111110000        01000000               001133445555421


Q ss_pred             ------CCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          192 ------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       192 ------~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                            .+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence                  2699999999999998654 45799999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.28  E-value=0.0021  Score=62.12  Aligned_cols=70  Identities=17%  Similarity=0.233  Sum_probs=47.0

Q ss_pred             EEEeeccCCceEEEEEEEcC-------CCcEEEEEEeec-cc-hhhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEE
Q 015298           75 AERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  144 (409)
                      ..+.|+.|....||++....       .+..+++|+... .. ....+|..+++.|...++ +++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            45678889999999998642       357899998844 22 344578888888853333 4554433     21    


Q ss_pred             EEEEeccch
Q 015298          145 NLVLEYVPE  153 (409)
Q Consensus       145 ~lv~e~~~~  153 (409)
                      .+|++|++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            268899875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.28  E-value=0.0025  Score=62.05  Aligned_cols=70  Identities=14%  Similarity=0.210  Sum_probs=45.8

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeeccch---hhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEEEEEEec
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      ..+.|+.|-...+|++.....+..+++|+......   ...+|..+++.|...++ +++++++     .+    .+||+|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            45678889999999998754457899998744322   22589999999965554 4555443     11    248999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.27  E-value=0.00082  Score=64.80  Aligned_cols=77  Identities=12%  Similarity=-0.048  Sum_probs=45.9

Q ss_pred             CCcEeecCCCCceeecCCCCcEEEeecCCccccccCCCCccccc--cccccccccccCCC--CCCchhhHHHHHHHHHHH
Q 015298          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGAT--EYTTAIDIWSAGCVVAEL  267 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~l~~~~--~~~~~~DiwslG~il~~l  267 (409)
                      ..++|+|++|.||+++.++  +.|+||+.+..............  ...|.+|+......  ......++.++...+|..
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3799999999999998654  99999999865322111111111  13356665542111  112234455777777777


Q ss_pred             HhC
Q 015298          268 MLG  270 (409)
Q Consensus       268 ltg  270 (409)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.25  E-value=0.0036  Score=56.83  Aligned_cols=71  Identities=15%  Similarity=0.165  Sum_probs=49.2

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCC---CeecccceeeecCCCCccEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHP---NVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~  144 (409)
                      ...-+..+|.|..+.||++.. .+|+.|++|+.....    ..+..|.+.|+.|...   -+++++..   ..      -
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~------~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD------R   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET------T
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cC------c
Confidence            355678899999999999984 578999999865332    3467899999988532   23333322   11      2


Q ss_pred             EEEEeccc
Q 015298          145 NLVLEYVP  152 (409)
Q Consensus       145 ~lv~e~~~  152 (409)
                      ++||||+.
T Consensus        86 ~lv~e~l~   93 (288)
T 3f7w_A           86 TLAMEWVD   93 (288)
T ss_dssp             EEEEECCC
T ss_pred             eEEEEeec
Confidence            57899886

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0028  Score=58.82  Aligned_cols=31  Identities=42%  Similarity=0.560  Sum_probs=26.4

Q ss_pred             CcEeecCCCCceeecCC---CCcEEEeecCCccc
Q 015298          193 GVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  223 (409)
Q Consensus       193 ~ivH~Dlkp~NIli~~~---~~~ikl~Dfg~a~~  223 (409)
                      .++|||+.+.||+++.+   ...+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999864   12799999998864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.08  E-value=0.0023  Score=58.94  Aligned_cols=72  Identities=17%  Similarity=0.065  Sum_probs=51.1

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-chhhHHHHHHHHhcC---CCCeecccceeeecCCCCccEEEEEEec
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (409)
                      -.+.|+.|....+|+...  ++..+++|+.... ...+..|.+.|+.|.   ...+++++....     .....++||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence            356789999999999875  5678899987644 344678988888874   245666655442     12346799999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            985

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0026  Score=60.25  Aligned_cols=138  Identities=17%  Similarity=0.263  Sum_probs=75.0

Q ss_pred             EeeccCCceEEEEEEEcC-------CCcEEEEEEeec---cchhhHHHHHHHHhcCCCC-eecccceeeecCCCCccEEE
Q 015298           77 RIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQ---DKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~  145 (409)
                      +.|..|....+|++....       ++..+++|+.-.   ......+|.++++.|.... ..++++.+     .+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            456667777888887532       357889998633   2234457999888874222 34554433     22    2


Q ss_pred             EEEeccchh-H-----------HHH---HHHhhhh----cCCCC--HHHHHHHHHHHHH-------------------HH
Q 015298          146 LVLEYVPET-V-----------HRV---VKHFNKL----NQRMP--MIYVKLYAYQIFR-------------------AL  185 (409)
Q Consensus       146 lv~e~~~~~-l-----------~~~---l~~~~~~----~~~l~--~~~~~~i~~qi~~-------------------~l  185 (409)
                      +||||++|. +           ..+   +...-..    .....  ...+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            799999851 1           111   1111111    11111  2344555544322                   12


Q ss_pred             HHHHh-------cCCcEeecCCCCceeecCC---CCcEEEeecCCccc
Q 015298          186 SYIHR-------SIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  223 (409)
Q Consensus       186 ~~LH~-------~~~ivH~Dlkp~NIli~~~---~~~ikl~Dfg~a~~  223 (409)
                      ..|.+       ...++|+|+.+.||+++.+   .+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33321       1259999999999999876   23799999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.92  E-value=0.003  Score=59.62  Aligned_cols=69  Identities=12%  Similarity=0.117  Sum_probs=40.5

Q ss_pred             EEeeccCCceEEEEEEEcC--------CCcEEEEEEeeccch---hhHHHHHHHHhcCCCC-eecccceeeecCCCCccE
Q 015298           76 ERIVGQGSFGVVFQAKCLE--------TGETVAIKKVLQDKR---YKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  143 (409)
                      ...|+.|....+|++....        .+..+++|+......   ....|.++++.+...+ .+++++.+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            4567778888999987643        136788998754322   2357888888875333 33554332     11   


Q ss_pred             EEEEEeccch
Q 015298          144 LNLVLEYVPE  153 (409)
Q Consensus       144 ~~lv~e~~~~  153 (409)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             468999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.89  E-value=0.0067  Score=56.00  Aligned_cols=72  Identities=14%  Similarity=0.003  Sum_probs=42.9

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCC--eecccceeeecCC--CCccEEEEEEec
Q 015298           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTD--KDELYLNLVLEY  150 (409)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~  150 (409)
                      .++ |....||++.. .+|+.+++|.....   ......|..+++.|....  +++++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            455 77788998763 35667999998632   345567888888774222  3444332  1000  012245689999


Q ss_pred             cch
Q 015298          151 VPE  153 (409)
Q Consensus       151 ~~~  153 (409)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.63  E-value=0.0035  Score=58.49  Aligned_cols=31  Identities=26%  Similarity=0.524  Sum_probs=26.8

Q ss_pred             CCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       192 ~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            3699999999999998765 799999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.51  E-value=0.093  Score=50.31  Aligned_cols=71  Identities=13%  Similarity=0.147  Sum_probs=45.1

Q ss_pred             EEEEeeccCCceEEEEEEEcCC-------CcEEEEEEeeccch---hhHHHHHHHHhcCCCC-eecccceeeecCCCCcc
Q 015298           74 MAERIVGQGSFGVVFQAKCLET-------GETVAIKKVLQDKR---YKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~  142 (409)
                      .-.+.|..|-...+|++.....       +..|++++......   ...+|..+++.+...+ .+++++.+     .   
T Consensus        73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---  144 (424)
T 3mes_A           73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P---  144 (424)
T ss_dssp             EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred             eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C---
Confidence            3456677788889999986421       57899998744321   2357898888884322 34444322     1   


Q ss_pred             EEEEEEeccch
Q 015298          143 YLNLVLEYVPE  153 (409)
Q Consensus       143 ~~~lv~e~~~~  153 (409)
                       -++|++|++|
T Consensus       145 -~~~I~efI~G  154 (424)
T 3mes_A          145 -EGRIEEFIDG  154 (424)
T ss_dssp             -TEEEEECCCS
T ss_pred             -CCEEEEEeCC
Confidence             1478999886

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=82.02  E-value=0.59  Score=44.32  Aligned_cols=30  Identities=27%  Similarity=0.512  Sum_probs=24.5

Q ss_pred             cEeecCCCCceeecC-----CCCcEEEeecCCccc
Q 015298          194 VCHRDIKPQNLLVNP-----HTHQVKLCDFGSAKV  223 (409)
Q Consensus       194 ivH~Dlkp~NIli~~-----~~~~ikl~Dfg~a~~  223 (409)
                      ++|+|+.+.||++..     +...+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999932     233799999999864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	409
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-127
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-75
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-70
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-67
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-64
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-61
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-60
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-58
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-56
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-53
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-49
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-47
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  367 bits (944), Expect = e-127
 Identities = 233/347 (67%), Positives = 285/347 (82%), Gaps = 4/347 (1%)

Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 116 QTMRLLDHPNVVSLKHCFFST-TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+   KDE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T L+A  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 355 PFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHAR 401
            FFDELRDPN +LP+GR  P LFNF + EL S P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (599), Expect = 5e-75
 Identities = 107/345 (31%), Positives = 181/345 (52%), Gaps = 25/345 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 127
           Y     +G+G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 243
           IH S  V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 302 -NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                     P     PW+++FP     +A+DL+ ++L ++P+ R     AL HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 361 RDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQCP 405
            DP+    +       F F   EL  +P E L +LI E   +  P
Sbjct: 302 YDPSDEPIA----EAPFKF-DMELDDLPKEKLKELIFEETARFQP 341

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 2e-70
 Identities = 96/304 (31%), Positives = 149/304 (49%), Gaps = 23/304 (7%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 127
             +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L   F     K  + L  V +++   +          +  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H+   + HRD+KP NLL++ +   +KL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           GA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP--N 364
              F      P H IF      + +DL+  L  ++P  R TA  AL   +F     P   
Sbjct: 234 YVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 365 ARLP 368
            +LP
Sbjct: 293 CQLP 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 3e-70
 Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 31/305 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                F       E+ +   +E++       +    K   R+P   +   +  + + L+Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            T Y+   DIWS G  + E+ +G+   P  D+   +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 307 EFKF--------------PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
              +                I   P  K+       E  D V++ L  +P  R      +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 353 IHPFF 357
           +H F 
Sbjct: 297 VHAFI 301

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  214 bits (546), Expect = 3e-67
 Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 21/300 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 130
           Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  D       LV E+V  T       F +L Q +    ++ Y Y+I +AL Y H 
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH- 146

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+     
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 310 FPQI----KAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
           F  I        W +         + PEA+D + +LL+Y    R TA +A+ HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-67
 Identities = 104/305 (34%), Positives = 165/305 (54%), Gaps = 20/305 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           +     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           E  L LV E++ + + + +         +P+  +K Y +Q+ + L+
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H S  V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCH-SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK-CMNPN 304
            G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD-- 362
             +  FP+     + K+ P  +  +   L+S++L Y PN R +A  AL HPFF ++    
Sbjct: 235 DYKPSFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

Query: 363 PNARL 367
           P+ RL
Sbjct: 294 PHLRL 298

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  214 bits (545), Expect = 8e-67
 Identities = 73/338 (21%), Positives = 131/338 (38%), Gaps = 41/338 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F    D +E+ +  + E++      + +     + +M       Y  Q+ + L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 189 HRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           H      H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G
Sbjct: 141 H-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
                   D+WS G +   L+ G   F G++  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP--NA 365
                             +  +  D + +LL   PN R T   AL HP+      P  ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 366 RLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHARKQ 403
           ++PS R+     + K+           +  I  ++  +
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLR 331

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-66
 Identities = 98/335 (29%), Positives = 161/335 (48%), Gaps = 24/335 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L   F      +E     ++ ++       +       Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           YIH S  + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIH-SADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                   Q+    +  +F     P AVDL+ ++L    + R TA  AL H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 364 NARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPE 398
           +        +   ++  S E + + ++    L  +
Sbjct: 311 DDEP-----VADPYDQ-SFESRDLLIDEWKSLTYD 339

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 2e-66
 Identities = 85/309 (27%), Positives = 147/309 (47%), Gaps = 22/309 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 127 VSLKHCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           V+L     +     ++ +  + LV ++    +       + +  +  +  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-----SYICSRY 238
            L YIH    + HRD+K  N+L+      +KL DFG A+     + +      + + + +
Sbjct: 129 GLYYIH-RNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 299 KCMNPNYTEFKFPQIKAHP---WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHP 355
             ++      K   +K        ++      P A+DL+ +LL   P  R  + DAL H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 356 FFDELRDPN 364
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 4e-66
 Identities = 100/318 (31%), Positives = 161/318 (50%), Gaps = 20/318 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 127 VSLKHCFFS-TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            YIH + G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIH-AAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                YT  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 306 TEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD 362
            +      P+++   +  I      P AV+L+ ++L      R TA +AL HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 363 PNARLPSGRFLPPLFNFK 380
                   ++     +  
Sbjct: 310 TEDEPQVQKYDDSFDDVD 327

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 9e-65
 Identities = 99/299 (33%), Positives = 153/299 (51%), Gaps = 17/299 (5%)

Query: 73  YMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQDKRYKN------RELQTMRLL---D 122
           Y     +G+G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           R L ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++   + Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
                  F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-64
 Identities = 98/299 (32%), Positives = 152/299 (50%), Gaps = 18/299 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           +  L LV E+  + + +     N     +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLG 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H    V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           FGA  Y+T+ID+WSAGC+ AEL     PLFPG+   DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                +P   A         ++     DL+  LL+ +P  R +A +AL HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  206 bits (525), Expect = 1e-63
 Identities = 80/341 (23%), Positives = 127/341 (37%), Gaps = 42/341 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F    DK E+ L  +LE++      +       + +M    V  Y  Q    L ++
Sbjct: 91  LHDAF---EDKYEMVL--ILEFLSG--GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 189 HRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE++  
Sbjct: 144 HEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
                   D+W+ G +   L+ G   F G+  ++ L  + +       +           
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED----------- 250

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-DELRDPNAR 366
                             + PEA D +  LLQ  P  R T  DAL HP+   +  +  +R
Sbjct: 251 --------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 367 LPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHA--RKQCP 405
           +PS R+       K         +  +  I   +  RK  P
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 337

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-63
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 32/305 (10%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 134
            +++G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 135 STTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +     +  L +V+E +    +   ++  ++ +Q             I  A+ Y+H SI 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131

Query: 194 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
           + HRD+KP+NLL         +KL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
             + D+WS G ++  L+ G P F  + G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF-DELRDPNARLPSG 370
             +           +  E   L+  LL+  P  R T  + + HP+     + P   L + 
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 371 RFLPP 375
           R L  
Sbjct: 290 RVLKE 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (514), Expect = 4e-63
 Identities = 94/295 (31%), Positives = 154/295 (52%), Gaps = 20/295 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           +  L LV E++ + + +     +     +  +  K +  Q+   ++
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           Y H    V HRD+KPQNLL+N    ++K+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCH-DRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN- 304
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
             +  F   +  PW       +    +DL+S++L+  PN R TA  AL H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (508), Expect = 1e-61
 Identities = 79/337 (23%), Positives = 136/337 (40%), Gaps = 53/337 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +  + C+     +   +L  V+EY   +   +++   K    +  + +    +   + L
Sbjct: 77  TIQYRGCY---LREHTAWL--VMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+H S  + HRD+K  N+L++     VKL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
               E  Y   +D+WS G    EL   KP     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                       +    +          + V   LQ  P  R T+   L H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 364 NARLPSGRFLPPLFNFKSHELKSVPVEILVKLIPEHA 400
              +     L         EL ++    + K++ + A
Sbjct: 277 TVIMD----LIQRTKDAVRELDNLQYRKMKKILFQEA 309

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-61
 Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 45/296 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V         T+     L +V+EY     +  V+    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 186 SYIHR----SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYR 240
              HR       V HRD+KP N+ ++   + VKL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                 E KF +I         P R   E  ++++R+L      R +  + L +P 
Sbjct: 228 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 3e-61
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 44/294 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F     ++ L++  ++E+             +L + +    +++   Q   AL+Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 247
           H +  + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 248 AT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            T     Y    D+WS G  + E+   +P     + +  L++I K               
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--------------- 229

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                      + P     P R      D + + L+ + + R T    L HPF 
Sbjct: 230 -----------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 61/289 (21%), Positives = 121/289 (41%), Gaps = 40/289 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           +  +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 190 -RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            R+  + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
               + +      F K   PE  +++   ++ + + R +  D L H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-61
 Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 50/293 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L   F    D   +YL  +LEY P  TV+R ++  +K +++        Y  ++  A
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           LSY H S  V HRDIKP+NLL+      +K+ DFG +          +   +  Y  PE+
Sbjct: 119 LSYCH-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEM 175

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G   +   +D+WS G +  E ++GKP F  ++  +    I +V  T            
Sbjct: 176 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------ 222

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF 357
                            FP  +   A DL+SRLL+++P+ R    + L HP+ 
Sbjct: 223 -----------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 7e-61
 Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 44/295 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                             L LEY             + +  MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H  IG+ HRDIKP+NLL++   + +K+ DFG A V               +  Y APEL
Sbjct: 119 LH-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     +   +D+WS G V+  ++ G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-------- 228

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
                              K++    + L+ ++L  +P+ R T  D     ++++
Sbjct: 229 ------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 8e-60
 Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 38/291 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 129
           YM    +G+G FG+V +     + +T   K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     +    L ++ E++      + +  N     +    +  Y +Q+  AL ++H
Sbjct: 67  HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 190 RSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            S  + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+    
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
              +TA D+WS G +V  L+ G   F  ++    +  I+    T   E            
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----------- 226

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE 359
                          K +  EA+D V RLL      R TA +AL HP+  +
Sbjct: 227 --------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 9e-60
 Identities = 99/344 (28%), Positives = 166/344 (48%), Gaps = 33/344 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 127 VSLKHCFFS-TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F    T ++   + LV+E +   + +V++        +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGI 132

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 306 TEF--KFPQIKAHPWHKIFP-----------KRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
             +    P+     + K+FP           K    +A DL+S++L   P  R +  DAL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 353 IHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVPVEILVKLI 396
            HP+ +   DP          P +++ +  E +   +E   +LI
Sbjct: 310 QHPYINVWYDPAEVEAP---PPQIYDKQLDEREH-TIEEWKELI 349

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  194 bits (492), Expect = 7e-59
 Identities = 94/349 (26%), Positives = 157/349 (44%), Gaps = 49/349 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 130 KH----------CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
                         F+    + +++ +V E + E +  ++K +   ++ +P+IYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-----QVKLCDFGSAKVLVKGEPNISYI 234
           Q+   L Y+HR  G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIK 288
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 289 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FPKRMPPEAVDLVS 335
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 336 RLLQYSPNLRCTALDALIHPFF------DELRDPNARL-PSGRFLPPLF 377
            +LQ  P  R  A   + HP+       +E+R P+  L  SG  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 43/301 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
               +      DEL++  V+EY+       V         M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFL 132

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H +  V HRDIK  N+L+      VKL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS G +  E++ G+P +  ++ +  L  I    GTP  +           
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQ----------- 237

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARL 367
                          P+++     D ++R L      R +A + L H F    +  ++  
Sbjct: 238 --------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

Query: 368 P 368
           P
Sbjct: 284 P 284

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  186 bits (473), Expect = 6e-57
 Identities = 71/306 (23%), Positives = 122/306 (39%), Gaps = 54/306 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------------LQDKRYKNRELQTMR 119
           Y  + I+G+G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 120 LL-DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
            +  HPN++ LK  +     +   +  LV + +       +  +      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALH-KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 239 YRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                  M+ NY +F  P+                   DLVSR L   P  R TA +AL 
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 354 HPFFDE 359
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 8e-57
 Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 44/304 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   +        LYL  +++ V    +   +       +R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K                
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------- 231

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN 364
                            +   +   A D +  L++  P  R T   AL HP+       +
Sbjct: 232 -----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

Query: 365 ARLP 368
             + 
Sbjct: 275 KNIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-56
 Identities = 83/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)

Query: 66  QPKQTI--SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQ 116
           QP++     +   +I+G+GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL 176
            M  LDHP  V L   F    D ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLY--FGLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 233
           Y  +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD- 228

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI 353
                                       FP++  P+A DLV +LL      R    +   
Sbjct: 229 ----------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260

Query: 354 ------HPFFDEL 360
                 HPFF+ +
Sbjct: 261 YGPLKAHPFFESV 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-54
 Identities = 70/324 (21%), Positives = 123/324 (37%), Gaps = 51/324 (15%)

Query: 68  KQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------REL 115
           ++ +   Y     +G G F VV + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
             ++ + HPNV++L   +    +K ++ L  +LE V       +  F    + +      
Sbjct: 65  SILKEIQHPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEAT 116

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNIS 232
            +  QI   + Y+H    + H D+KP+N+++   N    ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
              +  + APE++          D+WS G +   L+ G   F GD+  + L  +  V   
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
              E                         +       A D + RLL   P  R T  D+L
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

Query: 353 IHPFFDELRDPNARLPSGRFLPPL 376
            HP+    +D    L S    P  
Sbjct: 270 QHPWIKP-KDTQQALSSAWSHPQF 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 3e-53
 Identities = 77/354 (21%), Positives = 143/354 (40%), Gaps = 58/354 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--------MRLLDHP 124
           ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +  +   F     + +  L  V+EY+       + +  +   +  +     YA +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++H S G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLH-SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G  +Y  ++D WS G ++ E+++G+  F G    +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI-HPFFDELR- 361
                             +P+ +  EA DL+ +L    P  R      +  HP F E+  
Sbjct: 221 F-----------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263

Query: 362 -DPNARLPSGRFLPPL------FNFKSHELKSVPVEILVKLIPEHARKQCPFLG 408
            +   +     F P +       NF    L   P          ++  Q  F  
Sbjct: 264 EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRN 317

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-53
 Identities = 66/303 (21%), Positives = 114/303 (37%), Gaps = 56/303 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD 122
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 123 --HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
                V+ L   F      D   L  +LE       + +  F      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE---RPDSFVL--ILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           +  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE I     +  +  +WS G ++ +++ G   F  D       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                                F +R+  E   L+   L   P+ R T  +   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 361 RDP 363
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  176 bits (446), Expect = 5e-52
 Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 52/303 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 122
           +   RI+G+G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            P +V + + F      D+L    +L+ +       + +    +       ++ YA +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             L ++H +  V +RD+KP N+L++ H H V++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++     Y ++ D +S GC++ +L+ G   F      D+       L            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFF 357
                               P    PE   L+  LLQ   N R       A +    PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 358 DEL 360
             L
Sbjct: 269 RSL 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  172 bits (437), Expect = 3e-51
 Identities = 72/323 (22%), Positives = 132/323 (40%), Gaps = 62/323 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 125
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           ++ +   F     +D   + ++++Y+       +    + +QR P    K YA ++  AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            Y+H    + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                Y  +ID WS G ++ E++ G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFF--- 357
                           FP     +  DL+SRL+    + R         D   HP+F   
Sbjct: 216 ------------AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 358 --DELRDPNARLPSGRFLPPLFN 378
             ++L   N   P   + PP+  
Sbjct: 264 VWEKLLSRNIETP---YEPPIQQ 283

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (424), Expect = 1e-49
 Identities = 62/295 (21%), Positives = 109/295 (36%), Gaps = 43/295 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           Y    I+G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V++ +              +V+EYV       ++        M             +AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRA 241
           ++ H   G+ HRD+KP N++++   + VK+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSH-QNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE   G        D++S GCV+ E++ G+P F GDS V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                                 + +  +   +V + L  +P  R      +    
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-47
 Identities = 56/290 (19%), Positives = 106/290 (36%), Gaps = 47/290 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                         L +V ++   +   +  H + +  +  MI +   A Q  + + Y+H
Sbjct: 70  MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
               + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 247 G--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                 Y+   D+++ G V+ ELM G+  +   +  DQ++ ++                 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                  +    P         P     L++  L+   + R      L  
Sbjct: 224 -------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-47
 Identities = 68/311 (21%), Positives = 117/311 (37%), Gaps = 53/311 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K+ F      D L        +       +       +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
               V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +Y  A+D W  G V+ E+M G+  F           I+        EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEIR---------- 223

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDALIHPFFDELRDPN 364
                       FP+ + PEA  L++ LL+  P  R       A + + H FF  +    
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 365 ARLPSGRFLPP 375
             +   + LPP
Sbjct: 270 QDVVQKKLLPP 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 58/315 (18%), Positives = 106/315 (33%), Gaps = 54/315 (17%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 117
           +G R         Y   R +G GSFG ++    +  GE VAIK      ++     E + 
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
            +++     +       +  D    Y  +V+E +  ++      FN  +++  +  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---- 231
           A Q+   + YIH S    HRD+KP N L+      + V + DFG AK       +     
Sbjct: 109 ADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                                +  + K     ++  K  P E    ++       + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 348 A---LDALIHPFFDE 359
                    + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (396), Expect = 6e-45
 Identities = 73/345 (21%), Positives = 125/345 (36%), Gaps = 65/345 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F   ++   +   +    +   + R          R    + + YA QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+ + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  A+D W+ G ++ E+  G P F  D  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP-----NLRCTALDALIHPFFDEL--RD 362
                       FP     +  DL+  LLQ        NL+    D   H +F       
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

Query: 363 PNARLPSGRFLPPLFN---------FKSHELKSVPVEILVKLIPE 398
              R     F+P             ++  E++    E   K   E
Sbjct: 305 IYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFTE 349

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 7e-44
 Identities = 49/280 (17%), Positives = 98/280 (35%), Gaps = 41/280 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 134
           + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
               +++  L +V EY+ +         ++    +    +  ++  +  A+ Y+  +   
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            D+WS G ++ E+     +      +  +V  ++                          
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------------------------- 214

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
              +    P   PP   +++         +R + L     
Sbjct: 215 -KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (378), Expect = 7e-43
 Identities = 53/317 (16%), Positives = 103/317 (32%), Gaps = 62/317 (19%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 117
           +G           Y   R +G+GSFGV+F+   L   + VAIK   +         E +T
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
            +LL     +   + F      + L+  LV++ +  ++       +   ++  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNI-- 231
           A Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 232 ------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
                 +   +  Y +     G  E +   D+ + G V    + G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             ++                      + K     +      P E    +      + +  
Sbjct: 225 YERIG---------------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

Query: 346 CTALDALIHPFFDELRD 362
                    P +D L+ 
Sbjct: 264 ---------PDYDYLQG 271

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 72/308 (23%), Positives = 129/308 (41%), Gaps = 55/308 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCL---ETGETVAIKKV--------LQDKRYKNRELQTMRLL 121
           +   +++G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 122 DH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
              P +V+L + F     + +L+L L      E    + +       R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGE 137

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 237
           I  AL ++H+ +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           Y     +  G + +  A+D WS G ++ EL+ G   F  D   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR-----CTALDAL 352
                    + + P          +P+ M   A DL+ RLL   P  R       A +  
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290

Query: 353 IHPFFDEL 360
            H FF ++
Sbjct: 291 EHLFFQKI 298

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-42
 Identities = 53/292 (18%), Positives = 100/292 (34%), Gaps = 45/292 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    ++ +Y+  + EY+                ++ +  +   A QI   +++I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 247
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              +T   D+WS G ++ E++    +        ++++ ++                   
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------------------- 224

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL--IHPFF 357
                     +  + P   P E   L+    +  P  R T       +  FF
Sbjct: 225 --------RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 47/296 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 ++ +Y+  V EY+ +          +  + + +  +   A QI   ++Y+ R  
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM- 132

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 250
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 251 YTTAIDIWSAGCVVAEL-MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +T   D+WS G ++ EL   G+  +PG    + L ++ +    P                
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------- 234

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA--LDALIHPFFDELRDP 363
                        P   P    DL+ +  +  P  R T   L A +  +F      
Sbjct: 235 ------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 47/283 (16%), Positives = 97/283 (34%), Gaps = 43/283 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 133
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
               ++  +   LV E++         +            +      +   ++Y+  +  
Sbjct: 70  ---LEQAPIC--LVFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 251
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           ++  D+WS G ++ E+     +   +    ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                 +    P+        +++   +  P  R      L  
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 55/290 (18%), Positives = 115/290 (39%), Gaps = 43/290 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               T +   Y+    E++               Q +  + +   A QI  A+ Y+ +  
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK- 134

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 250
              HRD+  +N LV  + H VK+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           ++   D+W+ G ++ E+            + Q+ E+++                  +++ 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL 360
                       P+  P +  +L+    Q++P+ R +  +  IH  F+ +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 53/304 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + ++Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 244
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           I     YT   D+WS G  V ELM  G   + G        EI  +L    R        
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP 363
                              P     +   ++ +      + R    + +I  F    RDP
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274

Query: 364 NARL 367
              L
Sbjct: 275 QRYL 278

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 62/314 (19%), Positives = 111/314 (35%), Gaps = 70/314 (22%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKN-----RELQTM-RLLDHP 124
            +++G G+FG V  A      +T     VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--------------------ETVHRVVKHFNK 164
           N+V+L       T    +Y  L+ EY                      E  ++      +
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               +    +  +AYQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 225 VKGEPNISYICSR---YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
           +     +    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQY 340
               ++I+                   FK             P     E   ++     +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306

Query: 341 SPNLRCTALDALIH 354
               R +  +    
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 54/302 (17%), Positives = 109/302 (36%), Gaps = 37/302 (12%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 128
           + + +  +G+G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                 +  +     L LV +Y    ++   +         + +  +   A      L++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAH 115

Query: 188 IHRSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YIC 235
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 236 SRYYRAPELIFGA-----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
           ++ Y APE++  +      E     DI++ G V  E+     +        QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVP 233

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD 350
             P+ EE++ +          +++ +  ++            ++      +   R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 351 AL 352
             
Sbjct: 288 IK 289

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-39
 Identities = 53/284 (18%), Positives = 102/284 (35%), Gaps = 45/284 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 133
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T +  ++  ++ EY+         +  ++  R     +      +  A+ Y+     
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 251
             HRD+  +N LVN     VK+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 252 TTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           ++  DIW+ G ++ E+  LGK  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------- 221

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                       P     +   ++        + R T    L +
Sbjct: 222 -----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 7e-39
 Identities = 65/309 (21%), Positives = 113/309 (36%), Gaps = 54/309 (17%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET---VAIKKVL-----QDKRYKNRELQTMRLLDH 123
               E+++G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PNV+ L+      T    +   ++ E++           N  + +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 237
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            + APE I    ++T+A D+WS G V+ E+M  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP--- 253

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPF 356
                                     P   P     L+    Q   N R      +    
Sbjct: 254 -------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 357 FDELRDPNA 365
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 9e-39
 Identities = 57/299 (19%), Positives = 107/299 (35%), Gaps = 56/299 (18%)

Query: 76  ERIVGQGSFGVVFQAKC--LETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           ++ +G G+FG V +      +  +TVA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +        + +   L  V+E         +  + + N+ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 243
           +  S    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            I    ++++  D+WS G ++ E    G+  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA---LDALIHPFFD 358
                               P   P E  DL++    Y    R         L + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-38
 Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 53/299 (17%)

Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 126
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L     +        + +V E  P     ++    K      +  +  YA Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 243
           Y+  S    HRD+  +NLL+      VK+ DFG  + L + + +     +    +     
Sbjct: 126 YLE-SKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
                  ++ A D W  G  + E+   G+  + G +G   L +I K              
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR 361
                 + P+          P+  P +  +++ +   + P  R T +   +  F  E +
Sbjct: 230 ---EGERLPR----------PEDCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 60/294 (20%), Positives = 101/294 (34%), Gaps = 54/294 (18%)

Query: 80  GQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 132
           G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V L   
Sbjct: 18  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                      L LV+E          K      + +P+  V    +Q+   + Y+    
Sbjct: 78  C------QAEALMLVMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYLEEK- 128

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPELIFGA 248
              HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE I   
Sbjct: 129 NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF- 186

Query: 249 TEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            ++++  D+WS G  + E +  G+  +    G + +  I +                   
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------------- 232

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA---LDALIHPFFD 358
                          P   PPE   L+S    Y    R         +   ++ 
Sbjct: 233 --------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 55/304 (18%), Positives = 109/304 (35%), Gaps = 57/304 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           SL         + E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 242
           +       HRD+  +N +++     VK+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LASK-KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------LDALIHP 355
                              + P+  P    +++ +       +R +       + A+   
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 356 FFDE 359
           F  E
Sbjct: 295 FIGE 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 2e-36
 Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 65/307 (21%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRYKN-----RELQTM-RLLDHP 124
            + +G G+FG V +A        +   TVA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP---------------ETVHRVVKHFNKLNQRM 169
           N+V+L       T      +  + EY                                 +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            +  +  ++YQ+ + ++++  S    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 230 NISYICSR---YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           +IK                             +  + P+  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 346 CTALDAL 352
            T    +
Sbjct: 293 PTFKQIV 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 9e-36
 Identities = 67/293 (22%), Positives = 105/293 (35%), Gaps = 50/293 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHP 124
               R +G+G FG V Q   +        VAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++V L           E  + +++E       R           + +  + LYAYQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 242
           L+Y+       HRDI  +N+LV+ +   VKL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           E I     +T+A D+W  G  + E+++ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------- 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                                P   PP    L+++   Y P+ R    +    
Sbjct: 230 --------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 56/300 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-------------ETVHRVVKHFNKLNQRMPMIYV 174
           +L             YL L +EY P                       N     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             +A  + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLS-QKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH 354
                        ++             P     E  DL+ +  +  P  R +    L+ 
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 4e-35
 Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 50/294 (17%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLD 122
               ++++G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           H N++ L+             + ++ EY+        K   + +    ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----SRY 238
             + Y+       HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE I    ++T+A D+WS G V+ E+M        +    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL 352
                              +    P   P     L+ +  Q     R    D +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (321), Expect = 1e-34
 Identities = 60/319 (18%), Positives = 106/319 (33%), Gaps = 73/319 (22%)

Query: 77  RIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           R +G+G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP---------------------ETVHRVVKHFNKL 165
           V              + L  + EY+                        +    +  +  
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
              +        A Q+   ++Y+       HRD+  +N LV  +   VK+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 226 KGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
             +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            +  +               + N                  P+  P E  +L+       
Sbjct: 251 VIYYV--------------RDGNILA--------------CPENCPLELYNLMRLCWSKL 282

Query: 342 PNLRCTALDALIHPFFDEL 360
           P  R +     IH     +
Sbjct: 283 PADRPSFCS--IHRILQRM 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 6e-33
 Identities = 58/309 (18%), Positives = 110/309 (35%), Gaps = 64/309 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTM-R 119
            +  + +G+G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLN 166
           +  H N+++L       T    LY+  ++EY              P  +       +   
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 167 QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 226
           +++    +   AYQ+ R + Y+  S    HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 227 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
            +      +      + APE +F    YT   D+WS G ++ E+            V++L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
            +++K                                  P     E   ++       P+
Sbjct: 247 FKLLK---------------------------EGHRMDKPSNCTNELYMMMRDCWHAVPS 279

Query: 344 LRCTALDAL 352
            R T    +
Sbjct: 280 QRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 62/321 (19%), Positives = 113/321 (35%), Gaps = 64/321 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD------KRYKNRELQTMRLL 121
               + +G+G+FG V +A         T  TVA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-------------ETVHRVVKHFNKLNQR 168
            H NVV+L              L +++E+               E V   V   +     
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 169 MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 228
           + + ++  Y++Q+ + + ++  S    HRD+  +N+L++     VK+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 229 PNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLV 284
             +          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
             +K                                  P    PE    +       P+ 
Sbjct: 248 RRLK---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 280

Query: 345 RCTALDALIHPFFDELRDPNA 365
           R T  + + H     L   NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-31
 Identities = 59/312 (18%), Positives = 113/312 (36%), Gaps = 63/312 (20%)

Query: 76  ERIVGQGSFGVVFQAKC-----LETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +GQGSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYA 178
           VV         +        +++E +            R     N +     +  +   A
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--- 235
            +I   ++Y++ +    HRD+  +N +V      VK+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDAL-- 352
                                       P   P    +L+    QY+P +R + L+ +  
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 353 ----IHPFFDEL 360
               + P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 2e-19
 Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 34/205 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV--------------LQDKRYKNRELQTMRLLD 122
           +++G+G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 123 HPNVVSLKHCFFSTT-DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
              +  L+          +   +  ++E              K   R+ +         I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMI 112

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              ++  +    + H D+   N+LV      + + DF  +  +  GE     I  R  R 
Sbjct: 113 LEEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRN 167

Query: 242 PELIFGATEYTTAIDIWSAGCVVAE 266
               F    Y T  DI SA   + +
Sbjct: 168 IITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	409
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.17
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.78
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.78
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.48
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.36

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-64  Score=479.26  Aligned_cols=330  Identities=69%  Similarity=1.191  Sum_probs=295.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHhcCCCCeecccceeeecCC-CCccEEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLVL  148 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~  148 (409)
                      ..+|...++||+|+||+||+|+++.+|+.||||++..+.....+|+++|++++||||++++++|+.... .+..+++|||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            447999999999999999999999999999999998888788899999999999999999999876543 4567789999


Q ss_pred             eccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       149 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      |||++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+++......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            9999988888877777778899999999999999999999986 999999999999999887689999999998877777


Q ss_pred             CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCcccc
Q 015298          229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (409)
Q Consensus       229 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  308 (409)
                      ...+.+||+.|+|||++.+...++.++|||||||++|||++|+.||...+..+++..+.+.++.+..+.+....+.+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            77788999999999998877779999999999999999999999999999999999999999999999999888888888


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCCcccccCCC
Q 015298          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFKSHELKSVP  388 (409)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (409)
                      .++.....++.......+++++.+||.+||++||++|||+.|+|+||||+++.++..+.+..+..+..++|+..++.+.|
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  337 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP  337 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCG
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCc
Confidence            88888888888888888999999999999999999999999999999999999988888888888899999999988766


Q ss_pred             HHHHhhcChHHHh
Q 015298          389 VEILVKLIPEHAR  401 (409)
Q Consensus       389 ~~~~~~~~~~~~~  401 (409)
                       +.-...+|++.+
T Consensus       338 -~~~~~~~p~~~r  349 (350)
T d1q5ka_         338 -PLATILIPPHAR  349 (350)
T ss_dssp             -GGHHHHSCTTTT
T ss_pred             -cccccCCCcccc
Confidence             456667776654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-60  Score=434.57  Aligned_cols=253  Identities=25%  Similarity=0.326  Sum_probs=209.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...     .+.+.+|+++++.++||||+++++++..     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            45799999999999999999999999999999998643     2346789999999999999999999843     4458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +||||||++ +|.+.+.    ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999985 6655543    356899999999999999999999986 999999999999999887 899999999987


Q ss_pred             cccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          224 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       224 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .....   .....+||+.|||||++.+...++.++|||||||++|+|+||+.||....................      
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------  226 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------  226 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Confidence            64332   244678999999999997766567889999999999999999999987654433333222110000      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                          .....+|+++.+||.+||+.||++|||+.|+|+||||++
T Consensus       227 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         227 --------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             --------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             --------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                                012247899999999999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=428.21  Aligned_cols=248  Identities=31%  Similarity=0.485  Sum_probs=213.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..+|.+.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+++++.++||||+++++++     .+..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence            35799999999999999999999999999999998642       23456899999999999999999988     3445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++||||||++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            68899999994 77666654    46799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      +..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.-           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            765433 34567899999999999764 48999999999999999999999999888777666554310           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                        ..++..+|+++++||.+||++||++|||+.|+|+||||..
T Consensus       221 ------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                              0145568999999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=432.87  Aligned_cols=256  Identities=31%  Similarity=0.528  Sum_probs=216.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|++++++++||||+++++++     .+...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            4799999999999999999999999999999998642       23456899999999999999999988     44456


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++|||||+| +|.+.+..    .+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccce
Confidence            8999999995 66666554    56899999999999999999999996 999999999999999888 89999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       223 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      ......   .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++.+.-         
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------  226 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------  226 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------
T ss_pred             ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            764332   23456899999999999765 48999999999999999999999999888777766665320         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHH------HhCCCCccCCCCCCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALD------ALIHPFFDELRDPNARL  367 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~e------ll~hp~f~~~~~~~~~~  367 (409)
                                          -.++..+++++++||.+||+.||++|||+.|      +++||||+++.+.....
T Consensus       227 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         227 --------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence                                0145568999999999999999999999987      58899999988776543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=432.16  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=213.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++...    .+...+|+++++.++||||+++++++..     ..+++|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            3799999999999999999999999999999998643    2346789999999999999999998844     345889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |||||+| +|..++.     ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999995 5555443     35799999999999999999999986 999999999999999887 89999999998764


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .. ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......+.          
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------  236 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------  236 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------
T ss_pred             cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence            43 344567899999999999764 589999999999999999999999998887777766655321110          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                      ..+..+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus       237 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         237 ----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ----------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ----------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                            123457999999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-59  Score=432.66  Aligned_cols=278  Identities=34%  Similarity=0.607  Sum_probs=227.8

Q ss_pred             EEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++|||||++++++.     ...+++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            4678999999999999999999999999985432         24568999999999999999999883     344578


Q ss_pred             EEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       146 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |||||+.+++...+.   .....+++..++.+++||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            999999986544433   3357799999999999999999999996 999999999999999888 89999999997654


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .. ......+||+.|+|||++.....++.++|||||||++|+|+||.+||.+.+..+++..+.+.++.|....+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            43 33456789999999999977777899999999999999999999999999999999999999998887665443322


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .....+......++...+ ..+++++++||.+||++||++|||+.|+|+||||++...+
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            222223333333333322 3578999999999999999999999999999999876544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-59  Score=425.75  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .++|.+.+.||+|+||+||+|+++.+|+.||+|.+....      +.+.+|++++++++|||||++++++...   ....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence            357999999999999999999999999999999986432      3356899999999999999999987532   2334


Q ss_pred             EEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cEeecCCCCceeecCCCCcEEEee
Q 015298          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-----VCHRDIKPQNLLVNPHTHQVKLCD  217 (409)
Q Consensus       144 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-----ivH~Dlkp~NIli~~~~~~ikl~D  217 (409)
                      ++||||||+ |+|.+++.........+++..++.++.||+.||.|||++ |     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            789999998 588888877766778999999999999999999999986 6     99999999999999888 899999


Q ss_pred             cCCccccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          218 FGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       218 fg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      ||+|+...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+....+.....     
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-----  231 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  231 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            99998765433 33467899999999999654 589999999999999999999999998887776666654210     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCc
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFF  357 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f  357 (409)
                                             ..++..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus       232 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                   01345689999999999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=421.42  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=206.4

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      |++.++||+|+||+||+|.++.+++.||+|++....      +.+.+|+++++.++|||||++++++.... .....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            478889999999999999999999999999986432      34568999999999999999999876543 33456789


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 77776654    46899999999999999999999986 8  999999999999975333899999999975


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .. .....+.+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.+.......+.         
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~---------  232 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA---------  232 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG---------
T ss_pred             cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc---------
Confidence            43 334456789999999999854  489999999999999999999999987665554433322111110         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                       .++...++++.+||.+||++||++|||+.|+|+||||+
T Consensus       233 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 -----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             12334789999999999999999999999999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-58  Score=426.03  Aligned_cols=283  Identities=35%  Similarity=0.645  Sum_probs=230.7

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ++|.+++.||+|+||+||+|+++.+|+.||||++..+      .....+|+++++.++|||||++++++..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998543      2345689999999999999999999843     4458


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++||||+.+++...+...  ....+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            999999998766665432  256799999999999999999999986 999999999999999888 8999999999766


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            433 3445668999999999987777789999999999999999999999999999999999999888877654432211


Q ss_pred             C-ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          304 N-YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       304 ~-~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      . .....++......+... ...+++++++||.+||++||++|||+.|+|+||||+++..|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKV-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHH-STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhh-ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            0 00011111111121221 23578999999999999999999999999999999988655

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=425.94  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +.|++.+.||+|+||+||+|+++.+|+.||+|++...    .+.+.+|+++++.++|||||++++++..     ...++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998643    2456789999999999999999998843     345889


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~  225 (409)
                      |||||++ +|..++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 56555443   246799999999999999999999986 999999999999999888 89999999997553


Q ss_pred             cC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          226 KG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      .. ......+||+.|+|||++..    ...++.++|||||||++|+|+||+.||.+.+..+.+.++.+.....       
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-------  234 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------  234 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            32 12335789999999999842    3457899999999999999999999999988887777766521100       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                         ...+..+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       235 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 -------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                               0123457999999999999999999999999999999973

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-58  Score=429.05  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=200.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .+.|.+.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+++.++||||+++++++     .+..++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            456999999999999999999999999999999986432     3345799999999999999999988     445568


Q ss_pred             EEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC---CCCcEEEeecCC
Q 015298          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGS  220 (409)
Q Consensus       145 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~---~~~~ikl~Dfg~  220 (409)
                      +||||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+||++..   ++ .+||+|||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~  156 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDS-KIMISDFGL  156 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECCC--
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCc-eEEEeccce
Confidence            99999998 577777754    57899999999999999999999986 9999999999999953   44 899999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       221 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      |+.........+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.+....+       
T Consensus       157 a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------  228 (307)
T d1a06a_         157 SKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-------  228 (307)
T ss_dssp             ----------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-------
T ss_pred             eEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-------
Confidence            9877666666678899999999999664 58999999999999999999999999888777766665431111       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                        .......+|+++++||.+||++||.+|||+.|+|+||||++
T Consensus       229 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         229 ------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                              11133468999999999999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=423.24  Aligned_cols=286  Identities=34%  Similarity=0.572  Sum_probs=235.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCC-CcEEEEEEeecc------chhhHHHHHHHHhc---CCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|++++.||+|+||+||+|++..+ ++.||||++..+      .....+|+.+++.|   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45899999999999999999999765 677999998543      23445788887766   799999999998766656


Q ss_pred             CccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ...+++++|||+.+++......  .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceeecchh
Confidence            6778899999999876554443  2357799999999999999999999986 999999999999999888 89999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015298          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (409)
Q Consensus       220 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  299 (409)
                      +++............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99877666666778999999999999664 58999999999999999999999999999999999999999988876654


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      ...... ...+......+. ..+...+++.+++||.+||++||++|||+.|+|+||||+++..
T Consensus       241 ~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            322111 111111111222 2245568999999999999999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=422.49  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=218.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----------chhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      .++|.+.+.||+|+||+||+|+++.+|+.||||++.+.          ...+.+|+.+|+.++|||||++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            45799999999999999999999999999999998642          13456899999999999999999998     4


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC---cEEE
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVKL  215 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~---~ikl  215 (409)
                      +...++||||||+ |+|.+++..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.   .+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEe
Confidence            4556899999998 577777654    46899999999999999999999986 9999999999999987652   5999


Q ss_pred             eecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +|||+|.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999887666666778899999999999654 5899999999999999999999999998888877776553222111


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                                               ..+..+|+++++||++||+.||.+|||+.|+|+||||+...+
T Consensus       238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                                     123457999999999999999999999999999999987644

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.9e-58  Score=432.61  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=220.0

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|.+.+.||+|+||+||+|+++.+|+.||||++....    ..+.+|+.+++.++|||||++++++.     +...++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            458999999999999999999999999999999986543    34568999999999999999999884     344588


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC-CCcEEEeecCCccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~-~~~ikl~Dfg~a~~  223 (409)
                      ||||||+| +|.+.+.   ...+.+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       100 ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         100 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999985 6666553   2246799999999999999999999996 99999999999999643 23799999999988


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...........||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+.        
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  246 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  246 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------
T ss_pred             cccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            7766666778999999999999764 4899999999999999999999999988888887777654222111        


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPN  364 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~  364 (409)
                                       .....+|+++++||.+||++||++|||+.|+|+||||+....+.
T Consensus       247 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         247 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             -----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence                             11234789999999999999999999999999999999876543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=428.32  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=217.4

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            35799999999999999999999999999999999643       23456899999999999999999988     4555


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      ++++|||||+| +|...+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeecccc
Confidence            68999999995 56555543    57899999999999999999999996 999999999999999988 8999999999


Q ss_pred             ccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+...-          
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------  221 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----------
Confidence            86543 3445568899999999999665 48999999999999999999999999988877766655421          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRD  362 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~  362 (409)
                                         ..+|..+|+++++||++||++||.+|++     +.++++||||+++.+
T Consensus       222 -------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         222 -------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                               0145678999999999999999999994     999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.6e-58  Score=433.02  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=217.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....    ..+.+|+++++.++|||||+++++|     .....++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            357999999999999999999999999999999986543    3456799999999999999999988     4445689


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeec--CCCCcEEEeecCCcc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAK  222 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~--~~~~~ikl~Dfg~a~  222 (409)
                      ||||||+| +|.+.+   .....++++..++.++.||+.||.|||++ ||+||||||+|||++  .++ .+||+|||+|+
T Consensus       103 ivmE~~~gg~L~~~~---~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~  177 (352)
T d1koba_         103 LILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKAS-SVKIIDFGLAT  177 (352)
T ss_dssp             EEEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCC-CEEECCCTTCE
T ss_pred             EEEEcCCCChHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCC-eEEEeecccce
Confidence            99999995 554433   23356799999999999999999999986 999999999999997  344 89999999999


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ............||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.+....++        
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  248 (352)
T d1koba_         178 KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------  248 (352)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred             ecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            88776666778899999999999654 589999999999999999999999999888888777765322111        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                       ......+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus       249 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             11334589999999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-57  Score=423.39  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=211.0

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      ..|...+.||+|+||+||+|++..+|+.||||++....       +.+.+|+++++.++|||||++++++..     ...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            36999999999999999999999999999999986532       235689999999999999999998843     345


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++||||||.+++...+.   .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            88999999976544332   2257899999999999999999999996 999999999999999887 899999999986


Q ss_pred             cccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ...   .....||+.|+|||++.+.  ..|+.++|||||||++|+|++|..||.+.+..+.+..+......         
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~---------  232 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------  232 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            533   3457899999999998642  34889999999999999999999999988877777666542110         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                                        ...+..+|+++++||.+||+.||.+|||+.|+|+||||.+-
T Consensus       233 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         233 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             ------------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                              01234578999999999999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-58  Score=431.48  Aligned_cols=280  Identities=25%  Similarity=0.412  Sum_probs=208.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      .++|.+.+.||+|+||+||+|+++.+|+.||+|++..+.     ....+|+.+|+.++|||||+++++|.     +...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            468999999999999999999999999999999986432     34568999999999999999999984     44458


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +||||||.| +|.+++..    .+.+++..++.++.||+.||.|||++.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            999999995 77777654    467999999999999999999999633899999999999999888 899999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCCHHHHhhcC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV-EIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~  302 (409)
                      ..+. ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+... .+....+.+.........
T Consensus       155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6443 33467899999999999775 49999999999999999999999998766543322 122211211110000000


Q ss_pred             -------------CCccccc-cCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          303 -------------PNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       303 -------------~~~~~~~-~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                   +...... ................+|.++++||.+||++||.+|||+.|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                         0000000 0000000111111224689999999999999999999999999999998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-57  Score=422.36  Aligned_cols=250  Identities=26%  Similarity=0.467  Sum_probs=215.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (409)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .+...+|+.+++.++||||+++++++     ....+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            4799999999999999999999999999999998643       23456899999999999999999998     44456


Q ss_pred             EEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       144 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      +++|||||.| ++...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999996 44444433    67789999999999999999999986 999999999999999988 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ...+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.+.-            
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------  217 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------  217 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred             Eecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence            7643  34467899999999999654 48999999999999999999999999988888777766521            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                       ..++..+++++.++|.+||++||.+|+     |++++++||||+++.+.
T Consensus       218 -----------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         218 -----------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                             014556899999999999999999996     99999999999998654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=422.98  Aligned_cols=320  Identities=31%  Similarity=0.546  Sum_probs=242.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (409)
                      ..+|++++.||+|+||+||+|.++.+|+.||||++....      +...+|+++|+.++|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            458999999999999999999999999999999996432      235689999999999999999998865432 2334


Q ss_pred             EEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcc
Q 015298          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (409)
Q Consensus       143 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~  222 (409)
                      .+++||||++..+..+..     ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        97 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            578999999877766654     36799999999999999999999986 999999999999999988 89999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ....  ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...+....
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            6533  34567899999999999877778999999999999999999999999999999999999999998887665433


Q ss_pred             CCccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015298          303 PNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNF  379 (409)
Q Consensus       303 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  379 (409)
                      .....   ..++......+.. ....+++++.+||.+||++||.+|||+.|+|+||||+.+.++........     +.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~-----~~~  321 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK-----YDD  321 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC-----CCC
T ss_pred             chhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC-----CCC
Confidence            22111   1122223333333 33458999999999999999999999999999999998876543321111     111


Q ss_pred             CcccccCCCHHHHhhcChHHHhhhCC
Q 015298          380 KSHELKSVPVEILVKLIPEHARKQCP  405 (409)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (409)
                      .... -+.+.+.+.+++-..+...+|
T Consensus       322 ~~~~-~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         322 SFDD-VDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             C------CCHHHHHHHHHHHHHTCCC
T ss_pred             chhh-hhcCHHHHHHHHHHHhhcCCC
Confidence            1112 134567777777666655443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-56  Score=422.54  Aligned_cols=251  Identities=27%  Similarity=0.418  Sum_probs=215.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+++|+.++||||+++++++     ....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            468999999999999999999999999999999986431       3356899999999999999999988     4445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+.+ ++...+..    .+.+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 55555543    46899999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      +....  ......||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.....          
T Consensus       189 ~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------  255 (350)
T d1rdqe_         189 KRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------  255 (350)
T ss_dssp             EECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred             eeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----------
Confidence            87643  34467899999999999764 489999999999999999999999998887777777655211          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                         .++..+++++.+||++||++||.+|+     |++++++||||+.+.+.
T Consensus       256 -------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             -------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                               13456899999999999999999995     99999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-56  Score=410.17  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=217.6

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------------hhhHHHHHHHHhcC-CCCeecccceeeec
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  136 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~~~~  136 (409)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            57999999999999999999999999999999986532             13457999999997 99999999998   


Q ss_pred             CCCCccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                        .++..++||||||+ |+|.+++..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              44556899999998 588877764    56899999999999999999999986 999999999999999888 8999


Q ss_pred             eecCCccccccCCCCccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  290 (409)
                      +|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999988776666677889999999999852     3347889999999999999999999999988777776666531


Q ss_pred             CCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCC
Q 015298          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDEL  360 (409)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~  360 (409)
                      ..++                         ......+|+++++||.+||++||++|||+.|+|+||||++.
T Consensus       232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            1111                         00123589999999999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.8e-57  Score=428.24  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=210.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHH---HHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      .++|.+.+.||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||++++++.     
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence            357999999999999999999999999999999985421       12223   456667778999999999883     


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Df  218 (409)
                      ....+++|||||. |+|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeee
Confidence            4455889999999 577776654    56789999999999999999999996 999999999999999888 8999999


Q ss_pred             CCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015298          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (409)
Q Consensus       219 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  298 (409)
                      |+|+..... .....+||+.|+|||++.....++.++|||||||+||+|+||+.||.+.+..+...........      
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence            999866443 3456789999999999976667899999999999999999999999876544333222111111      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCC-----HHHHhCCCCccCCCCC
Q 015298          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----ALDALIHPFFDELRDP  363 (409)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s-----~~ell~hp~f~~~~~~  363 (409)
                                          ...++..+|+++++||.+||+.||.+|||     ++++++||||+++.+.
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence                                11145568999999999999999999999     7999999999987643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=419.21  Aligned_cols=322  Identities=32%  Similarity=0.599  Sum_probs=245.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +.+|++++.||+|+||+||+|.++.+|+.||||++....     ....+|+++|+.++||||+++++++.........++
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357999999999999999999999999999999996432     234579999999999999999999866554555567


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ++++++++++|.+++..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceeec
Confidence            78888887888888753     5799999999999999999999986 999999999999999887 8999999999765


Q ss_pred             ccCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          225 VKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       225 ~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      ....    .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........+.......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            4332    234567899999999997767789999999999999999999999999998888888888888887664432


Q ss_pred             cCCCc---cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCC
Q 015298          301 MNPNY---TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLF  377 (409)
Q Consensus       301 ~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  377 (409)
                      .....   .....+.....++...+ ..+++++++||.+||++||.+|||+.|+|+||||++..++....    .....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~  314 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  314 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCcc
Confidence            21100   01112222233333333 35789999999999999999999999999999999876654332    222334


Q ss_pred             CCCcccccCCCHHHHhhcChHHHhhhC
Q 015298          378 NFKSHELKSVPVEILVKLIPEHARKQC  404 (409)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (409)
                      .++ .+....+.+.+..++.+...+..
T Consensus       315 ~~~-~~~~~~~~~~l~~l~~~e~~~~~  340 (345)
T d1pmea_         315 KFD-MELDDLPKEKLKELIFEETARFQ  340 (345)
T ss_dssp             ---------CCHHHHHHHHHHHSGGGS
T ss_pred             CCC-hhhhhCCHHHHHHHHHHHHHhcC
Confidence            444 45566677777776665544443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-56  Score=412.31  Aligned_cols=277  Identities=34%  Similarity=0.621  Sum_probs=224.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ++|.+.+.||+|+||+||+|+++ +|+.||||++...      ...+.+|+.+|+.++||||+++++++...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            47999999999999999999985 7899999998643      23456899999999999999999988543     348


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +++|+|+.+++...+..   ..+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            89999999876655543   357899999999999999999999986 999999999999999988 8999999999765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4332 234567899999999998777789999999999999999999999999999999999999988887665543221


Q ss_pred             Cc-cccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          304 NY-TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       304 ~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                      .. ....+......++. .+...+++++.+||++||++||++|||+.|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            10 01111111222222 244568999999999999999999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=416.75  Aligned_cols=251  Identities=27%  Similarity=0.504  Sum_probs=212.5

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHH-HhcCCCCeecccceeeecCCCCcc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ++|.+.+.||+|+||+||+|+++.+|+.||||++.++.       .....|..++ +.++||||+++++++     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            47999999999999999999999999999999996431       2234566655 468999999999998     4445


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+||||||+++ +|..++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            68999999995 77776654    56799999999999999999999996 999999999999999887 8999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015298          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (409)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  300 (409)
                      +..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            865433 334457899999999999765 4899999999999999999999999998887777666541  11       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH-HHhCCCCccCCCC
Q 015298          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL-DALIHPFFDELRD  362 (409)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~-ell~hp~f~~~~~  362 (409)
                                          .++..+|+++++||.+||+.||.+|||+. ++++||||+++++
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                                14556899999999999999999999995 8999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=418.81  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=217.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .++|.+.+.||+|+||+||+|.++.+|+.||||++....   ....+|+++|+.++||||++++++|.     +...+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            457999999999999999999999999999999997543   34568999999999999999999884     3445899


Q ss_pred             EEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC-CcEEEeecCCcccc
Q 015298          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT-HQVKLCDFGSAKVL  224 (409)
Q Consensus       147 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~-~~ikl~Dfg~a~~~  224 (409)
                      |||||+| +|.+.+..   ....+++..++.|+.||+.||.|||++ ||+||||||+|||++.++ ..+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999995 66665542   234799999999999999999999986 999999999999997543 37999999999877


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      ..........+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+...       
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------
Confidence            666556677899999999998654 489999999999999999999999999998888888776433322221       


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                                        ...+|+++++||.+||+.||.+|||+.|+|+||||++
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                              1247999999999999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=407.12  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------hhhHHHHHHHHhcC--CCCeecccceeeecC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTT  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  137 (409)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.++.          ....+|+.++++++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            457999999999999999999999999999999986431          23458999999996  89999999988    


Q ss_pred             CCCccEEEEEEeccch--hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEE
Q 015298          138 DKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl  215 (409)
                       .....+++||||+.+  .+...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEE
Confidence             344458899999974  44455443    57899999999999999999999986 99999999999999876558999


Q ss_pred             eecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      +|||+|+.... ....+..||+.|+|||++.+...++.++|||||||++|+|++|+.||...+      .+.+.      
T Consensus       153 ~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            99999976533 344567899999999999776666788999999999999999999996532      11110      


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCC
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELR  361 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~  361 (409)
                                             ...++..+|+++++||.+||++||++|||+.|+|+||||+++.
T Consensus       220 -----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                                   0114556899999999999999999999999999999998764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.7e-55  Score=411.35  Aligned_cols=282  Identities=29%  Similarity=0.514  Sum_probs=223.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.+. ||||++++++|...   ...++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence            47999999999999999999999999999999987543 55678999999995 99999999987542   334578999


Q ss_pred             eccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccCC
Q 015298          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (409)
Q Consensus       149 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~~  228 (409)
                      |||.++...      ...+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||+|||+|+......
T Consensus       112 e~~~~~~L~------~~~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGG------GTTTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHH------HHhcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999964221      1246799999999999999999999986 999999999999999777579999999998877776


Q ss_pred             CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCCCccc
Q 015298          229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (409)
Q Consensus       229 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  307 (409)
                      .....++|+.|+|||.+.+...++.++||||+||++|+|++|..||... +..++...+...++.+....+.........
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            7778889999999999987777899999999999999999999999754 455666667777665544333221110000


Q ss_pred             c----ccCcccCCCCcccC----CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCC
Q 015298          308 F----KFPQIKAHPWHKIF----PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRD  362 (409)
Q Consensus       308 ~----~~~~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~  362 (409)
                      .    .........+....    ...+++++++||++||++||++|||++|+|+||||+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0    11111112222221    2347899999999999999999999999999999998764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=400.47  Aligned_cols=283  Identities=34%  Similarity=0.559  Sum_probs=226.9

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.+.      ....+|+.+++.++||||+++++++     ......
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            47999999999999999999999999999999986432      3446899999999999999999988     444457


Q ss_pred             EEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       145 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +++++++.++....+.   ...+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            8999999976544433   2367899999999999999999999986 999999999999999887 8999999999876


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5433 3344567889999999977776899999999999999999999885 5556677777788887777665443322


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDP  363 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~  363 (409)
                      .......................+++.+.+||++||++||++||||+|+|+||||+++.+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            2211112222222222333445689999999999999999999999999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=414.24  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             ccceEEEE-eeccCCceEEEEEEEcCCCcEEEEEEeeccchhhHHHHHHHHh-cCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAER-IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .++|.+.. .||+|+||+||+|+++.+|+.||||++.. .....+|++++.+ ++|||||+++++|.... ....++|||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            46898875 59999999999999999999999999865 4556789988654 58999999999885432 234568999


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCcccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  224 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a~~~  224 (409)
                      ||||+ |+|.+.+...  ....+++..++.|+.||+.||+|||+. ||+||||||+|||++.++  ..+||+|||+|+..
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence            99998 5788777632  245799999999999999999999986 999999999999998532  36999999999887


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  304 (409)
                      .........+||+.|+|||++.+ ..|+.++|||||||+||+|+||++||.+.+..+....+...+...           
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~-----------  232 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----------  232 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-----------
T ss_pred             cCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-----------
Confidence            77777778899999999999865 458999999999999999999999998776555444333211100           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                        ...++        ......+|+++.+||++||+.||.+|||+.|+|+||||.+
T Consensus       233 --~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         233 --QYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             --SSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             --CCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence              00000        0011247899999999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=411.53  Aligned_cols=317  Identities=30%  Similarity=0.511  Sum_probs=232.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      .+|+++++||+|+||+||+|+++.+|+.||||++....      ....+|+.+++.++||||++++++|..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            47999999999999999999999999999999996432      235689999999999999999998864432 34567


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +|+|||||.+++...+      ...+++..++.+++||+.||.|||+. ||+||||||+|||++.++ .+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999998866544      35789999999999999999999986 999999999999999988 799999999988


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..........++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......++....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            7777777778899999999999764 589999999999999999999999999999999999999999888876654432


Q ss_pred             CccccccC--cccCCCCcccC-----------CCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCC
Q 015298          304 NYTEFKFP--QIKAHPWHKIF-----------PKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSG  370 (409)
Q Consensus       304 ~~~~~~~~--~~~~~~~~~~~-----------~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~  370 (409)
                      ........  ......+...+           ....++++.+||++||++||++||||+|+|+||||+...++...... 
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~-  326 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP-  326 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCC-
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCC-
Confidence            21111000  00001111111           11246789999999999999999999999999999987654332211 


Q ss_pred             CCCCCCCCCCcccccCCCHHHHhhcChHHH
Q 015298          371 RFLPPLFNFKSHELKSVPVEILVKLIPEHA  400 (409)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (409)
                        .|..++....+ ...+++.|..+|-..+
T Consensus       327 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~  353 (355)
T d2b1pa1         327 --PPQIYDKQLDE-REHTIEEWKELIYKEV  353 (355)
T ss_dssp             --CC-------CC-CCCCHHHHHHHHHHHH
T ss_pred             --CCCCCCcchhh-hhcCHHHHHHHHHHHh
Confidence              12223322222 4556777777665443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=403.46  Aligned_cols=285  Identities=30%  Similarity=0.484  Sum_probs=220.7

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCC---CC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  140 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  140 (409)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++..+      .....+|+++|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            56899999999999999999999999999999998543      2335689999999999999999988754322   22


Q ss_pred             ccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ...+++||||+.+++.....   .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeecce
Confidence            34578999999977655433   3357899999999999999999999986 999999999999999988 899999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++.....     ....+.+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9755322     22345679999999999987777999999999999999999999999999999999999998888776


Q ss_pred             HHHhhcCCCccccccCcccC--CCCccc-CCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccC
Q 015298          296 EEIKCMNPNYTEFKFPQIKA--HPWHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDE  359 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~  359 (409)
                      +.+.................  ...... .....++++++||.+||++||++|||+.|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            54433221111101100000  000000 00124778899999999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=406.61  Aligned_cols=312  Identities=31%  Similarity=0.543  Sum_probs=238.8

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCC-CCccE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (409)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++||||+++++++..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999996542      234689999999999999999998755433 22334


Q ss_pred             EEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       144 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      +++++++++|+|.+++.     .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhcc
Confidence            55666666677777663     46799999999999999999999986 999999999999999988 899999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..  .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.......
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            42  3345678899999999987777789999999999999999999999999999999999999988887765543221


Q ss_pred             Cccc---cccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCccCCCCCCCCCCCCCCCCCCCCCC
Q 015298          304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFDELRDPNARLPSGRFLPPLFNFK  380 (409)
Q Consensus       304 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  380 (409)
                      ....   ..........+... ...+++++++||.+||++||.+|||+.|+|+||||+++.++....     +...+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~-----~~~~~~~~  322 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYDQS  322 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC-----CCCCCCCG
T ss_pred             hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC-----CCCCCCCc
Confidence            1110   01112222222222 235799999999999999999999999999999999887654432     22223332


Q ss_pred             cccccCCCHHHHhhcChH
Q 015298          381 SHELKSVPVEILVKLIPE  398 (409)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~  398 (409)
                       .+-.....+.+..++-.
T Consensus       323 -~~~~~~~~~~~k~~~~~  339 (348)
T d2gfsa1         323 -FESRDLLIDEWKSLTYD  339 (348)
T ss_dssp             -GGGCCCCHHHHHHHHHH
T ss_pred             -ccchhcCHHHHHHHHHH
Confidence             23345566666665533

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.7e-53  Score=388.55  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc-------hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .++|++.+.||+|+||+||+|++..+|+.||||++..+.       ..+.+|+++++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            457999999999999999999999999999999996432       23568999999999999999999876543 3345


Q ss_pred             EEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+||||||++| +|...+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhhh
Confidence            67899999995 55555443    56899999999999999999999986 999999999999999888 8999999988


Q ss_pred             cccccCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          222 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       222 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      .......    .....+||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+...++......++   
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---  234 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  234 (277)
T ss_dssp             EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred             hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence            6543322    23456899999999999654 589999999999999999999999998887777766655321111   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCCCCcc
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIHPFFD  358 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~hp~f~  358 (409)
                                            ......+|+++.+||.+||++||.+||+..+.|.|+|++
T Consensus       235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                  113346899999999999999999999555555576653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-53  Score=389.10  Aligned_cols=248  Identities=20%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|.+.+.||+|+||+||+|.++.+|+.||||++..+.   +.+.+|+++++.++|||||++++++..     ...++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeE
Confidence            3458999999999999999999999999999999996543   445789999999999999999998843     33478


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      ||||||+ |++...+..  .....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+..
T Consensus        90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeec
Confidence            9999999 567666653  2246799999999999999999999996 999999999999999888 8999999999876


Q ss_pred             ccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          225 VKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       225 ~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ......  ....||+.|+|||++.+. .++.++|||||||++|||++|..||........+.++.....           
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-----------  233 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  233 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             CCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-----------
Confidence            443322  234578899999998664 489999999999999999997766555444444443332110           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                      ...++..+++++.+||.+||+.||++|||+.++++
T Consensus       234 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         234 ----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                            11145568999999999999999999999999965

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=384.10  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=203.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|++.+.||+|+||+||+|.++ ++..||||++....   +.+.+|++++++++|||||++++++..     + .++
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~-~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----C-CeE
Confidence            3468999999999999999999975 67889999996543   446789999999999999999987621     1 157


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ +|.+.+...  ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+..
T Consensus        84 iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~  159 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (272)
T ss_dssp             EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEc
Confidence            89999994 665554332  234699999999999999999999986 999999999999999888 8999999999876


Q ss_pred             ccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|||+|| .+||......+.+..+.....          
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------  228 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence            5433  23346788999999999654 489999999999999999995 566666666555555433211          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCccC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI--HPFFDE  359 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~--hp~f~~  359 (409)
                                        ...+..+++++.+||.+||+.||++|||+.++++  |+||..
T Consensus       229 ------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                              1134568999999999999999999999999988  788853

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=382.99  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc------chhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      ..++|.+.+.||+|+||+||+|+.   +..||||++...      .+.+.+|++++++++|||||++++++..      .
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~   76 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P   76 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------c
Confidence            345799999999999999999985   336999998533      1345689999999999999999986521      1


Q ss_pred             EEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .++||||||+ |+|.+.+..   ....+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla  151 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLA  151 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCS
T ss_pred             EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEccccce
Confidence            2579999999 577776653   246799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCC---CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +......   ......||+.|||||++.+.  ..++.++|||||||+||||+||+.||.+.+..+.+.........++. 
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-  230 (276)
T d1uwha_         152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-  230 (276)
T ss_dssp             CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-
T ss_pred             eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-
Confidence            7664322   23456789999999998643  24789999999999999999999999988777666555543221110 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                            ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       231 ----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 ----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  111345689999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-52  Score=387.06  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=190.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc---EEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|++.+.||+|+||+||+|.++.+|+   .||||.+...     .+.+.+|+++|++++|||||++++++..     .
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----S   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            3579999999999999999999987765   5889987543     2345689999999999999999998843     3


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++|||||++ +|.+++..   ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCccc
Confidence            337899999995 56555442   245799999999999999999999986 999999999999999888 899999999


Q ss_pred             ccccccCCCC------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          221 AKVLVKGEPN------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       221 a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      ++........      ....||+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+......+
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9876443221      224568899999999654 58999999999999999998 899999888777666554321111


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                                  .+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                        344589999999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=380.46  Aligned_cols=244  Identities=20%  Similarity=0.311  Sum_probs=192.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||+||+|.+. +++.||||++..+   .+.+.+|+++++.++||||+++++++...     ..+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence            36999999999999999999975 5678999998654   34567899999999999999999988433     337899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||++ |+|.+++..   ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 566665543   246789999999999999999999996 999999999999999888 899999999987644


Q ss_pred             CCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.....            
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred             CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            332  2346789999999999665 48999999999999999999 5677776666666665544211            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                      ...+...++++.+||.+||+.||++|||++++++|
T Consensus       221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            11345578999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=391.46  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=203.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCc-----EEEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      ..+|.+.+.||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.+++++ +|||||++++++..   
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            4589999999999999999999876554     6999988543     23456899999988 89999999998843   


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeec
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD  198 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~D  198 (409)
                        ...+++|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||++ ||+|||
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRD  189 (325)
T d1rjba_         113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRD  189 (325)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred             --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence              334789999998 588887764321                   124589999999999999999999986 999999


Q ss_pred             CCCCceeecCCCCcEEEeecCCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 015298          199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLF  274 (409)
Q Consensus       199 lkp~NIli~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf  274 (409)
                      |||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+. .++.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999888 8999999999876554432   245679999999999654 48999999999999999998 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       275 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+.+..+.+.++......+                           ..+..+|+++++||.+||+.||++|||++|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9877766666655421111                           1355689999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=377.32  Aligned_cols=244  Identities=20%  Similarity=0.278  Sum_probs=204.1

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||+||+|+++ ++..||||+++..   ...+.+|+.++++++||||+++++++..     ...+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence            36899999999999999999974 7889999999754   3456789999999999999999998843     3347899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccccc
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~  226 (409)
                      |||+. |++...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 455555432   246789999999999999999999986 999999999999999887 899999999986544


Q ss_pred             CCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          227 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       227 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            332  2346789999999999654 48999999999999999998 89999998887776666542111           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                       ..+...++++.+||.+||+.||++|||+.++++|
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1345678999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=382.20  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             EeeccCCceEEEEEEEc--CCCcEEEEEEeeccc------hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEEE
Q 015298           77 RIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (409)
Q Consensus        77 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (409)
                      ++||+|+||+||+|.+.  .+++.||||++....      +.+.+|++++++++|||||++++++..     +. .+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-EEEEE
Confidence            57999999999999864  456789999985432      345689999999999999999997731     11 57999


Q ss_pred             eccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccccccC
Q 015298          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (409)
Q Consensus       149 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~~~~  227 (409)
                      ||+++ +|.+++..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.....
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            99984 67666654    57799999999999999999999996 999999999999999888 8999999999866443


Q ss_pred             CC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015298          228 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (409)
Q Consensus       228 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  302 (409)
                      ..    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+...           
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-----------  228 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-----------  228 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            22    2235688999999999654 48999999999999999998 8999998877666555543210           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH---hCCCCcc
Q 015298          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA---LIHPFFD  358 (409)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el---l~hp~f~  358 (409)
                                       ..++..+|+++.+||.+||+.||.+|||+.++   |+|+|++
T Consensus       229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                             01455689999999999999999999999998   4566653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=390.49  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=209.6

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc---CCCcEEEEEEeecc--------chhhHHHHHHHHhcCC-CCeecccceeeecC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  137 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  137 (409)
                      ..+|++++.||+|+||+||+|++.   .+|+.||||++...        .....+|++++++++| |||+++++++.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            467999999999999999999974   47899999998532        2345689999999977 89999998883   


Q ss_pred             CCCccEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEe
Q 015298          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~  216 (409)
                        +...++++|||+.+ +|...+..    .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEES
T ss_pred             --cCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCC-CEEEe
Confidence              34458899999994 66666554    56788999999999999999999986 999999999999999987 89999


Q ss_pred             ecCCccccccC--CCCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015298          217 DFGSAKVLVKG--EPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (409)
Q Consensus       217 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  293 (409)
                      |||+++.....  .......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99999765332  2234677899999999996543 47889999999999999999999998876655555554432110


Q ss_pred             CHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCC-----CHHHHhCCCCccCCCCC
Q 015298          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TALDALIHPFFDELRDP  363 (409)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~-----s~~ell~hp~f~~~~~~  363 (409)
                                               ...++..+|+++.+||++||++||.+||     |++|+++||||+++.+.
T Consensus       252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence                                     0114556899999999999999999999     58999999999987643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-52  Score=380.84  Aligned_cols=249  Identities=25%  Similarity=0.323  Sum_probs=202.4

Q ss_pred             ccceEEEEe-eccCCceEEEEEEEcC--CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERI-VGQGSFGVVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+. ||+|+||+||+|.++.  ++..||||++....     +.+.+|+++++.++|||||++++++..     +
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C
Confidence            356888884 9999999999998764  45579999986432     345689999999999999999997732     1


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                       .++||||||++ +|.+++.   .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchh
Confidence             16799999995 6666543   2246799999999999999999999996 999999999999999888 899999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015298          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (409)
Q Consensus       221 a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  295 (409)
                      ++.......    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+...    
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----  230 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----  230 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred             hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            987644322    2345678999999999654 48999999999999999998 9999998887776665543211    


Q ss_pred             HHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHH---hCCCCcc
Q 015298          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDA---LIHPFFD  358 (409)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~el---l~hp~f~  358 (409)
                                              ..++..+|+++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       231 ------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         231 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                    01455689999999999999999999999887   6788874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=376.89  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=198.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ...+|++.+.||+|+||+||+|+++.+ +.||||++....   ..+.+|+.++++++|||||++++++..     .. ++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~-~~   87 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EP-IY   87 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS-CE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CC-eE
Confidence            356899999999999999999998655 569999996543   456789999999999999999997621     11 56


Q ss_pred             EEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||+++ ++...+..  .....+++..++.++.||+.||+|||++ ||+||||||+||||+.++ .+||+|||+++..
T Consensus        88 lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~  163 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  163 (285)
T ss_dssp             EEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhhc
Confidence            89999995 45555443  2246799999999999999999999996 999999999999999887 8999999999866


Q ss_pred             ccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015298          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (409)
Q Consensus       225 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  301 (409)
                      ....  ......||+.|+|||++... .++.++|||||||++|||++|. +||......+.+..+.+....         
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------  233 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  233 (285)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             cCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence            4332  23346789999999999654 4899999999999999999965 555555555555554432111         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC--CCCccCCC
Q 015298          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI--HPFFDELR  361 (409)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~--hp~f~~~~  361 (409)
                                         ..+..+++++++||.+||+.||++|||+.++++  ++||....
T Consensus       234 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                               134568999999999999999999999999987  88997653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=373.88  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=190.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      ..+|.+.+.||+|+||.||+|.+..++   ..||||.+...     ...+.+|+.++++++||||+++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            458999999999999999999987553   56889988532     2345689999999999999999998721      


Q ss_pred             cEEEEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      ..+++||||+++ ++...+.   .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccchh
Confidence            236799999995 5544433   2356799999999999999999999996 999999999999999888 899999999


Q ss_pred             ccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015298          221 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (409)
Q Consensus       221 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  297 (409)
                      |+......  ......||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+......     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            98654332  22345678999999999654 48999999999999999998 89999988887777665542111     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                             .++..+|+++.+||.+||+.||.+|||+.++++|
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1455689999999999999999999999999876

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=370.01  Aligned_cols=243  Identities=21%  Similarity=0.278  Sum_probs=187.1

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCC----cEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCCCcc
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (409)
                      .|.+.++||+|+||+||+|.++.++    ..||||++....     ..+.+|+++++.++|||||++++++..     ..
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----YK   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----CC
Confidence            6999999999999999999987665    479999986432     245689999999999999999998843     33


Q ss_pred             EEEEEEeccchh-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCc
Q 015298          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (409)
Q Consensus       143 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a  221 (409)
                      .+++||||+.++ +...+.   .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus        83 ~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccchh
Confidence            378999999964 433333   2356799999999999999999999986 999999999999999988 8999999999


Q ss_pred             cccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHH
Q 015298          222 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL-FPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       222 ~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|||++|..| |...+..+....+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----  231 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-----  231 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----
Confidence            87644322    2235678999999999654 589999999999999999996544 555454444443332111     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                             ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       232 -----------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 -----------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                   1134567899999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=377.01  Aligned_cols=244  Identities=24%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCc----EEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCc
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (409)
                      .+|++++.||+|+||+||+|.+..+|+    .||+|.+...     .+.+.+|++++++++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999988886    5788877532     23567899999999999999999987432     


Q ss_pred             cEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~  220 (409)
                      . .+++++|+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence            2 456677766 566665443   357899999999999999999999996 999999999999999888 899999999


Q ss_pred             ccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015298          221 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (409)
Q Consensus       221 a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  296 (409)
                      |+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+....    
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred             ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9876543332   234679999999999765 48999999999999999998 89999887776655554432111    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                              ..+..+++++.+||.+||..||.+|||+.+++.|
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                    1345688999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=367.42  Aligned_cols=246  Identities=21%  Similarity=0.305  Sum_probs=197.1

Q ss_pred             ccccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEE
Q 015298           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (409)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (409)
                      ....+|++.+.||+|+||.||+|.+  +|..||||+++.+  .+.+.+|++++++++||||+++++++....    ..++
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            3445799999999999999999998  5789999999765  355678999999999999999999875322    2268


Q ss_pred             EEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCcccc
Q 015298          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (409)
Q Consensus       146 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~~  224 (409)
                      +||||++ |+|.+++....  ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus        78 lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~  153 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  153 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred             EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceec
Confidence            9999998 57777775432  34689999999999999999999986 999999999999999988 8999999999865


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC
Q 015298          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (409)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  303 (409)
                      ..  ......+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+..             
T Consensus       154 ~~--~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-------------  217 (262)
T d1byga_         154 SS--TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------  217 (262)
T ss_dssp             ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------
T ss_pred             CC--CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            33  23345678999999999764 48999999999999999998 789998887776666553311             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                     ...++..+++++.+||.+||..||.+|||+.+++++
T Consensus       218 ---------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 ---------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                           112455689999999999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=370.64  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (409)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||||++....     +...+|..++.++ .|+||+.+++++...  
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence            4579999999999999999999754     45789999986432     2334566666666 689999998876432  


Q ss_pred             CCccEEEEEEeccc-hhHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCcee
Q 015298          139 KDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (409)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIl  205 (409)
                        ...+++|||||+ |+|.+++.....            ....+++..+..++.||+.||.|||++ ||+||||||+|||
T Consensus        90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  166 (299)
T ss_dssp             --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEE
T ss_pred             --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCcccee
Confidence              233679999998 678887765432            134589999999999999999999986 9999999999999


Q ss_pred             ecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Q 015298          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVD  281 (409)
Q Consensus       206 i~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~  281 (409)
                      ++.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+....+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99888 899999999986544332   3356789999999999764 589999999999999999986 57888777666


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       282 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      .+..+......+                           ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       245 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            655554432111                           1445689999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=364.66  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=190.3

Q ss_pred             cceEEEEeeccCCceEEEEEEEcC-CC--cEEEEEEeecc-------chhhHHHHHHHHhcCCCCeecccceeeecCCCC
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLE-TG--ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (409)
                      .+|++.+.||+|+||.||+|+... ++  ..||||++.++       .+.+.+|+.+++.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            479999999999999999998653 33  36899988543       1345689999999999999999998832     


Q ss_pred             ccEEEEEEeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      . .+++||||++ +++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            1 2578999998 4555554432   45699999999999999999999996 999999999999999887 89999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015298          220 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (409)
Q Consensus       220 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  294 (409)
                      +++.......    .....|+..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+ 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            9987644432    2234567889999999764 58999999999999999998 899999988887776665421111 


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                                                ..+..+|+++.+||.+||..||++|||+.++++
T Consensus       235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                      134568999999999999999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-49  Score=367.72  Aligned_cols=248  Identities=23%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      .++|.+.+.||+|+||+||+|+++     .+++.||||++..+.     ..+.+|+++++.++||||+++++++...   
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG---   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence            457999999999999999999975     356889999986532     3467899999999999999999988443   


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeec
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFN--------------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD  198 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~D  198 (409)
                        ...+++|||+. |+|.+.+....                    .....+++..+..++.||+.||+|||++ +|||||
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence              33779999998 57777775321                    1134588999999999999999999986 999999


Q ss_pred             CCCCceeecCCCCcEEEeecCCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 015298          199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLF  274 (409)
Q Consensus       199 lkp~NIli~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf  274 (409)
                      |||+|||++.++ .+||+|||+|+......   ...+..||+.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999887 89999999998654332   22356788999999999654 4899999999999999999985 688


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       275 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .+.+..+.+..+.+...                            ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88877777666543210                            0135568999999999999999999999999954

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=371.45  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=203.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcE--EEEEEeecc-----chhhHHHHHHHHhc-CCCCeecccceeeecCCCCc
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (409)
                      -++|.+.+.||+|+||+||+|.++.+|..  ||||.+...     .+.+.+|+++|+++ +|||||++++++..     .
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~   83 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   83 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence            35899999999999999999999988874  677876432     34567899999998 79999999998854     3


Q ss_pred             cEEEEEEeccc-hhHHHHHHHh------------hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecC
Q 015298          142 LYLNLVLEYVP-ETVHRVVKHF------------NKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (409)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~  208 (409)
                      ..+++||||++ |+|.+++...            ......+++..+..++.||+.||.|||++ ||+||||||+|||++.
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  162 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcC
Confidence            34889999999 5787777542            12357799999999999999999999996 9999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHH
Q 015298          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEII  287 (409)
Q Consensus       209 ~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~  287 (409)
                      ++ .+||+|||+++............||+.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.
T Consensus       163 ~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~  240 (309)
T d1fvra_         163 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  240 (309)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            88 8999999999876655555567789999999999654 4899999999999999999965 6787777666555443


Q ss_pred             HHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      +..                            ....+..+++++.+||.+||+.||++|||+.++++|
T Consensus       241 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         241 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            311                            011345689999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-49  Score=364.21  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             cccceEEEEeeccCCceEEEEEEEcCCC-------cEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeee
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCLETG-------ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (409)
                      ...+|.+.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||++++++. 
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-   89 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   89 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence            4568999999999999999999986654       479999986543     2344677788777 8999999999884 


Q ss_pred             cCCCCccEEEEEEeccc-hhHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          136 TTDKDELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                          ++..+++||||+. |++.+++....            .....+++..++.++.||+.||+|||+. |||||||||+
T Consensus        90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~  164 (299)
T d1fgka_          90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  164 (299)
T ss_dssp             ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeeccc
Confidence                3345789999999 57777775432            1235689999999999999999999996 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (409)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|||++ |.+||.+.+
T Consensus       165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999988 899999999987655432   3346789999999999664 59999999999999999998 789998777


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       279 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+....+.... .                           ...+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~i~~~~-~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 VEELFKLLKEGH-R---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTTC-C---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCC-C---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            665544433211 1                           1145568999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=363.50  Aligned_cols=254  Identities=22%  Similarity=0.280  Sum_probs=206.1

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcC-----CCcEEEEEEeeccc-----hhhHHHHHHHHhcCCCCeecccceeeecCCC
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (409)
                      ..+|.+.+.||+|+||+||+|.++.     ++..||||++....     ..+.+|+.++++++||||+++++++..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            4689999999999999999998753     45789999996532     234689999999999999999998843    


Q ss_pred             CccEEEEEEeccc-hhHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCc
Q 015298          140 DELYLNLVLEYVP-ETVHRVVKHFNK------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (409)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~  212 (409)
                       ....++||||+. |+|.+++.....      ....++...+..++.|++.||.|||++ +|+||||||+|||++.++ +
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-C
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc-e
Confidence             233689999998 577776654321      124578899999999999999999986 999999999999999888 8


Q ss_pred             EEEeecCCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 015298          213 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIK  288 (409)
Q Consensus       213 ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~  288 (409)
                      +||+|||+++.......   .....||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986644332   2345689999999999654 489999999999999999998 588888877777666544


Q ss_pred             HhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC------CCCccC
Q 015298          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI------HPFFDE  359 (409)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~------hp~f~~  359 (409)
                      ...                            ...+..+++.+.++|.+||+.||++|||+.++++      +|+|++
T Consensus       251 ~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         251 GGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            211                            0134568899999999999999999999999987      677654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-48  Score=359.29  Aligned_cols=256  Identities=21%  Similarity=0.264  Sum_probs=198.9

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      +++|++.+.||+|+||.||+|++..+|+.||||++...  ......|+++++.++|+|++..+..+..    .....++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEE
Confidence            35799999999999999999999999999999987643  3456789999999998877666554433    23347899


Q ss_pred             EeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC--CcEEEeecCCccccc
Q 015298          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLV  225 (409)
Q Consensus       148 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~--~~ikl~Dfg~a~~~~  225 (409)
                      |||+++++...+..   ....+++..+..++.|++.||+|||++ ||+||||||+|||++..+  ..+||+|||+|+...
T Consensus        82 me~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          82 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99999887665543   356899999999999999999999996 999999999999986432  369999999998765


Q ss_pred             cCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCC
Q 015298          226 KGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG---TPT  294 (409)
Q Consensus       226 ~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---~~~  294 (409)
                      ....        .....||+.|+|||++.+. .++.++|||||||++|||+||..||......+....+.+...   .++
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            4322        2356799999999999664 489999999999999999999999987665554433322211   011


Q ss_pred             HHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHH---HHhCCCCcc
Q 015298          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAL---DALIHPFFD  358 (409)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~---ell~hp~f~  358 (409)
                      ..                        .....+|+++.+||.+||+.||.+||++.   ++|+|+|.+
T Consensus       237 ~~------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hh------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            10                        12345789999999999999999999986   457787764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=360.44  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             cccceEEEEeeccCCceEEEEEEEc-----CCCcEEEEEEeeccc-----hhhHHHHHHHHhc-CCCCeecccceeeecC
Q 015298           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (409)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (409)
                      ...+|.+.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++..  
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence            3468999999999999999999863     467899999996543     2355799999998 69999999998843  


Q ss_pred             CCCccEEEEEEeccc-hhHHHHHHHhh--------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCC
Q 015298          138 DKDELYLNLVLEYVP-ETVHRVVKHFN--------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (409)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~  202 (409)
                         ...+++|||||+ |+|...+....              .....+++..+..++.||+.||+|||++ ||+||||||+
T Consensus        99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~  174 (311)
T d1t46a_          99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (311)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecccccc
Confidence               333789999998 56777665432              1234689999999999999999999997 9999999999


Q ss_pred             ceeecCCCCcEEEeecCCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015298          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (409)
Q Consensus       203 NIli~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (409)
                      ||+++.++ .+||+|||.++........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+
T Consensus       175 NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            99999887 8999999999876543322   346789999999999654 58999999999999999998 677787777


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       279 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      ..+.+.++...-..+                           ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            766666665532111                           134567899999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-47  Score=366.89  Aligned_cols=285  Identities=28%  Similarity=0.458  Sum_probs=209.8

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc---hhhHHHHHHHHhcC-----------CCCeecccceeee
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFFS  135 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  135 (409)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            357999999999999999999999999999999997664   34467888888775           5789998887754


Q ss_pred             cCCCCccEEEEEEeccc--hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCC--
Q 015298          136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--  211 (409)
Q Consensus       136 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~--  211 (409)
                      ..   ..+.++++.++.  ++.....  .......+++..++.++.||+.||.|||+..||+||||||+|||++.++.  
T Consensus        92 ~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          92 KG---PNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EE---TTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             cc---ccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            22   223444555443  3332322  23446789999999999999999999997459999999999999976552  


Q ss_pred             ---cEEEeecCCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHH
Q 015298          212 ---QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQ  282 (409)
Q Consensus       212 ---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~  282 (409)
                         .++++|||.+.....  .....+||+.|+|||++.+. .++.++||||+||++++|++|+.||....      ..+.
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               499999999975533  34567899999999999764 48999999999999999999999997443      3456


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCccc-------cccCcccCCCCc------ccCCCCCChhHHHHHHHhcccCCCCCCCHH
Q 015298          283 LVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKAHPWH------KIFPKRMPPEAVDLVSRLLQYSPNLRCTAL  349 (409)
Q Consensus       283 ~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~s~~l~~li~~~L~~dp~~R~s~~  349 (409)
                      +......++.++...+.........       .........++.      ..+....++++.+||.+||++||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            6777788888777655332111000       011111111110      011223567899999999999999999999


Q ss_pred             HHhCCCCccCCCC
Q 015298          350 DALIHPFFDELRD  362 (409)
Q Consensus       350 ell~hp~f~~~~~  362 (409)
                      |+|+||||++...
T Consensus       324 e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         324 GLVNHPWLKDTLG  336 (362)
T ss_dssp             HHHTCGGGTTCTT
T ss_pred             HHhcCcccCCCCC
Confidence            9999999996643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=355.02  Aligned_cols=244  Identities=20%  Similarity=0.286  Sum_probs=189.3

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCC---cEEEEEEeecc-----chhhHHHHHHHHhcCCCCeecccceeeecCCCCccEE
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (409)
                      +...++||+|+||+||+|.+..++   ..||||++...     ...+.+|++++++++||||+++++++...    +..+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence            344688999999999999986643   36899998642     23467899999999999999999987543    2347


Q ss_pred             EEEEeccch-hHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCCCcEEEeecCCccc
Q 015298          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (409)
Q Consensus       145 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg~a~~  223 (409)
                      ++|||||++ ++.+++.   .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            899999995 5544443   2345678888999999999999999986 999999999999999887 899999999986


Q ss_pred             cccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 015298          224 LVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREE  297 (409)
Q Consensus       224 ~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  297 (409)
                      ......     .....||+.|+|||.+.+. .++.++|||||||++|||+||..||...... +....+...  .     
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~-----  251 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-----  251 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C-----
T ss_pred             ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            644322     2235689999999998654 4899999999999999999987777554332 222222221  0     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                                           ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       252 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ---------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 011345678999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.8e-47  Score=350.79  Aligned_cols=250  Identities=20%  Similarity=0.232  Sum_probs=199.2

Q ss_pred             ccceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcCC-CCeecccceeeecCCCCccEEEE
Q 015298           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      +++|++++.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++.     .....++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEE
Confidence            45899999999999999999999999999999988543  3456789999999976 89999988773     3445789


Q ss_pred             EEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCC----CCcEEEeecCCcc
Q 015298          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAK  222 (409)
Q Consensus       147 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~----~~~ikl~Dfg~a~  222 (409)
                      ||||++++|...+...   ...++...+..++.|++.||+|||++ ||+||||||+|||++.+    .+.+||+|||+|+
T Consensus        79 vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          79 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999999887776542   45799999999999999999999986 99999999999999742    2379999999998


Q ss_pred             ccccCC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 015298          223 VLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---DQLVEIIKVLG  291 (409)
Q Consensus       223 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~  291 (409)
                      ......        .....+||+.|||||++.+. .++.++|||||||++|+|+||..||.+....   +....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            764321        23356799999999999764 5899999999999999999999999865433   22333322211


Q ss_pred             CCCHHHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhC
Q 015298          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALI  353 (409)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~  353 (409)
                      .++...                        +...+|+++.+++..|+..+|++||+.+.+.+
T Consensus       234 ~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111111                        22347899999999999999999998776643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=349.08  Aligned_cols=267  Identities=19%  Similarity=0.183  Sum_probs=187.4

Q ss_pred             cceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccchh-hHH--HHHHHHhcCCCCeecccceeeecCCCCccEEEEE
Q 015298           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY-KNR--ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (409)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~--e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (409)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||++..+... ..+  |+..+..++||||+++++++.... .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4799999999999999999986  7899999999654322 223  444556789999999999886544 334467899


Q ss_pred             Eeccc-hhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-------cCCcEeecCCCCceeecCCCCcEEEeecC
Q 015298          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-------SIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (409)
Q Consensus       148 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------~~~ivH~Dlkp~NIli~~~~~~ikl~Dfg  219 (409)
                      ||||+ |+|...+..     ..+++..+..++.|++.||.|||.       ..||+||||||+||||+.++ .+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            99998 578777753     479999999999999999999995       13999999999999999888 89999999


Q ss_pred             CccccccCCC-----CccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015298          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (409)
Q Consensus       220 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  289 (409)
                      +++.......     .....||+.|+|||++.+..     .++.++|||||||+||||+||..||......+..... ..
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~  232 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LV  232 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TS
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cc
Confidence            9987654332     23567899999999985432     2567899999999999999999887432211000000 00


Q ss_pred             hCCCCHHHHhhcCCCccccccCcccCCCC-cccCCCCCChhHHHHHHHhcccCCCCCCCHHHHhCC
Q 015298          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPW-HKIFPKRMPPEAVDLVSRLLQYSPNLRCTALDALIH  354 (409)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~R~s~~ell~h  354 (409)
                      ...+....+....      ..... ..+. ...........+.+|+.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~------~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVV------CEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHH------TTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHH------hcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0000000000000      00000 0000 000011123468899999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.3e-25  Score=191.84  Aligned_cols=160  Identities=17%  Similarity=0.143  Sum_probs=116.4

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeeccc----------------------hhhHHHHHHHHhcCCCCeeccc
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  130 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~  130 (409)
                      |.+.++||+|+||+||+|.+. +|+.||||++....                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999974 78999999874211                      1123578888999999998876


Q ss_pred             ceeeecCCCCccEEEEEEeccchhHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCceeecCCC
Q 015298          131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (409)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ivH~Dlkp~NIli~~~~  210 (409)
                      ++.     .    .+++|||+++...          ..++...+..++.|++.+|.|||++ ||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            542     2    2589999997421          2245555678899999999999986 99999999999999954 


Q ss_pred             CcEEEeecCCccccccCCCCccccccccccc------cccccCCCCCCchhhHHHHHHHH
Q 015298          211 HQVKLCDFGSAKVLVKGEPNISYICSRYYRA------PELIFGATEYTTAIDIWSAGCVV  264 (409)
Q Consensus       211 ~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~~~DiwslG~il  264 (409)
                       .++|+|||+|........       ..|..      .+.+ . ..|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGW-------REILERDVRNIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence             599999999975432211       01111      1222 1 3478899999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.17  E-value=4.5e-06  Score=72.91  Aligned_cols=76  Identities=17%  Similarity=0.124  Sum_probs=49.5

Q ss_pred             ceEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc----chhhHHHHHHHHhcC-CCCeecccceeeecCCCCccEEEE
Q 015298           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (409)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (409)
                      .|+..+..+.++.+.||+..  .++..+++|+....    .....+|...++.+. +--+.+++.+.     ......++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            57777776656667899876  36677888987543    234568888888774 32244554433     22234678


Q ss_pred             EEeccchh
Q 015298          147 VLEYVPET  154 (409)
Q Consensus       147 v~e~~~~~  154 (409)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999873

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.82  E-value=5.4e-05  Score=70.20  Aligned_cols=71  Identities=17%  Similarity=0.144  Sum_probs=43.3

Q ss_pred             EEeeccCCceEEEEEEEcCCCcEEEEEEeecc-----------chhhHHHHHHHHhcC-C--CCeecccceeeecCCCCc
Q 015298           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTDKDE  141 (409)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~  141 (409)
                      .+.||.|....||++.+..+|+.+++|.-...           ......|.+.|+.+. +  ..+++++.+  .   ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            45689999999999998778889999965321           122356888887763 2  234444332  1   111


Q ss_pred             cEEEEEEeccch
Q 015298          142 LYLNLVLEYVPE  153 (409)
Q Consensus       142 ~~~~lv~e~~~~  153 (409)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2579999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.78  E-value=5.8e-05  Score=65.19  Aligned_cols=68  Identities=16%  Similarity=0.127  Sum_probs=42.9

Q ss_pred             ccCC-ceEEEEEEEcCCCcEEEEEEeeccc-hhhHHHHHHHHhcCCCC--eecccceeeecCCCCccEEEEEEeccch
Q 015298           80 GQGS-FGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (409)
Q Consensus        80 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (409)
                      ..|. -+.||+... ..+..+++|...... ....+|...++.+....  +.+++.+..     +....++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            3444 467898874 456678889775443 34678898888774333  444544332     22336789999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.78  E-value=0.0038  Score=57.23  Aligned_cols=70  Identities=17%  Similarity=0.222  Sum_probs=44.8

Q ss_pred             EEEeeccCCceEEEEEEEcC-------CCcEEEEEEeeccc--hhhHHHHHHHHhcCCCCe-ecccceeeecCCCCccEE
Q 015298           75 AERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYL  144 (409)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  144 (409)
                      .++.|+.|-.-.+|++....       .++.|.+++.-...  ....+|..+++.+.-.++ +++++++     .+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----
Confidence            34578888889999988643       34567777764322  234578888888743333 4555544     21    


Q ss_pred             EEEEeccch
Q 015298          145 NLVLEYVPE  153 (409)
Q Consensus       145 ~lv~e~~~~  153 (409)
                      .+|++|++|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            468898875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.48  E-value=0.0077  Score=53.53  Aligned_cols=69  Identities=16%  Similarity=-0.048  Sum_probs=39.7

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeecc---chhhHHHHHHHHhcCCCCee--cccceeeecCCCCccEEEEEEeccch
Q 015298           84 FGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVV--SLKHCFFSTTDKDELYLNLVLEYVPE  153 (409)
Q Consensus        84 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (409)
                      -..||++.. .+|..|++|+....   ...+..|...+..|....+.  ..+..--........+.+.+++++.|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            468999884 57889999998653   34466788888777432221  11110000000123346678888864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.36  E-value=0.014  Score=51.45  Aligned_cols=48  Identities=15%  Similarity=0.056  Sum_probs=30.5

Q ss_pred             eEEEEeeccCCceEEEEEEEcCCCcEEEEEEeecc--chhhHHHHHHHHhcC
Q 015298           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD  122 (409)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~  122 (409)
                      ..-.+.|..|---+.|+...  ++..+++|++...  ......|++++..|.
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             EEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             ceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            44456677888889999875  3345899998543  345567888888774